
<html lang="en"     class="pb-page"  data-request-id="af097cf1-8a2e-42c0-a4c2-1db414cc0125"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-11;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b01761;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Drug Discovery Targeting Bromodomain-Containing Protein 4" /></meta><meta name="dc.Creator" content="Zhiqing  Liu" /></meta><meta name="dc.Creator" content="Pingyuan  Wang" /></meta><meta name="dc.Creator" content="Haiying  Chen" /></meta><meta name="dc.Creator" content="Eric A.  Wold" /></meta><meta name="dc.Creator" content="Bing  Tian" /></meta><meta name="dc.Creator" content="Allan R.  Brasier" /></meta><meta name="dc.Creator" content="Jia  Zhou" /></meta><meta name="dc.Description" content="BRD4, the most extensively studied member of the BET family, is an epigenetic regulator that localizes to DNA via binding to acetylated histones and controls the expression of therapeutically impor..." /></meta><meta name="Description" content="BRD4, the most extensively studied member of the BET family, is an epigenetic regulator that localizes to DNA via binding to acetylated histones and controls the expression of therapeutically impor..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 2, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01761" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01761" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01761" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01761" /></link>
        
    
    

<title>Drug Discovery Targeting Bromodomain-Containing Protein 4 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01761" /></meta><meta property="og:title" content="Drug Discovery Targeting Bromodomain-Containing Protein 4" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0001.jpeg" /></meta><meta property="og:description" content="BRD4, the most extensively studied member of the BET family, is an epigenetic regulator that localizes to DNA via binding to acetylated histones and controls the expression of therapeutically important gene regulatory networks through the recruitment of transcription factors to form mediator complexes, phosphorylating RNA polymerase II, and by its intrinsic histone acetyltransferase activity. Disrupting the protein–protein interactions between BRD4 and acetyl-lysine has been shown to effectively block cell proliferation in cancer, cytokine production in acute inflammation, and so forth. To date, significant efforts have been devoted to the development of BRD4 inhibitors, and consequently, a dozen have progressed to human clinical trials. Herein, we summarize the advances in drug discovery and development of BRD4 inhibitors by focusing on their chemotypes, in vitro and in vivo activity, selectivity, relevant mechanisms of action, and therapeutic potential. Opportunities and challenges to achieve selective and efficacious BRD4 inhibitors as a viable therapeutic strategy for human diseases are also highlighted." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01761"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01761">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01761&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01761&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01761&amp;href=/doi/10.1021/acs.jmedchem.6b01761" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4533-4558</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01351" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00408" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Drug Discovery Targeting Bromodomain-Containing Protein 4</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqing++Liu">Zhiqing Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pingyuan++Wang">Pingyuan Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haiying++Chen">Haiying Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+A.++Wold">Eric A. Wold</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Tian">Bing Tian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>ξ</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan+R.++Brasier">Allan R. Brasier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>ξ</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Zhou">Jia Zhou</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>ξ</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Chemical Biology Program, Department of Pharmacology and Toxicology, <sup>‡</sup>Department of Internal Medicine, <sup>§</sup>Sealy Center for Molecular Medicine, <sup>ξ</sup>Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: +1 (409) 772-9748; Fax: +1 (409) 772-9648; E-mail: <a href="/cdn-cgi/l/email-protection#86eceffceee9f3c6f3f2ebe4a8e3e2f3"><span class="__cf_email__" data-cfemail="6802011200071d281d1c050a460d0c1d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01761&amp;href=/doi/10.1021%2Facs.jmedchem.6b01761" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4533–4558</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 14, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 December 2016</li><li><span class="item_label"><b>Published</b> online</span>2 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 June 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01761" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01761</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01761"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">11215</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">140</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01761" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Drug Discovery Targeting Bromodomain-Containing Protein 4&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhiqing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Pingyuan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Haiying&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;A. Wold&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;R. Brasier&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Zhou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;4533-4558&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01761&quot;},&quot;abstract&quot;:&quot;BRD4, the most extensively studied member of the BET family, is an epigenetic regulator that localizes to DNA via binding to acetylated histones and controls the expression of therapeutically important gene regulatory networks through the recruitment of transcription factors to form mediator complexes, phosphorylating RNA polymerase II, and by its intrinsic histone acetyltransferase activity. Disrupting the protein–protein interactions between BRD4 and acetyl-lysine has been shown to effectively block cell proliferation in cancer, cytokine production in acute inflammation, and so forth. To date, significant efforts have been devoted to the development of BRD4 inhibitors, and consequently, a dozen have progressed to human clinical trials. Herein, we summarize the advances in drug discovery and development of BRD4 inhibitors by focusing on their chemotypes, in vitro and in vivo activity, selectivity, relevant mechanisms of action, and therapeutic potential. Opportunities and challenges to achieve selective and &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01761&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01761" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01761&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01761" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01761&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01761" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01761&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01761&amp;href=/doi/10.1021/acs.jmedchem.6b01761" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01761" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01761" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01761%26sid%3Dliteratum%253Aachs%26pmid%3D28195723%26genre%3Darticle%26aulast%3DLiu%26date%3D2017%26atitle%3DDrug%2BDiscovery%2BTargeting%2BBromodomain-Containing%2BProtein%2B4%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D11%26spage%3D4533%26epage%3D4558%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/jmcmar.2017.60.issue-11/20170608/jmcmar.2017.60.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">BRD4, the most extensively studied member of the BET family, is an epigenetic regulator that localizes to DNA via binding to acetylated histones and controls the expression of therapeutically important gene regulatory networks through the recruitment of transcription factors to form mediator complexes, phosphorylating RNA polymerase II, and by its intrinsic histone acetyltransferase activity. Disrupting the protein–protein interactions between BRD4 and acetyl-lysine has been shown to effectively block cell proliferation in cancer, cytokine production in acute inflammation, and so forth. To date, significant efforts have been devoted to the development of BRD4 inhibitors, and consequently, a dozen have progressed to human clinical trials. Herein, we summarize the advances in drug discovery and development of BRD4 inhibitors by focusing on their chemotypes, in vitro and in vivo activity, selectivity, relevant mechanisms of action, and therapeutic potential. Opportunities and challenges to achieve selective and efficacious BRD4 inhibitors as a viable therapeutic strategy for human diseases are also highlighted.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chemical modifications of DNA (e.g., methylation of cytosine) and the chromosomal DNA-packing histone modifications (e.g., acetylation, methylation, phosphorylation, and ubiquitination) dictate the epigenetic regulation of gene activation and silencing in response to physiological and environmental stimuli.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Histone modification, a covalent posttranslational modification (PTM), has led to a well-established “histone code” hypothesis and an epigenetic mechanism for the regulation of a variety of normal and disease-related processes.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Acetylation of a histone lysine residue<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> was historically considered a hallmark of transcriptionally active genes.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> On the one hand, lysine acetylation can neutralize its positive charge leading to reduced affinity of histones for negatively charged DNA or disruption of nucleosome packing and ultimately to an open, accessible chromatin structure that is able to recruit transcriptional machinery.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> On the other hand, acetylated lysine provides binding sites for protein recognition modules. The large number (over 24,000) of lysine acetylations in human cells and frequent occurrence indicate that lysine acetylation plays important roles in signal transduction and signaling networks.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The ε-<i>N</i>-lysine acetylation (KAc) motifs can be recognized by bromodomains<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> as well as double plant homeodomain (PHD) fingers<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and pleckstrin homology domains.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Meanwhile, bromodomains exclusively recognize acetylation motifs. The bromodomain-containing proteins (BCPs) can thus act as KAc “readers” of modified histones mediating signaling transduction to changes in gene regulatory networks.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> These readers result in epigenetic modification of target genes through intrinsic histone acetyl transferase or kinase activity or by their ability to serve as scaffolds for assembly of chromatin-modifying enzymes. In the human genome, there are 61 bromodomains found within 46 proteins that can be divided into eight families based on structure/sequence similarity (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Among them, bromodomain and extra-terminal domain (BET) family (highlighted in green, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) bromodomains recognize acetylated lysine residues in histones H3 and H4.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Disrupting the protein–protein interactions between BET protein and acetylated lysine represents a promising target for human diseases including cancer and inflammation.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> BET family members have recently attracted increasing attention in drug discovery and are considered to be the most druggable target proteins among BCPs for regulating cellular epigenetics.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Eight families of bromodomain-containing proteins. Bromodomain-containing protein 4 (BRD4, highlighted in magenta) belongs to the BET family (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The BET family is composed of bromodomain-containing protein 2 (BRD2), BRD3, BRD4, and bromodomain testis-specific protein (BRDT). They share two N-terminal bromodomains and an extra C-terminal domain (ET) exhibiting high levels of sequence conservation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Normally, BET family proteins all localize in the nucleus<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and recruit transcriptional regulatory complexes to acetylated chromatin, thus being implicated in a number of DNA-centered processes including regulation of gene expression. Unlike other BCPs, which are typically displaced from condensed chromosomes during mitosis, BET proteins are able to associate with mitotic chromosomes.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> BRD2, BRD3, and BRD4 are ubiquitously expressed, whereas BRDT is a tissue-specific isoform expressed in pachytene spermatocytes, diplotene spermatocytes, and round spermatids.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Although their bromodomains share highly similar sequences of amino acids, BET family members recruit different partners. BRD4 recruits positive transcriptional elongation factor complex (P-TEFb), which plays an essential role in the regulation of transcription by RNA polymerase II (RNA Pol II) in eukaryotes.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In addition, the BRD4 ET domain recruits transcription-modifying factors (e.g., NSD3, a SET domain-containing histone methyltransferase) independently.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> BRD3 was reported to function in the recruitment of hematopoietic transcription factor GATA1 by regulating maturation of erythroid, megakaryocyte, and mast cell lineages.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> BRD2 exerts its function via the E2F transcription factor/retinoblastoma pathway in a P-TEFb-independent manner.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Under normal conditions, BRD2/3/4 perform transcription regulatory functions, and their dysfunction plays critical roles in a variety of human diseases.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Over the past decade, the number of small-molecule BET inhibitors has expanded dramatically. These inhibitors act as useful chemical probes for exploring the biological functions of BET proteins. Some of them (chemical structures shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) have been enrolled into different phases of human clinical trials (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), including RVX-208/Apabetalone (<b>1</b>),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> I-BET762/GSK-525762A (<b>2</b>),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> OTX-015/MK8628 (<b>3</b>),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> CPI-0610 (<b>4</b>),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> TEN-010 (<b>5</b>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and ABBV-075 (<b>6</b>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Most of their clinical investigations are focused on cancer therapies.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of selected BET inhibitors that are currently being evaluated in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. BET Inhibitors in Clinical Trials<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char=" " /></col><col align="left" /></col><col align="char" char=" " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug</th><th class="colsep0 rowsep0" align="center">sponsor</th><th class="colsep0 rowsep0" align="center" char=" ">phase</th><th class="colsep0 rowsep0" align="center">indications</th><th class="colsep0 rowsep0" align="center" char=" ">NCT identifier</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left"><b>1</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></td><td class="colsep0 rowsep0" rowspan="6" align="left">Resverlogix Corp</td><td class="colsep0 rowsep0" align="char" char=" ">III</td><td class="colsep0 rowsep0" align="left">T2DM; CAD; CVDs</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02586155</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">II</td><td class="colsep0 rowsep0" align="left">diabetes</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01728467</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">II</td><td class="colsep0 rowsep0" align="left">atherosclerosis; CAD</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01058018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">II</td><td class="colsep0 rowsep0" align="left">CAD; dyslipidemia</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01423188</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">II</td><td class="colsep0 rowsep0" align="left">CAD</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01067820</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I/II</td><td class="colsep0 rowsep0" align="left">dyslipidemia; atherosclerosis; ACS; CVDs</td><td class="colsep0 rowsep0" align="char" char=" ">NCT00768274</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left"><b>2</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></td><td class="colsep0 rowsep0" rowspan="4" align="left">GlaxoSmithKline</td><td class="colsep0 rowsep0" align="char" char=" ">II</td><td class="colsep0 rowsep0" align="left">ER+ breast cancer</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02964507</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">RRHMs</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01943851</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">NMC and other cancers</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01587703</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">drug interactions</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02706535</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>3</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></td><td class="colsep0 rowsep0" rowspan="2" align="left">OncoEthix GmbH</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">AML; DLBCL; ALL; MM</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01713582</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">NMC; TNBC; NSCLC; CRPC; PDAC</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02259114</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"> </td><td class="colsep0 rowsep0" rowspan="2" align="left">Merck Sharp and Dohme Corp.</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">AML; DLBCL</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02698189</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">NMC; TNBC; NSCLC; CRPC</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02698176</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><b>4</b><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></td><td class="colsep0 rowsep0" rowspan="3" align="left">Constellation</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">lymphoma</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01949883</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">MM</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02157636</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">AML; MDS; MDS/MPN, U; myelofibrosis</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02158858</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>5</b><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></td><td class="colsep0 rowsep0" rowspan="2" align="left">Hoffmann-La Roche</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">solid tumors; AST</td><td class="colsep0 rowsep0" align="char" char=" ">NCT01987362</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">MDS; AML</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02308761</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></td><td class="colsep0 rowsep0" align="left">AbbVie</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">advanced cancer; breast cancer; NSCLC; AML; MM</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02391480</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BI 894999<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Boehringer Ingelheim</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">neoplasms</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02516553</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMS-986158<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Bristol-Myers Squibb</td><td class="colsep0 rowsep0" align="char" char=" ">I/II</td><td class="colsep0 rowsep0" align="left">AST</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02419417</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FT-1101<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Forma Therapeutics</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">AML; MDS</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02543879</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INCB054329<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="char" char=" ">I/II</td><td class="colsep0 rowsep0" align="left">advanced malignancies</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02431260</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK2820151<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">GlaxoSmithKline</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">AST; RST</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02630251</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ZEN-3694<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Zenith Epigenetics</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">metastatic CRPC</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02711956/NCT02705469</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">GS-5829<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" rowspan="2" align="left">Gilead Sciences</td><td class="colsep0 rowsep0" align="char" char=" ">I/II</td><td class="colsep0 rowsep0" align="left">metastatic CRPC</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02607228</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">solid tumors; lymphomas</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02392611</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>N</i>-methyl-2-pyrrolidone (NMP)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td><td class="colsep0 rowsep0" align="left">Peter MacCallum Cancer Centre</td><td class="colsep0 rowsep0" align="char" char=" ">I</td><td class="colsep0 rowsep0" align="left">RRMM</td><td class="colsep0 rowsep0" align="char" char=" ">NCT02468687</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data collected from <a href="http://www.clinicaltrials.com" class="extLink">www.clinicaltrials.com</a> on Nov 19, 2016. Abbreviations: ACS, acute coronary syndrome; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; AST, advanced solid tumors; CAD, coronary artery disease; CRPC, castration-resistant prostate cancer; CVDs, cardiovascular diseases; DLBCL, diffuse large B-cell lymphoma; ER+ breast cancer, estrogen receptor-positive breast cancer; MDS, myelodysplastic syndrome; MM, multiple myeloma; MDS/MPN, U, myelodysplastic/myeloproliferative neoplasm, unclassifiable; NMC, NUT midline carcinoma; NMP, <i>N</i>-methyl-2-pyrrolidone; NSCLC, nonsmall cell lung cancer; PDAC, pancreatic ductal adenocarcinoma; RRHMs, relapsed refractory hematologic malignancies; RRMM, relapsed refractory multiple myeloma; RST, recurrent solid tumors; T2DM, type 2 diabetes mellitus; TNBC, triple negative breast cancer.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Structures are not disclosed.</p></div></div></div><div class="NLM_p last">As the most extensively characterized BET protein, BRD4 has been implicated in a number of human diseases including cancer, inflammation, cardiovascular diseases, central nervous system (CNS) disorders, and human immunodeficiency virus (HIV) infection.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> BRD4 represents a promising therapeutic target for various diseases, and targeting BRD4 has attracted significant interest in both pharmaceutical and academic settings. Herein, we mainly focus on summarizing the advances in the drug discovery and development of BRD4 inhibitors, and opportunities and challenges associated with this field are also discussed.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2 BRD4 as a Novel Therapeutic Target: Structures and Disease-Associated Functions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1 Structures of BRD4 Bromodomains</h3><div class="NLM_p">BRD4, originally named mitotic chromosomal-associated protein (MCAP) and also called Fshrg4 or Hunk1, was identified in 1988 from studies on the mammalian mediator complex, a multiprotein coactivator that links transcription factors to RNA Pol II activation.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> It has three isoforms of different length: one long isoform (1362 residues) and two shorter forms (722 and 796 residues, respectively).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> BRD4 contains two highly conserved N-terminal bromodomains (BD1 and BD2), an ET domain, and a C-terminal domain (CTD) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). BRD4 BD1 and BRD4 BD2 interact with acetylated chromatin as well as nonhistone proteins to regulate transcription, DNA replication, cell cycle progression, and other cellular activities.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Despite their sequence similarity (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b), BD1 and BD2 appear to have distinct functions due to their interactions with different lysine-acetylated histones (e.g., H3 and H4) or with transcriptional proteins. BRD4 BD1 binds to the diacetylated H4K5AcK8Ac mark to anchor its associated proteins to the target gene promoter and enhancer sites in chromatin. BRD4 BD2 does not interact with singly acetylated H3K4ac but displays a strong interaction with diacetylated H3K4AcK9Ac.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In addition, BRD4 BD2 is associated with the recruitment of nonhistone proteins (e.g., Twist).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Each BD of BRD4 is composed of a left-handed bundle of four helices (α<sub>Z</sub>, α<sub>A</sub>, α<sub>B</sub>, and α<sub>C</sub>) linked by the interhelical ZA loop and BC loop, which constitute the active acetyl-lysine binding pocket (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>c).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The specific residues (e.g., Gln85 of BD1 vs Lys383 of BD2, and Asp144 of BD1 vs His442 of BD2; highlighted by different colors in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b) within the loops of each BD contribute to determining the acetyl-lysine binding specificity. The cocrystal structure of BRD4 BD1 with histone H4K8Ac12Ac (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>c) indicates that the acetyl-lysine is recognized by a central hydrophobic cavity and anchored by a hydrogen bond with asparagine residue 140 (Asn140).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Additionally, a second interaction is formed between the acetyl carbonyl oxygen atom and the conserved Tyr97 via a water molecule. Most BRD4 inhibitors block the interactions between BRD4 and acetyl-lysine by mimicking acetyl-lysine and competing with it to bind BRD4. They all have a unique head moiety that can form critical hydrogen bonds with Asn140 and Tyr 97 like the O atom of the acetyl group does. In addition, a small hydrophobic group is usually attached to the moiety that can mimic the methyl group of acetyl to occupy the base of the pocket. Meanwhile, their interactions with “WPF shelf” (W81, P82, F83), a hydrophobic region of the BC loop that includes conserved Trp/Pro/Phe motif present in all of the BET family bromodomains, are also important for BRD4 binding affinities.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Domain organization of the long form of BRD4. (b) Conserved sequences of BRD4 BD1 and BRD4 BD2. The important critical residues that may contribute to the acetyl-lysine binding specificity are highlighted in different colors. (c) (left panel) Ribbon representation of BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UW9">3UW9</a>). (right panel) Surface representation of the KAc binding pocket of BRD4 BD1. Asn140 is highlighted in red, and the WPF shelf is highlighted in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2 Disease-Related Functions of BRD4</h3><div class="NLM_p">BRD4 plays an important role in cell cycle control of normal mammalian cells, affecting cellular processes including cell proliferation, apoptosis, and transcription.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Microinjection of a BRD4-specific antibody into HeLa cell nuclei can lead to cell cycle arrest, indicating that BRD4 is required for the G2-M phase transition.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Moreover, BRD4 is essential for the expression of Aurora B kinase, which is responsible for chromosome separation and cytokinesis during mitosis.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> BRD4 recruits transcriptional regulatory complexes to chromatin through various protein–protein interactions (e.g., acetylated histones, transcriptional factors, mediators, P-TEFb) mediated by its bromodomains as well as ET and CTD domains. BET inhibition exhibits effective therapeutic activity in a number of different pathologies, especially in models of cancer and inflammation (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Meanwhile, pharmacological BET inhibition also influences other organ systems such as cardiovascular and the CNS.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed action modes of BRD4 in selected diseases such as cancer, inflammation, and HPV. (left panel) Interaction of Twist and BRD4 at the enhancer/promoter of <i>WNT5A</i>, leading to the transcriptional activation of <i>WNT5A</i> expression in BLBC. (center panel) Interaction of RelA and BRD4, facilitating the transcription of NF-κB-dependent inflammatory genes. (right panel) BRD4 serves as the receptor of the E2/viral DNA complex on mitotic chromosomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Through interactions with cyclin T1 and CDK9 (a validated CLL target),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> BRD4 recruits P-TEFb<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> to mitotic chromosomes resulting in increased expression of growth-promoting genes.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Chromosomal translocation of BRD4 to the nuclear protein in the testis (NUT) locus generates a BRD4-NUT fusion protein that results in <i>c-MYC</i> overexpression and NUT midline carcinoma (NMC), an aggressive squamous cell malignancy unresponsive to conventional chemotherapeutics.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> BET inhibition downregulates <i>MYC</i> transcription and subsequent genome-wide MYC-dependent target genes.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Given the widespread pathogenetic role of <i>MYC</i> in cancers, pharmacological inhibition of <i>MYC</i> through the BET bromodomain holds great promise for the treatment of cancer.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> BRD4 inhibitor (+)-JQ1 (<b>7</b>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) is highly efficacious against NMC tumor growth in xenografted mice.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> BRD4 can also physically interact with androgen receptor (AR), and disruption of this interaction by a BET inhibitor can abrogate BRD4 localization to AR target loci and AR-mediated gene transcription. Interestingly, BET inhibition was found to be more efficacious in tumor reduction of CRPC in xenograft mouse models than direct AR antagonism.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Moreover, the diacetylated Twist protein binds the second domain of BRD4 and recruits the associated P-TEFb/RNA-Pol II to the WNT5A super enhancer to directly activate WNT5A expression, which is required for invasion and maintenance of cancer stem cell-like properties of basal-like breast cancer (BLBC) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, left panel).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Furthermore, BRD4 is amplified and overexpressed in a substantial subset of melanoma specimens and cell lines.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Treatment with compound <b>7</b> attenuates melanoma proliferation in vitro and impairs melanoma tumor growth in vivo, effects that can be mostly recapitulated by individual silencing of BRD4. RNAi screens have also identified BRD4 as a therapeutic target in acute myeloid leukemia (AML) and ovarian carcinoma.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> BRD4 is reported to play important roles in various other types of cancer proliferation, such as the activated B-cell-like subtype (ABC) of diffuse large B-cell lymphoma (DLBCL),<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> neuroblastoma,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> and lung adenocarcinoma.<a onclick="showRef(event, 'ref66 ref75'); return false;" href="javascript:void(0);" class="ref ref66 ref75">(66, 75)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Chemical structures of compounds <b>7</b> and <b>8</b>. (b) Cocrystal structure of <b>7</b> with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF">3MXF</a>). Residues Asn140 (N140), Tyr97 (Y97), Leu94 (L94), Val87 (V87), and Leu92 (L92) are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">BRD4 was found to be required for transcriptional coactivation of NF-κB, regulating the transcription of P-TEFb-dependent proinflammatory target genes. Specific binding of BRD4 with acetylated lysine-310 of RelA is proposed as a mechanism for the recruitment of NF-κB (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, center panel).<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a> BRD4 is highly enriched at enhancers associated with genes involved in multiple profibrotic pathways, where BRD4 is colocalized with profibrotic transcription factors. BRD4 inhibitors can not only abrogate cytokine-induced activation of hepatic stellate cells but also reverse the fibrotic response in carbon tetrachloride-induced fibrosis in mouse models.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> BRD4 inhibition can also attenuate experimental lung fibrosis induced by repetitive TGF-β challenge in a mouse model via the NF-κB/RelA signaling pathway.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> As a synthetic histone mimic, compound <b>2</b> was found to suppress inflammation in an LPS-induced C57BL mouse model, suggesting that targeting inflammatory gene expression by interfering with the recognition of acetylated histones by BET inhibitors is a new approach for treating inflammatory conditions.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> siRNA knockdown of BRD4 can induce upregulation of apolipoprotein A (ApoA1), which protects from atherosclerosis progression and other inflammatory processes.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> BRD4 is essential for IL-1β-induced inflammation in human airway epithelial cells, and BRD4 knockdown markedly reduces IL-6 and CXCL8 release, suggesting that BRD4 is a promising target for chronic obstructive pulmonary disease.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Pharmacological BRD4 inhibition can attenuate the enhanced migration, proliferation, and IL-6 release in lung fibroblasts from patients with rapidly progressing idiopathic pulmonary fibrosis. For example, compound <b>7</b> suppresses bleomycin-induced lung fibrosis in mice, indicating that BRD4 inhibitors may hold great promise for the treatment of rapidly progressing idiopathic pulmonary fibrosis.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a></div><div class="NLM_p">BET family proteins play a central role in gene control during heart failure pathogenesis. BET inhibition blocks cardiomyocyte hypertrophy in vitro and suppresses pathologic cardiac remodeling in vivo.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Compound <b>1</b> increases ApoA1 and HDL-C in vitro and in vivo, which are potential therapeutic targets for reducing atherosclerotic disease.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> In addition, BET family expression is increased during cardiac hypertrophy, which is an independent predictor of adverse outcomes in patients with heart failure. Compound <b>7</b> can block agonist-dependent hypertrophy of cultured neonatal rat ventricular myocytes and reverse the prototypical gene program associated with pathological cardiac hypertrophy.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p">In the CNS, BRD4 may mediate the transcriptional regulation underlying learning and memory, and the loss of BRD4 function affects critical synaptic proteins, leading to memory deficits in mice but also decreased seizure susceptibility.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> This study suggests that, on one hand, BRD4 inhibitors that can cross the blood-brain barrier (BBB) may pose a risk for neurological side effects, whereas on the other hand, they may possess therapeutic potential for epilepsy. BRD4 is significantly elevated in the nucleus accumbens (NAc) of mice and rats following repeated cocaine injections and self-administration.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Moreover, BRD4 inhibition by BET inhibitors attenuates transcriptional and behavioral responses to cocaine. Repeated cocaine injections enhance the binding of BRD4 to the promoter region of <i>Bdnf</i> in the NAc, whereas treatment with BRD4 inhibitors or siRNA-mediated knockdown of BRD4 reduces the expression of <i>Bdnf</i>. These findings indicate that BRD4 is a possible therapeutic target for the treatment of drug addiction. Interestingly, selective inhibition of the first domain of BET protein accelerates the progression of mouse primary oligodendrocyte progenitors toward differentiation, whereas blocking both bromodomains hinders differentiation.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> This suggests that selective modulation of BET bromodomains may enhance regenerative strategies in disorders characterized by myelin loss such as aging and neurodegeneration.</div><div class="NLM_p last">Knockdown experiments have implicated BRD4 in the transcriptional regulation of viruses such as HIV<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and Epstein–Barr virus (EBV)<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> as well as degradation of human papilloma virus (HPV).<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91, 92)</a> The bovine papillomavirus E2 protein binding to the CTD of BRD4 tethers the viral DNA to host mitotic chromosomes (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, right panel).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Disrupting the E2/BRD4 interaction can inhibit viral transformation, providing a new target for the treatment or prevention of HPV infections and related diseases. Bromodomains are linked to diverse aspects of the HIV life cycle, including transcription and integration.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Binding of the BRD4 CTD domain with P-TEFb disrupts the interaction between the HIV transactivator Tat and P-TEFb, thereby suppressing the ability of Tat to transactivate the HIV promoter.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> As a negative regulator of HIV-1 replication, BRD4 was found to increase proviral transcriptional elongation and alleviate HIV-1 latency in cell-line models. Both compounds <b>3</b> and <b>7</b> were reported to reactivate latent HIV, suggesting their potential for eliminating latent HIV-1 reservoirs, which is a major hurdle to a complete cure for AIDS.<a onclick="showRef(event, 'ref96 ref97 ref98 ref99 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref96 ref97 ref98 ref99 ref100 ref101">(96-101)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3 Discovery and Development of BRD4 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Given the extensive disease-related functions of BRD4 and proof-of-concept of disrupting the BRD4–acetyl-lysine interactions as a therapeutic target, significant efforts have thus been made to develop BRD4 inhibitors from both pharmaceutical and academic settings. Various discovery strategies have been utilized including high-throughput screening (HTS), midthroughput screening (MTS), virtual screening (VS), fragment-based drug design (FBDD), and structure-based drug design (SBDD) as well as drug repurposing. On the basis of their core scaffolds, the reported BRD4 inhibitors are chemically classified into several series including azepines, 3,5-dimethylisoxazoles, pyridones, triazolopyrazines, tetrahydroquinolines (THQs), 4-acyl pyrroles, 2-thiazolidinones, and so forth and are discussed below. These compounds show inhibitory effects on BRD4 either in vitro and/or in vivo with selectivity reported at various levels. Given the similarity of bromodomains across over 40 diverse proteins, the selectivity of BRD4 inhibitors can be classified into three categories. The first category is to selectively inhibit BET family proteins over other BCP families. The second category of selectivity is to target BD1 or BD2 of BET proteins. The third category is to specifically inhibit BRD4 BD1 or BRD4 BD2.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.1 Pan-BET BRD4 Inhibitors</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">3.1.1 Azepines</h4><div class="NLM_p">Compound <b>7</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a) is one of the first reported BET inhibitors and has now become a widely used chemical probe for exploring the mechanisms and functions of BRD4. Its design is based on molecular modeling and the observation that thienodiazepines possess binding activity for BRD4.<a onclick="showRef(event, 'ref68 ref102'); return false;" href="javascript:void(0);" class="ref ref68 ref102">(68, 102)</a> Thienodiazepines (reported by Mitsubishi Tanabe) were originally identified as anti-inflammatory or antiadhesion molecules from phenotypic efforts without prior knowledge of the target.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> In a binding assay based on differential scanning fluorimetry, binding of <b>7</b> significantly increases the thermal stability of all bromodomains of BET family with Δ<i>T</i><sub>m</sub><sup>obs</sup> values between 4.2 °C (BRDT BD1) and 10 °C (BRD4 BD1), whereas no obvious stability shifts are detected for bromodomains outside the BET family. Its stereoisomer (−)-JQ1 (<b>8</b>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a) displays no significant interactions with any bromodomains.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>7</b> is competitive with a tetra-acetylated histone H4 peptide with IC<sub>50</sub> values of 77 nM for BRD4 BD1 and 33 nM for BRD4 BD2. The cocrystal structure of <b>7</b> with BRD4 BD1 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b) reveals that it binds directly to the KAc binding site and shows extraordinary shape complementarity. One N atom of the triazole moiety mimics the O atom of the acetyl group to form a critical hydrogen bond with Asn140, and the methyl group attached to triazole acts exactly like the methyl group of acetyl-lysine. Ligand binding is stabilized by hydrophobic interactions with conserved residues in the ZA and BC loop (e.g., Leu 92, Leu 94, Val 87, and Tyr 97). Docking of <b>8</b> to BRD4 BD1 results in an energetically unfavorable conformation due to steric clashes with Leu92 and Leu94.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>7</b> displaces BRD4 from nuclear chromatin and results in differentiation and growth arrest of NMC cells. In vivo proof-of-concept for targeting BRD4 with compound <b>7</b> was also established via several xenograft models of NMC including clinically relevant disease models in mice. Although compound <b>7</b> is not being evaluated in human clinical trials due to a short half-life, it is widely used as a chemical probe in laboratory applications.<a onclick="showRef(event, 'ref104 ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref104 ref105 ref106">(104-106)</a> Furthermore, it provides a good lead compound for the subsequent optimization work on azepines.</div><div class="NLM_p">GlaxoSmithKline identified benzodiazepine (BZD) GW841819 (<b>9</b>, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) as a potent ApoA1 regulator via a stable human HepG2 hepatocyte cell line containing an ApoA1 luciferase reporter with an EC<sub>50</sub> value of 440 nM.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The BZD core was essential for the activity, and the phenyl group extending from the 6-position on the BZD ring was common to all active analogues. For its direct target to be identified, panels of kinases, ion channels, nuclear receptors, GPCRs, and other drug target proteins were screened using the luciferase assay but failed. Finally, a chemoproteomic approach<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107, 108)</a> was employed and has confirmed that BET proteins are its target and are responsible for the ApoA1 upregulation.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> With an IC<sub>50</sub> value of 501 nM for BRD4, compound <b>9</b> was considered as a good starting point for medicinal chemistry optimization. Substituents at the meta or para position were introduced (e.g., compound <b>10</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a>) to solve the issue of selectivity for BRDs over GABA receptor, which is usually the target of compounds containing a 1,4-benzodiazepine motif. The benzyl group on carbamate was replaced by alkyl (e.g., compound <b>11</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a>) to reduce both molecular weight (MW) and lipophilicity (cLogP) to a range more desirable for an oral drug (MW < 400 and cLogP < 3). Similar to compound <b>7</b>, only an enantiomer of <b>11</b> was found active. Moreover, a nitrogen atom (colored blue) at the side chain of the BZD ring was removed due to the acidic instability of <b>11</b> (<i>t</i><sub>1/2</sub> = 0.23 h at pH 2). All the favored modifications were incorporated into one molecule and led to <b>2</b>, which showed similar potency to that of <b>9</b> but was more suitable for in vivo experiments because of improved physicochemical and pharmacokinetic properties. It has high passive permeability (167 nm/s), excellent solubility in all vehicles (>3 mg/mL), good tissue distributions (6.5 L/kg in mouse), and nice oral bioavailability (44–61% in mouse, dog, and primate).<a onclick="showRef(event, 'ref33 ref109'); return false;" href="javascript:void(0);" class="ref ref33 ref109">(33, 109)</a> In vivo studies on <b>2</b> have demonstrated significant efficacy in various oncology and immunoinflammatory models.<a onclick="showRef(event, 'ref66 ref67 ref80'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref80">(66, 67, 80)</a> Currently, compound <b>2</b> is under Phase I/II clinical trials for the treatment of different cancers.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery and development of BRD4 inhibitor <b>2</b>. PBMC: peripheral blood mononuclear cells; BZDR: the central GABA receptor; <i>t</i><sub>1/2</sub>, determined by an in vitro assay; <i>T</i><sub>1/2</sub>, performed in vivo.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inspired by the similar crystallographic binding modes of amino-isoxazole fragment <b>12</b> and compound <b>7</b>, Albrecht et al. developed potent BRD4 inhibitor <b>13</b> by incorporating the isoxazole motif into an azepine scaffold (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Compound <b>13</b> showed potent inhibitory activity against BRD4 BD1 (IC<sub>50</sub> = 26 nM) and significant suppression of <i>MYC</i> expression in Raji cells (IC<sub>50</sub> = 140 nM). With the suitable PK profiles in rats, compound <b>13</b> was evaluated in the <i>MYC</i> PD model at doses of 10, 30, and 100 mg/kg. A dose-dependent decrease of <i>MYC</i> mRNA expression was observed in vivo after PO dosing. Replacement of the thiophene ring in <b>13</b>, which has the potential issue of metabolic instability, with a phenyl ring led to compound <b>4</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>),<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> which is currently undergoing evaluation in multiple Phase I clinical trials. Compound <b>4</b> was approximately 6-fold more potent against BET BD2 (BRD4 BD2 IC<sub>50</sub> = 18 nM) than against BET BD1 (BRD4 BD2 IC<sub>50</sub> = 120 nM). In an MV4-11 (an AML cell line) mouse model, compound <b>4</b> was orally dosed as a single agent at 30 mg/kg daily, 30 mg/kg twice daily, or 60 mg/kg once daily. Substantial suppression of tumor growth was observed (tumor growth inhibition (TGI) of 41, 80, and 74%, respectively) with no obvious body weight loss. Preliminary clinical results illustrated that dosing above 230 mg causes substantial modulation of biomarkers linked to BET and other clinically meaningful effects. Antitumor effects have also been observed following the use of <b>4</b> for treatment of patients with heavily pretreated DLBCL and follicular lymphoma.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Various heteroaromatic rings were introduced to the 8-position of 4-(<i>R</i>)-methyl benzoisoxazoleazepine chemotype, which exhibited modest potency in both biochemical and cellular assays. Compound <b>14</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), with an acetamide substituted pyrazole, showed potent BRD4 BD1 inhibition (IC<sub>50</sub> = 17 nM) and significant suppression of <i>MYC</i> expression in MV4-11 cells (IC<sub>50</sub> = 32 nM).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Compared to <b>13</b>, compound <b>14</b> has a longer half-life and 3-fold greater bioavailability. It was dosed subcutaneously at 5 and 15 mg/kg twice a day in a MV4-11 tumor xenografts Balb/c nude mouse model, resulting in 50 and 70% reductions in the <i>MYC</i> mRNA level 8 h after the second dose. Substituents on the 8-position were also explored for benzotriazolodiazepine leading to compound <b>15</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Compound <b>15</b>, with an aminopyridine at the 8-position, displayed a potent BRD4 BD1 inhibitory activity (IC<sub>50</sub> = 15 nM) and significant suppression of IL-6 from THP-1 cells (IC<sub>50</sub> = 13 nM). The cocrystal structure of <b>15</b> with BRD4 BD1 (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) illustrated that it adopted a cupped shape, filling the space between Asn140 and the WPF shelf and making hydrophobic contacts around gatekeeper residue Ile146. An edge-to-face interaction between aminopyridine and Trp81 explained its increased potency. An in vivo study of compound <b>15</b> demonstrated dose- and time-dependent suppression of plasma IL-6 in mice.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Development of isoxazole azepine analogues as BRD4 inhibitors and complex of <b>15</b> (colored magenta) with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q">4Z1Q</a>). V<sub>SS</sub>, volume of distribution at steady state.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other selected examples of triazoloazepines as BET BRD4 inhibitors are listed in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. Among them, compounds <b>16</b> and <b>17</b> from patent WO2016069578 with side chains at the 4-position displayed potent BRD4 BD1 inhibitory activities with IC<sub>50</sub> values of 1.3 and 0.43 nM, respectively.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> However, no additional information about selectivity or in vivo efficacy was provided. Benzotriazepine <b>18</b>,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> thienodiazepine <b>19</b>,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> and pyrrolodiazepine <b>20</b><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> showed promising BRD4 inhibitory activities with IC<sub>50</sub> values of 640, 34, and 30 nM, respectively.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structures of compounds <b>16</b>–<b>20</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A number of pyridoazepine derivatives (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>) as potent BET BRD4 inhibitors were reported in patents while having not been published in peer-reviewed journal articles. Both compounds <b>21</b> and <b>22</b> exhibited single-digit nanomolar BRD4 BD1 activity and potent antiproliferation activity in MV4-11 cell lines with EC<sub>50</sub> values of 2 and 13 nM, respectively.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Compound <b>23</b> displayed similar in vitro activity,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> indicating that replacement of the phenyl ring with an aliphatic ring on the 6-position is tolerable. Likely, <i>N</i>-methylpyridin-2(1<i>H</i>)-one is the moiety that can mimic the acetyl group to form the critical hydrogen bonds. Similar to <b>21</b>–<b>23</b>, compounds <b>24</b> and <b>25</b> with additional pyrrole rings also showed single-digit nanomolar BRD4 binding activity.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> In an OPM-2 human multiple myeloma cancer xenograft model, compound <b>24</b> displayed a TGI of 81% administrated orally at the dose of 5 mg/kg, but 44% of mice were removed due to morbidity or weight loss in excess of 20%. At the dose of 2.5 mg/kg, no mice were removed, but the TGI was decreased to 66%. Compound <b>25</b> had a TGI of 79% at the dose of 2.5 mg/kg in the same model, and no mice were removed, indicating a better efficacy and a safer profile. Interestingly, compound <b>26</b> without triazoles or isoxazoles retained micromolar BET BRD4 inhibitory activities.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Compounds <b>27</b>–<b>29</b> with novel bicyclic aliphatic rings can also suppress the proliferation of the MV4-11 cell line with IC<sub>50</sub> values of less than 100 nM.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of compounds <b>21</b>–<b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Another well-developed compound of this azepine series of BET BRD4 inhibitors is compound <b>3</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). It inhibits binding of BRD2/3/4 to acetylated H4 in a concentration-dependent manner with IC<sub>50</sub> values ranging from 92 to 112 nM. Its exposure leads to cell growth inhibition, cell cycle arrest, and apoptosis at submicromolar concentrations in acute leukemia cells and patient-derived leukemic cells.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Compound <b>3</b> is now under a Phase I clinical trial in relapsed/refractory leukemia patients.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">3.1.2 3,5-Dimethyl Isoxazoles</h4><div class="NLM_p">Inspired by the affinity of the solvent <i>N</i>-methylpyrrolidinone (NMP, <b>30</b>) with bromodomains (e.g., for CREBBP, IC<sub>50</sub> = 2.3 mM), Heightman et al. performed subsequent studies on methyl-bearing heterocycles such as dihydroquinazolinone-containing compound <b>31</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The X-ray crystal structure of BRD4 BD1 with <b>31</b> was solved, but additional unexplained electron density at the 4-position of the dihydroquinazolinone was observed. Its real structure was interpreted as compound <b>32</b>, which has a substituent of the ethylene glycol unit arising from oxidation at this position.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The ethylene glycol unit occupies a hydrophobic groove (formed by Trp81 and Pro82 from the ZA loop and Il46 and Met149 from helix C), which is believed to contribute to the selectivity for BET proteins over other bromodomains. The following modifications are focused on the mono- and dimeta-substituted 3,5-dimethyl-4-phenylisoxazole scaffolds to avoid ready oxidation and retain interactions with that important groove. Compound <b>33</b> stood out with IC<sub>50</sub> values of 4.8 and 1.6 μM against BRD4 and BRD2, respectively.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The cocrystal structure of compound <b>33</b> with BRD4 BD1 reveals that the dimethylisoxazole moiety acts as a KAc mimic and occupies the KAc binding pocket. The isoxazole oxygen atom of <b>33</b> forms the expected hydrogen bond with Asn140, and the nitrogen atom interacts with the phenol group of Tyr97 via a water molecule. The methyl group bound in the WPF shelf was replaced with larger substituents such as aromatic rings leading to compounds <b>34</b> and <b>35</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The (<i>R</i>)- and (<i>S</i>)-enantiomers of <b>34</b> display similar BRD4 inhibitory activities and identical binding modes. Both <b>34</b> and <b>35</b> have significant enhancement in BRD4 binding affinity compared to that of <b>33</b> with IC<sub>50</sub> values of 370–390 nM. Compound <b>35</b>, with an additional acetyl group, has a 7-fold selectivity over CREBBP, and the acetate carbonyl group was predicted to form a hydrogen bond with Gln85. Additionally, compounds <b>34</b> and <b>35</b> exhibit cytotoxicity in MV4-11 cells with IC<sub>50</sub> values of 794 and 616 nM but no appreciable cytotoxicity (IC<sub>50</sub> > 100 μM) in HeLa or U2OS cells, suggesting the effects result mainly from inhibition of the BET proteins.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery and development of BRD4 inhibitors <b>33</b>–<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>36</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>), developed by GSK via FBDD, has an IC<sub>50</sub> value of 500 nM against BRD4 in a TR-FRET assay, but its solubility is very poor (<1 μg/mL).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Introduction of polar groups to the phenyl ring para to the isoxazole of <b>36</b> led to compound <b>37</b>, which had substantially improved solubility (1125 μg/mL at pH 5).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Compound <b>38</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) containing an imidazo[1,2-<i>a</i>]pyrazine scaffold binds BRD4 with a <i>K</i><sub>d</sub> value of 550 nM and shows good cellular effects (IC<sub>50</sub> = 724 nM) in BRD4-dependent lines.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of compounds <b>36</b>–<b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">GW694481 (<b>39</b>, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) was identified as a potent ApoA1 upregulator (EC<sub>170</sub> = 500 nM; EC<sub>170</sub> was defined as the concentration of compound resulting in a 70% increase in the luciferase activity) by an HTS approach using a transcriptional cellular assay.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Optimizations on the 3- and 4-positions led to compound <b>40</b>,<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126, 127)</a> which was potent in ApoA1 upregulation with an EC<sub>170</sub> value of 200 nM and in BET inhibition with an IC<sub>50</sub> value of 750 nM against BRD4. However, its cytochrome P450 (CYP450) inhibition was in the low micromolar range. To address this issue, CONH<sub>2</sub> was eliminated, and the intramolecular hydrogen bond between C3 and C4 was frozen through cyclization leading to a series of imidazolone analogues. Among them, I-BET151 (<b>41</b>) displayed the most promising potency and properties.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Compound <b>41</b> showed an acceptable CYP450 profile with no observable time-dependent inhibition of CYP2D6 or CYP3A4, nonmutagenicity, significantly reduced PDE4 liability, and good bioavailability (65%) in rats. Additionally, it demonstrated a broad anti-inflammatory profile in an LPS-challenged Balb/C mouse model and efficacy in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukemia.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Recently, Wang et al. introduced a [6,5,6] tricyclic system to mimic the [6,6,5] tricyclic system in compound <b>41</b>, and compound <b>42</b> was obtained after a systematic structure–activity relationship (SAR) study (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Compound <b>42</b> is specific for BET members and has <i>K</i><sub>i</sub> values of 3.2–25 nM with BRD2–4 BD1 and BD2 domain proteins. Moreover, it potently inhibits the viability of MV4-11 and MOLM-13 cells but maintains no obvious inhibition (IC<sub>50</sub> > 2 μM) of cell growth in the K562 cell line harboring a BCR-ABL fusion protein.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Discovery and development of compounds <b>41</b> and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar tricyclic systems were applied on compounds <b>43</b>–<b>45</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Their IC<sub>50</sub> values against BRD4 are in the range of 10–21 nM, but compound <b>45</b> is less stable (after being incubated for 30 min in mouse and human liver microsomes, only 3.7% and 1.9% of compound can be recovered) due to the metabolically active CH<sub>2</sub> position.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Moreover, they are nonselective BET BRD4 inhibitors as they display similar inhibitory activities against BRD2 and BRD3. Taking the same [6,5,6] tricyclic system as Wang’s group used, researchers from BMS introduced a 1,2,3-triazole to replace its bioisostere isoxazole. Compounds <b>46</b>–<b>48</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>) displayed potent inhibition against BRD4 BD1 with IC<sub>50</sub> values of less than 5 nM.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> In vivo efficacy was evaluated in xenograft rodents models derived from H187 human small cell carcinoma or JJN3R multiple myeloma cell lines. At a dose of 1 mg/kg (e.g., compounds <b>47</b> and <b>48</b>), over 90% of TGI was achieved, but no additional data about toxicity were available. The results of compounds <b>46</b> and <b>48</b> remind us that deuteration may be an effective way of improving drug pharmacodynamics, tolerability, and efficacy as well as getting out of patent protection.<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132, 133)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of compounds <b>43</b>–<b>48</b>. FL, full length; MLM, mouse liver microsome; HLM, human liver microsome.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given that the 3,5-dimethyl group plays a critical role in forming hydrogen bonds with Asn and Tyr of BRD4, the main body of this series of BET BRD4 inhibitors are tolerant and so diverse that all single phenyl ring (e.g., compounds <b>33</b>–<b>38</b>), tricyclic systems (e.g., compounds <b>41</b>–<b>48</b>), and bicyclic rings<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) work very well with proper substituents. Compounds <b>49</b> and <b>50</b> with an indoline ring inhibit BRD4 with IC<sub>50</sub> values of 35 and 8 nM in a TR-FRET methodology and show promising antiproliferation cellular activity against MV4-11 cell lines.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Compounds <b>51</b> and <b>52</b>,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> containing a benzoimidazole ring, can displace labeled BRD4 BD1 ligand 2 (<i>K</i><sub>2</sub> was defined based on this ligand) and competitively bind to BRD4 with <i>K</i><sub>2</sub> values of 3 and 2.7 nM, respectively. Both of these significantly suppress the proliferation of the MT-4 cell line with IC<sub>50</sub> values around 9 nM. Cyclization of <i>N</i>-methyl with the adjacent carbonyl group of compound <b>53</b> led to compound <b>54</b>.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Introduction of a bulky piperidine to the <i>N</i>-methyl group of compound <b>55</b> gave <b>56</b>.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> All of them display similar BRD4 inhibitory activities with IC<sub>50</sub> values in the range of 14–36 nM.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures of compounds <b>49</b>–<b>56</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">3.1.3 Pyridones</h4><div class="NLM_p">Although few journal articles were previously published on pyridone-derived BET BRD4 inhibitors, this series of compounds have maintained a large proportion of relevant patents. Importantly, compound <b>6</b>, derived from pyridone, has entered into clinical trials for various cancers. Obviously, the pyridone plays a similar role as that of 3,5-dimethyl isoxazole, forming critical hydrogen bonds with BRD4. Compounds <b>57</b> and <b>58</b> (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>), developed by AbbVie, display both potent BRD4 BD1 and BD2 inhibitory activity (up to single-digit nanomolar) in vitro, but their cellular activities are not very consistent (submicromolar range).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Compounds <b>59</b> and <b>60</b>,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> fused with a 12-membered ring, exhibit dramatically improved antiproliferative activity in cellular assays (MX-1 cell lines) with EC<sub>50</sub> values of 5.7 and 8.7 nM, respectively. Their ability to inhibit LPS-induced IL-6 production was confirmed (83 and 81%, respectively) in a mouse model. Tricyclic (compounds <b>61</b> and <b>62</b>)<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> and bicyclic ring systems (compounds <b>63</b> and <b>64</b>)<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> attached to pyridone were investigated by researchers from Boehringer Ingelheim. These compounds show promising BRD4 BD1 inhibition with IC<sub>50</sub> values of 5, 2, 12, and 12 nM, respectively.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Chemical structures of compounds <b>57</b>–<b>64</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pyrrole-fused pyridones were also explored by researchers from AbbVie. As depicted in <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>, <i>O</i>- or <i>N</i>-substituents at 1-position and 4-sulfonyl substituents of the phenyl ring attached to pyrrolopyridone are their common features. Compounds <b>65</b>–<b>67</b> exhibit similar BRD4 BD1 and BD2 inhibitory activities with IC<sub>50</sub> values at the single-digit nanomolar level.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Compared to compound <b>6</b>, which is in Phase III clinical trials, an additional morpholine was introduced to give compound <b>68</b>, and its potency indicated that the 5-position of the phenyl ring is tolerable.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> A long side chain was introduced to pyrrole of compounds <b>69</b> and <b>70</b>, which both showed potent BRD4 inhibitory activities with IC<sub>50</sub> values in the single-digit nanomolar range.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> They inhibited cell proliferation with EC<sub>50</sub> values of 9.4 and 48 nM, respectively, against the MX-1 cell line.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Chemical structures of compounds <b>65</b>–<b>70</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">3.1.4 Triazolopyrazines</h4><div class="NLM_p">Patent US20160129001 covering [1,2,4]triazolo[4,3-<i>a</i>]pyrazines as BET BRD4 inhibitors was recently highlighted in <i>ACS Med. Chem. Lett</i>.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Compounds <b>71</b>–<b>73</b> (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) were identified as potent BRD4 BD1 inhibitors by the BRD4-H4 tetra-acetylated peptide inhibition AlphaScreen assay with remarkable IC<sub>50</sub> values of 8, 9, and 1 nM, respectively.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Unfortunately, no binding affinity data toward other close isoforms such as BRD4 BD2 or BRD2/3 were reported; thus, their target specificity remains unclear. Compound <b>74</b> expanded the amine on the 8-position of [1,2,4]triazolo[4,3-<i>a</i>]pyrazines, and it retained potent BRD4 BD1 inhibitory activity.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Compounds <b>75</b> and <b>76</b> introduced aliphatic side chains to replace the benzyl group without affecting their BRD4 inhibition ability.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of compounds <b>71</b>–<b>76</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers from Novartis introduced unique cyclic rings (dihydropyrrolopyrazoles and dihydropyrrolopyrroles) into bioisosteres of triazolopyrazines including triazolopyridazines and triazolopyridines (<a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>). Compounds <b>77</b> and <b>78</b> exhibit IC<sub>50</sub> values of less than 11 nM against BRD4 with over 150-fold selectivity against CREBBP.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Compared to <b>77</b>, compound <b>79</b> used the pyridone as a replacement of triazolopyridazine and its selectivity against CREBBP was decreased to 42-fold.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Compounds <b>80</b> and <b>81</b> introduced substituents on the <i>N</i>- position of pyrroles retaining potent BRD4 inhibition.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> The high potency (IC<sub>50</sub> < 11 nM) of compound <b>82</b> indicates that modifications on the 2-position of pyrrole are tolerable. The MV4-11 cell line was determined to be sensitive to these compounds with IC<sub>50</sub> values of less than 10 nM.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Chemical structures of compounds <b>77</b>–<b>82</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">3.1.5 Tetrahydroquinolines (THQs)</h4><div class="NLM_p">Compound <b>83</b> (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>), a THQ derivative, was identified via HTS as an ApoA1 upregulator in the HepG2 cell luciferase reporter assay.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Optimization on the N1- and 6-position led to compound <b>84</b>, which is a potent ApoA1 upregulator (EC<sub>170</sub> = 10 nM) and BRD4 (IC<sub>50</sub> = 398 nM) inhibitor.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> However, it shows moderate inhibition of multiple CYP450 isoforms. Further modifications on phenyl rings A and B gave compound I-BET726 (<b>85</b>, <a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>) with an improved CYP450 profile.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Its affinities with BET proteins (BRD4 IC<sub>50</sub> = 4.4–23 nM) were confirmed by different assays. The cocrystal structure of <b>85</b> with BRD4 reveals that the N1-acetyl group interacts with Asn140 to form a critical hydrogen bond and with Tyr97 to form a second one through a water molecule. It was further evaluated in mouse xenograft models of human neuroblastoma (orally),<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> an acute mouse inflammation model (orally), and mouse septic shock model (intravenously) with promising efficacy.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Discovery and development of compound <b>85</b> and its complex with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BJX">4BJX</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>86</b> (<a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>) developed by GSK was found to inhibit BRD4 BD2 potently with an IC<sub>50</sub> value of less than 100 nM and displayed 100-fold selectivity over that of BRD4 BD1.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> However, no data on other BET members were provided. Compounds <b>87</b> and <b>88</b> focused on modifications of the phenyl ring and displayed promising BRD4 BD1 and BD2 (less than 100 and 50 nM for BD1and BD2, respectively) inhibitory activities.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Additional N atoms were introduced to compound <b>89</b>, showing potent BRD4 BD1 and BD2 inhibition with IC<sub>50</sub> values of 20 and 43 nM, respectively.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Variants of THQ such as 3,4-dihydroquinazolin-2(1<i>H</i>)-one in compound <b>90</b><a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> and benzo[<i>cd</i>]indol-2(1<i>H</i>)-one) in compound <b>91</b><a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> are capable of mimicking the acetyl-lysine to form hydrogen bonds with conserved residues of BRD4 (e.g., Asn140 and Tyr97). Compound <b>90</b> has an IC<sub>50</sub> value of 220 nM against BRD4 BD1 and inhibits IL-6 production in human blood mononuclear cells stimulated by LPS with an EC<sub>50</sub> value of 1.9 μM. Its oral bioavailability (<i>F</i> = 32% in rats) is relatively low, likely owing to the suboptimal compound solubility in the gut.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Compound <b>91</b> was discovered and developed through structure-based virtual screening, and it had a temperature shift of 9.9 °C at a final concentration of 10 μM of proteins and 200 μM of compounds in the thermal stability shift assay. It exhibits high binding affinity for BRD4 BD1 with a <i>K</i><sub>d</sub> value of 137 nM and good PK property (<i>F</i> = 77%, <i>t</i><sub>1/2</sub> = 4 h, and cellular permeability = 10 × 10<sup>–6</sup> cm s<sup>–1</sup>).<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Chemical structures of compounds <b>86</b>–<b>91</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">3.1.6 4-Acyl Pyrroles</h4><div class="NLM_p">Compounds shown in <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a> are representatives of 4-acyl pyrrole-derived BET BRD4 inhibitors. Compound <b>92</b>, discovered by AbbVie, exhibits an IC<sub>50</sub> value of 38 nM against BRD4 BD1 and good antiproliferative activity (IC<sub>50</sub> = 433 nM) against the MX-1 cell line.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> With an EC<sub>50</sub> value of 160 nM against the MX-1 cell line, compound <b>93</b> was evaluated in the MX-1 human breast cancer xenograft model, and 80% TGI was achieved at a dose of 100 mg/kg.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Compound <b>94</b> was obtained through high-throughput virtual screening using a library containing more than 7 million small molecules.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> It is the most potent binder in this compound library against BRD4 BD1 with a <i>K</i><sub>D</sub> value of 237 nM. Among 56 cell lines (from nine different cancer types), it potently and selectively inhibits leukemia cells.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159, 160)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0022.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Chemical structures of compounds <b>92</b>–<b>94</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">3.1.7 2-Thiazolidinones</h4><div class="NLM_p">Shen et al. took fragment <b>95</b> (<a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>), which bears a 2-thiazolidinone core, as the starting point for integrated lead optimization.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> The 2-thiazolidinone motif of <b>95</b> can mimic the 3,5-dimethylisoxazole fragment that is mentioned above to occupy the KAc binding pocket. Similar modifications were performed at the meta or para position of the phenyl ring of <b>95</b>. Compound <b>96</b>, bearing only one thiophene sulfonamide at the meta position of the phenyl ring, displayed BRD4 inhibition with an IC<sub>50</sub> value of 4.1 μM in a fluorescence anisotropy assay.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Introducing an additional substituent at the meta position gave compound <b>97</b>, which is 17-fold more potent than that of <b>96</b> and more stable in liver microsomes.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> However, none of them showed acceptable proliferation inhibitory activity in human colon cancer HT-29 cell line (GI<sub>50</sub> of the best one is 37 μM). In the follow-up study, the sulfonamide group was reversed, and further modifications on the phenyl ring were explored. Compound <b>98</b> is the most potent one in this series using the cellular antiproliferation assay with IC<sub>50</sub> values of 860 nM in HT-29 cells and 180 nM in the MV4-11 cell line.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0023.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Discovery and development of 2-thiazolidinones as BRD4 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">3.1.8 Proteolysis Targeting Chimera (PROTAC)</h4><div class="NLM_p">Different from traditional small molecule drugs, proteolysis targeting chimera (PROTAC) is an emerging novel technology that takes advantage of a small molecule to control intracellular protein levels through recruiting target proteins to the ubiquitin/proteasome system for selective degradation.<a onclick="showRef(event, 'ref163 ref164 ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref163 ref164 ref165 ref166">(163-166)</a> It is a combination of small molecule and genetic knockdown techniques, and recently, this method was applied to BRD4. DBET1 (<b>99</b>, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>) was designed by conjugating compound <b>7</b> with thalidomide whose target is cereblon (CRBN), a component of a cullin-RING ubiquitin ligase.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Significant loss of BRD4 (>80%) was observed for the treatment of <b>99</b> at a concentration of 100 nM in MV4-11, whereas <b>7</b> or thalidomide alone was not sufficient to induce BRD4 degradation. Treatment of CRBN-deficient human MM cell line (MM1.S-CRBN<sup>–/–</sup>) with <b>99</b> was ineffectual, suggesting that proteasomal degradation of BRD4 by <b>99</b> is CRBN dependent. In a human leukemia xenograft mouse model, <b>99</b> also displayed improved antitumor efficacy compared with the effects of <b>7</b>. ARV-825 (<b>100</b>)<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> and MZ1 (<b>101</b>)<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> were designed based on a similar hypothesis. Compound <b>100</b> suppressed <i>c-MYC</i> levels, inhibited cell proliferation, and induced apoptosis in Burkitt’s lymphoma more effectively than using BRD4 inhibitors alone.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Compound <b>101</b>, by tethering <b>7</b> to a ligand for the E3 ubiquitin ligase VHL, induced selective removal of BRD4 over BRD3 and BRD2.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Given that compound <b>7</b> has no preference for binding BRD4 over BRD2/3, the observed selectivity was attributed to the more efficient polyubiquitination of lysine residues on the BRD4 surface or more productive formation of the VHL:<b>101</b>:BRD4 complex due to preferential direct interaction or reduced steric constraints between VHL and BRD4.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0024.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Chemical structures of compounds <b>99</b>–<b>101</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">3.1.9 Bivalent Inhibitors</h4><div class="NLM_p">Recently, bivalent BET BRD4 inhibitors have emerged. Compound <b>102</b> (MT1, <a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>) is the first one reported given that all previously reported BET BRD4 inhibitors bind in a monovalent fashion.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> A homodimer of compound <b>7</b> with a long PEG linker led to <b>102</b>, which has an IC<sub>50</sub> value of 3.1 nM against BRD4 BD1. Size-exclusion chromatography results indicate that it binds to tandem bromodomains in an intramolecular fashion and that both BRD4 bromodomains are directly involved. In cellular assays, it displayed a 100-fold higher potency over compound <b>7</b> (0.17 vs 72 nM in the MV4-11 cell line). Compound <b>102</b> significantly reduced leukemia burden in the aggressive disseminated leukemia mouse model at a dose of 25 mg/kg compared to vehicle and compound <b>7</b>. Compound <b>103</b> is a bivalent and potent BRD4 inhibitor with IC<sub>50</sub> values of 5 nM against full length BRD4 and 1.6 μM against BRD4 BD1.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> In a xenograft model of MV4-11, a dose-dependent TGI was observed for 1 (TGI = 72%), 2.5, and 5 mg/kg (regression) daily oral doses of compound <b>103</b>.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0025.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Chemical structures of compounds <b>102</b> and <b>103</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">3.2 Dual BRD4 and Kinase Inhibitors</h3><div class="NLM_p">Because the nonspecific CDK inhibitor Dinaciclib was reported to interact with the acetyl-lysine binding site of BRDT,<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> the vast chemical space of kinase inhibitors as bromodomain modulators is attracting more and more attention. Schönbrunn et al. evaluated the binding potential of 581 diverse kinase inhibitors toward BETs (taking BRD4 BD1 as a representative) via a robotic cocrystallization screening campaign.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Among the 14 identified kinase inhibitors, BI2536 (<b>104</b>), which was developed as a potent and selective PLK1 inhibitor (IC<sub>50</sub> = 0.83 nM) and is currently in clinical trials,<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> showed the most potent BRD4 inhibition with an IC<sub>50</sub> value of 25 nM. Cocrystal structure of <b>104</b> with BRD4 BD1 reveals that the dihydropteridine oxygen of <b>104</b> interacts with Asn140, and the aminopyrimidine moiety forms a network of hydrogen bonds with residues Glu85, Pro82, and water molecules of the ZA loop (<a class="ref internalNav" href="#fig25" aria-label="Figure 25">Figure 25</a>, left panel).<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> In the cocrystal structure of <b>104</b> with PLK1, it binds to the hinge region through the aminopyrimidine moiety while the carbonyl oxygen of the 2-amino-6-oxo-dihydropteridine moiety is involved in H<sub>2</sub>O-mediated interactions around the gatekeeper residue Leu130. TG-101209 (<b>105</b>), a JAK2 inhibitor, has an IC<sub>50</sub> value of 130 nM against BRD4.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> It was reported to form the critical hydrogen bonds with both BRD4 and JAK2 by the same fragment.</div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0026.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Chemical structure of dual kinase-bromodomain inhibitors <b>104</b>–<b>106</b> and their cocrystal structures with BRD4 BD1 as well as their target kinases. (left panel) Cocomplex of <b>104</b> with BRD4 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGI">4OGI</a>) and PLK1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RKU">2RKU</a>). (center panel) Crystal structures of <b>105</b> with BRD4 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O76">4O76</a>) and JAK2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JI9">4JI9</a>). (right panel) Cocomplex of <b>106</b> with BRD4 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O77">4O77</a>) and SB2 (4-(4-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1<i>H</i>-imidazol-5-yl)pyridine) with p38α (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZS5">3ZS5</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>105</b> utilizes the aminopyrimidine moiety to interact with Asn140 of BRD4 directly, whereas it forms hydrogen bonds with the hinge region residue Leu932 in JAK2 (<a class="ref internalNav" href="#fig25" aria-label="Figure 25">Figure 25</a>, center panel). SB202190 (<b>106</b>),<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> a p38α/β inhibitor, takes two different binding modes with BRD4 and p38α/β. Its cocrystal structure with BRD4 displays that imidazole nitrogen interacts with Asn140 and that it forms hydrogen bonds via the hydroxyl group with Tyr97 and Met132. It is suggested to interact with the hinge region through the pyridine ring (<a class="ref internalNav" href="#fig25" aria-label="Figure 25">Figure 25</a>, right panel). Compounds <b>104</b> and <b>105</b> were also reported to be able to displace BRD4 from chromatin and suppress <i>c-MYC</i> expression in MM.1S cells.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> These dual inhibitors remind us of potential off-target concerns but also provide us the opportunity to seek an efficient therapy by developing one single drug molecule to disrupt both transcriptional and cell signaling events. Meanwhile, with the binding modes in hand, re-exploring the SAR on these dual inhibitors is attractive for tuning the selectivity and achieving BRD4-selective inhibitors.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a></div><div class="NLM_p">Other dual BRD4/kinase inhibitors such as dual PI3K/BET BD1 inhibitor LY294002 (<b>107</b>),<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> dual EGFR/BRD4 inhibitor Z118332870 (<b>108</b>),<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> and dual HDAC/BRD4 inhibitor <b>109</b><a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> (<a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>) are also explored and provide good starting points for developing cancer therapeutics via an approach of polypharmacology.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0027.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Chemical structures of compounds <b>107</b>–<b>109</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">3.3 Relatively Selective BRD4 Inhibitors</h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">3.3.1 BD Domain Selective Inhibitors</h4><div class="NLM_p">Compound <b>1</b> (<a class="ref internalNav" href="#fig27" aria-label="Figure 27">Figure 27</a>), a derivative of the plant polyphenol resveratrol, was originally developed by Resverlogix Corporation for the treatment of cardiovascular disease associated with atherosclerosis given that it can increase the plasma level of the high-density lipid protein ApoA1.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> After entering clinical trials, the function of <b>1</b> as a bromodomain inhibitor was explored.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Temperature-shift assays show that <b>1</b> selectively targets BD2s of the BET subfamily. The <i>K</i><sub>D</sub> values of <b>1</b> by isothermal titration calorimetry (ITC) are 135 nM against BRD4 BD2 and 1142 nM against BRD4 BD1 with almost 10-fold selectivity. However, the selectivity of individual BET family members was not achieved. Cocrystal structures of <b>1</b> with the first and second domain of BET proteins display that the phenyl ring of <b>1</b> packs against the BD2 unique residue His433 (Asp in BD1 domain) to form a π–π interaction, which may explain its higher affinity for BD2 domains. Currently, a phase III clinical study of <b>1</b> is recruiting participants to explore whether this treatment in high-risk type 2 diabetes mellitus patients with coronary artery disease can increase the time to major adverse cardiovascular events.</div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0028.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. (left panel) Structure of compound <b>1</b> and <i>K</i><sub>D</sub> values with different BD domains of BET members. (right panel) Overlap of cocrystal structures of <b>1</b> with BRD4 BD1 (yellow; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR4">4MR4</a>) and BRD2 BD2 (turquoise; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR6">4MR6</a>). The labeled residue is His433 (magenta) in the BRD2 BD2 domain and Asp144 (green) in the BRD4 BD1 domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Starting from CREBBP inhibitor MS120 (<b>110</b>, <a class="ref internalNav" href="#fig28" aria-label="Figure 28">Figure 28</a>) with a modest inhibitory activity against BRD4 BD1 (<i>K</i><sub>i</sub> = 11 μM) and BRD4 BD2 (<i>K</i><sub>i</sub> = 20 μM) in a fluorescent polarization assay, diazobenzene compound MS436 (<b>111</b>) was developed with a potent affinity (<i>K</i><sub>i</sub> = 30–50 nM) for BRD4 BD1, i.e., 10-fold selectivity over that for BRD4 BD2.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> However, this selectivity is limited only for BRD4, it has similar affinity with BRD3 BD1 (<i>K</i><sub>i</sub> = 0.1 μM) and BRD3 BD2 (<i>K</i><sub>i</sub> = 0.14 μM). Compound <b>111</b> blocks LPS-induced proinflammatory cytokine IL-6 expression in macrophage cells and NF-κB-directed NO production in RAW264.7 cells with IC<sub>50</sub> values of 4.9 and 3.8 μM, respectively. Little cytotoxicity on cell growth or proliferation was observed in an MTT assay at concentrations up to 100 μM.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0029.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. (a) Development of compound <b>111</b>. (b) Development of compound <b>113</b>. (c) Cocrystal structure of <b>113</b> with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4QB3">4QB3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Inspired by the structural insights of tetrahydropyrido indole MS7972 (<b>112</b>, <a class="ref internalNav" href="#fig28" aria-label="Figure 28">Figure 28</a>) bound to the CREBBP BD domain, Olinone (<b>113</b>) was developed.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Compound <b>113</b> displays preferred BD1 binding over BD2 for all three BET proteins BRD4, BRD3, and BRD2, while exhibiting nearly no detectable binding to other BCPs. Cocrystal structure of <b>113</b> with BRD4 BD1 (<a class="ref internalNav" href="#fig28" aria-label="Figure 28">Figure 28</a>c) reveals that, besides the critical hydrogen bond with Asn140, compound <b>113</b> interacts with Asp144, which is one of a few residues that is distinct between BRD4 BD1 and BD2 in the acetyl-lysine binding site.</div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">3.3.2 BRD4 Selective Inhibitors</h4><div class="NLM_p last">BAY1238097 (structure not disclosed), developed by Bayer, displays potent inhibition against BRD4 with an IC<sub>50</sub> value of 63 nM, i.e., 10-fold selectivity over BRD3 and 39-fold selectivity over BRD2.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> It was enrolled into human clinical trials (NCT02369029), but the development is currently terminated due to unknown reasons.</div></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">3.3.3 BRD4 BD1 Selective Inhibitors</h4><div class="NLM_p">Compound <b>114</b> (<a class="ref internalNav" href="#fig29" aria-label="Figure 29">Figure 29</a>, left panel), an acetyl-lysine xanthine derivative inhibitor, was identified via an MTS follow-up program targeting BRD4 BD1.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> It displays inhibitory activity against BRD4 BD1 with an IC<sub>50</sub> value of 5 μM in a homogeneous time-resolved fluorescence assay, i.e., 10-fold selectivity of BD1 over its relatives, and no detectable inhibition against BD2 counterparts. From the superimposition of BRD4 with and without <b>114</b> (<a class="ref internalNav" href="#fig29" aria-label="Figure 29">Figure 29</a>, right panel), it is suggested that the ZA loop shift, which was not observed with the pan-BET inhibitors, is critical for selectivity.</div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0030.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. (left panel) Structure of compound <b>114</b> and IC<sub>50</sub> values for different BD1 domains of BET members. (right panel) Superimposition of BRD4 alone (green; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OSS">2OSS</a>) and BRD4 with compound <b>114</b> (yellow; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EGU">5EGU</a>). The ZA loop shift is highlighted by the magenta box.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">4 Concluding Remarks: Challenges and Opportunities</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As epigenetic readers of the histone code, BET family members play a critical role in a number of human diseases. Among them, BRD4 is the most extensively studied member. BRD4 recruits transcriptional regulatory complexes to acetylated chromatin via recognition of acetylated lysine. In this regard, BRD4 plays an important role as a serine kinase of RNA Pol II and an atypical histone acetyltransferase controlling gene expression through chromatin relaxation, transcriptional elongation, and ejection of histones from coding regions.<a onclick="showRef(event, 'ref10 ref183'); return false;" href="javascript:void(0);" class="ref ref10 ref183">(10, 183)</a> These activities make BRD4 an integral component of many disease-associated gene regulatory networks. BRD4 is thus considered as a promising therapeutic target for a variety of human diseases including cancer, inflammation, HIV infection, CNS disorders, and cardiovascular diseases. BET inhibition displays efficacy against various different pathologies especially cancer and inflammation. These effects have been attributed to the specific set of downstream target genes whose expression is disproportionately sensitive to pharmacological targeting of BET proteins. Over the past decade, the biological elucidation of BRD4 functions and the development of BRD4 inhibitors have made great progress along with the emergence of new technologies, such as PROTAC and the bump-and-hole approach.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Various series of BRD4 inhibitors have emerged such as azepines, 3,5-dimethyl isoxazoles, pyridones, triazolopyrazines, THQs, 4-acyl pyrroles, 2-thizalidinones, and so forth,<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> and some of them exhibit potent BRD4 inhibition in vitro and effective therapeutic activity in vivo with no obvious toxicity. The common feature of these molecules is that they all have a unique head moiety that can form critical hydrogen bonds with residues of the BRD4 binding pocket (e.g., Asn140 and Tyr 97). In addition, almost all of them contain a small hydrophobic group around the hydrogen bond, mostly a methyl group. Currently, more than a dozen diverse BET BRD4 inhibitors have been advanced into human clinical trials for the treatment of cancer, inflammation, and other diseases. Notably, compound <b>1</b>, a relatively selective inhibitor of BET BD2, is now in Phase III human clinical trials.</div><div class="NLM_p">Both challenges and opportunities remain regarding the drug development of BRD4 inhibitors. Primarily, more potent and specific BRD4 inhibitors are in urgent need including BRD4 BD1- and BRD4 BD2-selective compounds over other BET family members along with further exploration of the specific transcriptional effects and therapeutic end points. Although a number of BET BRD4 inhibitors described above are highly potent with single-digit nanomolar BRD4 inhibitory activity, very few of them exhibit excellent selectivity among BET family members or sub-bromodomains. For example, compound <b>80</b> has an IC<sub>50</sub> value of 12 nM against BRD4 as well as IC<sub>50</sub> values of 14 nM against BRD3 and 14 nM against BRD2. In contrast, compounds <b>60</b> and <b>61</b> are BRD4 selective, but the potency is only in the micromolar range. Several different approaches may contribute to developing inhibitors that are more BRD4 specific. The first is to take advantage of the crystallography and the subtle amino acid differences of BET members to design new inhibitors with improved BRD4 selectivity.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> The second is to develop inhibitors of BRD4 interacting proteins. Inhibiting the PPI interface can be achieved by targeting either of the proteins involved in the interaction. Inhibition of BRD4 interacting partners may be specific to one signaling pathway and affect only the desired genes’ expression. The third is to screen and repurpose known kinase inhibitors to target BRD4, which may accelerate the drug approval process. Chemical optimizations on dual kinase/BRD4 inhibitors to obtain kinase selective or BRD4 selective appear to be feasible.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Given that a number of kinase inhibitors were found effective on BET inhibition, using them to target BRD4 by selectivity tuning is thus less time-consuming because their physicochemical properties and metabolism profiles have been extensively explored. Moreover, evaluation of BRD4 selectivity and specificity should include the panel assays on kinases as well as BCPs and BET proteins. Although different chemical scaffolds are being explored, the privileged scaffold diazepine appears to dominate the BET BRD4 inhibitors in clinical trials. Many novel fragments have been discovered by fragment screening, rational design, bioisosterism, and cocrystal analyses and may be worth further exploration.<a onclick="showRef(event, 'ref187 ref188 ref189 ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref187 ref188 ref189 ref190 ref191">(187-191)</a> Clearly, there exists a large chemical space to develop structurally diverse BRD4 inhibitors. With the assistance of traditional drug discovery methods (HTS, VS, crystallography, SBDD, FBDD, etc.),<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> it is the opinion of the authors that more potent and specific BRD4 inhibitors with different chemotypes will enter human clinical trials in the near future.</div><div class="NLM_p">Along with the promising results of early clinical trials using BET inhibitors in hematologic malignancies,<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> resistance mechanisms were evaluated to optimize the clinical efficacy of these drugs. In human and mouse leukemia cells, increased WNT/β-catenin signaling is considered to be an alternative mechanism that regulates transcription and promotes resistance to the BET inhibitor <b>27</b>.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Negative modulation of this signaling can restore sensitivity to <b>27</b> in vitro and in vivo. Other studies identified WNT signaling as a driver and candidate biomarker of primary and acquired BET resistance in leukemia.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> In BET inhibition of resistant triple-negative breast cancer cells, a bromodomain-independent recruitment mechanism was facilitated by decreased protein phosphatase 2 activity and subsequent hyperphosphorylated BRD4, which binds more strongly to MED1, a mediator of RNA Pol II transcription subunit 1.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Resistance to BET inhibitors reported to be mediated by kinome reprogramming and cotargeting BET protein and RTK or PI3K signaling enhance growth inhibition in ovarian cancer cells.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> In this situation, combination of BET inhibitors and corresponding signaling negative modulator may overcome the BET inhibition resistance.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> In addition, the aforementioned one drug with polypharmacology holds great promise for mitigating resistance in cancer therapy and may guide the next generation of efficacious BRD4 inhibitors as anticancer agents.</div><div class="NLM_p">Given that BRD4 is involved in a variety of gene regulatory networks, signaling pathways, and disease-associated function explorations, more detailed molecular and mechanistic studies as well as establishment of novel in vivo animal models of disease are requisite for investigating the unique characteristics/partners of BRD4. Although targeting BET inhibition to combat cancer/inflammation with no obvious toxicity has been demonstrated as a proof-of-concept, attention should be paid to the major dose-limiting toxicity (e.g., thrombocytopenia observed in clinical trials of compound <b>3</b>).<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Whether the side effects are induced by global BET inhibition remains to be extensively explored and evaluated for drug development. The downstream target genes have different levels of sensitivity toward BET inhibition, and it is still challenging to block some of them while leaving others intact. Utilizing proper administration strategies, taking advantage of physicochemical properties of compounds and identifying different pharmacological mechanisms via divergent biological pathways may be of value for facilitating therapeutic development. Drug properties including physicochemical parameters should be considered in the early drug discovery of BRD4 inhibitors depending on the intended therapeutic applications. For example, compound <b>7</b> can cause memory deficits in mice, indicating its potential neurological side effects for patients with cancer. Thus, developing compounds that do not cross the BBB may benefit cancer patients with fewer side effects, whereas BRD4 inhibitors designed for the treatment of CNS disorders are required to be capable of penetrating the BBB. Thus, it is important to understand the tissue distribution of drug candidates. To this end, developing properly radiolabeled positron emission tomography imaging ligands of BRD4 inhibitors may be very powerful for this research field. Limited distribution to target cells, tissues, and organs may contribute to mitigating unwanted side effects. Different administration approaches may also be used to produce the desired distribution, elimination rate, and efficacy. For example, targeted delivery of drug candidates to specific tissues and organ systems can be achieved by encapsulating them into polymeric nanoparticles.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a></div><div class="NLM_p">Currently, the majority of drug development efforts have been focused on disrupting protein interaction networks between BET and KAc-modified proteins. However, BRD4 is a multifunctional protein that controls transcriptional elongation and also maintains intrinsic serine kinase activity directed toward the RNA Pol II CTD and CDK9.<a onclick="showRef(event, 'ref89 ref183'); return false;" href="javascript:void(0);" class="ref ref89 ref183">(89, 183)</a> Additionally, more recent work has shown that BRD4 is a previously unrecognized atypical histone acetyl-transferase whose activity is directed toward Lys residues on the periphery of the nucleosome, enabling RNA Pol II to more easily displace nucleosomes during the process of transcription.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Small molecule therapeutics developed to target these activities may also have very interesting actions and distinct toxicity profiles.</div><div class="NLM_p last">Taken together, targeting BRD4 with small molecules holds promise as a viable therapeutic strategy for various human diseases, as aforementioned. There remains a long road ahead toward market approval, and this effort will require interdisciplinary collaborations. Discovery of potent and specific acetyl-lysine competitive BRD4 inhibitors with high isoform or bromodomain selectivity will fill roles in multiple applications as useful pharmacological probes for elucidating BRD4 biological functions and in the development of potential medications to benefit patients in the near future.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01761" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Zhou</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Biology Program, Department of Pharmacology and Toxicology, ‡Department of Internal
Medicine, §Sealy Center for Molecular Medicine, ξInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#670d0e1d0f08122712130a0549020312"><span class="__cf_email__" data-cfemail="1c7675667473695c6968717e32797869">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqing Liu</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Biology Program, Department of Pharmacology and Toxicology, ‡Department of Internal
Medicine, §Sealy Center for Molecular Medicine, ξInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pingyuan Wang</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Biology Program, Department of Pharmacology and Toxicology, ‡Department of Internal
Medicine, §Sealy Center for Molecular Medicine, ξInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiying Chen</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Biology Program, Department of Pharmacology and Toxicology, ‡Department of Internal
Medicine, §Sealy Center for Molecular Medicine, ξInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric A. Wold</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Biology Program, Department of Pharmacology and Toxicology, ‡Department of Internal
Medicine, §Sealy Center for Molecular Medicine, ξInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Tian</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Biology Program, Department of Pharmacology and Toxicology, ‡Department of Internal
Medicine, §Sealy Center for Molecular Medicine, ξInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan R. Brasier</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Biology Program, Department of Pharmacology and Toxicology, ‡Department of Internal
Medicine, §Sealy Center for Molecular Medicine, ξInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Zhiqing Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=BIO-d89e3058-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhiqing Liu</b> received her B.S. degree in Pharmaceutical Engineering from Shandong Normal University in 2009. She obtained her Ph.D. degree from Shanghai Institute of Materia Medica, Chinese Academy of Sciences in 2014 under the supervision of Professor Ao Zhang. She is currently a postdoctoral research fellow in Professor Jia Zhou’s chemical biology program at the University of Texas Medical Branch (UTMB). Her research interests include the rational design and chemical synthesis of small molecules as novel pharmacological probes and therapeutics for inflammation, human cancer, and CNS disorders.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Pingyuan Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=BIO-d89e3063-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Pingyuan Wang</b> received his Ph.D. in Pesticide Science and Medicinal Chemistry from Central China Normal University (CCNU) in 2016 under the joint supervision of Professor Guang-Fu Yang from CCNU and Professor Ao Zhang from Shanghai Institute of Materia Medica, Chinese Academy of Sciences. He is currently pursuing his postdoctoral training under the supervision of Professor Jia Zhou at the Chemical Biology Program, Department of Pharmacology and Toxicology at UTMB. His research interests focus on the design and synthesis of novel small molecules as chemical probes and drug candidates for neurological disorders, cancer, and other human diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Haiying Chen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=BIO-d89e3068-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Haiying Chen</b> received her B.S. degree in Engineering from Tianjin University (Branch) in 1995. She worked as an engineer in Tianjin Research Institute of Construction Machinery associated with designing and programming computer testing systems. She joined Professor Jia Zhou’s drug discovery program in 2014 as a Research Associate. Her research interests focus on computer-assisted rational drug design of small molecules and understanding of the ligand–target interactions for CNS disorders, cancer/inflammation, and infectious diseases.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Eric A. Wold</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=BIO-d89e3073-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Eric A. Wold</b> received his B.S. degrees in Biotechnology and Biology from the University of Houston and completed his undergraduate thesis on microbial expression systems and enzymatic organophosphate hydrolysis under the guidance of Dr. Rupa Iyer. He is pursuing a Ph.D. in the Pharmacology program at UTMB under the training of Professor Jia Zhou. His research interests include the rational design and chemical synthesis of small molecules as novel pharmacological probes and therapeutics for CNS disorders and cancer.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Bing Tian</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=BIO-d89e3078-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Bing Tian</b> obtained his Ph.D. degree in Pharmacology from UTMB in 1999. He is now Assistant Professor in Internal Medicine and a member of the Sealy Center for Molecular Medicine at UTMB. He is an expert on innate immune signaling pathways with extensive experience in molecular biology, cell biology, pharmacology, and animal experimental methodology. He has been working on viral and cytokine-induced innate immune responses in airway epithelium and has made substantial contributions with more than 40 publications as the primary author or coauthor. He also holds two patents.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Allan R. Brasier</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=BIO-d89e3083-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Allan R. Brasier</b> received his M.D. in 1983 from the University of California, San Francisco. After completing a research fellowship in the Laboratory of Molecular Endocrinology at the Massachusetts General Hospital, he assumed a faculty position at UTMB. There, he directs the Sealy Center for Molecular Medicine and the Institute for Translational Sciences. As an expert in gene expression control by NF-κB in innate inflammation, he has published 150 peer reviewed manuscripts, 40 books and invited reviews, and holds seven patents.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Jia Zhou</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=BIO-d89e3088-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jia Zhou</b> received his Ph.D. in organic chemistry in 1997 from Nankai University, China. He joined the chemistry faculty there and was promoted to Associate Professor. In 1999, he started his postdoctoral training in organic chemistry with Dr. Sidney M. Hecht at the University of Virginia. After further training in medicinal chemistry with Dr. Alan P. Kozikowski at Georgetown University, he conducted research at Acenta Discovery and PsychoGenics as a Senior Principal Scientist for seven years. He is currently a tenured Professor and also a faculty member of the Center for Addiction Research, Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Molecular Medicine at UTMB. He is an author of more than 100 papers, seven book chapters, and an inventor of 16 patents.</p></figure></div><div class="ack" id="ACK-d89e3093-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants P30 DA028821, R01 DA038446, and T32 DA07287 from the National Institutes of Health, Sanofi Innovation Awards (iAwards) Program, Breast Cancer Research Program Breakthrough Award (BC160038) from the Department of Defense, Cancer Prevention Research Institute of Texas award, R. A. Welch Foundation Chemistry and Biology Collaborative Grant from the Gulf Coast Consortia, John Sealy Memorial Endowment Fund, Institute for Translational Sciences, Sealy Center for Molecular Medicine, and the Center for Addiction Research at UTMB.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> Abbreviations</h2><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">activated B-cell-like subtype</p></td></tr><tr><td class="NLM_term">ACS</td><td class="NLM_def"><p class="first last">acute coronary syndrome</p></td></tr><tr><td class="NLM_term">ALL</td><td class="NLM_def"><p class="first last">acute lymphoblastic leukemia</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">ApoA1</td><td class="NLM_def"><p class="first last">apolipoprotein A</p></td></tr><tr><td class="NLM_term">AST</td><td class="NLM_def"><p class="first last">advanced solid tumors</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood-brain barrier</p></td></tr><tr><td class="NLM_term">BCPs</td><td class="NLM_def"><p class="first last">bromodomain-containing proteins</p></td></tr><tr><td class="NLM_term">BET</td><td class="NLM_def"><p class="first last">bromodomain and extra-terminal domain</p></td></tr><tr><td class="NLM_term">BLBC</td><td class="NLM_def"><p class="first last">basal-like breast cancer</p></td></tr><tr><td class="NLM_term">BRD4</td><td class="NLM_def"><p class="first last">bromodomain-containing protein 4</p></td></tr><tr><td class="NLM_term">BZD</td><td class="NLM_def"><p class="first last">benzodiazepine</p></td></tr><tr><td class="NLM_term">CAD</td><td class="NLM_def"><p class="first last">coronary artery disease</p></td></tr><tr><td class="NLM_term">CDKs</td><td class="NLM_def"><p class="first last">cyclin-dependent kinases</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CRPC</td><td class="NLM_def"><p class="first last">castration-resistant prostate cancer</p></td></tr><tr><td class="NLM_term">CTD</td><td class="NLM_def"><p class="first last">C-terminal domain</p></td></tr><tr><td class="NLM_term">CVDs</td><td class="NLM_def"><p class="first last">cardiovascular diseases</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug design</p></td></tr><tr><td class="NLM_term">HPV</td><td class="NLM_def"><p class="first last">human papillomavirus</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">KAc</td><td class="NLM_def"><p class="first last">lysine acetylation</p></td></tr><tr><td class="NLM_term">MDS</td><td class="NLM_def"><p class="first last">myelodysplastic syndrome</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">multiple myeloma</p></td></tr><tr><td class="NLM_term">MPN, U</td><td class="NLM_def"><p class="first last">myeloproliferative neoplasm, unclassifiable</p></td></tr><tr><td class="NLM_term">MM1.S-CRBN<sup>–/–</sup></td><td class="NLM_def"><p class="first last">CRBN-deficient human MM cell line</p></td></tr><tr><td class="NLM_term">MTS</td><td class="NLM_def"><p class="first last">midthroughput screening</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NAc</td><td class="NLM_def"><p class="first last">nucleus accumbens</p></td></tr><tr><td class="NLM_term">NMC</td><td class="NLM_def"><p class="first last">NUT midline carcinoma</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methylpyrrolidinone</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">NUT</td><td class="NLM_def"><p class="first last">nuclear protein in testis</p></td></tr><tr><td class="NLM_term">PHD</td><td class="NLM_def"><p class="first last">plant homeodomain</p></td></tr><tr><td class="NLM_term">PROTAC</td><td class="NLM_def"><p class="first last">proteolysis targeting chimera</p></td></tr><tr><td class="NLM_term">P-TEFb</td><td class="NLM_def"><p class="first last">positive transcriptional elongation factor complex</p></td></tr><tr><td class="NLM_term">RNA Pol II</td><td class="NLM_def"><p class="first last">RNA polymerase II</p></td></tr><tr><td class="NLM_term">RRHMs</td><td class="NLM_def"><p class="first last">relapsed/refractory hematologic malignancies</p></td></tr><tr><td class="NLM_term">RRMM</td><td class="NLM_def"><p class="first last">relapsed/refractory multiple myeloma</p></td></tr><tr><td class="NLM_term">RST</td><td class="NLM_def"><p class="first last">recurrent solid tumors</p></td></tr><tr><td class="NLM_term">T2DM</td><td class="NLM_def"><p class="first last">type 2 diabetes mellitus</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">THQ</td><td class="NLM_def"><p class="first last">tetrahydroquinoline</p></td></tr><tr><td class="NLM_term">WPF</td><td class="NLM_def"><p class="first last">Trp-Pro-Phe</p></td></tr><tr><td class="NLM_term">VS</td><td class="NLM_def"><p class="first last">virtual screening</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 200 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Chromatin modifications and their function</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2007.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17320507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=693-705&author=T.+Kouzarides&title=Chromatin+modifications+and+their+function&doi=10.1016%2Fj.cell.2007.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin modifications and their function</span></div><div class="casAuthors">Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-705</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The surface of nucleosomes is studded with a multiplicity of modifications.  At least eight different classes have been characterized to date and many different sites have been identified for each class.  Operationally, modifications function either by disrupting chromatin contacts or by affecting the recruitment of nonhistone proteins to chromatin.  Their presence on histones can dictate the higher-order chromatin structure in which DNA is packaged and can orchestrate the ordered recruitment of enzyme complexes to manipulate DNA.  In this way, histone modifications have the potential to influence many fundamental biol. processes, some of which may be epigenetically inherited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAH9AX2dGicbVg90H21EOLACvtfcHk0lg9NwhJQhboJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D&md5=c5995fe68fd9473f4268d59c01d3b9de</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DChromatin%2520modifications%2520and%2520their%2520function%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D693%26epage%3D705%26doi%3D10.1016%2Fj.cell.2007.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, J. L.</span><span> </span><span class="NLM_article-title">The role of chromatin during transcription</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2007.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17320508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=707-719&author=B.+Liauthor=M.+Careyauthor=J.+L.+Workman&title=The+role+of+chromatin+during+transcription&doi=10.1016%2Fj.cell.2007.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The role of chromatin during transcription</span></div><div class="casAuthors">Li, Bing; Carey, Michael; Workman, Jerry L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">707-719</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Chromatin structure imposes significant obstacles on all aspects of transcription that are mediated by RNA polymerase II.  The dynamics of chromatin structure are tightly regulated through multiple mechanisms including histone modification, chromatin remodeling, histone variant incorporation, and histone eviction.  In this Review, we highlight advances in our understanding of chromatin regulation and discuss how such regulation affects the binding of transcription factors as well as the initiation and elongation steps of transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFT34JpGG5LVg90H21EOLACvtfcHk0lg9NwhJQhboJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7c%253D&md5=e32a4c422b39301636992808cb38b432</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCarey%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520role%2520of%2520chromatin%2520during%2520transcription%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D707%26epage%3D719%26doi%3D10.1016%2Fj.cell.2007.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Qiu, J.</span><span> </span><span class="NLM_article-title">Epigenetics: unfinished symphony</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1038/441143a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2F441143a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=143-145&author=J.+Qiu&title=Epigenetics%3A+unfinished+symphony&doi=10.1038%2F441143a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F441143a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F441143a%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DJ.%26atitle%3DEpigenetics%253A%2520unfinished%2520symphony%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D143%26epage%3D145%26doi%3D10.1038%2F441143a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bannister, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Regulation of chromatin by histone modifications</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span><span class="refDoi"> DOI: 10.1038/cr.2011.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fcr.2011.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21321607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVCgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=381-395&author=A.+J.+Bannisterauthor=T.+Kouzarides&title=Regulation+of+chromatin+by+histone+modifications&doi=10.1038%2Fcr.2011.22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of chromatin by histone modifications</span></div><div class="casAuthors">Bannister, Andrew J.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-395</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Chromatin is not an inert structure, but rather an instructive DNA scaffold that can respond to external cues to regulate the many uses of DNA.  A principal component of chromatin that plays a key role in this regulation is the modification of histones.  There is an ever-growing list of these modifications and the complexity of their action is only just beginning to be understood.  However, it is clear that histone modifications play fundamental roles in most biol. processes that are involved in the manipulation and expression of DNA.  Here, we describe the known histone modifications, define where they are found genomically and discuss some of their functional consequences, concg. mostly on transcription where the majority of characterization has taken place.  Cell Research (2011) 21:381-395. doi:10.1038/cr.2011.22; published online 15 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2ObWaVBHPorVg90H21EOLACvtfcHk0lhVnnDNDbQwmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVCgurc%253D&md5=bbdf55be25985810b90ba2efe6399f1b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fcr.2011.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2011.22%26sid%3Dliteratum%253Aachs%26aulast%3DBannister%26aufirst%3DA.%2BJ.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520chromatin%2520by%2520histone%2520modifications%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D381%26epage%3D395%26doi%3D10.1038%2Fcr.2011.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Epigenetic protein families: a new frontier for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1038/nrd3674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnrd3674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22498752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=384-400&author=C.+H.+Arrowsmithauthor=C.+Bountraauthor=P.+V.+Fishauthor=K.+Leeauthor=M.+Schapira&title=Epigenetic+protein+families%3A+a+new+frontier+for+drug+discovery&doi=10.1038%2Fnrd3674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic protein families: a new frontier for drug discovery</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Bountra, Chas; Fish, Paul V.; Lee, Kevin; Schapira, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">384-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases.  At the mol. level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones.  Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-contg. proteins and proteins that bind to methylated histones.  These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains.  In this article, we discuss the known links with disease, basic mol. mechanisms of action and recent progress in the pharmacol. modulation of each class of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcD99eCigNtLVg90H21EOLACvtfcHk0lhVnnDNDbQwmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D&md5=eb82034466a43107aa74a18ccf6d29f5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3674%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DEpigenetic%2520protein%2520families%253A%2520a%2520new%2520frontier%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D384%26epage%3D400%26doi%3D10.1038%2Fnrd3674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The language of covalent histone modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1038/47412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+language+of+covalent+histone+modifications&doi=10.1038%2F47412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2eYzt4TmDnJ0Abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520language%2520of%2520covalent%2520histone%2520modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45%26doi%3D10.1038%2F47412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Choudhary, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, M.</span><span> </span><span class="NLM_article-title">Lysine acetylation targets protein complexes and co-regulates major cellular functions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1126/science.1175371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1126%2Fscience.1175371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19608861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=834-840&author=C.+Choudharyauthor=C.+Kumarauthor=F.+Gnadauthor=M.+L.+Nielsenauthor=M.+Rehmanauthor=T.+C.+Waltherauthor=J.+V.+Olsenauthor=M.+Mann&title=Lysine+acetylation+targets+protein+complexes+and+co-regulates+major+cellular+functions&doi=10.1126%2Fscience.1175371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions</span></div><div class="casAuthors">Choudhary, Chunaram; Kumar, Chanchal; Gnad, Florian; Nielsen, Michael L.; Rehman, Michael; Walther, Tobias C.; Olsen, Jesper V.; Mann, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5942</span>),
    <span class="NLM_cas:pages">834-840</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Lysine acetylation is a reversible posttranslational modification of proteins and plays a key role in regulating gene expression.  Technol. limitations have so far prevented a global anal. of lysine acetylation's cellular roles.  We used high-resoln. mass spectrometry to identify 3600 lysine acetylation sites on 1750 proteins and quantified acetylation changes in response to the deacetylase inhibitors suberoylanilide hydroxamic acid and MS-275.  Lysine acetylation preferentially targets large macromol. complexes involved in diverse cellular processes, such as chromatin remodeling, cell cycle, splicing, nuclear transport, and actin nucleation.  Acetylation impaired phosphorylation-dependent interactions of 14-3-3 and regulated the yeast cyclin-dependent kinase Cdc28.  Our data demonstrate that the regulatory scope of lysine acetylation is broad and comparable with that of other major posttranslational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5eICW58ngkrVg90H21EOLACvtfcHk0lgmr0s4k0S0qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Ogt70%253D&md5=8f643db5ba91c50f0b61763ff3095d2c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1175371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1175371%26sid%3Dliteratum%253Aachs%26aulast%3DChoudhary%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DC.%26aulast%3DGnad%26aufirst%3DF.%26aulast%3DNielsen%26aufirst%3DM.%2BL.%26aulast%3DRehman%26aufirst%3DM.%26aulast%3DWalther%26aufirst%3DT.%2BC.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DMann%26aufirst%3DM.%26atitle%3DLysine%2520acetylation%2520targets%2520protein%2520complexes%2520and%2520co-regulates%2520major%2520cellular%2520functions%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D834%26epage%3D840%26doi%3D10.1126%2Fscience.1175371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9413</span><span class="refDoi"> DOI: 10.1021/jm300915b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300915b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9393-9413&author=D.+S.+Hewingsauthor=T.+P.+Rooneyauthor=L.+E.+Jenningsauthor=D.+A.+Hayauthor=C.+J.+Schofieldauthor=P.+E.+Brennanauthor=S.+Knappauthor=S.+J.+Conway&title=Progress+in+the+development+and+application+of+small+molecule+inhibitors+of+bromodomain-acetyl-lysine+interactions&doi=10.1021%2Fjm300915b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions</span></div><div class="casAuthors">Hewings, David S.; Rooney, Timothy P. C.; Jennings, Laura E.; Hay, Duncan A.; Schofield, Christopher J.; Brennan, Paul E.; Knapp, Stefan; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9393-9413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery.  These acetyl-lysine (KAc) reader domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information.  By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners.  There has been intense activity in developing potent and selective small mol. probes that disrupt the interaction between a given bromodomain and KAc.  Rapid success has been achieved with the BET family of bromodomains, and a no. of potent and selective probes have been reported.  These compds. have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets.  Herein, we review the biol. of the bromodomains and discuss the SAR for the existing small mol. probes.  The biol. that has been enabled by these compds. is summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8pl0pnLXruLVg90H21EOLACvtfcHk0lgmr0s4k0S0qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ&md5=486a87abb406c4c833404ccce61c1389</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm300915b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300915b%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520development%2520and%2520application%2520of%2520small%2520molecule%2520inhibitors%2520of%2520bromodomain-acetyl-lysine%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9393%26epage%3D9413%26doi%3D10.1021%2Fjm300915b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Acetylation: a regulatory modification to rival phosphorylation?</span> <span class="citation_source-journal">EMBO. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1179</span><span class="refDoi"> DOI: 10.1093/emboj/19.6.1176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1093%2Femboj%2F19.6.1176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10716917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Gms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1176-1179&author=T.+Kouzarides&title=Acetylation%3A+a+regulatory+modification+to+rival+phosphorylation%3F&doi=10.1093%2Femboj%2F19.6.1176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation: a regulatory modification to rival phosphorylation?</span></div><div class="casAuthors">Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1176-1179</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with ∼30 refs.  The fact that histones are modified by acetylation has been known for almost 30 yr.  The recent identification of enzymes that regulate histone acetylation has revealed a broader use of this modification than was suspected previously.  Acetylases are now known to modify a variety of proteins, including transcription factors, nuclear import factors and α-tubulin.  Acetylation regulates many diverse functions, including DNA recognition, protein-protein interaction and protein stability.  There is even a conserved structure, the bromodomain, that recognizes acetylated residues and may serve as a signaling domain.  If you think all this sounds familiar, it should be.  These are features characteristic of kinases.  So, is acetylation a modification analogous to phosphorylation.  This review sets out what we know about the broader substrate specificity and regulation of acetylases and goes on to compare acetylation with the process of phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzk4_IB8cJsbVg90H21EOLACvtfcHk0lgmr0s4k0S0qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Gms7o%253D&md5=df238adec63af260b74f1c37d2df607a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.6.1176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.6.1176%26sid%3Dliteratum%253Aachs%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DAcetylation%253A%2520a%2520regulatory%2520modification%2520to%2520rival%2520phosphorylation%253F%26jtitle%3DEMBO.%2520J.%26date%3D2000%26volume%3D19%26spage%3D1176%26epage%3D1179%26doi%3D10.1093%2Femboj%2F19.6.1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Devaiah, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case-Borden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gegonne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerzaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, D. S.</span><span> </span><span class="NLM_article-title">BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/nsmb.3228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnsmb.3228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27159561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFaitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=540-548&author=B.+N.+Devaiahauthor=C.+Case-Bordenauthor=A.+Gegonneauthor=C.+H.+Hsuauthor=Q.+Chenauthor=D.+Meerzamanauthor=A.+Deyauthor=K.+Ozatoauthor=D.+S.+Singer&title=BRD4+is+a+histone+acetyltransferase+that+evicts+nucleosomes+from+chromatin&doi=10.1038%2Fnsmb.3228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin</span></div><div class="casAuthors">Devaiah, Ballachanda N.; Case-Borden, Chanelle; Gegonne, Anne; Hsu, Chih Hao; Chen, Qingrong; Meerzaman, Daoud; Dey, Anup; Ozato, Keiko; Singer, Dinah S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-548</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (BRD4) is a chromatin-binding protein implicated in cancer and autoimmune diseases that functions as a scaffold for transcription factors at promoters and super-enhancers.  Although chromatin decompaction and transcriptional activation of target genes are assocd. with BRD4 binding, the mechanisms involved are unknown.  We report that BRD4 is a histone acetyltransferase (HAT) that acetylates histones H3 and H4 with a pattern distinct from those of other HATs.  Both mouse and human BRD4 have intrinsic HAT activity.  Importantly, BRD4 acetylates H3 K122, a residue crit. for nucleosome stability, thus resulting in nucleosome eviction and chromatin decompaction.  Nucleosome clearance by BRD4 occurs genome wide, including at its targets MYC, FOS and AURKB (Aurora B kinase), resulting in increased transcription.  These findings suggest a model wherein BRD4 actively links chromatin structure and transcription: it mediates chromatin decompaction by acetylating and evicting nucleosomes at target genes, thereby activating transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiIuN9x3auYLVg90H21EOLACvtfcHk0liNgos_kT73nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFaitbw%253D&md5=ce482733951b61a9cf0d024b8cd60d30</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3228%26sid%3Dliteratum%253Aachs%26aulast%3DDevaiah%26aufirst%3DB.%2BN.%26aulast%3DCase-Borden%26aufirst%3DC.%26aulast%3DGegonne%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DMeerzaman%26aufirst%3DD.%26aulast%3DDey%26aufirst%3DA.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DSinger%26aufirst%3DD.%2BS.%26atitle%3DBRD4%2520is%2520a%2520histone%2520acetyltransferase%2520that%2520evicts%2520nucleosomes%2520from%2520chromatin%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D540%26epage%3D548%26doi%3D10.1038%2Fnsmb.3228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Bromodomain: an acetyl-lysine binding domain</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/S0014-5793(01)03309-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS0014-5793%2801%2903309-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=11911891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2002&pages=124-128&author=L.+Zengauthor=M.+M.+Zhou&title=Bromodomain%3A+an+acetyl-lysine+binding+domain&doi=10.1016%2FS0014-5793%2801%2903309-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain: an acetyl-lysine binding domain</span></div><div class="casAuthors">Zeng, Lei; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-128</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 43 refs.  Bromodomains, an extensive family of evolutionarily conserved protein modules originally found in proteins assocd. with chromatin and in nearly all nuclear histone acetyltransferases, have been recently discovered to function as acetyllysine-binding domains.  More recent structural studies of bromodomain/peptide ligand complexes have enriched the understanding of differences in ligand selectivity of bromodomains.  These new findings demonstrate that bromodomain/acetyllysine recognition can serve as a pivotal mechanism for regulating protein-protein interactions in numerous cellular processes including chromatin remodeling and transcriptional activation, and reinforce the concept that functional diversity of a conserved protein modular structure is achieved by evolutionary changes of amino acid sequences in the ligand binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMESL8iZ9agLVg90H21EOLACvtfcHk0liNgos_kT73nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFejtbo%253D&md5=79070a63cd171f846ab577aa9f7092bb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2903309-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252903309-9%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DBromodomain%253A%2520an%2520acetyl-lysine%2520binding%2520domain%26jtitle%3DFEBS%2520Lett.%26date%3D2002%26volume%3D513%26spage%3D124%26epage%3D128%26doi%3D10.1016%2FS0014-5793%2801%2903309-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lange, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaynak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonjes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlesinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Just, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottbauer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelilah-Seyfried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, S.</span><span> </span><span class="NLM_article-title">Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2370</span><span class="NLM_x">–</span> <span class="NLM_lpage">2384</span><span class="refDoi"> DOI: 10.1101/gad.471408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1101%2Fgad.471408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18765789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2370-2384&author=M.+Langeauthor=B.+Kaynakauthor=U.+B.+Forsterauthor=M.+Tonjesauthor=J.+J.+Fischerauthor=C.+Grimmauthor=J.+Schlesingerauthor=S.+Justauthor=I.+Dunkelauthor=T.+Kruegerauthor=S.+Mebusauthor=H.+Lehrachauthor=R.+Lurzauthor=J.+Gobomauthor=W.+Rottbauerauthor=S.+Abdelilah-Seyfriedauthor=S.+Sperling&title=Regulation+of+muscle+development+by+DPF3%2C+a+novel+histone+acetylation+and+methylation+reader+of+the+BAF+chromatin+remodeling+complex&doi=10.1101%2Fgad.471408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex</span></div><div class="casAuthors">Lange, Martin; Kaynak, Bogac; Forster, Ulrike B.; Toenjes, Martje; Fischer, Jenny J.; Grimm, Christina; Schlesinger, Jenny; Just, Steffen; Dunkel, Ilona; Krueger, Tammo; Mebus, Siegrun; Lehrach, Hans; Lurz, Rudi; Gobom, Johan; Rottbauer, Wolfgang; Abdelilah-Seyfried, Salim; Sperling, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2370-2384</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Chromatin remodeling and histone modifications facilitate access of transcription factors to DNA by promoting the unwinding and destabilization of histone-DNA interactions.  We present DPF3, a new epigenetic key factor for heart and muscle development characterized by a double PHD finger.  DPF3 is assocd. with the BAF chromatin remodeling complex and binds methylated and acetylated lysine residues of histone 3 and 4.  Thus, DPF3 may represent the first plant homeodomains that bind acetylated lysines, a feature previously only shown for the bromodomain.  During development Dpf3 is expressed in the heart and somites of mouse, chicken, and zebrafish.  Morpholino knockdown of dpf3 in zebrafish leads to incomplete cardiac looping and severely reduced ventricular contractility, with disassembled muscular fibers caused by transcriptional deregulation of structural and regulatory proteins.  Promoter anal. identified Dpf3 as a novel downstream target of Mef2a.  Taken together, DPF3 adds a further layer of complexity to the BAF complex by representing a tissue-specific anchor between histone acetylations as well as methylations and chromatin remodeling.  Furthermore, this shows that plant homeodomain proteins play a yet unexplored role in recruiting chromatin remodeling complexes to acetylated histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKDUoXByUL7Vg90H21EOLACvtfcHk0liNgos_kT73nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI&md5=173473acf1587d33492b8cee1fa16f88</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1101%2Fgad.471408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.471408%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DM.%26aulast%3DKaynak%26aufirst%3DB.%26aulast%3DForster%26aufirst%3DU.%2BB.%26aulast%3DTonjes%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DJ.%2BJ.%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DSchlesinger%26aufirst%3DJ.%26aulast%3DJust%26aufirst%3DS.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DKrueger%26aufirst%3DT.%26aulast%3DMebus%26aufirst%3DS.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DGobom%26aufirst%3DJ.%26aulast%3DRottbauer%26aufirst%3DW.%26aulast%3DAbdelilah-Seyfried%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520muscle%2520development%2520by%2520DPF3%252C%2520a%2520novel%2520histone%2520acetylation%2520and%2520methylation%2520reader%2520of%2520the%2520BAF%2520chromatin%2520remodeling%2520complex%26jtitle%3DGenes%2520Dev.%26date%3D2008%26volume%3D22%26spage%3D2370%26epage%3D2384%26doi%3D10.1101%2Fgad.471408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span><span class="refDoi"> DOI: 10.1038/nature09139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature09139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20613843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=258-262&author=L.+Zengauthor=Q.+Zhangauthor=S.+Liauthor=A.+N.+Plotnikovauthor=M.+J.+Walshauthor=M.+M.+Zhou&title=Mechanism+and+regulation+of+acetylated+histone+binding+by+the+tandem+PHD+finger+of+DPF3b&doi=10.1038%2Fnature09139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b</span></div><div class="casAuthors">Zeng, Lei; Zhang, Qiang; Li, SiDe; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7303</span>),
    <span class="NLM_cas:pages">258-262</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone lysine acetylation and methylation have an important role during gene transcription in a chromatin context.  Knowledge concerning the types of protein modules that can interact with acetyl-lysine has so far been limited to bromodomains.  Recently, a tandem plant homeodomain (PHD) finger (PHD1-PHD2, or PHD12) of human DPF3b, which functions in assocn. with the BAF chromatin remodeling complex to initiate gene transcription during heart and muscle development, was reported to bind histones H3 and H4 in an acetylation-sensitive manner, making it the first alternative to bromodomains for acetyl-lysine binding.  Here we report the structural mechanism of acetylated histone binding by the double PHD fingers of DPF3b.  Our three-dimensional soln. structures and biochem. anal. of DPF3b highlight the mol. basis of the integrated tandem PHD finger, which acts as one functional unit in the sequence-specific recognition of lysine-14-acetylated histone H3 (H3K14ac).  Whereas the interaction with H3 is promoted by acetylation at lysine 14, it is inhibited by methylation at lysine 4, and these opposing influences are important during transcriptional activation of the mouse DPF3b target genes Pitx2 and Jmjd1c.  Binding of this tandem protein module to chromatin can thus be regulated by different histone modifications during the initiation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIs304GNjB0LVg90H21EOLACvtfcHk0lhT5GGMgUjM4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D&md5=48807136d91002d7454db72c56ece898</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09139%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DWalsh%26aufirst%3DM.%2BJ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DMechanism%2520and%2520regulation%2520of%2520acetylated%2520histone%2520binding%2520by%2520the%2520tandem%2520PHD%2520finger%2520of%2520DPF3b%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D258%26epage%3D262%26doi%3D10.1038%2Fnature09139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botuyan, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mer, G.</span><span> </span><span class="NLM_article-title">Structural basis for recognition of H3K56-acetylated histone H3-H4 by the chaperone Rtt106</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1038/nature10861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature10861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=104-107&author=D.+Suauthor=Q.+Huauthor=Q.+Liauthor=J.+R.+Thompsonauthor=G.+Cuiauthor=A.+Fazlyauthor=B.+A.+Daviesauthor=M.+V.+Botuyanauthor=Z.+Zhangauthor=G.+Mer&title=Structural+basis+for+recognition+of+H3K56-acetylated+histone+H3-H4+by+the+chaperone+Rtt106&doi=10.1038%2Fnature10861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature10861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10861%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DFazly%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DB.%2BA.%26aulast%3DBotuyan%26aufirst%3DM.%2BV.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMer%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520recognition%2520of%2520H3K56-acetylated%2520histone%2520H3-H4%2520by%2520the%2520chaperone%2520Rtt106%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D104%26epage%3D107%26doi%3D10.1038%2Fnature10861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Targeting bromodomains: epigenetic readers of lysine acetylation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1038/nrd4286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnrd4286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24751816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=337-356&author=P.+Filippakopoulosauthor=S.+Knapp&title=Targeting+bromodomains%3A+epigenetic+readers+of+lysine+acetylation&doi=10.1038%2Fnrd4286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bromodomains: epigenetic readers of lysine acetylation</span></div><div class="casAuthors">Filippakopoulos, Panagis; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">337-356</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Lysine acetylation is a key mechanism that regulates chromatin structure; aberrant acetylation levels have been linked to the development of several diseases.  Acetyl-lysine modifications create docking sites for bromodomains, which are small interaction modules found on diverse proteins, some of which have a key role in the acetylation-dependent assembly of transcriptional regulator complexes.  These complexes can then initiate transcriptional programs that result in phenotypic changes.  The recent discovery of potent and highly specific inhibitors for the BET (bromodomain and extra-terminal) family of bromodomains has stimulated intensive research activity in diverse therapeutic areas, particularly in oncol., where BET proteins regulate the expression of key oncogenes and anti-apoptotic proteins.  In addn., targeting BET bromodomains could hold potential for the treatment of inflammation and viral infection.  Here, we highlight recent progress in the development of bromodomain inhibitors, and their potential applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOSIcwBJKj4LVg90H21EOLACvtfcHk0lhT5GGMgUjM4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D&md5=77049c82ce6a19b4685e3b7950399a07</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd4286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4286%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DTargeting%2520bromodomains%253A%2520epigenetic%2520readers%2520of%2520lysine%2520acetylation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D337%26epage%3D356%26doi%3D10.1038%2Fnrd4286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chiang, C. M.</span><span> </span><span class="NLM_article-title">Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4</span> <span class="citation_source-journal">F1000Prime Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="refDoi"> DOI: 10.3410/B1-98</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.3410%2FB1-98" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=98&author=C.+M.+Chiang&title=Brd4+engagement+from+chromatin+targeting+to+transcriptional+regulation%3A+selective+contact+with+acetylated+histone+H3+and+H4&doi=10.3410%2FB1-98"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3410%2FB1-98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3410%252FB1-98%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DC.%2BM.%26atitle%3DBrd4%2520engagement%2520from%2520chromatin%2520targeting%2520to%2520transcriptional%2520regulation%253A%2520selective%2520contact%2520with%2520acetylated%2520histone%2520H3%2520and%2520H4%26jtitle%3DF1000Prime%2520Rep.%26date%3D2009%26volume%3D1%26spage%3D98%26doi%3D10.3410%2FB1-98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitsaz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">8758</span><span class="NLM_x">–</span> <span class="NLM_lpage">8763</span><span class="refDoi"> DOI: 10.1073/pnas.1433065100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1433065100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=8758-8763&author=A.+Deyauthor=F.+Chitsazauthor=A.+Abbasiauthor=T.+Misteliauthor=K.+Ozato&title=The+double+bromodomain+protein+Brd4+binds+to+acetylated+chromatin+during+interphase+and+mitosis&doi=10.1073%2Fpnas.1433065100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1433065100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1433065100%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DA.%26aulast%3DChitsaz%26aufirst%3DF.%26aulast%3DAbbasi%26aufirst%3DA.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DThe%2520double%2520bromodomain%2520protein%2520Brd4%2520binds%2520to%2520acetylated%2520chromatin%2520during%2520interphase%2520and%2520mitosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D8758%26epage%3D8763%26doi%3D10.1073%2Fpnas.1433065100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span> </span><span class="NLM_article-title">Disrupting acetyl-lysine recognition: Progress in the development of bromodomain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1298</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1271-1298&author=F.+A.+Romeroauthor=A.+M.+Taylorauthor=T.+D.+Crawfordauthor=V.+Tsuiauthor=A.+Coteauthor=S.+Magnuson&title=Disrupting+acetyl-lysine+recognition%3A+Progress+in+the+development+of+bromodomain+inhibitors&doi=10.1021%2Facs.jmedchem.5b01514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors</span></div><div class="casAuthors">Romero, F. Anthony; Taylor, Alexander M.; Crawford, Terry D.; Tsui, Vickie; Cote, Alexandre; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1271-1298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as "readers" that ultimately det. the functional outcome of the post-translational modification.  Because the initial discovery of selective BET inhibitors have helped define the role of that protein family in oncol. and inflammation, BET bromodomains have continued to garner the most attention of any other bromodomain.  More recently, non-BET bromodomain inhibitors that are potent and selective have been disclosed for ATAD2, CBP, BRD7/9, BRPF, BRPF/TRIM24, CECR2, SMARCA4, and BAZ2A/B.  Such novel inhibitors can be used to probe the physiol. function of these non-BET bromodomains and further understanding of their role in certain disease states.  Here, we provide an update to the progress in identifying selective bromodomain inhibitors and their use as biol. tools, as well as our perspective on the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgbRrKGlHaVLVg90H21EOLACvtfcHk0lhiuJBbJuPVVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO&md5=260352f61301aa88aad48c0b63e6152f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01514%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DDisrupting%2520acetyl-lysine%2520recognition%253A%2520Progress%2520in%2520the%2520development%2520of%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1271%26epage%3D1298%26doi%3D10.1021%2Facs.jmedchem.5b01514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ghoshal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yugandhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A. K.</span><span> </span><span class="NLM_article-title">BET inhibitors in cancer therapeutics: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1517/13543776.2016.1159299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1517%2F13543776.2016.1159299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26924192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Wksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=505-522&author=A.+Ghoshalauthor=D.+Yugandharauthor=A.+K.+Srivastava&title=BET+inhibitors+in+cancer+therapeutics%3A+a+patent+review&doi=10.1517%2F13543776.2016.1159299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitors in cancer therapeutics: a patent review</span></div><div class="casAuthors">Ghoshal, Anirban; Yugandhar, D.; Srivastava, Ajay Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-522</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Introduction: Inhibition of Bromodomain and Extra Terminal (BET) proteins is an emerging approach for developing advanced cancer therapeutics.  In 2015, at least thirty patents have been published for developing cancer chemotherapeutics by targeting BET.  Currently there are seven small mol. BET inhibitors in various stages of clin. trials for the development of anti-cancer drugs.  Areas covered: Important patents focusing on development of BET inhibitors as potential cancer therapeutics published in 2015 have been covered.  The reports are presented together with a review of the related structural chem. space.  This review mainly focuses on the therapeutic applications, chem. class and structural modifications along with the mols. currently in clin. trials.  Expert opinion: BET sub-family proteins are one of the emerging targets to develop anti-cancer agents.  Although many research groups have demonstrated the rationality of BET inhibition to combat cancer, a detailed mol. study needs to be performed to investigate the affected biol. pathways.  Selectivity among BET proteins should be kept in mind while developing BET inhibitors.  In-silico mol. modeling studies can also provide valuable information for designing selective BET inhibitors towards anti-cancer drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByvS8sb7HhLVg90H21EOLACvtfcHk0lhiuJBbJuPVVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Wksbw%253D&md5=02d7c0cc89a2a712990ceb2e19079f36</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1159299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1159299%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26aulast%3DYugandhar%26aufirst%3DD.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26atitle%3DBET%2520inhibitors%2520in%2520cancer%2520therapeutics%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D505%26epage%3D522%26doi%3D10.1517%2F13543776.2016.1159299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span> </span><span class="NLM_article-title">Small-molecule BET inhibitors in clinical and preclinical development and their therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.2174/1568026615666150302110135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.2174%2F1568026615666150302110135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25732788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=776-794&author=L.+Yuauthor=Z.+Wangauthor=Z.+Zhangauthor=X.+Renauthor=X.+Luauthor=K.+Ding&title=Small-molecule+BET+inhibitors+in+clinical+and+preclinical+development+and+their+therapeutic+potential&doi=10.2174%2F1568026615666150302110135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule BET Inhibitors in Clinical and Preclinical Development and Their Therapeutic Potential</span></div><div class="casAuthors">Yu, Lei; Wang, Zhen; Zhang, Zhang; Ren, Xiaomei; Lu, Xiaoyun; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">776-794</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Lysine acetylation is a pivotal mechanism in chromatin processes and the regulation of gene transcription.  The acetylated lysine residues of histones are exclusively recognized by bromodomains (BRDs) known as epigenetic reader.  Proteins contg. BRDs undergo a post-translational modification (PTM) with development of cellular signaling and disease biol.  The bromo and extra-terminal (BET) proteins are the second subfamily, which play important roles in cellular proliferation, cell cycle progression and chromatin compaction.  Recently, a variety of small mols. have been reported to interact with the BET family proteins and accelerate the validation of BET proteins as druggable targets for treatment of cancers, inflammation and related diseases.  In this review, we will summarize the small-mol. inhibitors in clin. and preclin. studies of the BET family bromodomains and their medicinal implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk52FOUPlX8bVg90H21EOLACvtfcHk0lhiuJBbJuPVVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D&md5=802bf7b832d46c2b18ef6ac77eda1445</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150302110135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150302110135%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DSmall-molecule%2520BET%2520inhibitors%2520in%2520clinical%2520and%2520preclinical%2520development%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D776%26epage%3D794%26doi%3D10.2174%2F1568026615666150302110135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7346</span><span class="NLM_x">–</span> <span class="NLM_lpage">7359</span><span class="refDoi"> DOI: 10.1021/jm300346w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300346w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7346-7359&author=L.+R.+Vidlerauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Druggability+analysis+and+structural+classification+of+bromodomain+acetyl-lysine+binding+sites&doi=10.1021%2Fjm300346w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites</span></div><div class="casAuthors">Vidler, Lewis R.; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7346-7359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are readers of the epigenetic code that specifically bind acetyl-lysine contg. recognition sites on proteins.  Recently the BET family of bromodomains has been demonstrated to be druggable through the discovery of potent inhibitors, sparking an interest in protein-protein interaction inhibitors that directly target gene transcription.  Here, we assess the druggability of diverse members of the bromodomain family using SiteMap and show that there are significant differences in predicted druggability.  Furthermore, we trace these differences in druggability back to unique amino acid signatures in the bromodomain acetyl-lysine binding sites.  These signatures were then used to generate a new classification of the bromodomain family, visualized as a classification tree.  This represents the first anal. of this type for the bromodomain family and can prove useful in the discovery of inhibitors, particularly for anticipating screening hit rates, identifying inhibitors that can be explored for lead hopping approaches, and selecting proteins for selectivity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxYqQyqqj7JrVg90H21EOLACvtfcHk0lgaRnrQEImBYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN&md5=bfb08154c1964aab5df51cb3513f2c1d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300346w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300346w%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDruggability%2520analysis%2520and%2520structural%2520classification%2520of%2520bromodomain%2520acetyl-lysine%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7346%26epage%3D7359%26doi%3D10.1021%2Fjm300346w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Dhalluin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Structure and ligand of a histone acetyltransferase bromodomain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1038/20974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2F20974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10365964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=491-496&author=C.+Dhalluinauthor=J.+E.+Carlsonauthor=L.+Zengauthor=C.+Heauthor=A.+K.+Aggarwalauthor=M.-M.+Zhou&title=Structure+and+ligand+of+a+histone+acetyltransferase+bromodomain&doi=10.1038%2F20974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and ligand of a histone acetyltransferase bromodomain</span></div><div class="casAuthors">Dhalluin, Christophe; Carlson, Justin E.; Zeng, Lei; He, Cheng; Aggarwal, Aneel K.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6735</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone acetylation is important in chromatin remodelling and gene activation.  Nearly all known histone-acetyltransferase (HAT)-assocd. transcriptional co-activators contain bromodomains, which are ∼110-amino-acid modules found in many chromatin-assocd. proteins.  Despite the wide occurrence of these bromodomains, their three-dimensional structure and binding partners remain unknown.  Here we report the soln. structure of the bromodomain of the HAT co-activator P/CAF (p300/CBP-assocd. factor).  The structure reveals an unusual left-handed up-and-down four-helix bundle.  In addn., we show by a combination of structural and site-directed mutagenesis studies that bromodomains can interact specifically with acetylated lysine, making them the first known protein modules to do so.  The nature of the recognition of acetyl-lysine by the P/CAF bromodomain is similar to that of acetyl-CoA by histone acetyltransferase.  Thus, the bromodomain is functionally linked to the HAT activity of co-activators in the regulation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTbwcjeBG_rVg90H21EOLACvtfcHk0lgaRnrQEImBYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D&md5=ff1063ba81d81b431065dd6e3751ba79</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F20974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F20974%26sid%3Dliteratum%253Aachs%26aulast%3DDhalluin%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DJ.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DAggarwal%26aufirst%3DA.%2BK.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DStructure%2520and%2520ligand%2520of%2520a%2520histone%2520acetyltransferase%2520bromodomain%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D491%26epage%3D496%26doi%3D10.1038%2F20974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fukazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masumi, A.</span><span> </span><span class="NLM_article-title">The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2064</span><span class="NLM_x">–</span> <span class="NLM_lpage">2068</span><span class="refDoi"> DOI: 10.1248/bpb.b12-00527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1248%2Fbpb.b12-00527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22971749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Oit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=2064-2068&author=H.+Fukazawaauthor=A.+Masumi&title=The+conserved+12-amino+acid+stretch+in+the+inter-bromodomain+region+of+BET+family+proteins+functions+as+a+nuclear+localization+signal&doi=10.1248%2Fbpb.b12-00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal</span></div><div class="casAuthors">Fukazawa, Hidesuke; Masumi, Atsuko</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2064-2068</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">The bromodomain and extraterminal (BET) family is a group of chromatin-binding proteins characterized by two bromodomains, an extraterminal (ET) domain, and several other conserved regions of unknown function.  In humans, the BET family consists of four members, BRD2, BRD3, BRD4 and BRDT, that all normally localize to the nucleus.  We identified a 12-amino acid stretch in the inter-bromodomain region that is perfectly conserved among the BET family members.  We deleted these residues and expressed the mutant proteins in HEK293T cells to investigate the function of this motif.  We found that the deletion of this motif alters the localization of BET proteins.  Mutated BRD3 and BRD4 were excluded from the nucleus, and BRDT was found to be diffused throughout the nucleus and cytoplasm.  Although the mutant BRD2 remained predominantly in the nucleus, a punctate distribution was also obsd. in the cytosol.  It has been reported that a conserved motif between the second bromodomain and the ET domain serves as a nuclear localization signal for BRD2.  Nevertheless, BET mutants lacking the reported nuclear localization signal motif but retaining the 12-amino acid stretch resided in the nucleus.  Furthermore, these mutants were diffused throughout the cytoplasm when the 12 residues were removed.  These results indicate that the conserved amino acid stretch in the inter-bromodomain region of the BET family functions as a nuclear localization signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXSbWjbeH6bVg90H21EOLACvtfcHk0lgaRnrQEImBYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Oit7g%253D&md5=25fcefbba354becd35ad702cc3420933</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b12-00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b12-00527%26sid%3Dliteratum%253Aachs%26aulast%3DFukazawa%26aufirst%3DH.%26aulast%3DMasumi%26aufirst%3DA.%26atitle%3DThe%2520conserved%252012-amino%2520acid%2520stretch%2520in%2520the%2520inter-bromodomain%2520region%2520of%2520BET%2520family%2520proteins%2520functions%2520as%2520a%2520nuclear%2520localization%2520signal%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D35%26spage%3D2064%26epage%3D2068%26doi%3D10.1248%2Fbpb.b12-00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Jones, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimane, M.</span><span> </span><span class="NLM_article-title">Identification and characterization of BRDT: A testis-specific gene related to the bromodomain genes RING3 and Drosophila fsh</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1006/geno.1997.5000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1006%2Fgeno.1997.5000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=529-534&author=M.+H.+Jonesauthor=M.+Numataauthor=M.+Shimane&title=Identification+and+characterization+of+BRDT%3A+A+testis-specific+gene+related+to+the+bromodomain+genes+RING3+and+Drosophila+fsh&doi=10.1006%2Fgeno.1997.5000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1997.5000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1997.5000%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%2BH.%26aulast%3DNumata%26aufirst%3DM.%26aulast%3DShimane%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520BRDT%253A%2520A%2520testis-specific%2520gene%2520related%2520to%2520the%2520bromodomain%2520genes%2520RING3%2520and%2520Drosophila%2520fsh%26jtitle%3DGenomics%26date%3D1997%26volume%3D45%26spage%3D529%26epage%3D534%26doi%3D10.1006%2Fgeno.1997.5000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Shang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolgemuth, D. J.</span><span> </span><span class="NLM_article-title">The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">3507</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span><span class="refDoi"> DOI: 10.1242/dev.004481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1242%2Fdev.004481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17728347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2007&pages=3507-3515&author=E.+Shangauthor=H.+D.+Nickersonauthor=D.+Wenauthor=X.+Wangauthor=D.+J.+Wolgemuth&title=The+first+bromodomain+of+Brdt%2C+a+testis-specific+member+of+the+BET+sub-family+of+double-bromodomain-containing+proteins%2C+is+essential+for+male+germ+cell+differentiation&doi=10.1242%2Fdev.004481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation</span></div><div class="casAuthors">Shang, Enyuan; Nickerson, Helen D.; Wen, Duancheng; Wang, Xiangyuan; Wolgemuth, Debra J.</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3507-3515</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Brdt is a testis-specific member of the distinctive BET sub-family of bromodomain motif-contg. proteins, a motif that binds acetylated lysines and is implicated in chromatin remodeling.  Its expression is restricted to the germ line, specifically to pachytene and diplotene spermatocytes and early spermatids.  Targeted mutagenesis was used to generate mice carrying a mutant allele of Brdt, BrdtΔBD1, which lacks only the first of the two bromodomains that uniquely characterize BET proteins.  Homozygous BrdtΔBD1/ΔBD1 mice were viable but males were sterile, producing fewer and morphol. abnormal sperm.  Aberrant morphogenesis was first detected in step 9 elongating spermatids, and those elongated spermatids that were formed lacked the distinctive foci of heterochromatin at the peri-nuclear envelope.  Quant. reverse transcription (RT)-PCR showed threefold increased levels of histone H1t (Hist1h1t) in BrdtΔBD1/ΔBD1 testes and chromatin immunopptn. revealed that Brdt protein, but not BrdtΔBD1 protein, was assocd. with the promoter of H1t.  Intracytoplasmic sperm injection suggested that the DNA in the BrdtΔBD1 mutant sperm could support early embryonic development and yield functional embryonic stem cells.  This is the first demonstration that deletion of just one of the two bromodomains in members of the BET sub-family of bromodomain-contg. proteins has profound effects on in vivo differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDa2lSw-mPaLVg90H21EOLACvtfcHk0liRJvaZyceaPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitbfJ&md5=f8ef8a8ab721f0eebf4441ffc35eee93</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1242%2Fdev.004481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.004481%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DE.%26aulast%3DNickerson%26aufirst%3DH.%2BD.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWolgemuth%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520first%2520bromodomain%2520of%2520Brdt%252C%2520a%2520testis-specific%2520member%2520of%2520the%2520BET%2520sub-family%2520of%2520double-bromodomain-containing%2520proteins%252C%2520is%2520essential%2520for%2520male%2520germ%2520cell%2520differentiation%26jtitle%3DDevelopment%26date%3D2007%26volume%3D134%26spage%3D3507%26epage%3D3515%26doi%3D10.1242%2Fdev.004481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. H.</span><span> </span><span class="NLM_article-title">RNA polymerase II elongation control</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1146/annurev-biochem-052610-095910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1146%2Fannurev-biochem-052610-095910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22404626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGls7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=119-143&author=Q.+Zhouauthor=T.+Liauthor=D.+H.+Price&title=RNA+polymerase+II+elongation+control&doi=10.1146%2Fannurev-biochem-052610-095910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">RNA polymerase II elongation control</span></div><div class="casAuthors">Zhou, Qiang; Li, Tiandao; Price, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-143</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Regulation of the elongation phase of transcription by RNA polymerase II (Pol II) is utilized extensively to generate the pattern of mRNAs needed to specify cell types and to respond to environmental changes.  After Pol II initiates, neg. elongation factors cause it to pause in a promoter proximal position.  These polymerases are poised to respond to the pos. transcription elongation factor P-TEFb, and then enter productive elongation only under the appropriate set of signals to generate full-length properly processed mRNAs.  Recent global analyses of Pol II and elongation factors, mechanisms that regulate P-TEFb involving the 7SK small nuclear ribonucleoprotein (snRNP), factors that control both the neg. and pos. elongation properties of Pol II, and the mRNA processing events that are coupled with elongation are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo60CSYt9WFzLVg90H21EOLACvtfcHk0liRJvaZyceaPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGls7bN&md5=38b677c9655caf0e767b1ea61e4b47b9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-052610-095910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-052610-095910%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DD.%2BH.%26atitle%3DRNA%2520polymerase%2520II%2520elongation%2520control%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2012%26volume%3D81%26spage%3D119%26epage%3D143%26doi%3D10.1146%2Fannurev-biochem-052610-095910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howley, P. M.</span><span> </span><span class="NLM_article-title">The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2641</span><span class="NLM_x">–</span> <span class="NLM_lpage">2652</span><span class="refDoi"> DOI: 10.1128/MCB.01341-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.01341-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21555454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=2641-2652&author=S.+Rahmanauthor=M.+E.+Sowaauthor=M.+Ottingerauthor=J.+A.+Smithauthor=Y.+Shiauthor=J.+W.+Harperauthor=P.+M.+Howley&title=The+Brd4+extraterminal+domain+confers+transcription+activation+independent+of+pTEFb+by+recruiting+multiple+proteins%2C+including+NSD3&doi=10.1128%2FMCB.01341-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3</span></div><div class="casAuthors">Rahman, Shaila; Sowa, Mathew E.; Ottinger, Matthias; Smith, Jennifer A.; Shi, Yang; Harper, J. Wade; Howley, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2641-2652</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (Brd4) plays crit. roles in development, cancer progression, and virus-host pathogenesis.  To gain mechanistic insight into the various biol. functions of Brd4, we performed a proteomic anal. to identify and characterize Brd4-assocd. cellular proteins.  We found that the extraterminal (ET) domain, whose function has to date not been detd., interacts with NSD3, JMJD6, CHD4, GLTSCR1, and ATAD5.  These ET-domain interactions were also conserved for Brd2 and Brd3, the other human BET proteins tested.  We demonstrated that GLTSCR1, NSD3, and JMJD6 impart a pTEFb-independent transcriptional activation function on Brd4.  NSD3 as well as JMJD6 is recruited to regulated genes in a Brd4-dependent manner.  Moreover, we found that depletion of Brd4 or NSD3 reduces H3K36 methylation, demonstrating that the Brd4/NSD3 complex regulates this specific histone modification.  Our results indicate that the Brd4 ET domain through the recruitment of the specific effectors regulates transcriptional activity.  In particular, we show that one of these effectors, NSD3, regulates transcription by modifying the chromatin microenvironment at Brd4 target genes.  Our study thus identifies the ET domain as a second important transcriptional regulatory domain for Brd4 in addn. to the carboxyl-terminal domain (CTD) that interacts with pTEFb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlypbenIW4s7Vg90H21EOLACvtfcHk0liRJvaZyceaPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7s%253D&md5=921d55b32a568783ffffdb20cef2f27c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.01341-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01341-10%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DSowa%26aufirst%3DM.%2BE.%26aulast%3DOttinger%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DHowley%26aufirst%3DP.%2BM.%26atitle%3DThe%2520Brd4%2520extraterminal%2520domain%2520confers%2520transcription%2520activation%2520independent%2520of%2520pTEFb%2520by%2520recruiting%2520multiple%2520proteins%252C%2520including%2520NSD3%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D2641%26epage%3D2652%26doi%3D10.1128%2FMCB.01341-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lamonica, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadauke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamsjaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billin, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardison, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, G. A.</span><span> </span><span class="NLM_article-title">Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">E159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1073/pnas.1102140108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1102140108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21536911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A280%3ADC%252BC3MrmtlGgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E159-168&author=J.+M.+Lamonicaauthor=W.+Dengauthor=S.+Kadaukeauthor=A.+E.+Campbellauthor=R.+Gamsjaegerauthor=H.+Wangauthor=Y.+Chengauthor=A.+N.+Billinauthor=R.+C.+Hardisonauthor=J.+P.+Mackayauthor=G.+A.+Blobel&title=Bromodomain+protein+Brd3+associates+with+acetylated+GATA1+to+promote+its+chromatin+occupancy+at+erythroid+target+genes&doi=10.1073%2Fpnas.1102140108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes</span></div><div class="casAuthors">Lamonica Janine M; Deng Wulan; Kadauke Stephan; Campbell Amy E; Gamsjaeger Roland; Wang Hongxin; Cheng Yong; Billin Andrew N; Hardison Ross C; Mackay Joel P; Blobel Gerd A</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">E159-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylation of histones triggers association with bromodomain-containing proteins that regulate diverse chromatin-related processes.  Although acetylation of transcription factors has been appreciated for some time, the mechanistic consequences are less well understood.  The hematopoietic transcription factor GATA1 is acetylated at conserved lysines that are required for its stable association with chromatin.  We show that the BET family protein Brd3 binds via its first bromodomain (BD1) to GATA1 in an acetylation-dependent manner in vitro and in vivo.  Mutation of a single residue in BD1 that is involved in acetyl-lysine binding abrogated recruitment of Brd3 by GATA1, demonstrating that acetylation of GATA1 is essential for Brd3 association with chromatin.  Notably, Brd3 is recruited by GATA1 to both active and repressed target genes in a fashion seemingly independent of histone acetylation.  Anti-Brd3 ChIP followed by massively parallel sequencing in GATA1-deficient erythroid precursor cells and those that are GATA1 replete revealed that GATA1 is a major determinant of Brd3 recruitment to genomic targets within chromatin.  A pharmacologic compound that occupies the acetyl-lysine binding pockets of Brd3 bromodomains disrupts the Brd3-GATA1 interaction, diminishes the chromatin occupancy of both proteins, and inhibits erythroid maturation.  Together these findings provide a mechanism for GATA1 acetylation and suggest that Brd3 "reads" acetyl marks on nuclear factors to promote their stable association with chromatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeZ8VSdvvG7p6KlWarZTAzfW6udTcc2ebgxeblqLauCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrmtlGgtQ%253D%253D&md5=b81056e4aee1351dce3899fb8d4e86e8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1102140108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1102140108%26sid%3Dliteratum%253Aachs%26aulast%3DLamonica%26aufirst%3DJ.%2BM.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DKadauke%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%2BE.%26aulast%3DGamsjaeger%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DHardison%26aufirst%3DR.%2BC.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26aulast%3DBlobel%26aufirst%3DG.%2BA.%26atitle%3DBromodomain%2520protein%2520Brd3%2520associates%2520with%2520acetylated%2520GATA1%2520to%2520promote%2520its%2520chromatin%2520occupancy%2520at%2520erythroid%2520target%2520genes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3DE159%26epage%3D168%26doi%3D10.1073%2Fpnas.1102140108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gamsjaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamonica, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span> </span><span class="NLM_article-title">Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2632</span><span class="NLM_x">–</span> <span class="NLM_lpage">2640</span><span class="refDoi"> DOI: 10.1128/MCB.05413-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.05413-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21555453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=2632-2640&author=R.+Gamsjaegerauthor=S.+R.+Webbauthor=J.+M.+Lamonicaauthor=A.+Billinauthor=G.+A.+Blobelauthor=J.+P.+Mackay&title=Structural+basis+and+specificity+of+acetylated+transcription+factor+GATA1+recognition+by+BET+family+bromodomain+protein+Brd3&doi=10.1128%2FMCB.05413-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3</span></div><div class="casAuthors">Gamsjaeger, Roland; Webb, Sarah R.; Lamonica, Janine M.; Billin, Andrew; Blobel, Gerd A.; MacKay, Joel P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2632-2640</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Recent data demonstrate that small synthetic compds. specifically targeting bromodomain proteins can modulate the expression of cancer-related or inflammatory genes.  Although these studies have focused on the ability of bromodomains to recognize acetylated histones, it is increasingly becoming clear that histone-like modifications exist on other important proteins, such as transcription factors.  However, our understanding of the mol. mechanisms through which these modifications modulate protein function is far from complete.  The transcription factor GATA1 can be acetylated at lysine residues adjacent to the zinc finger domains, and this acetylation is essential for the normal chromatin occupancy of GATA1.  We have recently identified the bromodomain-contg. protein Brd3 as a cofactor that interacts with acetylated GATA1 and shown that this interaction is essential for the targeting of GATA1 to chromatin.  Here we describe the structural basis for this interaction.  Our data reveal for the first time the mol. details of an interaction between a transcription factor bearing multiple acetylation modifications and its cognate recognition module.  We also show that this interaction can be inhibited by an acetyllysine mimic, highlighting the importance of further increasing the specificity of compds. that target bromodomain and extraterminal (BET) bromodomains in order to fully realize their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMrxbrtYbDm7Vg90H21EOLACvtfcHk0ljRwKjZU9oB_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7o%253D&md5=c4acf39a79bef71519e318ff3dff6423</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FMCB.05413-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.05413-11%26sid%3Dliteratum%253Aachs%26aulast%3DGamsjaeger%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DS.%2BR.%26aulast%3DLamonica%26aufirst%3DJ.%2BM.%26aulast%3DBillin%26aufirst%3DA.%26aulast%3DBlobel%26aufirst%3DG.%2BA.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520basis%2520and%2520specificity%2520of%2520acetylated%2520transcription%2520factor%2520GATA1%2520recognition%2520by%2520BET%2520family%2520bromodomain%2520protein%2520Brd3%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D2632%26epage%3D2640%26doi%3D10.1128%2FMCB.05413-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1007/s11010-006-9223-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1007%2Fs11010-006-9223-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2007&pages=45-54&author=J.+Pengauthor=W.+Dongauthor=L.+Chenauthor=T.+Zouauthor=Y.+Qiauthor=Y.+Liu&title=Brd2+is+a+TBP-associated+protein+and+recruits+TBP+into+E2F-1+transcriptional+complex+in+response+to+serum+stimulation&doi=10.1007%2Fs11010-006-9223-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs11010-006-9223-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-006-9223-6%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DT.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DBrd2%2520is%2520a%2520TBP-associated%2520protein%2520and%2520recruits%2520TBP%2520into%2520E2F-1%2520transcriptional%2520complex%2520in%2520response%2520to%2520serum%2520stimulation%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D294%26spage%3D45%26epage%3D54%26doi%3D10.1007%2Fs11010-006-9223-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Place your BETs: the therapeutic potential of bromodomains</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1016/j.tips.2011.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.tips.2011.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22277300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=146-153&author=R.+K.+Prinjhaauthor=J.+Witheringtonauthor=K.+Lee&title=Place+your+BETs%3A+the+therapeutic+potential+of+bromodomains&doi=10.1016%2Fj.tips.2011.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Place your BETs: the therapeutic potential of bromodomains</span></div><div class="casAuthors">Prinjha, R. K.; Witherington, J.; Lee, K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">146-153</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Therapeutic targeting of the processes that regulate histone modification is a growing area of scientific exploration.  Although most interest has concd. on the various families of enzymes that contribute to these processes, this review focuses on emerging data demonstrating the chem. tractability and therapeutic potential of a hitherto underexplored family of proteins, namely the bromodomain (BRD) family of reader proteins.  These proteins perform a crucial role in translating histone modifications with powerful transcriptional consequences.  We review current knowledge of the biol. of this emergent target class and highlight recent breakthroughs that now make the BRD family of reader proteins attractive for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_N9p7ru787rVg90H21EOLACvtfcHk0ljRwKjZU9oB_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOlt74%253D&md5=ea1e9e5740b1131239aa0407748d549b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2011.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2011.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DPlace%2520your%2520BETs%253A%2520the%2520therapeutic%2520potential%2520of%2520bromodomains%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D146%26epage%3D153%26doi%3D10.1016%2Fj.tips.2011.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez-Dacal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span> </span><span class="NLM_article-title">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">19754</span><span class="NLM_x">–</span> <span class="NLM_lpage">19759</span><span class="refDoi"> DOI: 10.1073/pnas.1310658110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1310658110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24248379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19754-19759&author=S.+Picaudauthor=C.+Wellsauthor=I.+Felletarauthor=D.+Brothertonauthor=S.+Martinauthor=P.+Savitskyauthor=B.+Diez-Dacalauthor=M.+Philpottauthor=C.+Bountraauthor=H.+Lingardauthor=O.+Fedorovauthor=S.+Mullerauthor=P.+E.+Brennanauthor=S.+Knappauthor=P.+Filippakopoulos&title=RVX-208%2C+an+inhibitor+of+BET+transcriptional+regulators+with+selectivity+for+the+second+bromodomain&doi=10.1073%2Fpnas.1310658110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</span></div><div class="casAuthors">Picaud, Sarah; Wells, Christopher; Felletar, Ildiko; Brotherton, Deborah; Martin, Sarah; Savitsky, Pavel; Diez-Dacal, Beatriz; Philpott, Martin; Bountra, Chas; Lingard, Hannah; Fedorov, Oleg; Muller, Susanne; Brennan, Paul E.; Knapp, Stefan; Filippakopoulos, Panagis</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19754-19759,S19754/1-S19754/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bromodomains have emerged as attractive candidates for the development of inhibitors targeting gene transcription.  Inhibitors of the bromo and extraterminal (BET) family recently showed promising activity in diverse disease models.  However, the pleiotropic nature of BET proteins regulating tissue-specific transcription has raised safety concerns and suggested that attempts should be made for domain-specific targeting.  Here, we report that RVX-208, a compd. currently in phase II clin. trials, is a BET bromodomain inhibitor specific for second bromodomains (BD2s).  Cocrystal structures revealed binding modes of RVX-208 and its synthetic precursor, and fluorescent recovery after photobleaching demonstrated that RVX-208 displaces BET proteins from chromatin.  However, gene-expression data showed that BD2 inhibition only modestly affects BET-dependent gene transcription.  Our data demonstrate the feasibility of specific targeting within the BET family resulting in different transcriptional outcomes and highlight the importance of BD1 in transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamW8vnIopKrVg90H21EOLACvtfcHk0lhoJ81runtCbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN&md5=c918702c9fdb91241bc837732730f7f6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1310658110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1310658110%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DDiez-Dacal%26aufirst%3DB.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DLingard%26aufirst%3DH.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3DRVX-208%252C%2520an%2520inhibitor%2520of%2520BET%2520transcriptional%2520regulators%2520with%2520selectivity%2520for%2520the%2520second%2520bromodomain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D19754%26epage%3D19759%26doi%3D10.1073%2Fpnas.1310658110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnathan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7501</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span><span class="refDoi"> DOI: 10.1021/jm401088k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401088k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSls7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7501-7515&author=O.+Mirguetauthor=R.+Gosminiauthor=J.+Toumauthor=C.+A.+Clementauthor=M.+Barnathanauthor=J.+M.+Brusqauthor=J.+E.+Mordauntauthor=R.+M.+Grimesauthor=M.+Croweauthor=O.+Pineauauthor=M.+Ajakaneauthor=A.+Dauganauthor=P.+Jeffreyauthor=L.+Cutlerauthor=A.+C.+Haynesauthor=N.+N.+Smithersauthor=C.+W.+Chungauthor=P.+Bamboroughauthor=I.+J.+Uingsauthor=A.+Lewisauthor=J.+Witheringtonauthor=N.+Parrauthor=R.+K.+Prinjhaauthor=E.+Nicodeme&title=Discovery+of+epigenetic+regulator+I-BET762%3A+lead+optimization+to+afford+a+clinical+candidate+inhibitor+of+the+BET+bromodomains&doi=10.1021%2Fjm401088k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains</span></div><div class="casAuthors">Mirguet, Olivier; Gosmini, Romain; Toum, Jerome; Clement, Catherine A.; Barnathan, Melanie; Brusq, Jean-Marie; Mordaunt, Jacqueline E.; Grimes, Richard M.; Crowe, Miriam; Pineau, Olivier; Ajakane, Myriam; Daugan, Alain; Jeffrey, Phillip; Cutler, Leanne; Haynes, Andrea C.; Smithers, Nicholas N.; Chung, Chun-wa; Bamborough, Paul; Uings, Iain J.; Lewis, Antonia; Witherington, Jason; Parr, Nigel; Prinjha, Rab K.; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7501-7515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bromo and extra C-terminal domain (BET) family of bromodomains are involved in binding epigenetic marks on histone proteins, more specifically acetylated lysine residues.  This paper describes the discovery and structure-activity relationships (SAR) of potent benzodiazepine inhibitors that disrupt the function of the BET family of bromodomains (BRD2, BRD3, and BRD4).  This work has yielded a potent, selective compd. I-BET762 (I) that is now under evaluation in a phase I/II clin. trial for nuclear protein in testis (NUT) midline carcinoma and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDitaXJSnFE7Vg90H21EOLACvtfcHk0lhoJ81runtCbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSls7jJ&md5=5d059b0be08a74a5721b72a120f7e090</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm401088k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401088k%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBarnathan%26aufirst%3DM.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DGrimes%26aufirst%3DR.%2BM.%26aulast%3DCrowe%26aufirst%3DM.%26aulast%3DPineau%26aufirst%3DO.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%2BC.%26aulast%3DSmithers%26aufirst%3DN.%2BN.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520epigenetic%2520regulator%2520I-BET762%253A%2520lead%2520optimization%2520to%2520afford%2520a%2520clinical%2520candidate%2520inhibitor%2520of%2520the%2520BET%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7501%26epage%3D7515%26doi%3D10.1021%2Fjm401088k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Coude, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffoux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzykson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delord, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riveiro, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herait, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baruchel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, C.</span><span> </span><span class="NLM_article-title">BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">17698</span><span class="NLM_x">–</span> <span class="NLM_lpage">17712</span><span class="refDoi"> DOI: 10.18632/oncotarget.4131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.18632%2Foncotarget.4131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25989842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A280%3ADC%252BC2MflsVChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=17698-17712&author=M.+M.+Coudeauthor=T.+Braunauthor=J.+Berrouauthor=M.+Dupontauthor=S.+Bertrandauthor=A.+Masseauthor=E.+Raffouxauthor=R.+Itzyksonauthor=M.+Delordauthor=M.+E.+Riveiroauthor=P.+Heraitauthor=A.+Baruchelauthor=H.+Dombretauthor=C.+Gardin&title=BET+inhibitor+OTX015+targets+BRD2+and+BRD4+and+decreases+c-MYC+in+acute+leukemia+cells&doi=10.18632%2Foncotarget.4131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells</span></div><div class="casAuthors">Coude Marie-Magdelaine; Braun Thorsten; Berrou Jeannig; Dupont Melanie; Bertrand Sibyl; Masse Aline; Raffoux Emmanuel; Itzykson Raphael; Baruchel Andre; Dombret Herve; Gardin Claude; Coude Marie-Magdelaine; Braun Thorsten; Gardin Claude; Raffoux Emmanuel; Itzykson Raphael; Dombret Herve; Delord Marc; Riveiro Maria E; Herait Patrice; Baruchel Andre</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">17698-712</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The bromodomain (BRD) and extraterminal (BET) proteins including BRD2, BRD3 and BRD4 have been identified as key targets for leukemia maintenance.  A novel oral inhibitor of BRD2/3/4, the thienotriazolodiazepine compound OTX015, suitable for human use, is available.  Here we report its biological effects in AML and ALL cell lines and leukemic samples.  Exposure to OTX015 lead to cell growth inhibition, cell cycle arrest and apoptosis at submicromolar concentrations in acute leukemia cell lines and patient-derived leukemic cells, as described with the canonical JQ1 BET inhibitor.  Treatment with JQ1 and OTX15 induces similar gene expression profiles in sensitive cell lines, including a c-MYC decrease and an HEXIM1 increase.  OTX015 exposure also induced a strong decrease of BRD2, BRD4 and c-MYC and increase of HEXIM1 proteins, while BRD3 expression was unchanged. c-MYC, BRD2, BRD3, BRD4 and HEXIM1 mRNA levels did not correlate however with viability following exposure to OTX015.  Sequential combinations of OTX015 with other epigenetic modifying drugs, panobinostat and azacitidine have a synergic effect on growth of the KASUMI cell line.  Our results indicate that OTX015 and JQ1 have similar biological effects in leukemic cells, supporting OTX015 evaluation in a Phase Ib trial in relapsed/refractory leukemia patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlHRu3Td8hIa_dlEzl_fBafW6udTcc2ebTCxXpNK_SIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MflsVChsA%253D%253D&md5=0db953a0a24b12ec2918a02d1a2df00b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4131%26sid%3Dliteratum%253Aachs%26aulast%3DCoude%26aufirst%3DM.%2BM.%26aulast%3DBraun%26aufirst%3DT.%26aulast%3DBerrou%26aufirst%3DJ.%26aulast%3DDupont%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DA.%26aulast%3DRaffoux%26aufirst%3DE.%26aulast%3DItzykson%26aufirst%3DR.%26aulast%3DDelord%26aufirst%3DM.%26aulast%3DRiveiro%26aufirst%3DM.%2BE.%26aulast%3DHerait%26aufirst%3DP.%26aulast%3DBaruchel%26aufirst%3DA.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DGardin%26aufirst%3DC.%26atitle%3DBET%2520inhibitor%2520OTX015%2520targets%2520BRD2%2520and%2520BRD4%2520and%2520decreases%2520c-MYC%2520in%2520acute%2520leukemia%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D17698%26epage%3D17712%26doi%3D10.18632%2Foncotarget.4131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Siu, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koulnis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N. S.</span><span> </span><span class="NLM_article-title">Effect of the BET inhibitor, Cpi-0610, alone and in combination with lenalidomide in multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">4255</span><span class="NLM_x">–</span> <span class="NLM_lpage">4255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=4255-4255&author=K.+T.+Siuauthor=H.+Edaauthor=L.+Santoauthor=J.+Ramachandranauthor=M.+Koulnisauthor=J.+Mertzauthor=R.+J.+Simsauthor=M.+Cooperauthor=N.+S.+Raje&title=Effect+of+the+BET+inhibitor%2C+Cpi-0610%2C+alone+and+in+combination+with+lenalidomide+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DK.%2BT.%26aulast%3DEda%26aufirst%3DH.%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DRamachandran%26aufirst%3DJ.%26aulast%3DKoulnis%26aufirst%3DM.%26aulast%3DMertz%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DRaje%26aufirst%3DN.%2BS.%26atitle%3DEffect%2520of%2520the%2520BET%2520inhibitor%252C%2520Cpi-0610%252C%2520alone%2520and%2520in%2520combination%2520with%2520lenalidomide%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D4255%26epage%3D4255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowlati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagey, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landau, S. B.</span><span> </span><span class="NLM_article-title">Abstract A49: Clinically efficacy of the BET bromodomain inhibitor TEN-010 in an open-label substudy with patients with documented NUT-midline carcinoma (NMC)</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">A49</span><span class="NLM_x">–</span> <span class="NLM_lpage">A49</span><span class="refDoi"> DOI: 10.1158/1535-7163.TARG-15-A49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.TARG-15-A49" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=A49-A49&author=G.+I.+Shapiroauthor=A.+Dowlatiauthor=P.+M.+LoRussoauthor=J.+P.+Ederauthor=A.+Andersonauthor=K.+T.+Doauthor=M.+H.+Kageyauthor=C.+Sirardauthor=J.+E.+Bradnerauthor=S.+B.+Landau&title=Abstract+A49%3A+Clinically+efficacy+of+the+BET+bromodomain+inhibitor+TEN-010+in+an+open-label+substudy+with+patients+with+documented+NUT-midline+carcinoma+%28NMC%29&doi=10.1158%2F1535-7163.TARG-15-A49"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-15-A49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-15-A49%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DDowlati%26aufirst%3DA.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26aulast%3DEder%26aufirst%3DJ.%2BP.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DDo%26aufirst%3DK.%2BT.%26aulast%3DKagey%26aufirst%3DM.%2BH.%26aulast%3DSirard%26aufirst%3DC.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLandau%26aufirst%3DS.%2BB.%26atitle%3DAbstract%2520A49%253A%2520Clinically%2520efficacy%2520of%2520the%2520BET%2520bromodomain%2520inhibitor%2520TEN-010%2520in%2520an%2520open-label%2520substudy%2520with%2520patients%2520with%2520documented%2520NUT-midline%2520carcinoma%2520%2528NMC%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3DA49%26epage%3DA49%26doi%3D10.1158%2F1535-7163.TARG-15-A49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Sarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faivre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidanze, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uziel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajaraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">Abstract 4718: ABBV-075, a novel BET family bromodomain inhibitor, represents a promising therapeutic agent for a broad spectrum of cancer indications</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4718</span><span class="NLM_x">–</span> <span class="NLM_lpage">4718</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1538-7445.AM2016-4718" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4718-4718&author=A.+Sarthyauthor=L.+Liauthor=D.+H.+Albertauthor=X.+Linauthor=W.+Scottauthor=E.+Faivreauthor=M.+H.+Buiauthor=X.+Huangauthor=D.+M.+Wilcoxauthor=T.+Magocauthor=F.+G.+Buchananauthor=P.+Tapangauthor=G.+S.+Sheppardauthor=L.+Wangauthor=S.+D.+Fidanzeauthor=J.+Prattauthor=D.+Liuauthor=L.+Hasvoldauthor=P.+Hesslerauthor=T.+Uzielauthor=L.+Lamauthor=G.+Rajaramanauthor=G.+Fangauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=K.+McDanielauthor=W.+Katiauthor=Y.+Shen&title=Abstract+4718%3A+ABBV-075%2C+a+novel+BET+family+bromodomain+inhibitor%2C+represents+a+promising+therapeutic+agent+for+a+broad+spectrum+of+cancer+indications&doi=10.1158%2F1538-7445.AM2016-4718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4718%26sid%3Dliteratum%253Aachs%26aulast%3DSarthy%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DScott%26aufirst%3DW.%26aulast%3DFaivre%26aufirst%3DE.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWilcox%26aufirst%3DD.%2BM.%26aulast%3DMagoc%26aufirst%3DT.%26aulast%3DBuchanan%26aufirst%3DF.%2BG.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DPratt%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DHessler%26aufirst%3DP.%26aulast%3DUziel%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DMcDaniel%26aufirst%3DK.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DAbstract%25204718%253A%2520ABBV-075%252C%2520a%2520novel%2520BET%2520family%2520bromodomain%2520inhibitor%252C%2520represents%2520a%2520promising%2520therapeutic%2520agent%2520for%2520a%2520broad%2520spectrum%2520of%2520cancer%2520indications%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4718%26epage%3D4718%26doi%3D10.1158%2F1538-7445.AM2016-4718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Belkina, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, G. V.</span><span> </span><span class="NLM_article-title">BET domain co-regulators in obesity, inflammation and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1038/nrc3256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnrc3256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22722403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=465-477&author=A.+C.+Belkinaauthor=G.+V.+Denis&title=BET+domain+co-regulators+in+obesity%2C+inflammation+and+cancer&doi=10.1038%2Fnrc3256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">BET domain co-regulators in obesity, inflammation and cancer</span></div><div class="casAuthors">Belkina, Anna C.; Denis, Gerald V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helixes and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes.  Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression.  Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets.  However, small mols. that inhibit bromodomain and extraterminal (BET) proteins have been described.  We examine these developments and discuss the implications for small mol. epigenetic targeting of chromatin networks in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1x-bD67oukrVg90H21EOLACvtfcHk0li4ltnxjk52sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D&md5=d06d88ef0d5d4d71115f40a2f901f53d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrc3256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3256%26sid%3Dliteratum%253Aachs%26aulast%3DBelkina%26aufirst%3DA.%2BC.%26aulast%3DDenis%26aufirst%3DG.%2BV.%26atitle%3DBET%2520domain%2520co-regulators%2520in%2520obesity%252C%2520inflammation%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D465%26epage%3D477%26doi%3D10.1038%2Fnrc3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Padmanabhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, S.</span><span> </span><span class="NLM_article-title">Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases</span> <span class="citation_source-journal">J. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.1007/s12038-016-9600-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1007%2Fs12038-016-9600-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27240990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFOqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=295-311&author=B.+Padmanabhanauthor=S.+Mathurauthor=R.+Manjulaauthor=S.+Tripathi&title=Bromodomain+and+extra-terminal+%28BET%29+family+proteins%3A+New+therapeutic+targets+in+major+diseases&doi=10.1007%2Fs12038-016-9600-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases</span></div><div class="casAuthors">Padmanabhan, Balasundaram; Mathur, Shruti; Manjula, Ramu; Tripathi, Shailesh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biosciences (New Delhi, India)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-311</span>CODEN:
                <span class="NLM_cas:coden">JOBSDN</span>;
        ISSN:<span class="NLM_cas:issn">0250-5991</span>.
    
            (<span class="NLM_cas:orgname">Springer (India) Private Ltd.</span>)
        </div><div class="casAbstract">The bromodomains and extra-terminal domain (BET) family proteins recognize acetylated chromatin through their bromodomains (BDs) and help in regulating gene expression.  BDs are chromatin 'readers': by interacting with acetylated lysines on the histone tails, they recruit chromatin-regulating proteins on the promoter region to regulate gene expression and repression.  Extensive efforts have been employed by scientific communities worldwide to identify and develop potential inhibitors of BET family BDs to regulate protein expression by inhibiting acetylated histone (H3/H4) interactions.  Several small mol. inhibitors have been reported, which not only have high affinity but also have high specificity to BET BDs.  These developments make BET family proteins an important therapeutic targets for major diseases such as cancer, neurol. disorders, obesity and inflammation.  Here, we review and discuss the structural biol. of BET family BDs and their applications in major diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87geC_AUDErVg90H21EOLACvtfcHk0lhAnx98eC__DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFOqtbw%253D&md5=2555d6cb5db8e4151b63f7add86c7250</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12038-016-9600-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12038-016-9600-6%26sid%3Dliteratum%253Aachs%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DMathur%26aufirst%3DS.%26aulast%3DManjula%26aufirst%3DR.%26aulast%3DTripathi%26aufirst%3DS.%26atitle%3DBromodomain%2520and%2520extra-terminal%2520%2528BET%2529%2520family%2520proteins%253A%2520New%2520therapeutic%2520targets%2520in%2520major%2520diseases%26jtitle%3DJ.%2520Biosci.%26date%3D2016%26volume%3D41%26spage%3D295%26epage%3D311%26doi%3D10.1007%2Fs12038-016-9600-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savarese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaya, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweifer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span> </span><span class="NLM_article-title">Abstract B79: BI 894999, a novel BET inhibitor: Treatment of hematological malignancies by repression of super-enhancer driven oncogenes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">B79</span><span class="refDoi"> DOI: 10.1158/1535-7163.TARG-15-B79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.TARG-15-B79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=B79&author=U.+Tontsch-Gruntauthor=F.+Savareseauthor=D.+Gerlachauthor=D.+Gianniauthor=A.+Baumauthor=D.+Scharnauthor=H.+Engelhardtauthor=O.+Kayaauthor=N.+Schweiferauthor=T.+Gerstbergerauthor=N.+Kraut&title=Abstract+B79%3A+BI+894999%2C+a+novel+BET+inhibitor%3A+Treatment+of+hematological+malignancies+by+repression+of+super-enhancer+driven+oncogenes&doi=10.1158%2F1535-7163.TARG-15-B79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-15-B79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-15-B79%26sid%3Dliteratum%253Aachs%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DSavarese%26aufirst%3DF.%26aulast%3DGerlach%26aufirst%3DD.%26aulast%3DGianni%26aufirst%3DD.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DScharn%26aufirst%3DD.%26aulast%3DEngelhardt%26aufirst%3DH.%26aulast%3DKaya%26aufirst%3DO.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DGerstberger%26aufirst%3DT.%26aulast%3DKraut%26aufirst%3DN.%26atitle%3DAbstract%2520B79%253A%2520BI%2520894999%252C%2520a%2520novel%2520BET%2520inhibitor%253A%2520Treatment%2520of%2520hematological%2520malignancies%2520by%2520repression%2520of%2520super-enhancer%2520driven%2520oncogenes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3DB79%26doi%3D10.1158%2F1535-7163.TARG-15-B79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span>Study of BMS-986158 in subjects with select advanced solid tumors (BET). Clinical trials, 2 April,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02419417" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02419417</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+BMS-986158+in+subjects+with+select+advanced+solid+tumors+%28BET%29.+Clinical+trials%2C+2+April%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02419417."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez Morales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobedo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser-Bricker, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershaw, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luke, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muskiewicz, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, S. E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. L.</span><span> </span><span class="NLM_article-title">FT-1101: A structurally distinct pan-BET bromodomain inhibitor with activity in preclinical models of hematologic malignancies</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1367&author=D.+S.+Millanauthor=M.+A.+Alvarez+Moralesauthor=K.+J.+Barrauthor=D.+Cardilloauthor=A.+Collisauthor=C.+J.+Dinsmoreauthor=J.+A.+Escobedoauthor=K.+P.+Foleyauthor=T.+Herbertzauthor=S.+Hubbsauthor=G.+S.+Kauffmanauthor=K.+J.+Kayser-Brickerauthor=M.+T.+Kershawauthor=G.+P.+Lukeauthor=M.+W.+Martinauthor=C.+McKinnonauthor=R.+L.+Mendesauthor=K.+R.+Muskiewiczauthor=S.+E.+R.+Schillerauthor=P.+Soulardauthor=A.+C.+Talbotauthor=D.+Walkerauthor=L.+Yaoauthor=G.+L.+Williams&title=FT-1101%3A+A+structurally+distinct+pan-BET+bromodomain+inhibitor+with+activity+in+preclinical+models+of+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DAlvarez%2BMorales%26aufirst%3DM.%2BA.%26aulast%3DBarr%26aufirst%3DK.%2BJ.%26aulast%3DCardillo%26aufirst%3DD.%26aulast%3DCollis%26aufirst%3DA.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHubbs%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DG.%2BS.%26aulast%3DKayser-Bricker%26aufirst%3DK.%2BJ.%26aulast%3DKershaw%26aufirst%3DM.%2BT.%26aulast%3DLuke%26aufirst%3DG.%2BP.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcKinnon%26aufirst%3DC.%26aulast%3DMendes%26aufirst%3DR.%2BL.%26aulast%3DMuskiewicz%26aufirst%3DK.%2BR.%26aulast%3DSchiller%26aufirst%3DS.%2BE.%2BR.%26aulast%3DSoulard%26aufirst%3DP.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DG.%2BL.%26atitle%3DFT-1101%253A%2520A%2520structurally%2520distinct%2520pan-BET%2520bromodomain%2520inhibitor%2520with%2520activity%2520in%2520preclinical%2520models%2520of%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Liu, P. C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maduskuie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolotarjova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volgina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMatteo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falahatpisheh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond-Fosbenner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeleswaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G.</span><span> </span><span class="NLM_article-title">Abstract 3523: Discovery of a novel BET inhibitor INCB054329</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3523</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-3523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1538-7445.AM2015-3523" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3523&author=P.+C.+C.+Liuauthor=X.+M.+Liuauthor=M.+C.+Stubbsauthor=T.+Maduskuieauthor=R.+Sparksauthor=N.+Zolotarjovaauthor=J.+Liauthor=X.+Wenauthor=M.+Favataauthor=P.+Feldmanauthor=A.+Volginaauthor=D.+DiMatteoauthor=R.+Collinsauthor=N.+Falahatpishehauthor=P.+Polamauthor=Y.+Liauthor=M.+Covingtonauthor=S.+Diamond-Fosbennerauthor=R.+Wynnauthor=T.+Burnauthor=K.+Vaddiauthor=S.+Yeleswaramauthor=A.+P.+Combsauthor=W.+Yaoauthor=R.+Huberauthor=P.+Scherleauthor=G.+Hollis&title=Abstract+3523%3A+Discovery+of+a+novel+BET+inhibitor+INCB054329&doi=10.1158%2F1538-7445.AM2015-3523"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-3523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-3523%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%2BC.%2BC.%26aulast%3DLiu%26aufirst%3DX.%2BM.%26aulast%3DStubbs%26aufirst%3DM.%2BC.%26aulast%3DMaduskuie%26aufirst%3DT.%26aulast%3DSparks%26aufirst%3DR.%26aulast%3DZolotarjova%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DFeldman%26aufirst%3DP.%26aulast%3DVolgina%26aufirst%3DA.%26aulast%3DDiMatteo%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DFalahatpisheh%26aufirst%3DN.%26aulast%3DPolam%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DDiamond-Fosbenner%26aufirst%3DS.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DHollis%26aufirst%3DG.%26atitle%3DAbstract%25203523%253A%2520Discovery%2520of%2520a%2520novel%2520BET%2520inhibitor%2520INCB054329%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3523%26doi%3D10.1158%2F1538-7445.AM2015-3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span>Dose escalation study of GSK2820151 in subjects with advanced or recurrent solid tumors. Clinical trials, 30 November,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02630251" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02630251</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dose+escalation+study+of+GSK2820151+in+subjects+with+advanced+or+recurrent+solid+tumors.+Clinical+trials%2C+30+November%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02630251."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujikawa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calosing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhotia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H.</span><span> </span><span class="NLM_article-title">Abstract C86: The clinical candidate ZEN-3694, a novel BET bromodomain inhibitor, is efficacious in the treatment of a variety of solid tumor and hematological malignancies, alone or in combination with several standard of care and targeted therapies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">C86</span><span class="refDoi"> DOI: 10.1158/1535-7163.TARG-15-C86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.TARG-15-C86" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=C86&author=S.+Attwellauthor=E.+Campeauauthor=R.+Jahagirdarauthor=O.+Kharenkoauthor=K.+Norekauthor=L.+Tsujikawaauthor=C.+Calosingauthor=R.+Patelauthor=E.+Gesnerauthor=S.+Lakhotiaauthor=H.+Hansen&title=Abstract+C86%3A+The+clinical+candidate+ZEN-3694%2C+a+novel+BET+bromodomain+inhibitor%2C+is+efficacious+in+the+treatment+of+a+variety+of+solid+tumor+and+hematological+malignancies%2C+alone+or+in+combination+with+several+standard+of+care+and+targeted+therapies&doi=10.1158%2F1535-7163.TARG-15-C86"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-15-C86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-15-C86%26sid%3Dliteratum%253Aachs%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DCampeau%26aufirst%3DE.%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DKharenko%26aufirst%3DO.%26aulast%3DNorek%26aufirst%3DK.%26aulast%3DTsujikawa%26aufirst%3DL.%26aulast%3DCalosing%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DGesner%26aufirst%3DE.%26aulast%3DLakhotia%26aufirst%3DS.%26aulast%3DHansen%26aufirst%3DH.%26atitle%3DAbstract%2520C86%253A%2520The%2520clinical%2520candidate%2520ZEN-3694%252C%2520a%2520novel%2520BET%2520bromodomain%2520inhibitor%252C%2520is%2520efficacious%2520in%2520the%2520treatment%2520of%2520a%2520variety%2520of%2520solid%2520tumor%2520and%2520hematological%2520malignancies%252C%2520alone%2520or%2520in%2520combination%2520with%2520several%2520standard%2520of%2520care%2520and%2520targeted%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3DC86%26doi%3D10.1158%2F1535-7163.TARG-15-C86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Bates, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breckenridge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D.</span><span> </span><span class="NLM_article-title">The combination of a BET inhibitor (GS-5829) and a BTK Inhibitor (GS-4059) potentiates DLBCL cell line cell death and reduces expression of MYC, IL-10, and IL-6 in vitro</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">5116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1182%2Fblood.V128.22.5116.5116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=5116&author=J.+Batesauthor=S.+Kusamauthor=S.+Tannheimerauthor=J.+Chanauthor=Y.+Liauthor=D.+Breckenridgeauthor=D.+Tumas&title=The+combination+of+a+BET+inhibitor+%28GS-5829%29+and+a+BTK+Inhibitor+%28GS-4059%29+potentiates+DLBCL+cell+line+cell+death+and+reduces+expression+of+MYC%2C+IL-10%2C+and+IL-6+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1182%2Fblood.V128.22.5116.5116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V128.22.5116.5116%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DJ.%26aulast%3DKusam%26aufirst%3DS.%26aulast%3DTannheimer%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBreckenridge%26aufirst%3DD.%26aulast%3DTumas%26aufirst%3DD.%26atitle%3DThe%2520combination%2520of%2520a%2520BET%2520inhibitor%2520%2528GS-5829%2529%2520and%2520a%2520BTK%2520Inhibitor%2520%2528GS-4059%2529%2520potentiates%2520DLBCL%2520cell%2520line%2520cell%2520death%2520and%2520reduces%2520expression%2520of%2520MYC%252C%2520IL-10%252C%2520and%2520IL-6%2520in%2520vitro%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D5116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gjoksi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghayor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenobi-Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, F. E.</span><span> </span><span class="NLM_article-title">The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model</span> <span class="citation_source-journal">Clin. Epigenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="refDoi"> DOI: 10.1186/s13148-016-0209-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1186%2Fs13148-016-0209-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27110299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=42&author=B.+Gjoksiauthor=C.+Ghayorauthor=I.+Bhattacharyaauthor=M.+Zenobi-Wongauthor=F.+E.+Weber&title=The+bromodomain+inhibitor+N-methyl+pyrrolidone+reduced+fat+accumulation+in+an+ovariectomized+rat+model&doi=10.1186%2Fs13148-016-0209-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model</span></div><div class="casAuthors">Gjoksi, Bebeka; Ghayor, Chafik; Bhattacharya, Indranil; Zenobi-Wong, Marcy; Weber, Franz E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42/1-42/10</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Wt. gain is one of the consequences of estrogen deficiency and constitutes a major health problem.  The present study highlights the effects of N-Me pyrrolidone (NMP) on adipogenesis in osteoporosis induced by estrogen deficiency in an ovariectomized rat model.  Results: Ovariectomy resulted in body wt. gain, increased femoral marrow adipocytes, and hypertrophic adipocytes in white adipose tissue, distorted serum leptin, and TNF-α and PPARγ levels.  Treatment with NMP normalized these parameters similar to the control group.  In vitro, NMP inhibited the differentiation of 3T3-L1 pre-adipocytes and hMSCs, indicating its anti-adipogenic effect.  Moreover, PPARγ was significantly reduced with NMP treatment in in vivo and in vitro expts.  NMP inhibited BRD2 and BRD4 binding in an AlphaScreen assay, with an IC50 of 3 and 4 mM, resp.  The effect of NMP was consistent with its role as a bromodomain inhibitor.  Conclusions: Our data indicates that NMP inhibits the adipogenic effect of estrogen deficiency at the level of PPARγ expression by BRD4 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobU9sDz5yB6bVg90H21EOLACvtfcHk0lgJXt58mTziEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsrs%253D&md5=021c9e5ec046c8994b1527a873053ef2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1186%2Fs13148-016-0209-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-016-0209-2%26sid%3Dliteratum%253Aachs%26aulast%3DGjoksi%26aufirst%3DB.%26aulast%3DGhayor%26aufirst%3DC.%26aulast%3DBhattacharya%26aufirst%3DI.%26aulast%3DZenobi-Wong%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DF.%2BE.%26atitle%3DThe%2520bromodomain%2520inhibitor%2520N-methyl%2520pyrrolidone%2520reduced%2520fat%2520accumulation%2520in%2520an%2520ovariectomized%2520rat%2520model%26jtitle%3DClin.%2520Epigenet.%26date%3D2016%26volume%3D8%26spage%3D42%26doi%3D10.1186%2Fs13148-016-0209-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Jiang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veschambre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornberg, R. D.</span><span> </span><span class="NLM_article-title">Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">8538</span><span class="NLM_x">–</span> <span class="NLM_lpage">8543</span><span class="refDoi"> DOI: 10.1073/pnas.95.15.8538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.95.15.8538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=9671713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8538-8543&author=Y.+W.+Jiangauthor=P.+Veschambreauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=J.+W.+Conawayauthor=R.+C.+Conawayauthor=R.+D.+Kornberg&title=Mammalian+mediator+of+transcriptional+regulation+and+its+possible+role+as+an+end-point+of+signal+transduction+pathways&doi=10.1073%2Fpnas.95.15.8538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways</span></div><div class="casAuthors">Jiang, Yi Wei; Veschambre, Philippe; Erdjument-Bromage, Hediye; Tempst, Paul; Conaway, Joan W.; Conaway, Ronald C.; Kornberg, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8538-8543</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A multiprotein complex isolated from murine cells is identified as a counterpart of the yeast Mediator of transcriptional regulation on the basis of the following: homologs of two subunits of yeast Mediator, Srb7 and Med7, copurify with the complex; peptide sequencing reveals, in addn., homologs of the yeast Mediator subunits Rgr1 and Med6; as with yeast Mediator, the mouse complex binds to the RNA polymerase II C-terminal domain (CTD) and stimulates phosphorylation of the CTD by TFIIH.  Peptide sequencing also identifies a component of mouse Mediator as a relative of Ring-3 protein, a mitogen-activated nuclear protein kinase, raising the possibility of Mediator as an end point of signal transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMgqVnIZyEDrVg90H21EOLACvtfcHk0lhuNLB4pGppPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFamu7o%253D&md5=474c58900d675368e6b18c646d2a6cec</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.15.8538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.15.8538%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%2BW.%26aulast%3DVeschambre%26aufirst%3DP.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DKornberg%26aufirst%3DR.%2BD.%26atitle%3DMammalian%2520mediator%2520of%2520transcriptional%2520regulation%2520and%2520its%2520possible%2520role%2520as%2520an%2520end-point%2520of%2520signal%2520transduction%2520pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D8538%26epage%3D8543%26doi%3D10.1073%2Fpnas.95.15.8538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Floyd, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannell, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rameseder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fydrych, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rosario, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, M. B.</span><span> </span><span class="NLM_article-title">The bromodomain protein Brd4 insulates chromatin from DNA damage signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1038/nature12147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature12147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2013&pages=246-250&author=S.+R.+Floydauthor=M.+E.+Pacoldauthor=Q.+Huangauthor=S.+M.+Clarkeauthor=F.+C.+Lamauthor=I.+G.+Cannellauthor=B.+D.+Brysonauthor=J.+Ramesederauthor=M.+J.+Leeauthor=E.+J.+Blakeauthor=A.+Fydrychauthor=R.+Hoauthor=B.+A.+Greenbergerauthor=G.+C.+Chenauthor=A.+Maffaauthor=A.+M.+Del+Rosarioauthor=D.+E.+Rootauthor=A.+E.+Carpenterauthor=W.+C.+Hahnauthor=D.+M.+Sabatiniauthor=C.+C.+Chenauthor=F.+M.+Whiteauthor=J.+E.+Bradnerauthor=M.+B.+Yaffe&title=The+bromodomain+protein+Brd4+insulates+chromatin+from+DNA+damage+signalling&doi=10.1038%2Fnature12147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnature12147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12147%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DS.%2BR.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DClarke%26aufirst%3DS.%2BM.%26aulast%3DLam%26aufirst%3DF.%2BC.%26aulast%3DCannell%26aufirst%3DI.%2BG.%26aulast%3DBryson%26aufirst%3DB.%2BD.%26aulast%3DRameseder%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DBlake%26aufirst%3DE.%2BJ.%26aulast%3DFydrych%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DR.%26aulast%3DGreenberger%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DG.%2BC.%26aulast%3DMaffa%26aufirst%3DA.%26aulast%3DDel%2BRosario%26aufirst%3DA.%2BM.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DCarpenter%26aufirst%3DA.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DWhite%26aufirst%3DF.%2BM.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DYaffe%26aufirst%3DM.%2BB.%26atitle%3DThe%2520bromodomain%2520protein%2520Brd4%2520insulates%2520chromatin%2520from%2520DNA%2520damage%2520signalling%26jtitle%3DNature%26date%3D2013%26volume%3D498%26spage%3D246%26epage%3D250%26doi%3D10.1038%2Fnature12147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. M.</span><span> </span><span class="NLM_article-title">The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">13141</span><span class="NLM_x">–</span> <span class="NLM_lpage">13145</span><span class="refDoi"> DOI: 10.1074/jbc.R700001200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.R700001200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17329240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1Ghtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=13141-13145&author=S.+Y.+Wuauthor=C.+M.+Chiang&title=The+double+bromodomain-containing+chromatin+adaptor+Brd4+and+transcriptional+regulation&doi=10.1074%2Fjbc.R700001200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation</span></div><div class="casAuthors">Wu, Shwu-Yuan; Chiang, Cheng-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">13141-13145</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Brd4 is a double bromodomain-contg. protein that binds preferentially to acetylated chromatin.  It belongs to the BET (bromodomains and extraterminal) family that includes mammalian Brd2, Brd3, Brd4, Brdt, Drosophila Fsh, yeast Bdf1, Bdf2, and corresponding homologues in other species.  Brd4 is essential for cellular growth and has been implicated in cell cycle control, DNA replication, and gene rearrangement found in t(15;19)-assocd. carcinomas.  Recently, Brd4 has been found in several transcription complexes, including the general cofactor Mediator and the P-TEFb elongation factor, and is capable of stimulating HIV-1 transcription in a Tat-independent manner.  In addn., Brd4 is used as a cellular adaptor by some animal and human papillomaviruses (HPV) for anchoring viral genomes to mitotic chromosomes.  This tethering, mediated by Brd4 interaction with virus-encoded E2 protein, facilitates viral genome segregation during mitosis.  Interestingly, Brd4 is also identified in a transcriptional silencing complex assembled by HPV E2 and turns out to be the long sought cellular corepressor that inhibits the expression of HPV-encoded E6 and E7 oncoproteins that antagonize p53 and pRB tumor suppressor activity, resp.  The dual role of Brd4 in gene activation and repression illustrates how a dynamic chromatin-binding adaptor is able to recruit distinct transcriptional regulators to modulate promoter activity through cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohccDdZC9iKLVg90H21EOLACvtfcHk0lhuNLB4pGppPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1Ghtbo%253D&md5=b025a5222b510a7009eca4289370b1d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R700001200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R700001200%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DChiang%26aufirst%3DC.%2BM.%26atitle%3DThe%2520double%2520bromodomain-containing%2520chromatin%2520adaptor%2520Brd4%2520and%2520transcriptional%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D13141%26epage%3D13145%26doi%3D10.1074%2Fjbc.R700001200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Histone recognition and large-scale structural analysis of the human bromodomain family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.cell.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22464331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=214-231&author=P.+Filippakopoulosauthor=S.+Picaudauthor=M.+Mangosauthor=T.+Keatesauthor=J.+P.+Lambertauthor=D.+Barsyte-Lovejoyauthor=I.+Felletarauthor=R.+Volkmerauthor=S.+Mullerauthor=T.+Pawsonauthor=A.+C.+Gingrasauthor=C.+H.+Arrowsmithauthor=S.+Knapp&title=Histone+recognition+and+large-scale+structural+analysis+of+the+human+bromodomain+family&doi=10.1016%2Fj.cell.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Muller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-231</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks.  The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity.  Here, we present 29 high-resoln. crystal structures, covering all BRD families.  These proteins are: ASH1L, ATAD2, BAZ2B, BPTF, BRD1, BRD3(1), BRD3(2), BRD4(1), BRD4(2), BRD9, BRDT(1), CECR2, EP300, CREBBP, GCN5L2, KIAA1240, PB1(1), PB1(2), PB1(3), PB1(4), PB1(5), PB1(6), PCAF, PHIP(2), TAF1(2), WDR9(2), BRD4(1).  Comprehensive crossfamily structural anal. identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition.  Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences.  We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-contg. peptides by BRD4.  These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FSIcPoXZLVg90H21EOLACvtfcHk0li3KHZDj5nXAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D&md5=05583a01a1cd4c3b59fc59c00e4c4777</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMangos%26aufirst%3DM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DJ.%2BP.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DHistone%2520recognition%2520and%2520large-scale%2520structural%2520analysis%2520of%2520the%2520human%2520bromodomain%2520family%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D214%26epage%3D231%26doi%3D10.1016%2Fj.cell.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. P.</span><span> </span><span class="NLM_article-title">Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.1016/j.ccr.2014.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ccr.2014.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24525235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlCisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=210-225&author=J.+Shiauthor=Y.+Wangauthor=L.+Zengauthor=Y.+Wuauthor=J.+Dengauthor=Q.+Zhangauthor=Y.+Linauthor=J.+Liauthor=T.+Kangauthor=M.+Taoauthor=E.+Rusinovaauthor=G.+Zhangauthor=C.+Wangauthor=H.+Zhuauthor=J.+Yaoauthor=Y.+X.+Zengauthor=B.+M.+Eversauthor=M.+M.+Zhouauthor=B.+P.+Zhou&title=Disrupting+the+interaction+of+BRD4+with+diacetylated+Twist+suppresses+tumorigenesis+in+basal-like+breast+cancer&doi=10.1016%2Fj.ccr.2014.01.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer</span></div><div class="casAuthors">Shi, Jian; Wang, Yifan; Zeng, Lei; Wu, Yadi; Deng, Jiong; Zhang, Qiang; Lin, Yiwei; Li, Junlin; Kang, Tiebang; Tao, Min; Rusinova, Elena; Zhang, Guangtao; Wang, Chi; Zhu, Haining; Yao, Jun; Zeng, Yi-Xin; Evers, B. Mark; Zhou, Ming-Ming; Zhou, Binhua P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-225</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Twist is a key transcription activator of epithelial-mesenchymal transition (EMT).  It remains unclear how Twist induces gene expression.  Here we report a mechanism by which Twist recruits BRD4 to direct WNT5A expression in basal-like breast cancer (BLBC).  Twist contains a "histone H4-mimic" GK-X-GK motif that is diacetylated by Tip60.  The diacetylated Twist binds the second bromodomain of BRD4, whose first bromodomain interacts with acetylated H4, thereby constructing an activated Twist/BRD4/P-TEFb/RNA-Pol II complex at the WNT5A promoter and enhancer.  Pharmacol. inhibition of the Twist-BRD4 assocn. reduced WNT5A expression and suppressed invasion, cancer stem cell (CSC)-like properties, and tumorigenicity of BLBC cells.  Our study indicates that the interaction with BRD4 is crit. for the oncogenic function of Twist in BLBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovIzriI8A6ZrVg90H21EOLACvtfcHk0li3KHZDj5nXAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlCisrs%253D&md5=d207cbc1abb187a53d807452b4f10d8f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DT.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DZhou%26aufirst%3DB.%2BP.%26atitle%3DDisrupting%2520the%2520interaction%2520of%2520BRD4%2520with%2520diacetylated%2520Twist%2520suppresses%2520tumorigenesis%2520in%2520basal-like%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D210%26epage%3D225%26doi%3D10.1016%2Fj.ccr.2014.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Vollmuth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M.</span><span> </span><span class="NLM_article-title">Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">36547</span><span class="NLM_x">–</span> <span class="NLM_lpage">36556</span><span class="refDoi"> DOI: 10.1074/jbc.M109.033712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.M109.033712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=36547-36556&author=F.+Vollmuthauthor=W.+Blankenfeldtauthor=M.+Geyer&title=Structures+of+the+dual+bromodomains+of+the+P-TEFb-activating+protein+Brd4+at+atomic+resolution&doi=10.1074%2Fjbc.M109.033712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033712%26sid%3Dliteratum%253Aachs%26aulast%3DVollmuth%26aufirst%3DF.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DGeyer%26aufirst%3DM.%26atitle%3DStructures%2520of%2520the%2520dual%2520bromodomains%2520of%2520the%2520P-TEFb-activating%2520protein%2520Brd4%2520at%2520atomic%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D36547%26epage%3D36556%26doi%3D10.1074%2Fjbc.M109.033712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span><span class="refDoi"> DOI: 10.1021/jm200108t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.+W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.+M.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Clementauthor=A.+B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+characterization+of+small+molecule+inhibitors+of+the+BET+family+bromodomains&doi=10.1021%2Fjm200108t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0li3KHZDj5nXAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520small%2520molecule%2520inhibitors%2520of%2520the%2520BET%2520family%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838%26doi%3D10.1021%2Fjm200108t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Kanno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenardo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">Selective recognition of acetylated histones by bromodomain proteins visualized in living cells</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00482-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS1097-2765%2803%2900482-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=33-43&author=T.+Kannoauthor=Y.+Kannoauthor=R.+M.+Siegelauthor=M.+K.+Jangauthor=M.+J.+Lenardoauthor=K.+Ozato&title=Selective+recognition+of+acetylated+histones+by+bromodomain+proteins+visualized+in+living+cells&doi=10.1016%2FS1097-2765%2803%2900482-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900482-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900482-9%26sid%3Dliteratum%253Aachs%26aulast%3DKanno%26aufirst%3DT.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DSiegel%26aufirst%3DR.%2BM.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DSelective%2520recognition%2520of%2520acetylated%2520histones%2520by%2520bromodomain%2520proteins%2520visualized%2520in%2520living%2520cells%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26spage%3D33%26epage%3D43%26doi%3D10.1016%2FS1097-2765%2803%2900482-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4899</span><span class="NLM_x">–</span> <span class="NLM_lpage">4909</span><span class="refDoi"> DOI: 10.1091/mbc.E09-05-0380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1091%2Fmbc.E09-05-0380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19812244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnslSk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=4899-4909&author=A.+Deyauthor=A.+Nishiyamaauthor=T.+Karpovaauthor=J.+McNallyauthor=K.+Ozato&title=Brd4+marks+select+genes+on+mitotic+chromatin+and+directs+postmitotic+transcription&doi=10.1091%2Fmbc.E09-05-0380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription</span></div><div class="casAuthors">Dey, Anup; Nishiyama, Akira; Karpova, Tatiana; McNally, James; Ozato, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4899-4909</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">On entry into mitosis, many transcription factors dissoc. from chromatin, resulting in global transcriptional shutdown.  During mitosis, some genes are marked to ensure the inheritance of their expression in the next generation of cells.  The nature of mitotic gene marking, however, has been obscure.  Brd4 is a double bromodomain protein that localizes to chromosomes during mitosis and is implicated in holding mitotic memory.  In interphase, Brd4 interacts with P-TEFb and functions as a global transcriptional coactivator.  We found that throughout mitosis, Brd4 remained bound to the transcription start sites of many M/G1 genes that are programmed to be expressed at the end of, or immediately after mitosis.  In contrast, Brd4 did not bind to genes that are expressed at later phases of cell cycle.  Brd4 binding to M/G1 genes increased at telophase, the end phase of mitosis, coinciding with increased acetylation of histone H3 and H4 in these genes.  Increased Brd4 binding was accompanied by the recruitment of P-TEFb and de novo M/G1 gene transcription, the events impaired in Brd4 knockdown cells.  In sum, Brd4 marks M/G1 genes for transcriptional memory during mitosis, and upon exiting mitosis, this mark acts as a signal for initiating their prompt transcription in daughter cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV0990TLKdcrVg90H21EOLACvtfcHk0lj0-vP8fXBtGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnslSk&md5=f4225feea3d0ccffeea10159defea447</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E09-05-0380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E09-05-0380%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DA.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DKarpova%26aufirst%3DT.%26aulast%3DMcNally%26aufirst%3DJ.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DBrd4%2520marks%2520select%2520genes%2520on%2520mitotic%2520chromatin%2520and%2520directs%2520postmitotic%2520transcription%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2009%26volume%3D20%26spage%3D4899%26epage%3D4909%26doi%3D10.1091%2Fmbc.E09-05-0380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellenberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciortino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippincott-Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6537</span><span class="NLM_x">–</span> <span class="NLM_lpage">6549</span><span class="refDoi"> DOI: 10.1128/MCB.20.17.6537-6549.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.20.17.6537-6549.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10938129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFens7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=6537-6549&author=A.+Deyauthor=J.+Ellenbergauthor=A.+Farinaauthor=A.+E.+Colemanauthor=T.+Maruyamaauthor=S.+Sciortinoauthor=J.+Lippincott-Schwartzauthor=K.+Ozato&title=A+bromodomain+protein%2C+MCAP%2C+associates+with+mitotic+chromosomes+and+affects+G%282%29-to-M+transition&doi=10.1128%2FMCB.20.17.6537-6549.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G2-to-M transition</span></div><div class="casAuthors">Dey, Anup; Ellenberg, Jan; Farina, Andrea; Coleman, Allen E.; Maruyama, Tetsuo; Sciortino, Selvaggia; Lippincott-Schwartz, Jennifer; Ozato, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6537-6549</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We describe a novel nuclear factor called mitotic chromosome-assocd. protein (MCAP), which belongs to the poorly understood BET subgroup of the bromodomain superfamily.  Expression of the 200-kDa MCAP was linked to cell division, as it was induced by growth stimulation and repressed by growth inhibition.  The most notable feature of MCAP was its assocn. with chromosomes during mitosis, obsd. at a time when the majority of nuclear regulatory factors were released into the cytoplasm, coinciding with global cessation of transcription.  Indicative of its predominant interaction with euchromatin, MCAP localized on mitotic chromosomes with exquisite specificity: (i) MCAP-chromosome assocn. became evident subsequent to the initiation of histone H3 phosphorylation and early chromosomal condensation; and (ii) MCAP was absent from centromeres, the sites of heterochromatin.  Supporting a role for MCAP in G2/M transition, microinjection of anti-MCAP antibody into HeLa cell nuclei completely inhibited the entry into mitosis, without abrogating the ongoing DNA replication.  These results suggest that MCAP plays a role in a process governing chromosomal dynamics during mitosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAVlo6ULiazrVg90H21EOLACvtfcHk0lj0-vP8fXBtGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFens7s%253D&md5=0a0b95f84770c36457076f04521e116d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.17.6537-6549.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.17.6537-6549.2000%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DA.%26aulast%3DEllenberg%26aufirst%3DJ.%26aulast%3DFarina%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DA.%2BE.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DSciortino%26aufirst%3DS.%26aulast%3DLippincott-Schwartz%26aufirst%3DJ.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DA%2520bromodomain%2520protein%252C%2520MCAP%252C%2520associates%2520with%2520mitotic%2520chromosomes%2520and%2520affects%2520G%25282%2529-to-M%2520transition%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D6537%26epage%3D6549%26doi%3D10.1128%2FMCB.20.17.6537-6549.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">You, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howley, P. M.</span><span> </span><span class="NLM_article-title">Regulation of aurora B expression by the bromodomain protein Brd4</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5094</span><span class="NLM_x">–</span> <span class="NLM_lpage">5103</span><span class="refDoi"> DOI: 10.1128/MCB.00299-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.00299-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19596781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5094-5103&author=J.+Youauthor=Q.+Liauthor=C.+Wuauthor=J.+Kimauthor=M.+Ottingerauthor=P.+M.+Howley&title=Regulation+of+aurora+B+expression+by+the+bromodomain+protein+Brd4&doi=10.1128%2FMCB.00299-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of aurora B expression by the bromodomain protein Brd4</span></div><div class="casAuthors">You, Jianxin; Li, Qing; Wu, Chong; Kim, Jina; Ottinger, Matthias; Howley, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5094-5103</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The bromodomain protein Brd4 plays crit. roles in cellular proliferation and cell cycle progression.  In this study, we investigated the involvement of Brd4 in cell cycle regulation and obsd. aberrant chromosome segregation and failures in cytokinesis in cancer cells as well as in primary keratinocytes in which Brd4 has been knocked down by RNA interference.  Suppression of Brd4 protein levels in proliferating cells decreased Aurora B protein and transcript levels and abolished its chromosomal distribution.  In contrast, exogenous Brd4 expression stimulated Aurora B promoter reporter activity and upregulated endogenous Aurora B expression.  Aurora B kinase is a chromosomal passenger protein that is essential for chromosome segregation and cytokinesis.  Either overexpression of Aurora B or its inactivation can induce defects in centrosome function, spindle assembly, chromosome alignment, and cytokinesis in various cancer cells.  The impaired regulation of Aurora B expression in human cells by Brd4 knockdown or overexpression coincided with mitotic catastrophe and multinucleation that are typically obsd. when Aurora B is inactivated or overexpressed.  Overall, our data suggest that Brd4 is essential for the maintenance of the cell cycle progression mediated at least in part through the control of transcription of the Aurora B kinase cell cycle regulatory gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3p1hw3uxY7rVg90H21EOLACvtfcHk0lhSRnYwT_mm0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjs7rJ&md5=c69f475c1e073d6239c2228b0c3d6704</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FMCB.00299-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00299-09%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOttinger%26aufirst%3DM.%26aulast%3DHowley%26aufirst%3DP.%2BM.%26atitle%3DRegulation%2520of%2520aurora%2520B%2520expression%2520by%2520the%2520bromodomain%2520protein%2520Brd4%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5094%26epage%3D5103%26doi%3D10.1128%2FMCB.00299-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artero, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaiti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alazem, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margulies, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappola, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plutzky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, S. M.</span><span> </span><span class="NLM_article-title">BET bromodomains mediate transcriptional pause release in heart failure</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1016/j.cell.2013.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2013.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23911322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=569-582&author=P.+Anandauthor=J.+D.+Brownauthor=C.+Y.+Linauthor=J.+Qiauthor=R.+Zhangauthor=P.+C.+Arteroauthor=M.+A.+Alaitiauthor=J.+Bullardauthor=K.+Alazemauthor=K.+B.+Marguliesauthor=T.+P.+Cappolaauthor=M.+Lemieuxauthor=J.+Plutzkyauthor=J.+E.+Bradnerauthor=S.+M.+Haldar&title=BET+bromodomains+mediate+transcriptional+pause+release+in+heart+failure&doi=10.1016%2Fj.cell.2013.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure</span></div><div class="casAuthors">Anand, Priti; Brown, Jonathan D.; Lin, Charles Y.; Qi, Jun; Zhang, Rongli; Artero, Pedro Calderon; Alaiti, M. Amer; Bullard, Jace; Alazem, Kareem; Margulies, Kenneth B.; Cappola, Thomas P.; Lemieux, Madeleine; Plutzky, Jorge; Bradner, James E.; Haldar, Saptarsi M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-582</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heart failure (HF) is driven by the interplay between regulatory transcription factors and dynamic alterations in chromatin structure.  Pathol. gene transactivation in HF is assocd. with recruitment of histone acetyl-transferases and local chromatin hyperacetylation.  We therefore assessed the role of acetyl-lysine reader proteins, or bromodomains, in HF.  Using a chem. genetic approach, we establish a central role for BET family bromodomain proteins in gene control during HF pathogenesis.  BET inhibition potently suppresses cardiomyocyte hypertrophy in vitro and pathol. cardiac remodeling in vivo.  Integrative transcriptional and epigenomic analyses reveal that BET proteins function mechanistically as pause-release factors crit. to expression of genes that are central to HF pathogenesis and relevant to the pathobiol. of failing human hearts.  This study implicates epigenetic readers as essential effectors of transcriptional pause release during HF pathogenesis and identifies BET coactivator proteins as therapeutic targets in the heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZbQWpJYqt7bVg90H21EOLACvtfcHk0lhSRnYwT_mm0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzI&md5=33410607098cb42f1a7a52fa7ec0108b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DArtero%26aufirst%3DP.%2BC.%26aulast%3DAlaiti%26aufirst%3DM.%2BA.%26aulast%3DBullard%26aufirst%3DJ.%26aulast%3DAlazem%26aufirst%3DK.%26aulast%3DMargulies%26aufirst%3DK.%2BB.%26aulast%3DCappola%26aufirst%3DT.%2BP.%26aulast%3DLemieux%26aufirst%3DM.%26aulast%3DPlutzky%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DHaldar%26aufirst%3DS.%2BM.%26atitle%3DBET%2520bromodomains%2520mediate%2520transcriptional%2520pause%2520release%2520in%2520heart%2520failure%26jtitle%3DCell%26date%3D2013%26volume%3D154%26spage%3D569%26epage%3D582%26doi%3D10.1016%2Fj.cell.2013.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Korb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucker-Scharff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span><span class="refDoi"> DOI: 10.1038/nn.4095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnn.4095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26301327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlynsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=1464-1473&author=E.+Korbauthor=M.+Herreauthor=I.+Zucker-Scharffauthor=R.+B.+Darnellauthor=C.+D.+Allis&title=BET+protein+Brd4+activates+transcription+in+neurons+and+BET+inhibitor+Jq1+blocks+memory+in+mice&doi=10.1038%2Fnn.4095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice</span></div><div class="casAuthors">Korb, Erica; Herre, Margo; Zucker-Scharff, Ilana; Darnell, Robert B.; Allis, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1464-1473</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Precise regulation of transcription is crucial for the cellular mechanisms underlying memory formation.  However, the link between neuronal stimulation and the proteins that directly interact with histone modifications to activate transcription in neurons remains unclear.  Brd4 is a member of the bromodomain and extra-terminal domain (BET) protein family, which binds acetylated histones and is a crit. regulator of transcription in many cell types, including transcription in response to external cues.  Small mol. BET inhibitors are in clin. trials, yet almost nothing is known about Brd4 function in the brain.  Here we show that Brd4 mediates the transcriptional regulation underlying learning and memory.  The loss of Brd4 function affects crit. synaptic proteins, which results in memory deficits in mice but also decreases seizure susceptibility.  Thus Brd4 provides a crit. link between neuronal activation and the transcriptional responses that occur during memory formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbuMwCm6NDBLVg90H21EOLACvtfcHk0lhSRnYwT_mm0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlynsL%252FN&md5=0a09dea39378424cfc003a1e9e40ab9a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnn.4095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4095%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DE.%26aulast%3DHerre%26aufirst%3DM.%26aulast%3DZucker-Scharff%26aufirst%3DI.%26aulast%3DDarnell%26aufirst%3DR.%2BB.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DBET%2520protein%2520Brd4%2520activates%2520transcription%2520in%2520neurons%2520and%2520BET%2520inhibitor%2520Jq1%2520blocks%2520memory%2520in%2520mice%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D1464%26epage%3D1473%26doi%3D10.1038%2Fnn.4095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. H.</span><span> </span><span class="NLM_article-title">Identification of multiple cyclin subunits of human P-TEFb</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.1101/gad.12.5.755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1101%2Fgad.12.5.755" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=755-762&author=J.+Pengauthor=Y.+Zhuauthor=J.+T.+Miltonauthor=D.+H.+Price&title=Identification+of+multiple+cyclin+subunits+of+human+P-TEFb&doi=10.1101%2Fgad.12.5.755"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.5.755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.5.755%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DMilton%26aufirst%3DJ.%2BT.%26aulast%3DPrice%26aufirst%3DD.%2BH.%26atitle%3DIdentification%2520of%2520multiple%2520cyclin%2520subunits%2520of%2520human%2520P-TEFb%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D755%26epage%3D762%26doi%3D10.1101%2Fgad.12.5.755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yik, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.06.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.molcel.2005.06.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=16109377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=535-545&author=Z.+Yangauthor=J.+H.+Yikauthor=R.+Chenauthor=N.+Heauthor=M.+K.+Jangauthor=K.+Ozatoauthor=Q.+Zhou&title=Recruitment+of+P-TEFb+for+stimulation+of+transcriptional+elongation+by+the+bromodomain+protein+Brd4&doi=10.1016%2Fj.molcel.2005.06.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4</span></div><div class="casAuthors">Yang, Zhiyuan; Yik, Jasper H. N.; Chen, Ruichuan; He, Nanhai; Jang, Moon Kyoo; Ozato, Keiko; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cyclinT1/Cdk9 heterodimer that constitutes core P-TEFb is generally presumed to be the transcriptionally active form for stimulating RNA polymerase II elongation.  About half of cellular P-TEFb also exists in an inactive complex with the 7SK snRNA and the HEXIM1 protein.  Here, we show that the remaining half assocs. with the bromodomain protein Brd4.  In stress-induced cells, the 7SK/HEXIM1-bound P-TEFb is quant. converted into the Brd4-assocd. form.  The assocn. with Brd4 is necessary to form the transcriptionally active P-TEFb, recruits P-TEFb to a promoter, and enables P-TEFb to contact the Mediator complex, a potential target for the Brd4-mediated recruitment.  Although generally required for transcription, the P-TEFb-recruitment function of Brd4 can be substituted by that of HIV-1 Tat, which recruits P-TEFb directly for activated HIV-1 transcription.  Brd4, HEXIM1, and 7SK are all implicated in regulating cell growth, which may result from their dynamic control of the general transcription factor P-TEFb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFELcZRBnvLVg90H21EOLACvtfcHk0ljLH4JUGSmTJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur8%253D&md5=50325264e1eb27789eb46999ca3f799d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.06.029%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYik%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DRecruitment%2520of%2520P-TEFb%2520for%2520stimulation%2520of%2520transcriptional%2520elongation%2520by%2520the%2520bromodomain%2520protein%2520Brd4%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D535%26epage%3D545%26doi%3D10.1016%2Fj.molcel.2005.06.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.molcel.2005.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=16109376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=523-534&author=M.+K.+Jangauthor=K.+Mochizukiauthor=M.+Zhouauthor=H.+S.+Jeongauthor=J.+N.+Bradyauthor=K.+Ozato&title=The+bromodomain+protein+Brd4+is+a+positive+regulatory+component+of+P-TEFb+and+stimulates+RNA+polymerase+II-dependent+transcription&doi=10.1016%2Fj.molcel.2005.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription</span></div><div class="casAuthors">Jang, Moon Kyoo; Mochizuki, Kazuki; Zhou, Meisheng; Jeong, Ho-Sang; Brady, John N.; Ozato, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">523-534</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Brd4 is a mammalian bromodomain protein that binds to acetylated chromatin.  Proteomic anal. revealed that Brd4 interacts with cyclinT1 and Cdk9 that constitutes core pos. transcription elongation factor b (P-TEFb).  Brd4 interacted with P-TEFb in the living nucleus through its bromodomain.  About half of P-TEFb was bound to the inhibitory subunit and functionally inactive.  Brd4 interacted with P-TEFb that was free of the inhibitory subunit.  An increase in Brd4 expression led to increased P-TEFb-dependent phosphorylation of RNA polymerase II (RNAPII) CTD and stimulation of transcription from promoters in vivo.  Conversely, a redn. in Brd4 expression by siRNA reduced CTD phosphorylation and transcription, revealing that Brd4 is a pos. regulatory component of P-TEFb.  In chromatin immunopptn. (ChlP) assays, the recruitment of P-TEFb to a promoter was dependent on Brd4 and was enhanced by an increase in chromatin acetylation.  Together, P-TEFb alternately interacts with Brd4 and the inhibitory subunit to maintain functional equil. in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeaKLJgZobzrVg90H21EOLACvtfcHk0ljLH4JUGSmTJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur4%253D&md5=90a7c10d7e7dd0e47d28ac708f9965ae</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DMochizuki%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DJeong%26aufirst%3DH.%2BS.%26aulast%3DBrady%26aufirst%3DJ.%2BN.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DThe%2520bromodomain%2520protein%2520Brd4%2520is%2520a%2520positive%2520regulatory%2520component%2520of%2520P-TEFb%2520and%2520stimulates%2520RNA%2520polymerase%2520II-dependent%2520transcription%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D523%26epage%3D534%26doi%3D10.1016%2Fj.molcel.2005.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span><span class="refDoi"> DOI: 10.1128/MCB.01020-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.01020-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18039861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=967-976&author=Z.+Yangauthor=N.+Heauthor=Q.+Zhou&title=Brd4+recruits+P-TEFb+to+chromosomes+at+late+mitosis+to+promote+G1+gene+expression+and+cell+cycle+progression&doi=10.1128%2FMCB.01020-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression</span></div><div class="casAuthors">Yang, Zhiyuan; He, Nanhai; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">967-976</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brd4, a bromodomain protein capable of interacting with acetylated histones, is implicated in transmitting epigenetic memory through mitosis.  It also functions as an assocd. factor and pos. regulator of P-TEFb, a Cdk9-cyclin T1 heterodimer that stimulates transcriptional elongation by phosphorylating RNA polymerase II.  In the present study, expts. were performed to det. whether these two functions of Brd4 are interrelated and, if so, how they may impact cell cycle progression.  Our data demonstrate that while the P-TEFb level remains const., the Brd4-P-TEFb interaction increases dramatically in cells progressing from late mitosis to early G1.  Concurrently, P-TEFb is recruited to chromosomes, beginning around mid- to late anaphase and before nuclear envelope/lamina formation and nuclear import of other general transcription factors.  Importantly, the recruitment of P-TEFb depends on Brd4.  Abrogation of this process through Brd4 knockdown reduces the binding of P-TEFb to and expression of key G1 and growth-assocd. genes, leading to G1 cell cycle arrest and apoptosis.  Because P-TEFb is synonymous with productive elongation, its recruitment by Brd4 to chromosomes at late mitosis may indicate those genes whose active transcription status must be preserved across cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_qFlZcTzQiLVg90H21EOLACvtfcHk0ljLH4JUGSmTJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWqur4%253D&md5=99b71de9dec48e64ecbcb59fda3b6d1d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1128%2FMCB.01020-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01020-07%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DBrd4%2520recruits%2520P-TEFb%2520to%2520chromosomes%2520at%2520late%2520mitosis%2520to%2520promote%2520G1%2520gene%2520expression%2520and%2520cell%2520cycle%2520progression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D967%26epage%3D976%26doi%3D10.1128%2FMCB.01020-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubonishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Atayde, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=12543779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Klug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=304-307&author=C.+A.+Frenchauthor=I.+Miyoshiauthor=I.+Kubonishiauthor=H.+E.+Grierauthor=A.+R.+Perez-Ataydeauthor=J.+A.+Fletcher&title=BRD4-NUT+fusion+oncogene%3A+a+novel+mechanism+in+aggressive+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4-NUT Fusion Oncogene: A Novel Mechanism in Aggressive Carcinoma</span></div><div class="casAuthors">French, Christopher A.; Miyoshi, Isao; Kubonishi, Ichiro; Grier, Holcombe E.; Perez-Atayde, Antonio R.; Fletcher, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">304-307</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The poorly differentiated carcinoma with t(15;19)(q13,p13.1) is characterized by its highly aggressive, invariably lethal clin. course.  The chromosome 19 translocation breakpoint targets the BRD4 double bromodomain-contg. gene, which functions in regulation of cell cycle progression.  Herein the authors demonstrate that BRD4 is fused with nearly the entire transcript of the novel 15q13 gene, NUT (nuclear protein in testis), forming a 6.4-kb fusion oncogene, BRD4-NUT.  NUT, like BRD4, is predicted to encode a nuclear protein but, unlike the ubiquitous BRD4 transcript, is expressed only in testis.  These findings establish a model to elucidate the oncogenic consequences of unscheduled NUT expression and altered BRD4 function.  Very few fusion oncogenes have been identified in epithelial tumors, and BRD4-NUT is the first fusion oncogene mechanism identified in a highly lethal form of carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTa0K_kBu2pLVg90H21EOLACvtfcHk0liu2whe6_O91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Klug%253D%253D&md5=e927ea5874b2013c7467f981e10d7efd</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DMiyoshi%26aufirst%3DI.%26aulast%3DKubonishi%26aufirst%3DI.%26aulast%3DGrier%26aufirst%3DH.%2BE.%26aulast%3DPerez-Atayde%26aufirst%3DA.%2BR.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DBRD4-NUT%2520fusion%2520oncogene%253A%2520a%2520novel%2520mechanism%2520in%2520aggressive%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D304%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Delmore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastritis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilpatrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a therapeutic strategy to target c-Myc</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2011.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21889194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=904-917&author=J.+E.+Delmoreauthor=G.+C.+Issaauthor=M.+E.+Lemieuxauthor=P.+B.+Rahlauthor=J.+Shiauthor=H.+M.+Jacobsauthor=E.+Kastritisauthor=T.+Gilpatrickauthor=R.+M.+Paranalauthor=J.+Qiauthor=M.+Chesiauthor=A.+C.+Schinzelauthor=M.+R.+McKeownauthor=T.+P.+Heffernanauthor=C.+R.+Vakocauthor=P.+L.+Bergsagelauthor=I.+M.+Ghobrialauthor=P.+G.+Richardsonauthor=R.+A.+Youngauthor=W.+C.+Hahnauthor=K.+C.+Andersonauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=C.+S.+Mitsiades&title=BET+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-Myc&doi=10.1016%2Fj.cell.2011.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc</span></div><div class="casAuthors">Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E.; Rahl, Peter B.; Shi, Jun-Wei; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Chesi, Marta; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Vakoc, Christopher R.; Bergsagel, P. Leif; Ghobrial, Irene M.; Richardson, Paul G.; Young, Richard A.; Hahn, William C.; Anderson, Kenneth C.; Kung, Andrew L.; Bradner, James E.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904-917</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: MYC contributes to the pathogenesis of a majority of human cancers, yet strategies to modulate the function of the c-Myc oncoprotein do not exist.  Toward this objective, we have targeted MYC transcription by interfering with chromatin-dependent signal transduction to RNA polymerase, specifically by inhibiting the acetyl-lysine recognition domains (bromodomains) of putative coactivator proteins implicated in transcriptional initiation and elongation.  Using a selective small-mol. bromodomain inhibitor, JQ1, we identify BET bromodomain proteins as regulatory factors for c-Myc.  BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes.  In exptl. models of multiple myeloma, a Myc-dependent hematol. malignancy, JQ1 produces a potent antiproliferative effect assocd. with cell-cycle arrest and cellular senescence.  Efficacy of JQ1 in three murine models of multiple myeloma establishes the therapeutic rationale for BET bromodomain inhibition in this disease and other malignancies characterized by pathol. activation of c-Myc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevD1QHKmOhLVg90H21EOLACvtfcHk0liu2whe6_O91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF&md5=013674b8224214a9a1c8f0b75583a5a6</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelmore%26aufirst%3DJ.%2BE.%26aulast%3DIssa%26aufirst%3DG.%2BC.%26aulast%3DLemieux%26aufirst%3DM.%2BE.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DH.%2BM.%26aulast%3DKastritis%26aufirst%3DE.%26aulast%3DGilpatrick%26aufirst%3DT.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520to%2520target%2520c-Myc%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D904%26epage%3D917%26doi%3D10.1016%2Fj.cell.2011.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span> </span><span class="NLM_article-title">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">16669</span><span class="NLM_x">–</span> <span class="NLM_lpage">16674</span><span class="refDoi"> DOI: 10.1073/pnas.1108190108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1108190108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21949397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=16669-16674&author=J.+A.+Mertzauthor=A.+R.+Coneryauthor=B.+M.+Bryantauthor=P.+Sandyauthor=S.+Balasubramanianauthor=D.+A.+Meleauthor=L.+Bergeronauthor=R.+J.+Sims&title=Targeting+MYC+dependence+in+cancer+by+inhibiting+BET+bromodomains&doi=10.1073%2Fpnas.1108190108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span></div><div class="casAuthors">Mertz, Jennifer A.; Conery, Andrew R.; Bryant, Barbara M.; Sandy, Peter; Balasubramanian, Srividya; Mele, Deanna A.; Bergeron, Louise; Sims, Robert J., III</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16669-16674, S16669/1-S16669/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The MYC transcription factor is a master regulator of diverse cellular functions and has been long considered a compelling therapeutic target because of its role in a range of human malignancies.  However, pharmacol. inhibition of MYC function has proven challenging because of both the diverse mechanisms driving its aberrant expression and the challenge of disrupting protein-DNA interactions.  Here, we demonstrate the rapid and potent abrogation of MYC gene transcription by representative small mol. inhibitors of the BET family of chromatin adaptors.  MYC transcriptional suppression was obsd. in the context of the natural, chromosomally translocated, and amplified gene locus.  Inhibition of BET bromodomain-promoter interactions and subsequent redn. of MYC transcript and protein levels resulted in G1 arrest and extensive apoptosis in a variety of leukemia and lymphoma cell lines.  Exogenous expression of MYC from an artificial promoter that is resistant to BET regulation significantly protected cells from cell cycle arrest and growth suppression by BET inhibitors.  MYC suppression was accompanied by deregulation of the MYC transcriptome, including potent reactivation of the p21 tumor suppressor.  Treatment with a BET inhibitor resulted in significant antitumor activity in xenograft models of Burkitt's lymphoma and acute myeloid leukemia.  These findings demonstrate that pharmacol. inhibition of MYC is achievable through targeting BET bromodomains.  Such inhibitors may have clin. utility given the widespread pathogenetic role of MYC in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UHj1YB_ikrVg90H21EOLACvtfcHk0liu2whe6_O91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL&md5=b1f0fd41fa56bbfcbb1ad6c8d48f7f80</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1108190108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1108190108%26sid%3Dliteratum%253Aachs%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DMele%26aufirst%3DD.%2BA.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520MYC%2520dependence%2520in%2520cancer%2520by%2520inhibiting%2520BET%2520bromodomains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D16669%26epage%3D16674%26doi%3D10.1073%2Fpnas.1108190108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Thangue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Selective inhibition of BET bromodomains</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span><span class="refDoi"> DOI: 10.1038/nature09504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature09504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20871596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1067-1073&author=P.+Filippakopoulosauthor=J.+Qiauthor=S.+Picaudauthor=Y.+Shenauthor=W.+B.+Smithauthor=O.+Fedorovauthor=E.+M.+Morseauthor=T.+Keatesauthor=T.+T.+Hickmanauthor=I.+Felletarauthor=M.+Philpottauthor=S.+Munroauthor=M.+R.+McKeownauthor=Y.+Wangauthor=A.+L.+Christieauthor=N.+Westauthor=M.+J.+Cameronauthor=B.+Schwartzauthor=T.+D.+Heightmanauthor=N.+La+Thangueauthor=C.+A.+Frenchauthor=O.+Wiestauthor=A.+L.+Kungauthor=S.+Knappauthor=J.+E.+Bradner&title=Selective+inhibition+of+BET+bromodomains&doi=10.1038%2Fnature09504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of BET bromodomains</span></div><div class="casAuthors">Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shongah; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic proteins are intently pursued targets in ligand discovery.  So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'.  Potent inhibitors of histone binding modules have not yet been described.  Here the authors report a cell-permeable small mol. (I,JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains.  High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity.  Recurrent translocation of BRD4 is obsd. in a genetically-defined, incurable subtype of human squamous carcinoma.  Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models.  These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chem. scaffold for the development of chem. probes more broadly throughout the bromodomain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ZbtmZM8m_LVg90H21EOLACvtfcHk0lhQO2BupIqb7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D&md5=bd9cadac86124d2c6c3cd5b2a92d68c2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnature09504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09504%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMorse%26aufirst%3DE.%2BM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DHickman%26aufirst%3DT.%2BT.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DWest%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DLa%2BThangue%26aufirst%3DN.%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DSelective%2520inhibition%2520of%2520BET%2520bromodomains%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1067%26epage%3D1073%26doi%3D10.1038%2Fnature09504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Asangani, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dommeti, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escara-Wilke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilder-Romans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanireddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1038/nature13229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature13229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24759320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=278-282&author=I.+A.+Asanganiauthor=V.+L.+Dommetiauthor=X.+Wangauthor=R.+Malikauthor=M.+Cieslikauthor=R.+Yangauthor=J.+Escara-Wilkeauthor=K.+Wilder-Romansauthor=S.+Dhanireddyauthor=C.+Engelkeauthor=M.+K.+Iyerauthor=X.+Jingauthor=Y.+M.+Wuauthor=X.+Caoauthor=Z.+S.+Qinauthor=S.+Wangauthor=F.+Y.+Fengauthor=A.+M.+Chinnaiyan&title=Therapeutic+targeting+of+BET+bromodomain+proteins+in+castration-resistant+prostate+cancer&doi=10.1038%2Fnature13229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer</span></div><div class="casAuthors">Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Yang, Rendong; Escara-Wilke, June; Wilder-Romans, Kari; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Qin, Zhaohui S.; Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7504</span>),
    <span class="NLM_cas:pages">278-282</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Men who develop metastatic castration-resistant prostate cancer (CRPC) invariably succumb to the disease.  Progression to CRPC after androgen ablation therapy is predominantly driven by deregulated androgen receptor (AR) signaling.  Despite the success of recently approved therapies targeting AR signaling, such as abiraterone and second-generation anti-androgens including MDV3100 (also known as enzalutamide), durable responses are limited, presumably owing to acquired resistance.  Recently, JQ1 and I-BET762 two selective small-mol. inhibitors that target the N-terminal bromodomains of BRD4, have been shown to exhibit anti-proliferative effects in a range of malignancies.  AR-signaling-competent human CRPC cell lines are preferentially sensitive to bromodomain and extraterminal (BET) inhibition.  BRD4 phys. interacts with the N-terminal domain of AR and can be disrupted by JQ1 (refs 11, 13).  Like the direct AR antagonist MDV3100, JQ1 disrupted AR recruitment to target gene loci.  By contrast with MDV3100, JQ1 functions downstream of AR, and more potently abrogated BRD4 localization to AR target loci and AR-mediated gene transcription, including induction of the TMPRSS2-ERG gene fusion and its oncogenic activity.  In vivo, BET bromodomain inhibition was more efficacious than direct AR antagonism in CRPC xenograft mouse models.  Taken together, these studies provide a novel epigenetic approach for the concerted blockade of oncogenic drivers in advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfXutywHDWrVg90H21EOLACvtfcHk0lhQO2BupIqb7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D&md5=bef4b5faf5d23dc7d125ab1941c3ee39</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnature13229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13229%26sid%3Dliteratum%253Aachs%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DDommeti%26aufirst%3DV.%2BL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMalik%26aufirst%3DR.%26aulast%3DCieslik%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DEscara-Wilke%26aufirst%3DJ.%26aulast%3DWilder-Romans%26aufirst%3DK.%26aulast%3DDhanireddy%26aufirst%3DS.%26aulast%3DEngelke%26aufirst%3DC.%26aulast%3DIyer%26aufirst%3DM.%2BK.%26aulast%3DJing%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DZ.%2BS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DTherapeutic%2520targeting%2520of%2520BET%2520bromodomain%2520proteins%2520in%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D278%26epage%3D282%26doi%3D10.1038%2Fnature13229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Segura, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanals-Cirera, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaziel-Sovran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanniford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Gomez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubierre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darvishian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernando, E.</span><span> </span><span class="NLM_article-title">BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6276</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-0122-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F0008-5472.CAN-13-0122-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23950209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ahur7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=6264-6276&author=M.+F.+Seguraauthor=B.+Fontanals-Cireraauthor=A.+Gaziel-Sovranauthor=M.+V.+Guijarroauthor=D.+Hannifordauthor=G.+Zhangauthor=P.+Gonzalez-Gomezauthor=M.+Moranteauthor=L.+Jubierreauthor=W.+Zhangauthor=F.+Darvishianauthor=M.+Ohlmeyerauthor=I.+Osmanauthor=M.+M.+Zhouauthor=E.+Hernando&title=BRD4+sustains+melanoma+proliferation+and+represents+a+new+target+for+epigenetic+therapy&doi=10.1158%2F0008-5472.CAN-13-0122-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy</span></div><div class="casAuthors">Segura, Miguel F.; Fontanals-Cirera, Barbara; Gaziel-Sovran, Avital; Guijarro, Maria V.; Hanniford, Doug; Zhang, Guangtao; Gonzalez-Gomez, Pilar; Morante, Marta; Jubierre, Luz; Zhang, Weijia; Darvishian, Farbod; Ohlmeyer, Michael; Osman, Iman; Zhou, Ming-Ming; Hernando, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6264-6276</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Metastatic melanoma remains a mostly incurable disease.  Although newly approved targeted therapies are efficacious in a subset of patients, resistance and relapse rapidly ensue.  Alternative therapeutic strategies to manipulate epigenetic regulators and disrupt the transcriptional program that maintains tumor cell identity are emerging.  Bromodomain and extraterminal domain (BET) proteins are epigenome readers known to exert key roles at the interface between chromatin remodeling and transcriptional regulation.  Here, we report that BRD4, a BET family member, is significantly upregulated in primary and metastatic melanoma tissues compared with melanocytes and nevi.  Treatment with BET inhibitors impaired melanoma cell proliferation in vitro and tumor growth and metastatic behavior in vivo, effects that were mostly recapitulated by individual silencing of BRD4.  RNA sequencing of BET inhibitor-treated cells followed by Gene Ontol. anal. showed a striking impact on transcriptional programs controlling cell growth, proliferation, cell-cycle regulation, and differentiation.  In particular, we found that, rapidly after BET displacement, key cell-cycle genes (SKP2, ERK1, and c-MYC) were downregulated concomitantly with the accumulation of cyclin-dependent kinase (CDK) inhibitors (p21 and p27), followed by cell-cycle arrest.  Importantly, BET inhibitor efficacy was not influenced by BRAF or NRAS mutational status, opening the possibility of using these small-mol. compds. to treat patients for whom no effective targeted therapy exists.  Collectively, our study reveals a crit. role for BRD4 in melanoma tumor maintenance and renders it a legitimate and novel target for epigenetic therapy directed against the core transcriptional program of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq80TZH2ueQFbVg90H21EOLACvtfcHk0ljOiOxgXit71Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ahur7N&md5=a4a77f188de01c4c84f7293a32478fc7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-0122-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-0122-T%26sid%3Dliteratum%253Aachs%26aulast%3DSegura%26aufirst%3DM.%2BF.%26aulast%3DFontanals-Cirera%26aufirst%3DB.%26aulast%3DGaziel-Sovran%26aufirst%3DA.%26aulast%3DGuijarro%26aufirst%3DM.%2BV.%26aulast%3DHanniford%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGonzalez-Gomez%26aufirst%3DP.%26aulast%3DMorante%26aufirst%3DM.%26aulast%3DJubierre%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDarvishian%26aufirst%3DF.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DHernando%26aufirst%3DE.%26atitle%3DBRD4%2520sustains%2520melanoma%2520proliferation%2520and%2520represents%2520a%2520new%2520target%2520for%2520epigenetic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D6264%26epage%3D6276%26doi%3D10.1158%2F0008-5472.CAN-13-0122-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Zuber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sison, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wunderlich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chicas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulloy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span> </span><span class="NLM_article-title">RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1038/nature10334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature10334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21814200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=524-528&author=J.+Zuberauthor=J.+Shiauthor=E.+Wangauthor=A.+R.+Rappaportauthor=H.+Herrmannauthor=E.+A.+Sisonauthor=D.+Magoonauthor=J.+Qiauthor=K.+Blattauthor=M.+Wunderlichauthor=M.+J.+Taylorauthor=C.+Johnsauthor=A.+Chicasauthor=J.+C.+Mulloyauthor=S.+C.+Koganauthor=P.+Brownauthor=P.+Valentauthor=J.+E.+Bradnerauthor=S.+W.+Loweauthor=C.+R.+Vakoc&title=RNAi+screen+identifies+Brd4+as+a+therapeutic+target+in+acute+myeloid+leukaemia&doi=10.1038%2Fnature10334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia</span></div><div class="casAuthors">Zuber, Johannes; Shi, Junwei; Wang, Eric; Rappaport, Amy R.; Herrmann, Harald; Sison, Edward A.; Magoon, Daniel; Qi, Jun; Blatt, Katharina; Wunderlich, Mark; Taylor, Meredith J.; Johns, Christopher; Chicas, Agustin; Mulloy, James C.; Kogan, Scott C.; Brown, Patrick; Valent, Peter; Bradner, James E.; Lowe, Scott W.; Vakoc, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">524-528</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic pathways can regulate gene expression by controlling and interpreting chromatin modifications.  Cancer cells are characterized by altered epigenetic landscapes, and commonly exploit the chromatin regulatory machinery to enforce oncogenic gene expression programs.  Although chromatin alterations are, in principle, reversible and often amenable to drug intervention, the promise of targeting such pathways therapeutically has been limited by an incomplete understanding of cancer-specific dependencies on epigenetic regulators.  Here the authors describe a non-biased approach to probe epigenetic vulnerabilities in acute myeloid leukemia (AML), an aggressive hematopoietic malignancy that is often assocd. with aberrant chromatin states.  By screening a custom library of small hairpin RNAs (shRNAs) targeting known chromatin regulators in a genetically defined AML mouse model, the authors identify the protein bromodomain-contg. 4 (Brd4) as being critically required for disease maintenance.  Suppression of Brd4 using shRNAs or the small-mol. inhibitor JQ1 led to robust antileukemic effects in vitro and in vivo, accompanied by terminal myeloid differentiation and elimination of leukemia stem cells.  Similar sensitivities were obsd. in a variety of human AML cell lines and primary patient samples, revealing that JQ1 has broad activity in diverse AML subtypes.  The effects of Brd4 suppression are, at least in part, due to its role in sustaining Myc expression to promote aberrant self-renewal, which implicates JQ1 as a pharmacol. means to suppress MYC in cancer.  The authors' results establish small-mol. inhibition of Brd4 as a promising therapeutic strategy in AML and, potentially, other cancers, and highlight the utility of RNA interference (RNAi) screening for revealing epigenetic vulnerabilities that can be exploited for direct pharmacol. intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVyWFIqFkUVrVg90H21EOLACvtfcHk0ljOiOxgXit71Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers7%252FP&md5=618793a766f037bff5909524743fedb7</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnature10334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10334%26sid%3Dliteratum%253Aachs%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DRappaport%26aufirst%3DA.%2BR.%26aulast%3DHerrmann%26aufirst%3DH.%26aulast%3DSison%26aufirst%3DE.%2BA.%26aulast%3DMagoon%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBlatt%26aufirst%3DK.%26aulast%3DWunderlich%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DJohns%26aufirst%3DC.%26aulast%3DChicas%26aufirst%3DA.%26aulast%3DMulloy%26aufirst%3DJ.%2BC.%26aulast%3DKogan%26aufirst%3DS.%2BC.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26atitle%3DRNAi%2520screen%2520identifies%2520Brd4%2520as%2520a%2520therapeutic%2520target%2520in%2520acute%2520myeloid%2520leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D524%26epage%3D528%26doi%3D10.1038%2Fnature10334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Baratta, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhayay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman-Colin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drapkin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span> </span><span class="NLM_article-title">An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1073/pnas.1422165112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1422165112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=232-237&author=M.+G.+Barattaauthor=A.+C.+Schinzelauthor=Y.+Zwangauthor=P.+Bandopadhayayauthor=C.+Bowman-Colinauthor=J.+Kuttauthor=J.+Curtisauthor=H.+Piaoauthor=L.+C.+Wongauthor=A.+L.+Kungauthor=R.+Beroukhimauthor=J.+E.+Bradnerauthor=R.+Drapkinauthor=W.+C.+Hahnauthor=J.+F.+Liuauthor=D.+M.+Livingston&title=An+in-tumor+genetic+screen+reveals+that+the+BET+bromodomain+protein%2C+BRD4%2C+is+a+potential+therapeutic+target+in+ovarian+carcinoma&doi=10.1073%2Fpnas.1422165112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422165112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422165112%26sid%3Dliteratum%253Aachs%26aulast%3DBaratta%26aufirst%3DM.%2BG.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DBandopadhayay%26aufirst%3DP.%26aulast%3DBowman-Colin%26aufirst%3DC.%26aulast%3DKutt%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DJ.%26aulast%3DPiao%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DL.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DDrapkin%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DAn%2520in-tumor%2520genetic%2520screen%2520reveals%2520that%2520the%2520BET%2520bromodomain%2520protein%252C%2520BRD4%252C%2520is%2520a%2520potential%2520therapeutic%2520target%2520in%2520ovarian%2520carcinoma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D232%26epage%3D237%26doi%3D10.1073%2Fpnas.1422165112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Ceribelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews Griner, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span> </span><span class="NLM_article-title">Blockade of oncogenic IkappaB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">11365</span><span class="NLM_x">–</span> <span class="NLM_lpage">11370</span><span class="refDoi"> DOI: 10.1073/pnas.1411701111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1411701111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=11365-11370&author=M.+Ceribelliauthor=P.+N.+Kellyauthor=A.+L.+Shafferauthor=G.+W.+Wrightauthor=W.+Xiaoauthor=Y.+Yangauthor=L.+A.+Mathews+Grinerauthor=R.+Guhaauthor=P.+Shinnauthor=J.+M.+Kellerauthor=D.+Liuauthor=P.+R.+Patelauthor=M.+Ferrerauthor=S.+Joshiauthor=S.+Nerleauthor=P.+Sandyauthor=E.+Normantauthor=C.+J.+Thomasauthor=L.+M.+Staudt&title=Blockade+of+oncogenic+IkappaB+kinase+activity+in+diffuse+large+B-cell+lymphoma+by+bromodomain+and+extraterminal+domain+protein+inhibitors&doi=10.1073%2Fpnas.1411701111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1411701111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1411701111%26sid%3Dliteratum%253Aachs%26aulast%3DCeribelli%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DP.%2BN.%26aulast%3DShaffer%26aufirst%3DA.%2BL.%26aulast%3DWright%26aufirst%3DG.%2BW.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMathews%2BGriner%26aufirst%3DL.%2BA.%26aulast%3DGuha%26aufirst%3DR.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DKeller%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DNerle%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DBlockade%2520of%2520oncogenic%2520IkappaB%2520kinase%2520activity%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%2520by%2520bromodomain%2520and%2520extraterminal%2520domain%2520protein%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D11365%26epage%3D11370%26doi%3D10.1073%2Fpnas.1411701111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Puissant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frumm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassil, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanthery, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nekritz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greninger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmaier, K.</span><span> </span><span class="NLM_article-title">Targeting MYCN in neuroblastoma by BET bromodomain inhibition</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F2159-8290.CD-12-0418" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=308-323&author=A.+Puissantauthor=S.+M.+Frummauthor=G.+Alexeauthor=C.+F.+Bassilauthor=J.+Qiauthor=Y.+H.+Chantheryauthor=E.+A.+Nekritzauthor=R.+Zeidauthor=W.+C.+Gustafsonauthor=P.+Greningerauthor=M.+J.+Garnettauthor=U.+McDermottauthor=C.+H.+Benesauthor=A.+L.+Kungauthor=W.+A.+Weissauthor=J.+E.+Bradnerauthor=K.+Stegmaier&title=Targeting+MYCN+in+neuroblastoma+by+BET+bromodomain+inhibition&doi=10.1158%2F2159-8290.CD-12-0418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0418%26sid%3Dliteratum%253Aachs%26aulast%3DPuissant%26aufirst%3DA.%26aulast%3DFrumm%26aufirst%3DS.%2BM.%26aulast%3DAlexe%26aufirst%3DG.%26aulast%3DBassil%26aufirst%3DC.%2BF.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChanthery%26aufirst%3DY.%2BH.%26aulast%3DNekritz%26aufirst%3DE.%2BA.%26aulast%3DZeid%26aufirst%3DR.%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DU.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DStegmaier%26aufirst%3DK.%26atitle%3DTargeting%2520MYCN%2520in%2520neuroblastoma%2520by%2520BET%2520bromodomain%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D308%26epage%3D323%26doi%3D10.1158%2F2159-8290.CD-12-0418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Lockwood, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H.</span><span> </span><span class="NLM_article-title">Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">19408</span><span class="NLM_x">–</span> <span class="NLM_lpage">19413</span><span class="refDoi"> DOI: 10.1073/pnas.1216363109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1216363109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=19408-19413&author=W.+W.+Lockwoodauthor=K.+Zejnullahuauthor=J.+E.+Bradnerauthor=H.+Varmus&title=Sensitivity+of+human+lung+adenocarcinoma+cell+lines+to+targeted+inhibition+of+BET+epigenetic+signaling+proteins&doi=10.1073%2Fpnas.1216363109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1216363109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1216363109%26sid%3Dliteratum%253Aachs%26aulast%3DLockwood%26aufirst%3DW.%2BW.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DSensitivity%2520of%2520human%2520lung%2520adenocarcinoma%2520cell%2520lines%2520to%2520targeted%2520inhibition%2520of%2520BET%2520epigenetic%2520signaling%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D19408%26epage%3D19413%26doi%3D10.1073%2Fpnas.1216363109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. F.</span><span> </span><span class="NLM_article-title">Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1128/MCB.01365-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.01365-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19103749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlylsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=1375-1387&author=B.+Huangauthor=X.+D.+Yangauthor=M.+M.+Zhouauthor=K.+Ozatoauthor=L.+F.+Chen&title=Brd4+coactivates+transcriptional+activation+of+NF-kappaB+via+specific+binding+to+acetylated+RelA&doi=10.1128%2FMCB.01365-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Brd4 coactivates transcriptional activation of NF-κB via specific binding to acetylated RelA</span></div><div class="casAuthors">Huang, Bo; Yang, Xiao-Dong; Zhou, Ming-Ming; Ozato, Keiko; Chen, Lin-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1375-1387</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acetylation of the RelA subunit of NF-κB, esp. at lysine-310, is crit. for the transcriptional activation of NF-κB and the expression of inflammatory genes.  In this study, we demonstrate that bromodomains of Brd4 bind to acetylated lysine-310.  Brd4 enhances transcriptional activation of NF-κB and the expression of a subset of NF-κB-responsive inflammatory genes in an acetylated lysine-310-dependent manner.  Bromodomains of Brd4 and acetylated lysine-310 of RelA are both required for the mutual interaction and coactivation function of Brd4.  Finally, we demonstrate that Brd4 further recruits CDK9 to phosphorylate C-terminal domain of RNA polymerase II and facilitate the transcription of NF-κB-dependent inflammatory genes.  Our results identify Brd4 as a novel coactivator of NF-κB through specifically binding to acetylated lysine-310 of RelA.  In addn., these studies reveal a mechanism by which acetylated RelA stimulates the transcriptional activity of NF-κB and the NF-κB-dependent inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBnS4p5wzT2LVg90H21EOLACvtfcHk0lgT4hRIF_W58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlylsrc%253D&md5=ae4e16c84d17c5e0e268ff80703a4608</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1128%2FMCB.01365-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01365-08%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DX.%2BD.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DL.%2BF.%26atitle%3DBrd4%2520coactivates%2520transcriptional%2520activation%2520of%2520NF-kappaB%2520via%2520specific%2520binding%2520to%2520acetylated%2520RelA%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D1375%26epage%3D1387%26doi%3D10.1128%2FMCB.01365-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Chen, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, W. C.</span><span> </span><span class="NLM_article-title">Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB</span> <span class="citation_source-journal">EMBO. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6539</span><span class="NLM_x">–</span> <span class="NLM_lpage">6548</span><span class="refDoi"> DOI: 10.1093/emboj/cdf660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1093%2Femboj%2Fcdf660" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6539-6548&author=L.+F.+Chenauthor=Y.+Muauthor=W.+C.+Greene&title=Acetylation+of+RelA+at+discrete+sites+regulates+distinct+nuclear+functions+of+NF-kappaB&doi=10.1093%2Femboj%2Fcdf660"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdf660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdf660%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BF.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DGreene%26aufirst%3DW.%2BC.%26atitle%3DAcetylation%2520of%2520RelA%2520at%2520discrete%2520sites%2520regulates%2520distinct%2520nuclear%2520functions%2520of%2520NF-kappaB%26jtitle%3DEMBO.%2520J.%26date%3D2002%26volume%3D21%26spage%3D6539%26epage%3D6548%26doi%3D10.1093%2Femboj%2Fcdf660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Ding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span> </span><span class="NLM_article-title">BRD4 is a novel therapeutic target for liver fibrosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15713</span><span class="NLM_x">–</span> <span class="NLM_lpage">15718</span><span class="refDoi"> DOI: 10.1073/pnas.1522163112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1522163112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15713-15718&author=N.+Dingauthor=N.+Hahauthor=R.+T.+Yuauthor=M.+H.+Shermanauthor=C.+Bennerauthor=M.+Leblancauthor=M.+Heauthor=C.+Liddleauthor=M.+Downesauthor=R.+M.+Evans&title=BRD4+is+a+novel+therapeutic+target+for+liver+fibrosis&doi=10.1073%2Fpnas.1522163112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1522163112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1522163112%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DN.%26aulast%3DHah%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DSherman%26aufirst%3DM.%2BH.%26aulast%3DBenner%26aufirst%3DC.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLiddle%26aufirst%3DC.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DBRD4%2520is%2520a%2520novel%2520therapeutic%2520target%2520for%2520liver%2520fibrosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15713%26epage%3D15718%26doi%3D10.1073%2Fpnas.1522163112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Tian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasier, A. R.</span><span> </span><span class="NLM_article-title">BRD4 mediates NFkB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">L1183</span><span class="refDoi"> DOI: 10.1152/ajplung.00224.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1152%2Fajplung.00224.2016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=L1183&author=B.+Tianauthor=Y.+Zhaoauthor=H.+Sunauthor=Y.+Zhangauthor=J.+Yangauthor=A.+R.+Brasier&title=BRD4+mediates+NFkB-dependent+epithelial-mesenchymal+transition+and+pulmonary+fibrosis+via+transcriptional+elongation&doi=10.1152%2Fajplung.00224.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00224.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00224.2016%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DBrasier%26aufirst%3DA.%2BR.%26atitle%3DBRD4%2520mediates%2520NFkB-dependent%2520epithelial-mesenchymal%2520transition%2520and%2520pulmonary%2520fibrosis%2520via%2520transcriptional%2520elongation%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2016%26volume%3D311%26spage%3DL1183%26doi%3D10.1152%2Fajplung.00224.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandwani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marazzi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span> </span><span class="NLM_article-title">Suppression of inflammation by a synthetic histone mimic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1038/nature09589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature09589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21068722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1119-1123&author=E.+Nicodemeauthor=K.+L.+Jeffreyauthor=U.+Schaeferauthor=S.+Beinkeauthor=S.+Dewellauthor=C.+W.+Chungauthor=R.+Chandwaniauthor=I.+Marazziauthor=P.+Wilsonauthor=H.+Costeauthor=J.+Whiteauthor=J.+Kirilovskyauthor=C.+M.+Riceauthor=J.+M.+Loraauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=A.+Tarakhovsky&title=Suppression+of+inflammation+by+a+synthetic+histone+mimic&doi=10.1038%2Fnature09589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of inflammation by a synthetic histone mimic</span></div><div class="casAuthors">Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression.  This response, although vital for immune defense, is frequently deleterious to the host due to the exaggerated prodn. of inflammatory proteins.  The scope of inflammatory responses reflects the activation state of signaling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression.  Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a crit. step in the regulation of gene expression.  Here we present a novel pharmacol. approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins.  We describe a synthetic compd. (I-BET) that by mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis.  Our findings suggest that synthetic compds. specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxc3_PNaiuKLVg90H21EOLACvtfcHk0lgT4hRIF_W58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP&md5=0dfccd9d01b87859512bf591e1c5a93c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnature09589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09589%26sid%3Dliteratum%253Aachs%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DK.%2BL.%26aulast%3DSchaefer%26aufirst%3DU.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DDewell%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChandwani%26aufirst%3DR.%26aulast%3DMarazzi%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520inflammation%2520by%2520a%2520synthetic%2520histone%2520mimic%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1119%26epage%3D1123%26doi%3D10.1038%2Fnature09589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Khan, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Brd4 is essential for IL-1beta-induced inflammation in human airway epithelial cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e95051</span><span class="refDoi"> DOI: 10.1371/journal.pone.0095051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1371%2Fjournal.pone.0095051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e95051&author=Y.+M.+Khanauthor=P.+Kirkhamauthor=P.+J.+Barnesauthor=I.+M.+Adcock&title=Brd4+is+essential+for+IL-1beta-induced+inflammation+in+human+airway+epithelial+cells&doi=10.1371%2Fjournal.pone.0095051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0095051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0095051%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DY.%2BM.%26aulast%3DKirkham%26aufirst%3DP.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DBrd4%2520is%2520essential%2520for%2520IL-1beta-induced%2520inflammation%2520in%2520human%2520airway%2520epithelial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De95051%26doi%3D10.1371%2Fjournal.pone.0095051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguzman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apparsundaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogaboam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span> </span><span class="NLM_article-title">Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2013.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ajpath.2013.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23759512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFynur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2013&pages=470-479&author=X.+Tangauthor=R.+Pengauthor=J.+E.+Phillipsauthor=J.+Deguzmanauthor=Y.+Renauthor=S.+Apparsundaramauthor=Q.+Luoauthor=C.+M.+Bauerauthor=M.+E.+Fuentesauthor=J.+A.+DeMartinoauthor=G.+Tyagiauthor=R.+Garridoauthor=C.+M.+Hogaboamauthor=C.+P.+Dentonauthor=A.+M.+Holmesauthor=C.+Kitsonauthor=C.+S.+Stevensonauthor=D.+C.+Budd&title=Assessment+of+Brd4+inhibition+in+idiopathic+pulmonary+fibrosis+lung+fibroblasts+and+in+vivo+models+of+lung+fibrosis&doi=10.1016%2Fj.ajpath.2013.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of Brd4 Inhibition in Idiopathic Pulmonary Fibrosis Lung Fibroblasts and in Vivo Models of Lung Fibrosis</span></div><div class="casAuthors">Tang, Xiaoyan; Peng, Ruoqi; Phillips, Jonathan E.; Deguzman, Jeremy; Ren, Yonglin; Apparsundaram, Subramanium; Luo, Qi; Bauer, Carla M.; Fuentes, Maria E.; DeMartino, Julie A.; Tyagi, Gaurav; Garrido, Rosario; Hogaboam, Cory M.; Denton, Christopher P.; Holmes, Alan M.; Kitson, Christopher; Stevenson, Christopher S.; Budd, David C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">470-479</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of high unmet medical need.  Although bromodomain (Brd) and extra terminal domain isoforms have recently been implicated in mediating inflammatory and oncol. indications, their roles in lung fibrosis have not been comprehensively assessed.  We investigated the role of Brd on the profibrotic responses of lung fibroblasts (LFs) in patients with rapidly progressing IPF and a mouse bleomycin model of lung fibrosis.  The enhanced migration, proliferation, and IL-6 release obsd. in LFs from patients with rapidly progressing IPF are attenuated by pharmacol. inhibition of Brd4.  These changes are accompanied by enhanced histone H4 lysine5 acetylation and assocn. of Brd4 with genes involved in the profibrotic responses in IPF LFs as demonstrated using chromatin immunopptn. and quant. PCR.  Oral administration of 200 mg/kg per day Brd4 inhibitor JQ1 in a therapeutic dosing regimen substantially attenuated lung fibrosis induced by bleomycin in C57BL/6 mice.  In conclusion, this study shows that the Brd4 inhibitor JQ1, administered in a therapeutic dosage, is capable of inhibiting the profibrotic effects of IPF LFs and attenuates bleomycin-induced lung fibrosis in mice.  These results suggest that Brd4 inhibitors may represent a novel therapy for the treatment of rapidly progressing IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeyA6Tfi6PObVg90H21EOLACvtfcHk0lg5POv7ymCz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFynur7I&md5=8a7b094630ce44df6cd1b2b9de6cc6ec</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2013.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2013.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DPhillips%26aufirst%3DJ.%2BE.%26aulast%3DDeguzman%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DApparsundaram%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DBauer%26aufirst%3DC.%2BM.%26aulast%3DFuentes%26aufirst%3DM.%2BE.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTyagi%26aufirst%3DG.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DHogaboam%26aufirst%3DC.%2BM.%26aulast%3DDenton%26aufirst%3DC.%2BP.%26aulast%3DHolmes%26aufirst%3DA.%2BM.%26aulast%3DKitson%26aufirst%3DC.%26aulast%3DStevenson%26aufirst%3DC.%2BS.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26atitle%3DAssessment%2520of%2520Brd4%2520inhibition%2520in%2520idiopathic%2520pulmonary%2520fibrosis%2520lung%2520fibroblasts%2520and%2520in%2520vivo%2520models%2520of%2520lung%2520fibrosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2013%26volume%3D183%26spage%3D470%26epage%3D479%26doi%3D10.1016%2Fj.ajpath.2013.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apparsundaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguzman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span> </span><span class="NLM_article-title">BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1124/mol.112.081661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1124%2Fmol.112.081661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23115324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=283-293&author=X.+Tangauthor=R.+Pengauthor=Y.+Renauthor=S.+Apparsundaramauthor=J.+Deguzmanauthor=C.+M.+Bauerauthor=A.+F.+Hoffmanauthor=S.+Hamiltonauthor=Z.+Liangauthor=H.+Zengauthor=M.+E.+Fuentesauthor=J.+A.+Demartinoauthor=C.+Kitsonauthor=C.+S.+Stevensonauthor=D.+C.+Budd&title=BET+bromodomain+proteins+mediate+downstream+signaling+events+following+growth+factor+stimulation+in+human+lung+fibroblasts+and+are+involved+in+bleomycin-induced+pulmonary+fibrosis&doi=10.1124%2Fmol.112.081661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis</span></div><div class="casAuthors">Tang, Xiaoyan; Peng, Ruoqi; Ren, Yonglin; Apparsundaram, Subramanium; Deguzman, Jeremy; Bauer, Carla M.; Hoffman, Ann F.; Hamilton, Shannon; Liang, Zhenmin; Zeng, Hang; Fuentes, Maria E.; DeMartino, Julie A.; Kitson, Christopher; Stevenson, Christopher S.; Budd, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-293</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Epigenetic alterations, such as histone acetylation, regulate the signaling outcomes and phenotypic responses of fibroblasts after growth factor stimulation.  The bromodomain and extra-terminal domain-contg. proteins (Brd) bind to acetylated histone residues, resulting in recruitment of components of the transcriptional machinery and subsequent gene transcription.  Given the central importance of fibroblasts in tissue fibrosis, this study sought to det. the role of Brd proteins in human lung fibroblasts (LFs) after growth factor stimulation and in the murine bleomycin model of lung fibrosis.  Using small interfering RNA against human Brd2 and Brd4 and pharmacol. Brd inhibitors, this study found that Brd2 and Brd4 are essential in mediating the phenotypic responses of LFs downstream of multiple growth factor pathways.  Growth factor stimulation of LFs causes increased histone acetylation, assocn. of Brd4 with growth factor-responsive genes, and enhanced transcription of these genes that could be attenuated with pharmacol. Brd inhibitors.  Of note, lung fibrosis induced after intratracheal bleomycin challenge in mice could be prevented by pretreatment of animals with pharmacol. inhibitors of Brd proteins.  This study is the first demonstration of a role for Brd2 and Brd4 proteins in mediating the responses of LFs after growth factor stimulation and in driving the induction of lung fibrosis in mice in response to bleomycin challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLn5H_z8-iULVg90H21EOLACvtfcHk0lg5POv7ymCz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLc%253D&md5=59f634a394e3a0f09b72e07a1eb0ccda</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.081661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.081661%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DApparsundaram%26aufirst%3DS.%26aulast%3DDeguzman%26aufirst%3DJ.%26aulast%3DBauer%26aufirst%3DC.%2BM.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DHamilton%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DFuentes%26aufirst%3DM.%2BE.%26aulast%3DDemartino%26aufirst%3DJ.%2BA.%26aulast%3DKitson%26aufirst%3DC.%26aulast%3DStevenson%26aufirst%3DC.%2BS.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26atitle%3DBET%2520bromodomain%2520proteins%2520mediate%2520downstream%2520signaling%2520events%2520following%2520growth%2520factor%2520stimulation%2520in%2520human%2520lung%2520fibroblasts%2520and%2520are%2520involved%2520in%2520bleomycin-induced%2520pulmonary%2520fibrosis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26spage%3D283%26epage%3D293%26doi%3D10.1124%2Fmol.112.081661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafiane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiacchia, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimbou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, J.</span><span> </span><span class="NLM_article-title">RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span><span class="NLM_x">–</span> <span class="NLM_lpage">2589</span><span class="refDoi"> DOI: 10.1016/j.jacc.2010.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.jacc.2010.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20513599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2010&pages=2580-2589&author=D.+Baileyauthor=R.+Jahagirdarauthor=A.+Gordonauthor=A.+Hafianeauthor=S.+Campbellauthor=S.+Chaturauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=F.+S.+Chiacchiaauthor=J.+Johanssonauthor=L.+Krimbouauthor=N.+C.+Wongauthor=J.+Genest&title=RVX-208%3A+a+small+molecule+that+increases+apolipoprotein+A-I+and+high-density+lipoprotein+cholesterol+in+vitro+and+in+vivo&doi=10.1016%2Fj.jacc.2010.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208. A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span></div><div class="casAuthors">Bailey, Dana; Jahagirdar, Ravi; Gordon, Allan; Hafiane, Anouar; Campbell, Steven; Chatur, Safia; Wagner, Gregory S.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; Johansson, Jan; Krimbou, Larbi; Wong, Norman C. W.; Genest, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2580-2589</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to det. whether a novel small mol. RVX-208 affects apolipoprotein (apo)A-I and high-d. lipoprotein cholesterol (HDL-C) levels in vitro and in vivo.  Background: Increased apoA-I and HDL-C levels are potential therapeutic targets for reducing atherosclerotic disease.  Methods: HepG2 cells were treated with 0 to 60 μmol/l RVX-208 followed by assays for apoA-I and HDL-C prodn.  For in vivo studies, African green monkeys (AGMs) received 15 to 60 mg/kg/day RVX-208, and the serum was analyzed for lipoprotein levels, HDL-subparticle distribution, cholesterol efflux, and activity of lipid-modifying enzymes.  A phase I clin. trial was conducted in healthy volunteers (given 1 to 20 mg/kg/day of RVX-208) to assess safety, tolerability, and pharmacokinetics.  Results: The RVX-208 induced apoA-I mRNA and protein synthesis in HepG2 cells, leading to in- creased levels of pre-β-migrating and α-lipoprotein particles contg. apoA-I (LpA-I) in spent media.  Similarly, in AGMs, RVX-208 treatment for 63 days increased serum apoA-I and HDL-C levels (60% and 97%, resp.).  In addn., the levels of pre-β1-LpA-I and α1-LpA-I HDL-subparticles were increased as well as ATP binding cassette AI, ATP binding cassette G1, and scavenger receptor class B type I-dependent cholesterol efflux.  These changes were not mediated by cholesteryl-ester-transfer protein.  Treatment of humans for 1 wk with oral RVX-208 increased apoA-I, pre-β-HDL, and HDL functionality.  Conclusions: RVX-208 increases apoA-I and HDL-C in vitro and in vivo.  In AGMs, RVX-208 raises serum pre-β1-LpA-I and α-LpA-I levels and enhances cholesterol efflux.  Data in humans point to beneficial features of RVX-208 that might be useful for treating atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGExcnx6drLVg90H21EOLACvtfcHk0lg9DcX9Fr8a-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D&md5=aab9ac26e73704f1cd569e2ff47d0c51</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2010.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2010.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DHafiane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DChatur%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DChiacchia%26aufirst%3DF.%2BS.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DKrimbou%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DGenest%26aufirst%3DJ.%26atitle%3DRVX-208%253A%2520a%2520small%2520molecule%2520that%2520increases%2520apolipoprotein%2520A-I%2520and%2520high-density%2520lipoprotein%2520cholesterol%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2010%26volume%3D55%26spage%3D2580%26epage%3D2589%26doi%3D10.1016%2Fj.jacc.2010.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span> </span><span class="NLM_article-title">A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2014.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.atherosclerosis.2014.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25016363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2014&pages=91-100&author=R.+Jahagirdarauthor=H.+Zhangauthor=S.+Azharauthor=J.+Tobinauthor=S.+Attwellauthor=R.+Yuauthor=J.+Wuauthor=K.+G.+McLureauthor=H.+C.+Hansenauthor=G.+S.+Wagnerauthor=P.+R.+Youngauthor=R.+A.+Srivastavaauthor=N.+C.+Wongauthor=J.+Johansson&title=A+novel+BET+bromodomain+inhibitor%2C+RVX-208%2C+shows+reduction+of+atherosclerosis+in+hyperlipidemic+ApoE+deficient+mice&doi=10.1016%2Fj.atherosclerosis.2014.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice</span></div><div class="casAuthors">Jahagirdar, Ravi; Zhang, Haiyan; Azhar, Salman; Tobin, Jennifer; Attwell, Sarah; Yu, Raymond; Wu, Jin; McLure, Kevin G.; Hansen, Henrik C.; Wagner, Gregory S.; Young, Peter R.; Srivastava, Rai Ajit K.; Wong, Norman C. W.; Johansson, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the benefit of statins in reducing cardiovascular risk, a sizable proportion of patients still remain at risk.  Since HDL reduces CVD risk through a process that involves formation of pre-beta particles that facilitates the removal of cholesterol from the lipid-laden macrophages in the arteries, inducing pre-beta particles, may reduce the risk of CVD.  A novel BET bromodomain antagonist, RVX-208, was reported to raise apoA-I and increase preβ-HDL particles in non-human primates and humans.  In the present study, we investigated the effect of RVX-208 on aortic lesion formation in hyperlipidemic apoE-/- mice.  Oral treatments of apoE-/- mice with 150 mg/kg b.i.d RVX-208 for 12 wk significantly reduced aortic lesion formation, accompanied by 2-fold increases in the levels of circulating HDL-C, and ∼50% decreases in LDL-C, although no significant changes in plasma apoA-I were obsd.  Circulating adhesion mols. as well as cytokines also showed significant redn.  Haptoglobin, a proinflammatory protein, known to bind with HDL/apoA-I, decreased >2.5-fold in the RVX-208 treated group.  With a therapeutic dosing regimen in which mice were fed Western diet for 10 wk to develop lesions followed by switching to a low fat diet and concurrent treatment with RVX-208 for 14 wk, RVX-208 similarly reduced lesion formation by 39% in the whole aorta without significant changes in the plasma lipid parameters.  RVX-208 significantly reduced the proinflammatory cytokines IP-10, MIP1 and MDC.  These results show that the antiatherogenic activity of BET inhibitor, RVX-208, occurs via a combination of lipid changes and anti-inflammatory activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXAgzwwmvsdrVg90H21EOLACvtfcHk0lg9DcX9Fr8a-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grt77P&md5=135bbfa7ce02b3684be45e9c39f9e092</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2014.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2014.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAzhar%26aufirst%3DS.%26aulast%3DTobin%26aufirst%3DJ.%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DSrivastava%26aufirst%3DR.%2BA.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DJohansson%26aufirst%3DJ.%26atitle%3DA%2520novel%2520BET%2520bromodomain%2520inhibitor%252C%2520RVX-208%252C%2520shows%2520reduction%2520of%2520atherosclerosis%2520in%2520hyperlipidemic%2520ApoE%2520deficient%2520mice%26jtitle%3DAtherosclerosis%26date%3D2014%26volume%3D236%26spage%3D91%26epage%3D100%26doi%3D10.1016%2Fj.atherosclerosis.2014.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Spiltoir, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavasin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demos-Davies, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">BET acetyl-lysine binding proteins control pathological cardiac hypertrophy</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2013.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.yjmcc.2013.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23939492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCju7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=175-179&author=J.+I.+Spiltoirauthor=M.+S.+Strattonauthor=M.+A.+Cavasinauthor=K.+Demos-Daviesauthor=B.+G.+Reidauthor=J.+Qiauthor=J.+E.+Bradnerauthor=T.+A.+McKinsey&title=BET+acetyl-lysine+binding+proteins+control+pathological+cardiac+hypertrophy&doi=10.1016%2Fj.yjmcc.2013.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">BET acetyl-lysine binding proteins control pathological cardiac hypertrophy</span></div><div class="casAuthors">Spiltoir, Jessica I.; Stratton, Matthew S.; Cavasin, Maria A.; Demos-Davies, Kim; Reid, Brian G.; Qi, Jun; Bradner, James E.; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175-179</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cardiac hypertrophy is an independent predictor of adverse outcomes in patients with heart failure, and thus represents an attractive target for novel therapeutic intervention.  JQ1, a small mol. inhibitor of bromodomain and extraterminal (BET) acetyl-lysine reader proteins, was identified in a high throughput screen designed to discover novel small mol. regulators of cardiomyocyte hypertrophy.  JQ1 dose-dependently blocked agonist-dependent hypertrophy of cultured neonatal rat ventricular myocytes (NRVMs) and reversed the prototypical gene program assocd. with pathol. cardiac hypertrophy.  JQ1 also blocked left ventricular hypertrophy (LVH) and improved cardiac function in adult mice subjected to transverse aortic constriction (TAC).  The BET family consists of BRD2, BRD3, BRD4 and BRDT.  BRD4 protein expression was increased during cardiac hypertrophy, and hypertrophic stimuli promoted recruitment of BRD4 to the transcriptional start site (TSS) of the gene encoding atrial natriuretic factor (ANF).  Binding of BRD4 to the ANF TSS was assocd. with increased phosphorylation of local RNA polymerase II.  These findings define a novel function for BET proteins as signal-responsive regulators of cardiac hypertrophy, and suggest that small mol. inhibitors of these epigenetic reader proteins have potential as therapeutics for heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDUzCSA2tNtrVg90H21EOLACvtfcHk0lg9DcX9Fr8a-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCju7%252FF&md5=ffe6d80a94c27e5d89b38baf33af365c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2013.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2013.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DSpiltoir%26aufirst%3DJ.%2BI.%26aulast%3DStratton%26aufirst%3DM.%2BS.%26aulast%3DCavasin%26aufirst%3DM.%2BA.%26aulast%3DDemos-Davies%26aufirst%3DK.%26aulast%3DReid%26aufirst%3DB.%2BG.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DBET%2520acetyl-lysine%2520binding%2520proteins%2520control%2520pathological%2520cardiac%2520hypertrophy%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2013%26volume%3D63%26spage%3D175%26epage%3D179%26doi%3D10.1016%2Fj.yjmcc.2013.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Sartor, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brothers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlestedt, C.</span><span> </span><span class="NLM_article-title">Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">15062</span><span class="NLM_x">–</span> <span class="NLM_lpage">15072</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0826-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1523%2FJNEUROSCI.0826-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26558777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1aqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=15062-15072&author=G.+C.+Sartorauthor=S.+K.+Powellauthor=S.+P.+Brothersauthor=C.+Wahlestedt&title=Epigenetic+readers+of+lysine+acetylation+regulate+cocaine-induced+plasticity&doi=10.1523%2FJNEUROSCI.0826-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity</span></div><div class="casAuthors">Sartor, Gregory C.; Powell, Samuel K.; Brothers, Shaun P.; Wahlestedt, Claes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">15062-15072</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Epigenetic processes that regulate histone acetylation play an essential role in behavioral and mol. responses to cocaine.  To date, however, only a small fraction of the mechanisms involved in the addiction-assocd. acetylome have been investigated.  Members of the bromodomain and extraterminal (BET) family of epigenetic "reader" proteins (BRD2, BRD3, BRD4, and BRDT) bind acetylated histones and serve as a scaffold for the recruitment of macromol. complexes to modify chromatin accessibility and transcriptional activity.  The role of BET proteins in cocaine-induced plasticity, however, remains elusive.  Here, we used behavioral, pharmacol., and mol. techniques to examine the involvement of BET bromodomains in cocaine reward.  Of the BET proteins, BRD4, but not BRD2 or BRD3, was significantly elevated in the nucleus accumbens (NAc) of mice and rats following repeated cocaine injections and self-administration.  Systemic and intra-accumbal inhibition of BRD4 with the BET inhibitor, JQ1, attenuated the rewarding effects of cocaine in a conditioned place preference procedure but did not affect conditioned place aversion, nor did JQ1 alone induce conditioned aversion or preference.  Investigating the underlying mechanisms, we found that repeated cocaine injections enhanced the binding of BRD4, but not BRD3, to the promoter region of Bdnf in the NAc, whereas systemic injection of JQ1 attenuated cocaine-induced expression of Bdnf in the NAc.  JQ1 and siRNA-mediated knockdown of BRD4 in vitro also reduced expression of Bdnf.  These findings indicate that disrupting the interaction between BET proteins and their acetylated lysine substrates may provide a new therapeutic avenue for the treatment of drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov84m9moPm7Vg90H21EOLACvtfcHk0livwmF2qdyhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1aqsbs%253D&md5=62570845f668d81a6d90924bc2b7722d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0826-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0826-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DSartor%26aufirst%3DG.%2BC.%26aulast%3DPowell%26aufirst%3DS.%2BK.%26aulast%3DBrothers%26aufirst%3DS.%2BP.%26aulast%3DWahlestedt%26aufirst%3DC.%26atitle%3DEpigenetic%2520readers%2520of%2520lysine%2520acetylation%2520regulate%2520cocaine-induced%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D15062%26epage%3D15072%26doi%3D10.1523%2FJNEUROSCI.0826-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Gacias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerona-Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casaccia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2014.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.chembiol.2014.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24954007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=841-854&author=M.+Gaciasauthor=G.+Gerona-Navarroauthor=A.+N.+Plotnikovauthor=G.+Zhangauthor=L.+Zengauthor=J.+Kaurauthor=G.+Moyauthor=E.+Rusinovaauthor=Y.+Rodriguezauthor=B.+Matikainenauthor=A.+Vincekauthor=J.+Joshuaauthor=P.+Casacciaauthor=M.+M.+Zhou&title=Selective+chemical+modulation+of+gene+transcription+favors+oligodendrocyte+lineage+progression&doi=10.1016%2Fj.chembiol.2014.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression</span></div><div class="casAuthors">Gacias, Mar; Gerona-Navarro, Guillermo; Plotnikov, Alexander N.; Zhang, Guangtao; Zeng, Lei; Kaur, Jasbir; Moy, Gregory; Rusinova, Elena; Rodriguez, Yoel; Matikainen, Bridget; Vincek, Adam; Joshua, Jennifer; Casaccia, Patrizia; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">841-854</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lysine acetylation regulates gene expression through modulating protein-protein interactions in chromatin.  Chem. inhibition of acetyl-lysine binding bromodomains of the major chromatin regulators BET (bromodomain and extraterminal domain) proteins has been shown to effectively block cell proliferation in cancer and inflammation.  However, whether selective inhibition of individual BET bromodomains has distinctive functional consequences remains only partially understood.  In this study, we show that selective chem. inhibition of the first bromodomain of BET proteins using our small-mol. inhibitor, Olinone, accelerated the progression of mouse primary oligodendrocyte progenitors toward differentiation, whereas inhibition of both bromodomains of BET proteins hindered differentiation.  This effect was target specific, as it was not detected in cells treated with inactive analogs and independent of any effect on proliferation.  Therefore, selective chem. modulation of individual bromodomains, rather than use of broad-based inhibitors, may enhance regenerative strategies in disorders characterized by myelin loss such as aging and neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1fCvOR18yE7Vg90H21EOLACvtfcHk0livwmF2qdyhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemtLrK&md5=6b377663a8d0d07441ab4f8a5d8191b3</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DGacias%26aufirst%3DM.%26aulast%3DGerona-Navarro%26aufirst%3DG.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DMoy%26aufirst%3DG.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DRodriguez%26aufirst%3DY.%26aulast%3DMatikainen%26aufirst%3DB.%26aulast%3DVincek%26aufirst%3DA.%26aulast%3DJoshua%26aufirst%3DJ.%26aulast%3DCasaccia%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DSelective%2520chemical%2520modulation%2520of%2520gene%2520transcription%2520favors%2520oligodendrocyte%2520lineage%2520progression%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D841%26epage%3D854%26doi%3D10.1016%2Fj.chembiol.2014.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klase, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashanchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pise-Masison, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J. N.</span><span> </span><span class="NLM_article-title">Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1036</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1128/JVI.01316-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FJVI.01316-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18971272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlCmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=1036-1044&author=M.+Zhouauthor=K.+Huangauthor=K.+J.+Jungauthor=W.+K.+Choauthor=Z.+Klaseauthor=F.+Kashanchiauthor=C.+A.+Pise-Masisonauthor=J.+N.+Brady&title=Bromodomain+protein+Brd4+regulates+human+immunodeficiency+virus+transcription+through+phosphorylation+of+CDK9+at+threonine+29&doi=10.1128%2FJVI.01316-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29</span></div><div class="casAuthors">Zhou, Meisheng; Huang, Keven; Jung, Kyung-Jin; Cho, Won-Kyung; Klase, Zach; Kashanchi, Fatah; Pise-Masison, Cynthia A.; Brady, John N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1036-1044</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pos. transcription elongation factor b (P-TEFb), composed of cyclin-dependent kinase 9 (CDK9) and cyclin T, is a global transcription factor for eukaryotic gene expression, as well as a key factor for human immunodeficiency virus (HIV) transcription elongation.  P-TEFb phosphorylates the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II (RNAP II), facilitating the transition from nonprocessive to processive transcription elongation.  Recently, the bromodomain protein Brd4 has been shown to interact with the low-mol.-wt., active P-TEFb complex and recruit P-TEFb to the HIV type 1 long terminal repeat (LTR) promoter.  However, the subsequent events through which Brd4 regulates CDK9 kinase activity and RNAP II-dependent transcription are not clearly understood.  Here the authors provide evidence that Brd4 regulates P-TEFb kinase activity by inducing a neg. pathway.  Moreover, by analyzing stepwise initiation and elongation complexes, the authors demonstrate that P-TEFb activity is regulated in the transcription complex.  Brd4 induces phosphorylation of CDK9 at threonine 29 (T29) in the HIV transcription initiation complex, inhibiting CDK9 kinase activity.  P-TEFb inhibition is transient, as Brd4 is released from the transcription complex between positions +14 and +36.  Removal of the phosphate group at T29 by an incoming phosphatase released P-TEFb activity, resulting in increased RNAP II CTD phosphorylation and transcription.  Finally, the authors present chromatin immunopptn. studies showing that CDK9 with phosphorylated T29 is assocd. with the HIV promoter region in the integrated and transcriptionally silent HIV genome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjgnBf4fTF37Vg90H21EOLACvtfcHk0livwmF2qdyhQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlCmtb4%253D&md5=729579b619a01f2d9b915dfd1b029f4a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1128%2FJVI.01316-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01316-08%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DK.%2BJ.%26aulast%3DCho%26aufirst%3DW.%2BK.%26aulast%3DKlase%26aufirst%3DZ.%26aulast%3DKashanchi%26aufirst%3DF.%26aulast%3DPise-Masison%26aufirst%3DC.%2BA.%26aulast%3DBrady%26aufirst%3DJ.%2BN.%26atitle%3DBromodomain%2520protein%2520Brd4%2520regulates%2520human%2520immunodeficiency%2520virus%2520transcription%2520through%2520phosphorylation%2520of%2520CDK9%2520at%2520threonine%252029%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D1036%26epage%3D1044%26doi%3D10.1128%2FJVI.01316-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frappier, L.</span><span> </span><span class="NLM_article-title">The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">12009</span><span class="NLM_x">–</span> <span class="NLM_lpage">12019</span><span class="refDoi"> DOI: 10.1128/JVI.01680-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FJVI.01680-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18922874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyms7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=12009-12019&author=A.+Linauthor=S.+Wangauthor=T.+Nguyenauthor=K.+Shireauthor=L.+Frappier&title=The+EBNA1+protein+of+Epstein-Barr+virus+functionally+interacts+with+Brd4&doi=10.1128%2FJVI.01680-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4</span></div><div class="casAuthors">Lin, Ammy; Wang, Shan; Nguyen, Tin; Shire, Kathy; Frappier, Lori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">12009-12019</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The EBNA1 protein of Epstein-Barr virus (EBV) is essential for EBV latent infection in ensuring the replication and stable segregation of the EBV genomes and in activating the transcription of other EBV latency genes.  We have tested the ability of four host proteins (Brd2, Brd4, DEK, and MeCP2) implicated in the segregation of papillomavirus and Kaposi's sarcoma-assocd. herpesvirus to support EBNA1-mediated segregation of EBV-based plasmids in Saccharomyces cerevisiae.  We found that Brd4 enabled EBNA1-mediated segregation while Brd2 and MeCP2 had a general stimulatory effect on plasmid maintenance.  EBNA1 interacted with Brd4 in both yeast and human cells through N-terminal sequences previously shown to mediate transcriptional activation but not segregation.  In keeping with this interaction site, silencing of Brd4 in human cells decreased transcriptional activation by EBNA1 but not the mitotic chromosome attachment of EBNA1 that is required for segregation.  In addn., Brd4 was found to be preferentially localized to the FR enhancer element regulated by EBNA1, over other EBV sequences, in latently EBV-infected cells.  The results indicate that EBNA1 can functionally interact with Brd4 in native and heterologous systems and that this interaction facilitates transcriptional activation by EBNA1 from the FR element.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB-c-UFT5qu7Vg90H21EOLACvtfcHk0lgETPU8p539TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyms7fP&md5=b56939c63b9ae55c69d5c0b18519ee98</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1128%2FJVI.01680-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01680-08%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DShire%26aufirst%3DK.%26aulast%3DFrappier%26aufirst%3DL.%26atitle%3DThe%2520EBNA1%2520protein%2520of%2520Epstein-Barr%2520virus%2520functionally%2520interacts%2520with%2520Brd4%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26spage%3D12009%26epage%3D12019%26doi%3D10.1128%2FJVI.01680-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Gagnon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senechal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fradet-Turcotte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archambault, J.</span><span> </span><span class="NLM_article-title">Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4127</span><span class="NLM_x">–</span> <span class="NLM_lpage">4139</span><span class="refDoi"> DOI: 10.1128/JVI.02468-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FJVI.02468-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19211738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=4127-4139&author=D.+Gagnonauthor=S.+Joubertauthor=H.+Senechalauthor=A.+Fradet-Turcotteauthor=S.+Torreauthor=J.+Archambault&title=Proteasomal+degradation+of+the+papillomavirus+E2+protein+is+inhibited+by+overexpression+of+bromodomain-containing+protein+4&doi=10.1128%2FJVI.02468-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4</span></div><div class="casAuthors">Gagnon, David; Joubert, Simon; Senechal, Helene; Fradet-Turcotte, Amelie; Torre, Sabrina; Archambault, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4127-4139</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The E2 protein of human papillomavirus (HPV) binds to specific sites in the viral genome to regulate its transcription, replication, and maintenance in infected cells.  Like most regulatory proteins, E2 is rapidly turned over.  A high-throughput assay was developed to quantify the expression and stability of E2 in vivo, based on its fusion to Renilla luciferase (RLuc).  The steady-state levels of Rluc-E2 were quantified by measuring the amts. of assocd. luciferase activity, and its degrdn. was measured by monitoring the decrease in enzymic activity occurring after a block of translation with cycloheximide.  Using this assay, the E2 proteins from a low-risk (HPV11) and a high-risk (HPV31) human papillomavirus (HPV) type were found to have short half-lives of 60 min in C33A cervical carcinoma cells and to be ubiquitinated and degraded by the proteasome.  Anal. of mutant proteins showed that the instability of E2 is independent of its DNA-binding and transcriptional activities but is encoded within its transactivation domain, the region that binds to the cellular chromatin factor bromodomain-contg. protein 4 (Brd4) to regulate viral gene transcription.  Overexpression of Brd4, or of its C-terminal E2-interaction domain, was found to increase the steady-state levels and stability of wild-type E2 but not of E2 mutants defective for binding Brd4.  These results indicate that the stability of E2 is increased upon complex formation with Brd4 and highlight the value of the luciferase assay for the study of E2 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZGrEsZsTwYrVg90H21EOLACvtfcHk0lgETPU8p539TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtb4%253D&md5=f3cfe00c7a20c8cb0daf1da94ce9f87c</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1128%2FJVI.02468-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02468-08%26sid%3Dliteratum%253Aachs%26aulast%3DGagnon%26aufirst%3DD.%26aulast%3DJoubert%26aufirst%3DS.%26aulast%3DSenechal%26aufirst%3DH.%26aulast%3DFradet-Turcotte%26aufirst%3DA.%26aulast%3DTorre%26aufirst%3DS.%26aulast%3DArchambault%26aufirst%3DJ.%26atitle%3DProteasomal%2520degradation%2520of%2520the%2520papillomavirus%2520E2%2520protein%2520is%2520inhibited%2520by%2520overexpression%2520of%2520bromodomain-containing%2520protein%25204%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D4127%26epage%3D4139%26doi%3D10.1128%2FJVI.02468-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemper, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. M.</span><span> </span><span class="NLM_article-title">Brd4 links chromatin targeting to HPV transcriptional silencing</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2383</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span><span class="refDoi"> DOI: 10.1101/gad.1448206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1101%2Fgad.1448206" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2383-2396&author=S.+Y.+Wuauthor=A.+Y.+Leeauthor=S.+Y.+Houauthor=J.+K.+Kemperauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=C.+M.+Chiang&title=Brd4+links+chromatin+targeting+to+HPV+transcriptional+silencing&doi=10.1101%2Fgad.1448206"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1101%2Fgad.1448206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1448206%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DA.%2BY.%26aulast%3DHou%26aufirst%3DS.%2BY.%26aulast%3DKemper%26aufirst%3DJ.%2BK.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DChiang%26aufirst%3DC.%2BM.%26atitle%3DBrd4%2520links%2520chromatin%2520targeting%2520to%2520HPV%2520transcriptional%2520silencing%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D2383%26epage%3D2396%26doi%3D10.1101%2Fgad.1448206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">You, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croyle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howley, P. M.</span><span> </span><span class="NLM_article-title">Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/S0092-8674(04)00402-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS0092-8674%2804%2900402-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=349-360&author=J.+Youauthor=J.+L.+Croyleauthor=A.+Nishimuraauthor=K.+Ozatoauthor=P.+M.+Howley&title=Interaction+of+the+bovine+papillomavirus+E2+protein+with+Brd4+tethers+the+viral+DNA+to+host+mitotic+chromosomes&doi=10.1016%2FS0092-8674%2804%2900402-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900402-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900402-7%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DJ.%26aulast%3DCroyle%26aufirst%3DJ.%2BL.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DHowley%26aufirst%3DP.%2BM.%26atitle%3DInteraction%2520of%2520the%2520bovine%2520papillomavirus%2520E2%2520protein%2520with%2520Brd4%2520tethers%2520the%2520viral%2520DNA%2520to%2520host%2520mitotic%2520chromosomes%26jtitle%3DCell%26date%3D2004%26volume%3D117%26spage%3D349%26epage%3D360%26doi%3D10.1016%2FS0092-8674%2804%2900402-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Boehm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span> </span><span class="NLM_article-title">Bromodomain proteins in HIV infection</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span><span class="refDoi"> DOI: 10.3390/v5061571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.3390%2Fv5061571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23793227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKlurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1571-1586&author=D.+Boehmauthor=R.+J.+Conradauthor=M.+Ott&title=Bromodomain+proteins+in+HIV+infection&doi=10.3390%2Fv5061571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain proteins in HIV infection</span></div><div class="casAuthors">Boehm, Daniela; Conrad, Ryan J.; Ott, Melanie</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1571-1586</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Bromodomains are conserved protein modules of ∼110 amino acids that bind acetylated lysine residues in histone and non-histone proteins.  Bromodomains are present in many chromatin-assocd. transcriptional regulators and have been linked to diverse aspects of the HIV life cycle, including transcription and integration.  Here, we review the role of bromodomain-contg. proteins in HIV infection.  We begin with a focus on acetylated viral factors, followed by a discussion of structural and biol. studies defining the involvement of bromodomain proteins in the HIV life cycle.  We end with an overview of promising new studies of bromodomain inhibitory compds. for the treatment of HIV latency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL1rfpEYvuSbVg90H21EOLACvtfcHk0lgum_OgO6lqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKlurrE&md5=0bed1b62cf36f41df96918a305658218</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.3390%2Fv5061571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5061571%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DD.%26aulast%3DConrad%26aufirst%3DR.%2BJ.%26aulast%3DOtt%26aufirst%3DM.%26atitle%3DBromodomain%2520proteins%2520in%2520HIV%2520infection%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26spage%3D1571%26epage%3D1586%26doi%3D10.3390%2Fv5061571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Bisgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henklein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">13690</span><span class="NLM_x">–</span> <span class="NLM_lpage">13695</span><span class="refDoi"> DOI: 10.1073/pnas.0705053104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.0705053104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17690245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVOjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=13690-13695&author=D.+A.+Bisgroveauthor=T.+Mahmoudiauthor=P.+Henkleinauthor=E.+Verdin&title=Conserved+P-TEFb-interacting+domain+of+BRD4+inhibits+HIV+transcription&doi=10.1073%2Fpnas.0705053104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription</span></div><div class="casAuthors">Bisgrove, Dwayne A.; Mahmoudi, Tokameh; Henklein, Peter; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">13690-13695</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have identified a conserved region in the C-terminal domain of bromodomain-contg. protein 4 (BRD4) that mediates its specific interaction with pos. transcription elongation factor b (P-TEFb).  This domain is highly conserved in testis-specific bromodomain protein (BRDT) and Drosophila fs(1)h.  Both BRDT and fs(1)h specifically interact with P-TEFb in mammalian cells, and this interaction depends on their C-terminal domains.  Overexpression of the BRD4 P-TEFb-interacting domain disrupts the interaction between the HIV transactivator Tat and P-TEFb and suppresses the ability of Tat to transactivate the HIV promoter.  Incubation of cells with a synthetic peptide contg. the C-terminal domain of BRD4 interferes with transactivation of the HIV promoter by the Tat protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7C_2ZREaOELVg90H21EOLACvtfcHk0lgum_OgO6lqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVOjsLc%253D&md5=6091d31044bc49d054c0c4b89f690384</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705053104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705053104%26sid%3Dliteratum%253Aachs%26aulast%3DBisgrove%26aufirst%3DD.%2BA.%26aulast%3DMahmoudi%26aufirst%3DT.%26aulast%3DHenklein%26aufirst%3DP.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DConserved%2520P-TEFb-interacting%2520domain%2520of%2520BRD4%2520inhibits%2520HIV%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D13690%26epage%3D13695%26doi%3D10.1073%2Fpnas.0705053104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiha, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, A. L.</span><span> </span><span class="NLM_article-title">Reactivation of latent HIV-1 by inhibition of BRD4</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.celrep.2012.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23041316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCls73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=807-816&author=J.+Zhuauthor=G.+D.+Gaihaauthor=S.+P.+Johnauthor=T.+Pertelauthor=C.+R.+Chinauthor=G.+Gaoauthor=H.+Quauthor=B.+D.+Walkerauthor=S.+J.+Elledgeauthor=A.+L.+Brass&title=Reactivation+of+latent+HIV-1+by+inhibition+of+BRD4&doi=10.1016%2Fj.celrep.2012.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of latent HIV-1 by inhibition of BRD4</span></div><div class="casAuthors">Zhu, Jian; Gaiha, Gaurav D.; John, Sinu P.; Pertel, Thomas; Chin, Christopher R.; Gao, Geng; Qu, Hongjing; Walker, Bruce D.; Elledge, Stephen J.; Brass, Abraham L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-816</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HIV-1 depends on many host factors for propagation.  Other host factors, however, antagonize HIV-1 and may have profound effects on viral activation.  Curing HIV-1 requires the redn. of latent viral reservoirs that remain in the face of antiretroviral therapy.  Using orthologous genetic screens, we identified bromodomain contg. 4 (BRD4) as a neg. regulator of HIV-1 replication.  Antagonism of BRD4, via RNA interference or with a small mol. inhibitor, JQ1, both increased proviral transcriptional elongation and alleviated HIV-1 latency in cell-line models.  In multiple instances, JQ1, when used in combination with the NF-κB activators Prostratin or PHA, enhanced the in vitro reactivation of latent HIV-1 in primary T cells.  These data are consistent with a model wherein BRD4 competes with the virus for HIV-1 dependency factors (HDFs) and suggests that combinatorial therapies that activate HDFs and antagonize HIV-1 competitive factors may be useful for curing HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosSPB0bZraJbVg90H21EOLACvtfcHk0lgum_OgO6lqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCls73E&md5=210b459b66ccf10a84c57ef10b03b684</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DGaiha%26aufirst%3DG.%2BD.%26aulast%3DJohn%26aufirst%3DS.%2BP.%26aulast%3DPertel%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DC.%2BR.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DBrass%26aufirst%3DA.%2BL.%26atitle%3DReactivation%2520of%2520latent%2520HIV-1%2520by%2520inhibition%2520of%2520BRD4%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D807%26epage%3D816%26doi%3D10.1016%2Fj.celrep.2012.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">24100</span><span class="refDoi"> DOI: 10.1038/srep24100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fsrep24100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27067814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFalur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=24100&author=P.+Luauthor=X.+Quauthor=Y.+Shenauthor=Z.+Jiangauthor=P.+Wangauthor=H.+Zengauthor=H.+Jiauthor=J.+Dengauthor=X.+Yangauthor=X.+Liauthor=H.+Luauthor=H.+Zhu&title=The+BET+inhibitor+OTX015+reactivates+latent+HIV-1+through+P-TEFb&doi=10.1038%2Fsrep24100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb</span></div><div class="casAuthors">Lu, Panpan; Qu, Xiying; Shen, Yinzhong; Jiang, Zhengtao; Wang, Pengfei; Zeng, Hanxian; Ji, Haiyan; Deng, Junxiao; Yang, Xinyi; Li, Xian; Lu, Hongzhou; Zhu, Huanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24100</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">None of the currently used anti-HIV-1 agents can effectively eliminate latent HIV-1 reservoirs, which is a major hurdle to a complete cure for AIDS.  We report here that a novel oral BET inhibitor OTX015, a thienotriazolodiazepine compd. that has entered phase Ib clin. development for advanced hematol. malignancies, can effectively reactivate HIV-1 in different latency models with an EC50 value 1.95-4.34 times lower than JQ1, a known BET inhibitor that can reactivate HIV-1 latency.  We also found that OTX015 was more potent when used in combination with prostratin.  More importantly, OTX015 treatment induced HIV-1 full-length transcripts and viral outgrowth in resting CD4+ T cells from infected individuals receiving suppressive antiretroviral therapy (ART), while exerting minimal toxicity and effects on T cell activation.  Finally, biochem. anal. showed that OTX015-mediated activation of HIV-1 involved an increase in CDK9 occupancy and RNAP II C-terminal domain (CTD) phosphorylation.  Our results suggest that the BET inhibitor OTX015 may be a candidate for anti-HIV-1-latency therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpous2yyU9wxLVg90H21EOLACvtfcHk0lgum_OgO6lqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFalur8%253D&md5=fcd78a52d439c8d151c54a4955a69c52</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fsrep24100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep24100%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DThe%2520BET%2520inhibitor%2520OTX015%2520reactivates%2520latent%2520HIV-1%2520through%2520P-TEFb%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D24100%26doi%3D10.1038%2Fsrep24100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Banerjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaels, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belkina, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastiani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montano, M.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a novel strategy for reactivation of HIV-1</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1189/jlb.0312165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1189%2Fjlb.0312165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22802445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCmu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2012&pages=1147-1154&author=C.+Banerjeeauthor=N.+Archinauthor=D.+Michaelsauthor=A.+C.+Belkinaauthor=G.+V.+Denisauthor=J.+Bradnerauthor=P.+Sebastianiauthor=D.+M.+Margolisauthor=M.+Montano&title=BET+bromodomain+inhibition+as+a+novel+strategy+for+reactivation+of+HIV-1&doi=10.1189%2Fjlb.0312165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibition as a novel strategy for reactivation of HIV-1</span></div><div class="casAuthors">Banerjee, Camellia; Archin, Nancie; Michaels, Daniel; Belkina, Anna C.; Denis, Gerald V.; Bradner, James; Sebastiani, Paola; Margolis, David M.; Montano, Monty</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1147-1154</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">The persistence of latent HIV-1 remains a major challenge in therapeutic efforts to eradicate infection.  We report the capacity for HIV reactivation by a selective small mol. inhibitor of BET family bromodomains, JQ1, a promising therapeutic agent with antioncogenic properties.  JQ1 reactivated HIV transcription in models of latent T cell infection and latent monocyte infection.  We also tested the effect of exposure to JQ1 to allow recovery of replication-competent HIV from pools of resting CD4+ T cells isolated from HIV-infected, ART-treated patients.  In one of three patients, JQ1 allowed recovery of virus at a frequency above unstimulated conditions.  JQ1 potently suppressed T cell proliferation with minimal cytotoxic effect.  Transcriptional profiling of T cells with JQ1 showed potent down-regulation of T cell activation genes, including CD3, CD28, and CXCR4, similar to HDAC inhibitors, but JQ1 also showed potent up-regulation of chromatin modification genes, including SIRT1, HDAC6, and multiple lysine demethylases (KDMs).  Thus, JQ1 reactivates HIV-1 while suppressing T cell activation genes and up-regulating histone modification genes predicted to favor increased Tat activity.  Thus, JQ1 may be useful in studies of potentially novel mechanisms for transcriptional control as well as in translational efforts to identify therapeutic mols. to achieve viral eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Fl0Y8EEG1LVg90H21EOLACvtfcHk0lh7n_MR4lJo-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCmu73P&md5=3de91afdb94e5d65c7fc9089d8e16a47</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1189%2Fjlb.0312165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.0312165%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DC.%26aulast%3DArchin%26aufirst%3DN.%26aulast%3DMichaels%26aufirst%3DD.%26aulast%3DBelkina%26aufirst%3DA.%2BC.%26aulast%3DDenis%26aufirst%3DG.%2BV.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DSebastiani%26aufirst%3DP.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26aulast%3DMontano%26aufirst%3DM.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520novel%2520strategy%2520for%2520reactivation%2520of%2520HIV-1%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2012%26volume%3D92%26spage%3D1147%26epage%3D1154%26doi%3D10.1189%2Fjlb.0312165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Boehm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvanese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planelles, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span> </span><span class="NLM_article-title">BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span><span class="refDoi"> DOI: 10.4161/cc.23309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.4161%2Fcc.23309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=452-462&author=D.+Boehmauthor=V.+Calvaneseauthor=R.+D.+Darauthor=S.+Xingauthor=S.+Schroederauthor=L.+Martinsauthor=K.+Aullauthor=P.+C.+Liauthor=V.+Planellesauthor=J.+E.+Bradnerauthor=M.+M.+Zhouauthor=R.+F.+Silicianoauthor=L.+Weinbergerauthor=E.+Verdinauthor=M.+Ott&title=BET+bromodomain-targeting+compounds+reactivate+HIV+from+latency+via+a+Tat-independent+mechanism&doi=10.4161%2Fcc.23309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.4161%2Fcc.23309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.23309%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DD.%26aulast%3DCalvanese%26aufirst%3DV.%26aulast%3DDar%26aufirst%3DR.%2BD.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DMartins%26aufirst%3DL.%26aulast%3DAull%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DP.%2BC.%26aulast%3DPlanelles%26aufirst%3DV.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26aulast%3DWeinberger%26aufirst%3DL.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DOtt%26aufirst%3DM.%26atitle%3DBET%2520bromodomain-targeting%2520compounds%2520reactivate%2520HIV%2520from%2520latency%2520via%2520a%2520Tat-independent%2520mechanism%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26spage%3D452%26epage%3D462%26doi%3D10.4161%2Fcc.23309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1093/nar/gks976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1093%2Fnar%2Fgks976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23087374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=277-287&author=Z.+Liauthor=J.+Guoauthor=Y.+Wuauthor=Q.+Zhou&title=The+BET+bromodomain+inhibitor+JQ1+activates+HIV+latency+through+antagonizing+Brd4+inhibition+of+Tat-transactivation&doi=10.1093%2Fnar%2Fgks976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation</span></div><div class="casAuthors">Li, Zichong; Guo, Jia; Wu, Yuntao; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-287</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Latent HIV reservoirs are the primary hurdle to eradication of infection.  Identification of agents, pathways and mol. mechanisms that activate latent provirus may, in the presence of highly active antiretroviral therapy, permit clearance of infected cells by the immune system.  Promoter-proximal pausing of RNA polymerase (Pol) II is a major rate-limiting step in HIV gene expression.  The viral Tat protein recruits human Super Elongation Complex (SEC) to paused Pol II to overcome this limitation.  Here, we identify the bromodomain protein Brd4 and its inhibition of Tat-transactivation as a major impediment to latency reactivation.  Brd4 competitively blocks the Tat-SEC interaction on HIV promoter.  The BET bromodomain inhibitor JQ1 dissocs. Brd4 from the HIV promoter to allow Tat recruitment of SEC to stimulate HIV elongation.  JQ1 synergizes with another latency activator prostratin, which promotes Pol II loading onto the viral promoter.  Because JQ1 activates viral latency without inducing global T cell activation, this and other closely related compds. and their antagonization of Brd4 to promote Tat-SEC interaction merit further investigations as effective agents/strategies for eliminating latent HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_cOKnnk8oLVg90H21EOLACvtfcHk0lh7n_MR4lJo-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFertQ%253D%253D&md5=87866d81d13af3d5051844ed6c17c98d</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgks976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgks976%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DThe%2520BET%2520bromodomain%2520inhibitor%2520JQ1%2520activates%2520HIV%2520latency%2520through%2520antagonizing%2520Brd4%2520inhibition%2520of%2520Tat-transactivation%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D277%26epage%3D287%26doi%3D10.1093%2Fnar%2Fgks976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liberty, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashuba, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruc, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strain, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudgens, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1038/nature11286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature11286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22837004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=482-485&author=N.+M.+Archinauthor=A.+L.+Libertyauthor=A.+D.+Kashubaauthor=S.+K.+Choudharyauthor=J.+D.+Kurucauthor=A.+M.+Crooksauthor=D.+C.+Parkerauthor=E.+M.+Andersonauthor=M.+F.+Kearneyauthor=M.+C.+Strainauthor=D.+D.+Richmanauthor=M.+G.+Hudgensauthor=R.+J.+Boschauthor=J.+M.+Coffinauthor=J.+J.+Eronauthor=D.+J.+Hazudaauthor=D.+M.+Margolis&title=Administration+of+vorinostat+disrupts+HIV-1+latency+in+patients+on+antiretroviral+therapy&doi=10.1038%2Fnature11286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span></div><div class="casAuthors">Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7408</span>),
    <span class="NLM_cas:pages">482-485</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection.  Inducing the expression of latent genomes within resting CD4+ T cells is the primary strategy to clear this reservoir.  Although histone deacetylase inhibitors such as suberoylanilide hydroxamic acid (also known as vorinostat, VOR) can disrupt HIV-1 latency in vitro, the utility of this approach has never been directly proven in a translational clin. study of HIV-infected patients.  Here we isolated the circulating resting CD4+ T cells of patients in whom viremia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir.  In each of eight patients, a single dose of VOR increased both biomarkers of cellular acetylation, and simultaneously induced an increase in HIV RNA expression in resting CD4+ cells (mean increase, 4.8-fold).  This demonstrates that a mol. mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK97t6JvwKNrVg90H21EOLACvtfcHk0lhkrov1_npfCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP&md5=bfe1b9c441d7eeda40d46897a9801311</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnature11286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11286%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DLiberty%26aufirst%3DA.%2BL.%26aulast%3DKashuba%26aufirst%3DA.%2BD.%26aulast%3DChoudhary%26aufirst%3DS.%2BK.%26aulast%3DKuruc%26aufirst%3DJ.%2BD.%26aulast%3DCrooks%26aufirst%3DA.%2BM.%26aulast%3DParker%26aufirst%3DD.%2BC.%26aulast%3DAnderson%26aufirst%3DE.%2BM.%26aulast%3DKearney%26aufirst%3DM.%2BF.%26aulast%3DStrain%26aufirst%3DM.%2BC.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DHudgens%26aufirst%3DM.%2BG.%26aulast%3DBosch%26aufirst%3DR.%2BJ.%26aulast%3DCoffin%26aufirst%3DJ.%2BM.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DAdministration%2520of%2520vorinostat%2520disrupts%2520HIV-1%2520latency%2520in%2520patients%2520on%2520antiretroviral%2520therapy%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D482%26epage%3D485%26doi%3D10.1038%2Fnature11286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Miyoshi, S.; Ooike, S.; Iwata, K.; Hikawa, H.; Sugahara, K.</span><span> </span><span class="NLM_article-title">Antitumor agents</span>. WO2009084693,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Miyoshi&author=S.+Ooike&author=K.+Iwata&author=H.+Hikawa&author=K.+Sugahara&title=Antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DS.%26atitle%3DAntitumor%2520agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Nasveschuk, C. G.; Audia, J. E.; Leblanc, Y.; Hewitt, M. C.; Côté, A.; Vaswani, R. G.; Albrecht, B. K.; Taylor, A. M.; Harmange, J. C.; Gehling, V. S.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors and uses thereof</span>. US08796261,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+G.+Nasveschuk&author=J.+E.+Audia&author=Y.+Leblanc&author=M.+C.+Hewitt&author=A.+C%C3%B4t%C3%A9&author=R.+G.+Vaswani&author=B.+K.+Albrecht&author=A.+M.+Taylor&author=J.+C.+Harmange&author=V.+S.+Gehling&title=Bromodomain+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26atitle%3DBromodomain%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Jang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, Y. H.</span><span> </span><span class="NLM_article-title">AMPK-ULK1-mediated autophagy confers resistance to BET inhibitor JQ1 in acute myeloid leukemia stem cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1078-0432.CCR-16-1903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1-39&author=J.+E.+Jangauthor=J.+I.+Eomauthor=H.+K.+Jeungauthor=J.+W.+Cheongauthor=J.+Y.+Leeauthor=J.+S.+Kimauthor=Y.+H.+Min&title=AMPK-ULK1-mediated+autophagy+confers+resistance+to+BET+inhibitor+JQ1+in+acute+myeloid+leukemia+stem+cells&doi=10.1158%2F1078-0432.CCR-16-1903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1903%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DJ.%2BE.%26aulast%3DEom%26aufirst%3DJ.%2BI.%26aulast%3DJeung%26aufirst%3DH.%2BK.%26aulast%3DCheong%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DMin%26aufirst%3DY.%2BH.%26atitle%3DAMPK-ULK1-mediated%2520autophagy%2520confers%2520resistance%2520to%2520BET%2520inhibitor%2520JQ1%2520in%2520acute%2520myeloid%2520leukemia%2520stem%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26spage%3D1%26epage%3D39%26doi%3D10.1158%2F1078-0432.CCR-16-1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Yokoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossenkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palozola, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showe, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaret, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speicher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conejo-Garcia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordog, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitler, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span> </span><span class="NLM_article-title">BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">6320</span><span class="NLM_x">–</span> <span class="NLM_lpage">6330</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F0008-5472.CAN-16-0854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=6320-6330&author=Y.+Yokoyamaauthor=H.+Zhuauthor=J.+H.+Leeauthor=A.+V.+Kossenkovauthor=S.+Y.+Wuauthor=J.+M.+Wickramasingheauthor=X.+Yinauthor=K.+C.+Palozolaauthor=A.+Gardiniauthor=L.+C.+Showeauthor=K.+S.+Zaretauthor=Q.+Liuauthor=D.+Speicherauthor=J.+R.+Conejo-Garciaauthor=J.+E.+Bradnerauthor=Z.+Zhangauthor=A.+K.+Soodauthor=T.+Ordogauthor=B.+G.+Bitlerauthor=R.+Zhang&title=BET+inhibitors+suppress+ALDH+activity+by+targeting+ALDH1A1+super-enhancer+in+ovarian+cancer&doi=10.1158%2F0008-5472.CAN-16-0854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0854%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DKossenkov%26aufirst%3DA.%2BV.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DWickramasinghe%26aufirst%3DJ.%2BM.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DPalozola%26aufirst%3DK.%2BC.%26aulast%3DGardini%26aufirst%3DA.%26aulast%3DShowe%26aufirst%3DL.%2BC.%26aulast%3DZaret%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSpeicher%26aufirst%3DD.%26aulast%3DConejo-Garcia%26aufirst%3DJ.%2BR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DOrdog%26aufirst%3DT.%26aulast%3DBitler%26aufirst%3DB.%2BG.%26aulast%3DZhang%26aufirst%3DR.%26atitle%3DBET%2520inhibitors%2520suppress%2520ALDH%2520activity%2520by%2520targeting%2520ALDH1A1%2520super-enhancer%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D6320%26epage%3D6330%26doi%3D10.1158%2F0008-5472.CAN-16-0854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">da Motta, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purshouse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bastiani, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baban, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigfield, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klamt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, A.</span><span> </span><span class="NLM_article-title">The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="refDoi"> DOI: 10.1038/onc.2016.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fonc.2016.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27292261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1ejtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=122&author=L.+L.+da+Mottaauthor=I.+Ledakiauthor=K.+Purshouseauthor=S.+Haiderauthor=M.+A.+De+Bastianiauthor=D.+Babanauthor=M.+Morottiauthor=G.+Steersauthor=S.+Wigfieldauthor=E.+Bridgesauthor=J.+L.+Liauthor=S.+Knappauthor=D.+Ebnerauthor=F.+Klamtauthor=A.+L.+Harrisauthor=A.+McIntyre&title=The+BET+inhibitor+JQ1+selectively+impairs+tumour+response+to+hypoxia+and+downregulates+CA9+and+angiogenesis+in+triple+negative+breast+cancer&doi=10.1038%2Fonc.2016.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer</span></div><div class="casAuthors">da Motta, L. L.; Ledaki, I.; Purshouse, K.; Haider, S.; De Bastiani, M. A.; Baban, D.; Morotti, M.; Steers, G.; Wigfield, S.; Bridges, E.; Li, J.-L.; Knapp, S.; Ebner, D.; Klamt, F.; Harris, A. L.; McIntyre, A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-132</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The availability of bromodomain and extra-terminal inhibitors (BETi) has enabled translational epigenetic studies in cancer.  BET proteins regulate transcription by selectively recognizing acetylated lysine residues on chromatin.  BETi compete with this process leading to both downregulation and upregulation of gene expression.  Hypoxia enables progression of triple neg. breast cancer (TNBC), the most aggressive form of breast cancer, partly by driving metabolic adaptation, angiogenesis and metastasis through upregulation of hypoxia-regulated genes (for example, carbonic anhydrase 9 (CA9) and vascular endothelial growth factor A (VEGF-A).  Responses to hypoxia can be mediated epigenetically, thus we investigated whether BETi JQ1 could impair the TNBC response induced by hypoxia and exert anti-tumor effects.  JQ1 significantly modulated 44% of hypoxia-induced genes, of which two-thirds were downregulated including CA9 and VEGF-A.  JQ1 prevented HIF binding to the hypoxia response element in CA9 promoter, but did not alter HIF expression or activity, suggesting some HIF targets are BET-dependent.  JQ1 reduced TNBC growth in vitro and in vivo and inhibited xenograft vascularization.  These findings identify that BETi dually targets angiogenesis and the hypoxic response, an effective combination at reducing tumor growth in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79-F0o2tp6bVg90H21EOLACvtfcHk0lgek4zz_XA7Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1ejtr4%253D&md5=9f1592548db8e6306703bdab7e1e1c90</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.184%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BMotta%26aufirst%3DL.%2BL.%26aulast%3DLedaki%26aufirst%3DI.%26aulast%3DPurshouse%26aufirst%3DK.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DDe%2BBastiani%26aufirst%3DM.%2BA.%26aulast%3DBaban%26aufirst%3DD.%26aulast%3DMorotti%26aufirst%3DM.%26aulast%3DSteers%26aufirst%3DG.%26aulast%3DWigfield%26aufirst%3DS.%26aulast%3DBridges%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DJ.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DEbner%26aufirst%3DD.%26aulast%3DKlamt%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DMcIntyre%26aufirst%3DA.%26atitle%3DThe%2520BET%2520inhibitor%2520JQ1%2520selectively%2520impairs%2520tumour%2520response%2520to%2520hypoxia%2520and%2520downregulates%2520CA9%2520and%2520angiogenesis%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D122%26doi%3D10.1038%2Fonc.2016.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Krugmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coadwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguinoa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipp, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manifava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktistakis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Painter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuring, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michell, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grewal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazarian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span> </span><span class="NLM_article-title">Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span><span class="refDoi"> DOI: 10.1016/S1097-2765(02)00434-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS1097-2765%2802%2900434-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=95-108&author=S.+Krugmannauthor=K.+E.+Andersonauthor=S.+H.+Ridleyauthor=N.+Rissoauthor=A.+McGregorauthor=J.+Coadwellauthor=K.+Davidsonauthor=A.+Eguinoaauthor=C.+D.+Ellsonauthor=P.+Lippauthor=M.+Manifavaauthor=N.+Ktistakisauthor=G.+Painterauthor=J.+W.+Thuringauthor=M.+A.+Cooperauthor=Z.+Y.+Limauthor=A.+B.+Holmesauthor=S.+K.+Doveauthor=R.+H.+Michellauthor=A.+Grewalauthor=A.+Nazarianauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=L.+R.+Stephensauthor=P.+T.+Hawkins&title=Identification+of+ARAP3%2C+a+novel+PI3K+effector+regulating+both+Arf+and+Rho+GTPases%2C+by+selective+capture+on+phosphoinositide+affinity+matrices&doi=10.1016%2FS1097-2765%2802%2900434-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2802%2900434-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252802%252900434-3%26sid%3Dliteratum%253Aachs%26aulast%3DKrugmann%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DRidley%26aufirst%3DS.%2BH.%26aulast%3DRisso%26aufirst%3DN.%26aulast%3DMcGregor%26aufirst%3DA.%26aulast%3DCoadwell%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DEguinoa%26aufirst%3DA.%26aulast%3DEllson%26aufirst%3DC.%2BD.%26aulast%3DLipp%26aufirst%3DP.%26aulast%3DManifava%26aufirst%3DM.%26aulast%3DKtistakis%26aufirst%3DN.%26aulast%3DPainter%26aufirst%3DG.%26aulast%3DThuring%26aufirst%3DJ.%2BW.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26aulast%3DLim%26aufirst%3DZ.%2BY.%26aulast%3DHolmes%26aufirst%3DA.%2BB.%26aulast%3DDove%26aufirst%3DS.%2BK.%26aulast%3DMichell%26aufirst%3DR.%2BH.%26aulast%3DGrewal%26aufirst%3DA.%26aulast%3DNazarian%26aufirst%3DA.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DIdentification%2520of%2520ARAP3%252C%2520a%2520novel%2520PI3K%2520effector%2520regulating%2520both%2520Arf%2520and%2520Rho%2520GTPases%252C%2520by%2520selective%2520capture%2520on%2520phosphoinositide%2520affinity%2520matrices%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D9%26spage%3D95%26epage%3D108%26doi%3D10.1016%2FS1097-2765%2802%2900434-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grove, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Painter, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuring, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catimel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktistakis, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. B.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of phosphatidylinositol phosphate affinity probes</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1039/B913399B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1039%2FB913399B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20024134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFekurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=66-76&author=S.+J.+Conwayauthor=J.+Gardinerauthor=S.+J.+Groveauthor=M.+K.+Johnsauthor=Z.+Y.+Limauthor=G.+F.+Painterauthor=D.+E.+Robinsonauthor=C.+Schieberauthor=J.+W.+Thuringauthor=L.+S.+Wongauthor=M.+X.+Yinauthor=A.+W.+Burgessauthor=B.+Catimelauthor=P.+T.+Hawkinsauthor=N.+T.+Ktistakisauthor=L.+R.+Stephensauthor=A.+B.+Holmes&title=Synthesis+and+biological+evaluation+of+phosphatidylinositol+phosphate+affinity+probes&doi=10.1039%2FB913399B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of phosphatidylinositol phosphate affinity probes</span></div><div class="casAuthors">Conway, Stuart J.; Gardiner, James; Grove, Simon J. A.; Johns, Melloney K.; Lim, Ze-Yi; Painter, Gavin F.; Robinson, Diane E. J. E.; Schieber, Christine; Thuring, Jan W.; Wong, Leon S.-M.; Yin, Meng-Xin; Burgess, Antony W.; Catimel, Bruno; Hawkins, Phillip T.; Ktistakis, Nicholas T.; Stephens, Leonard R.; Holmes, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-76</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of the complete family of phosphatidylinositol phosphate analogs (PIPs) from five key core intermediates is described.  These core compds. were obtained from myo-inositol orthoformate via regioselective DIBAL-H and trimethylaluminium-mediated cleavages and a resoln.-protection process using camphor acetals.  Coupling of cores with phosphoramidites which were derived from the requisite protected lipid side chains afforded the fully-protected PIPs.  Removal of the remaining protecting groups was achieved via hydrogenolysis using palladium black or palladium hydroxide on carbon in the presence of sodium bicarbonate to afford the complete family of dipalmitoyl- and amino-PIP analogs.  Investigations using affinity probes incorporating these compds. have identified novel proteins involved in the PI3K intracellular signaling network and have allowed a comprehensive proteomic anal. of phosphoinositide interacting proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcudQ48YzGrVg90H21EOLACvtfcHk0lgek4zz_XA7Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFekurnI&md5=2a9eed72d2b26e568ed3326744fc3fd0</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2FB913399B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB913399B%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DGardiner%26aufirst%3DJ.%26aulast%3DGrove%26aufirst%3DS.%2BJ.%26aulast%3DJohns%26aufirst%3DM.%2BK.%26aulast%3DLim%26aufirst%3DZ.%2BY.%26aulast%3DPainter%26aufirst%3DG.%2BF.%26aulast%3DRobinson%26aufirst%3DD.%2BE.%26aulast%3DSchieber%26aufirst%3DC.%26aulast%3DThuring%26aufirst%3DJ.%2BW.%26aulast%3DWong%26aufirst%3DL.%2BS.%26aulast%3DYin%26aufirst%3DM.%2BX.%26aulast%3DBurgess%26aufirst%3DA.%2BW.%26aulast%3DCatimel%26aufirst%3DB.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DKtistakis%26aufirst%3DN.%2BT.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHolmes%26aufirst%3DA.%2BB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520phosphatidylinositol%2520phosphate%2520affinity%2520probes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D66%26epage%3D76%26doi%3D10.1039%2FB913399B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">The making of I-BET762, a BET bromodomain inhibitor now in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7498</span><span class="NLM_x">–</span> <span class="NLM_lpage">7500</span><span class="refDoi"> DOI: 10.1021/jm4014407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7498-7500&author=Y.+Zhaoauthor=C.+Y.+Yangauthor=S.+Wang&title=The+making+of+I-BET762%2C+a+BET+bromodomain+inhibitor+now+in+clinical+development&doi=10.1021%2Fjm4014407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The Making of I-BET762, a BET Bromodomain Inhibitor Now in Clinical Development</span></div><div class="casAuthors">Zhao, Yujun; Yang, Chao-Yie; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7498-7500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain and extra-terminal (BET) proteins belong to a class of proteins collectively called epigenetic "readers".  BET bromodomains have emerged as promising drug targets for treatment of cancers, inflammatory diseases, and other medical conditions.  GlaxoSmithKline scientists have successfully optimized a class of benzodiazepines as inhibitors of BET bromodomains, without any prior knowledge of identified mol. targets.  It thus is possible to hit a target without aiming at it.  The optimized lead compd. I-BET762 is currently being evaluated in a phase I clin. trial for treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN-T-2VhynyrVg90H21EOLACvtfcHk0lgu7ds_lk3UYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbF&md5=61aa569c1b1b129b54229b9f8401f46b</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm4014407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014407%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520making%2520of%2520I-BET762%252C%2520a%2520BET%2520bromodomain%2520inhibitor%2520now%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7498%26epage%3D7500%26doi%3D10.1021%2Fjm4014407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellapantula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bangalore Srinivasamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birudukota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, design, and optimization of isoxazole azepine BET inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1021/ml4001485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4001485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFanu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=835-840&author=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=Y.+Leblancauthor=A.+Coteauthor=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.+C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=R.+Sankaranarayananauthor=S.+Yellapantulaauthor=N.+Bangalore+Srinivasamurthyauthor=S.+Birudukotaauthor=B.+K.+Albrecht&title=Discovery%2C+design%2C+and+optimization+of+isoxazole+azepine+BET+inhibitors&doi=10.1021%2Fml4001485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors</span></div><div class="casAuthors">Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Leblanc, Yves; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaram, Hariharan; Sankaranarayanan, Ravichandran; Yellapantula, Sreegouri; Bangalore Srinivasamurthy, Nandana; Birudukota, Swarnakumari; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">835-840</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of a novel series of small mol. BET inhibitors is described.  Using crystallog. binding modes of an amino-isoxazole fragment and known BET inhibitors, a structure-based drug design effort lead to a novel isoxazole azepine scaffold, e.g. I.  This scaffold showed good potency in biochem. and cellular assays and oral activity in an in vivo model of BET inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCIGHOq7LlgrVg90H21EOLACvtfcHk0lgu7ds_lk3UYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFanu7jI&md5=7a3ab8ec50ba88e865c5a6524cf02c48</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fml4001485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001485%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSankaranarayanan%26aufirst%3DR.%26aulast%3DYellapantula%26aufirst%3DS.%26aulast%3DBangalore%2BSrinivasamurthy%26aufirst%3DN.%26aulast%3DBirudukota%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%252C%2520and%2520optimization%2520of%2520isoxazole%2520azepine%2520BET%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D835%26epage%3D840%26doi%3D10.1021%2Fml4001485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Identification of a benzoisoxazoloazepine inhibitor (CPI-0610) of the bromodomain and extra-terminal (BET) Family as a candidate for human clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1330-1339&author=B.+K.+Albrechtauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=A.+Coteauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=S.+Bellonauthor=L.+Bergeronauthor=R.+Campbellauthor=N.+Cantoneauthor=M.+R.+Cooperauthor=R.+T.+Cummingsauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Normantauthor=M.+O%E2%80%99Mearaauthor=E.+Pardoauthor=F.+Poyauthor=P.+Sandyauthor=J.+Supkoauthor=R.+J.+Simsauthor=J.+C.+Harmangeauthor=A.+M.+Taylorauthor=J.+E.+Audia&title=Identification+of+a+benzoisoxazoloazepine+inhibitor+%28CPI-0610%29+of+the+bromodomain+and+extra-terminal+%28BET%29+Family+as+a+candidate+for+human+clinical+trials&doi=10.1021%2Facs.jmedchem.5b01882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span></div><div class="casAuthors">Albrecht, Brian K.; Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Cote, Alexandre; Leblanc, Yves; Nasveschuk, Christopher G.; Bellon, Steve; Bergeron, Louise; Campbell, Robert; Cantone, Nico; Cooper, Michael R.; Cummings, Richard T.; Jayaram, Hariharan; Joshi, Shivangi; Mertz, Jennifer A.; Neiss, Adrianne; Normant, Emmanuel; O'Meara, Michael; Pardo, Eneida; Poy, Florence; Sandy, Peter; Supko, Jeffrey; Sims, Robert J.; Harmange, Jean-Christophe; Taylor, Alexander M.; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1330-1339</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB.  Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clin. trials for hematol. malignancies (CPI-0610).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40qjnYl4EZLVg90H21EOLACvtfcHk0lgu7ds_lk3UYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D&md5=5e1c5aab26aa58844a9f6670a7bbd78b</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01882%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520a%2520benzoisoxazoloazepine%2520inhibitor%2520%2528CPI-0610%2529%2520of%2520the%2520bromodomain%2520and%2520extra-terminal%2520%2528BET%2529%2520Family%2520as%2520a%2520candidate%2520for%2520human%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1330%26epage%3D1339%26doi%3D10.1021%2Facs.jmedchem.5b01882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Development of methyl isoxazoleazepines as inhibitors of BET</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2015.03.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25851940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1842-1848&author=M.+C.+Hewittauthor=Y.+Leblancauthor=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=A.+Coteauthor=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.+C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=R.+Cummingsauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Development+of+methyl+isoxazoleazepines+as+inhibitors+of+BET&doi=10.1016%2Fj.bmcl.2015.03.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Development of methyl isoxazoleazepines as inhibitors of BET</span></div><div class="casAuthors">Hewitt, Michael C.; Leblanc, Yves; Gehling, Victor S.; Vaswani, Rishi G.; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Cummings, Rich; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaran, Hariharan; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the Me isoxazoleazepine chemotype) exemplified by carboxamide 23.  The Me isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrdQuVhIoU1rVg90H21EOLACvtfcHk0liPkD4MYZnkIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D&md5=fb9a78528287f82ccf004e751e491ee4</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDevelopment%2520of%2520methyl%2520isoxazoleazepines%2520as%2520inhibitors%2520of%2520BET%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmcl.2015.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery of benzotriazolo[4,3-d][1,4]diazepines as orally active inhibitors of BET bromodomains</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1021/ml500411h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500411h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=145-150&author=A.+M.+Taylorauthor=R.+G.+Vaswaniauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=Y.+Leblancauthor=J.+E.+Audiaauthor=S.+Bellonauthor=R.+T.+Cummingsauthor=A.+Coteauthor=J.+C.+Harmangeauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+M.+Loraauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Pardoauthor=C.+G.+Nasveschukauthor=F.+Poyauthor=P.+Sandyauthor=J.+W.+Setserauthor=R.+J.+Simsauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Discovery+of+benzotriazolo%5B4%2C3-d%5D%5B1%2C4%5Ddiazepines+as+orally+active+inhibitors+of+BET+bromodomains&doi=10.1021%2Fml500411h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains</span></div><div class="casAuthors">Taylor, Alexander M.; Vaswani, Rishi G.; Gehling, Victor S.; Hewitt, Michael C.; Leblanc, Yves; Audia, James E.; Bellon, Steve; Cummings, Richard T.; Cote, Alexandre; Harmange, Jean-Christophe; Jayaram, Hari; Joshi, Shivangi; Lora, Jose M.; Mertz, Jennifer A.; Neiss, Adrianne; Pardo, Eneida; Nasveschuk, Christopher G.; Poy, Florence; Sandy, Peter; Setser, Jeremy W.; Sims, Robert J.; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the bromodomains of the BET family, of which BRD4 is a member, has been shown to decrease myc and interleukin (IL) 6 in vivo, markers that are of therapeutic relevance to cancer and inflammatory disease, resp.  Herein the authors report substituted benzo[b]isoxazolo[4,5-d]azepines and benzotriazolo[4,3-d][1,4]diazepines as fragment-derived novel inhibitors of the bromodomain of BRD4.  Compds. from these series were potent and selective in cells, and subsequent optimization of microsomal stability yielded representatives that demonstrated dose- and time-dependent redn. of plasma IL-6 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDybfuij7kebVg90H21EOLACvtfcHk0liPkD4MYZnkIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D&md5=38759c818814869d6c951a035bad7617</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fml500411h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500411h%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSetser%26aufirst%3DJ.%2BW.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%2520of%2520benzotriazolo%255B4%252C3-d%255D%255B1%252C4%255Ddiazepines%2520as%2520orally%2520active%2520inhibitors%2520of%2520BET%2520bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D145%26epage%3D150%26doi%3D10.1021%2Fml500411h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Landau, S. B.; Kagey, M.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. WO2016069578,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+B.+Landau&author=M.+Kagey&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DS.%2BB.%26atitle%3DBromodomain%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1878</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.10.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmc.2011.10.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22137933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1878-1886&author=P.+Filippakopoulosauthor=S.+Picaudauthor=O.+Fedorovauthor=M.+Kellerauthor=M.+Wrobelauthor=O.+Morgensternauthor=F.+Bracherauthor=S.+Knapp&title=Benzodiazepines+and+benzotriazepines+as+protein+interaction+inhibitors+targeting+bromodomains+of+the+BET+family&doi=10.1016%2Fj.bmc.2011.10.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Fedorov, Oleg; Keller, Marco; Wrobel, Matthias; Morgenstern, Olaf; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1878-1886</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Benzodiazepines are psychoactive drugs with anxiolytic, sedative, skeletal muscle relaxant and amnestic properties.  Recently triazolo-benzodiazepines have been also described as potent and highly selective protein interaction inhibitors of bromodomain and extra-terminal (BET) proteins, a family of transcriptional co-regulators that play a key role in cancer cell survival and proliferation, but the requirements for high affinity interaction of this compd. class with bromodomains has not been described.  Here we provide insight into the structure-activity relationship (SAR) and selectivity of this versatile scaffold.  In addn., using high resoln. crystal structures we compared the binding mode of a series of benzodiazepine (BzD) and related triazolo-benzotriazepines (BzT) derivs. including clin. approved drugs such as alprazolam and midazolam.  Our anal. revealed the importance of the 1-Me triazolo ring system for BET binding and suggests modifications for the development of further high affinity bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9BT8VUvs8_LVg90H21EOLACvtfcHk0lhWRv_UyS0avA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOksrw%253D&md5=aed7023bdb44ee0b83af1605f0be0ddd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.10.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.10.080%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DWrobel%26aufirst%3DM.%26aulast%3DMorgenstern%26aufirst%3DO.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DBenzodiazepines%2520and%2520benzotriazepines%2520as%2520protein%2520interaction%2520inhibitors%2520targeting%2520bromodomains%2520of%2520the%2520BET%2520family%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1878%26epage%3D1886%26doi%3D10.1016%2Fj.bmc.2011.10.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Endo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooike, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumichika, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2016.01.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26869194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVahsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1365-1370&author=J.+Endoauthor=H.+Hikawaauthor=M.+Hamadaauthor=S.+Ishibuchiauthor=N.+Fujieauthor=N.+Sugiyamaauthor=M.+Tanakaauthor=H.+Kobayashiauthor=K.+Sugaharaauthor=K.+Oshitaauthor=K.+Iwataauthor=S.+Ooikeauthor=M.+Murataauthor=H.+Sumichikaauthor=K.+Chibaauthor=K.+Adachi&title=A+phenotypic+drug+discovery+study+on+thienodiazepine+derivatives+as+inhibitors+of+T+cell+proliferation+induced+by+CD28+co-stimulation+leads+to+the+discovery+of+a+first+bromodomain+inhibitor&doi=10.1016%2Fj.bmcl.2016.01.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor</span></div><div class="casAuthors">Endo, Junichi; Hikawa, Hidemasa; Hamada, Maiko; Ishibuchi, Seigo; Fujie, Naoto; Sugiyama, Naoki; Tanaka, Minoru; Kobayashi, Haruhito; Sugahara, Kunio; Oshita, Koichi; Iwata, Kazunori; Ooike, Shinsuke; Murata, Meguru; Sumichika, Hiroshi; Chiba, Kenji; Adachi, Kunitomo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1365-1370</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A phenotypic screening of thienodiazepines derived from a hit compd. found through a binding assay targeting co-stimulatory mols. on T cells and antigen presenting cells successfully led to the discovery of a thienotriazolodiazepine compd. (7f) possessing potent immunosuppressive activity.  A chem. biol. approach has succeeded in revealing that 7f is a first inhibitor of epigenetic bromodomain-contg. proteins. 7f is expected to become an anti-cancer agent as well as an immunosuppressive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeajoPFavBUbVg90H21EOLACvtfcHk0lhWRv_UyS0avA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVahsL8%253D&md5=e414d4c7fad718d7b2c5a76a20aed0d7</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.084%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DJ.%26aulast%3DHikawa%26aufirst%3DH.%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DIshibuchi%26aufirst%3DS.%26aulast%3DFujie%26aufirst%3DN.%26aulast%3DSugiyama%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DOshita%26aufirst%3DK.%26aulast%3DIwata%26aufirst%3DK.%26aulast%3DOoike%26aufirst%3DS.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DSumichika%26aufirst%3DH.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DA%2520phenotypic%2520drug%2520discovery%2520study%2520on%2520thienodiazepine%2520derivatives%2520as%2520inhibitors%2520of%2520T%2520cell%2520proliferation%2520induced%2520by%2520CD28%2520co-stimulation%2520leads%2520to%2520the%2520discovery%2520of%2520a%2520first%2520bromodomain%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1365%26epage%3D1370%26doi%3D10.1016%2Fj.bmcl.2016.01.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Schmees, N.; Buchmann, B.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Kruger, M.; Fernandez-Montalvan, A.; Kunzer, H.; Rehwinkel, H.</span><span> </span><span class="NLM_article-title">4-Substituted pyrrolo- and pyrazolo- diazepines</span>. WO2014128111,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=B.+Buchmann&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=M.+Kruger&author=A.+Fernandez-Montalvan&author=H.+Kunzer&author=H.+Rehwinkel&title=4-Substituted+pyrrolo-+and+pyrazolo-+diazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3D4-Substituted%2520pyrrolo-%2520and%2520pyrazolo-%2520diazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Vadivelu, S.; Rajagopal, S.; Chinnapattu, M.; Gondrala, P. K.; Sivanandhan, D.; Mulakala, C.</span><span> </span><span class="NLM_article-title">Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer</span>. WO2016157221,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Vadivelu&author=S.+Rajagopal&author=M.+Chinnapattu&author=P.+K.+Gondrala&author=D.+Sivanandhan&author=C.+Mulakala&title=Tricyclic+fused+derivatives+of+1-%28cyclo%29alkyl+pyridin-2-one+useful+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVadivelu%26aufirst%3DS.%26atitle%3DTricyclic%2520fused%2520derivatives%2520of%25201-%2528cyclo%2529alkyl%2520pyridin-2-one%2520useful%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Liu, D.; Pratt, J.; Wang, L.; Hasvold, L. A.; Bogdan, A.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. US20140256710,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Liu&author=J.+Pratt&author=L.+Wang&author=L.+A.+Hasvold&author=A.+Bogdan&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DBromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, L.</span><span> </span><span class="NLM_article-title">Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ejmech.2016.05.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27266999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSjsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=294-299&author=J.+Liauthor=P.+Wangauthor=B.+Zhouauthor=J.+Shiauthor=J.+Liuauthor=X.+Liauthor=L.+Fanauthor=Y.+Zhengauthor=L.+Ouyang&title=Development+of+4%2C5-dihydro-benzodiazepinone+derivatives+as+a+new+chemical+series+of+BRD4+inhibitors&doi=10.1016%2Fj.ejmech.2016.05.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors</span></div><div class="casAuthors">Li, Jie; Wang, Peiqi; Zhou, Bihui; Shi, Jianyou; Liu, Jie; Li, Xiangrong; Fan, Limei; Zheng, Yaxin; Ouyang, Liang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">294-299</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new chem. scaffold 3,4-dihydroquinoxalin-2(1H)-ones were developed from structural modifications of previously reported BRD4 inhibitors.  A series of compds., e.g., I, were synthesized and the BRD4-inhibitory activity and anti-proliferative effect of these compds. were evaluated.  We found compd., e.g., II, had remarkable anti-proliferative activities toward leukemia cells and could induce apoptosis by mitochondrial pathways.  Notably, the anal. of mol. docking suggested that hydrophobic interaction was essential for compd. II to bind to BD1.  In conclusion, these results demonstrated the potential of compd. II to be utilized as a BRD4 inhibitor with apoptosis inducing effect in future leukemia therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq_MyywxjOrbVg90H21EOLACvtfcHk0liUGpQOWCT-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSjsLrL&md5=4fce15e1274d9842310817b17ff3d309</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.057%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DOuyang%26aufirst%3DL.%26atitle%3DDevelopment%2520of%25204%252C5-dihydro-benzodiazepinone%2520derivatives%2520as%2520a%2520new%2520chemical%2520series%2520of%2520BRD4%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D294%26epage%3D299%26doi%3D10.1016%2Fj.ejmech.2016.05.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Siegel, S.; Baurle, S.; Cleve, A.; Haendler, B.; Fernandez-Montalvan, A.; Monning, U.; Krause, S.; Lejeune, P.; Busemann, M.; Kuhnke, J.</span><span> </span><span class="NLM_article-title">Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines</span>. WO2014128067,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Siegel&author=S.+Baurle&author=A.+Cleve&author=B.+Haendler&author=A.+Fernandez-Montalvan&author=U.+Monning&author=S.+Krause&author=P.+Lejeune&author=M.+Busemann&author=J.+Kuhnke&title=Bicyclo+2%2C3-benzodiazepines+and+spirocyclically+substituted+2%2C3-benzodiazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DS.%26atitle%3DBicyclo%25202%252C3-benzodiazepines%2520and%2520spirocyclically%2520substituted%25202%252C3-benzodiazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppusetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6761</span><span class="NLM_x">–</span> <span class="NLM_lpage">6770</span><span class="refDoi"> DOI: 10.1021/jm200640v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200640v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6761-6770&author=D.+S.+Hewingsauthor=M.+Wangauthor=M.+Philpottauthor=O.+Fedorovauthor=S.+Uttarkarauthor=P.+Filippakopoulosauthor=S.+Picaudauthor=C.+Vuppusettyauthor=B.+Marsdenauthor=S.+Knappauthor=S.+J.+Conwayauthor=T.+D.+Heightman&title=3%2C5-dimethylisoxazoles+act+as+acetyl-lysine-mimetic+bromodomain+ligands&doi=10.1021%2Fjm200640v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Wang, Minghua; Philpott, Martin; Fedorov, Oleg; Uttarkar, Sagar; Filippakopoulos, Panagis; Picaud, Sarah; Vuppusetty, Chaitanya; Marsden, Brian; Knapp, Stefan; Conway, Stuart J.; Heightman, Tom D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6761-6770</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone-lysine acetylation is a vital chromatin post-translational modification involved in the epigenetic regulation of gene transcription.  Bromodomains bind acetylated lysines, acting as readers of the histone-acetylation code.  Competitive inhibitors of this interaction have antiproliferative and anti-inflammatory properties.  With 57 distinct bromodomains known, the discovery of subtype-selective inhibitors of the histone-bromodomain interaction is of great importance.  We have identified the 3,5-dimethylisoxazole moiety as a novel acetyl-lysine bioisostere, which displaces acetylated histone-mimicking peptides from bromodomains.  Using X-ray crystallog. anal., we have detd. the interactions responsible for the activity and selectivity of 4-substituted 3,5-dimethylisoxazoles against a selection of phylogenetically diverse bromodomains.  By exploiting these interactions, we have developed compd. 4d, which has IC50 values of <5 μM for the bromodomain-contg. proteins BRD2(1) and BRD4(1).  These compds. are promising leads for the further development of selective probes for the bromodomain and extra C-terminal domain (BET) family and CREBBP bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzK4xMvJhXrVg90H21EOLACvtfcHk0liUGpQOWCT-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO&md5=7d6f9eff2735c8a7189dec4fb5c5d13d</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm200640v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200640v%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DUttarkar%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DVuppusetty%26aufirst%3DC.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3D3%252C5-dimethylisoxazoles%2520act%2520as%2520acetyl-lysine-mimetic%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6761%26epage%3D6770%26doi%3D10.1021%2Fjm200640v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3217</span><span class="NLM_x">–</span> <span class="NLM_lpage">3227</span><span class="refDoi"> DOI: 10.1021/jm301588r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301588r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3217-3227&author=D.+S.+Hewingsauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=S.+Picaudauthor=A.+Tumberauthor=C.+Wellsauthor=M.+M.+Olcinaauthor=K.+Freemanauthor=A.+Gillauthor=A.+J.+Ritchieauthor=D.+W.+Sheppardauthor=A.+J.+Russellauthor=E.+M.+Hammondauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=Optimization+of+3%2C5-dimethylisoxazole+derivatives+as+potent+bromodomain+ligands&doi=10.1021%2Fjm301588r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Fedorov, Oleg; Filippakopoulos, Panagis; Martin, Sarah; Picaud, Sarah; Tumber, Anthony; Wells, Christopher; Olcina, Monica M.; Freeman, Katherine; Gill, Andrew; Ritchie, Alison J.; Sheppard, David W.; Russell, Angela J.; Hammond, Ester M.; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3217-3227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Isoxazolylphenyl)arylmethanols such as I (R = H; R1 = HO; R2 = H; R3 = Ph), I (R = HO; R1 = H; R2 = H; R3 = Ph), and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = Ph, 3-FC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4) were prepd. as inhibitors of the bromodomain and extra terminal domain (BET) bromodomain family member BRD4(1) for potential use as antitumor agents.  The structures of I (R = H; R1 = HO; R2 = H; R3 = Ph) and I (R = HO; R1 = H; R2 = H; R3 = Ph) bound to human BRD4(1) were detd. by X-ray crystallog. to det. features useful for selective binding to BRD4(1).  I (R = H, HO; R1 = HO, H; R2 = H, MeCO; R3 = Ph) and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = 3-ClC6H4) inhibited a human acute myeloid leukemia cell line in vitro with 3-4 fold reduced inhibition and reduced toxicity in other human cells compared to a known BRD4(1) inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVEQ5OOJGC8bVg90H21EOLACvtfcHk0liUGpQOWCT-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D&md5=bb4890291db8c3e8d404a75dd9dcbb87</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm301588r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301588r%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DFreeman%26aufirst%3DK.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DA.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DOptimization%2520of%25203%252C5-dimethylisoxazole%2520derivatives%2520as%2520potent%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3217%26epage%3D3227%26doi%3D10.1021%2Fjm301588r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodrow, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span><span class="refDoi"> DOI: 10.1021/jm201283q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201283q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=587-596&author=P.+Bamboroughauthor=H.+Dialloauthor=J.+D.+Goodacreauthor=L.+Gordonauthor=A.+Lewisauthor=J.+T.+Sealauthor=D.+M.+Wilsonauthor=M.+D.+Woodrowauthor=C.+W.+Chung&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+2%3A+optimization+of+phenylisoxazole+sulfonamides&doi=10.1021%2Fjm201283q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides</span></div><div class="casAuthors">Bamborough, Paul; Diallo, Hawa; Goodacre, Jonathan D.; Gordon, Laurie; Lewis, Antonia; Seal, Jonathan T.; Wilson, David M.; Woodrow, Michael D.; Chung, Chun-wa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">587-596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are epigenetic reader modules that regulate gene transcription through their recognition of acetyl-lysine modified histone tails.  Inhibitors of this protein-protein interaction have the potential to modulate multiple diseases as demonstrated by the profound anti-inflammatory and antiproliferative effects of a recently disclosed class of BET compds.  While these compds. were discovered using phenotypic assays, here we present a highly efficient alternative approach to find new chem. templates, exploiting the abundant structural knowledge that exists for this target class.  A Ph di-Me isoxazole chemotype resulting from a focused fragment screen has been rapidly optimized through structure-based design, leading to a sulfonamide series showing anti-inflammatory activity in cellular assays.  This proof-of-principle expt. demonstrates the tractability of the BET family and bromodomain target class to fragment-based hit discovery and structure-based lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6lsic9qjJrVg90H21EOLACvtfcHk0ljzRj9gj7WSnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF&md5=e73b16b3fddf88b43b037264b000b276</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm201283q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201283q%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DGoodacre%26aufirst%3DJ.%2BD.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DSeal%26aufirst%3DJ.%2BT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWoodrow%26aufirst%3DM.%2BD.%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520phenylisoxazole%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D587%26epage%3D596%26doi%3D10.1021%2Fjm201283q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marineau, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklow, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Biased multicomponent reactions to develop novel bromodomain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9019</span><span class="NLM_x">–</span> <span class="NLM_lpage">9027</span><span class="refDoi"> DOI: 10.1021/jm501120z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501120z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9019-9027&author=M.+R.+McKeownauthor=D.+L.+Shawauthor=H.+Fuauthor=S.+Liuauthor=X.+Xuauthor=J.+J.+Marineauauthor=Y.+Huangauthor=X.+Zhangauthor=D.+L.+Buckleyauthor=A.+Kadamauthor=Z.+Zhangauthor=S.+C.+Blacklowauthor=J.+Qiauthor=W.+Zhangauthor=J.+E.+Bradner&title=Biased+multicomponent+reactions+to+develop+novel+bromodomain+inhibitors&doi=10.1021%2Fjm501120z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors</span></div><div class="casAuthors">McKeown, Michael R.; Shaw, Daniel L.; Fu, Harry; Liu, Shuai; Xu, Xiang; Marineau, Jason J.; Huang, Yibo; Zhang, Xiaofeng; Buckley, Dennis L.; Kadam, Asha; Zhang, Zijuan; Blacklow, Stephen C.; Qi, Jun; Zhang, Wei; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9019-9027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer.  Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands as probes of bromodomain function.  Using fluorous-tagged multicomponent reactions, we developed a focused chem. library of bromodomain inhibitors around a 3,5-dimethylisoxazole biasing element with micromolar biochem. IC50.  Iterative synthesis and biochem. assessment allowed optimization of novel BET bromodomain inhibitors based on an imidazo[1,2-a]pyrazine scaffold.  Lead compd. I (UMB-32) binds BRD4 with a Kd of 550 nM and 724 nM cellular potency in BRD4-dependent lines.  Addnl., compd. I shows potency against TAF1, a bromodomain-contg. transcription factor previously unapproached by discovery chem.  Compd. I was cocrystd. with BRD4, yielding a 1.56 Å resoln. crystal structure.  This research showcases new applications of fluorous and multicomponent chem. synthesis for the development of novel epigenetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocWEf4LoDJTrVg90H21EOLACvtfcHk0ljzRj9gj7WSnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN&md5=a4e20101f5a0b547451814af73c0418f</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm501120z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501120z%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DShaw%26aufirst%3DD.%2BL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DMarineau%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DKadam%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DBiased%2520multicomponent%2520reactions%2520to%2520develop%2520novel%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9019%26epage%3D9027%26doi%3D10.1021%2Fjm501120z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delannee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudit, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2963</span><span class="NLM_x">–</span> <span class="NLM_lpage">2967</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2012.01.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22386529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2963-2967&author=O.+Mirguetauthor=Y.+Lamotteauthor=F.+Doncheauthor=J.+Toumauthor=F.+Gellibertauthor=A.+Bouillotauthor=R.+Gosminiauthor=V.+L.+Nguyenauthor=D.+Delanneeauthor=J.+Sealauthor=F.+Blandelauthor=A.+B.+Boullayauthor=E.+Boursierauthor=S.+Martinauthor=J.+M.+Brusqauthor=G.+Krysaauthor=A.+Riouauthor=R.+Tellierauthor=A.+Costazauthor=P.+Huetauthor=Y.+Duditauthor=L.+Trottetauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=From+ApoA1+upregulation+to+BET+family+bromodomain+inhibition%3A+discovery+of+I-BET151&doi=10.1016%2Fj.bmcl.2012.01.125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151</span></div><div class="casAuthors">Mirguet, Olivier; Lamotte, Yann; Donche, Frederic; Toum, Jerome; Gellibert, Francoise; Bouillot, Anne; Gosmini, Romain; Nguyen, Van-Loc; Delannee, Delphine; Seal, Jonathan; Blandel, Florence; Boullay, Anne-Benedicte; Boursier, Eric; Martin, Sandrine; Brusq, Jean-Marie; Krysa, Gael; Riou, Alizon; Tellier, Remi; Costaz, Agnes; Huet, Pascal; Dudit, Yann; Trottet, Lionel; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2963-2967</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery, synthesis, and biol. evaluation of a novel series of 7-isoxazoloquinolines is described.  Several analogs are shown to increase ApoA1 expression within the nanomolar range in the human hepatic cell line HepG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIu6f80tbgE7Vg90H21EOLACvtfcHk0ljzRj9gj7WSnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D&md5=48c9a8dc4b70bea4a86807f7a1cec5f1</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.125%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DDelannee%26aufirst%3DD.%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DBlandel%26aufirst%3DF.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DRiou%26aufirst%3DA.%26aulast%3DTellier%26aufirst%3DR.%26aulast%3DCostaz%26aufirst%3DA.%26aulast%3DHuet%26aufirst%3DP.%26aulast%3DDudit%26aufirst%3DY.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DFrom%2520ApoA1%2520upregulation%2520to%2520BET%2520family%2520bromodomain%2520inhibition%253A%2520discovery%2520of%2520I-BET151%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2963%26epage%3D2967%26doi%3D10.1016%2Fj.bmcl.2012.01.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioja, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span> </span><span class="NLM_article-title">Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2968</span><span class="NLM_x">–</span> <span class="NLM_lpage">2972</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2012.02.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22437115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2968-2972&author=J.+Sealauthor=Y.+Lamotteauthor=F.+Doncheauthor=A.+Bouillotauthor=O.+Mirguetauthor=F.+Gellibertauthor=E.+Nicodemeauthor=G.+Krysaauthor=J.+Kirilovskyauthor=S.+Beinkeauthor=S.+McClearyauthor=I.+Riojaauthor=P.+Bamboroughauthor=C.+W.+Chungauthor=L.+Gordonauthor=T.+Lewisauthor=A.+L.+Walkerauthor=L.+Cutlerauthor=D.+Lugoauthor=D.+M.+Wilsonauthor=J.+Witheringtonauthor=K.+Leeauthor=R.+K.+Prinjha&title=Identification+of+a+novel+series+of+BET+family+bromodomain+inhibitors%3A+binding+mode+and+profile+of+I-BET151+%28GSK1210151A%29&doi=10.1016%2Fj.bmcl.2012.02.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)</span></div><div class="casAuthors">Seal, Jonathan; Lamotte, Yann; Donche, Frederic; Bouillot, Anne; Mirguet, Olivier; Gellibert, Francoise; Nicodeme, Edwige; Krysa, Gael; Kirilovsky, Jorge; Beinke, Soren; McCleary, Scott; Rioja, Inma; Bamborough, Paul; Chung, Chun-Wa; Gordon, Laurie; Lewis, Toni; Walker, Ann L.; Cutler, Leanne; Lugo, David; Wilson, David M.; Witherington, Jason; Lee, Kevin; Prinjha, Rab K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2968-2972</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of quinoline isoxazole BET family bromodomain inhibitors are discussed.  Crystallog. is used to illustrate binding modes and rationalize their SAR.  One member, I-BET151 (GSK1210151A), shows good oral bioavailability in both the rat and minipig as well as demonstrating efficient suppression of bacterial induced inflammation and sepsis in a murine in vivo endotoxemia model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJKtxBCr-pRbVg90H21EOLACvtfcHk0ljMPfz__iSzGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D&md5=a8037c89bcb93948d663208bd1ebfd55</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.041%26sid%3Dliteratum%253Aachs%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DRioja%26aufirst%3DI.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520BET%2520family%2520bromodomain%2520inhibitors%253A%2520binding%2520mode%2520and%2520profile%2520of%2520I-BET151%2520%2528GSK1210151A%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2968%26epage%3D2972%26doi%3D10.1016%2Fj.bmcl.2012.02.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudgin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.1038/nature10509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature10509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21964340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=529-533&author=M.+A.+Dawsonauthor=R.+K.+Prinjhaauthor=A.+Dittmannauthor=G.+Giotopoulosauthor=M.+Bantscheffauthor=W.+I.+Chanauthor=S.+C.+Robsonauthor=C.+W.+Chungauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=C.+Huthmacherauthor=E.+Gudginauthor=D.+Lugoauthor=S.+Beinkeauthor=T.+D.+Chapmanauthor=E.+J.+Robertsauthor=P.+E.+Sodenauthor=K.+R.+Augerauthor=O.+Mirguetauthor=K.+Doehnerauthor=R.+Delwelauthor=A.+K.+Burnettauthor=P.+Jeffreyauthor=G.+Drewesauthor=K.+Leeauthor=B.+J.+Huntlyauthor=T.+Kouzarides&title=Inhibition+of+BET+recruitment+to+chromatin+as+an+effective+treatment+for+MLL-fusion+leukaemia&doi=10.1038%2Fnature10509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span></div><div class="casAuthors">Dawson, Mark A.; Prinjha, Rab K.; Dittman, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">529-533</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent chromosomal translocations involving the mixed lineage leukemia (MLL) gene initiate aggressive forms of leukemia, which are often refractory to conventional therapies.  Many MLL-fusion partners are members of the super elongation complex (SEC), a crit. regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukemia induction.  Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-assocd. factor complex (PAFc), are assocd. with the BET family of acetyl-lysine recognizing, chromatin adaptor' proteins.  These data provided the basis for therapeutic intervention in MLL-fusion leukemia, via the displacement of the BET family of proteins from chromatin.  We show that a novel small mol. inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukemic cell lines, through the induction of early cell cycle arrest and apoptosis.  I-BET151 treatment in two human leukemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes.  The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin.  In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukemia.  Finally, the efficacy of I-BET151 against human leukemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential.  These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4FbgJpjftv7Vg90H21EOLACvtfcHk0ljMPfz__iSzGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO&md5=dffb4b81da4ca8291c27139d0df86324</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fnature10509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10509%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.%2BI.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DGudgin%26aufirst%3DE.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%2BD.%26aulast%3DRoberts%26aufirst%3DE.%2BJ.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DDoehner%26aufirst%3DK.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520BET%2520recruitment%2520to%2520chromatin%2520as%2520an%2520effective%2520treatment%2520for%2520MLL-fusion%2520leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D529%26epage%3D533%26doi%3D10.1038%2Fnature10509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Ran, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaswamy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of gamma-carboline analogues as potent and specific BET bromodomain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4927-4939&author=X.+Ranauthor=Y.+Zhaoauthor=L.+Liuauthor=L.+Baiauthor=C.+Y.+Yangauthor=B.+Zhouauthor=J.+L.+Meagherauthor=K.+Chinnaswamyauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Structure-based+design+of+gamma-carboline+analogues+as+potent+and+specific+BET+bromodomain+inhibitors&doi=10.1021%2Facs.jmedchem.5b00613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors</span></div><div class="casAuthors">Ran, Xu; Zhao, Yujun; Liu, Liu; Bai, Longchuan; Yang, Chao-Yie; Zhou, Bing; Meagher, Jennifer L.; Chinnaswamy, Krishnapriya; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4927-4939</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of bromodomain and extra terminal proteins (BET), including BRD2, BRD3, and BRD4 proteins have therapeutic potential for the treatment of human cancers and other diseases and conditions.  In this paper, the authors report the design, synthesis, and evaluation of γ-carboline-contg. compds. as a new class of small-mol. BET inhibitors.  The most potent inhibitor I (RX-37) obtained from this study binds to BET bromodomain proteins (BRD2, BRD3, and BRD4) with Ki values of 3.2-24.7 nM and demonstrates high selectivity over other non-BET bromodomain-contg. proteins.  Compd. I potently and selectively inhibits cell growth in human acute leukemia cell lines harboring the rearranged mixed lineage leukemia 1 gene.  The authors have detd. a cocrystal structure of I in complex with BRD4 BD2 at 1.4 Å resoln., which provides a solid structural basis for the compd.'s high binding affinity and for its further structure-based optimization.  Compd. I represents a promising lead compd. for the development of a new class of therapeutics for the treatment of human cancer and other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-VCfWLBWYLVg90H21EOLACvtfcHk0ljvIHSQuDgVXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM&md5=e6e150169812e439c1d7d91416eb3ee9</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00613%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520gamma-carboline%2520analogues%2520as%2520potent%2520and%2520specific%2520BET%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4927%26epage%3D4939%26doi%3D10.1021%2Facs.jmedchem.5b00613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Slassi, A.; Dove, P.</span><span> </span><span class="NLM_article-title">Fluorinated imidazo[4,5-<i>c</i>]quinoline derivatives as inhibitors of bromodomain containing proteins</span>. WO2016123709,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Slassi&author=P.+Dove&title=Fluorinated+imidazo%5B4%2C5-c%5Dquinoline+derivatives+as+inhibitors+of+bromodomain+containing+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSlassi%26aufirst%3DA.%26atitle%3DFluorinated%2520imidazo%255B4%252C5-c%255Dquinoline%2520derivatives%2520as%2520inhibitors%2520of%2520bromodomain%2520containing%2520proteins%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Norris, D. J.; Dellucca, G. V.; Gavai, A. V.; Quesnelle, C. A.; Gill, P.; O’malley, D.; Vaccaro, W.; lEE, F. Y.; Debenedetto, M. V.; Degnan, A. P.; Fang, H.; Hill, M. D.; Huang, H.; Schmitz, W. D.; Starrett, J. E.; Han, W.; Tokarski, J. S.; Mandal, S. K.</span><span> </span><span class="NLM_article-title">Tricyclic compounds as anticancer agents</span>. WO2015100282,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+J.+Norris&author=G.+V.+Dellucca&author=A.+V.+Gavai&author=C.+A.+Quesnelle&author=P.+Gill&author=D.+O%E2%80%99malley&author=W.+Vaccaro&author=F.+Y.+lEE&author=M.+V.+Debenedetto&author=A.+P.+Degnan&author=H.+Fang&author=M.+D.+Hill&author=H.+Huang&author=W.+D.+Schmitz&author=J.+E.+Starrett&author=W.+Han&author=J.+S.+Tokarski&author=S.+K.+Mandal&title=Tricyclic+compounds+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNorris%26aufirst%3DD.%2BJ.%26atitle%3DTricyclic%2520compounds%2520as%2520anticancer%2520agents%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Foster, A. B.</span><span> </span><span class="NLM_article-title">Deuterium isotope effects in studies of drug metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1016/0165-6147(84)90534-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2F0165-6147%2884%2990534-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADyaL2MXovFCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1984&pages=524-527&author=A.+B.+Foster&title=Deuterium+isotope+effects+in+studies+of+drug+metabolism&doi=10.1016%2F0165-6147%2884%2990534-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects in studies of drug metabolism</span></div><div class="casAuthors">Foster, Allan B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">524-7</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 16 refs.  Substitution of one or more C-bonded H atoms in a drug mol. with deuterium imposes negligible steric effects and influences phys.-chem. properties minimally.  Yet the resultant increased bond stability may cause dramatic changes in biol. properties, particularly by retarding certain pathways of its metab.  The potential of deuteration in modifying drug action is described.  A specific biol. action of a drug may be enhanced, reduced or prolonged; its metab. may be diverted along a pathway which promotes formation of highly active metabolites, or avoids the formation of toxic metabolites.  Cost of toxicol. testing and clin. trials may underline the pharmaceutical industry's reluctance to synthesize deuterated analogs.  Nonetheless, deuteration remains a promising possibility for future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAE7REz_uf8LVg90H21EOLACvtfcHk0ljvIHSQuDgVXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXovFCktQ%253D%253D&md5=0084c0f831cd80b8ae6b51f557c9bd78</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2884%2990534-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252884%252990534-0%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BB.%26atitle%3DDeuterium%2520isotope%2520effects%2520in%2520studies%2520of%2520drug%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1984%26volume%3D5%26spage%3D524%26epage%3D527%26doi%3D10.1016%2F0165-6147%2884%2990534-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Timmins, G. S.</span><span> </span><span class="NLM_article-title">Deuterated drugs: where are we now?</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1075</span><span class="refDoi"> DOI: 10.1517/13543776.2014.943184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1517%2F13543776.2014.943184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25069517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1067-1075&author=G.+S.+Timmins&title=Deuterated+drugs%3A+where+are+we+now%3F&doi=10.1517%2F13543776.2014.943184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs: where are we now?</span></div><div class="casAuthors">Timmins, Graham S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1067-1075</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Deuterated versions of existing drugs can exhibit improved pharmacokinetic or toxicol. properties due the stronger deuterium- carbon bond modifying their metab.  There is great interest in the current state of development of this approach.  Areas covered: This review covers recent US patent applications and prosecutions in this area that are based on beneficial modifications in metab. of deuterated versions of existing drugs.  The current state of 35 U.S.C. 103 'obviousness' rejections are emphasized, as is the development of strategies to overcome such rejections.  Current trials and market considerations are also discussed.  Expert opinion: Deuterated drugs collectively are worth at least US$1 billion.  It would seem that the likelihood of obviousness rejections is increasing in this area.  However, careful elucidation of metabolic outcomes from deuteration that would not be anticipated from the prior art, and are instead unexpected and unobvious, has enabled allowance.  Showing that drug deuteration alters pharmacokinetics by mechanisms not currently part of the prior art surrounding deuterated drugs has also been successful.  Development of these and other strategies, combined with developing the extensive base of issued patents will enable the field to remain com. attractive for some time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0xlLKQqhufrVg90H21EOLACvtfcHk0ljvIHSQuDgVXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE&md5=c697e60a642f7ea3d8ad9f4588bc3ade</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.943184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.943184%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26atitle%3DDeuterated%2520drugs%253A%2520where%2520are%2520we%2520now%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1067%26epage%3D1075%26doi%3D10.1517%2F13543776.2014.943184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Hay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1039/C2MD20189E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1039%2FC2MD20189E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=140-144&author=D.+Hayauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=M.+Philpottauthor=S.+Picaudauthor=D.+S.+Hewingsauthor=S.+Uttakarauthor=T.+D.+Heightmanauthor=S.+J.+Conwayauthor=S.+Knappauthor=P.+E.+Brennan&title=The+design+and+synthesis+of+5-+and+6-isoxazolylbenzimidazoles+as+selective+inhibitors+of+the+BET+bromodomains&doi=10.1039%2FC2MD20189E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1039%2FC2MD20189E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20189E%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DUttakar%26aufirst%3DS.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%25205-%2520and%25206-isoxazolylbenzimidazoles%2520as%2520selective%2520inhibitors%2520of%2520the%2520BET%2520bromodomains%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D140%26epage%3D144%26doi%3D10.1039%2FC2MD20189E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Ren, B.; Zhou, C.; Wang, H.</span><span> </span><span class="NLM_article-title">Substituted 5-(3,5-dimethylisoxazole-4-yl)indoline-2-ones</span>. WO2014173241,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Ren&author=C.+Zhou&author=H.+Wang&title=Substituted+5-%283%2C5-dimethylisoxazole-4-yl%29indoline-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DB.%26atitle%3DSubstituted%25205-%25283%252C5-dimethylisoxazole-4-yl%2529indoline-2-ones%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Aktoudianakis, E.; Chin, G.; Corkey, B. K.; Elbel, J. D.; Jiang, K.; Kobayashi, R.; Martinez, T.; Metobo, T. R.; Mish, S. E.; Shevick, M.; Sperandio, S.; Yang, D.; Zablocki, H.</span><span> </span><span class="NLM_article-title">J. Benzimidazolone derivatives as bromodomain inhibitors</span>. WO2014160873,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=E.+Aktoudianakis&author=G.+Chin&author=B.+K.+Corkey&author=J.+D.+Elbel&author=K.+Jiang&author=R.+Kobayashi&author=T.+Martinez&author=T.+R.+Metobo&author=S.+E.+Mish&author=M.+Shevick&author=S.+Sperandio&author=D.+Yang&author=H.+Zablocki&title=J.+Benzimidazolone+derivatives+as+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAktoudianakis%26aufirst%3DE.%26atitle%3DJ.%2520Benzimidazolone%2520derivatives%2520as%2520bromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Mantoulidis, A.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Indolinone analogues as BRD4 inhibitors</span>. WO2014154760,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+Engelhardt&author=D.+Gianni&author=A.+Mantoulidis&author=C.+Smethurst&title=Indolinone+analogues+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DIndolinone%2520analogues%2520as%2520BRD4%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Smethurst, C.; Engelhardt, H.; Gianni, D.; Reiser, U.</span><span> </span><span class="NLM_article-title">Dihydroquinazolinone analogues as BRD4 inhibitors</span>. WO2014154762,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Smethurst&author=H.+Engelhardt&author=D.+Gianni&author=U.+Reiser&title=Dihydroquinazolinone+analogues+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmethurst%26aufirst%3DC.%26atitle%3DDihydroquinazolinone%2520analogues%2520as%2520BRD4%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Bogdan, A.; Kati, W. M.; Mcdaniel, K. F.; Park, C. H.; Sheppard, G. S.; Wang, L.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. US20150158873,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Bogdan&author=W.+M.+Kati&author=K.+F.+Mcdaniel&author=C.+H.+Park&author=G.+S.+Sheppard&author=L.+Wang&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBogdan%26aufirst%3DA.%26atitle%3DBromodomain%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Wang, L.; Frey, R. R.; Hansen, T. M.; Liu, D.; Mcclellan, W. J.; Mcdaniel, K. F.; Pratt, J. K.; Wada, C. K.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. WO2015085925,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Wang&author=R.+R.+Frey&author=T.+M.+Hansen&author=D.+Liu&author=W.+J.+Mcclellan&author=K.+F.+Mcdaniel&author=J.+K.+Pratt&author=C.+K.+Wada&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Engelhardt, H.</span><span> </span><span class="NLM_article-title">Benzimidazole derivatives</span>. WO2015169962,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&title=Benzimidazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DBenzimidazole%2520derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Engelhardt, H.; Martin, L.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Pyridinones</span>. WO2015022332,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&author=L.+Martin&author=C.+Smethurst&title=Pyridinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DPyridinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Wang, L.; Dai, Y.; Holms, J.; Liu, D.; Mcclellan, W.; Mcdaniel, K.; Hasvold, L.; Fidanze, S. D.; Sheppard, G.; Marjanovic, J.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. WO2014206150,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Wang&author=Y.+Dai&author=J.+Holms&author=D.+Liu&author=W.+Mcclellan&author=K.+Mcdaniel&author=L.+Hasvold&author=S.+D.+Fidanze&author=G.+Sheppard&author=J.+Marjanovic&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span> </span><span class="NLM_article-title">Inhibitors of BRD4 as potential cancer therapy</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00259</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00259" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=728-729&author=A.+F.+Abdel-Magid&title=Inhibitors+of+BRD4+as+potential+cancer+therapy&doi=10.1021%2Facsmedchemlett.6b00259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00259%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26atitle%3DInhibitors%2520of%2520BRD4%2520as%2520potential%2520cancer%2520therapy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D728%26epage%3D729%26doi%3D10.1021%2Facsmedchemlett.6b00259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Substituted [1,2,4]triazolo[4,3-<i>a</i>]pyrazines as BRD4 inhibitors</span>. US20160129001,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Engelhardt&author=D.+Gianni&author=C.+Smethurst&title=Substituted+%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazines+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DSubstituted%2520%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazines%2520as%2520BRD4%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Engelhardt, H.</span><span> </span><span class="NLM_article-title">Triazolopyrazine derivatives as BRD4 inhibitors</span>. WO2015067770,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&title=Triazolopyrazine+derivatives+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DTriazolopyrazine%2520derivatives%2520as%2520BRD4%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Bordas, V.; Cotesta, S.; Guagnano, V.; Rueeger, H.; Vaupel, A.</span><span> </span><span class="NLM_article-title">Pyrazolopyrrolidine derivatives and their use in the treatment of disease</span>. US20140349990,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=V.+Bordas&author=S.+Cotesta&author=V.+Guagnano&author=H.+Rueeger&author=A.+Vaupel&title=Pyrazolopyrrolidine+derivatives+and+their+use+in+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBordas%26aufirst%3DV.%26atitle%3DPyrazolopyrrolidine%2520derivatives%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520disease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Blank, J.; Bold, G.; Bordas, V.; Cotesta, S.; Guagnano, V.; Rueger, H.; Vaupel, A.</span><span> </span><span class="NLM_article-title">Pyrrolopyrrolone derivatives and their use as BET inhibitors</span>. WO2015075665,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Blank&author=G.+Bold&author=V.+Bordas&author=S.+Cotesta&author=V.+Guagnano&author=H.+Rueger&author=A.+Vaupel&title=Pyrrolopyrrolone+derivatives+and+their+use+as+BET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlank%26aufirst%3DJ.%26atitle%3DPyrrolopyrrolone%2520derivatives%2520and%2520their%2520use%2520as%2520BET%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou-Eymard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8111</span><span class="NLM_x">–</span> <span class="NLM_lpage">8131</span><span class="refDoi"> DOI: 10.1021/jm5010539</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010539" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8111-8131&author=R.+Gosminiauthor=V.+L.+Nguyenauthor=J.+Toumauthor=C.+Simonauthor=J.+M.+Brusqauthor=G.+Krysaauthor=O.+Mirguetauthor=A.+M.+Riou-Eymardauthor=E.+V.+Boursierauthor=L.+Trottetauthor=P.+Bamboroughauthor=H.+Clarkauthor=C.+W.+Chungauthor=L.+Cutlerauthor=E.+H.+Demontauthor=R.+Kaurauthor=A.+J.+Lewisauthor=M.+B.+Schillingauthor=P.+E.+Sodenauthor=S.+Taylorauthor=A.+L.+Walkerauthor=M.+D.+Walkerauthor=R.+K.+Prinjhaauthor=E.+Nicodeme&title=The+discovery+of+I-BET726+%28GSK1324726A%29%2C+a+potent+tetrahydroquinoline+ApoA1+up-regulator+and+selective+BET+bromodomain+inhibitor&doi=10.1021%2Fjm5010539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor</span></div><div class="casAuthors">Gosmini, Romain; Nguyen, Van Loc; Toum, Jerome; Simon, Christophe; Brusq, Jean-Marie G.; Krysa, Gael; Mirguet, Olivier; Riou-Eymard, Alizon M.; Boursier, Eric V.; Trottet, Lionel; Bamborough, Paul; Clark, Hugh; Chung, Chun-wa; Cutler, Leanne; Demont, Emmanuel H.; Kaur, Rejbinder; Lewis, Antonia J.; Schilling, Mark B.; Soden, Peter E.; Taylor, Simon; Walker, Ann L.; Walker, Matthew D.; Prinjha, Rab K.; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8111-8131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through their function as epigenetic readers of the histone code, the BET family of bromodomain-contg. proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation.  BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncol. and inflammation models, and the first compds. have now progressed into clin. trials.  The exciting biol. of the BETs has led to great interest in the discovery of novel inhibitor classes.  Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compds. active in murine models of septic shock and neuroblastoma.  At the mol. level, these effects are produced by inhibition of BET bromodomains.  X-ray crystallog. reveals the interactions explaining the structure-activity relationships of binding.  The resulting lead mol., I-BET726, represents a new, potent, and selective class of tetrahydroquinoline-based BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5OdMn_TjoFLVg90H21EOLACvtfcHk0lg7MaJxIoLhZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J&md5=b1c9c9cae73c41252cf73908d561bd9b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm5010539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010539%26sid%3Dliteratum%253Aachs%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DC.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DRiou-Eymard%26aufirst%3DA.%2BM.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DClark%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DA.%2BJ.%26aulast%3DSchilling%26aufirst%3DM.%2BB.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DThe%2520discovery%2520of%2520I-BET726%2520%2528GSK1324726A%2529%252C%2520a%2520potent%2520tetrahydroquinoline%2520ApoA1%2520up-regulator%2520and%2520selective%2520BET%2520bromodomain%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8111%26epage%3D8131%26doi%3D10.1021%2Fjm5010539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolven, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span><span class="refDoi"> DOI: 10.1021/jm201320w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201320w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=576-586&author=C.+W.+Chungauthor=A.+W.+Deanauthor=J.+M.+Woolvenauthor=P.+Bamborough&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+1%3A+inhibitor+binding+modes+and+implications+for+lead+discovery&doi=10.1021%2Fjm201320w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery</span></div><div class="casAuthors">Chung, Chun-wa; Dean, Anthony W.; Woolven, James M.; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">576-586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. proteins are key epigenetic regulators of gene transcription and readers of the histone code.  However, the therapeutic benefits of modulating this target class are largely unexplored due to the lack of suitable chem. probes.  This article describes the generation of lead mols. for the BET bromodomains through screening a fragment set chosen using structural insights and computational approaches.  Anal. of 40 BRD2/fragment x-ray complexes highlights both shared and disparate interaction features that may be exploited for affinity and selectivity.  Six representative crystal structures are then exemplified in detail.  Two of the fragments are completely new bromodomain chemotypes, and three have never before been crystd. in a bromodomain, so our results significantly extend the limited public knowledge-base of crystallog. small mol./bromodomain interactions.  Certain fragments (including paracetamol) bind in a consistent mode to different bromodomains such as CREBBP, suggesting their potential to act as generic bromodomain templates.  An important implication is that the bromodomains are not only a phylogenetic family but also a system in which chem. and structural knowledge of one bromodomain gives insights transferable to others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonNb7GnZnS_rVg90H21EOLACvtfcHk0lg7MaJxIoLhZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN&md5=5b7d7239d0de57266d94beef1ea080ae</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm201320w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201320w%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDean%26aufirst%3DA.%2BW.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25201%253A%2520inhibitor%2520binding%2520modes%2520and%2520implications%2520for%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D576%26epage%3D586%26doi%3D10.1021%2Fjm201320w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Wyce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbash, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy-Wilson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span> </span><span class="NLM_article-title">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e72967</span><span class="refDoi"> DOI: 10.1371/journal.pone.0072967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1371%2Fjournal.pone.0072967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24009722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72967&author=A.+Wyceauthor=G.+Ganjiauthor=K.+N.+Smithemanauthor=C.+W.+Chungauthor=S.+Korenchukauthor=Y.+Baiauthor=O.+Barbashauthor=B.+Leauthor=P.+D.+Craggsauthor=M.+T.+McCabeauthor=K.+M.+Kennedy-Wilsonauthor=L.+V.+Sanchezauthor=R.+L.+Gosminiauthor=N.+Parrauthor=C.+F.+McHughauthor=D.+Dhanakauthor=R.+K.+Prinjhaauthor=K.+R.+Augerauthor=P.+J.+Tummino&title=BET+inhibition+silences+expression+of+MYCN+and+BCL2+and+induces+cytotoxicity+in+neuroblastoma+tumor+models&doi=10.1371%2Fjournal.pone.0072967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span></div><div class="casAuthors">Wyce, Anastasia; Ganji, Gopinath; Smitheman, Kimberly N.; Chung, Chun-Wa; Korenchuk, Susan; Bai, Yuchen; Barbash, Olena; Le, Bao Chau; Craggs, Peter D.; McCabe, Michael T.; Kennedy-Wilson, Karen M.; Sanchez, Lydia V.; Gosmini, Romain L.; Parr, Nigel; McHugh, Charles F.; Dhanak, Dashyant; Prinjha, Rab K.; Auger, Kurt R.; Tummino, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e72967</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">BET family proteins are epigenetic regulators known to control expression of genes involved in cell growth and oncogenesis.  Selective inhibitors of BET proteins exhibit potent anti-proliferative activity in a no. of hematol. cancer models, in part through suppression of the MYC oncogene and downstream Myc-driven pathways.  However, little is currently known about the activity of BET inhibitors in solid tumor models, and whether down-regulation of MYC family genes contributes to sensitivity.  Here we provide evidence for potent BET inhibitor activity in neuroblastoma, a pediatric solid tumor assocd. with a high frequency of MYCN amplifications.  We treated a panel of neuroblastoma cell lines with a novel small mol. inhibitor of BET proteins, GSK1324726A (I-BET726), and obsd. potent growth inhibition and cytotoxicity in most cell lines irresp. of MYCN copy no. or expression level.  Gene expression analyses in neuroblastoma cell lines suggest a role of BET inhibition in apoptosis, signaling, and N-Myc-driven pathways, including the direct suppression of BCL2 and MYCN.  Reversal of MYCN or BCL2 suppression reduces the potency of I-BET726-induced cytotoxicity in a cell line-specific manner; however, neither factor fully accounts for I-BET726 sensitivity.  Oral administration of I-BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down-regulation MYCN and BCL2 expression, suggesting a potential role for these genes in tumor growth.  Taken together, our data highlight the potential of BET inhibitors as novel therapeutics for neuroblastoma, and suggest that sensitivity is driven by pleiotropic effects on cell growth and apoptotic pathways in a context-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecB0_0elFVbVg90H21EOLACvtfcHk0lhSFbI5Gp7yEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI&md5=d39ce25a50de58f18a278a9f67935bbc</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072967%26sid%3Dliteratum%253Aachs%26aulast%3DWyce%26aufirst%3DA.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DBarbash%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DB.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DKennedy-Wilson%26aufirst%3DK.%2BM.%26aulast%3DSanchez%26aufirst%3DL.%2BV.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26atitle%3DBET%2520inhibition%2520silences%2520expression%2520of%2520MYCN%2520and%2520BCL2%2520and%2520induces%2520cytotoxicity%2520in%2520neuroblastoma%2520tumor%2520models%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De72967%26doi%3D10.1371%2Fjournal.pone.0072967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Amans, D.; Atkinson, S. J.; Harrison, D. J.; Hirst, D. J.; Law, R. P.; Lindon, M.; Preston, A.; Seal, J. T.; Wellaway, C. R.</span><span> </span><span class="NLM_article-title">2,3-Disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors</span>. WO2014140076,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Amans&author=S.+J.+Atkinson&author=D.+J.+Harrison&author=D.+J.+Hirst&author=R.+P.+Law&author=M.+Lindon&author=A.+Preston&author=J.+T.+Seal&author=C.+R.+Wellaway&title=2%2C3-Disubstituted+1-acyl-4-amino-1%2C2%2C3%2C4-tetrahydroquinoline+derivatives+and+their+use+as+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmans%26aufirst%3DD.%26atitle%3D2%252C3-Disubstituted%25201-acyl-4-amino-1%252C2%252C3%252C4-tetrahydroquinoline%2520derivatives%2520and%2520their%2520use%2520as%2520bromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Bair, K. W.; Herbertz, T.; Kauffman, G. S.; Kayser-Bricker, K. J.; Luke, G. P.; Martin, M. W.; Millan, D. S.; Schiller, S. R.; Talbot, A. C.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline composition as BET bromodomain inhibitors</span>. WO2015074064,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+W.+Bair&author=T.+Herbertz&author=G.+S.+Kauffman&author=K.+J.+Kayser-Bricker&author=G.+P.+Luke&author=M.+W.+Martin&author=D.+S.+Millan&author=S.+R.+Schiller&author=A.+C.+Talbot&title=Tetrahydroquinoline+composition+as+BET+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DTetrahydroquinoline%2520composition%2520as%2520BET%2520bromodomain%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Schmees, N.; Haendler, B.; Stockigt, D.; Gallenkamp, D.; Bissell, R. A.; Bouglas, R. A.</span><span> </span><span class="NLM_article-title">Modified BET-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones</span>. WO2015004075,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Schmees&author=B.+Haendler&author=D.+Stockigt&author=D.+Gallenkamp&author=R.+A.+Bissell&author=R.+A.+Bouglas&title=Modified+BET-protein-inhibiting+dihydroquinoxalinones+and+dihydropyridopyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DModified%2520BET-protein-inhibiting%2520dihydroquinoxalinones%2520and%2520dihydropyridopyrazinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primiano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciammetta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span> </span><span class="NLM_article-title">Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9831</span><span class="NLM_x">–</span> <span class="NLM_lpage">9837</span><span class="refDoi"> DOI: 10.1021/jm3010515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9831-9837&author=P.+V.+Fishauthor=P.+Filippakopoulosauthor=G.+Bishauthor=P.+E.+Brennanauthor=M.+E.+Bunnageauthor=A.+S.+Cookauthor=O.+Federovauthor=B.+S.+Gerstenbergerauthor=H.+Jonesauthor=S.+Knappauthor=B.+Marsdenauthor=K.+Nockaauthor=D.+R.+Owenauthor=M.+Philpottauthor=S.+Picaudauthor=M.+J.+Primianoauthor=M.+J.+Ralphauthor=N.+Sciammettaauthor=J.+D.+Trzupek&title=Identification+of+a+chemical+probe+for+bromo+and+extra+C-terminal+bromodomain+inhibition+through+optimization+of+a+fragment-derived+hit&doi=10.1021%2Fjm3010515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit</span></div><div class="casAuthors">Fish, Paul V.; Filippakopoulos, Panagis; Bish, Gerwyn; Brennan, Paul E.; Bunnage, Mark E.; Cook, Andrew S.; Federov, Oleg; Gerstenberger, Brian S.; Jones, Hannah; Knapp, Stefan; Marsden, Brian; Nocka, Karl; Owen, Dafydd R.; Philpott, Martin; Picaud, Sarah; Primiano, Michael J.; Ralph, Michael J.; Sciammetta, Nunzio; Trzupek, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9831-9837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The posttranslational modification of chromatin through acetylation at selected histone lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (HDACs).  The significance of this subset of the epigenetic code is interrogated and interpreted by an acetyllysine-specific protein-protein interaction with bromodomain reader modules.  Selective inhibition of the bromo and extra C-terminal domain (BET) family of bromodomains with a small mol. is feasible, and this may represent an opportunity for disease intervention through the recently disclosed antiproliferative and anti-inflammatory properties of such inhibitors.  Herein, we describe the discovery and structure-activity relationship (SAR) of a novel, small-mol. chem. probe for BET family inhibition that was identified through the application of structure-based fragment assessment and optimization techniques.  This has yielded a potent, selective compd. with cell-based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzpWnuXoLdrVg90H21EOLACvtfcHk0lhSFbI5Gp7yEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE&md5=ba864f3916bea5f793dd0b26732784f0</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm3010515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010515%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DFederov%26aufirst%3DO.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPrimiano%26aufirst%3DM.%2BJ.%26aulast%3DRalph%26aufirst%3DM.%2BJ.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520chemical%2520probe%2520for%2520bromo%2520and%2520extra%2520C-terminal%2520bromodomain%2520inhibition%2520through%2520optimization%2520of%2520a%2520fragment-derived%2520hit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9831%26epage%3D9837%26doi%3D10.1021%2Fjm3010515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Xue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Discovery of benzo[cd]indol-2(1H)-ones as potent and specific BET bromodomain inhibitors: Structure-based virtual screening, optimization, and biological evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1579</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01511</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01511" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1565-1579&author=X.+Xueauthor=Y.+Zhangauthor=Z.+Liuauthor=M.+Songauthor=Y.+Xingauthor=Q.+Xiangauthor=Z.+Wangauthor=Z.+Tuauthor=Y.+Zhouauthor=K.+Dingauthor=Y.+Xu&title=Discovery+of+benzo%5Bcd%5Dindol-2%281H%29-ones+as+potent+and+specific+BET+bromodomain+inhibitors%3A+Structure-based+virtual+screening%2C+optimization%2C+and+biological+evaluation&doi=10.1021%2Facs.jmedchem.5b01511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation</span></div><div class="casAuthors">Xue, Xiaoqian; Zhang, Yan; Liu, Zhaoxuan; Song, Ming; Xing, Yanli; Xiang, Qiuping; Wang, Zhen; Tu, Zhengchao; Zhou, Yulai; Ding, Ke; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1565-1579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of inhibitors of bromodomain and extra terminal domain (BET) has achieved great progress, and at least seven inhibitors have progressed into clin. trials for the treatment of cancer or inflammatory diseases.  Here, the authors describe the identification, optimization, and evaluation of benzo[cd]indol-2(1H)-one contg. compds. as a new class of BET bromodomain inhibitors, starting from structure-based virtual screening (SBVS).  Through structure-based optimization, potent compds. were obtained with significantly improved activity.  The two most potent compds. bind to the BRD4 bromodomain, with Kd values of 124 and 137 nM.  Selected compds. exhibited high selectivity over other non-BET subfamily members.  Notably, compd. I demonstrated a reasonable antiproliferation effect on MV4;11 leukemia cells and exhibited a good pharmacokinetic profile with high oral bioavailability (75.8%) and moderate half-life (T1/2 = 3.95 h).  The resulting lead mol. I represents a new, potent, and selective class of BET bromodomain inhibitors for the development of therapeutics to treat cancer and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl7CO2ESpHObVg90H21EOLACvtfcHk0lj8nrTgHtnsYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqsA%253D%253D&md5=d1cd7b961fd4c417c886a1c2274cdacb</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01511%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520benzo%255Bcd%255Dindol-2%25281H%2529-ones%2520as%2520potent%2520and%2520specific%2520BET%2520bromodomain%2520inhibitors%253A%2520Structure-based%2520virtual%2520screening%252C%2520optimization%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1565%26epage%3D1579%26doi%3D10.1021%2Facs.jmedchem.5b01511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Hasvold, L. A.; Pratt, J. K.; Mcdaniel, K. F.; Sheppard, G. S.; Liu, D.; Elmore, S. W.; Hubbard, R. D.</span><span> </span><span class="NLM_article-title">Pyrrole-3-carboxamide bromodomain inhibitors</span>. US20140275079,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+A.+Hasvold&author=J.+K.+Pratt&author=K.+F.+Mcdaniel&author=G.+S.+Sheppard&author=D.+Liu&author=S.+W.+Elmore&author=R.+D.+Hubbard&title=Pyrrole-3-carboxamide+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DPyrrole-3-carboxamide%2520bromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Hasvold, L. A.; Liu, D.; Park, C. H.; Pratt, J. K.; Sheppard, G. S.; Wang, L.</span><span> </span><span class="NLM_article-title">Isoindolone derivatives</span>. WO2013158952,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+A.+Hasvold&author=D.+Liu&author=C.+H.+Park&author=J.+K.+Pratt&author=G.+S.+Sheppard&author=L.+Wang&title=Isoindolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DIsoindolone%2520derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Lucas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlwend, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schule, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, S.</span><span> </span><span class="NLM_article-title">4-Acyl pyrroles: mimicking acetylated lysines in histone code reading</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">14055</span><span class="NLM_x">–</span> <span class="NLM_lpage">14059</span><span class="refDoi"> DOI: 10.1002/anie.201307652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1002%2Fanie.201307652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVaksrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=14055-14059&author=X.+Lucasauthor=D.+Wohlwendauthor=M.+Hugleauthor=K.+Schmidtkunzauthor=S.+Gerhardtauthor=R.+Schuleauthor=M.+Jungauthor=O.+Einsleauthor=S.+Gunther&title=4-Acyl+pyrroles%3A+mimicking+acetylated+lysines+in+histone+code+reading&doi=10.1002%2Fanie.201307652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">4-Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading</span></div><div class="casAuthors">Lucas, Xavier; Wohlwend, Daniel; Huegle, Martin; Schmidtkunz, Karin; Gerhardt, Stefan; Schuele, Roland; Jung, Manfred; Einsle, Oliver; Guenther, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">14055-14059</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors performed a high throughput virtual screening expt. using a library contg. more than 7 million small mol. compds., aiming at the identification of novel inhibitors of the first bromodomain of BRD4.  The authors selected 22 candidate compds. for further exptl. validation by ITC measurements, eventually leading to the discovery of 7 compds. (XD1, XD14, XD15, XD16, XD19, XD22 and XD24) with significant binding affinity towards BRD4.  The validated hits comprise 6 different previously unknown scaffolds that are potent binders of BRD4.  Notably, the 4-acyl pyrrole XD14 showed a 700-fold increase in binding affinity as compared to the structurally closely related 5-isoxazole XD15 (KD = 0.2 μM and 168 μM, resp.), rendering XD14 the most potent binder of the entire screening.  Furthermore, the authors also found that poisonous alkaloid colchiceine (XD1) and its methoxylated analog colchicine (XD25) have affinity for the protein (KD-46 μM and 20 μM, resp.).  For co-crystn. and X-ray structure anal. we chose the most promising candidates XD14, XD1 and XD25.  The authors further assessed the antiproliferative potential of XD14 by the NCI60 human tumor cell line anticancer drug screen.  The results reported herein stress the validity of high-throughput virtual screening in the identification of novel active mols. in the epigenetics field, and indicate that the newly discovered XD14 is a representative of a new class of BET bromodomain inhibitors featuring a 4-acyl pyrrole moiety.  Future studies will be directed at assessing the therapeutic potential of XD14, and performing a knowledge-driven lead optimization of the identified hits.  The core compd. XD46 will be subjected to fragment-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl3sU9EWWqorVg90H21EOLACvtfcHk0lj8nrTgHtnsYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVaksrzP&md5=cd905bc3c772a8b2e74779b65182dbbb</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307652%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DWohlwend%26aufirst%3DD.%26aulast%3DHugle%26aufirst%3DM.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DGunther%26aufirst%3DS.%26atitle%3D4-Acyl%2520pyrroles%253A%2520mimicking%2520acetylated%2520lysines%2520in%2520histone%2520code%2520reading%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D14055%26epage%3D14059%26doi%3D10.1002%2Fanie.201307652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Hugle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovskyi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlwend, D.</span><span> </span><span class="NLM_article-title">4-Acyl pyrrole derivatives yield novel vectors for designing inhibitors of the acetyl-lysine recognition site of BRD4(1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">–</span> <span class="NLM_lpage">1530</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1518-1530&author=M.+Hugleauthor=X.+Lucasauthor=G.+Weitzelauthor=D.+Ostrovskyiauthor=B.+Breitauthor=S.+Gerhardtauthor=O.+Einsleauthor=S.+Guntherauthor=D.+Wohlwend&title=4-Acyl+pyrrole+derivatives+yield+novel+vectors+for+designing+inhibitors+of+the+acetyl-lysine+recognition+site+of+BRD4%281%29&doi=10.1021%2Facs.jmedchem.5b01267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01267%26sid%3Dliteratum%253Aachs%26aulast%3DHugle%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DWeitzel%26aufirst%3DG.%26aulast%3DOstrovskyi%26aufirst%3DD.%26aulast%3DBreit%26aufirst%3DB.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DWohlwend%26aufirst%3DD.%26atitle%3D4-Acyl%2520pyrrole%2520derivatives%2520yield%2520novel%2520vectors%2520for%2520designing%2520inhibitors%2520of%2520the%2520acetyl-lysine%2520recognition%2520site%2520of%2520BRD4%25281%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1518%26epage%3D1530%26doi%3D10.1021%2Facs.jmedchem.5b01267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3833</span><span class="NLM_x">–</span> <span class="NLM_lpage">3851</span><span class="refDoi"> DOI: 10.1021/jm301793a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301793a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3833-3851&author=L.+Zhaoauthor=D.+Caoauthor=T.+Chenauthor=Y.+Wangauthor=Z.+Miaoauthor=Y.+Xuauthor=W.+Chenauthor=X.+Wangauthor=Y.+Liauthor=Z.+Duauthor=B.+Xiongauthor=J.+Liauthor=C.+Xuauthor=N.+Zhangauthor=J.+Heauthor=J.+Shen&title=Fragment-based+drug+discovery+of+2-thiazolidinones+as+inhibitors+of+the+histone+reader+BRD4+bromodomain&doi=10.1021%2Fjm301793a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain</span></div><div class="casAuthors">Zhao, Lele; Cao, Danyan; Chen, Tiantian; Wang, Yingqing; Miao, Zehong; Xu, Yechun; Chen, Wuyan; Wang, Xin; Li, Yanlian; Du, Zhiyan; Xiong, Bing; Li, Jian; Xu, Chunyan; Zhang, Naixia; He, Jianhua; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3833-3851</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recognizing acetyllysine of histone is a vital process of epigenetic regulation that is mediated by a protein module called bromodomain.  To contribute novel scaffolds for developing into bromodomain inhibitors, the authors utilize a fragment-based drug discovery approach.  By successively applying docking and x-ray crystallog., they were able to identify 9 fragment hits from diffracting more than 60 crystals.  In the present work, they described four of them and carried out the integrated lead optimization for fragment I, which bears a 2-thiazolidinone core.  After several rounds of structure guided modifications, they assessed the druggability of 2-thiazolidinone by modulating in vitro pharmacokinetic studies and cellular activity assay.  The results showed that two potent of 2-thiazolidinone compds. II and III have good metabolic stability.  Also, the cellular assay confirmed the activities of 2-thiazolidinones.  Together, they hope the identified 2-thiazolidinone chemotype and other fragment hits described herein can stimulate researchers to develop more diversified bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfi2pyYq6c4LVg90H21EOLACvtfcHk0lgucwopQTEj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D&md5=8308db5d83cb72b29f261cc134514ece</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fjm301793a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301793a%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520of%25202-thiazolidinones%2520as%2520inhibitors%2520of%2520the%2520histone%2520reader%2520BRD4%2520bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3833%26epage%3D3851%26doi%3D10.1021%2Fjm301793a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1021/jm501504k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501504k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1281-1297&author=L.+Zhaoauthor=Y.+Wangauthor=D.+Caoauthor=T.+Chenauthor=Q.+Wangauthor=Y.+Liauthor=Y.+Xuauthor=N.+Zhangauthor=X.+Wangauthor=D.+Chenauthor=L.+Chenauthor=Y.+L.+Chenauthor=G.+Xiaauthor=Z.+Shiauthor=Y.+C.+Liuauthor=Y.+Linauthor=Z.+Miaoauthor=J.+Shenauthor=B.+Xiong&title=Fragment-based+drug+discovery+of+2-thiazolidinones+as+BRD4+inhibitors%3A+2.+Structure-based+optimization&doi=10.1021%2Fjm501504k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: Structure-Based Optimization</span></div><div class="casAuthors">Zhao, Lele; Wang, Yingqing; Cao, Danyan; Chen, Tiantian; Wang, Qi; Li, Yanlian; Xu, Yechun; Zhang, Naixia; Wang, Xin; Chen, Danqi; Chen, Lin; Chen, Yue-Lei; Xia, Guangxin; Shi, Zhe; Liu, Yu-Chih; Lin, Yijyun; Miao, Zehong; Shen, Jingkang; Xiong, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1281-1297</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The signal transduction of acetylated histone can be processed through a recognition module, bromodomain.  Several inhibitors targeting BRD4, one of the bromodomain members, are in clin. trials as anticancer drugs.  Hereby, the authors report the efforts on discovery and optimization of a new series of 2-thiazolidinones as BRD4 inhibitors along the previous study.  In this work, guided by crystal structure anal., the authors reversed the sulfonamide group and identified a new binding mode.  A structure-activity relationship study on this new series led to several potent BRD4 inhibitors with IC50 of about 0.05-0.1 μM in FP binding assay and GI50 of 0.1-0.3 μM in cell based assays.  To complete the lead-like assessment of this series, the authors further checked its effects on BRD4 downstream protein c-Myc, investigated its selectivity among five different bromodomain proteins, as well as the metabolic stability test, and reinforced the utility of 2-thiazolidinone scaffold as BET bromodomain inhibitors in novel anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4x-5lE2iPzbVg90H21EOLACvtfcHk0lgucwopQTEj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D&md5=4056ac1a6d6598dc61be7cc7ef82a3da</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm501504k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501504k%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%2BC.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DFragment-based%2520drug%2520discovery%2520of%25202-thiazolidinones%2520as%2520BRD4%2520inhibitors%253A%25202.%2520Structure-based%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1281%26epage%3D1297%26doi%3D10.1021%2Fjm501504k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Toure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-molecule PROTACS: new approaches to protein degradation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span><span class="refDoi"> DOI: 10.1002/anie.201507978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1002%2Fanie.201507978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1966-1973&author=M.+Toureauthor=C.+M.+Crews&title=Small-molecule+PROTACS%3A+new+approaches+to+protein+degradation&doi=10.1002%2Fanie.201507978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule PROTACS: New Approaches to Protein Degradation</span></div><div class="casAuthors">Toure, Momar; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1966-1973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The current inhibitor-based approach to therapeutics has inherent limitations owing to its occupancy-based model: there is a need to maintain high systemic exposure to ensure sufficient in vivo inhibition, high in vivo concns. bring potential for off-target side effects, and there is a need to bind to an active site, thus limiting the drug target space.  As an alternative, induced protein degrdn. lacks these limitations.  Based on an event-driven model, this approach offers a novel catalytic mechanism to irreversibly inhibit protein function by targeting protein destruction through recruitment to the cellular quality control machinery.  Prior protein degrading strategies have lacked therapeutic potential.  However, recent reports of small-mol.-based proteolysis-targeting chimeras (PROTACs) have demonstrated that this technol. can effectively decrease the cellular levels of several protein classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdaqlIjCSsgrVg90H21EOLACvtfcHk0lgucwopQTEj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D&md5=47838cd15719757317cb8282c26cc59e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507978%26sid%3Dliteratum%253Aachs%26aulast%3DToure%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520PROTACS%253A%2520new%2520approaches%2520to%2520protein%2520degradation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D1966%26epage%3D1973%26doi%3D10.1002%2Fanie.201507978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span><span class="refDoi"> DOI: 10.1002/anie.201307761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1002%2Fanie.201307761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=2312-2330&author=D.+L.+Buckleyauthor=C.+M.+Crews&title=Small-molecule+control+of+intracellular+protein+levels+through+modulation+of+the+ubiquitin+proteasome+system&doi=10.1002%2Fanie.201307761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Control of Intracellular Protein Levels through Modulation of the Ubiquitin Proteasome System</span></div><div class="casAuthors">Buckley, Dennis L.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2312-2330</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Traditionally, biol. probes and drugs have targeted the activities of proteins (such as enzymes and receptors) that can be readily controlled by small mols.  The remaining majority of the proteome has been deemed "undruggable".  By using small-mol. modulators of the ubiquitin proteasome, protein levels, rather than protein activity, can be targeted instead, thus increasing the no. of druggable targets.  Whereas targeting of the proteasome itself can lead to a global increase in protein levels, the targeting of other components of the UPS (e.g., the E3 ubiquitin ligases) can lead to an increase in protein levels in a more targeted fashion.  Alternatively, multiple strategies for inducing protein degrdn. with small-mol. probes are emerging.  With the ability to induce and inhibit the degrdn. of targeted proteins, small-mol. modulators of the UPS have the potential to significantly expand the druggable portion of the proteome beyond traditional targets, such as enzymes and receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUSadJB1NNJ7Vg90H21EOLACvtfcHk0ljgZhKUAvVeAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlegsLo%253D&md5=4d88e9c3f2dbf92c9db4aa81bd8cdac1</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307761%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520control%2520of%2520intracellular%2520protein%2520levels%2520through%2520modulation%2520of%2520the%2520ubiquitin%2520proteasome%2520system%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D2312%26epage%3D2330%26doi%3D10.1002%2Fanie.201307761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Chemical inducers of targeted protein degradation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">11057</span><span class="NLM_x">–</span> <span class="NLM_lpage">11060</span><span class="refDoi"> DOI: 10.1074/jbc.R109.078105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.R109.078105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20147751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFGlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=11057-11060&author=K.+Rainaauthor=C.+M.+Crews&title=Chemical+inducers+of+targeted+protein+degradation&doi=10.1074%2Fjbc.R109.078105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Inducers of Targeted Protein Degradation</span></div><div class="casAuthors">Raina, Kanak; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">11057-11060</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  The functions of many cellular proteins have been elucidated by selective gene inactivation and subsequent phenotypic anal.  For example, genetic mutations, gene knock-out generation, and the use of RNA interference to target mRNA for degrdn. can all result in decreased prodn. of a specific protein, yielding informative cellular phenotypes.  However, these techniques each have certain inherent limitations.  This minireview focuses on the recent development of new approaches to study protein function at the post-translational level, namely chem. induction of targeted protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAHr6BsXliLVg90H21EOLACvtfcHk0ljgZhKUAvVeAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFGlsrs%253D&md5=f5142a890c2e1c859d58ddb25c077052</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R109.078105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R109.078105%26sid%3Dliteratum%253Aachs%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DChemical%2520inducers%2520of%2520targeted%2520protein%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D11057%26epage%3D11060%26doi%3D10.1074%2Fjbc.R109.078105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Bulatov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.1042/BJ20141450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1042%2FBJ20141450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2015&pages=365-386&author=E.+Bulatovauthor=A.+Ciulli&title=Targeting+Cullin%E2%80%93RING+E3+ubiquitin+ligases+for+drug+discovery%3A+structure%2C+assembly+and+small-molecule+modulation&doi=10.1042%2FBJ20141450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1042%2FBJ20141450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20141450%26sid%3Dliteratum%253Aachs%26aulast%3DBulatov%26aufirst%3DE.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DTargeting%2520Cullin%25E2%2580%2593RING%2520E3%2520ubiquitin%2520ligases%2520for%2520drug%2520discovery%253A%2520structure%252C%2520assembly%2520and%2520small-molecule%2520modulation%26jtitle%3DBiochem.%2520J.%26date%3D2015%26volume%3D467%26spage%3D365%26epage%3D386%26doi%3D10.1042%2FBJ20141450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Winter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span><span class="refDoi"> DOI: 10.1126/science.aab1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1126%2Fscience.aab1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25999370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1376-1381&author=G.+E.+Winterauthor=D.+L.+Buckleyauthor=J.+Paulkauthor=J.+M.+Robertsauthor=A.+Souzaauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=DRUG+DEVELOPMENT.+Phthalimide+conjugation+as+a+strategy+for+in+vivo+target+protein+degradation&doi=10.1126%2Fscience.aab1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalimide conjugation as a strategy for in vivo target protein degradation</span></div><div class="casAuthors">Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6241</span>),
    <span class="NLM_cas:pages">1376-1381</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The development of effective pharmacol. inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem.  In part, this is because many small-mol. antagonists disrupt the activity of only one domain in the target protein.  The authors devised a chem. strategy that promotes ligand-dependent target protein degrdn. using as an example the transcriptional coactivator BRD4, a protein crit. for cancer cell growth and survival.  The authors appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex.  The resultant compd., dBET1, induced highly selective cereblon-dependent BET protein degrdn. in vitro and in vivo and delayed leukemia progression in mice.  A second series of probes resulted in selective degrdn. of the cytosolic protein FKBP12.  This chem. strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ZW4zjRjXi7Vg90H21EOLACvtfcHk0ljgZhKUAvVeAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D&md5=b0277cc95d318d926b96e7a119066e3b</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1126%2Fscience.aab1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aab1433%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%2BE.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DDRUG%2520DEVELOPMENT.%2520Phthalimide%2520conjugation%2520as%2520a%2520strategy%2520for%2520in%2520vivo%2520target%2520protein%2520degradation%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D1376%26epage%3D1381%26doi%3D10.1126%2Fscience.aab1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+E3+ubiquitin+ligase+cereblon+to+efficiently+target+BRD4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0liYIgUfqTshRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520E3%2520ubiquitin%2520ligase%2520cereblon%2520to%2520efficiently%2520target%2520BRD4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selective small molecule induced degradation of the BET bromodomain protein BRD4</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1777</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1770-1777&author=M.+Zengerleauthor=K.+H.+Chanauthor=A.+Ciulli&title=Selective+small+molecule+induced+degradation+of+the+BET+bromodomain+protein+BRD4&doi=10.1021%2Facschembio.5b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span></div><div class="casAuthors">Zengerle, Michael; Chan, Kwok-Ho; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1770-1777</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bromo- and Extra-Terminal (BET) proteins BRD2, BRD3, and BRD4 play important roles in transcriptional regulation, epigenetics, and cancer and are the targets of pan-BET selective bromodomain inhibitor JQ1.  However, the lack of intra-BET selectivity limits the scope of current inhibitors as probes for target validation and could lead to unwanted side effects or toxicity in a therapeutic setting.  We designed Proteolysis Targeted Chimeras (PROTACs) that tether JQ1 to a ligand for the E3 ubiquitin ligase VHL, aimed at triggering the intracellular destruction of BET proteins.  Compd. MZ1 potently and rapidly induces reversible, long-lasting, and unexpectedly selective removal of BRD4 over BRD2 and BRD3.  The activity of MZ1 is dependent on binding to VHL but is achieved at a sufficiently low concn. not to induce stabilization of HIF-1α.  Gene expression profiles of selected cancer-related genes responsive to JQ1 reveal distinct and more limited transcriptional responses induced by MZ1, consistent with selective suppression of BRD4.  Our discovery opens up new opportunities to elucidate the cellular phenotypes and therapeutic implications assocd. with selective targeting of BRD4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmSv7p9MZOrVg90H21EOLACvtfcHk0liYIgUfqTshRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D&md5=b7514fd274eff8e4bb6a771f5aaf9ab5</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00216%26sid%3Dliteratum%253Aachs%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelective%2520small%2520molecule%2520induced%2520degradation%2520of%2520the%2520BET%2520bromodomain%2520protein%2520BRD4%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1770%26epage%3D1777%26doi%3D10.1021%2Facschembio.5b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Design and characterization of bivalent BET inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1038/nchembio.2209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnchembio.2209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27775715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslehurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1089-1096&author=M.+Tanakaauthor=J.+M.+Robertsauthor=H.+S.+Seoauthor=A.+Souzaauthor=J.+Paulkauthor=T.+G.+Scottauthor=S.+L.+DeAngeloauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=Design+and+characterization+of+bivalent+BET+inhibitors&doi=10.1038%2Fnchembio.2209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Design and characterization of bivalent BET inhibitors</span></div><div class="casAuthors">Tanaka, Minoru; Roberts, Justin M.; Seo, Hyuk-Soo; Souza, Amanda; Paulk, Joshiawa; Scott, Thomas G.; DeAngelo, Stephen L.; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1089-1096</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cellular signaling is often propagated by multivalent interactions.  Multivalency creates avidity, allowing stable biophys. recognition.  Multivalency is an attractive strategy for achieving potent binding to protein targets, as the affinity of bivalent ligands is often greater than the sum of monovalent affinities.  The bromodomain and extraterminal domain (BET) family of transcriptional coactivators features tandem bromodomains through which BET proteins bind acetylated histones and transcription factors.  All reported antagonists of the BET protein BRD4 bind in a monovalent fashion.  Here the authors describe, to the knowledge for the first time, a bivalent BET bromodomain inhibitor-MT1-which has unprecedented potency.  Biophys. and biochem. studies suggest MT1 is an intramol. bivalent BRD4 binder that is more than 100-fold more potent, in cellular assays, than the corresponding monovalent antagonist, JQ1.  MT1 significantly (P < 0.05) delayed leukemia progression in mice, as compared to JQ1.  These data qualify a powerful chem. probe for BET bromodomains and a rationale for further development of multidomain inhibitors of epigenetic reader proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQwc6X0VYYbVg90H21EOLACvtfcHk0liYIgUfqTshRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslehurrM&md5=7319203dac409d5dee3c580b49fcf185</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2209%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSeo%26aufirst%3DH.%2BS.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DT.%2BG.%26aulast%3DDeAngelo%26aufirst%3DS.%2BL.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DDesign%2520and%2520characterization%2520of%2520bivalent%2520BET%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D1089%26epage%3D1096%26doi%3D10.1038%2Fnchembio.2209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Rhyasen, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattersley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petteruti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriotta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahdesmaki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabow, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">AZD5153: A novel bivalent BET bromodomain inhibitor highly active against hematologic malignancies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2563</span><span class="NLM_x">–</span> <span class="NLM_lpage">2574</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.MCT-16-0141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27573426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=2563-2574&author=G.+W.+Rhyasenauthor=M.+M.+Hattersleyauthor=Y.+Yaoauthor=A.+Dulakauthor=W.+Wangauthor=P.+Petterutiauthor=I.+L.+Daleauthor=S.+Boikoauthor=T.+Cheungauthor=J.+Zhangauthor=S.+Wenauthor=L.+Castriottaauthor=D.+Lawsonauthor=M.+Collinsauthor=L.+Baoauthor=M.+J.+Ahdesmakiauthor=G.+Walkerauthor=G.+O%E2%80%99Connorauthor=T.+C.+Yehauthor=A.+A.+Rabowauthor=J.+R.+Dryauthor=C.+Reimerauthor=P.+Lyneauthor=G.+B.+Millsauthor=S.+E.+Fawellauthor=M.+J.+Waringauthor=M.+Zindaauthor=E.+Clarkauthor=H.+Chen&title=AZD5153%3A+A+novel+bivalent+BET+bromodomain+inhibitor+highly+active+against+hematologic+malignancies&doi=10.1158%2F1535-7163.MCT-16-0141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">AZD5153: a novel bivalent BET bromodomain inhibitor highly active against hematologic malignancies</span></div><div class="casAuthors">Rhyasen, Garrett W.; Hattersley, Maureen M.; Yao, Yi; Dulak, Austin; Wang, Wenxian; Petteruti, Philip; Dale, Ian L.; Boiko, Scott; Cheung, Tony; Zhang, Jingwen; Wen, Shenghua; Castriotta, Lillian; Lawson, Deborah; Collins, Michael; Bao, Larry; Ahdesmaki, Miika J.; Walker, Graeme; O'Connor, Greg; Yeh, Tammie C.; Rabow, Alfred A.; Dry, Jonathan R.; Reimer, Corinne; Lyne, Paul; Mills, Gordon B.; Fawell, Stephen E.; Waring, Michael J.; Zinda, Michael; Clark, Edwin; Chen, Huawei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2563-2574</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The bromodomain and extraterminal (BET) protein BRD4 regulates gene expression via recruitment of transcriptional regulatory complexes to acetylated chromatin.  Pharmacol. targeting of BRD4 bromodomains by small mol. inhibitors has proven to be an effective means to disrupt aberrant transcriptional programs crit. for tumor growth and/or survival.  Herein, we report AZD5153, a potent, selective, and orally available BET/BRD4 bromodomain inhibitor possessing a bivalent binding mode.  Unlike previously described monovalent inhibitors, AZD5153 ligates two bromodomains in BRD4 simultaneously.  The enhanced avidity afforded through bivalent binding translates into increased cellular and antitumor activity in preclin. hematol. tumor models.  In vivo administration of AZD5153 led to tumor stasis or regression in multiple xenograft models of acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma.  The relationship between AZD5153 exposure and efficacy suggests that prolonged BRD4 target coverage is a primary efficacy driver.  AZD5153 treatment markedly affects transcriptional programs of MYC, E2F, and mTOR.  Of note, mTOR pathway modulation is assocd. with cell line sensitivity to AZD5153.  Transcriptional modulation of MYC and HEXIM1 was confirmed in AZD5153-treated human whole blood, thus supporting their use as clin. pharmacodynamic biomarkers.  This study establishes AZD5153 as a highly potent, orally available BET/BRD4 inhibitor and provides a rationale for clin. development in hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAiKYOFhro1bVg90H21EOLACvtfcHk0lig1RxWO-xL6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVOqsrk%253D&md5=8d0ac899d081705aaa12d49fd90165a3</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0141%26sid%3Dliteratum%253Aachs%26aulast%3DRhyasen%26aufirst%3DG.%2BW.%26aulast%3DHattersley%26aufirst%3DM.%2BM.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDulak%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DPetteruti%26aufirst%3DP.%26aulast%3DDale%26aufirst%3DI.%2BL.%26aulast%3DBoiko%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DCastriotta%26aufirst%3DL.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DAhdesmaki%26aufirst%3DM.%2BJ.%26aulast%3DWalker%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DG.%26aulast%3DYeh%26aufirst%3DT.%2BC.%26aulast%3DRabow%26aufirst%3DA.%2BA.%26aulast%3DDry%26aufirst%3DJ.%2BR.%26aulast%3DReimer%26aufirst%3DC.%26aulast%3DLyne%26aufirst%3DP.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DZinda%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DAZD5153%253A%2520A%2520novel%2520bivalent%2520BET%2520bromodomain%2520inhibitor%2520highly%2520active%2520against%2520hematologic%2520malignancies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D2563%26epage%3D2574%26doi%3D10.1158%2F1535-7163.MCT-16-0141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2360</span><span class="NLM_x">–</span> <span class="NLM_lpage">2365</span><span class="refDoi"> DOI: 10.1021/cb4003283</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4003283" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2360-2365&author=M.+P.+Martinauthor=S.+H.+Olesenauthor=G.+I.+Georgauthor=E.+Schonbrunn&title=Cyclin-dependent+kinase+inhibitor+dinaciclib+interacts+with+the+acetyl-lysine+recognition+site+of+bromodomains&doi=10.1021%2Fcb4003283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains</span></div><div class="casAuthors">Martin, Mathew P.; Olesen, Sanne H.; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2360-2365</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. proteins are considered atypical kinases, but their potential to interact with kinase inhibitors is unknown.  Dinaciclib is a potent inhibitor of cyclin-dependent kinases (CDKs), which recently advanced to Phase III clin. trials for the treatment of leukemia.  The authors detd. the crystal structure of dinaciclib in complex with CDK2 at 1.7 Å resoln., revealing an elaborate network of binding interactions in the ATP site, which explains the extraordinary potency and selectivity of this inhibitor.  Remarkably, dinaciclib also interacted with the acetyl-lysine recognition site of the bromodomain testis-specific protein BRDT, a member of the BET family of bromodomains.  The binding mode of dinaciclib to BRDT at 2.0 Å resoln. suggests that general kinase inhibitors (hinge binders) possess a previously unrecognized potential to act as protein-protein inhibitors of bromodomains.  The findings may provide a new structural framework for the design of next-generation bromodomain inhibitors using the vast chem. space of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonrxl9QUxkE7Vg90H21EOLACvtfcHk0lig1RxWO-xL6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvN&md5=1ae089e8e571ad11aadcdc4a1a5769b5</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fcb4003283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4003283%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DOlesen%26aufirst%3DS.%2BH.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitor%2520dinaciclib%2520interacts%2520with%2520the%2520acetyl-lysine%2520recognition%2520site%2520of%2520bromodomains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2360%26epage%3D2365%26doi%3D10.1021%2Fcb4003283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Ember, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span><span class="refDoi"> DOI: 10.1021/cb500072z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500072z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1160-1171&author=S.+W.+Emberauthor=J.+Y.+Zhuauthor=S.+H.+Olesenauthor=M.+P.+Martinauthor=A.+Beckerauthor=N.+Berndtauthor=G.+I.+Georgauthor=E.+Schonbrunn&title=Acetyl-lysine+binding+site+of+bromodomain-containing+protein+4+%28BRD4%29+interacts+with+diverse+kinase+inhibitors&doi=10.1021%2Fcb500072z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors</span></div><div class="casAuthors">Ember, Stuart W. J.; Zhu, Jin-Yi; Olesen, Sanne H.; Martin, Mathew P.; Becker, Andreas; Berndt, Norbert; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1160-1171</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the bromodomain and extra terminal (BET) family of proteins are essential for the recognition of acetylated lysine (KAc) residues in histones and have emerged as promising drug targets in cancer, inflammation, and contraception research.  In co-crystn. screening campaigns using the first bromodomain of BRD4 (BRD4-1) against kinase inhibitor libraries, we identified and characterized 14 kinase inhibitors (10 distinct chem. scaffolds) as ligands of the KAc binding site.  Among these, the PLK1 inhibitor BI2536 and the JAK2 inhibitor TG101209 displayed strongest inhibitory potential against BRD4 (IC50 = 25 nM and 130 nM, resp.) and high selectivity for BET bromodomains.  Comparative structural anal. revealed markedly different binding modes of kinase hinge-binding scaffolds in the KAc binding site, suggesting that BET proteins are potential off-targets of diverse kinase inhibitors.  Combined, these findings provide a new structural framework for the rational design of next-generation BET-selective and dual-activity BET-kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0X1hjt7cBbVg90H21EOLACvtfcHk0liagwu29c5EYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D&md5=5ca37df00cdaa0ba81c0cb4a0f70ba5d</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fcb500072z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500072z%26sid%3Dliteratum%253Aachs%26aulast%3DEmber%26aufirst%3DS.%2BW.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DOlesen%26aufirst%3DS.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DAcetyl-lysine%2520binding%2520site%2520of%2520bromodomain-containing%2520protein%25204%2520%2528BRD4%2529%2520interacts%2520with%2520diverse%2520kinase%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1160%26epage%3D1171%26doi%3D10.1021%2Fcb500072z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Steegmaier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petronczki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krssak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurtler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolf, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1016/j.cub.2006.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cub.2006.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17291758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=316-322&author=M.+Steegmaierauthor=M.+Hoffmannauthor=A.+Baumauthor=P.+Lenartauthor=M.+Petronczkiauthor=M.+Krssakauthor=U.+Gurtlerauthor=P.+Garin-Chesaauthor=S.+Liebauthor=J.+Quantauthor=M.+Grauertauthor=G.+R.+Adolfauthor=N.+Krautauthor=J.+M.+Petersauthor=W.+J.+Rettig&title=BI+2536%2C+a+potent+and+selective+inhibitor+of+polo-like+kinase+1%2C+inhibits+tumor+growth+in+vivo&doi=10.1016%2Fj.cub.2006.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo</span></div><div class="casAuthors">Steegmaier, Martin; Hoffmann, Matthias; Baum, Anke; Lenart, Peter; Petronczki, Mark; Krssak, Martin; Guertler, Ulrich; Garin-Chesa, Pilar; Lieb, Simone; Quant, Jens; Grauert, Matthias; Adolf, Guenther R.; Kraut, Norbert; Peters, Jan-Michael; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">316-322</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fine-mapping of the cell-division cycle, notably the identification of mitotic kinase signaling pathways, provides novel opportunities for cancer-drug discovery.  As a key regulator of multiple steps during mitotic progression across eukaryotic species, the serine/threonine-specific Polo-like kinase 1 (Plk1) is highly expressed in malignant cells and serves as a neg. prognostic marker in specific human cancer types .  Here, we report the discovery of a potent small-mol. inhibitor of mammalian Plk1, BI 2536, which inhibits Plk1 enzyme activity at low nanomolar concns.  The compd. potently causes a mitotic arrest and induces apoptosis in human cancer cell lines of diverse tissue origin and oncogenome signature.  BI 2536 inhibits growth of human tumor xenografts in nude mice and induces regression of large tumors with well-tolerated i.v. dose regimens.  In treated tumors, cells arrest in prometaphase, accumulate phosphohistone H3, and contain aberrant mitotic spindles.  This mitotic arrest is followed by a surge in apoptosis, detectable by immunohistochem. and noninvasive optical and magnetic resonance imaging.  For addressing the therapeutic potential of Plk1 inhibition, BI 2536 has progressed into clin. studies in patients with locally advanced or metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eEWnSYWORbVg90H21EOLACvtfcHk0liagwu29c5EYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D&md5=49807e335b4ab8cf8209b55597fc7b4e</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2006.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2006.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DSteegmaier%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DLenart%26aufirst%3DP.%26aulast%3DPetronczki%26aufirst%3DM.%26aulast%3DKrssak%26aufirst%3DM.%26aulast%3DGurtler%26aufirst%3DU.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DLieb%26aufirst%3DS.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DGrauert%26aufirst%3DM.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DBI%25202536%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520polo-like%2520kinase%25201%252C%2520inhibits%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DCurr.%2520Biol.%26date%3D2007%26volume%3D17%26spage%3D316%26epage%3D322%26doi%3D10.1016%2Fj.cub.2006.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasater, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/nchembio.1471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnchembio.1471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24584101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=305-312&author=P.+Ciceriauthor=S.+Mullerauthor=A.+O%E2%80%99Mahonyauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=J.+P.+Huntauthor=E.+A.+Lasaterauthor=G.+Pallaresauthor=S.+Picaudauthor=C.+Wellsauthor=S.+Martinauthor=L.+M.+Wodickaauthor=N.+P.+Shahauthor=D.+K.+Treiberauthor=S.+Knapp&title=Dual+kinase-bromodomain+inhibitors+for+rationally+designed+polypharmacology&doi=10.1038%2Fnchembio.1471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</span></div><div class="casAuthors">Ciceri, Pietro; Mueller, Susanne; O'Mahony, Alison; Fedorov, Oleg; Filippakopoulos, Panagis; Hunt, Jeremy P.; Lasater, Elisabeth A.; Pallares, Gabriel; Picaud, Sarah; Wells, Christopher; Martin, Sarah; Wodicka, Lisa M.; Shah, Neil P.; Treiber, Daniel K.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clin. responses to targeted therapies.  The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clin. development challenges.  Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy.  Here the authors report that several clin. kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors.  Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clin. PLK1 and JAK2-FLT3 kinase inhibitors, resp., is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacol. targeting.  Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotPedDED4FJLVg90H21EOLACvtfcHk0liagwu29c5EYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D&md5=a00117db2648ea38dd03750faf3b3cb9</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1471%26sid%3Dliteratum%253Aachs%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLasater%26aufirst%3DE.%2BA.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DDual%2520kinase-bromodomain%2520inhibitors%2520for%2520rationally%2520designed%2520polypharmacology%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D305%26epage%3D312%26doi%3D10.1038%2Fnchembio.1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanning, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fountain, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheenstra, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strovel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span> </span><span class="NLM_article-title">BRD4 structure-activity relationships of dual PLK1 kinase/BRD4 bromodomain inhibitor BI-2536</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=764-769&author=L.+Chenauthor=J.+L.+Yapauthor=M.+Yoshiokaauthor=M.+E.+Lanningauthor=R.+N.+Fountainauthor=M.+Rajeauthor=J.+A.+Scheenstraauthor=J.+W.+Strovelauthor=S.+Fletcher&title=BRD4+structure-activity+relationships+of+dual+PLK1+kinase%2FBRD4+bromodomain+inhibitor+BI-2536&doi=10.1021%2Facsmedchemlett.5b00084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536</span></div><div class="casAuthors">Chen, Lijia; Yap, Jeremy L.; Yoshioka, Makoto; Lanning, Maryanna E.; Fountain, Rachel N.; Raje, Mithun; Scheenstra, Jacob A.; Strovel, Jeffrey W.; Fletcher, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A focused library of analogs of the dual PLK1 kinase/BRD4 bromodomain inhibitor BI-2536 was prepd. and then analyzed for BRD4 and PLK1 inhibitory activities.  Particularly, replacement of the cyclopentyl group with a 3-bromobenzyl moiety afforded the most potent BRD4 inhibitor of the series (39j) with a Ki = 8.7 nM, which was equipotent against PLK1.  The superior affinity of 39j over the parental compd. to BRD4 possibly derives from improved interactions with the WPF shelf.  Meanwhile, substitution of the pyrimidine NH with an oxygen atom reversed the PLK1/BRD4 selectivity to convert BI-2536 into a BRD4-selective inhibitor, likely owing to the loss of a crit. hydrogen bond in PLK1.  We believe further fine-tuning will furnish a BRD4 "magic bullet" or an even more potent PLK1/BRD4 dual inhibitor toward the expansion and improved efficacy of the chemotherapy arsenal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UnNSmf1L17Vg90H21EOLACvtfcHk0lhePcZ1VldFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D&md5=f39070e652bca20c03a3bc5fe070a7fc</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00084%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYap%26aufirst%3DJ.%2BL.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DLanning%26aufirst%3DM.%2BE.%26aulast%3DFountain%26aufirst%3DR.%2BN.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DScheenstra%26aufirst%3DJ.%2BA.%26aulast%3DStrovel%26aufirst%3DJ.%2BW.%26aulast%3DFletcher%26aufirst%3DS.%26atitle%3DBRD4%2520structure-activity%2520relationships%2520of%2520dual%2520PLK1%2520kinase%252FBRD4%2520bromodomain%2520inhibitor%2520BI-2536%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D764%26epage%3D769%26doi%3D10.1021%2Facsmedchemlett.5b00084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falth Savitski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/cb400789e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400789e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=495-502&author=A.+Dittmannauthor=T.+Wernerauthor=C.+W.+Chungauthor=M.+M.+Savitskiauthor=M.+Falth+Savitskiauthor=P.+Grandiauthor=C.+Hopfauthor=M.+Lindonauthor=G.+Neubauerauthor=R.+K.+Prinjhaauthor=M.+Bantscheffauthor=G.+Drewes&title=The+commonly+used+PI3-kinase+probe+LY294002+is+an+inhibitor+of+BET+bromodomains&doi=10.1021%2Fcb400789e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains</span></div><div class="casAuthors">Dittmann, Antje; Werner, Thilo; Chung, Chun-Wa; Savitski, Mikhail M.; Faelth Savitski, Maria; Grandi, Paola; Hopf, Carsten; Lindon, Matthew; Neubauer, Gitte; Prinjha, Rabinder K.; Bantscheff, Marcus; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A commonly used small-mol. probe in cell-signaling research is the phosphoinositide 3-kinase inhibitor LY294002.  Quant. chemoproteomic profiling shows that LY294002 and LY303511, a close analog devoid of PI3K activity, inhibit the BET bromodomain proteins BRD2, BRD3, and BRD4 that comprise a family of targets structurally unrelated to PI3K.  Both compds. competitively inhibit acetyl-lysine binding of the first but not the second bromodomain of BET proteins in cell exts.  X-ray crystallog. shows that the chromen-4-one scaffold represents a new bromodomain pharmacophore and establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, whereas LY303511 exhibits anti-inflammatory and antiproliferative effects similar to the recently discovered BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbIVXFQARTKLVg90H21EOLACvtfcHk0lhePcZ1VldFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO&md5=13435c7d6a6747dc5699e3c3865c8243</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1021%2Fcb400789e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400789e%26sid%3Dliteratum%253Aachs%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DFalth%2BSavitski%26aufirst%3DM.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DLindon%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DThe%2520commonly%2520used%2520PI3-kinase%2520probe%2520LY294002%2520is%2520an%2520inhibitor%2520of%2520BET%2520bromodomains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D495%26epage%3D502%26doi%3D10.1021%2Fcb400789e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Allen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ember, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurer, S. C.</span><span> </span><span class="NLM_article-title">Large-scale computational screening identifies first in class multitarget inhibitor of EGFR kinase and BRD4</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">16924</span><span class="refDoi"> DOI: 10.1038/srep16924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fsrep16924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26596901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFentrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=16924&author=B.+K.+Allenauthor=S.+Mehtaauthor=S.+W.+Emberauthor=E.+Schonbrunnauthor=N.+Ayadauthor=S.+C.+Schurer&title=Large-scale+computational+screening+identifies+first+in+class+multitarget+inhibitor+of+EGFR+kinase+and+BRD4&doi=10.1038%2Fsrep16924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4</span></div><div class="casAuthors">Allen, Bryce K.; Mehta, Saurabh; Ember, Stewart W. J.; Schonbrunn, Ernst; Ayad, Nagi; Schurer, Stephan C.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16924</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of cancer-promoting kinases is an established therapeutic strategy for the treatment of many cancers, although resistance to kinase inhibitors is common.  One way to overcome resistance is to target orthogonal cancer-promoting pathways.  Bromo and Extra-Terminal (BET) domain proteins, which belong to the family of epigenetic readers, have recently emerged as promising therapeutic targets in multiple cancers.  The development of multitarget drugs that inhibit kinase and BET proteins therefore may be a promising strategy to overcome tumor resistance and prolong therapeutic efficacy in the clinic.  We developed a general computational screening approach to identify novel dual kinase/bromodomain inhibitors from millions of com. available small mols.  Our method integrated machine learning using big datasets of kinase inhibitors and structure-based drug design.  Here we describe the computational methodol., including validation and characterization of our models and their application and integration into a scalable virtual screening pipeline.  We screened over 6 million com. available compds. and selected 24 for testing in BRD4 and EGFR biochem. assays.  We identified several novel BRD4 inhibitors, among them a first in class dual EGFR-BRD4 inhibitor.  Our studies suggest that this computational screening approach may be broadly applicable for identifying dual kinase/BET inhibitors with potential for treating various cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2LBJWDL9se7Vg90H21EOLACvtfcHk0lhePcZ1VldFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFentrrI&md5=341f9fedbdfd9e66829e5c43d602d510</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1038%2Fsrep16924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep16924%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DB.%2BK.%26aulast%3DMehta%26aufirst%3DS.%26aulast%3DEmber%26aufirst%3DS.%2BW.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DAyad%26aufirst%3DN.%26aulast%3DSchurer%26aufirst%3DS.%2BC.%26atitle%3DLarge-scale%2520computational%2520screening%2520identifies%2520first%2520in%2520class%2520multitarget%2520inhibitor%2520of%2520EGFR%2520kinase%2520and%2520BRD4%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D16924%26doi%3D10.1038%2Fsrep16924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2931</span><span class="NLM_x">–</span> <span class="NLM_lpage">2935</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2016.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27142751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XntFCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2931-2935&author=Z.+Zhangauthor=S.+Houauthor=H.+Chenauthor=T.+Ranauthor=F.+Jiangauthor=Y.+Bianauthor=D.+Zhangauthor=Y.+Zhiauthor=L.+Wangauthor=L.+Zhangauthor=H.+Liauthor=Y.+Zhangauthor=W.+Tangauthor=T.+Luauthor=Y.+Chen&title=Targeting+epigenetic+reader+and+eraser%3A+Rational+design%2C+synthesis+and+in+vitro+evaluation+of+dimethylisoxazoles+derivatives+as+BRD4%2FHDAC+dual+inhibitors&doi=10.1016%2Fj.bmcl.2016.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors</span></div><div class="casAuthors">Zhang, Zhimin; Hou, Shaohua; Chen, Hongli; Ran, Ting; Jiang, Fei; Bian, Yuanyuan; Zhang, Dewei; Zhi, Yanle; Wang, Lu; Zhang, Li; Li, Hongmei; Zhang, Yanmin; Tang, Weifang; Lu, Tao; Chen, Yadong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2931-2935</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bromodomain protein module and histone deacetylase (HDAC), which recognize and remove acetylated lysine, resp., have emerged as important epigenetic therapeutic targets in cancer treatments.  Herein the authors presented a novel design approach for cancer drug development by combination of bromodomain and HDAC inhibitory activity in one mol.  The designed compds. were synthesized which showed inhibitory activity against bromodomain 4 and HDAC1.  The representative dual bromodomain/HDAC inhibitors, compds. N1-(3-benzoyl-5-(3,5-dimethylisoxazol-4-yl)phenyl)-N7-hydroxyheptanediamide and N1-(3-benzoyl-5-(3,5-dimethylisoxazol-4-yl)phenyl)-N8-hydroxyoctanediamide showed potent antiproliferative activities against human leukemia cell line K562 and MV4-11 in cellular assays.  This work may lay the foundation for developing dual bromodomain/HDAC inhibitors as potential anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriS0VB1G-QoLVg90H21EOLACvtfcHk0lgsO5O0Xe1PlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntFCmt7o%253D&md5=a6ebdbd6402e3117a2f9d96ed071790c</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRan%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DTargeting%2520epigenetic%2520reader%2520and%2520eraser%253A%2520Rational%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520dimethylisoxazoles%2520derivatives%2520as%2520BRD4%252FHDAC%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2931%26epage%3D2935%26doi%3D10.1016%2Fj.bmcl.2016.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9251</span><span class="NLM_x">–</span> <span class="NLM_lpage">9264</span><span class="refDoi"> DOI: 10.1021/jm401334s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401334s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9251-9264&author=G.+Zhangauthor=A.+N.+Plotnikovauthor=E.+Rusinovaauthor=T.+Shenauthor=K.+Morohashiauthor=J.+Joshuaauthor=L.+Zengauthor=S.+Mujtabaauthor=M.+Ohlmeyerauthor=M.+M.+Zhou&title=Structure-guided+design+of+potent+diazobenzene+inhibitors+for+the+BET+bromodomains&doi=10.1021%2Fjm401334s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains</span></div><div class="casAuthors">Zhang, Guangtao; Plotnikov, Alexander N.; Rusinova, Elena; Shen, Tong; Morohashi, Keita; Joshua, Jennifer; Zeng, Lei; Mujtaba, Shiraz; Ohlmeyer, Michael; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9251-9264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BRD4, characterized by two acetyl-lysine binding bromodomains and an extra-terminal (ET) domain, is a key chromatin organizer that directs gene activation in chromatin through transcription factor recruitment, enhancer assembly, and pause release of the RNA polymerase II complex for transcription elongation.  BRD4 has been recently validated as a new epigenetic drug target for cancer and inflammation.  Our current knowledge of the functional differences of the two bromodomains of BRD4, however, is limited and is hindered by the lack of selective inhibitors.  Here, we report our structure-guided development of diazobenzene-based small-mol. inhibitors for the BRD4 bromodomains that have over 90% sequence identity at the acetyl-lysine binding site.  Our lead compd., MS436, through a set of water-mediated interactions, exhibits low nanomolar affinity (estd. Ki of 30-50 nM), with preference for the first bromodomain over the second.  We demonstrated that MS436 effectively inhibits BRD4 activity in NF-κB-directed prodn. of nitric oxide and proinflammatory cytokine interleukin-6 in murine macrophages.  MS436 represents a new class of bromodomain inhibitors and will facilitate further investigation of the biol. functions of the two bromodomains of BRD4 in gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlT4IPx_3s7rVg90H21EOLACvtfcHk0lgsO5O0Xe1PlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO&md5=24c7b50636fc4e0bbbfb80446e4dd23c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fjm401334s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401334s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DMorohashi%26aufirst%3DK.%26aulast%3DJoshua%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DStructure-guided%2520design%2520of%2520potent%2520diazobenzene%2520inhibitors%2520for%2520the%2520BET%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9251%26epage%3D9264%26doi%3D10.1021%2Fjm401334s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.4155%2Ffmc-2016-0059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27193077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1655-1680&author=C.+Galdeanoauthor=A.+Ciulli&title=Selectivity+on-target+of+bromodomain+chemical+probes+by+structure-guided+medicinal+chemistry+and+chemical+biology&doi=10.4155%2Ffmc-2016-0059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology</span></div><div class="casAuthors">Galdeano, Carles; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1655-1680</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Targeting epigenetic proteins is a rapidly growing area for medicinal chem. and drug discovery.  Recent years have seen an explosion of interest in developing small mols. binding to bromodomains, the readers of acetyl-lysine modifications.  A plethora of co-crystal structures has motivated focused fragment-based design and optimization programs within both industry and academia.  These efforts have yielded several compds. entering the clinic, and many more are increasingly being used as chem. probes to interrogate bromodomain biol.  High selectivity of chem. probes is necessary to ensure biol. activity is due to an on-target effect.  Here, we review the state-of-the-art of bromodomain-targeting compds., focusing on the structural basis for their on-target selectivity or lack thereof.  We also highlight chem. biol. approaches to enhance on-target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1bg8K3kh-RLVg90H21EOLACvtfcHk0lgsO5O0Xe1PlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3K&md5=a4c02dd517e8582755a918eabd7bfeea</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0059%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelectivity%2520on-target%2520of%2520bromodomain%2520chemical%2520probes%2520by%2520structure-guided%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1655%26epage%3D1680%26doi%3D10.4155%2Ffmc-2016-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Raux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voitovich, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derviaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebuffet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinquet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collette, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, X.</span><span> </span><span class="NLM_article-title">Exploring selective inhibition of the first bromodomain of the human bromodomain and extra-terminal domain (BET) proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1634-1641&author=B.+Rauxauthor=Y.+Voitovichauthor=C.+Derviauxauthor=A.+Lugariauthor=E.+Rebuffetauthor=S.+Milhasauthor=S.+Prietauthor=T.+Rouxauthor=E.+Trinquetauthor=J.+C.+Guillemotauthor=S.+Knappauthor=J.+M.+Brunelauthor=A.+Y.+Fedorovauthor=Y.+Colletteauthor=P.+Rocheauthor=S.+Betziauthor=S.+Combesauthor=X.+Morelli&title=Exploring+selective+inhibition+of+the+first+bromodomain+of+the+human+bromodomain+and+extra-terminal+domain+%28BET%29+proteins&doi=10.1021%2Facs.jmedchem.5b01708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins</span></div><div class="casAuthors">Raux, Brigitt; Voitovich, Yuliia; Derviaux, Carine; Lugari, Adrien; Rebuffet, Etienne; Milhas, Sabine; Priet, Stephane; Roux, Thomas; Trinquet, Eric; Guillemot, Jean-Claude; Knapp, Stefan; Brunel, Jean-Michel; Fedorov, Alexey Yu.; Collette, Yves; Roche, Philippe; Betzi, Stephane; Combes, Sebastien; Morelli, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1634-1641</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A midthroughput screening follow-up program targeting the first bromodomain of the human BRD4 protein, BRD4(BD1), identified an acetylated-mimic xanthine deriv. inhibitor.  This compd. binds with an affinity in the low micromolar range yet exerts suitable unexpected selectivity in vitro against the other members of the bromodomain and extra-terminal domain (BET) family.  A structure-based program pinpointed a role of the ZA loop, paving the way for the development of potent and selective BET-BRDi probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQdXvF3r4zLVg90H21EOLACvtfcHk0lhrvoKYsRA7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKhsr0%253D&md5=fb9cfc20c76f65fcf409370b60aecc0a</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01708%26sid%3Dliteratum%253Aachs%26aulast%3DRaux%26aufirst%3DB.%26aulast%3DVoitovich%26aufirst%3DY.%26aulast%3DDerviaux%26aufirst%3DC.%26aulast%3DLugari%26aufirst%3DA.%26aulast%3DRebuffet%26aufirst%3DE.%26aulast%3DMilhas%26aufirst%3DS.%26aulast%3DPriet%26aufirst%3DS.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DGuillemot%26aufirst%3DJ.%2BC.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrunel%26aufirst%3DJ.%2BM.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26aulast%3DCollette%26aufirst%3DY.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DMorelli%26aufirst%3DX.%26atitle%3DExploring%2520selective%2520inhibition%2520of%2520the%2520first%2520bromodomain%2520of%2520the%2520human%2520bromodomain%2520and%2520extra-terminal%2520domain%2520%2528BET%2529%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1634%26epage%3D1641%26doi%3D10.1021%2Facs.jmedchem.5b01708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Devaiah, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, D. S.</span><span> </span><span class="NLM_article-title">BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">6927</span><span class="NLM_x">–</span> <span class="NLM_lpage">6932</span><span class="refDoi"> DOI: 10.1073/pnas.1120422109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1120422109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22509028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVWksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=6927-6932&author=B.+N.+Devaiahauthor=B.+A.+Lewisauthor=N.+Chermanauthor=M.+C.+Hewittauthor=B.+K.+Albrechtauthor=P.+G.+Robeyauthor=K.+Ozatoauthor=R.+J.+Simsauthor=D.+S.+Singer&title=BRD4+is+an+atypical+kinase+that+phosphorylates+serine2+of+the+RNA+polymerase+II+carboxy-terminal+domain&doi=10.1073%2Fpnas.1120422109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA polymerase II carboxy-terminal domain</span></div><div class="casAuthors">Devaiah, Ballachanda N.; Lewis, Brian A.; Cherman, Natasha; Hewitt, Michael C.; Albrecht, Brian K.; Robey, Pamela G.; Ozato, Keiko; Sims, Robert J., III; Singer, Dinah S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6927-6932, S6927/1-S6927/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bromodomain protein BRD4 has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt's lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer.  BRD4 also contributes to regulation of both cell cycle and transcription of oncogenes, HIV, and human papilloma virus (HPV).  Despite its role in a broad range of biol. processes, the precise mol. mechanism of BRD4 function remains unknown.  Here, the authors report that BRD4 is an atypical kinase that binds to the C-terminal domain (CTD) of RNA polymerase II and directly phosphorylates its Ser-2 sites both in vitro and in vivo under conditions where other CTD kinases are inactive.  Phosphorylation of the CTD Ser-2 residue was inhibited in vivo by a BRD4 inhibitor that blocked its binding to chromatin.  This finding that BRD4 is an RNA polymerase II CTD Ser-2 kinase implicates it as a regulator of eukaryotic transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_kIxSaI3kbVg90H21EOLACvtfcHk0lhrvoKYsRA7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVWksL4%253D&md5=0c682d9f376133840a874cc8854352d8</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1120422109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1120422109%26sid%3Dliteratum%253Aachs%26aulast%3DDevaiah%26aufirst%3DB.%2BN.%26aulast%3DLewis%26aufirst%3DB.%2BA.%26aulast%3DCherman%26aufirst%3DN.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DRobey%26aufirst%3DP.%2BG.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DSinger%26aufirst%3DD.%2BS.%26atitle%3DBRD4%2520is%2520an%2520atypical%2520kinase%2520that%2520phosphorylates%2520serine2%2520of%2520the%2520RNA%2520polymerase%2520II%2520carboxy-terminal%2520domain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D6927%26epage%3D6932%26doi%3D10.1073%2Fpnas.1120422109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Baud, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin-Shiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardote, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pschibul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1126/science.1249830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1126%2Fscience.1249830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25323695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2014&pages=638-641&author=M.+G.+Baudauthor=E.+Lin-Shiaoauthor=T.+Cardoteauthor=C.+Tallantauthor=A.+Pschibulauthor=K.+H.+Chanauthor=M.+Zengerleauthor=J.+R.+Garciaauthor=T.+T.+Kwanauthor=F.+M.+Fergusonauthor=A.+Ciulli&title=Chemical+biology.+A+bump-and-hole+approach+to+engineer+controlled+selectivity+of+BET+bromodomain+chemical+probes&doi=10.1126%2Fscience.1249830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes</span></div><div class="casAuthors">Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Tallant, Cynthia; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Kwan, Terence T.-L.; Ferguson, Fleur M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6209</span>),
    <span class="NLM_cas:pages">638-641</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. are useful tools for probing the biol. function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins.  The bromodomain and extra-terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer.  The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-mol. inhibitors, but these inhibitors lack selectivity for individual family members.  We developed an Et deriv. of an existing small-mol. inhibitor, I-BET/JQ1, and showed that it binds leucine/alanine mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains.  Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin.  Expansion of this approach could help identify the individual roles of single BET proteins in human physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9EnzLtvUKwbVg90H21EOLACvtfcHk0lhrvoKYsRA7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL&md5=04fe967e4681fb4b2b3168f4d5f8ff81</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249830%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%26aulast%3DLin-Shiao%26aufirst%3DE.%26aulast%3DCardote%26aufirst%3DT.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DPschibul%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DJ.%2BR.%26aulast%3DKwan%26aufirst%3DT.%2BT.%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DChemical%2520biology.%2520A%2520bump-and-hole%2520approach%2520to%2520engineer%2520controlled%2520selectivity%2520of%2520BET%2520bromodomain%2520chemical%2520probes%26jtitle%3DScience%26date%3D2014%26volume%3D346%26spage%3D638%26epage%3D641%26doi%3D10.1126%2Fscience.1249830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Garnier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1517/13543776.2014.859244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1517%2F13543776.2014.859244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24261714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=185-199&author=J.+M.+Garnierauthor=P.+P.+Sharpauthor=C.+J.+Burns&title=BET+bromodomain+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2014.859244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibitors: a patent review</span></div><div class="casAuthors">Garnier, Jean-Marc; Sharp, Phillip P.; Burns, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The bromodomain (BRD) and extra-C terminal domain (BET) protein family consists of four members (BRD2, BRD3, BRD4 and BRDT).  These "epigenetic readers" bind to acetyllysine (KAc) residues on the tails of histones H3 and H4, and regulate chromatin structure and gene expression.  There is increasing evidence of their role in human disease, and recently a no. of small-mol. inhibitors have been reported.  There is increasing interest in the inhibition of BET proteins for a variety of therapeutic applications that have resulted in considerable patent activity from academia and biotechnol. and pharmaceutical companies.  Areas covered: Data supporting the use of BET inhibitors in treating disease are outlined, and the current patent literature is discussed.  The survey is focused on patents claiming compds. as BET inhibitors and addnl. patents covering compds. now reported as BET inhibitors have been included.  Expert opinion: There is now compelling preclin. data demonstrating BET inhibition as a strategy to target processes known to be involved in disease development and progression with clin. trials of two bona fide BET inhibitors now underway.  Patent activity in this area is increasing with initial activity focused on variations to reported BET inhibitors and more recent patents disclosing novel chemotypes as BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6PVpCrReabVg90H21EOLACvtfcHk0lj4tpTvk2aWOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlWgtg%253D%253D&md5=bb33008eefa34f3689e0ee4a49a2539e</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.859244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.859244%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier%26aufirst%3DJ.%2BM.%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBET%2520bromodomain%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D185%26epage%3D199%26doi%3D10.1517%2F13543776.2014.859244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badock, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberspacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosmayer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmees, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Montalvan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haendler, B.</span><span> </span><span class="NLM_article-title">Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">9304</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span><span class="refDoi"> DOI: 10.1074/jbc.M113.523019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.M113.523019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24497639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVWjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=9304-9319&author=M.+Jungauthor=M.+Philpottauthor=S.+Mullerauthor=J.+Schulzeauthor=V.+Badockauthor=U.+Eberspacherauthor=D.+Moosmayerauthor=B.+Baderauthor=N.+Schmeesauthor=A.+Fernandez-Montalvanauthor=B.+Haendler&title=Affinity+map+of+bromodomain+protein+4+%28BRD4%29+interactions+with+the+histone+H4+tail+and+the+small+molecule+inhibitor+JQ1&doi=10.1074%2Fjbc.M113.523019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity Map of Bromodomain Protein 4 (BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1</span></div><div class="casAuthors">Jung, Marie; Philpott, Martin; Mueller, Susanne; Schulze, Jessica; Badock, Volker; Eberspaecher, Uwe; Moosmayer, Dieter; Bader, Benjamin; Schmees, Norbert; Fernandez-Montalvan, Amaury; Haendler, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">9304-9319</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain (BET) protein family.  It binds to acetylated histone tails via its tandem bromodomains BD1 and BD2 and forms a complex with the pos. transcription elongation factor b, which controls phosphorylation of RNA polymerase II, ultimately leading to stimulation of transcription elongation.  An essential role of BRD4 in cell proliferation and cancer growth has been reported in several recent studies.  We analyzed the binding of BRD4 BD1 and BD2 to different partners and showed that the strongest interactions took place with di- and tetra-acetylated peptides derived from the histone 4 N-terminal tail.  We also found that several histone 4 residues neighboring the acetylated lysines significantly influenced binding.  We generated 10 different BRD4 BD1 mutants and analyzed their affinities to acetylated histone tails and to the BET inhibitor JQ1 using several complementary biochem. and biophys. methods.  The impact of these mutations was confirmed in a cellular environment.  Altogether, the results show that Trp-81, Tyr-97, Asn-140, and Met-149 play similarly important roles in the recognition of acetylated histones and JQ1.  Pro-82, Leu-94, Asp-145, and Ile-146 have a more differentiated role, suggesting that different kinds of interactions take place and that resistance mutations compatible with BRD4 function are possible.  Our study extends the knowledge on the contribution of individual BRD4 amino acids to histone and JQ1 binding and may help in the design of new BET antagonists with improved pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8wAGYLccT1bVg90H21EOLACvtfcHk0lj4tpTvk2aWOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVWjs70%253D&md5=bf1d882e680e82660065b3e7b0a0f0f9</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.523019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.523019%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DEberspacher%26aufirst%3DU.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DSchmees%26aufirst%3DN.%26aulast%3DFernandez-Montalvan%26aufirst%3DA.%26aulast%3DHaendler%26aufirst%3DB.%26atitle%3DAffinity%2520map%2520of%2520bromodomain%2520protein%25204%2520%2528BRD4%2529%2520interactions%2520with%2520the%2520histone%2520H4%2520tail%2520and%2520the%2520small%2520molecule%2520inhibitor%2520JQ1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D9304%26epage%3D9319%26doi%3D10.1074%2Fjbc.M113.523019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Sharp, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span> </span><span class="NLM_article-title">Evaluation of functional groups as acetyl-lysine mimetics for BET bromodomain inhibition</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1834</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span><span class="refDoi"> DOI: 10.1039/C4MD00182F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1039%2FC4MD00182F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1834-1842&author=P.+P.+Sharpauthor=J.-M.+Garnierauthor=D.+C.+S.+Huangauthor=C.+J.+Burns&title=Evaluation+of+functional+groups+as+acetyl-lysine+mimetics+for+BET+bromodomain+inhibition&doi=10.1039%2FC4MD00182F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1039%2FC4MD00182F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00182F%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DGarnier%26aufirst%3DJ.-M.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520functional%2520groups%2520as%2520acetyl-lysine%2520mimetics%2520for%2520BET%2520bromodomain%2520inhibition%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D1834%26epage%3D1842%26doi%3D10.1039%2FC4MD00182F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Duffy, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarasimhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitchen, D. B.</span><span> </span><span class="NLM_article-title">Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2818</span><span class="NLM_x">–</span> <span class="NLM_lpage">2823</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2015.04.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2818-2823&author=B.+C.+Duffyauthor=S.+Liuauthor=G.+S.+Martinauthor=R.+Wangauthor=M.+M.+Hsiaauthor=H.+Zhaoauthor=C.+Guoauthor=M.+Ellisauthor=J.+F.+Quinnauthor=O.+A.+Kharenkoauthor=K.+Norekauthor=E.+M.+Gesnerauthor=P.+R.+Youngauthor=K.+G.+McLureauthor=G.+S.+Wagnerauthor=D.+Lakshminarasimhanauthor=A.+Whiteauthor=R.+K.+Sutoauthor=H.+C.+Hansenauthor=D.+B.+Kitchen&title=Discovery+of+a+new+chemical+series+of+BRD4%281%29+inhibitors+using+protein-ligand+docking+and+structure-guided+design&doi=10.1016%2Fj.bmcl.2015.04.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.107%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DB.%2BC.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DHsia%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DEllis%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DNorek%26aufirst%3DK.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DLakshminarasimhan%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DKitchen%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520new%2520chemical%2520series%2520of%2520BRD4%25281%2529%2520inhibitors%2520using%2520protein-ligand%2520docking%2520and%2520structure-guided%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2818%26epage%3D2823%26doi%3D10.1016%2Fj.bmcl.2015.04.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartenmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliotopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2496</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2014.04.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2493-2496&author=H.+Zhaoauthor=L.+Gartenmannauthor=J.+Dongauthor=D.+Spiliotopoulosauthor=A.+Caflisch&title=Discovery+of+BRD4+bromodomain+inhibitors+by+fragment-based+high-throughput+docking&doi=10.1016%2Fj.bmcl.2014.04.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGartenmann%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520BRD4%2520bromodomain%2520inhibitors%2520by%2520fragment-based%2520high-throughput%2520docking%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2493%26epage%3D2496%26doi%3D10.1016%2Fj.bmcl.2014.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Noguchi-Yachide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span> </span><span class="NLM_article-title">Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmc.2015.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25678016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=953-959&author=T.+Noguchi-Yachideauthor=T.+Sakaiauthor=Y.+Hashimotoauthor=T.+Yamaguchi&title=Discovery+and+structure-activity+relationship+studies+of+N6-benzoyladenine+derivatives+as+novel+BRD4+inhibitors&doi=10.1016%2Fj.bmc.2015.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors</span></div><div class="casAuthors">Noguchi-Yachide, Tomomi; Sakai, Taki; Hashimoto, Yuichi; Yamaguchi, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">953-959</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that bind to acetylated lysines in histones.  Among them, BRD4 is a candidate target mol. of therapeutic agents for diverse diseases, including cancer and inflammatory disease.  As a part of the continuing structural development studies of thalidomide to obtain a broad spectrum of biol. modifiers based on the 'multitemplate' approach, in this work the authors focused on BRD4-inhibitory activity, and discovered that N6-benzoyladenine derivs. exhibit this activity.  Structure-activity relationship studies led to N6-(2,4,5-trimethoxybenzoyl)adenine I, which exhibits potent BRD4 bromodomain1 inhibitory activity with an IC50 value of 0.427 μM.  N6-Benzoyladenine appears to be a new chem. scaffold for development of BRD4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwaLfpkAET7Vg90H21EOLACvtfcHk0lh0MtHvI-IgbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D&md5=889cf81c25fd1e62def22cb2f32dc06e</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi-Yachide%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520N6-benzoyladenine%2520derivatives%2520as%2520novel%2520BRD4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D953%26epage%3D959%26doi%3D10.1016%2Fj.bmc.2015.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8073</span><span class="NLM_x">–</span> <span class="NLM_lpage">8088</span><span class="refDoi"> DOI: 10.1021/jm4011302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8073-8088&author=L.+R.+Vidlerauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=S.+Martinauthor=M.+Tomsettauthor=H.+Woodwardauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Discovery+of+novel+small-molecule+inhibitors+of+BRD4+using+structure-based+virtual+screening&doi=10.1021%2Fjm4011302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening</span></div><div class="casAuthors">Vidler, Lewis R.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Martin, Sarah; Tomsett, Michael; Woodward, Hannah; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8073-8088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are epigenetic readers that recognize acetylated-lysine (KAc) on proteins and are implicated in a no. of diseases.  We describe a virtual screening approach to identify BRD inhibitors.  Key elements of this approach are the extensive design and use of substructure queries to compile a set of com. available compds. featuring novel putative KAc mimetics and docking this set for final compd. selection.  We describe the validation of this approach by applying it to the first BRD of BRD4.  The selection and testing of 143 compds. lead to the discovery of six novel hits, including four unprecedented KAc mimetics.  We solved the crystal structure of four hits, detd. their binding mode, and improved their potency through synthesis and the purchase of derivs.  This work provides a validated virtual screening approach that is applicable to other BRDs and describes novel KAc mimetics that can be further explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow5yj8bnohUbVg90H21EOLACvtfcHk0ljMknX4hgv2xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI&md5=c1f76e4838713335be7a93ebe4c68701</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Fjm4011302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011302%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTomsett%26aufirst%3DM.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520BRD4%2520using%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8073%26epage%3D8088%26doi%3D10.1021%2Fjm4011302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.drudis.2014.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25263697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=105-113&author=H.+Chenauthor=X.+Zhouauthor=A.+Wangauthor=Y.+Zhengauthor=Y.+Gaoauthor=J.+Zhou&title=Evolutions+in+fragment-based+drug+design%3A+the+deconstruction-reconstruction+approach&doi=10.1016%2Fj.drudis.2014.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span></div><div class="casAuthors">Chen, Haijun; Zhou, Xiaobin; Wang, Ailan; Zheng, Yunquan; Gao, Yu; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of mol. recognition and protein-ligand interactions have facilitated rapid development of potent and selective ligands for therapeutically relevant targets.  Over the past two decades, a variety of useful approaches and emerging techniques have been developed to promote the identification and optimization of leads that have high potential for generating new therapeutic agents.  Intriguingly, the innovation of a fragment-based drug design (FBDD) approach has enabled rapid and efficient progress in drug discovery.  In this crit. review, we focus on the construction of fragment libraries and the advantages and disadvantages of various fragment-based screening (FBS) for constructing such libraries.  We also highlight the deconstruction-reconstruction strategy by utilizing privileged fragments of reported ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWzbA5c5707Vg90H21EOLACvtfcHk0ljMknX4hgv2xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO&md5=13ce52517b336a860136ac3eb4151b16</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEvolutions%2520in%2520fragment-based%2520drug%2520design%253A%2520the%2520deconstruction-reconstruction%2520approach%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D105%26epage%3D113%26doi%3D10.1016%2Fj.drudis.2014.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Herait, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieblemont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffoux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magarotto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leleu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Roca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odore, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesnel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucca, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michallet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvitkovic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preudhomme, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span> </span><span class="NLM_article-title">Abstract CT231: BET-bromodomain inhibitor OTX015 shows clinically meaningful activity at nontoxic doses: interim results of an ongoing phase I trial in hematologic malignancies</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">CT231</span><span class="NLM_x">–</span> <span class="NLM_lpage">CT231</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-CT231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1538-7445.AM2014-CT231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=CT231-CT231&author=P.+E.+Heraitauthor=C.+Berthonauthor=C.+Thieblemontauthor=E.+Raffouxauthor=V.+Magarottoauthor=A.+Stathisauthor=X.+Thomasauthor=X.+Leleuauthor=C.+Gomez-Rocaauthor=E.+Odoreauthor=C.+Roumierauthor=F.+Bourdelauthor=B.+Quesnelauthor=E.+Zuccaauthor=M.+Michalletauthor=C.+Recherauthor=E.+Cvitkovicauthor=K.+Rezaiauthor=C.+Preudhommeauthor=T.+Faconauthor=A.+Palumboauthor=H.+Dombret&title=Abstract+CT231%3A+BET-bromodomain+inhibitor+OTX015+shows+clinically+meaningful+activity+at+nontoxic+doses%3A+interim+results+of+an+ongoing+phase+I+trial+in+hematologic+malignancies&doi=10.1158%2F1538-7445.AM2014-CT231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-CT231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-CT231%26sid%3Dliteratum%253Aachs%26aulast%3DHerait%26aufirst%3DP.%2BE.%26aulast%3DBerthon%26aufirst%3DC.%26aulast%3DThieblemont%26aufirst%3DC.%26aulast%3DRaffoux%26aufirst%3DE.%26aulast%3DMagarotto%26aufirst%3DV.%26aulast%3DStathis%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DX.%26aulast%3DLeleu%26aufirst%3DX.%26aulast%3DGomez-Roca%26aufirst%3DC.%26aulast%3DOdore%26aufirst%3DE.%26aulast%3DRoumier%26aufirst%3DC.%26aulast%3DBourdel%26aufirst%3DF.%26aulast%3DQuesnel%26aufirst%3DB.%26aulast%3DZucca%26aufirst%3DE.%26aulast%3DMichallet%26aufirst%3DM.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DCvitkovic%26aufirst%3DE.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DPreudhomme%26aufirst%3DC.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DDombret%26aufirst%3DH.%26atitle%3DAbstract%2520CT231%253A%2520BET-bromodomain%2520inhibitor%2520OTX015%2520shows%2520clinically%2520meaningful%2520activity%2520at%2520nontoxic%2520doses%253A%2520interim%2520results%2520of%2520an%2520ongoing%2520phase%2520I%2520trial%2520in%2520hematologic%2520malignancies%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3DCT231%26epage%3DCT231%26doi%3D10.1158%2F1538-7445.AM2014-CT231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Fong, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ftouni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papenfuss, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M. A.</span><span> </span><span class="NLM_article-title">BET inhibitor resistance emerges from leukaemia stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1038/nature14888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature14888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26367796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=538-542&author=C.+Y.+Fongauthor=O.+Gilanauthor=E.+Y.+Lamauthor=A.+F.+Rubinauthor=S.+Ftouniauthor=D.+Tylerauthor=K.+Stanleyauthor=D.+Sinhaauthor=P.+Yehauthor=J.+Morisonauthor=G.+Giotopoulosauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+C.+Leeauthor=C.+Carpenterauthor=R.+Gregoryauthor=R.+G.+Ramsayauthor=S.+W.+Laneauthor=O.+Abdel-Wahabauthor=T.+Kouzaridesauthor=R.+W.+Johnstoneauthor=S.+J.+Dawsonauthor=B.+J.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+T.+Papenfussauthor=M.+A.+Dawson&title=BET+inhibitor+resistance+emerges+from+leukaemia+stem+cells&doi=10.1038%2Fnature14888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor resistance emerges from leukaemia stem cells</span></div><div class="casAuthors">Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Rubin, Alan F.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Morison, Jessica; Giotopoulos, George; Lugo, Dave; Jeffrey, Philip; Lee, Stanley Chun-Wei; Carpenter, Christopher; Gregory, Richard; Ramsay, Robert G.; Lane, Steven W.; Abdel-Wahab, Omar; Kouzarides, Tony; Johnstone, Ricky W.; Dawson, Sarah-Jane; Huntly, Brian J. P.; Prinjha, Rab K.; Papenfuss, Anthony T.; Dawson, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">538-542</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks.  Early clin. trials have shown promise, esp. in acute myeloid leukemia, and therefore the evaluation of resistance mechanisms is crucial to optimize the clin. efficacy of these drugs.  Here we use primary mouse hematopoietic stem and progenitor cells immortalized with the fusion protein MLL-AF9 to generate several single-cell clones that demonstrate resistance, in vitro and in vivo, to the prototypical BET inhibitor, I-BET.  Resistance to I-BET confers cross-resistance to chem. distinct BET inhibitors such as JQ1, as well as resistance to genetic knockdown of BET proteins.  Resistance is not mediated through increased drug efflux or metab., but is shown to emerge from leukemia stem cells both ex vivo and in vivo.  Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate transcription.  We demonstrate that resistance to BET inhibitors, in human and mouse leukemia cells, is in part a consequence of increased Wnt/β-catenin signaling, and neg. regulation of this pathway results in restoration of sensitivity to I-BET in vitro and in vivo.  Together, these findings provide new insights into the biol. of acute myeloid leukemia, highlight potential therapeutic limitations of BET inhibitors, and identify strategies that may enhance the clin. utility of these unique targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Lg1n64SCWrVg90H21EOLACvtfcHk0ljMknX4hgv2xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL&md5=47d1769e077b1c6c92ff52a051368404</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fnature14888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14888%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DC.%2BY.%26aulast%3DGilan%26aufirst%3DO.%26aulast%3DLam%26aufirst%3DE.%2BY.%26aulast%3DRubin%26aufirst%3DA.%2BF.%26aulast%3DFtouni%26aufirst%3DS.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DStanley%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMorison%26aufirst%3DJ.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DCarpenter%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DR.%26aulast%3DRamsay%26aufirst%3DR.%2BG.%26aulast%3DLane%26aufirst%3DS.%2BW.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DDawson%26aufirst%3DS.%2BJ.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DPapenfuss%26aufirst%3DA.%2BT.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26atitle%3DBET%2520inhibitor%2520resistance%2520emerges%2520from%2520leukaemia%2520stem%2520cells%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D538%26epage%3D542%26doi%3D10.1038%2Fnature14888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Rathert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muerdter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deswal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny-Reiterer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jude, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boryn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweifer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuber, J.</span><span> </span><span class="NLM_article-title">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1038/nature14898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature14898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26367798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=543-547&author=P.+Rathertauthor=M.+Rothauthor=T.+Neumannauthor=F.+Muerdterauthor=J.+S.+Roeauthor=M.+Muharauthor=S.+Deswalauthor=S.+Cerny-Reitererauthor=B.+Peterauthor=J.+Judeauthor=T.+Hoffmannauthor=L.+M.+Borynauthor=E.+Axelssonauthor=N.+Schweiferauthor=U.+Tontsch-Gruntauthor=L.+E.+Dowauthor=D.+Gianniauthor=M.+Pearsonauthor=P.+Valentauthor=A.+Starkauthor=N.+Krautauthor=C.+R.+Vakocauthor=J.+Zuber&title=Transcriptional+plasticity+promotes+primary+and+acquired+resistance+to+BET+inhibition&doi=10.1038%2Fnature14898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span></div><div class="casAuthors">Rathert, Philipp; Roth, Mareike; Neumann, Tobias; Muerdter, Felix; Roe, Jae-Seok; Muhar, Matthias; Deswal, Sumit; Cerny-Reiterer, Sabine; Peter, Barbara; Jude, Julian; Hoffmann, Thomas; Boryn, Lukasz M.; Axelsson, Elin; Schweifer, Norbert; Tontsch-Grunt, Ulrike; Dow, Lukas E.; Gianni, Davide; Pearson, Mark; Valent, Peter; Stark, Alexander; Kraut, Norbert; Vakoc, Christopher R.; Zuber, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">543-547</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Following the discovery of BRD4 as a non-oncogene addiction target in acute myeloid leukemia (AML), bromodomain and extra terminal protein (BET) inhibitors are being explored as a promising therapeutic avenue in numerous cancers.  While clin. trials have reported single-agent activity in advanced hematol. malignancies, mechanisms detg. the response to BET inhibition remain poorly understood.  To identify factors involved in primary and acquired BET resistance in leukemia, here we perform a chromatin-focused RNAi screen in a sensitive MLL-AF9;NrasG12D-driven AML mouse model, and investigate dynamic transcriptional profiles in sensitive and resistant mouse and human leukemias.  Our screen shows that suppression of the PRC2 complex, contrary to effects in other contexts, promotes BET inhibitor resistance in AML.  PRC2 suppression does not directly affect the regulation of Brd4-dependent transcripts, but facilitates the remodelling of regulatory pathways that restore the transcription of key targets such as Myc.  Similarly, while BET inhibition triggers acute MYC repression in human leukemias regardless of their sensitivity, resistant leukemias are uniformly characterized by their ability to rapidly restore MYC transcription.  This process involves the activation and recruitment of WNT signaling components, which compensate for the loss of BRD4 and drive resistance in various cancer models.  Dynamic chromatin immunopptn. sequencing and self-transcribing active regulatory region sequencing of enhancer profiles reveal that BET-resistant states are characterized by remodelled regulatory landscapes, involving the activation of a focal MYC enhancer that recruits WNT machinery in response to BET inhibition.  Together, our results identify and validate WNT signaling as a driver and candidate biomarker of primary and acquired BET resistance in leukemia, and implicate the rewiring of transcriptional programs as an important mechanism promoting resistance to BET inhibitors and, potentially, other chromatin-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDgeY3nFr4GrVg90H21EOLACvtfcHk0lhIYREreRWMZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO&md5=6d6cf4c4123ad6a698b88f02f95a2ebe</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1038%2Fnature14898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14898%26sid%3Dliteratum%253Aachs%26aulast%3DRathert%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DT.%26aulast%3DMuerdter%26aufirst%3DF.%26aulast%3DRoe%26aufirst%3DJ.%2BS.%26aulast%3DMuhar%26aufirst%3DM.%26aulast%3DDeswal%26aufirst%3DS.%26aulast%3DCerny-Reiterer%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DB.%26aulast%3DJude%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DBoryn%26aufirst%3DL.%2BM.%26aulast%3DAxelsson%26aufirst%3DE.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DGianni%26aufirst%3DD.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DA.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DZuber%26aufirst%3DJ.%26atitle%3DTranscriptional%2520plasticity%2520promotes%2520primary%2520and%2520acquired%2520resistance%2520to%2520BET%2520inhibition%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D543%26epage%3D547%26doi%3D10.1038%2Fnature14898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Shu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witwicki, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabassum, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammed, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekram, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peluffo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Santos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krop, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span> </span><span class="NLM_article-title">Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">529</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1038/nature16508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature16508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26735014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1Gmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=529&publication_year=2016&pages=413-417&author=S.+Shuauthor=C.+Y.+Linauthor=H.+H.+Heauthor=R.+M.+Witwickiauthor=D.+P.+Tabassumauthor=J.+M.+Robertsauthor=M.+Janiszewskaauthor=S.+J.+Huhauthor=Y.+Liangauthor=J.+Ryanauthor=E.+Dohertyauthor=H.+Mohammedauthor=H.+Guoauthor=D.+G.+Stoverauthor=M.+B.+Ekramauthor=G.+Peluffoauthor=J.+Brownauthor=C.+D%E2%80%99Santosauthor=I.+E.+Kropauthor=D.+Dillonauthor=M.+McKeownauthor=C.+Ottauthor=J.+Qiauthor=M.+Niauthor=P.+K.+Raoauthor=M.+Duarteauthor=S.+Y.+Wuauthor=C.+M.+Chiangauthor=L.+Andersauthor=R.+A.+Youngauthor=E.+P.+Winerauthor=A.+Letaiauthor=W.+T.+Barryauthor=J.+S.+Carrollauthor=H.+W.+Longauthor=M.+Brownauthor=X.+S.+Liuauthor=C.+A.+Meyerauthor=J.+E.+Bradnerauthor=K.+Polyak&title=Response+and+resistance+to+BET+bromodomain+inhibitors+in+triple-negative+breast+cancer&doi=10.1038%2Fnature16508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer</span></div><div class="casAuthors">Shu, Shaokun; Lin, Charles Y.; He, Housheng Hansen; Witwicki, Robert M.; Tabassum, Doris P.; Roberts, Justin M.; Janiszewska, Michalina; Huh, Sung Jin; Liang, Yi; Ryan, Jeremy; Doherty, Ernest; Mohammed, Hisham; Guo, Hao; Stover, Daniel G.; Ekram, Muhammad B.; Peluffo, Guillermo; Brown, Jonathan; D'Santos, Clive; Krop, Ian E.; Dillon, Deborah; McKeown, Michael; Ott, Christopher; Qi, Jun; Ni, Min; Rao, Prakash K.; Duarte, Melissa; Wu, Shwu-Yuan; Chiang, Cheng-Ming; Anders, Lars; Young, Richard A.; Winer, Eric P.; Letai, Antony; Barry, William T.; Carroll, Jason S.; Long, Henry W.; Brown, Myles; Shirley Liu, X.; Meyer, Clifford A.; Bradner, James E.; Polyak, Kornelia</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">529</span>
        (<span class="NLM_cas:issue">7586</span>),
    <span class="NLM_cas:pages">413-417</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a heterogeneous and clin. aggressive disease for which there is no targeted therapy.  BET bromodomain inhibitors, which have shown efficacy in several models of cancer, have not been evaluated in TNBC.  These inhibitors displace BET bromodomain proteins such as BRD4 from chromatin by competing with their acetyl-lysine recognition modules, leading to inhibition of oncogenic transcriptional programs.  Here we report the preferential sensitivity of TNBCs to BET bromodomain inhibition in vitro and in vivo, establishing a rationale for clin. investigation and further motivation to understand mechanisms of resistance.  In paired cell lines selected for acquired resistance to BET inhibition from previously sensitive TNBCs, we failed to identify gatekeeper mutations, new driver events or drug pump activation.  BET-resistant TNBC cells remain dependent on wild-type BRD4, which supports transcription and cell proliferation in a bromodomain-independent manner.  Proteomic studies of resistant TNBC identify strong assocn. with MED1 and hyper-phosphorylation of BRD4 attributable to decreased activity of PP2A, identified here as a principal BRD4 serine phosphatase.  Together, these studies provide a rationale for BET inhibition in TNBC and present mechanism-based combination strategies to anticipate clin. drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZu5A85pdQDbVg90H21EOLACvtfcHk0lhIYREreRWMZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1Gmtw%253D%253D&md5=50a03861d9156ee6e344e95c5f5361b9</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fnature16508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16508%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DHe%26aufirst%3DH.%2BH.%26aulast%3DWitwicki%26aufirst%3DR.%2BM.%26aulast%3DTabassum%26aufirst%3DD.%2BP.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DJaniszewska%26aufirst%3DM.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DMohammed%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DStover%26aufirst%3DD.%2BG.%26aulast%3DEkram%26aufirst%3DM.%2BB.%26aulast%3DPeluffo%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Santos%26aufirst%3DC.%26aulast%3DKrop%26aufirst%3DI.%2BE.%26aulast%3DDillon%26aufirst%3DD.%26aulast%3DMcKeown%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DNi%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DP.%2BK.%26aulast%3DDuarte%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DChiang%26aufirst%3DC.%2BM.%26aulast%3DAnders%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DW.%2BT.%26aulast%3DCarroll%26aufirst%3DJ.%2BS.%26aulast%3DLong%26aufirst%3DH.%2BW.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BS.%26aulast%3DMeyer%26aufirst%3DC.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DResponse%2520and%2520resistance%2520to%2520BET%2520bromodomain%2520inhibitors%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DNature%26date%3D2016%26volume%3D529%26spage%3D413%26epage%3D417%26doi%3D10.1038%2Fnature16508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Kurimchak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbasov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounsbury, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chernoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, J. S.</span><span> </span><span class="NLM_article-title">Resistance to BET bromodomain inhibitors is mediated by kinome reprogramming in ovarian cancer</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span><span class="refDoi"> DOI: 10.1016/j.celrep.2016.06.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.celrep.2016.06.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27452461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1CksrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1273-1286&author=A.+M.+Kurimchakauthor=C.+Sheltonauthor=K.+E.+Duncanauthor=K.+J.+Johnsonauthor=J.+Brownauthor=S.+O%E2%80%99Brienauthor=R.+Gabbasovauthor=L.+S.+Finkauthor=Y.+Liauthor=N.+Lounsburyauthor=M.+Abou-Gharbiaauthor=W.+E.+Childersauthor=D.+C.+Connollyauthor=J.+Chernoffauthor=J.+R.+Petersonauthor=J.+S.+Duncan&title=Resistance+to+BET+bromodomain+inhibitors+is+mediated+by+kinome+reprogramming+in+ovarian+cancer&doi=10.1016%2Fj.celrep.2016.06.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer</span></div><div class="casAuthors">Kurimchak, Alison M.; Shelton, Claude; Duncan, Kelly E.; Johnson, Katherine J.; Brown, Jennifer; O'Brien, Shane; Gabbasov, Rashid; Fink, Lauren S.; Li, Yuesheng; Lounsbury, Nicole; Abou-Gharbia, Magid; Childers, Wayne E.; Connolly, Denise C.; Chernoff, Jonathan; Peterson, Jeffrey R.; Duncan, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1273-1286</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Small-mol. BET bromodomain inhibitors (BETis) are actively being pursued in clin. trials for the treatment of a variety of cancers, but the mechanisms of resistance to BETis remain poorly understood.  Using a mass spectrometry approach that globally measures kinase signaling at the proteomic level, we evaluated the response of the kinome to targeted BETi treatment in a panel of BRD4-dependent ovarian carcinoma (OC) cell lines.  Despite initial inhibitory effects of BETi, OC cells acquired resistance following sustained treatment with the BETi JQ1.  Through application of multiplexed inhibitor beads (MIBs) and mass spectrometry, we demonstrate that BETi resistance is mediated by adaptive kinome reprogramming, where activation of compensatory pro-survival kinase networks overcomes BET protein inhibition.  Furthermore, drug combinations blocking these kinases may prevent or delay the development of drug resistance and enhance the efficacy of BETi therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPzs6AVtF-WbVg90H21EOLACvtfcHk0lhPFSpFzaFw5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1CksrzP&md5=a6634682be95335e2616c94d123b1265</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.06.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.06.091%26sid%3Dliteratum%253Aachs%26aulast%3DKurimchak%26aufirst%3DA.%2BM.%26aulast%3DShelton%26aufirst%3DC.%26aulast%3DDuncan%26aufirst%3DK.%2BE.%26aulast%3DJohnson%26aufirst%3DK.%2BJ.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DGabbasov%26aufirst%3DR.%26aulast%3DFink%26aufirst%3DL.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLounsbury%26aufirst%3DN.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DConnolly%26aufirst%3DD.%2BC.%26aulast%3DChernoff%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26aulast%3DDuncan%26aufirst%3DJ.%2BS.%26atitle%3DResistance%2520to%2520BET%2520bromodomain%2520inhibitors%2520is%2520mediated%2520by%2520kinome%2520reprogramming%2520in%2520ovarian%2520cancer%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D16%26spage%3D1273%26epage%3D1286%26doi%3D10.1016%2Fj.celrep.2016.06.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Muralidharan, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhadury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. A.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4689</span><span class="NLM_x">–</span> <span class="NLM_lpage">4697</span><span class="refDoi"> DOI: 10.1038/onc.2015.521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fonc.2015.521" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=4689-4697&author=S.+V.+Muralidharanauthor=J.+Bhaduryauthor=L.+M.+Nilssonauthor=L.+C.+Greenauthor=K.+G.+McLureauthor=J.+A.+Nilsson&title=BET+bromodomain+inhibitors+synergize+with+ATR+inhibitors+to+induce+DNA+damage%2C+apoptosis%2C+senescence-associated+secretory+pathway+and+ER+stress+in+Myc-induced+lymphoma+cells&doi=10.1038%2Fonc.2015.521"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.521%26sid%3Dliteratum%253Aachs%26aulast%3DMuralidharan%26aufirst%3DS.%2BV.%26aulast%3DBhadury%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DL.%2BM.%26aulast%3DGreen%26aufirst%3DL.%2BC.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DNilsson%26aufirst%3DJ.%2BA.%26atitle%3DBET%2520bromodomain%2520inhibitors%2520synergize%2520with%2520ATR%2520inhibitors%2520to%2520induce%2520DNA%2520damage%252C%2520apoptosis%252C%2520senescence-associated%2520secretory%2520pathway%2520and%2520ER%2520stress%2520in%2520Myc-induced%2520lymphoma%2520cells%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D4689%26epage%3D4697%26doi%3D10.1038%2Fonc.2015.521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Amorim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magarotto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leleu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morschhauser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broussais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herait, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahatt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokiec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucca, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieblemont, C.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study</span> <span class="citation_source-journal">Lancet Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e196</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1016/S2352-3026(16)00021-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS2352-3026%2816%2900021-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27063978" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=e196-204&author=S.+Amorimauthor=A.+Stathisauthor=M.+Gleesonauthor=S.+Iyengarauthor=V.+Magarottoauthor=X.+Leleuauthor=F.+Morschhauserauthor=L.+Karlinauthor=F.+Broussaisauthor=K.+Rezaiauthor=P.+Heraitauthor=C.+Kahattauthor=F.+Lokiecauthor=G.+Sallesauthor=T.+Faconauthor=A.+Palumboauthor=D.+Cunninghamauthor=E.+Zuccaauthor=C.+Thieblemont&title=Bromodomain+inhibitor+OTX015+in+patients+with+lymphoma+or+multiple+myeloma%3A+a+dose-escalation%2C+open-label%2C+pharmacokinetic%2C+phase+1+study&doi=10.1016%2FS2352-3026%2816%2900021-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2FS2352-3026%2816%2900021-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2352-3026%252816%252900021-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmorim%26aufirst%3DS.%26aulast%3DStathis%26aufirst%3DA.%26aulast%3DGleeson%26aufirst%3DM.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DMagarotto%26aufirst%3DV.%26aulast%3DLeleu%26aufirst%3DX.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DBroussais%26aufirst%3DF.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DHerait%26aufirst%3DP.%26aulast%3DKahatt%26aufirst%3DC.%26aulast%3DLokiec%26aufirst%3DF.%26aulast%3DSalles%26aufirst%3DG.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DZucca%26aufirst%3DE.%26aulast%3DThieblemont%26aufirst%3DC.%26atitle%3DBromodomain%2520inhibitor%2520OTX015%2520in%2520patients%2520with%2520lymphoma%2520or%2520multiple%2520myeloma%253A%2520a%2520dose-escalation%252C%2520open-label%252C%2520pharmacokinetic%252C%2520phase%25201%2520study%26jtitle%3DLancet%2520Haematol.%26date%3D2016%26volume%3D3%26spage%3De196%26epage%3D204%26doi%3D10.1016%2FS2352-3026%2816%2900021-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Amarnath Praphakar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munusamy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadasivuni, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajan, M.</span><span> </span><span class="NLM_article-title">Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x">, </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2016.09.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ijpharm.2016.09.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27693734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Sjs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2016&pages=628-635&author=R.+Amarnath+Praphakarauthor=M.+A.+Munusamyauthor=K.+K.+Sadasivuniauthor=M.+Rajan&title=Targeted+delivery+of+rifampicin+to+tuberculosis-infected+macrophages%3A+design%2C+in-vitro%2C+and+in-vivo+performance+of+rifampicin-loaded+poly%28ester+amide%29s+nanocarriers&doi=10.1016%2Fj.ijpharm.2016.09.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers</span></div><div class="casAuthors">Amarnath Praphakar, Rajendran; Munusamy, Murugan A.; Sadasivuni, Kishor Kumar; Rajan, Mariappan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">628-635</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed a nano drug delivery system for the treatment of tuberculosis (TB) using rifampicin (RF) encapsulated in poly(ester amide)s nanoparticles (PEA-RF-NPs), which are biocompatible polymers.  In this study, biodegradable amino acid based poly(ester amide)s (PEAs) were synthesized by the poly condensation reaction and RF-loaded NPs were fabricated by the dialysis method.  The surface morphol. and in-vitro drug release efficiency were examd.  The effect of time and temp. on the cellular uptake of PEA-RF-NPs in NR8383 cells was evaluated.  Fluorescence microscopic results of PEA-RF-NPs from NR8383 cell lines suggest its potential application in treating TB.  The antibacterial activity of RF against Mycobacterium smegmatis was also evaluated.  Based on these results, this approach provides a new means for controlled and efficient release of RF using the PEA-NPs delivery system and is promising for the treatment of TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnJhfkg3lyULVg90H21EOLACvtfcHk0lhab82anWspDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Sjs77L&md5=cb499632c63621bf06a4ba47aefb9a45</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2016.09.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2016.09.080%26sid%3Dliteratum%253Aachs%26aulast%3DAmarnath%2BPraphakar%26aufirst%3DR.%26aulast%3DMunusamy%26aufirst%3DM.%2BA.%26aulast%3DSadasivuni%26aufirst%3DK.%2BK.%26aulast%3DRajan%26aufirst%3DM.%26atitle%3DTargeted%2520delivery%2520of%2520rifampicin%2520to%2520tuberculosis-infected%2520macrophages%253A%2520design%252C%2520in-vitro%252C%2520and%2520in-vivo%2520performance%2520of%2520rifampicin-loaded%2520poly%2528ester%2520amide%2529s%2520nanocarriers%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2016%26volume%3D513%26spage%3D628%26epage%3D635%26doi%3D10.1016%2Fj.ijpharm.2016.09.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 140 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yi Zhang, Deqin Rong, Bingbing Li, <span class="NLM_string-name hlFld-ContribAuthor">Yuanxiang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7900-7925. <a href="https://doi.org/10.1021/acs.jmedchem.0c02055" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BEpigenetic%252BRegulators%252Bwith%252BCovalent%252BSmall-Molecule%252BInhibitors%26aulast%3DZhang%26aufirst%3DYi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26112020%26date%3D18022021%26volume%3D64%26issue%3D12%26spage%3D7900%26epage%3D7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiyoung Kim, <span class="NLM_string-name hlFld-ContribAuthor">Eun Jeong Yoo</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Ring Expansion of Activated Heteroarenes Enabled by Regioselective Dearomatization. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (11)
                                     , 4256-4260. <a href="https://doi.org/10.1021/acs.orglett.1c01173" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01173%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BRing%252BExpansion%252Bof%252BActivated%252BHeteroarenes%252BEnabled%252Bby%252BRegioselective%252BDearomatization%26aulast%3DKim%26aufirst%3DJiyoung%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D09042021%26date%3D24052021%26volume%3D23%26issue%3D11%26spage%3D4256%26epage%3D4260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Helen E. Aylott, Stephen J. Atkinson, Paul Bamborough, Anna Bassil, Chun-wa Chung, Laurie Gordon, Paola Grandi, James R. J. Gray, Lee A. Harrison, Thomas G. Hayhow, Cassie Messenger, Darren Mitchell, Alexander Phillipou, Alex Preston, Rab K. Prinjha, Francesco Rianjongdee, Inmaculada Rioja, Jonathan T. Seal, Ian D. Wall, Robert J. Watson, James M. Woolven, <span class="NLM_string-name hlFld-ContribAuthor">Emmanuel H. Demont</span>. </span><span class="cited-content_cbyCitation_article-title">Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3249-3281. <a href="https://doi.org/10.1021/acs.jmedchem.0c02156" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02156%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTemplate-Hopping%252BApproach%252BLeads%252Bto%252BPotent%25252C%252BSelective%25252C%252Band%252BHighly%252BSoluble%252BBromo%252Band%252BExtraterminal%252BDomain%252B%252528BET%252529%252BSecond%252BBromodomain%252B%252528BD2%252529%252BInhibitors%26aulast%3DAylott%26aufirst%3DHelen%2BE.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14122020%26date%3D04032021%26volume%3D64%26issue%3D6%26spage%3D3249%26epage%3D3281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pan Tang, Jifa Zhang, Jie Liu, Cheng-Ming Chiang, <span class="NLM_string-name hlFld-ContribAuthor">Liang Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2419-2435. <a href="https://doi.org/10.1021/acs.jmedchem.0c01487" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01487%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BBromodomain%252Band%252BExtraterminal%252BProteins%252Bfor%252BDrug%252BDiscovery%25253A%252BFrom%252BCurrent%252BProgress%252Bto%252BTechnological%252BDevelopment%26aulast%3DTang%26aufirst%3DPan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26082020%26date%3D22022021%26volume%3D64%26issue%3D5%26spage%3D2419%26epage%3D2435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Sunil Bhakta, Nicole Blaquiere, Jinhua Chen, Josefa dela Cruz-Chuh, Karen E. Gascoigne, Steven J. Hartman, Mingtao He, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liang Liu, Liling Liu, Qi Liu, Ying Lu, Fanwei Meng, Melinda M. Mulvihill, Aimee O’Donohue, Rebecca K. Rowntree, Leanna R. Staben, Steven T. Staben, John Wai, Jian Wang, BinQing Wei, Catherine Wilson, Jianfeng Xin, Zijin Xu, Hui Yao, Donglu Zhang, Hongyan Zhang, Hao Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2534-2575. <a href="https://doi.org/10.1021/acs.jmedchem.0c01845" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01845%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibody-Mediated%252BDelivery%252Bof%252BChimeric%252BBRD4%252BDegraders.%252BPart%252B1%25253A%252BExploration%252Bof%252BAntibody%252BLinker%25252C%252BPayload%252BLoading%25252C%252Band%252BPayload%252BMolecular%252BProperties%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21102020%26date%3D17022021%26volume%3D64%26issue%3D5%26spage%3D2534%26epage%3D2575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Jinhua Chen, Nicholas Corr, Josefa dela Cruz-Chuh, Geoffrey Del Rosario, Aaron Fullerton, Steven J. Hartman, Fan Jiang, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liling Liu, Ying Lu, Melinda M. Mulvihill, Jeremy M. Murray, Aimee O’Donohue, Rebecca K. Rowntree, William S. Sawyer, Leanna R. Staben, John Wai, Jian Wang, BinQing Wei, Wentao Wei, Zijin Xu, Hui Yao, Shang-Fan Yu, Donglu Zhang, Hongyan Zhang, Shenhua Zhang, Yongxin Zhao, Hao Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2576-2607. <a href="https://doi.org/10.1021/acs.jmedchem.0c01846" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01846%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibody-Mediated%252BDelivery%252Bof%252BChimeric%252BBRD4%252BDegraders.%252BPart%252B2%25253A%252BImprovement%252Bof%252BIn%252BVitro%252BAntiproliferation%252BActivity%252Band%252BIn%252BVivo%252BAntitumor%252BEfficacy%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21102020%26date%3D17022021%26volume%3D64%26issue%3D5%26spage%3D2576%26epage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yifei Yang, Lincheng Fang, Pan Chen, Huibin Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jinpei Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 3,5-Dimethylisoxazole Derivatives as BRD4 Inhibitors for the Treatment of Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2174-2181. <a href="https://doi.org/10.1021/acsmedchemlett.0c00294" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00294%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B3%25252C5-Dimethylisoxazole%252BDerivatives%252Bas%252BBRD4%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BColorectal%252BCancer%26aulast%3DYang%26aufirst%3DYifei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29052020%26date%3D31082020%26date%3D02092020%26date%3D31082020%26volume%3D11%26issue%3D11%26spage%3D2174%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bianca Altenburg, Marcus Frings, Jan-Hendrik Schöbel, Jonas Goßen, Kristina Pannen, Kim Vanderliek, Giulia Rossetti, Steffen Koschmieder, Nicolas Chatain, <span class="NLM_string-name hlFld-ContribAuthor">Carsten Bolm</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid Malignancies. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1928-1934. <a href="https://doi.org/10.1021/acsmedchemlett.9b00625" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00625%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DChiral%252BAnalogues%252Bof%252BPFI-1%252Bas%252BBET%252BInhibitors%252Band%252BTheir%252BFunctional%252BRole%252Bin%252BMyeloid%252BMalignancies%26aulast%3DAltenburg%26aufirst%3DBianca%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19122019%26date%3D02042020%26date%3D07042020%26date%3D02042020%26volume%3D11%26issue%3D10%26spage%3D1928%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher R. Wellaway, Paul Bamborough, Sharon G. Bernard, Chun-wa Chung, Peter D. Craggs, Leanne Cutler, Emmanuel H. Demont, John P. Evans, Laurie Gordon, Bhumika Karamshi, Antonia J. Lewis, Matthew J. Lindon, Darren J. Mitchell, Inmaculada Rioja, Peter E. Soden, Simon Taylor, Robert J. Watson, Rob Willis, James M. Woolven, Beata S. Wyspiańska, William J. Kerr, <span class="NLM_string-name hlFld-ContribAuthor">Rab K. Prinjha</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9020-9044. <a href="https://doi.org/10.1021/acs.jmedchem.0c00566" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00566%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ba%252BBromodomain%252Band%252BExtraterminal%252BDomain%252B%252528BET%252529%252BInhibitor%252BSelective%252Bfor%252Bthe%252BN-Terminal%252BBromodomains%252BThat%252BRetains%252Ban%252BAnti-inflammatory%252Band%252BAntiproliferative%252BPhenotype%26aulast%3DWellaway%26aufirst%3DChristopher%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06042020%26date%3D03082020%26volume%3D63%26issue%3D17%26spage%3D9020%26epage%3D9044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alex Preston, Stephen Atkinson, Paul Bamborough, Chun-wa Chung, Peter D. Craggs, Laurie Gordon, Paola Grandi, James R. J. Gray, Emma J. Jones, Matthew Lindon, Anne-Marie Michon, Darren J. Mitchell, Rab K. Prinjha, Francesco Rianjongdee, Inmaculada Rioja, Jonathan Seal, Simon Taylor, Ian Wall, Robert J. Watson, James Woolven, <span class="NLM_string-name hlFld-ContribAuthor">Emmanuel H Demont</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of Proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9070-9092. <a href="https://doi.org/10.1021/acs.jmedchem.0c00605" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00605%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252Ba%252BHighly%252BSelective%252Band%252BIn%252BVivo-Capable%252BInhibitor%252Bof%252Bthe%252BSecond%252BBromodomain%252Bof%252Bthe%252BBromodomain%252Band%252BExtra%252BTerminal%252BDomain%252BFamily%252Bof%252BProteins%26aulast%3DPreston%26aufirst%3DAlex%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16042020%26date%3D20082020%26date%3D21072020%26volume%3D63%26issue%3D17%26spage%3D9070%26epage%3D9092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jonathan T. Seal, Stephen J. Atkinson, Helen Aylott, Paul Bamborough, Chun-wa Chung, Royston C. B. Copley, Laurie Gordon, Paola Grandi, James R. J. Gray, Lee A. Harrison, Thomas G. Hayhow, Matthew Lindon, Cassie Messenger, Anne-Marie Michon, Darren Mitchell, Alex Preston, Rab K. Prinjha, Inmaculada Rioja, Simon Taylor, Ian D. Wall, Robert J. Watson, James M. Woolven, <span class="NLM_string-name hlFld-ContribAuthor">Emmanuel H. Demont</span>. </span><span class="cited-content_cbyCitation_article-title">The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9093-9126. <a href="https://doi.org/10.1021/acs.jmedchem.0c00796" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00796%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BOptimization%252Bof%252Ba%252BNovel%25252C%252BWeak%252BBromo%252Band%252BExtra%252BTerminal%252BDomain%252B%252528BET%252529%252BBromodomain%252BFragment%252BLigand%252Bto%252Ba%252BPotent%252Band%252BSelective%252BSecond%252BBromodomain%252B%252528BD2%252529%252BInhibitor%26aulast%3DSeal%26aufirst%3DJonathan%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11052020%26date%3D30082020%26date%3D23072020%26volume%3D63%26issue%3D17%26spage%3D9093%26epage%3D9126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yangfeng Li, Jiong Zhao, Lauren M. Gutgesell, Zhengnan Shen, Kiira Ratia, Katherine Dye, Oleksii Dubrovskyi, Huiping Zhao, Fei Huang, Debra A. Tonetti, Gregory R. J. Thatcher, <span class="NLM_string-name hlFld-ContribAuthor">Rui Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 7186-7210. <a href="https://doi.org/10.1021/acs.jmedchem.0c00456" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00456%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPyrrolopyridone%252BBromodomain%252Band%252BExtra-Terminal%252BMotif%252B%252528BET%252529%252BInhibitors%252BEffective%252Bin%252BEndocrine-Resistant%252BER%25252B%252BBreast%252BCancer%252Bwith%252BAcquired%252BResistance%252Bto%252BFulvestrant%252Band%252BPalbociclib%26aulast%3DLi%26aufirst%3DYangfeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18032020%26date%3D15062020%26date%3D26052020%26volume%3D63%26issue%3D13%26spage%3D7186%26epage%3D7210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiqing Liu, Haiying Chen, Pingyuan Wang, Yi Li, Eric A. Wold, Paul G. Leonard, Sarah Joseph, Allan R. Brasier, Bing Tian, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5242-5256. <a href="https://doi.org/10.1021/acs.jmedchem.0c00035" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BOrally%252BBioavailable%252BChromone%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252BBRD4%252BInhibitors%25253A%252BScaffold%252BHopping%25252C%252BOptimization%25252C%252Band%252BPharmacological%252BEvaluation%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08012020%26date%3D22042020%26date%3D07042020%26volume%3D63%26issue%3D10%26spage%3D5242%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">George S. Sheppard, Le Wang, Steven D. Fidanze, Lisa A. Hasvold, Dachun Liu, John K. Pratt, Chang H. Park, Kenton Longenecker, Wei Qiu, Maricel Torrent, Peter J. Kovar, Mai Bui, Emily Faivre, Xiaoli Huang, Xiaoyu Lin, Denise Wilcox, Lu Zhang, Yu Shen, Daniel H. Albert, Terrance J. Magoc, Ganesh Rajaraman, Warren M. Kati, <span class="NLM_string-name hlFld-ContribAuthor">Keith F. McDaniel</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5585-5623. <a href="https://doi.org/10.1021/acs.jmedchem.0c00628" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00628%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-Ethyl-4-%25255B2-%2525284-fluoro-2%25252C6-dimethyl-phenoxy%252529-5-%2525281-hydroxy-1-methyl-ethyl%252529phenyl%25255D-6-methyl-7-oxo-1H-pyrrolo%25255B2%25252C3-c%25255Dpyridine-2-carboxamide%252B%252528ABBV-744%252529%25252C%252Ba%252BBET%252BBromodomain%252BInhibitor%252Bwith%252BSelectivity%252Bfor%252Bthe%252BSecond%252BBromodomain%26aulast%3DSheppard%26aufirst%3DGeorge%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16042020%26date%3D07052020%26date%3D23042020%26volume%3D63%26issue%3D10%26spage%3D5585%26epage%3D5623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuepeng Chen, Xinglei Liu, Wei Shi, Shilong Zheng, Guangdi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Ling He</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of Seven-Membered Heterocyclic Derivatives of Diazepines Involving Copper-Catalyzed Rearrangement Cascade Allyl-Amination. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 5146-5157. <a href="https://doi.org/10.1021/acs.joc.9b02710" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02710%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-Pot%252BSynthesis%252Bof%252BSeven-Membered%252BHeterocyclic%252BDerivatives%252Bof%252BDiazepines%252BInvolving%252BCopper-Catalyzed%252BRearrangement%252BCascade%252BAllyl-Amination%26aulast%3DChen%26aufirst%3DYuepeng%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D07102019%26date%3D06042020%26date%3D17032020%26volume%3D85%26issue%3D8%26spage%3D5146%26epage%3D5157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher R. Wellaway, Dominique Amans, Paul Bamborough, Heather Barnett, Rino A. Bit, Jack A. Brown, Neil R. Carlson, Chun-wa Chung, Anthony W. J. Cooper, Peter D. Craggs, Robert P. Davis, Tony W. Dean, John P. Evans, Laurie Gordon, Isobel L. Harada, David J. Hirst, Philip G. Humphreys, Katherine L. Jones, Antonia J. Lewis, Matthew J. Lindon, Dave Lugo, Mahnoor Mahmood, Scott McCleary, Patricia Medeiros, Darren J. Mitchell, Michael O’Sullivan, Armelle Le Gall, Vipulkumar K. Patel, Chris Patten, Darren L. Poole, Rishi R. Shah, Jane E. Smith, Kayleigh A. J. Stafford, Pamela J. Thomas, Mythily Vimal, Ian D. Wall, Robert J. Watson, Natalie Wellaway, Gang Yao, <span class="NLM_string-name hlFld-ContribAuthor">Rab K. Prinjha</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 714-746. <a href="https://doi.org/10.1021/acs.jmedchem.9b01670" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01670%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BBromodomain%252Band%252BExtraterminal%252BInhibitor%252Bwith%252Ba%252BLow%252BPredicted%252BHuman%252BDose%252Bthrough%252BSynergistic%252BUse%252Bof%252BEncoded%252BLibrary%252BTechnology%252Band%252BFragment%252BScreening%26aulast%3DWellaway%26aufirst%3DChristopher%2BR.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D08102019%26date%3D06012020%26volume%3D63%26issue%3D2%26spage%3D714%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fei Jiang, Qinghua Hu, Zhimin Zhang, Hongmei Li, Huili Li, Dewei Zhang, Hanwen Li, Yu Ma, Jingjing Xu, Haifang Chen, Yong Cui, Yanle Zhi, Yanmin Zhang, Junyu Xu, Jiapeng Zhu, Tao Lu, <span class="NLM_string-name hlFld-ContribAuthor">Yadong Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Benzo[cd]indol-2(1H)-ones and Pyrrolo[4,3,2-de]quinolin-2(1H)-ones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain with Potential High Efficiency against Acute Gouty Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11080-11107. <a href="https://doi.org/10.1021/acs.jmedchem.9b01010" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBenzo%25255Bcd%25255Dindol-2%2525281H%252529-ones%252Band%252BPyrrolo%25255B4%25252C3%25252C2-de%25255Dquinolin-2%2525281H%252529-ones%252Bas%252BBromodomain%252Band%252BExtra-Terminal%252BDomain%252B%252528BET%252529%252BInhibitors%252Bwith%252BSelectivity%252Bfor%252Bthe%252BFirst%252BBromodomain%252Bwith%252BPotential%252BHigh%252BEfficiency%252Bagainst%252BAcute%252BGouty%252BArthritis%26aulast%3DJiang%26aufirst%3DFei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26062019%26date%3D13122019%26date%3D30112019%26volume%3D62%26issue%3D24%26spage%3D11080%26epage%3D11107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Luyi Huang, Hui Li, Linli Li, Lu Niu, Raina Seupel, Chengyong Wu, Wei Cheng, Chong Chen, Bisen Ding, Paul E. Brennan, <span class="NLM_string-name hlFld-ContribAuthor">Shengyong Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyrrolo[3,2-d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4526-4542. <a href="https://doi.org/10.1021/acs.jmedchem.9b00096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPyrrolo%25255B3%25252C2-d%25255Dpyrimidin-4-one%252BDerivatives%252Bas%252Ba%252BNew%252BClass%252Bof%252BPotent%252Band%252BCell-Active%252BInhibitors%252Bof%252BP300%25252FCBP-Associated%252BFactor%252BBromodomain%26aulast%3DHuang%26aufirst%3DLuyi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15012019%26date%3D30042019%26date%3D18042019%26volume%3D62%26issue%3D9%26spage%3D4526%26epage%3D4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yujun Zhao, Bing Zhou, Longchuan Bai, Liu Liu, Chao-Yie Yang, Jennifer L. Meagher, Jeanne A. Stuckey, Donna McEachern, Sally Przybranowski, Mi Wang, Xu Ran, Angelo Aguilar, Yang Hu, Jeff W. Kampf, Xiaoqin Li, Ting Zhao, Siwei Li, Bo Wen, Duxin Sun, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 6110-6120. <a href="https://doi.org/10.1021/acs.jmedchem.8b00483" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00483%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BCF53%252Bas%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BBromodomain%252Band%252BExtra-Terminal%252B%252528BET%252529%252BBromodomain%252BInhibitor%26aulast%3DZhao%26aufirst%3DYujun%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27032018%26date%3D17072018%26volume%3D61%26issue%3D14%26spage%3D6110%26epage%3D6120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laurent Hoffer, Yuliia V. Voitovich, Brigitt Raux, Kendall Carrasco, Christophe Muller, Aleksey Y. Fedorov, Carine Derviaux, Agnès Amouric, Stéphane Betzi, Dragos Horvath, Alexandre Varnek, Yves Collette, Sébastien Combes, Philippe Roche, <span class="NLM_string-name hlFld-ContribAuthor">Xavier Morelli</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5719-5732. <a href="https://doi.org/10.1021/acs.jmedchem.8b00653" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00653%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrated%252BStrategy%252Bfor%252BLead%252BOptimization%252BBased%252Bon%252BFragment%252BGrowing%25253A%252BThe%252BDiversity-Oriented-Target-Focused-Synthesis%252BApproach%26aulast%3DHoffer%26aufirst%3DLaurent%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25042018%26date%3D22062018%26date%3D08062018%26volume%3D61%26issue%3D13%26spage%3D5719%26epage%3D5732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert P. Law, Stephen J. Atkinson, Paul Bamborough, Chun-wa Chung, Emmanuel H. Demont, Laurie J. Gordon, Matthew Lindon, Rab K. Prinjha, Allan J. B. Watson, <span class="NLM_string-name hlFld-ContribAuthor">David J. Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4317-4334. <a href="https://doi.org/10.1021/acs.jmedchem.7b01666" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01666%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BTetrahydroquinoxalines%252Bas%252BBromodomain%252Band%252BExtra-Terminal%252BDomain%252B%252528BET%252529%252BInhibitors%252Bwith%252BSelectivity%252Bfor%252Bthe%252BSecond%252BBromodomain%26aulast%3DLaw%26aufirst%3DRobert%2BP.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D11112017%26date%3D03052018%26date%3D15042018%26volume%3D61%26issue%3D10%26spage%3D4317%26epage%3D4334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibraheem  Ali</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Conrad</span>, <span class="hlFld-ContribAuthor ">Eric  Verdin</span>, and <span class="hlFld-ContribAuthor ">Melanie  Ott</span>  . </span><span class="cited-content_cbyCitation_article-title">Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 1216-1252. <a href="https://doi.org/10.1021/acs.chemrev.7b00181" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00181%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DLysine%252BAcetylation%252BGoes%252BGlobal%25253A%252BFrom%252BEpigenetics%252Bto%252BMetabolism%252Band%252BTherapeutics%26aulast%3DAli%26aufirst%3DIbraheem%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D31032017%26date%3D06022018%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D1216%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Lan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Leilei  Fu</span>, <span class="hlFld-ContribAuthor ">Dahong  Yao</span>, <span class="hlFld-ContribAuthor ">Yuqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Shouyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>, and <span class="hlFld-ContribAuthor ">Bo  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 9990-10012. <a href="https://doi.org/10.1021/acs.jmedchem.7b00275" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00275%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSmall-Molecule%252BBromodomain-Containing%252BProtein%252B4%252B%252528BRD4%252529%252BInhibitor%252BThat%252BInduces%252BAMP-Activated%252BProtein%252BKinase-Modulated%252BAutophagy-Associated%252BCell%252BDeath%252Bin%252BBreast%252BCancer%26aulast%3DOuyang%26aufirst%3DLiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04032017%26date%3D07122017%26date%3D28122017%26date%3D27112017%26volume%3D60%26issue%3D24%26spage%3D9990%26epage%3D10012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phillip P.  Sharp</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Garnier</span>, <span class="hlFld-ContribAuthor ">Tamas  Hatfaludi</span>, <span class="hlFld-ContribAuthor ">Zhen  Xu</span>, <span class="hlFld-ContribAuthor ">David  Segal</span>, <span class="hlFld-ContribAuthor ">Kate E.  Jarman</span>, <span class="hlFld-ContribAuthor ">Hélène  Jousset</span>, <span class="hlFld-ContribAuthor ">Alexandra  Garnham</span>, <span class="hlFld-ContribAuthor ">John T.  Feutrill</span>, <span class="hlFld-ContribAuthor ">Anthony  Cuzzupe</span>, <span class="hlFld-ContribAuthor ">Peter  Hall</span>, <span class="hlFld-ContribAuthor ">Scott  Taylor</span>, <span class="hlFld-ContribAuthor ">Carl R.  Walkley</span>, <span class="hlFld-ContribAuthor ">Dean  Tyler</span>, <span class="hlFld-ContribAuthor ">Mark A.  Dawson</span>, <span class="hlFld-ContribAuthor ">Peter  Czabotar</span>, <span class="hlFld-ContribAuthor ">Andrew F.  Wilks</span>, <span class="hlFld-ContribAuthor ">Stefan  Glaser</span>, <span class="hlFld-ContribAuthor ">David C. S.  Huang</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  Burns</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 1298-1303. <a href="https://doi.org/10.1021/acsmedchemlett.7b00389" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00389%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BActivity%252Bof%252B1%25252C2%25252C3-Triazolobenzodiazepine%252BBET%252BBromodomain%252BInhibitors%26aulast%3DSharp%26aufirst%3DPhillip%2BP.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25092017%26date%3D14112017%26date%3D01122017%26date%3D14122017%26date%3D14112017%26volume%3D8%26issue%3D12%26spage%3D1298%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith F.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Le  Wang</span>, <span class="hlFld-ContribAuthor ">Todd  Soltwedel</span>, <span class="hlFld-ContribAuthor ">Steven D.  Fidanze</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Hasvold</span>, <span class="hlFld-ContribAuthor ">Dachun  Liu</span>, <span class="hlFld-ContribAuthor ">Robert A.  Mantei</span>, <span class="hlFld-ContribAuthor ">John K.  Pratt</span>, <span class="hlFld-ContribAuthor ">George S.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Mai H.  Bui</span>, <span class="hlFld-ContribAuthor ">Emily J.  Faivre</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Huang</span>, <span class="hlFld-ContribAuthor ">Leiming  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Lin</span>, <span class="hlFld-ContribAuthor ">Rongqi  Wang</span>, <span class="hlFld-ContribAuthor ">Scott E.  Warder</span>, <span class="hlFld-ContribAuthor ">Denise  Wilcox</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Albert</span>, <span class="hlFld-ContribAuthor ">Terrance J.  Magoc</span>, <span class="hlFld-ContribAuthor ">Ganesh  Rajaraman</span>, <span class="hlFld-ContribAuthor ">Chang H.  Park</span>, <span class="hlFld-ContribAuthor ">Charles W.  Hutchins</span>, <span class="hlFld-ContribAuthor ">Jianwei J.  Shen</span>, <span class="hlFld-ContribAuthor ">Rohinton P.  Edalji</span>, <span class="hlFld-ContribAuthor ">Chaohong C.  Sun</span>, <span class="hlFld-ContribAuthor ">Ruth  Martin</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Shekman  Wong</span>, <span class="hlFld-ContribAuthor ">Guowei  Fang</span>, <span class="hlFld-ContribAuthor ">Steven W.  Elmore</span>, <span class="hlFld-ContribAuthor ">Yu  Shen</span>, and <span class="hlFld-ContribAuthor ">Warren M.  Kati</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8369-8384. <a href="https://doi.org/10.1021/acs.jmedchem.7b00746" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00746%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-%2525282%25252C4-Difluorophenoxy%252529-3-%2525286-methyl-7-oxo-6%25252C7-dihydro-1H-pyrrolo%25255B2%25252C3-c%25255Dpyridin-4-yl%252529phenyl%252529ethanesulfonamide%252B%252528ABBV-075%25252FMivebresib%252529%25252C%252Ba%252BPotent%252Band%252BOrally%252BAvailable%252BBromodomain%252Band%252BExtraterminal%252BDomain%252B%252528BET%252529%252BFamily%252BBromodomain%252BInhibitor%26aulast%3DMcDaniel%26aufirst%3DKeith%2BF.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19052017%26date%3D12102017%26date%3D26102017%26date%3D26092017%26volume%3D60%26issue%3D20%26spage%3D8369%26epage%3D8384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryce K.  Allen</span>, <span class="hlFld-ContribAuthor ">Saurabh  Mehta</span>, <span class="hlFld-ContribAuthor ">Stuart W. J.  Ember</span>, <span class="hlFld-ContribAuthor ">Jin-Yi  Zhu</span>, <span class="hlFld-ContribAuthor ">Ernst  Schönbrunn</span>, <span class="hlFld-ContribAuthor ">Nagi G.  Ayad</span>, and <span class="hlFld-ContribAuthor ">Stephan C.  Schürer</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2017,</strong> <em>2 </em>
                                    (8)
                                     , 4760-4771. <a href="https://doi.org/10.1021/acsomega.7b00553" title="DOI URL">https://doi.org/10.1021/acsomega.7b00553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b00553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b00553%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DIdentification%252Bof%252Ba%252BNovel%252BClass%252Bof%252BBRD4%252BInhibitors%252Bby%252BComputational%252BScreening%252Band%252BBinding%252BSimulations%26aulast%3DAllen%26aufirst%3DBryce%2BK.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04052017%26date%3D27072017%26date%3D31082017%26volume%3D2%26issue%3D8%26spage%3D4760%26epage%3D4771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David S.  Millan</span>, <span class="hlFld-ContribAuthor ">Katherine J.  Kayser-Bricker</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Martin</span>, <span class="hlFld-ContribAuthor ">Adam C.  Talbot</span>, <span class="hlFld-ContribAuthor ">Shawn E. R.  Schiller</span>, <span class="hlFld-ContribAuthor ">Torsten  Herbertz</span>, <span class="hlFld-ContribAuthor ">Grace L.  Williams</span>, <span class="hlFld-ContribAuthor ">George P.  Luke</span>, <span class="hlFld-ContribAuthor ">Stephen  Hubbs</span>, <span class="hlFld-ContribAuthor ">Monica A.  Alvarez Morales</span>, <span class="hlFld-ContribAuthor ">Daniel  Cardillo</span>, <span class="hlFld-ContribAuthor ">Paul  Troccolo</span>, <span class="hlFld-ContribAuthor ">Rachel L.  Mendes</span>, and <span class="hlFld-ContribAuthor ">Crystal  McKinnon</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 847-852. <a href="https://doi.org/10.1021/acsmedchemlett.7b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BOptimization%252Bof%252BBenzopiperazines%252Bas%252BPotent%252BInhibitors%252Bof%252BBET%252BBromodomains%26aulast%3DMillan%26aufirst%3DDavid%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04052017%26date%3D14072017%26date%3D19072017%26date%3D10082017%26date%3D14072017%26volume%3D8%26issue%3D8%26spage%3D847%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edrous  Alamer</span>, <span class="hlFld-ContribAuthor ">Chaojie  Zhong</span>, <span class="hlFld-ContribAuthor ">Renee  Hajnik</span>, <span class="hlFld-ContribAuthor ">Lynn  Soong</span>, <span class="hlFld-ContribAuthor ">Haitao  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure. </span><span class="cited-content_cbyCitation_journal-name">Retrovirology</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12977-020-00547-9" title="DOI URL">https://doi.org/10.1186/s12977-020-00547-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12977-020-00547-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12977-020-00547-9%26sid%3Dliteratum%253Aachs%26jtitle%3DRetrovirology%26atitle%3DModulation%252Bof%252BBRD4%252Bin%252BHIV%252Bepigenetic%252Bregulation%25253A%252Bimplications%252Bfor%252Bfinding%252Ban%252BHIV%252Bcure%26aulast%3DAlamer%26aufirst%3DEdrous%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2021,</strong> <em>28 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-021-00721-x" title="DOI URL">https://doi.org/10.1186/s12929-021-00721-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-021-00721-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-021-00721-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DRecent%252Bdevelopments%252Bin%252Bepigenetic%252Bcancer%252Btherapeutics%25253A%252Bclinical%252Badvancement%252Band%252Bemerging%252Btrends%26aulast%3DNepali%26aufirst%3DKunal%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Chao  Duan</span>, <span class="hlFld-ContribAuthor ">Shao-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Lin-Feng  Jin</span>, <span class="hlFld-ContribAuthor ">Tong  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Song</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113588. <a href="https://doi.org/10.1016/j.ejmech.2021.113588" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113588%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252Bdual%252Binhibitors%252Btargeting%252Bcrosstalk%252Bbetween%252Bhistone%252Bepigenetic%252Bmodulators%252Bfor%252Bcancer%252Btherapy%26aulast%3DDuan%26aufirst%3DYing-Chao%26date%3D2021%26volume%3D222%26spage%3D113588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Yu  Gui</span>, <span class="hlFld-ContribAuthor ">Xi‐Long  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain‐containing protein 4 and its role in cardiovascular diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2021,</strong> <em>236 </em>
                                    (7)
                                     , 4829-4840. <a href="https://doi.org/10.1002/jcp.30225" title="DOI URL">https://doi.org/10.1002/jcp.30225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.30225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.30225%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DBromodomain%2525E2%252580%252590containing%252Bprotein%252B4%252Band%252Bits%252Brole%252Bin%252Bcardiovascular%252Bdiseases%26aulast%3DLi%26aufirst%3DLiang%26date%3D2021%26date%3D2020%26volume%3D236%26issue%3D7%26spage%3D4829%26epage%3D4840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">Haiquan  Fang</span>, <span class="hlFld-ContribAuthor ">John  Tokarski</span>, <span class="hlFld-ContribAuthor ">Carolynn  Fanslau</span>, <span class="hlFld-ContribAuthor ">Zuzana  Haarhoff</span>, <span class="hlFld-ContribAuthor ">Christine  Huang</span>, <span class="hlFld-ContribAuthor ">Melissa  Kramer</span>, <span class="hlFld-ContribAuthor ">Krista  Menard</span>, <span class="hlFld-ContribAuthor ">Laura  Monereau</span>, <span class="hlFld-ContribAuthor ">John  Morrison</span>, <span class="hlFld-ContribAuthor ">Asoka  Ranasinghe</span>, <span class="hlFld-ContribAuthor ">Eric E.  Shields</span>, <span class="hlFld-ContribAuthor ">Ching Kim  Tye</span>, <span class="hlFld-ContribAuthor ">Richard  Westhouse</span>, <span class="hlFld-ContribAuthor ">Gerry  Everlof</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Chunhong  Yan</span>, <span class="hlFld-ContribAuthor ">Frank  Marsilio</span>, <span class="hlFld-ContribAuthor ">Lisa  Zhang</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Francis  Lee</span>, <span class="hlFld-ContribAuthor ">Ashvinikumar V.  Gavai</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Degnan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of BET inhibitors as potential treatments for cancer: A search for structural diversity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>44 </em>, 128108. <a href="https://doi.org/10.1016/j.bmcl.2021.128108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252BBET%252Binhibitors%252Bas%252Bpotential%252Btreatments%252Bfor%252Bcancer%25253A%252BA%252Bsearch%252Bfor%252Bstructural%252Bdiversity%26aulast%3DHill%26aufirst%3DMatthew%2BD.%26date%3D2021%26volume%3D44%26spage%3D128108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos  Damaskos</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Garmpis</span>, <span class="hlFld-ContribAuthor ">Anna  Garmpi</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Nikolettos</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Sarantis</span>, <span class="hlFld-ContribAuthor ">Vasiliki E.  Georgakopoulou</span>, <span class="hlFld-ContribAuthor ">Afroditi  Nonni</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Schizas</span>, <span class="hlFld-ContribAuthor ">Efstathios A.  Antoniou</span>, <span class="hlFld-ContribAuthor ">Michalis V.  Karamouzis</span>, <span class="hlFld-ContribAuthor ">Nikos  Nikolettos</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Kontzoglou</span>, <span class="hlFld-ContribAuthor ">Alexandros  Patsouras</span>, <span class="hlFld-ContribAuthor ">Errika  Voutyritsa</span>, <span class="hlFld-ContribAuthor ">Athanasios  Syllaios</span>, <span class="hlFld-ContribAuthor ">Evangelos  Koustas</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Trakas</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Dimitroulis</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational Drug Treatments for Triple-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Personalized Medicine</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 652. <a href="https://doi.org/10.3390/jpm11070652" title="DOI URL">https://doi.org/10.3390/jpm11070652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jpm11070652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjpm11070652%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Personalized%2520Medicine%26atitle%3DInvestigational%252BDrug%252BTreatments%252Bfor%252BTriple-Negative%252BBreast%252BCancer%26aulast%3DDamaskos%26aufirst%3DChristos%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenyin  Shen</span>, <span class="hlFld-ContribAuthor ">Jianzhao  Peng</span>, <span class="hlFld-ContribAuthor ">Yuqing  Deng</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>10 </em>, 116328. <a href="https://doi.org/10.1016/j.bmc.2021.116328" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116328%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bisoform%25252Fdomain-selective%252Bfragments%252Bfrom%252Bthe%252Bselection%252Bof%252BDNA-encoded%252Bdynamic%252Blibrary%26aulast%3DZhou%26aufirst%3DYu%26date%3D2021%26volume%3D10%26spage%3D116328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhangxu  He</span>, <span class="hlFld-ContribAuthor ">Haomiao  Jiao</span>, <span class="hlFld-ContribAuthor ">Qi  An</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Zengyangzong</span>, <span class="hlFld-ContribAuthor ">Jiale  Xu</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>, <span class="hlFld-ContribAuthor ">Liying  Ma</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>399 </em><a href="https://doi.org/10.1016/j.apsb.2021.07.018" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.07.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.07.018%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDiscovery%252Bof%252Bnovel%252B4-phenylquinazoline-based%252BBRD4%252Binhibitors%252Bfor%252Bcardiac%252Bfibrosis%26aulast%3DHe%26aufirst%3DZhangxu%26date%3D2021%26volume%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Poonam  Tewary</span>, <span class="hlFld-ContribAuthor ">Alan D.  Brooks</span>, <span class="hlFld-ContribAuthor ">Ya-Ming  Xu</span>, <span class="hlFld-ContribAuthor ">E.M. Kithsiri  Wijeratne</span>, <span class="hlFld-ContribAuthor ">Ashley L.  Babyak</span>, <span class="hlFld-ContribAuthor ">Timothy C.  Back</span>, <span class="hlFld-ContribAuthor ">Raj  Chari</span>, <span class="hlFld-ContribAuthor ">Christine N.  Evans</span>, <span class="hlFld-ContribAuthor ">Curtis J.  Henrich</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Meyer</span>, <span class="hlFld-ContribAuthor ">Elijah F.  Edmondson</span>, <span class="hlFld-ContribAuthor ">Maria T. Prudente  de Aquino</span>, <span class="hlFld-ContribAuthor ">Thanigaivelan  Kanagasabai</span>, <span class="hlFld-ContribAuthor ">Anil  Shanker</span>, <span class="hlFld-ContribAuthor ">A.A. Leslie  Gunatilaka</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Sayers</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2021,</strong> <em>81 </em>
                                    (12)
                                     , 3374-3386. <a href="https://doi.org/10.1158/0008-5472.CAN-20-2634" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-20-2634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-20-2634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-20-2634%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DSmall-Molecule%252BNatural%252BProduct%252BPhysachenolide%252BC%252BPotentiates%252BImmunotherapy%252BEfficacy%252Bby%252BTargeting%252BBET%252BProteins%26aulast%3DTewary%26aufirst%3DPoonam%26date%3D2021%26date%3D2021%26volume%3D81%26issue%3D12%26spage%3D3374%26epage%3D3386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Martínez‐Andújar</span>, <span class="hlFld-ContribAuthor ">Ascensión  Martínez‐Pérez</span>, <span class="hlFld-ContribAuthor ">Alfonso  Albacete</span>, <span class="hlFld-ContribAuthor ">Purificación A.  Martínez‐Melgarejo</span>, <span class="hlFld-ContribAuthor ">Ian C.  Dodd</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Thompson</span>, <span class="hlFld-ContribAuthor ">Fady  Mohareb</span>, <span class="hlFld-ContribAuthor ">Lucia  Estelles‐Lopez</span>, <span class="hlFld-ContribAuthor ">Zoltan  Kevei</span>, <span class="hlFld-ContribAuthor ">Almudena  Ferrández‐Ayela</span>, <span class="hlFld-ContribAuthor ">José Manuel  Pérez‐Pérez</span>, <span class="hlFld-ContribAuthor ">Miriam L.  Gifford</span>, <span class="hlFld-ContribAuthor ">Francisco  Pérez‐Alfocea</span>. </span><span class="cited-content_cbyCitation_article-title">Overproduction of
              ABA
              in rootstocks alleviates salinity stress in tomato shoots. </span><span class="cited-content_cbyCitation_journal-name">Plant, Cell & Environment</span><span> <strong>2021,</strong> <em>2 </em><a href="https://doi.org/10.1111/pce.14121" title="DOI URL">https://doi.org/10.1111/pce.14121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/pce.14121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpce.14121%26sid%3Dliteratum%253Aachs%26jtitle%3DPlant%252C%2520Cell%2520%2526%2520Environment%26atitle%3DOverproduction%252Bof%252BABA%252Bin%252Brootstocks%252Balleviates%252Bsalinity%252Bstress%252Bin%252Btomato%252Bshoots%26aulast%3DMart%25C3%25ADnez%25E2%2580%2590And%25C3%25BAjar%26aufirst%3DCristina%26date%3D2021%26date%3D2021%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lincheng  Fang</span>, <span class="hlFld-ContribAuthor ">Zhaoxue  Hu</span>, <span class="hlFld-ContribAuthor ">Yifei  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,5-dimethylisoxazole derivatives as novel, potent inhibitors for bromodomain and extraterminal domain (BET) family. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>39 </em>, 116133. <a href="https://doi.org/10.1016/j.bmc.2021.116133" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116133%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3%25252C5-dimethylisoxazole%252Bderivatives%252Bas%252Bnovel%25252C%252Bpotent%252Binhibitors%252Bfor%252Bbromodomain%252Band%252Bextraterminal%252Bdomain%252B%252528BET%252529%252Bfamily%26aulast%3DFang%26aufirst%3DLincheng%26date%3D2021%26volume%3D39%26spage%3D116133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Xie</span>, <span class="hlFld-ContribAuthor ">Huidan  Tan</span>, <span class="hlFld-ContribAuthor ">Minru  Liao</span>, <span class="hlFld-ContribAuthor ">Shiou  Zhu</span>, <span class="hlFld-ContribAuthor ">Ling-Li  Zheng</span>, <span class="hlFld-ContribAuthor ">Haixia  Huang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>13 </em>, 105702. <a href="https://doi.org/10.1016/j.phrs.2021.105702" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105702%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252Bcancer%252Bepigenetic%252Bpathways%252Bwith%252Bsmall-molecule%252Bcompounds%25253A%252BTherapeutic%252Befficacy%252Band%252Bcombination%252Btherapies%26aulast%3DWang%26aufirst%3DYi%26date%3D2021%26volume%3D13%26spage%3D105702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Li  Wei</span>, <span class="hlFld-ContribAuthor ">Yang  Xun</span>, <span class="hlFld-ContribAuthor ">Anping  Yang</span>, <span class="hlFld-ContribAuthor ">Hua  You</span>. </span><span class="cited-content_cbyCitation_article-title">BRD4: An emerging prospective therapeutic target in glioma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Therapy - Oncolytics</span><span> <strong>2021,</strong> <em>21 </em>, 1-14. <a href="https://doi.org/10.1016/j.omto.2021.03.005" title="DOI URL">https://doi.org/10.1016/j.omto.2021.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.omto.2021.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.omto.2021.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Therapy%2520-%2520Oncolytics%26atitle%3DBRD4%25253A%252BAn%252Bemerging%252Bprospective%252Btherapeutic%252Btarget%252Bin%252Bglioma%26aulast%3DYang%26aufirst%3DHua%26date%3D2021%26volume%3D21%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamed  Haghshenas</span>, <span class="hlFld-ContribAuthor ">Bita  Kaviani</span>, <span class="hlFld-ContribAuthor ">Monireh  Firouzeh</span>, <span class="hlFld-ContribAuthor ">Hossein  Tavakol</span>. </span><span class="cited-content_cbyCitation_article-title">Developing a variation of
              3D‐QSAR
              /
              MD
              method in drug design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2021,</strong> <em>42 </em>
                                    (13)
                                     , 917-929. <a href="https://doi.org/10.1002/jcc.26514" title="DOI URL">https://doi.org/10.1002/jcc.26514</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.26514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.26514%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DDeveloping%252Ba%252Bvariation%252Bof%252B3D%2525E2%252580%252590QSAR%252B%25252F%252BMD%252Bmethod%252Bin%252Bdrug%252Bdesign%26aulast%3DHaghshenas%26aufirst%3DHamed%26date%3D2021%26date%3D2021%26volume%3D42%26issue%3D13%26spage%3D917%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atsushi  Yoshimori</span>, <span class="hlFld-ContribAuthor ">Huabin  Hu</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Adapting the DeepSARM approach for dual-target ligand design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2021,</strong> <em>35 </em>
                                    (5)
                                     , 587-600. <a href="https://doi.org/10.1007/s10822-021-00379-5" title="DOI URL">https://doi.org/10.1007/s10822-021-00379-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-021-00379-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-021-00379-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DAdapting%252Bthe%252BDeepSARM%252Bapproach%252Bfor%252Bdual-target%252Bligand%252Bdesign%26aulast%3DYoshimori%26aufirst%3DAtsushi%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D5%26spage%3D587%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Najla  Kfoury</span>, <span class="hlFld-ContribAuthor ">Zongtai  Qi</span>, <span class="hlFld-ContribAuthor ">Briana C.  Prager</span>, <span class="hlFld-ContribAuthor ">Michael N.  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Lauren  Broestl</span>, <span class="hlFld-ContribAuthor ">Kristopher C.  Berrett</span>, <span class="hlFld-ContribAuthor ">Arnav  Moudgil</span>, <span class="hlFld-ContribAuthor ">Sumithra  Sankararaman</span>, <span class="hlFld-ContribAuthor ">Xuhua  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Gertz</span>, <span class="hlFld-ContribAuthor ">Jeremy N.  Rich</span>, <span class="hlFld-ContribAuthor ">Robi D.  Mitra</span>, <span class="hlFld-ContribAuthor ">Joshua B.  Rubin</span>. </span><span class="cited-content_cbyCitation_article-title">Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (16)
                                     , e2017148118. <a href="https://doi.org/10.1073/pnas.2017148118" title="DOI URL">https://doi.org/10.1073/pnas.2017148118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2017148118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2017148118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DBrd4-bound%252Benhancers%252Bdrive%252Bcell-intrinsic%252Bsex%252Bdifferences%252Bin%252Bglioblastoma%26aulast%3DKfoury%26aufirst%3DNajla%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D16%26spage%3De2017148118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Verena B. K.  Kunig</span>, <span class="hlFld-ContribAuthor ">Marco  Potowski</span>, <span class="hlFld-ContribAuthor ">Mateja  Klika Škopić</span>, <span class="hlFld-ContribAuthor ">Andreas  Brunschweiger</span>. </span><span class="cited-content_cbyCitation_article-title">Scanning Protein Surfaces with DNA‐Encoded Libraries. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (7)
                                     , 1048-1062. <a href="https://doi.org/10.1002/cmdc.202000869" title="DOI URL">https://doi.org/10.1002/cmdc.202000869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000869%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DScanning%252BProtein%252BSurfaces%252Bwith%252BDNA%2525E2%252580%252590Encoded%252BLibraries%26aulast%3DKunig%26aufirst%3DVerena%2BB.%2BK.%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D7%26spage%3D1048%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinghua  Ren</span>, <span class="hlFld-ContribAuthor ">Wenqian  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Current status in the discovery of dual BET/HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127829. <a href="https://doi.org/10.1016/j.bmcl.2021.127829" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127829%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCurrent%252Bstatus%252Bin%252Bthe%252Bdiscovery%252Bof%252Bdual%252BBET%25252FHDAC%252Binhibitors%26aulast%3DRen%26aufirst%3DQinghua%26date%3D2021%26volume%3D38%26spage%3D127829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhu</span>, <span class="hlFld-ContribAuthor ">Li Ting  Song</span>, <span class="hlFld-ContribAuthor ">Rui Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>, <span class="hlFld-ContribAuthor ">Ya Jie  Meng</span>, <span class="hlFld-ContribAuthor ">Cui Ling  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition mechanism of nitroxoline to the BET family: Insight from molecular simulations. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2021,</strong> <em>270 </em>, 119141. <a href="https://doi.org/10.1016/j.lfs.2021.119141" title="DOI URL">https://doi.org/10.1016/j.lfs.2021.119141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2021.119141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2021.119141%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DSelective%252Binhibition%252Bmechanism%252Bof%252Bnitroxoline%252Bto%252Bthe%252BBET%252Bfamily%25253A%252BInsight%252Bfrom%252Bmolecular%252Bsimulations%26aulast%3DZhu%26aufirst%3DMin%26date%3D2021%26volume%3D270%26spage%3D119141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Wu</span>, <span class="hlFld-ContribAuthor ">Dan-Qi  Chen</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Xia-Juan  Huan</span>, <span class="hlFld-ContribAuthor ">Xu-Bin  Bao</span>, <span class="hlFld-ContribAuthor ">Chang-Qing  Tian</span>, <span class="hlFld-ContribAuthor ">Jianping  Hu</span>, <span class="hlFld-ContribAuthor ">Kai-Kai  Lv</span>, <span class="hlFld-ContribAuthor ">Ying-Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>, <span class="hlFld-ContribAuthor ">Ze-Hong  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>185 </em>, 114435. <a href="https://doi.org/10.1016/j.bcp.2021.114435" title="DOI URL">https://doi.org/10.1016/j.bcp.2021.114435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2021.114435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2021.114435%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DNovel%252Bbivalent%252BBET%252Binhibitor%252BN2817%252Bexhibits%252Bpotent%252Banticancer%252Bactivity%252Band%252Binhibits%252BTAF1%26aulast%3DWu%26aufirst%3DQian%26date%3D2021%26volume%3D185%26spage%3D114435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masanori  Sato</span>, <span class="hlFld-ContribAuthor ">Takekazu  Kondo</span>, <span class="hlFld-ContribAuthor ">Yasushi  Kohno</span>, <span class="hlFld-ContribAuthor ">Shigeki  Seto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of benzo[f]pyrido[4,3-b][1,4]oxazepin-10-one derivatives as orally available bromodomain and extra-terminal domain (BET) inhibitors with efficacy in an in vivo psoriatic animal model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>34 </em>, 116015. <a href="https://doi.org/10.1016/j.bmc.2021.116015" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbenzo%25255Bf%25255Dpyrido%25255B4%25252C3-b%25255D%25255B1%25252C4%25255Doxazepin-10-one%252Bderivatives%252Bas%252Borally%252Bavailable%252Bbromodomain%252Band%252Bextra-terminal%252Bdomain%252B%252528BET%252529%252Binhibitors%252Bwith%252Befficacy%252Bin%252Ban%252Bin%252Bvivo%252Bpsoriatic%252Banimal%252Bmodel%26aulast%3DSato%26aufirst%3DMasanori%26date%3D2021%26volume%3D34%26spage%3D116015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliana Romano  Lopes</span>, <span class="hlFld-ContribAuthor ">Diego Eidy  Chiba</span>, <span class="hlFld-ContribAuthor ">Jean Leandro  Dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">HIV latency reversal agents: A potential path for functional cure?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113213. <a href="https://doi.org/10.1016/j.ejmech.2021.113213" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113213%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHIV%252Blatency%252Breversal%252Bagents%25253A%252BA%252Bpotential%252Bpath%252Bfor%252Bfunctional%252Bcure%25253F%26aulast%3DLopes%26aufirst%3DJuliana%2BRomano%26date%3D2021%26volume%3D213%26spage%3D113213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Gautam  Borthakur</span>, <span class="hlFld-ContribAuthor ">Naveen  Pemmaraju</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Leukemia & Lymphoma</span><span> <strong>2021,</strong> <em>62 </em>
                                    (3)
                                     , 528-537. <a href="https://doi.org/10.1080/10428194.2020.1842399" title="DOI URL">https://doi.org/10.1080/10428194.2020.1842399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10428194.2020.1842399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10428194.2020.1842399%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%2520%2526%2520Lymphoma%26atitle%3DBromodomain%252Band%252Bextra-terminal%252B%252528BET%252529%252Binhibitors%252Bin%252Btreating%252Bmyeloid%252Bneoplasms%26aulast%3DChen%26aufirst%3DNatalie%2BCheng%26date%3D2021%26date%3D2020%26volume%3D62%26issue%3D3%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohua  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yalei  Li</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Huaqian  Ding</span>, <span class="hlFld-ContribAuthor ">Wenjing  Huang</span>, <span class="hlFld-ContribAuthor ">Chunyong  Ding</span>, <span class="hlFld-ContribAuthor ">Hongchun  Liu</span>, <span class="hlFld-ContribAuthor ">Wenfu  Tan</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 488-504. <a href="https://doi.org/10.1016/j.apsb.2020.07.007" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDevelopment%252Bof%252Bhedgehog%252Bpathway%252Binhibitors%252Bby%252Bepigenetically%252Btargeting%252BGLI%252Bthrough%252BBET%252Bbromodomain%252Bfor%252Bthe%252Btreatment%252Bof%252Bmedulloblastoma%26aulast%3DLiu%26aufirst%3DXiaohua%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D488%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinghua  Ren</span>, <span class="hlFld-ContribAuthor ">Wenqian  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Current status in the discovery of dual BET/HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>31 </em>, 127671. <a href="https://doi.org/10.1016/j.bmcl.2020.127671" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127671%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCurrent%252Bstatus%252Bin%252Bthe%252Bdiscovery%252Bof%252Bdual%252BBET%25252FHDAC%252Binhibitors%26aulast%3DRen%26aufirst%3DQinghua%26date%3D2021%26volume%3D31%26spage%3D127671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd.  Muddassir</span>, <span class="hlFld-ContribAuthor ">Kunjal  Soni</span>, <span class="hlFld-ContribAuthor ">Chetan B.  Sangani</span>, <span class="hlFld-ContribAuthor ">Abdullah  Alarifi</span>, <span class="hlFld-ContribAuthor ">Mohd.  Afzal</span>, <span class="hlFld-ContribAuthor ">Naaser A. Y.  Abduh</span>, <span class="hlFld-ContribAuthor ">Yongtao  Duan</span>, <span class="hlFld-ContribAuthor ">Poonam  Bhadja</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 612-636. <a href="https://doi.org/10.1039/D0RA07971E" title="DOI URL">https://doi.org/10.1039/D0RA07971E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA07971E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA07971E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBromodomain%252Band%252BBET%252Bfamily%252Bproteins%252Bas%252Bepigenetic%252Btargets%252Bin%252Bcancer%252Btherapy%25253A%252Btheir%252Bdegradation%25252C%252Bpresent%252Bdrugs%25252C%252Band%252Bpossible%252BPROTACs%26aulast%3DMuddassir%26aufirst%3DMohd.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D612%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Sujuan  Duan</span>, <span class="hlFld-ContribAuthor ">Alan  Jang</span>, <span class="hlFld-ContribAuthor ">Longbing  Mao</span>, <span class="hlFld-ContribAuthor ">Xing  Liu</span>, <span class="hlFld-ContribAuthor ">Guofu  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Experimental Eye Research</span><span> <strong>2021,</strong> <em>202 </em>, 108304. <a href="https://doi.org/10.1016/j.exer.2020.108304" title="DOI URL">https://doi.org/10.1016/j.exer.2020.108304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.exer.2020.108304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.exer.2020.108304%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Eye%2520Research%26atitle%3DJQ1%25252C%252Ba%252Bselective%252Binhibitor%252Bof%252BBRD4%25252C%252Bsuppresses%252Bretinoblastoma%252Bcell%252Bgrowth%252Bby%252Binducing%252Bcell%252Bcycle%252Barrest%252Band%252Bapoptosis%26aulast%3DZhang%26aufirst%3DYanyan%26date%3D2021%26volume%3D202%26spage%3D108304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuliya O.  Kuchkovska</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Azepines and Their Fused-Ring Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00073-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00073-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00073-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00073-1%26sid%3Dliteratum%253Aachs%26atitle%3DAzepines%252Band%252BTheir%252BFused-Ring%252BDerivatives%26aulast%3DKuchkovska%26aufirst%3DYuliya%2BO.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen E.  Guest</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Pickett</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Structural variation of protein–ligand complexes of the first bromodomain of BRD4. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>1 </em><a href="https://doi.org/10.1039/D1OB00658D" title="DOI URL">https://doi.org/10.1039/D1OB00658D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00658D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00658D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DStructural%252Bvariation%252Bof%252Bprotein%2525E2%252580%252593ligand%252Bcomplexes%252Bof%252Bthe%252Bfirst%252Bbromodomain%252Bof%252BBRD4%26aulast%3DGuest%26aufirst%3DEllen%2BE.%26date%3D2021%26date%3D2021%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Desh Deepak  Singh</span>, <span class="hlFld-ContribAuthor ">Ihn  Han</span>, <span class="hlFld-ContribAuthor ">Eun-Ha  Choi</span>, <span class="hlFld-ContribAuthor ">Dharmendra Kumar  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2021,</strong> <em>19 </em>, 2384-2397. <a href="https://doi.org/10.1016/j.csbj.2021.04.036" title="DOI URL">https://doi.org/10.1016/j.csbj.2021.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2021.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2021.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DCRISPR%25252FCas9%252Bbased%252Bgenome%252Bediting%252Bfor%252Btargeted%252Btranscriptional%252Bcontrol%252Bin%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DSingh%26aufirst%3DDesh%2BDeepak%26date%3D2021%26volume%3D19%26spage%3D2384%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Xu</span>, <span class="hlFld-ContribAuthor ">Xiu-Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen-Bo  Li</span>, <span class="hlFld-ContribAuthor ">Xing-Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai  Wang</span>, <span class="hlFld-ContribAuthor ">Xue-Peng  Qiao</span>, <span class="hlFld-ContribAuthor ">Shi-Wu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112780. <a href="https://doi.org/10.1016/j.ejmech.2020.112780" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112780%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bindole-2-one%252Bderivatives%252Bas%252Bpotent%252BBRD4%252Binhibitors%26aulast%3DXu%26aufirst%3DYu%26date%3D2020%26volume%3D208%26spage%3D112780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mandakini B.  Singh</span>, <span class="hlFld-ContribAuthor ">Gregory C.  Sartor</span>. </span><span class="cited-content_cbyCitation_article-title">BET bromodomains as novel epigenetic targets for brain health and disease. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>181 </em>, 108306. <a href="https://doi.org/10.1016/j.neuropharm.2020.108306" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108306%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DBET%252Bbromodomains%252Bas%252Bnovel%252Bepigenetic%252Btargets%252Bfor%252Bbrain%252Bhealth%252Band%252Bdisease%26aulast%3DSingh%26aufirst%3DMandakini%2BB.%26date%3D2020%26volume%3D181%26spage%3D108306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javier  Checa</span>, <span class="hlFld-ContribAuthor ">Josep M.  Aran</span>. </span><span class="cited-content_cbyCitation_article-title">Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9317. <a href="https://doi.org/10.3390/ijms21239317" title="DOI URL">https://doi.org/10.3390/ijms21239317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239317%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DAirway%252BRedox%252BHomeostasis%252Band%252BInflammation%252BGone%252BAwry%25253A%252BFrom%252BMolecular%252BPathogenesis%252Bto%252BEmerging%252BTherapeutics%252Bin%252BRespiratory%252BPathology%26aulast%3DCheca%26aufirst%3DJavier%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingzhu  Yin</span>, <span class="hlFld-ContribAuthor ">Ying  Guo</span>, <span class="hlFld-ContribAuthor ">Rui  Hu</span>, <span class="hlFld-ContribAuthor ">Wesley L.  Cai</span>, <span class="hlFld-ContribAuthor ">Yao  Li</span>, <span class="hlFld-ContribAuthor ">Shiyao  Pei</span>, <span class="hlFld-ContribAuthor ">Hongyin  Sun</span>, <span class="hlFld-ContribAuthor ">Cong  Peng</span>, <span class="hlFld-ContribAuthor ">Jiali  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Ye</span>, <span class="hlFld-ContribAuthor ">Qiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Nenghui  Wang</span>, <span class="hlFld-ContribAuthor ">Yongguang  Tao</span>, <span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Qin  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-15290-0" title="DOI URL">https://doi.org/10.1038/s41467-020-15290-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-15290-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-15290-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DPotent%252BBRD4%252Binhibitor%252Bsuppresses%252Bcancer%252Bcell-macrophage%252Binteraction%26aulast%3DYin%26aufirst%3DMingzhu%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Hehe  Lv</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Predicting DNA binding protein-drug interactions based on network similarity. </span><span class="cited-content_cbyCitation_journal-name">BMC Bioinformatics</span><span> <strong>2020,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12859-020-03664-6" title="DOI URL">https://doi.org/10.1186/s12859-020-03664-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12859-020-03664-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12859-020-03664-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Bioinformatics%26atitle%3DPredicting%252BDNA%252Bbinding%252Bprotein-drug%252Binteractions%252Bbased%252Bon%252Bnetwork%252Bsimilarity%26aulast%3DWang%26aufirst%3DWei%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma K.  Grant</span>, <span class="hlFld-ContribAuthor ">David J.  Fallon</span>, <span class="hlFld-ContribAuthor ">Michael M.  Hann</span>, <span class="hlFld-ContribAuthor ">Ken G. M.  Fantom</span>, <span class="hlFld-ContribAuthor ">Chad  Quinn</span>, <span class="hlFld-ContribAuthor ">Francesca  Zappacosta</span>, <span class="hlFld-ContribAuthor ">Roland S.  Annan</span>, <span class="hlFld-ContribAuthor ">Chun‐wa  Chung</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">David P.  Dixon</span>, <span class="hlFld-ContribAuthor ">Peter  Stacey</span>, <span class="hlFld-ContribAuthor ">David  House</span>, <span class="hlFld-ContribAuthor ">Vipulkumar K.  Patel</span>, <span class="hlFld-ContribAuthor ">Nicholas C. O.  Tomkinson</span>, <span class="hlFld-ContribAuthor ">Jacob T.  Bush</span>. </span><span class="cited-content_cbyCitation_article-title">A Photoaffinity‐Based Fragment‐Screening Platform for Efficient Identification of Protein Ligands. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (47)
                                     , 21282-21291. <a href="https://doi.org/10.1002/ange.202008361" title="DOI URL">https://doi.org/10.1002/ange.202008361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202008361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202008361%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DA%252BPhotoaffinity%2525E2%252580%252590Based%252BFragment%2525E2%252580%252590Screening%252BPlatform%252Bfor%252BEfficient%252BIdentification%252Bof%252BProtein%252BLigands%26aulast%3DGrant%26aufirst%3DEmma%2BK.%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D47%26spage%3D21282%26epage%3D21291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma K.  Grant</span>, <span class="hlFld-ContribAuthor ">David J.  Fallon</span>, <span class="hlFld-ContribAuthor ">Michael M.  Hann</span>, <span class="hlFld-ContribAuthor ">Ken G. M.  Fantom</span>, <span class="hlFld-ContribAuthor ">Chad  Quinn</span>, <span class="hlFld-ContribAuthor ">Francesca  Zappacosta</span>, <span class="hlFld-ContribAuthor ">Roland S.  Annan</span>, <span class="hlFld-ContribAuthor ">Chun‐wa  Chung</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">David P.  Dixon</span>, <span class="hlFld-ContribAuthor ">Peter  Stacey</span>, <span class="hlFld-ContribAuthor ">David  House</span>, <span class="hlFld-ContribAuthor ">Vipulkumar K.  Patel</span>, <span class="hlFld-ContribAuthor ">Nicholas C. O.  Tomkinson</span>, <span class="hlFld-ContribAuthor ">Jacob T.  Bush</span>. </span><span class="cited-content_cbyCitation_article-title">A Photoaffinity‐Based Fragment‐Screening Platform for Efficient Identification of Protein Ligands. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (47)
                                     , 21096-21105. <a href="https://doi.org/10.1002/anie.202008361" title="DOI URL">https://doi.org/10.1002/anie.202008361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202008361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202008361%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DA%252BPhotoaffinity%2525E2%252580%252590Based%252BFragment%2525E2%252580%252590Screening%252BPlatform%252Bfor%252BEfficient%252BIdentification%252Bof%252BProtein%252BLigands%26aulast%3DGrant%26aufirst%3DEmma%2BK.%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D47%26spage%3D21096%26epage%3D21105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yinliang  Qi</span>, <span class="hlFld-ContribAuthor ">Le  Xu</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Li</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Tao  Hu</span>, <span class="hlFld-ContribAuthor ">Bixi  Yin</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yunlei  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel pteridinone derivatives as potent dual inhibitors of PLK1 and BRD4. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (38)
                                     , 16477-16490. <a href="https://doi.org/10.1039/D0NJ03477K" title="DOI URL">https://doi.org/10.1039/D0NJ03477K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ03477K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ03477K%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpteridinone%252Bderivatives%252Bas%252Bpotent%252Bdual%252Binhibitors%252Bof%252BPLK1%252Band%252BBRD4%26aulast%3DQi%26aufirst%3DYinliang%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D38%26spage%3D16477%26epage%3D16490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valeria V.  Kleandrova</span>, <span class="hlFld-ContribAuthor ">Alejandro  Speck-Planche</span>. </span><span class="cited-content_cbyCitation_article-title">The QSAR Paradigm in Fragment-Based Drug Discovery: From the Virtual Generation of Target Inhibitors to Multi-Scale Modeling. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (14)
                                     , 1357-1374. <a href="https://doi.org/10.2174/1389557520666200204123156" title="DOI URL">https://doi.org/10.2174/1389557520666200204123156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557520666200204123156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557520666200204123156%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DThe%252BQSAR%252BParadigm%252Bin%252BFragment-Based%252BDrug%252BDiscovery%25253A%252BFrom%252Bthe%252BVirtual%252BGeneration%252Bof%252BTarget%252BInhibitors%252Bto%252BMulti-Scale%252BModeling%26aulast%3DKleandrova%26aufirst%3DValeria%2BV.%26date%3D2020%26volume%3D20%26issue%3D14%26spage%3D1357%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuqing  Deng</span>, <span class="hlFld-ContribAuthor ">Jianzhao  Peng</span>, <span class="hlFld-ContribAuthor ">Feng  Xiong</span>, <span class="hlFld-ContribAuthor ">Yinan  Song</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianfu  Zhang</span>, <span class="hlFld-ContribAuthor ">Fong Sang  Lam</span>, <span class="hlFld-ContribAuthor ">Chao  Xie</span>, <span class="hlFld-ContribAuthor ">Wenyin  Shen</span>, <span class="hlFld-ContribAuthor ">Yiran  Huang</span>, <span class="hlFld-ContribAuthor ">Ling  Meng</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Selection of DNA‐Encoded Dynamic Chemical Libraries for Direct Inhibitor Discovery. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (35)
                                     , 15075-15082. <a href="https://doi.org/10.1002/ange.202005070" title="DOI URL">https://doi.org/10.1002/ange.202005070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202005070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202005070%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSelection%252Bof%252BDNA%2525E2%252580%252590Encoded%252BDynamic%252BChemical%252BLibraries%252Bfor%252BDirect%252BInhibitor%252BDiscovery%26aulast%3DDeng%26aufirst%3DYuqing%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D35%26spage%3D15075%26epage%3D15082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuqing  Deng</span>, <span class="hlFld-ContribAuthor ">Jianzhao  Peng</span>, <span class="hlFld-ContribAuthor ">Feng  Xiong</span>, <span class="hlFld-ContribAuthor ">Yinan  Song</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianfu  Zhang</span>, <span class="hlFld-ContribAuthor ">Fong Sang  Lam</span>, <span class="hlFld-ContribAuthor ">Chao  Xie</span>, <span class="hlFld-ContribAuthor ">Wenyin  Shen</span>, <span class="hlFld-ContribAuthor ">Yiran  Huang</span>, <span class="hlFld-ContribAuthor ">Ling  Meng</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Selection of DNA‐Encoded Dynamic Chemical Libraries for Direct Inhibitor Discovery. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (35)
                                     , 14965-14972. <a href="https://doi.org/10.1002/anie.202005070" title="DOI URL">https://doi.org/10.1002/anie.202005070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202005070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202005070%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSelection%252Bof%252BDNA%2525E2%252580%252590Encoded%252BDynamic%252BChemical%252BLibraries%252Bfor%252BDirect%252BInhibitor%252BDiscovery%26aulast%3DDeng%26aufirst%3DYuqing%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D35%26spage%3D14965%26epage%3D14972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dailin  Liang</span>, <span class="hlFld-ContribAuthor ">Yifan  Yu</span>, <span class="hlFld-ContribAuthor ">Zonghui  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112426. <a href="https://doi.org/10.1016/j.ejmech.2020.112426" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112426%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bstrategies%252Btargeting%252Bbromodomain-containing%252Bprotein%252B4%252B%252528BRD4%252529%252Bfor%252Bcancer%252Bdrug%252Bdiscovery%26aulast%3DLiang%26aufirst%3DDailin%26date%3D2020%26volume%3D200%26spage%3D112426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter D.  Ycas</span>, <span class="hlFld-ContribAuthor ">Huda  Zahid</span>, <span class="hlFld-ContribAuthor ">Alice  Chan</span>, <span class="hlFld-ContribAuthor ">Noelle M.  Olson</span>, <span class="hlFld-ContribAuthor ">Jorden A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Siva K.  Talluri</span>, <span class="hlFld-ContribAuthor ">Ernst  Schonbrunn</span>, <span class="hlFld-ContribAuthor ">William C. K.  Pomerantz</span>. </span><span class="cited-content_cbyCitation_article-title">New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (27)
                                     , 5174-5182. <a href="https://doi.org/10.1039/D0OB00506A" title="DOI URL">https://doi.org/10.1039/D0OB00506A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00506A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00506A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DNew%252Binhibitors%252Bfor%252Bthe%252BBPTF%252Bbromodomain%252Benabled%252Bby%252Bstructural%252Bbiology%252Band%252Bbiophysical%252Bassay%252Bdevelopment%26aulast%3DYcas%26aufirst%3DPeter%2BD.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D27%26spage%3D5174%26epage%3D5182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijun  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Li</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Lixun  Huang</span>, <span class="hlFld-ContribAuthor ">Yuying  Yao</span>, <span class="hlFld-ContribAuthor ">Liuyou  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Chen</span>, <span class="hlFld-ContribAuthor ">Rongxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Lijing  Wang</span>, <span class="hlFld-ContribAuthor ">Qian-Qian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.01043" title="DOI URL">https://doi.org/10.3389/fphar.2020.01043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.01043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.01043%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DA%252BBromodomain-Containing%252BProtein%252B4%252B%252528BRD4%252529%252BInhibitor%252BSuppresses%252BAngiogenesis%252Bby%252BRegulating%252BAP-1%252BExpression%26aulast%3DZhou%26aufirst%3DZijun%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang  Yu</span>, <span class="hlFld-ContribAuthor ">Peiting  Zhou</span>, <span class="hlFld-ContribAuthor ">Wu  Du</span>, <span class="hlFld-ContribAuthor ">Ruixue  Xu</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Yufang  Deng</span>, <span class="hlFld-ContribAuthor ">Xinghai  Li</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>, 113946. <a href="https://doi.org/10.1016/j.bcp.2020.113946" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113946%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DMetabolically%252Bstable%252Bdiphenylamine%252Bderivatives%252Bsuppress%252Bandrogen%252Breceptor%252Band%252BBET%252Bprotein%252Bin%252Bprostate%252Bcancer%26aulast%3DYu%26aufirst%3DJiang%26date%3D2020%26volume%3D177%26spage%3D113946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atukuri  Dorababu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology Profile of Recently Developed Multi‐Functional Azoles; SAR‐Based Predictive Structural Modification. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (22)
                                     , 6730-6758. <a href="https://doi.org/10.1002/slct.202000294" title="DOI URL">https://doi.org/10.1002/slct.202000294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202000294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202000294%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DPharmacology%252BProfile%252Bof%252BRecently%252BDeveloped%252BMulti%2525E2%252580%252590Functional%252BAzoles%25253B%252BSAR%2525E2%252580%252590Based%252BPredictive%252BStructural%252BModification%26aulast%3DDorababu%26aufirst%3DAtukuri%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D22%26spage%3D6730%26epage%3D6758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edrous  Alamer</span>, <span class="hlFld-ContribAuthor ">Chaojie  Zhong</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Qingli  Niu</span>, <span class="hlFld-ContribAuthor ">Fuquan  Long</span>, <span class="hlFld-ContribAuthor ">Lulu  Guo</span>, <span class="hlFld-ContribAuthor ">Benjamin B.  Gelman</span>, <span class="hlFld-ContribAuthor ">Lynn  Soong</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Haitao  Hu</span>, . </span><span class="cited-content_cbyCitation_article-title">Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2020,</strong> <em>94 </em>
                                    (11)
                                     <a href="https://doi.org/10.1128/JVI.01880-19" title="DOI URL">https://doi.org/10.1128/JVI.01880-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.01880-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.01880-19%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DEpigenetic%252BSuppression%252Bof%252BHIV%252Bin%252BMyeloid%252BCells%252Bby%252Bthe%252BBRD4-Selective%252BSmall%252BMolecule%252BModulator%252BZL0580%26aulast%3DAlamer%26aufirst%3DEdrous%26date%3D2020%26volume%3D94%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuanglei  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxi  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongshou  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Application of carbamyl in structural optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>98 </em>, 103757. <a href="https://doi.org/10.1016/j.bioorg.2020.103757" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103757</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103757%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DApplication%252Bof%252Bcarbamyl%252Bin%252Bstructural%252Boptimization%26aulast%3DWang%26aufirst%3DKuanglei%26date%3D2020%26volume%3D98%26spage%3D103757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allan R.  Brasier</span>. </span><span class="cited-content_cbyCitation_article-title">RSV Reprograms the CDK9•BRD4 Chromatin Remodeling Complex to Couple Innate Inflammation to Airway Remodeling. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 472. <a href="https://doi.org/10.3390/v12040472" title="DOI URL">https://doi.org/10.3390/v12040472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v12040472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv12040472%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DRSV%252BReprograms%252Bthe%252BCDK9%2525E2%252580%2525A2BRD4%252BChromatin%252BRemodeling%252BComplex%252Bto%252BCouple%252BInnate%252BInflammation%252Bto%252BAirway%252BRemodeling%26aulast%3DBrasier%26aufirst%3DAllan%2BR.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Fan  Tan</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiu-Heng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of BRD4 prevents proliferation and epithelial–mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     <a href="https://doi.org/10.1038/s41419-020-2431-2" title="DOI URL">https://doi.org/10.1038/s41419-020-2431-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-020-2431-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-020-2431-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DInhibition%252Bof%252BBRD4%252Bprevents%252Bproliferation%252Band%252Bepithelial%2525E2%252580%252593mesenchymal%252Btransition%252Bin%252Brenal%252Bcell%252Bcarcinoma%252Bvia%252BNLRP3%252Binflammasome-induced%252Bpyroptosis%26aulast%3DTan%26aufirst%3DYi-Fan%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoel  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Guillermo  Gerona‐Navarro</span>, <span class="hlFld-ContribAuthor ">Roman  Osman</span>, <span class="hlFld-ContribAuthor ">Ming‐Ming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2020,</strong> <em>88 </em>
                                    (3)
                                     , 414-430. <a href="https://doi.org/10.1002/prot.25818" title="DOI URL">https://doi.org/10.1002/prot.25818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.25818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.25818%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DIn%252Bsilico%252Bdesign%252Band%252Bmolecular%252Bbasis%252Bfor%252Bthe%252Bselectivity%252Bof%252BOlinone%252Btoward%252Bthe%252Bfirst%252Bover%252Bthe%252Bsecond%252Bbromodomain%252Bof%252BBRD4%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DYoel%26date%3D2020%26date%3D2019%26volume%3D88%26issue%3D3%26spage%3D414%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hualong  He</span>, <span class="hlFld-ContribAuthor ">Xi  Hu</span>, <span class="hlFld-ContribAuthor ">Fei  Teng</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Qiangsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhanzhan  Feng</span>, <span class="hlFld-ContribAuthor ">Qiang  Feng</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of (E)-1,2-diphenylethene-based EZH2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 126957. <a href="https://doi.org/10.1016/j.bmcl.2020.126957" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126957</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126957%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B%252528E%252529-1%25252C2-diphenylethene-based%252BEZH2%252Binhibitors%26aulast%3DHe%26aufirst%3DHualong%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D126957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (8)
                                     , 3052-3056. <a href="https://doi.org/10.1002/ange.201915896" title="DOI URL">https://doi.org/10.1002/ange.201915896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201915896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201915896%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPotent%252BDual%252BBET%25252FHDAC%252BInhibitors%252Bfor%252BEfficient%252BTreatment%252Bof%252BPancreatic%252BCancer%26aulast%3DHe%26aufirst%3DShipeng%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D8%26spage%3D3052%26epage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (8)
                                     , 3028-3032. <a href="https://doi.org/10.1002/anie.201915896" title="DOI URL">https://doi.org/10.1002/anie.201915896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201915896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201915896%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPotent%252BDual%252BBET%25252FHDAC%252BInhibitors%252Bfor%252BEfficient%252BTreatment%252Bof%252BPancreatic%252BCancer%26aulast%3DHe%26aufirst%3DShipeng%26date%3D2020%26volume%3D59%26issue%3D8%26spage%3D3028%26epage%3D3032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Wang</span>, <span class="hlFld-ContribAuthor ">Dandan  Shen</span>, <span class="hlFld-ContribAuthor ">Lijie  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaohan  Yuan</span>, <span class="hlFld-ContribAuthor ">Jialing  Cheng</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Yichao  Zheng</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of [1,2,4]triazolo[1,5-a]pyrimidine derivatives as new bromodomain-containing protein 4 (BRD4) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2020,</strong> <em>31 </em>
                                    (2)
                                     , 418-422. <a href="https://doi.org/10.1016/j.cclet.2019.08.029" title="DOI URL">https://doi.org/10.1016/j.cclet.2019.08.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2019.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2019.08.029%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDiscovery%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bas%252Bnew%252Bbromodomain-containing%252Bprotein%252B4%252B%252528BRD4%252529%252Binhibitors%26aulast%3DWang%26aufirst%3DShuai%26date%3D2020%26volume%3D31%26issue%3D2%26spage%3D418%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas H.  Pillow</span>, <span class="hlFld-ContribAuthor ">Pragya  Adhikari</span>, <span class="hlFld-ContribAuthor ">Robert A.  Blake</span>, <span class="hlFld-ContribAuthor ">Jinhua  Chen</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Del Rosario</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Isabel  Figueroa</span>, <span class="hlFld-ContribAuthor ">Karen E.  Gascoigne</span>, <span class="hlFld-ContribAuthor ">Amrita V.  Kamath</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Katherine R.  Kozak</span>, <span class="hlFld-ContribAuthor ">Brandon  Latifi</span>, <span class="hlFld-ContribAuthor ">Douglas D.  Leipold</span>, <span class="hlFld-ContribAuthor ">Chun  Sing Li</span>, <span class="hlFld-ContribAuthor ">Ruina  Li</span>, <span class="hlFld-ContribAuthor ">Melinda M.  Mulvihill</span>, <span class="hlFld-ContribAuthor ">Aimee  O'Donohue</span>, <span class="hlFld-ContribAuthor ">Rebecca K.  Rowntree</span>, <span class="hlFld-ContribAuthor ">Jack D.  Sadowsky</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Xinxin  Wang</span>, <span class="hlFld-ContribAuthor ">Cong  Wu</span>, <span class="hlFld-ContribAuthor ">Zijin  Xu</span>, <span class="hlFld-ContribAuthor ">Hui  Yao</span>, <span class="hlFld-ContribAuthor ">Shang‐Fan  Yu</span>, <span class="hlFld-ContribAuthor ">Donglu  Zhang</span>, <span class="hlFld-ContribAuthor ">Richard  Zang</span>, <span class="hlFld-ContribAuthor ">Hongyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody Conjugation of a Chimeric BET Degrader Enables
              in vivo
              Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     , 17-25. <a href="https://doi.org/10.1002/cmdc.201900497" title="DOI URL">https://doi.org/10.1002/cmdc.201900497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900497%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAntibody%252BConjugation%252Bof%252Ba%252BChimeric%252BBET%252BDegrader%252BEnables%252Bin%2525E2%252580%252585vivo%252BActivity%26aulast%3DPillow%26aufirst%3DThomas%2BH.%26date%3D2020%26date%3D2019%26volume%3D15%26issue%3D1%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of BRD4 inhibitors (2013-2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (1)
                                     , 57-81. <a href="https://doi.org/10.1080/13543776.2020.1702645" title="DOI URL">https://doi.org/10.1080/13543776.2020.1702645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1702645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1702645%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252BBRD4%252Binhibitors%252B%2525282013-2019%252529%26aulast%3DLu%26aufirst%3DTian%26date%3D2020%26date%3D2019%26volume%3D30%26issue%3D1%26spage%3D57%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando D.  Prieto-Martínez</span>, <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Current advances on the development of BET inhibitors: insights from computational methods. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 127-180. <a href="https://doi.org/10.1016/bs.apcsb.2020.06.002" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2020.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2020.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2020.06.002%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252Badvances%252Bon%252Bthe%252Bdevelopment%252Bof%252BBET%252Binhibitors%25253A%252Binsights%252Bfrom%252Bcomputational%252Bmethods%26aulast%3DPrieto-Mart%25C3%25ADnez%26aufirst%3DFernando%2BD.%26date%3D2020%26spage%3D127%26epage%3D180%26pub%3DElsevier%26date%3D2020%26volume%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allan R.  Brasier</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 126-132. <a href="https://doi.org/10.1016/j.drudis.2019.11.002" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DValidation%252Bof%252Bthe%252Bepigenetic%252Breader%252Bbromodomain-containing%252Bprotein%252B4%252B%252528BRD4%252529%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Btreatment%252Bof%252Bairway%252Bremodeling%26aulast%3DBrasier%26aufirst%3DAllan%2BR.%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D126%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Oscar D.  Villarreal</span>, <span class="hlFld-ContribAuthor ">Rongjie  Fu</span>, <span class="hlFld-ContribAuthor ">Ella  Bedford</span>, <span class="hlFld-ContribAuthor ">Jingzhuang  Dou</span>, <span class="hlFld-ContribAuthor ">Anish Y.  Patel</span>, <span class="hlFld-ContribAuthor ">Mark T.  Bedford</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Shi</span>, <span class="hlFld-ContribAuthor ">Taiping  Chen</span>, <span class="hlFld-ContribAuthor ">Blaine  Bartholomew</span>, <span class="hlFld-ContribAuthor ">Han  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-12489-8" title="DOI URL">https://doi.org/10.1038/s41467-019-12489-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-12489-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-12489-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DDe%252Bnovo%252Bidentification%252Bof%252Bessential%252Bprotein%252Bdomains%252Bfrom%252BCRISPR-Cas9%252Btiling-sgRNA%252Bknockout%252Bscreens%26aulast%3DHe%26aufirst%3DWei%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deheng  Chen</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Ziqin  Yan</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Feilong  Zhou</span>, <span class="hlFld-ContribAuthor ">Xilin  Lyu</span>, <span class="hlFld-ContribAuthor ">Biling  Xu</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111633. <a href="https://doi.org/10.1016/j.ejmech.2019.111633" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111633%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252Bstructural%252Binsight%25252C%252Band%252Bbioactivities%252Bof%252BBY27%252Bas%252Ba%252Bselective%252Binhibitor%252Bof%252Bthe%252Bsecond%252Bbromodomains%252Bof%252BBET%252Bproteins%26aulast%3DChen%26aufirst%3DDeheng%26date%3D2019%26volume%3D182%26spage%3D111633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingbing  Li</span>, <span class="hlFld-ContribAuthor ">Deqin  Rong</span>, <span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (21)
                                     , 1872-1876. <a href="https://doi.org/10.2174/1568026619666191011163410" title="DOI URL">https://doi.org/10.2174/1568026619666191011163410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191011163410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191011163410%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BProtein-Protein%252BInteraction%252Bwith%252BCovalent%252BSmall-Molecule%252BInhibitors%26aulast%3DLi%26aufirst%3DBingbing%26date%3D2019%26volume%3D19%26issue%3D21%26spage%3D1872%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esther  Barreiro</span>, <span class="hlFld-ContribAuthor ">Xuejie  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">COPD: preclinical models and emerging therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (10)
                                     , 829-838. <a href="https://doi.org/10.1080/14728222.2019.1667976" title="DOI URL">https://doi.org/10.1080/14728222.2019.1667976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1667976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1667976%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DCOPD%25253A%252Bpreclinical%252Bmodels%252Band%252Bemerging%252Btherapeutic%252Btargets%26aulast%3DBarreiro%26aufirst%3DEsther%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D10%26spage%3D829%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Junyan  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Co‐inhibition of BET proteins and PD‐L1 as a potential therapy for OSCC through synergistic inhibition of FOXM1 and PD‐L1 expressions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Oral Pathology & Medicine</span><span> <strong>2019,</strong> <em>48 </em>
                                    (9)
                                     , 817-825. <a href="https://doi.org/10.1111/jop.12906" title="DOI URL">https://doi.org/10.1111/jop.12906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jop.12906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjop.12906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Oral%2520Pathology%2520%2526%2520Medicine%26atitle%3DCo%2525E2%252580%252590inhibition%252Bof%252BBET%252Bproteins%252Band%252BPD%2525E2%252580%252590L1%252Bas%252Ba%252Bpotential%252Btherapy%252Bfor%252BOSCC%252Bthrough%252Bsynergistic%252Binhibition%252Bof%252BFOXM1%252Band%252BPD%2525E2%252580%252590L1%252Bexpressions%26aulast%3DWang%26aufirst%3DWei%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D9%26spage%3D817%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franca-Maria  Klingler</span>, <span class="hlFld-ContribAuthor ">Marcus  Gastreich</span>, <span class="hlFld-ContribAuthor ">Oleksandr  Grygorenko</span>, <span class="hlFld-ContribAuthor ">Olena  Savych</span>, <span class="hlFld-ContribAuthor ">Petro  Borysko</span>, <span class="hlFld-ContribAuthor ">Anastasia  Griniukova</span>, <span class="hlFld-ContribAuthor ">Kateryna  Gubina</span>, <span class="hlFld-ContribAuthor ">Christian  Lemmen</span>, <span class="hlFld-ContribAuthor ">Yurii  Moroz</span>. </span><span class="cited-content_cbyCitation_article-title">SAR by Space: Enriching Hit Sets from the Chemical Space. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (17)
                                     , 3096. <a href="https://doi.org/10.3390/molecules24173096" title="DOI URL">https://doi.org/10.3390/molecules24173096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24173096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24173096%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSAR%252Bby%252BSpace%25253A%252BEnriching%252BHit%252BSets%252Bfrom%252Bthe%252BChemical%252BSpace%26aulast%3DKlingler%26aufirst%3DFranca-Maria%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D17%26spage%3D3096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Speck-Planche</span>, <span class="hlFld-ContribAuthor ">Marcus T.  Scotti</span>. </span><span class="cited-content_cbyCitation_article-title">BET bromodomain inhibitors: fragment-based in silico design using multi-target QSAR models. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 555-572. <a href="https://doi.org/10.1007/s11030-018-9890-8" title="DOI URL">https://doi.org/10.1007/s11030-018-9890-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-9890-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-9890-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DBET%252Bbromodomain%252Binhibitors%25253A%252Bfragment-based%252Bin%252Bsilico%252Bdesign%252Busing%252Bmulti-target%252BQSAR%252Bmodels%26aulast%3DSpeck-Planche%26aufirst%3DAlejandro%26date%3D2019%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D555%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Yu</span>, <span class="hlFld-ContribAuthor ">Wenjing  Liu</span>, <span class="hlFld-ContribAuthor ">Jinghui  Ren</span>, <span class="hlFld-ContribAuthor ">Yingying  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Ning</span>, <span class="hlFld-ContribAuthor ">Mingqi  Huang</span>, <span class="hlFld-ContribAuthor ">Xinyi  Hu</span>, <span class="hlFld-ContribAuthor ">Lili  Wei</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>, <span class="hlFld-ContribAuthor ">Jin  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of hypolipidemic compounds based on BRD4 inhibitor RVX-208. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2168-2172. <a href="https://doi.org/10.1016/j.bmcl.2019.06.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bhypolipidemic%252Bcompounds%252Bbased%252Bon%252BBRD4%252Binhibitor%252BRVX-208%26aulast%3DYu%26aufirst%3DPing%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2168%26epage%3D2172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew S.  Stratton</span>, <span class="hlFld-ContribAuthor ">Floriana Maria  Farina</span>, <span class="hlFld-ContribAuthor ">Leonardo  Elia</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetics and vascular diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular and Cellular Cardiology</span><span> <strong>2019,</strong> <em>133 </em>, 148-163. <a href="https://doi.org/10.1016/j.yjmcc.2019.06.010" title="DOI URL">https://doi.org/10.1016/j.yjmcc.2019.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yjmcc.2019.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yjmcc.2019.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520and%2520Cellular%2520Cardiology%26atitle%3DEpigenetics%252Band%252Bvascular%252Bdiseases%26aulast%3DStratton%26aufirst%3DMatthew%2BS.%26date%3D2019%26volume%3D133%26spage%3D148%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Conery</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomains: a new target class for drug development. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (8)
                                     , 609-628. <a href="https://doi.org/10.1038/s41573-019-0030-7" title="DOI URL">https://doi.org/10.1038/s41573-019-0030-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0030-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0030-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DBromodomains%25253A%252Ba%252Bnew%252Btarget%252Bclass%252Bfor%2525C2%2525A0drug%252Bdevelopment%26aulast%3DCochran%26aufirst%3DAndrea%2BG.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D8%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingxin  Zhao</span>, <span class="hlFld-ContribAuthor ">Bing  Tian</span>, <span class="hlFld-ContribAuthor ">Hong  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yueqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Maxim  Ivannikov</span>, <span class="hlFld-ContribAuthor ">Massoud  Motamedi</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Lata  Kaphalia</span>, <span class="hlFld-ContribAuthor ">William J.  Calhoun</span>, <span class="hlFld-ContribAuthor ">Rosario  Maroto</span>, <span class="hlFld-ContribAuthor ">Allan R.  Brasier</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacoproteomics reveal novel protective activity of bromodomain containing 4 inhibitors on vascular homeostasis in TLR3-mediated airway remodeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteomics</span><span> <strong>2019,</strong> <em>205 </em>, 103415. <a href="https://doi.org/10.1016/j.jprot.2019.103415" title="DOI URL">https://doi.org/10.1016/j.jprot.2019.103415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jprot.2019.103415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jprot.2019.103415%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteomics%26atitle%3DPharmacoproteomics%252Breveal%252Bnovel%252Bprotective%252Bactivity%252Bof%252Bbromodomain%252Bcontaining%252B4%252Binhibitors%252Bon%252Bvascular%252Bhomeostasis%252Bin%252BTLR3-mediated%252Bairway%252Bremodeling%26aulast%3DZhao%26aufirst%3DYingxin%26date%3D2019%26volume%3D205%26spage%3D103415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingli  Niu</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Edrous  Alamer</span>, <span class="hlFld-ContribAuthor ">Xiuzhen  Fan</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Janice  Endsley</span>, <span class="hlFld-ContribAuthor ">Benjamin B.  Gelman</span>, <span class="hlFld-ContribAuthor ">Bing  Tian</span>, <span class="hlFld-ContribAuthor ">Jerome H.  Kim</span>, <span class="hlFld-ContribAuthor ">Nelson L.  Michael</span>, <span class="hlFld-ContribAuthor ">Merlin L.  Robb</span>, <span class="hlFld-ContribAuthor ">Jintanat  Ananworanich</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Haitao  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2019,</strong> <em>129 </em>
                                    (8)
                                     , 3361-3373. <a href="https://doi.org/10.1172/JCI120633" title="DOI URL">https://doi.org/10.1172/JCI120633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI120633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI120633%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DStructure-guided%252Bdrug%252Bdesign%252Bidentifies%252Ba%252BBRD4-selective%252Bsmall%252Bmolecule%252Bthat%252Bsuppresses%252BHIV%26aulast%3DNiu%26aufirst%3DQingli%26date%3D2019%26date%3D2019%26volume%3D129%26issue%3D8%26spage%3D3361%26epage%3D3373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heeyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Dahye  Kang</span>, <span class="hlFld-ContribAuthor ">Sang Hoon  Han</span>, <span class="hlFld-ContribAuthor ">Rina  Chun</span>, <span class="hlFld-ContribAuthor ">Ashok Kumar  Pandey</span>, <span class="hlFld-ContribAuthor ">Neeraj Kumar  Mishra</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>, <span class="hlFld-ContribAuthor ">In Su  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Allylic Acetals as Acrolein Oxonium Precursors in Tandem C−H Allylation and [3+2] Dipolar Cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (28)
                                     , 9570-9574. <a href="https://doi.org/10.1002/ange.201903983" title="DOI URL">https://doi.org/10.1002/ange.201903983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201903983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201903983%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DAllylic%252BAcetals%252Bas%252BAcrolein%252BOxonium%252BPrecursors%252Bin%252BTandem%252BC%2525E2%252588%252592H%252BAllylation%252Band%252B%25255B3%25252B2%25255D%252BDipolar%252BCycloaddition%26aulast%3DLee%26aufirst%3DHeeyoung%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D28%26spage%3D9570%26epage%3D9574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heeyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Dahye  Kang</span>, <span class="hlFld-ContribAuthor ">Sang Hoon  Han</span>, <span class="hlFld-ContribAuthor ">Rina  Chun</span>, <span class="hlFld-ContribAuthor ">Ashok Kumar  Pandey</span>, <span class="hlFld-ContribAuthor ">Neeraj Kumar  Mishra</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>, <span class="hlFld-ContribAuthor ">In Su  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Allylic Acetals as Acrolein Oxonium Precursors in Tandem C−H Allylation and [3+2] Dipolar Cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (28)
                                     , 9470-9474. <a href="https://doi.org/10.1002/anie.201903983" title="DOI URL">https://doi.org/10.1002/anie.201903983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201903983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201903983%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DAllylic%252BAcetals%252Bas%252BAcrolein%252BOxonium%252BPrecursors%252Bin%252BTandem%252BC%2525E2%252588%252592H%252BAllylation%252Band%252B%25255B3%25252B2%25255D%252BDipolar%252BCycloaddition%26aulast%3DLee%26aufirst%3DHeeyoung%26date%3D2019%26volume%3D58%26issue%3D28%26spage%3D9470%26epage%3D9474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.6b01761&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-11%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01761%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=140&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Eight families of bromodomain-containing proteins. Bromodomain-containing protein 4 (BRD4, highlighted in magenta) belongs to the BET family (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of selected BET inhibitors that are currently being evaluated in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Domain organization of the long form of BRD4. (b) Conserved sequences of BRD4 BD1 and BRD4 BD2. The important critical residues that may contribute to the acetyl-lysine binding specificity are highlighted in different colors. (c) (left panel) Ribbon representation of BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UW9">3UW9</a>). (right panel) Surface representation of the KAc binding pocket of BRD4 BD1. Asn140 is highlighted in red, and the WPF shelf is highlighted in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Proposed action modes of BRD4 in selected diseases such as cancer, inflammation, and HPV. (left panel) Interaction of Twist and BRD4 at the enhancer/promoter of <i>WNT5A</i>, leading to the transcriptional activation of <i>WNT5A</i> expression in BLBC. (center panel) Interaction of RelA and BRD4, facilitating the transcription of NF-κB-dependent inflammatory genes. (right panel) BRD4 serves as the receptor of the E2/viral DNA complex on mitotic chromosomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Chemical structures of compounds <b>7</b> and <b>8</b>. (b) Cocrystal structure of <b>7</b> with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF">3MXF</a>). Residues Asn140 (N140), Tyr97 (Y97), Leu94 (L94), Val87 (V87), and Leu92 (L92) are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery and development of BRD4 inhibitor <b>2</b>. PBMC: peripheral blood mononuclear cells; BZDR: the central GABA receptor; <i>t</i><sub>1/2</sub>, determined by an in vitro assay; <i>T</i><sub>1/2</sub>, performed in vivo.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Development of isoxazole azepine analogues as BRD4 inhibitors and complex of <b>15</b> (colored magenta) with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q">4Z1Q</a>). V<sub>SS</sub>, volume of distribution at steady state.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structures of compounds <b>16</b>–<b>20</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of compounds <b>21</b>–<b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery and development of BRD4 inhibitors <b>33</b>–<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of compounds <b>36</b>–<b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Discovery and development of compounds <b>41</b> and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of compounds <b>43</b>–<b>48</b>. FL, full length; MLM, mouse liver microsome; HLM, human liver microsome.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures of compounds <b>49</b>–<b>56</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Chemical structures of compounds <b>57</b>–<b>64</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Chemical structures of compounds <b>65</b>–<b>70</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of compounds <b>71</b>–<b>76</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Chemical structures of compounds <b>77</b>–<b>82</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Discovery and development of compound <b>85</b> and its complex with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BJX">4BJX</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Chemical structures of compounds <b>86</b>–<b>91</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0022.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Chemical structures of compounds <b>92</b>–<b>94</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0023.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Discovery and development of 2-thiazolidinones as BRD4 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0024.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Chemical structures of compounds <b>99</b>–<b>101</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0025.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Chemical structures of compounds <b>102</b> and <b>103</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0026.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Chemical structure of dual kinase-bromodomain inhibitors <b>104</b>–<b>106</b> and their cocrystal structures with BRD4 BD1 as well as their target kinases. (left panel) Cocomplex of <b>104</b> with BRD4 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGI">4OGI</a>) and PLK1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RKU">2RKU</a>). (center panel) Crystal structures of <b>105</b> with BRD4 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O76">4O76</a>) and JAK2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JI9">4JI9</a>). (right panel) Cocomplex of <b>106</b> with BRD4 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O77">4O77</a>) and SB2 (4-(4-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1<i>H</i>-imidazol-5-yl)pyridine) with p38α (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZS5">3ZS5</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0027.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Chemical structures of compounds <b>107</b>–<b>109</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0028.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. (left panel) Structure of compound <b>1</b> and <i>K</i><sub>D</sub> values with different BD domains of BET members. (right panel) Overlap of cocrystal structures of <b>1</b> with BRD4 BD1 (yellow; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR4">4MR4</a>) and BRD2 BD2 (turquoise; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR6">4MR6</a>). The labeled residue is His433 (magenta) in the BRD2 BD2 domain and Asp144 (green) in the BRD4 BD1 domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0029.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. (a) Development of compound <b>111</b>. (b) Development of compound <b>113</b>. (c) Cocrystal structure of <b>113</b> with BRD4 BD1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4QB3">4QB3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/medium/jm-2016-01761h_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0030.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. (left panel) Structure of compound <b>114</b> and IC<sub>50</sub> values for different BD1 domains of BET members. (right panel) Superimposition of BRD4 alone (green; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OSS">2OSS</a>) and BRD4 with compound <b>114</b> (yellow; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EGU">5EGU</a>). The ZA loop shift is highlighted by the magenta box.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.6b01761/20170602/images/large/jm-2016-01761h_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01761&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 200 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Chromatin modifications and their function</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2007.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17320507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=693-705&author=T.+Kouzarides&title=Chromatin+modifications+and+their+function&doi=10.1016%2Fj.cell.2007.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin modifications and their function</span></div><div class="casAuthors">Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-705</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The surface of nucleosomes is studded with a multiplicity of modifications.  At least eight different classes have been characterized to date and many different sites have been identified for each class.  Operationally, modifications function either by disrupting chromatin contacts or by affecting the recruitment of nonhistone proteins to chromatin.  Their presence on histones can dictate the higher-order chromatin structure in which DNA is packaged and can orchestrate the ordered recruitment of enzyme complexes to manipulate DNA.  In this way, histone modifications have the potential to influence many fundamental biol. processes, some of which may be epigenetically inherited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAH9AX2dGicbVg90H21EOLACvtfcHk0lgyev-nNOZH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D&md5=c5995fe68fd9473f4268d59c01d3b9de</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DChromatin%2520modifications%2520and%2520their%2520function%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D693%26epage%3D705%26doi%3D10.1016%2Fj.cell.2007.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, J. L.</span><span> </span><span class="NLM_article-title">The role of chromatin during transcription</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2007.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17320508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=707-719&author=B.+Liauthor=M.+Careyauthor=J.+L.+Workman&title=The+role+of+chromatin+during+transcription&doi=10.1016%2Fj.cell.2007.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The role of chromatin during transcription</span></div><div class="casAuthors">Li, Bing; Carey, Michael; Workman, Jerry L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">707-719</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Chromatin structure imposes significant obstacles on all aspects of transcription that are mediated by RNA polymerase II.  The dynamics of chromatin structure are tightly regulated through multiple mechanisms including histone modification, chromatin remodeling, histone variant incorporation, and histone eviction.  In this Review, we highlight advances in our understanding of chromatin regulation and discuss how such regulation affects the binding of transcription factors as well as the initiation and elongation steps of transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFT34JpGG5LVg90H21EOLACvtfcHk0lgyev-nNOZH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7c%253D&md5=e32a4c422b39301636992808cb38b432</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCarey%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520role%2520of%2520chromatin%2520during%2520transcription%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D707%26epage%3D719%26doi%3D10.1016%2Fj.cell.2007.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Qiu, J.</span><span> </span><span class="NLM_article-title">Epigenetics: unfinished symphony</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1038/441143a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2F441143a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=143-145&author=J.+Qiu&title=Epigenetics%3A+unfinished+symphony&doi=10.1038%2F441143a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F441143a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F441143a%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DJ.%26atitle%3DEpigenetics%253A%2520unfinished%2520symphony%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D143%26epage%3D145%26doi%3D10.1038%2F441143a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bannister, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Regulation of chromatin by histone modifications</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span><span class="refDoi"> DOI: 10.1038/cr.2011.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fcr.2011.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21321607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVCgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=381-395&author=A.+J.+Bannisterauthor=T.+Kouzarides&title=Regulation+of+chromatin+by+histone+modifications&doi=10.1038%2Fcr.2011.22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of chromatin by histone modifications</span></div><div class="casAuthors">Bannister, Andrew J.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-395</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Chromatin is not an inert structure, but rather an instructive DNA scaffold that can respond to external cues to regulate the many uses of DNA.  A principal component of chromatin that plays a key role in this regulation is the modification of histones.  There is an ever-growing list of these modifications and the complexity of their action is only just beginning to be understood.  However, it is clear that histone modifications play fundamental roles in most biol. processes that are involved in the manipulation and expression of DNA.  Here, we describe the known histone modifications, define where they are found genomically and discuss some of their functional consequences, concg. mostly on transcription where the majority of characterization has taken place.  Cell Research (2011) 21:381-395. doi:10.1038/cr.2011.22; published online 15 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2ObWaVBHPorVg90H21EOLACvtfcHk0lgq_oDl_ghHvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVCgurc%253D&md5=bbdf55be25985810b90ba2efe6399f1b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fcr.2011.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2011.22%26sid%3Dliteratum%253Aachs%26aulast%3DBannister%26aufirst%3DA.%2BJ.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520chromatin%2520by%2520histone%2520modifications%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D381%26epage%3D395%26doi%3D10.1038%2Fcr.2011.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Epigenetic protein families: a new frontier for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1038/nrd3674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnrd3674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22498752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=384-400&author=C.+H.+Arrowsmithauthor=C.+Bountraauthor=P.+V.+Fishauthor=K.+Leeauthor=M.+Schapira&title=Epigenetic+protein+families%3A+a+new+frontier+for+drug+discovery&doi=10.1038%2Fnrd3674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic protein families: a new frontier for drug discovery</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Bountra, Chas; Fish, Paul V.; Lee, Kevin; Schapira, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">384-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases.  At the mol. level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones.  Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-contg. proteins and proteins that bind to methylated histones.  These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains.  In this article, we discuss the known links with disease, basic mol. mechanisms of action and recent progress in the pharmacol. modulation of each class of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcD99eCigNtLVg90H21EOLACvtfcHk0lgq_oDl_ghHvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D&md5=eb82034466a43107aa74a18ccf6d29f5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3674%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DEpigenetic%2520protein%2520families%253A%2520a%2520new%2520frontier%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D384%26epage%3D400%26doi%3D10.1038%2Fnrd3674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The language of covalent histone modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1038/47412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+language+of+covalent+histone+modifications&doi=10.1038%2F47412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2eb3QtUC5PbXlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520language%2520of%2520covalent%2520histone%2520modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45%26doi%3D10.1038%2F47412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Choudhary, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, M.</span><span> </span><span class="NLM_article-title">Lysine acetylation targets protein complexes and co-regulates major cellular functions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1126/science.1175371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1126%2Fscience.1175371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19608861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=834-840&author=C.+Choudharyauthor=C.+Kumarauthor=F.+Gnadauthor=M.+L.+Nielsenauthor=M.+Rehmanauthor=T.+C.+Waltherauthor=J.+V.+Olsenauthor=M.+Mann&title=Lysine+acetylation+targets+protein+complexes+and+co-regulates+major+cellular+functions&doi=10.1126%2Fscience.1175371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions</span></div><div class="casAuthors">Choudhary, Chunaram; Kumar, Chanchal; Gnad, Florian; Nielsen, Michael L.; Rehman, Michael; Walther, Tobias C.; Olsen, Jesper V.; Mann, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5942</span>),
    <span class="NLM_cas:pages">834-840</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Lysine acetylation is a reversible posttranslational modification of proteins and plays a key role in regulating gene expression.  Technol. limitations have so far prevented a global anal. of lysine acetylation's cellular roles.  We used high-resoln. mass spectrometry to identify 3600 lysine acetylation sites on 1750 proteins and quantified acetylation changes in response to the deacetylase inhibitors suberoylanilide hydroxamic acid and MS-275.  Lysine acetylation preferentially targets large macromol. complexes involved in diverse cellular processes, such as chromatin remodeling, cell cycle, splicing, nuclear transport, and actin nucleation.  Acetylation impaired phosphorylation-dependent interactions of 14-3-3 and regulated the yeast cyclin-dependent kinase Cdc28.  Our data demonstrate that the regulatory scope of lysine acetylation is broad and comparable with that of other major posttranslational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5eICW58ngkrVg90H21EOLACvtfcHk0lg5TT1TtEWqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Ogt70%253D&md5=8f643db5ba91c50f0b61763ff3095d2c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1175371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1175371%26sid%3Dliteratum%253Aachs%26aulast%3DChoudhary%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DC.%26aulast%3DGnad%26aufirst%3DF.%26aulast%3DNielsen%26aufirst%3DM.%2BL.%26aulast%3DRehman%26aufirst%3DM.%26aulast%3DWalther%26aufirst%3DT.%2BC.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DMann%26aufirst%3DM.%26atitle%3DLysine%2520acetylation%2520targets%2520protein%2520complexes%2520and%2520co-regulates%2520major%2520cellular%2520functions%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D834%26epage%3D840%26doi%3D10.1126%2Fscience.1175371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9413</span><span class="refDoi"> DOI: 10.1021/jm300915b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300915b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9393-9413&author=D.+S.+Hewingsauthor=T.+P.+Rooneyauthor=L.+E.+Jenningsauthor=D.+A.+Hayauthor=C.+J.+Schofieldauthor=P.+E.+Brennanauthor=S.+Knappauthor=S.+J.+Conway&title=Progress+in+the+development+and+application+of+small+molecule+inhibitors+of+bromodomain-acetyl-lysine+interactions&doi=10.1021%2Fjm300915b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions</span></div><div class="casAuthors">Hewings, David S.; Rooney, Timothy P. C.; Jennings, Laura E.; Hay, Duncan A.; Schofield, Christopher J.; Brennan, Paul E.; Knapp, Stefan; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9393-9413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery.  These acetyl-lysine (KAc) reader domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information.  By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners.  There has been intense activity in developing potent and selective small mol. probes that disrupt the interaction between a given bromodomain and KAc.  Rapid success has been achieved with the BET family of bromodomains, and a no. of potent and selective probes have been reported.  These compds. have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets.  Herein, we review the biol. of the bromodomains and discuss the SAR for the existing small mol. probes.  The biol. that has been enabled by these compds. is summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8pl0pnLXruLVg90H21EOLACvtfcHk0lg5TT1TtEWqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ&md5=486a87abb406c4c833404ccce61c1389</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm300915b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300915b%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520development%2520and%2520application%2520of%2520small%2520molecule%2520inhibitors%2520of%2520bromodomain-acetyl-lysine%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9393%26epage%3D9413%26doi%3D10.1021%2Fjm300915b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Acetylation: a regulatory modification to rival phosphorylation?</span> <span class="citation_source-journal">EMBO. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1179</span><span class="refDoi"> DOI: 10.1093/emboj/19.6.1176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1093%2Femboj%2F19.6.1176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10716917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Gms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1176-1179&author=T.+Kouzarides&title=Acetylation%3A+a+regulatory+modification+to+rival+phosphorylation%3F&doi=10.1093%2Femboj%2F19.6.1176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation: a regulatory modification to rival phosphorylation?</span></div><div class="casAuthors">Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1176-1179</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with ∼30 refs.  The fact that histones are modified by acetylation has been known for almost 30 yr.  The recent identification of enzymes that regulate histone acetylation has revealed a broader use of this modification than was suspected previously.  Acetylases are now known to modify a variety of proteins, including transcription factors, nuclear import factors and α-tubulin.  Acetylation regulates many diverse functions, including DNA recognition, protein-protein interaction and protein stability.  There is even a conserved structure, the bromodomain, that recognizes acetylated residues and may serve as a signaling domain.  If you think all this sounds familiar, it should be.  These are features characteristic of kinases.  So, is acetylation a modification analogous to phosphorylation.  This review sets out what we know about the broader substrate specificity and regulation of acetylases and goes on to compare acetylation with the process of phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzk4_IB8cJsbVg90H21EOLACvtfcHk0liBZXiW5hRQkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Gms7o%253D&md5=df238adec63af260b74f1c37d2df607a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.6.1176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.6.1176%26sid%3Dliteratum%253Aachs%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DAcetylation%253A%2520a%2520regulatory%2520modification%2520to%2520rival%2520phosphorylation%253F%26jtitle%3DEMBO.%2520J.%26date%3D2000%26volume%3D19%26spage%3D1176%26epage%3D1179%26doi%3D10.1093%2Femboj%2F19.6.1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Devaiah, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case-Borden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gegonne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerzaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, D. S.</span><span> </span><span class="NLM_article-title">BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/nsmb.3228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnsmb.3228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27159561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFaitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=540-548&author=B.+N.+Devaiahauthor=C.+Case-Bordenauthor=A.+Gegonneauthor=C.+H.+Hsuauthor=Q.+Chenauthor=D.+Meerzamanauthor=A.+Deyauthor=K.+Ozatoauthor=D.+S.+Singer&title=BRD4+is+a+histone+acetyltransferase+that+evicts+nucleosomes+from+chromatin&doi=10.1038%2Fnsmb.3228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin</span></div><div class="casAuthors">Devaiah, Ballachanda N.; Case-Borden, Chanelle; Gegonne, Anne; Hsu, Chih Hao; Chen, Qingrong; Meerzaman, Daoud; Dey, Anup; Ozato, Keiko; Singer, Dinah S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-548</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (BRD4) is a chromatin-binding protein implicated in cancer and autoimmune diseases that functions as a scaffold for transcription factors at promoters and super-enhancers.  Although chromatin decompaction and transcriptional activation of target genes are assocd. with BRD4 binding, the mechanisms involved are unknown.  We report that BRD4 is a histone acetyltransferase (HAT) that acetylates histones H3 and H4 with a pattern distinct from those of other HATs.  Both mouse and human BRD4 have intrinsic HAT activity.  Importantly, BRD4 acetylates H3 K122, a residue crit. for nucleosome stability, thus resulting in nucleosome eviction and chromatin decompaction.  Nucleosome clearance by BRD4 occurs genome wide, including at its targets MYC, FOS and AURKB (Aurora B kinase), resulting in increased transcription.  These findings suggest a model wherein BRD4 actively links chromatin structure and transcription: it mediates chromatin decompaction by acetylating and evicting nucleosomes at target genes, thereby activating transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiIuN9x3auYLVg90H21EOLACvtfcHk0liBZXiW5hRQkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFaitbw%253D&md5=ce482733951b61a9cf0d024b8cd60d30</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3228%26sid%3Dliteratum%253Aachs%26aulast%3DDevaiah%26aufirst%3DB.%2BN.%26aulast%3DCase-Borden%26aufirst%3DC.%26aulast%3DGegonne%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DMeerzaman%26aufirst%3DD.%26aulast%3DDey%26aufirst%3DA.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DSinger%26aufirst%3DD.%2BS.%26atitle%3DBRD4%2520is%2520a%2520histone%2520acetyltransferase%2520that%2520evicts%2520nucleosomes%2520from%2520chromatin%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D540%26epage%3D548%26doi%3D10.1038%2Fnsmb.3228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Bromodomain: an acetyl-lysine binding domain</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/S0014-5793(01)03309-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS0014-5793%2801%2903309-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=11911891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2002&pages=124-128&author=L.+Zengauthor=M.+M.+Zhou&title=Bromodomain%3A+an+acetyl-lysine+binding+domain&doi=10.1016%2FS0014-5793%2801%2903309-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain: an acetyl-lysine binding domain</span></div><div class="casAuthors">Zeng, Lei; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-128</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 43 refs.  Bromodomains, an extensive family of evolutionarily conserved protein modules originally found in proteins assocd. with chromatin and in nearly all nuclear histone acetyltransferases, have been recently discovered to function as acetyllysine-binding domains.  More recent structural studies of bromodomain/peptide ligand complexes have enriched the understanding of differences in ligand selectivity of bromodomains.  These new findings demonstrate that bromodomain/acetyllysine recognition can serve as a pivotal mechanism for regulating protein-protein interactions in numerous cellular processes including chromatin remodeling and transcriptional activation, and reinforce the concept that functional diversity of a conserved protein modular structure is achieved by evolutionary changes of amino acid sequences in the ligand binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMESL8iZ9agLVg90H21EOLACvtfcHk0liBZXiW5hRQkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFejtbo%253D&md5=79070a63cd171f846ab577aa9f7092bb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2903309-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252903309-9%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DBromodomain%253A%2520an%2520acetyl-lysine%2520binding%2520domain%26jtitle%3DFEBS%2520Lett.%26date%3D2002%26volume%3D513%26spage%3D124%26epage%3D128%26doi%3D10.1016%2FS0014-5793%2801%2903309-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lange, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaynak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonjes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlesinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Just, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottbauer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelilah-Seyfried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, S.</span><span> </span><span class="NLM_article-title">Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2370</span><span class="NLM_x">–</span> <span class="NLM_lpage">2384</span><span class="refDoi"> DOI: 10.1101/gad.471408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1101%2Fgad.471408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18765789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2370-2384&author=M.+Langeauthor=B.+Kaynakauthor=U.+B.+Forsterauthor=M.+Tonjesauthor=J.+J.+Fischerauthor=C.+Grimmauthor=J.+Schlesingerauthor=S.+Justauthor=I.+Dunkelauthor=T.+Kruegerauthor=S.+Mebusauthor=H.+Lehrachauthor=R.+Lurzauthor=J.+Gobomauthor=W.+Rottbauerauthor=S.+Abdelilah-Seyfriedauthor=S.+Sperling&title=Regulation+of+muscle+development+by+DPF3%2C+a+novel+histone+acetylation+and+methylation+reader+of+the+BAF+chromatin+remodeling+complex&doi=10.1101%2Fgad.471408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex</span></div><div class="casAuthors">Lange, Martin; Kaynak, Bogac; Forster, Ulrike B.; Toenjes, Martje; Fischer, Jenny J.; Grimm, Christina; Schlesinger, Jenny; Just, Steffen; Dunkel, Ilona; Krueger, Tammo; Mebus, Siegrun; Lehrach, Hans; Lurz, Rudi; Gobom, Johan; Rottbauer, Wolfgang; Abdelilah-Seyfried, Salim; Sperling, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2370-2384</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Chromatin remodeling and histone modifications facilitate access of transcription factors to DNA by promoting the unwinding and destabilization of histone-DNA interactions.  We present DPF3, a new epigenetic key factor for heart and muscle development characterized by a double PHD finger.  DPF3 is assocd. with the BAF chromatin remodeling complex and binds methylated and acetylated lysine residues of histone 3 and 4.  Thus, DPF3 may represent the first plant homeodomains that bind acetylated lysines, a feature previously only shown for the bromodomain.  During development Dpf3 is expressed in the heart and somites of mouse, chicken, and zebrafish.  Morpholino knockdown of dpf3 in zebrafish leads to incomplete cardiac looping and severely reduced ventricular contractility, with disassembled muscular fibers caused by transcriptional deregulation of structural and regulatory proteins.  Promoter anal. identified Dpf3 as a novel downstream target of Mef2a.  Taken together, DPF3 adds a further layer of complexity to the BAF complex by representing a tissue-specific anchor between histone acetylations as well as methylations and chromatin remodeling.  Furthermore, this shows that plant homeodomain proteins play a yet unexplored role in recruiting chromatin remodeling complexes to acetylated histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKDUoXByUL7Vg90H21EOLACvtfcHk0ljsPpaDwZbqtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI&md5=173473acf1587d33492b8cee1fa16f88</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1101%2Fgad.471408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.471408%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DM.%26aulast%3DKaynak%26aufirst%3DB.%26aulast%3DForster%26aufirst%3DU.%2BB.%26aulast%3DTonjes%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DJ.%2BJ.%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DSchlesinger%26aufirst%3DJ.%26aulast%3DJust%26aufirst%3DS.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DKrueger%26aufirst%3DT.%26aulast%3DMebus%26aufirst%3DS.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DGobom%26aufirst%3DJ.%26aulast%3DRottbauer%26aufirst%3DW.%26aulast%3DAbdelilah-Seyfried%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520muscle%2520development%2520by%2520DPF3%252C%2520a%2520novel%2520histone%2520acetylation%2520and%2520methylation%2520reader%2520of%2520the%2520BAF%2520chromatin%2520remodeling%2520complex%26jtitle%3DGenes%2520Dev.%26date%3D2008%26volume%3D22%26spage%3D2370%26epage%3D2384%26doi%3D10.1101%2Fgad.471408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span><span class="refDoi"> DOI: 10.1038/nature09139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature09139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20613843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=258-262&author=L.+Zengauthor=Q.+Zhangauthor=S.+Liauthor=A.+N.+Plotnikovauthor=M.+J.+Walshauthor=M.+M.+Zhou&title=Mechanism+and+regulation+of+acetylated+histone+binding+by+the+tandem+PHD+finger+of+DPF3b&doi=10.1038%2Fnature09139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b</span></div><div class="casAuthors">Zeng, Lei; Zhang, Qiang; Li, SiDe; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7303</span>),
    <span class="NLM_cas:pages">258-262</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone lysine acetylation and methylation have an important role during gene transcription in a chromatin context.  Knowledge concerning the types of protein modules that can interact with acetyl-lysine has so far been limited to bromodomains.  Recently, a tandem plant homeodomain (PHD) finger (PHD1-PHD2, or PHD12) of human DPF3b, which functions in assocn. with the BAF chromatin remodeling complex to initiate gene transcription during heart and muscle development, was reported to bind histones H3 and H4 in an acetylation-sensitive manner, making it the first alternative to bromodomains for acetyl-lysine binding.  Here we report the structural mechanism of acetylated histone binding by the double PHD fingers of DPF3b.  Our three-dimensional soln. structures and biochem. anal. of DPF3b highlight the mol. basis of the integrated tandem PHD finger, which acts as one functional unit in the sequence-specific recognition of lysine-14-acetylated histone H3 (H3K14ac).  Whereas the interaction with H3 is promoted by acetylation at lysine 14, it is inhibited by methylation at lysine 4, and these opposing influences are important during transcriptional activation of the mouse DPF3b target genes Pitx2 and Jmjd1c.  Binding of this tandem protein module to chromatin can thus be regulated by different histone modifications during the initiation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIs304GNjB0LVg90H21EOLACvtfcHk0ljsPpaDwZbqtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D&md5=48807136d91002d7454db72c56ece898</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09139%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DWalsh%26aufirst%3DM.%2BJ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DMechanism%2520and%2520regulation%2520of%2520acetylated%2520histone%2520binding%2520by%2520the%2520tandem%2520PHD%2520finger%2520of%2520DPF3b%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D258%26epage%3D262%26doi%3D10.1038%2Fnature09139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botuyan, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mer, G.</span><span> </span><span class="NLM_article-title">Structural basis for recognition of H3K56-acetylated histone H3-H4 by the chaperone Rtt106</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1038/nature10861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature10861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=104-107&author=D.+Suauthor=Q.+Huauthor=Q.+Liauthor=J.+R.+Thompsonauthor=G.+Cuiauthor=A.+Fazlyauthor=B.+A.+Daviesauthor=M.+V.+Botuyanauthor=Z.+Zhangauthor=G.+Mer&title=Structural+basis+for+recognition+of+H3K56-acetylated+histone+H3-H4+by+the+chaperone+Rtt106&doi=10.1038%2Fnature10861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature10861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10861%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DFazly%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DB.%2BA.%26aulast%3DBotuyan%26aufirst%3DM.%2BV.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMer%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520recognition%2520of%2520H3K56-acetylated%2520histone%2520H3-H4%2520by%2520the%2520chaperone%2520Rtt106%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D104%26epage%3D107%26doi%3D10.1038%2Fnature10861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Targeting bromodomains: epigenetic readers of lysine acetylation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1038/nrd4286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnrd4286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24751816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=337-356&author=P.+Filippakopoulosauthor=S.+Knapp&title=Targeting+bromodomains%3A+epigenetic+readers+of+lysine+acetylation&doi=10.1038%2Fnrd4286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bromodomains: epigenetic readers of lysine acetylation</span></div><div class="casAuthors">Filippakopoulos, Panagis; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">337-356</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Lysine acetylation is a key mechanism that regulates chromatin structure; aberrant acetylation levels have been linked to the development of several diseases.  Acetyl-lysine modifications create docking sites for bromodomains, which are small interaction modules found on diverse proteins, some of which have a key role in the acetylation-dependent assembly of transcriptional regulator complexes.  These complexes can then initiate transcriptional programs that result in phenotypic changes.  The recent discovery of potent and highly specific inhibitors for the BET (bromodomain and extra-terminal) family of bromodomains has stimulated intensive research activity in diverse therapeutic areas, particularly in oncol., where BET proteins regulate the expression of key oncogenes and anti-apoptotic proteins.  In addn., targeting BET bromodomains could hold potential for the treatment of inflammation and viral infection.  Here, we highlight recent progress in the development of bromodomain inhibitors, and their potential applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOSIcwBJKj4LVg90H21EOLACvtfcHk0lgaa-1QbGxFDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D&md5=77049c82ce6a19b4685e3b7950399a07</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd4286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4286%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DTargeting%2520bromodomains%253A%2520epigenetic%2520readers%2520of%2520lysine%2520acetylation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D337%26epage%3D356%26doi%3D10.1038%2Fnrd4286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chiang, C. M.</span><span> </span><span class="NLM_article-title">Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4</span> <span class="citation_source-journal">F1000Prime Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="refDoi"> DOI: 10.3410/B1-98</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.3410%2FB1-98" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=98&author=C.+M.+Chiang&title=Brd4+engagement+from+chromatin+targeting+to+transcriptional+regulation%3A+selective+contact+with+acetylated+histone+H3+and+H4&doi=10.3410%2FB1-98"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3410%2FB1-98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3410%252FB1-98%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DC.%2BM.%26atitle%3DBrd4%2520engagement%2520from%2520chromatin%2520targeting%2520to%2520transcriptional%2520regulation%253A%2520selective%2520contact%2520with%2520acetylated%2520histone%2520H3%2520and%2520H4%26jtitle%3DF1000Prime%2520Rep.%26date%3D2009%26volume%3D1%26spage%3D98%26doi%3D10.3410%2FB1-98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitsaz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misteli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">8758</span><span class="NLM_x">–</span> <span class="NLM_lpage">8763</span><span class="refDoi"> DOI: 10.1073/pnas.1433065100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1433065100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=8758-8763&author=A.+Deyauthor=F.+Chitsazauthor=A.+Abbasiauthor=T.+Misteliauthor=K.+Ozato&title=The+double+bromodomain+protein+Brd4+binds+to+acetylated+chromatin+during+interphase+and+mitosis&doi=10.1073%2Fpnas.1433065100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1433065100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1433065100%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DA.%26aulast%3DChitsaz%26aufirst%3DF.%26aulast%3DAbbasi%26aufirst%3DA.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DThe%2520double%2520bromodomain%2520protein%2520Brd4%2520binds%2520to%2520acetylated%2520chromatin%2520during%2520interphase%2520and%2520mitosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D8758%26epage%3D8763%26doi%3D10.1073%2Fpnas.1433065100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span> </span><span class="NLM_article-title">Disrupting acetyl-lysine recognition: Progress in the development of bromodomain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1298</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1271-1298&author=F.+A.+Romeroauthor=A.+M.+Taylorauthor=T.+D.+Crawfordauthor=V.+Tsuiauthor=A.+Coteauthor=S.+Magnuson&title=Disrupting+acetyl-lysine+recognition%3A+Progress+in+the+development+of+bromodomain+inhibitors&doi=10.1021%2Facs.jmedchem.5b01514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors</span></div><div class="casAuthors">Romero, F. Anthony; Taylor, Alexander M.; Crawford, Terry D.; Tsui, Vickie; Cote, Alexandre; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1271-1298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as "readers" that ultimately det. the functional outcome of the post-translational modification.  Because the initial discovery of selective BET inhibitors have helped define the role of that protein family in oncol. and inflammation, BET bromodomains have continued to garner the most attention of any other bromodomain.  More recently, non-BET bromodomain inhibitors that are potent and selective have been disclosed for ATAD2, CBP, BRD7/9, BRPF, BRPF/TRIM24, CECR2, SMARCA4, and BAZ2A/B.  Such novel inhibitors can be used to probe the physiol. function of these non-BET bromodomains and further understanding of their role in certain disease states.  Here, we provide an update to the progress in identifying selective bromodomain inhibitors and their use as biol. tools, as well as our perspective on the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgbRrKGlHaVLVg90H21EOLACvtfcHk0lgaa-1QbGxFDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO&md5=260352f61301aa88aad48c0b63e6152f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01514%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DDisrupting%2520acetyl-lysine%2520recognition%253A%2520Progress%2520in%2520the%2520development%2520of%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1271%26epage%3D1298%26doi%3D10.1021%2Facs.jmedchem.5b01514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ghoshal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yugandhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A. K.</span><span> </span><span class="NLM_article-title">BET inhibitors in cancer therapeutics: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1517/13543776.2016.1159299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1517%2F13543776.2016.1159299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26924192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Wksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=505-522&author=A.+Ghoshalauthor=D.+Yugandharauthor=A.+K.+Srivastava&title=BET+inhibitors+in+cancer+therapeutics%3A+a+patent+review&doi=10.1517%2F13543776.2016.1159299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitors in cancer therapeutics: a patent review</span></div><div class="casAuthors">Ghoshal, Anirban; Yugandhar, D.; Srivastava, Ajay Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-522</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Introduction: Inhibition of Bromodomain and Extra Terminal (BET) proteins is an emerging approach for developing advanced cancer therapeutics.  In 2015, at least thirty patents have been published for developing cancer chemotherapeutics by targeting BET.  Currently there are seven small mol. BET inhibitors in various stages of clin. trials for the development of anti-cancer drugs.  Areas covered: Important patents focusing on development of BET inhibitors as potential cancer therapeutics published in 2015 have been covered.  The reports are presented together with a review of the related structural chem. space.  This review mainly focuses on the therapeutic applications, chem. class and structural modifications along with the mols. currently in clin. trials.  Expert opinion: BET sub-family proteins are one of the emerging targets to develop anti-cancer agents.  Although many research groups have demonstrated the rationality of BET inhibition to combat cancer, a detailed mol. study needs to be performed to investigate the affected biol. pathways.  Selectivity among BET proteins should be kept in mind while developing BET inhibitors.  In-silico mol. modeling studies can also provide valuable information for designing selective BET inhibitors towards anti-cancer drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByvS8sb7HhLVg90H21EOLACvtfcHk0lg5AdW440uU7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Wksbw%253D&md5=02d7c0cc89a2a712990ceb2e19079f36</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1159299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1159299%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26aulast%3DYugandhar%26aufirst%3DD.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26atitle%3DBET%2520inhibitors%2520in%2520cancer%2520therapeutics%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D505%26epage%3D522%26doi%3D10.1517%2F13543776.2016.1159299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span> </span><span class="NLM_article-title">Small-molecule BET inhibitors in clinical and preclinical development and their therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.2174/1568026615666150302110135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.2174%2F1568026615666150302110135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25732788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=776-794&author=L.+Yuauthor=Z.+Wangauthor=Z.+Zhangauthor=X.+Renauthor=X.+Luauthor=K.+Ding&title=Small-molecule+BET+inhibitors+in+clinical+and+preclinical+development+and+their+therapeutic+potential&doi=10.2174%2F1568026615666150302110135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule BET Inhibitors in Clinical and Preclinical Development and Their Therapeutic Potential</span></div><div class="casAuthors">Yu, Lei; Wang, Zhen; Zhang, Zhang; Ren, Xiaomei; Lu, Xiaoyun; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">776-794</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Lysine acetylation is a pivotal mechanism in chromatin processes and the regulation of gene transcription.  The acetylated lysine residues of histones are exclusively recognized by bromodomains (BRDs) known as epigenetic reader.  Proteins contg. BRDs undergo a post-translational modification (PTM) with development of cellular signaling and disease biol.  The bromo and extra-terminal (BET) proteins are the second subfamily, which play important roles in cellular proliferation, cell cycle progression and chromatin compaction.  Recently, a variety of small mols. have been reported to interact with the BET family proteins and accelerate the validation of BET proteins as druggable targets for treatment of cancers, inflammation and related diseases.  In this review, we will summarize the small-mol. inhibitors in clin. and preclin. studies of the BET family bromodomains and their medicinal implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk52FOUPlX8bVg90H21EOLACvtfcHk0lg5AdW440uU7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D&md5=802bf7b832d46c2b18ef6ac77eda1445</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150302110135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150302110135%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DSmall-molecule%2520BET%2520inhibitors%2520in%2520clinical%2520and%2520preclinical%2520development%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D776%26epage%3D794%26doi%3D10.2174%2F1568026615666150302110135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7346</span><span class="NLM_x">–</span> <span class="NLM_lpage">7359</span><span class="refDoi"> DOI: 10.1021/jm300346w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300346w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7346-7359&author=L.+R.+Vidlerauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Druggability+analysis+and+structural+classification+of+bromodomain+acetyl-lysine+binding+sites&doi=10.1021%2Fjm300346w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites</span></div><div class="casAuthors">Vidler, Lewis R.; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7346-7359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are readers of the epigenetic code that specifically bind acetyl-lysine contg. recognition sites on proteins.  Recently the BET family of bromodomains has been demonstrated to be druggable through the discovery of potent inhibitors, sparking an interest in protein-protein interaction inhibitors that directly target gene transcription.  Here, we assess the druggability of diverse members of the bromodomain family using SiteMap and show that there are significant differences in predicted druggability.  Furthermore, we trace these differences in druggability back to unique amino acid signatures in the bromodomain acetyl-lysine binding sites.  These signatures were then used to generate a new classification of the bromodomain family, visualized as a classification tree.  This represents the first anal. of this type for the bromodomain family and can prove useful in the discovery of inhibitors, particularly for anticipating screening hit rates, identifying inhibitors that can be explored for lead hopping approaches, and selecting proteins for selectivity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxYqQyqqj7JrVg90H21EOLACvtfcHk0lg5AdW440uU7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN&md5=bfb08154c1964aab5df51cb3513f2c1d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300346w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300346w%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDruggability%2520analysis%2520and%2520structural%2520classification%2520of%2520bromodomain%2520acetyl-lysine%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7346%26epage%3D7359%26doi%3D10.1021%2Fjm300346w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Dhalluin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Structure and ligand of a histone acetyltransferase bromodomain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1038/20974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2F20974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10365964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=491-496&author=C.+Dhalluinauthor=J.+E.+Carlsonauthor=L.+Zengauthor=C.+Heauthor=A.+K.+Aggarwalauthor=M.-M.+Zhou&title=Structure+and+ligand+of+a+histone+acetyltransferase+bromodomain&doi=10.1038%2F20974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and ligand of a histone acetyltransferase bromodomain</span></div><div class="casAuthors">Dhalluin, Christophe; Carlson, Justin E.; Zeng, Lei; He, Cheng; Aggarwal, Aneel K.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6735</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone acetylation is important in chromatin remodelling and gene activation.  Nearly all known histone-acetyltransferase (HAT)-assocd. transcriptional co-activators contain bromodomains, which are ∼110-amino-acid modules found in many chromatin-assocd. proteins.  Despite the wide occurrence of these bromodomains, their three-dimensional structure and binding partners remain unknown.  Here we report the soln. structure of the bromodomain of the HAT co-activator P/CAF (p300/CBP-assocd. factor).  The structure reveals an unusual left-handed up-and-down four-helix bundle.  In addn., we show by a combination of structural and site-directed mutagenesis studies that bromodomains can interact specifically with acetylated lysine, making them the first known protein modules to do so.  The nature of the recognition of acetyl-lysine by the P/CAF bromodomain is similar to that of acetyl-CoA by histone acetyltransferase.  Thus, the bromodomain is functionally linked to the HAT activity of co-activators in the regulation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTbwcjeBG_rVg90H21EOLACvtfcHk0lg5AdW440uU7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D&md5=ff1063ba81d81b431065dd6e3751ba79</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F20974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F20974%26sid%3Dliteratum%253Aachs%26aulast%3DDhalluin%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DJ.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DAggarwal%26aufirst%3DA.%2BK.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DStructure%2520and%2520ligand%2520of%2520a%2520histone%2520acetyltransferase%2520bromodomain%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D491%26epage%3D496%26doi%3D10.1038%2F20974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fukazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masumi, A.</span><span> </span><span class="NLM_article-title">The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2064</span><span class="NLM_x">–</span> <span class="NLM_lpage">2068</span><span class="refDoi"> DOI: 10.1248/bpb.b12-00527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1248%2Fbpb.b12-00527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22971749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Oit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=2064-2068&author=H.+Fukazawaauthor=A.+Masumi&title=The+conserved+12-amino+acid+stretch+in+the+inter-bromodomain+region+of+BET+family+proteins+functions+as+a+nuclear+localization+signal&doi=10.1248%2Fbpb.b12-00527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal</span></div><div class="casAuthors">Fukazawa, Hidesuke; Masumi, Atsuko</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2064-2068</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">The bromodomain and extraterminal (BET) family is a group of chromatin-binding proteins characterized by two bromodomains, an extraterminal (ET) domain, and several other conserved regions of unknown function.  In humans, the BET family consists of four members, BRD2, BRD3, BRD4 and BRDT, that all normally localize to the nucleus.  We identified a 12-amino acid stretch in the inter-bromodomain region that is perfectly conserved among the BET family members.  We deleted these residues and expressed the mutant proteins in HEK293T cells to investigate the function of this motif.  We found that the deletion of this motif alters the localization of BET proteins.  Mutated BRD3 and BRD4 were excluded from the nucleus, and BRDT was found to be diffused throughout the nucleus and cytoplasm.  Although the mutant BRD2 remained predominantly in the nucleus, a punctate distribution was also obsd. in the cytosol.  It has been reported that a conserved motif between the second bromodomain and the ET domain serves as a nuclear localization signal for BRD2.  Nevertheless, BET mutants lacking the reported nuclear localization signal motif but retaining the 12-amino acid stretch resided in the nucleus.  Furthermore, these mutants were diffused throughout the cytoplasm when the 12 residues were removed.  These results indicate that the conserved amino acid stretch in the inter-bromodomain region of the BET family functions as a nuclear localization signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXSbWjbeH6bVg90H21EOLACvtfcHk0lhOdlxs-HVVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Oit7g%253D&md5=25fcefbba354becd35ad702cc3420933</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b12-00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b12-00527%26sid%3Dliteratum%253Aachs%26aulast%3DFukazawa%26aufirst%3DH.%26aulast%3DMasumi%26aufirst%3DA.%26atitle%3DThe%2520conserved%252012-amino%2520acid%2520stretch%2520in%2520the%2520inter-bromodomain%2520region%2520of%2520BET%2520family%2520proteins%2520functions%2520as%2520a%2520nuclear%2520localization%2520signal%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D35%26spage%3D2064%26epage%3D2068%26doi%3D10.1248%2Fbpb.b12-00527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Jones, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimane, M.</span><span> </span><span class="NLM_article-title">Identification and characterization of BRDT: A testis-specific gene related to the bromodomain genes RING3 and Drosophila fsh</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1006/geno.1997.5000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1006%2Fgeno.1997.5000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=529-534&author=M.+H.+Jonesauthor=M.+Numataauthor=M.+Shimane&title=Identification+and+characterization+of+BRDT%3A+A+testis-specific+gene+related+to+the+bromodomain+genes+RING3+and+Drosophila+fsh&doi=10.1006%2Fgeno.1997.5000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1997.5000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1997.5000%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%2BH.%26aulast%3DNumata%26aufirst%3DM.%26aulast%3DShimane%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520BRDT%253A%2520A%2520testis-specific%2520gene%2520related%2520to%2520the%2520bromodomain%2520genes%2520RING3%2520and%2520Drosophila%2520fsh%26jtitle%3DGenomics%26date%3D1997%26volume%3D45%26spage%3D529%26epage%3D534%26doi%3D10.1006%2Fgeno.1997.5000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Shang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolgemuth, D. J.</span><span> </span><span class="NLM_article-title">The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">3507</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span><span class="refDoi"> DOI: 10.1242/dev.004481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1242%2Fdev.004481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17728347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2007&pages=3507-3515&author=E.+Shangauthor=H.+D.+Nickersonauthor=D.+Wenauthor=X.+Wangauthor=D.+J.+Wolgemuth&title=The+first+bromodomain+of+Brdt%2C+a+testis-specific+member+of+the+BET+sub-family+of+double-bromodomain-containing+proteins%2C+is+essential+for+male+germ+cell+differentiation&doi=10.1242%2Fdev.004481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation</span></div><div class="casAuthors">Shang, Enyuan; Nickerson, Helen D.; Wen, Duancheng; Wang, Xiangyuan; Wolgemuth, Debra J.</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3507-3515</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Brdt is a testis-specific member of the distinctive BET sub-family of bromodomain motif-contg. proteins, a motif that binds acetylated lysines and is implicated in chromatin remodeling.  Its expression is restricted to the germ line, specifically to pachytene and diplotene spermatocytes and early spermatids.  Targeted mutagenesis was used to generate mice carrying a mutant allele of Brdt, BrdtΔBD1, which lacks only the first of the two bromodomains that uniquely characterize BET proteins.  Homozygous BrdtΔBD1/ΔBD1 mice were viable but males were sterile, producing fewer and morphol. abnormal sperm.  Aberrant morphogenesis was first detected in step 9 elongating spermatids, and those elongated spermatids that were formed lacked the distinctive foci of heterochromatin at the peri-nuclear envelope.  Quant. reverse transcription (RT)-PCR showed threefold increased levels of histone H1t (Hist1h1t) in BrdtΔBD1/ΔBD1 testes and chromatin immunopptn. revealed that Brdt protein, but not BrdtΔBD1 protein, was assocd. with the promoter of H1t.  Intracytoplasmic sperm injection suggested that the DNA in the BrdtΔBD1 mutant sperm could support early embryonic development and yield functional embryonic stem cells.  This is the first demonstration that deletion of just one of the two bromodomains in members of the BET sub-family of bromodomain-contg. proteins has profound effects on in vivo differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDa2lSw-mPaLVg90H21EOLACvtfcHk0lhOdlxs-HVVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitbfJ&md5=f8ef8a8ab721f0eebf4441ffc35eee93</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1242%2Fdev.004481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.004481%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DE.%26aulast%3DNickerson%26aufirst%3DH.%2BD.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWolgemuth%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520first%2520bromodomain%2520of%2520Brdt%252C%2520a%2520testis-specific%2520member%2520of%2520the%2520BET%2520sub-family%2520of%2520double-bromodomain-containing%2520proteins%252C%2520is%2520essential%2520for%2520male%2520germ%2520cell%2520differentiation%26jtitle%3DDevelopment%26date%3D2007%26volume%3D134%26spage%3D3507%26epage%3D3515%26doi%3D10.1242%2Fdev.004481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. H.</span><span> </span><span class="NLM_article-title">RNA polymerase II elongation control</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1146/annurev-biochem-052610-095910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1146%2Fannurev-biochem-052610-095910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22404626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGls7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=119-143&author=Q.+Zhouauthor=T.+Liauthor=D.+H.+Price&title=RNA+polymerase+II+elongation+control&doi=10.1146%2Fannurev-biochem-052610-095910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">RNA polymerase II elongation control</span></div><div class="casAuthors">Zhou, Qiang; Li, Tiandao; Price, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-143</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Regulation of the elongation phase of transcription by RNA polymerase II (Pol II) is utilized extensively to generate the pattern of mRNAs needed to specify cell types and to respond to environmental changes.  After Pol II initiates, neg. elongation factors cause it to pause in a promoter proximal position.  These polymerases are poised to respond to the pos. transcription elongation factor P-TEFb, and then enter productive elongation only under the appropriate set of signals to generate full-length properly processed mRNAs.  Recent global analyses of Pol II and elongation factors, mechanisms that regulate P-TEFb involving the 7SK small nuclear ribonucleoprotein (snRNP), factors that control both the neg. and pos. elongation properties of Pol II, and the mRNA processing events that are coupled with elongation are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo60CSYt9WFzLVg90H21EOLACvtfcHk0ljgY1mB2dgU3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGls7bN&md5=38b677c9655caf0e767b1ea61e4b47b9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-052610-095910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-052610-095910%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPrice%26aufirst%3DD.%2BH.%26atitle%3DRNA%2520polymerase%2520II%2520elongation%2520control%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2012%26volume%3D81%26spage%3D119%26epage%3D143%26doi%3D10.1146%2Fannurev-biochem-052610-095910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howley, P. M.</span><span> </span><span class="NLM_article-title">The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2641</span><span class="NLM_x">–</span> <span class="NLM_lpage">2652</span><span class="refDoi"> DOI: 10.1128/MCB.01341-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.01341-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21555454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=2641-2652&author=S.+Rahmanauthor=M.+E.+Sowaauthor=M.+Ottingerauthor=J.+A.+Smithauthor=Y.+Shiauthor=J.+W.+Harperauthor=P.+M.+Howley&title=The+Brd4+extraterminal+domain+confers+transcription+activation+independent+of+pTEFb+by+recruiting+multiple+proteins%2C+including+NSD3&doi=10.1128%2FMCB.01341-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3</span></div><div class="casAuthors">Rahman, Shaila; Sowa, Mathew E.; Ottinger, Matthias; Smith, Jennifer A.; Shi, Yang; Harper, J. Wade; Howley, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2641-2652</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (Brd4) plays crit. roles in development, cancer progression, and virus-host pathogenesis.  To gain mechanistic insight into the various biol. functions of Brd4, we performed a proteomic anal. to identify and characterize Brd4-assocd. cellular proteins.  We found that the extraterminal (ET) domain, whose function has to date not been detd., interacts with NSD3, JMJD6, CHD4, GLTSCR1, and ATAD5.  These ET-domain interactions were also conserved for Brd2 and Brd3, the other human BET proteins tested.  We demonstrated that GLTSCR1, NSD3, and JMJD6 impart a pTEFb-independent transcriptional activation function on Brd4.  NSD3 as well as JMJD6 is recruited to regulated genes in a Brd4-dependent manner.  Moreover, we found that depletion of Brd4 or NSD3 reduces H3K36 methylation, demonstrating that the Brd4/NSD3 complex regulates this specific histone modification.  Our results indicate that the Brd4 ET domain through the recruitment of the specific effectors regulates transcriptional activity.  In particular, we show that one of these effectors, NSD3, regulates transcription by modifying the chromatin microenvironment at Brd4 target genes.  Our study thus identifies the ET domain as a second important transcriptional regulatory domain for Brd4 in addn. to the carboxyl-terminal domain (CTD) that interacts with pTEFb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlypbenIW4s7Vg90H21EOLACvtfcHk0ljgY1mB2dgU3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7s%253D&md5=921d55b32a568783ffffdb20cef2f27c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.01341-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01341-10%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DSowa%26aufirst%3DM.%2BE.%26aulast%3DOttinger%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DHowley%26aufirst%3DP.%2BM.%26atitle%3DThe%2520Brd4%2520extraterminal%2520domain%2520confers%2520transcription%2520activation%2520independent%2520of%2520pTEFb%2520by%2520recruiting%2520multiple%2520proteins%252C%2520including%2520NSD3%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D2641%26epage%3D2652%26doi%3D10.1128%2FMCB.01341-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lamonica, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadauke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamsjaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billin, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardison, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, G. A.</span><span> </span><span class="NLM_article-title">Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">E159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1073/pnas.1102140108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1102140108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21536911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A280%3ADC%252BC3MrmtlGgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E159-168&author=J.+M.+Lamonicaauthor=W.+Dengauthor=S.+Kadaukeauthor=A.+E.+Campbellauthor=R.+Gamsjaegerauthor=H.+Wangauthor=Y.+Chengauthor=A.+N.+Billinauthor=R.+C.+Hardisonauthor=J.+P.+Mackayauthor=G.+A.+Blobel&title=Bromodomain+protein+Brd3+associates+with+acetylated+GATA1+to+promote+its+chromatin+occupancy+at+erythroid+target+genes&doi=10.1073%2Fpnas.1102140108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes</span></div><div class="casAuthors">Lamonica Janine M; Deng Wulan; Kadauke Stephan; Campbell Amy E; Gamsjaeger Roland; Wang Hongxin; Cheng Yong; Billin Andrew N; Hardison Ross C; Mackay Joel P; Blobel Gerd A</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">E159-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylation of histones triggers association with bromodomain-containing proteins that regulate diverse chromatin-related processes.  Although acetylation of transcription factors has been appreciated for some time, the mechanistic consequences are less well understood.  The hematopoietic transcription factor GATA1 is acetylated at conserved lysines that are required for its stable association with chromatin.  We show that the BET family protein Brd3 binds via its first bromodomain (BD1) to GATA1 in an acetylation-dependent manner in vitro and in vivo.  Mutation of a single residue in BD1 that is involved in acetyl-lysine binding abrogated recruitment of Brd3 by GATA1, demonstrating that acetylation of GATA1 is essential for Brd3 association with chromatin.  Notably, Brd3 is recruited by GATA1 to both active and repressed target genes in a fashion seemingly independent of histone acetylation.  Anti-Brd3 ChIP followed by massively parallel sequencing in GATA1-deficient erythroid precursor cells and those that are GATA1 replete revealed that GATA1 is a major determinant of Brd3 recruitment to genomic targets within chromatin.  A pharmacologic compound that occupies the acetyl-lysine binding pockets of Brd3 bromodomains disrupts the Brd3-GATA1 interaction, diminishes the chromatin occupancy of both proteins, and inhibits erythroid maturation.  Together these findings provide a mechanism for GATA1 acetylation and suggest that Brd3 "reads" acetyl marks on nuclear factors to promote their stable association with chromatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeZ8VSdvvG7p6KlWarZTAzfW6udTcc2ebK8wMhsLEEl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrmtlGgtQ%253D%253D&md5=b81056e4aee1351dce3899fb8d4e86e8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1102140108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1102140108%26sid%3Dliteratum%253Aachs%26aulast%3DLamonica%26aufirst%3DJ.%2BM.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DKadauke%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%2BE.%26aulast%3DGamsjaeger%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBillin%26aufirst%3DA.%2BN.%26aulast%3DHardison%26aufirst%3DR.%2BC.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26aulast%3DBlobel%26aufirst%3DG.%2BA.%26atitle%3DBromodomain%2520protein%2520Brd3%2520associates%2520with%2520acetylated%2520GATA1%2520to%2520promote%2520its%2520chromatin%2520occupancy%2520at%2520erythroid%2520target%2520genes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3DE159%26epage%3D168%26doi%3D10.1073%2Fpnas.1102140108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gamsjaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamonica, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span> </span><span class="NLM_article-title">Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2632</span><span class="NLM_x">–</span> <span class="NLM_lpage">2640</span><span class="refDoi"> DOI: 10.1128/MCB.05413-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.05413-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21555453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=2632-2640&author=R.+Gamsjaegerauthor=S.+R.+Webbauthor=J.+M.+Lamonicaauthor=A.+Billinauthor=G.+A.+Blobelauthor=J.+P.+Mackay&title=Structural+basis+and+specificity+of+acetylated+transcription+factor+GATA1+recognition+by+BET+family+bromodomain+protein+Brd3&doi=10.1128%2FMCB.05413-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3</span></div><div class="casAuthors">Gamsjaeger, Roland; Webb, Sarah R.; Lamonica, Janine M.; Billin, Andrew; Blobel, Gerd A.; MacKay, Joel P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2632-2640</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Recent data demonstrate that small synthetic compds. specifically targeting bromodomain proteins can modulate the expression of cancer-related or inflammatory genes.  Although these studies have focused on the ability of bromodomains to recognize acetylated histones, it is increasingly becoming clear that histone-like modifications exist on other important proteins, such as transcription factors.  However, our understanding of the mol. mechanisms through which these modifications modulate protein function is far from complete.  The transcription factor GATA1 can be acetylated at lysine residues adjacent to the zinc finger domains, and this acetylation is essential for the normal chromatin occupancy of GATA1.  We have recently identified the bromodomain-contg. protein Brd3 as a cofactor that interacts with acetylated GATA1 and shown that this interaction is essential for the targeting of GATA1 to chromatin.  Here we describe the structural basis for this interaction.  Our data reveal for the first time the mol. details of an interaction between a transcription factor bearing multiple acetylation modifications and its cognate recognition module.  We also show that this interaction can be inhibited by an acetyllysine mimic, highlighting the importance of further increasing the specificity of compds. that target bromodomain and extraterminal (BET) bromodomains in order to fully realize their therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMrxbrtYbDm7Vg90H21EOLACvtfcHk0lgR9oPecH-b4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFKjs7o%253D&md5=c4acf39a79bef71519e318ff3dff6423</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FMCB.05413-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.05413-11%26sid%3Dliteratum%253Aachs%26aulast%3DGamsjaeger%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DS.%2BR.%26aulast%3DLamonica%26aufirst%3DJ.%2BM.%26aulast%3DBillin%26aufirst%3DA.%26aulast%3DBlobel%26aufirst%3DG.%2BA.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520basis%2520and%2520specificity%2520of%2520acetylated%2520transcription%2520factor%2520GATA1%2520recognition%2520by%2520BET%2520family%2520bromodomain%2520protein%2520Brd3%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D2632%26epage%3D2640%26doi%3D10.1128%2FMCB.05413-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1007/s11010-006-9223-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1007%2Fs11010-006-9223-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2007&pages=45-54&author=J.+Pengauthor=W.+Dongauthor=L.+Chenauthor=T.+Zouauthor=Y.+Qiauthor=Y.+Liu&title=Brd2+is+a+TBP-associated+protein+and+recruits+TBP+into+E2F-1+transcriptional+complex+in+response+to+serum+stimulation&doi=10.1007%2Fs11010-006-9223-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs11010-006-9223-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-006-9223-6%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DT.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DBrd2%2520is%2520a%2520TBP-associated%2520protein%2520and%2520recruits%2520TBP%2520into%2520E2F-1%2520transcriptional%2520complex%2520in%2520response%2520to%2520serum%2520stimulation%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D294%26spage%3D45%26epage%3D54%26doi%3D10.1007%2Fs11010-006-9223-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Place your BETs: the therapeutic potential of bromodomains</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1016/j.tips.2011.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.tips.2011.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22277300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=146-153&author=R.+K.+Prinjhaauthor=J.+Witheringtonauthor=K.+Lee&title=Place+your+BETs%3A+the+therapeutic+potential+of+bromodomains&doi=10.1016%2Fj.tips.2011.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Place your BETs: the therapeutic potential of bromodomains</span></div><div class="casAuthors">Prinjha, R. K.; Witherington, J.; Lee, K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">146-153</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Therapeutic targeting of the processes that regulate histone modification is a growing area of scientific exploration.  Although most interest has concd. on the various families of enzymes that contribute to these processes, this review focuses on emerging data demonstrating the chem. tractability and therapeutic potential of a hitherto underexplored family of proteins, namely the bromodomain (BRD) family of reader proteins.  These proteins perform a crucial role in translating histone modifications with powerful transcriptional consequences.  We review current knowledge of the biol. of this emergent target class and highlight recent breakthroughs that now make the BRD family of reader proteins attractive for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_N9p7ru787rVg90H21EOLACvtfcHk0lgR9oPecH-b4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOlt74%253D&md5=ea1e9e5740b1131239aa0407748d549b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2011.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2011.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DPlace%2520your%2520BETs%253A%2520the%2520therapeutic%2520potential%2520of%2520bromodomains%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D146%26epage%3D153%26doi%3D10.1016%2Fj.tips.2011.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez-Dacal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span> </span><span class="NLM_article-title">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">19754</span><span class="NLM_x">–</span> <span class="NLM_lpage">19759</span><span class="refDoi"> DOI: 10.1073/pnas.1310658110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1310658110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24248379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19754-19759&author=S.+Picaudauthor=C.+Wellsauthor=I.+Felletarauthor=D.+Brothertonauthor=S.+Martinauthor=P.+Savitskyauthor=B.+Diez-Dacalauthor=M.+Philpottauthor=C.+Bountraauthor=H.+Lingardauthor=O.+Fedorovauthor=S.+Mullerauthor=P.+E.+Brennanauthor=S.+Knappauthor=P.+Filippakopoulos&title=RVX-208%2C+an+inhibitor+of+BET+transcriptional+regulators+with+selectivity+for+the+second+bromodomain&doi=10.1073%2Fpnas.1310658110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</span></div><div class="casAuthors">Picaud, Sarah; Wells, Christopher; Felletar, Ildiko; Brotherton, Deborah; Martin, Sarah; Savitsky, Pavel; Diez-Dacal, Beatriz; Philpott, Martin; Bountra, Chas; Lingard, Hannah; Fedorov, Oleg; Muller, Susanne; Brennan, Paul E.; Knapp, Stefan; Filippakopoulos, Panagis</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19754-19759,S19754/1-S19754/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bromodomains have emerged as attractive candidates for the development of inhibitors targeting gene transcription.  Inhibitors of the bromo and extraterminal (BET) family recently showed promising activity in diverse disease models.  However, the pleiotropic nature of BET proteins regulating tissue-specific transcription has raised safety concerns and suggested that attempts should be made for domain-specific targeting.  Here, we report that RVX-208, a compd. currently in phase II clin. trials, is a BET bromodomain inhibitor specific for second bromodomains (BD2s).  Cocrystal structures revealed binding modes of RVX-208 and its synthetic precursor, and fluorescent recovery after photobleaching demonstrated that RVX-208 displaces BET proteins from chromatin.  However, gene-expression data showed that BD2 inhibition only modestly affects BET-dependent gene transcription.  Our data demonstrate the feasibility of specific targeting within the BET family resulting in different transcriptional outcomes and highlight the importance of BD1 in transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamW8vnIopKrVg90H21EOLACvtfcHk0lgR9oPecH-b4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN&md5=c918702c9fdb91241bc837732730f7f6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1310658110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1310658110%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DDiez-Dacal%26aufirst%3DB.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DLingard%26aufirst%3DH.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3DRVX-208%252C%2520an%2520inhibitor%2520of%2520BET%2520transcriptional%2520regulators%2520with%2520selectivity%2520for%2520the%2520second%2520bromodomain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D19754%26epage%3D19759%26doi%3D10.1073%2Fpnas.1310658110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnathan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7501</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span><span class="refDoi"> DOI: 10.1021/jm401088k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401088k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSls7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7501-7515&author=O.+Mirguetauthor=R.+Gosminiauthor=J.+Toumauthor=C.+A.+Clementauthor=M.+Barnathanauthor=J.+M.+Brusqauthor=J.+E.+Mordauntauthor=R.+M.+Grimesauthor=M.+Croweauthor=O.+Pineauauthor=M.+Ajakaneauthor=A.+Dauganauthor=P.+Jeffreyauthor=L.+Cutlerauthor=A.+C.+Haynesauthor=N.+N.+Smithersauthor=C.+W.+Chungauthor=P.+Bamboroughauthor=I.+J.+Uingsauthor=A.+Lewisauthor=J.+Witheringtonauthor=N.+Parrauthor=R.+K.+Prinjhaauthor=E.+Nicodeme&title=Discovery+of+epigenetic+regulator+I-BET762%3A+lead+optimization+to+afford+a+clinical+candidate+inhibitor+of+the+BET+bromodomains&doi=10.1021%2Fjm401088k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains</span></div><div class="casAuthors">Mirguet, Olivier; Gosmini, Romain; Toum, Jerome; Clement, Catherine A.; Barnathan, Melanie; Brusq, Jean-Marie; Mordaunt, Jacqueline E.; Grimes, Richard M.; Crowe, Miriam; Pineau, Olivier; Ajakane, Myriam; Daugan, Alain; Jeffrey, Phillip; Cutler, Leanne; Haynes, Andrea C.; Smithers, Nicholas N.; Chung, Chun-wa; Bamborough, Paul; Uings, Iain J.; Lewis, Antonia; Witherington, Jason; Parr, Nigel; Prinjha, Rab K.; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7501-7515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bromo and extra C-terminal domain (BET) family of bromodomains are involved in binding epigenetic marks on histone proteins, more specifically acetylated lysine residues.  This paper describes the discovery and structure-activity relationships (SAR) of potent benzodiazepine inhibitors that disrupt the function of the BET family of bromodomains (BRD2, BRD3, and BRD4).  This work has yielded a potent, selective compd. I-BET762 (I) that is now under evaluation in a phase I/II clin. trial for nuclear protein in testis (NUT) midline carcinoma and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDitaXJSnFE7Vg90H21EOLACvtfcHk0liMsE_1V62P2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSls7jJ&md5=5d059b0be08a74a5721b72a120f7e090</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm401088k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401088k%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBarnathan%26aufirst%3DM.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DGrimes%26aufirst%3DR.%2BM.%26aulast%3DCrowe%26aufirst%3DM.%26aulast%3DPineau%26aufirst%3DO.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%2BC.%26aulast%3DSmithers%26aufirst%3DN.%2BN.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520epigenetic%2520regulator%2520I-BET762%253A%2520lead%2520optimization%2520to%2520afford%2520a%2520clinical%2520candidate%2520inhibitor%2520of%2520the%2520BET%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7501%26epage%3D7515%26doi%3D10.1021%2Fjm401088k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Coude, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffoux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzykson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delord, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riveiro, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herait, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baruchel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, C.</span><span> </span><span class="NLM_article-title">BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">17698</span><span class="NLM_x">–</span> <span class="NLM_lpage">17712</span><span class="refDoi"> DOI: 10.18632/oncotarget.4131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.18632%2Foncotarget.4131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25989842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A280%3ADC%252BC2MflsVChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=17698-17712&author=M.+M.+Coudeauthor=T.+Braunauthor=J.+Berrouauthor=M.+Dupontauthor=S.+Bertrandauthor=A.+Masseauthor=E.+Raffouxauthor=R.+Itzyksonauthor=M.+Delordauthor=M.+E.+Riveiroauthor=P.+Heraitauthor=A.+Baruchelauthor=H.+Dombretauthor=C.+Gardin&title=BET+inhibitor+OTX015+targets+BRD2+and+BRD4+and+decreases+c-MYC+in+acute+leukemia+cells&doi=10.18632%2Foncotarget.4131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells</span></div><div class="casAuthors">Coude Marie-Magdelaine; Braun Thorsten; Berrou Jeannig; Dupont Melanie; Bertrand Sibyl; Masse Aline; Raffoux Emmanuel; Itzykson Raphael; Baruchel Andre; Dombret Herve; Gardin Claude; Coude Marie-Magdelaine; Braun Thorsten; Gardin Claude; Raffoux Emmanuel; Itzykson Raphael; Dombret Herve; Delord Marc; Riveiro Maria E; Herait Patrice; Baruchel Andre</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">17698-712</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The bromodomain (BRD) and extraterminal (BET) proteins including BRD2, BRD3 and BRD4 have been identified as key targets for leukemia maintenance.  A novel oral inhibitor of BRD2/3/4, the thienotriazolodiazepine compound OTX015, suitable for human use, is available.  Here we report its biological effects in AML and ALL cell lines and leukemic samples.  Exposure to OTX015 lead to cell growth inhibition, cell cycle arrest and apoptosis at submicromolar concentrations in acute leukemia cell lines and patient-derived leukemic cells, as described with the canonical JQ1 BET inhibitor.  Treatment with JQ1 and OTX15 induces similar gene expression profiles in sensitive cell lines, including a c-MYC decrease and an HEXIM1 increase.  OTX015 exposure also induced a strong decrease of BRD2, BRD4 and c-MYC and increase of HEXIM1 proteins, while BRD3 expression was unchanged. c-MYC, BRD2, BRD3, BRD4 and HEXIM1 mRNA levels did not correlate however with viability following exposure to OTX015.  Sequential combinations of OTX015 with other epigenetic modifying drugs, panobinostat and azacitidine have a synergic effect on growth of the KASUMI cell line.  Our results indicate that OTX015 and JQ1 have similar biological effects in leukemic cells, supporting OTX015 evaluation in a Phase Ib trial in relapsed/refractory leukemia patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlHRu3Td8hIa_dlEzl_fBafW6udTcc2eY1Bjn_tsZjQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MflsVChsA%253D%253D&md5=0db953a0a24b12ec2918a02d1a2df00b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4131%26sid%3Dliteratum%253Aachs%26aulast%3DCoude%26aufirst%3DM.%2BM.%26aulast%3DBraun%26aufirst%3DT.%26aulast%3DBerrou%26aufirst%3DJ.%26aulast%3DDupont%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DA.%26aulast%3DRaffoux%26aufirst%3DE.%26aulast%3DItzykson%26aufirst%3DR.%26aulast%3DDelord%26aufirst%3DM.%26aulast%3DRiveiro%26aufirst%3DM.%2BE.%26aulast%3DHerait%26aufirst%3DP.%26aulast%3DBaruchel%26aufirst%3DA.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DGardin%26aufirst%3DC.%26atitle%3DBET%2520inhibitor%2520OTX015%2520targets%2520BRD2%2520and%2520BRD4%2520and%2520decreases%2520c-MYC%2520in%2520acute%2520leukemia%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D17698%26epage%3D17712%26doi%3D10.18632%2Foncotarget.4131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Siu, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koulnis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N. S.</span><span> </span><span class="NLM_article-title">Effect of the BET inhibitor, Cpi-0610, alone and in combination with lenalidomide in multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">4255</span><span class="NLM_x">–</span> <span class="NLM_lpage">4255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=4255-4255&author=K.+T.+Siuauthor=H.+Edaauthor=L.+Santoauthor=J.+Ramachandranauthor=M.+Koulnisauthor=J.+Mertzauthor=R.+J.+Simsauthor=M.+Cooperauthor=N.+S.+Raje&title=Effect+of+the+BET+inhibitor%2C+Cpi-0610%2C+alone+and+in+combination+with+lenalidomide+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DK.%2BT.%26aulast%3DEda%26aufirst%3DH.%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DRamachandran%26aufirst%3DJ.%26aulast%3DKoulnis%26aufirst%3DM.%26aulast%3DMertz%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DRaje%26aufirst%3DN.%2BS.%26atitle%3DEffect%2520of%2520the%2520BET%2520inhibitor%252C%2520Cpi-0610%252C%2520alone%2520and%2520in%2520combination%2520with%2520lenalidomide%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D4255%26epage%3D4255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowlati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagey, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landau, S. B.</span><span> </span><span class="NLM_article-title">Abstract A49: Clinically efficacy of the BET bromodomain inhibitor TEN-010 in an open-label substudy with patients with documented NUT-midline carcinoma (NMC)</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">A49</span><span class="NLM_x">–</span> <span class="NLM_lpage">A49</span><span class="refDoi"> DOI: 10.1158/1535-7163.TARG-15-A49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.TARG-15-A49" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=A49-A49&author=G.+I.+Shapiroauthor=A.+Dowlatiauthor=P.+M.+LoRussoauthor=J.+P.+Ederauthor=A.+Andersonauthor=K.+T.+Doauthor=M.+H.+Kageyauthor=C.+Sirardauthor=J.+E.+Bradnerauthor=S.+B.+Landau&title=Abstract+A49%3A+Clinically+efficacy+of+the+BET+bromodomain+inhibitor+TEN-010+in+an+open-label+substudy+with+patients+with+documented+NUT-midline+carcinoma+%28NMC%29&doi=10.1158%2F1535-7163.TARG-15-A49"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-15-A49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-15-A49%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DDowlati%26aufirst%3DA.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26aulast%3DEder%26aufirst%3DJ.%2BP.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DDo%26aufirst%3DK.%2BT.%26aulast%3DKagey%26aufirst%3DM.%2BH.%26aulast%3DSirard%26aufirst%3DC.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLandau%26aufirst%3DS.%2BB.%26atitle%3DAbstract%2520A49%253A%2520Clinically%2520efficacy%2520of%2520the%2520BET%2520bromodomain%2520inhibitor%2520TEN-010%2520in%2520an%2520open-label%2520substudy%2520with%2520patients%2520with%2520documented%2520NUT-midline%2520carcinoma%2520%2528NMC%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3DA49%26epage%3DA49%26doi%3D10.1158%2F1535-7163.TARG-15-A49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Sarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faivre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidanze, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uziel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajaraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">Abstract 4718: ABBV-075, a novel BET family bromodomain inhibitor, represents a promising therapeutic agent for a broad spectrum of cancer indications</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4718</span><span class="NLM_x">–</span> <span class="NLM_lpage">4718</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-4718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1538-7445.AM2016-4718" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4718-4718&author=A.+Sarthyauthor=L.+Liauthor=D.+H.+Albertauthor=X.+Linauthor=W.+Scottauthor=E.+Faivreauthor=M.+H.+Buiauthor=X.+Huangauthor=D.+M.+Wilcoxauthor=T.+Magocauthor=F.+G.+Buchananauthor=P.+Tapangauthor=G.+S.+Sheppardauthor=L.+Wangauthor=S.+D.+Fidanzeauthor=J.+Prattauthor=D.+Liuauthor=L.+Hasvoldauthor=P.+Hesslerauthor=T.+Uzielauthor=L.+Lamauthor=G.+Rajaramanauthor=G.+Fangauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=K.+McDanielauthor=W.+Katiauthor=Y.+Shen&title=Abstract+4718%3A+ABBV-075%2C+a+novel+BET+family+bromodomain+inhibitor%2C+represents+a+promising+therapeutic+agent+for+a+broad+spectrum+of+cancer+indications&doi=10.1158%2F1538-7445.AM2016-4718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-4718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-4718%26sid%3Dliteratum%253Aachs%26aulast%3DSarthy%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DScott%26aufirst%3DW.%26aulast%3DFaivre%26aufirst%3DE.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWilcox%26aufirst%3DD.%2BM.%26aulast%3DMagoc%26aufirst%3DT.%26aulast%3DBuchanan%26aufirst%3DF.%2BG.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DPratt%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHasvold%26aufirst%3DL.%26aulast%3DHessler%26aufirst%3DP.%26aulast%3DUziel%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DMcDaniel%26aufirst%3DK.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DAbstract%25204718%253A%2520ABBV-075%252C%2520a%2520novel%2520BET%2520family%2520bromodomain%2520inhibitor%252C%2520represents%2520a%2520promising%2520therapeutic%2520agent%2520for%2520a%2520broad%2520spectrum%2520of%2520cancer%2520indications%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4718%26epage%3D4718%26doi%3D10.1158%2F1538-7445.AM2016-4718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Belkina, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, G. V.</span><span> </span><span class="NLM_article-title">BET domain co-regulators in obesity, inflammation and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1038/nrc3256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnrc3256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22722403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=465-477&author=A.+C.+Belkinaauthor=G.+V.+Denis&title=BET+domain+co-regulators+in+obesity%2C+inflammation+and+cancer&doi=10.1038%2Fnrc3256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">BET domain co-regulators in obesity, inflammation and cancer</span></div><div class="casAuthors">Belkina, Anna C.; Denis, Gerald V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helixes and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes.  Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression.  Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets.  However, small mols. that inhibit bromodomain and extraterminal (BET) proteins have been described.  We examine these developments and discuss the implications for small mol. epigenetic targeting of chromatin networks in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1x-bD67oukrVg90H21EOLACvtfcHk0lgvMi6GJFTEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D&md5=d06d88ef0d5d4d71115f40a2f901f53d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrc3256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3256%26sid%3Dliteratum%253Aachs%26aulast%3DBelkina%26aufirst%3DA.%2BC.%26aulast%3DDenis%26aufirst%3DG.%2BV.%26atitle%3DBET%2520domain%2520co-regulators%2520in%2520obesity%252C%2520inflammation%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D465%26epage%3D477%26doi%3D10.1038%2Fnrc3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Padmanabhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, S.</span><span> </span><span class="NLM_article-title">Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases</span> <span class="citation_source-journal">J. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.1007/s12038-016-9600-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1007%2Fs12038-016-9600-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27240990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFOqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=295-311&author=B.+Padmanabhanauthor=S.+Mathurauthor=R.+Manjulaauthor=S.+Tripathi&title=Bromodomain+and+extra-terminal+%28BET%29+family+proteins%3A+New+therapeutic+targets+in+major+diseases&doi=10.1007%2Fs12038-016-9600-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases</span></div><div class="casAuthors">Padmanabhan, Balasundaram; Mathur, Shruti; Manjula, Ramu; Tripathi, Shailesh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biosciences (New Delhi, India)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-311</span>CODEN:
                <span class="NLM_cas:coden">JOBSDN</span>;
        ISSN:<span class="NLM_cas:issn">0250-5991</span>.
    
            (<span class="NLM_cas:orgname">Springer (India) Private Ltd.</span>)
        </div><div class="casAbstract">The bromodomains and extra-terminal domain (BET) family proteins recognize acetylated chromatin through their bromodomains (BDs) and help in regulating gene expression.  BDs are chromatin 'readers': by interacting with acetylated lysines on the histone tails, they recruit chromatin-regulating proteins on the promoter region to regulate gene expression and repression.  Extensive efforts have been employed by scientific communities worldwide to identify and develop potential inhibitors of BET family BDs to regulate protein expression by inhibiting acetylated histone (H3/H4) interactions.  Several small mol. inhibitors have been reported, which not only have high affinity but also have high specificity to BET BDs.  These developments make BET family proteins an important therapeutic targets for major diseases such as cancer, neurol. disorders, obesity and inflammation.  Here, we review and discuss the structural biol. of BET family BDs and their applications in major diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87geC_AUDErVg90H21EOLACvtfcHk0lgvMi6GJFTEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFOqtbw%253D&md5=2555d6cb5db8e4151b63f7add86c7250</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12038-016-9600-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12038-016-9600-6%26sid%3Dliteratum%253Aachs%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DMathur%26aufirst%3DS.%26aulast%3DManjula%26aufirst%3DR.%26aulast%3DTripathi%26aufirst%3DS.%26atitle%3DBromodomain%2520and%2520extra-terminal%2520%2528BET%2529%2520family%2520proteins%253A%2520New%2520therapeutic%2520targets%2520in%2520major%2520diseases%26jtitle%3DJ.%2520Biosci.%26date%3D2016%26volume%3D41%26spage%3D295%26epage%3D311%26doi%3D10.1007%2Fs12038-016-9600-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savarese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaya, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweifer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span> </span><span class="NLM_article-title">Abstract B79: BI 894999, a novel BET inhibitor: Treatment of hematological malignancies by repression of super-enhancer driven oncogenes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">B79</span><span class="refDoi"> DOI: 10.1158/1535-7163.TARG-15-B79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.TARG-15-B79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=B79&author=U.+Tontsch-Gruntauthor=F.+Savareseauthor=D.+Gerlachauthor=D.+Gianniauthor=A.+Baumauthor=D.+Scharnauthor=H.+Engelhardtauthor=O.+Kayaauthor=N.+Schweiferauthor=T.+Gerstbergerauthor=N.+Kraut&title=Abstract+B79%3A+BI+894999%2C+a+novel+BET+inhibitor%3A+Treatment+of+hematological+malignancies+by+repression+of+super-enhancer+driven+oncogenes&doi=10.1158%2F1535-7163.TARG-15-B79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-15-B79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-15-B79%26sid%3Dliteratum%253Aachs%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DSavarese%26aufirst%3DF.%26aulast%3DGerlach%26aufirst%3DD.%26aulast%3DGianni%26aufirst%3DD.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DScharn%26aufirst%3DD.%26aulast%3DEngelhardt%26aufirst%3DH.%26aulast%3DKaya%26aufirst%3DO.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DGerstberger%26aufirst%3DT.%26aulast%3DKraut%26aufirst%3DN.%26atitle%3DAbstract%2520B79%253A%2520BI%2520894999%252C%2520a%2520novel%2520BET%2520inhibitor%253A%2520Treatment%2520of%2520hematological%2520malignancies%2520by%2520repression%2520of%2520super-enhancer%2520driven%2520oncogenes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3DB79%26doi%3D10.1158%2F1535-7163.TARG-15-B79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span>Study of BMS-986158 in subjects with select advanced solid tumors (BET). Clinical trials, 2 April,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02419417" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02419417</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+BMS-986158+in+subjects+with+select+advanced+solid+tumors+%28BET%29.+Clinical+trials%2C+2+April%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02419417."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez Morales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobedo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser-Bricker, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershaw, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luke, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muskiewicz, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, S. E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. L.</span><span> </span><span class="NLM_article-title">FT-1101: A structurally distinct pan-BET bromodomain inhibitor with activity in preclinical models of hematologic malignancies</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1367&author=D.+S.+Millanauthor=M.+A.+Alvarez+Moralesauthor=K.+J.+Barrauthor=D.+Cardilloauthor=A.+Collisauthor=C.+J.+Dinsmoreauthor=J.+A.+Escobedoauthor=K.+P.+Foleyauthor=T.+Herbertzauthor=S.+Hubbsauthor=G.+S.+Kauffmanauthor=K.+J.+Kayser-Brickerauthor=M.+T.+Kershawauthor=G.+P.+Lukeauthor=M.+W.+Martinauthor=C.+McKinnonauthor=R.+L.+Mendesauthor=K.+R.+Muskiewiczauthor=S.+E.+R.+Schillerauthor=P.+Soulardauthor=A.+C.+Talbotauthor=D.+Walkerauthor=L.+Yaoauthor=G.+L.+Williams&title=FT-1101%3A+A+structurally+distinct+pan-BET+bromodomain+inhibitor+with+activity+in+preclinical+models+of+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DAlvarez%2BMorales%26aufirst%3DM.%2BA.%26aulast%3DBarr%26aufirst%3DK.%2BJ.%26aulast%3DCardillo%26aufirst%3DD.%26aulast%3DCollis%26aufirst%3DA.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHubbs%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DG.%2BS.%26aulast%3DKayser-Bricker%26aufirst%3DK.%2BJ.%26aulast%3DKershaw%26aufirst%3DM.%2BT.%26aulast%3DLuke%26aufirst%3DG.%2BP.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcKinnon%26aufirst%3DC.%26aulast%3DMendes%26aufirst%3DR.%2BL.%26aulast%3DMuskiewicz%26aufirst%3DK.%2BR.%26aulast%3DSchiller%26aufirst%3DS.%2BE.%2BR.%26aulast%3DSoulard%26aufirst%3DP.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DG.%2BL.%26atitle%3DFT-1101%253A%2520A%2520structurally%2520distinct%2520pan-BET%2520bromodomain%2520inhibitor%2520with%2520activity%2520in%2520preclinical%2520models%2520of%2520hematologic%2520malignancies%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Liu, P. C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maduskuie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolotarjova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volgina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMatteo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falahatpisheh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond-Fosbenner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeleswaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G.</span><span> </span><span class="NLM_article-title">Abstract 3523: Discovery of a novel BET inhibitor INCB054329</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3523</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-3523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1538-7445.AM2015-3523" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3523&author=P.+C.+C.+Liuauthor=X.+M.+Liuauthor=M.+C.+Stubbsauthor=T.+Maduskuieauthor=R.+Sparksauthor=N.+Zolotarjovaauthor=J.+Liauthor=X.+Wenauthor=M.+Favataauthor=P.+Feldmanauthor=A.+Volginaauthor=D.+DiMatteoauthor=R.+Collinsauthor=N.+Falahatpishehauthor=P.+Polamauthor=Y.+Liauthor=M.+Covingtonauthor=S.+Diamond-Fosbennerauthor=R.+Wynnauthor=T.+Burnauthor=K.+Vaddiauthor=S.+Yeleswaramauthor=A.+P.+Combsauthor=W.+Yaoauthor=R.+Huberauthor=P.+Scherleauthor=G.+Hollis&title=Abstract+3523%3A+Discovery+of+a+novel+BET+inhibitor+INCB054329&doi=10.1158%2F1538-7445.AM2015-3523"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-3523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-3523%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%2BC.%2BC.%26aulast%3DLiu%26aufirst%3DX.%2BM.%26aulast%3DStubbs%26aufirst%3DM.%2BC.%26aulast%3DMaduskuie%26aufirst%3DT.%26aulast%3DSparks%26aufirst%3DR.%26aulast%3DZolotarjova%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DFeldman%26aufirst%3DP.%26aulast%3DVolgina%26aufirst%3DA.%26aulast%3DDiMatteo%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DFalahatpisheh%26aufirst%3DN.%26aulast%3DPolam%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DDiamond-Fosbenner%26aufirst%3DS.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DHollis%26aufirst%3DG.%26atitle%3DAbstract%25203523%253A%2520Discovery%2520of%2520a%2520novel%2520BET%2520inhibitor%2520INCB054329%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3523%26doi%3D10.1158%2F1538-7445.AM2015-3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span>Dose escalation study of GSK2820151 in subjects with advanced or recurrent solid tumors. Clinical trials, 30 November,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02630251" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02630251</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dose+escalation+study+of+GSK2820151+in+subjects+with+advanced+or+recurrent+solid+tumors.+Clinical+trials%2C+30+November%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02630251."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujikawa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calosing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhotia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H.</span><span> </span><span class="NLM_article-title">Abstract C86: The clinical candidate ZEN-3694, a novel BET bromodomain inhibitor, is efficacious in the treatment of a variety of solid tumor and hematological malignancies, alone or in combination with several standard of care and targeted therapies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">C86</span><span class="refDoi"> DOI: 10.1158/1535-7163.TARG-15-C86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.TARG-15-C86" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=C86&author=S.+Attwellauthor=E.+Campeauauthor=R.+Jahagirdarauthor=O.+Kharenkoauthor=K.+Norekauthor=L.+Tsujikawaauthor=C.+Calosingauthor=R.+Patelauthor=E.+Gesnerauthor=S.+Lakhotiaauthor=H.+Hansen&title=Abstract+C86%3A+The+clinical+candidate+ZEN-3694%2C+a+novel+BET+bromodomain+inhibitor%2C+is+efficacious+in+the+treatment+of+a+variety+of+solid+tumor+and+hematological+malignancies%2C+alone+or+in+combination+with+several+standard+of+care+and+targeted+therapies&doi=10.1158%2F1535-7163.TARG-15-C86"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.TARG-15-C86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.TARG-15-C86%26sid%3Dliteratum%253Aachs%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DCampeau%26aufirst%3DE.%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DKharenko%26aufirst%3DO.%26aulast%3DNorek%26aufirst%3DK.%26aulast%3DTsujikawa%26aufirst%3DL.%26aulast%3DCalosing%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DGesner%26aufirst%3DE.%26aulast%3DLakhotia%26aufirst%3DS.%26aulast%3DHansen%26aufirst%3DH.%26atitle%3DAbstract%2520C86%253A%2520The%2520clinical%2520candidate%2520ZEN-3694%252C%2520a%2520novel%2520BET%2520bromodomain%2520inhibitor%252C%2520is%2520efficacious%2520in%2520the%2520treatment%2520of%2520a%2520variety%2520of%2520solid%2520tumor%2520and%2520hematological%2520malignancies%252C%2520alone%2520or%2520in%2520combination%2520with%2520several%2520standard%2520of%2520care%2520and%2520targeted%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3DC86%26doi%3D10.1158%2F1535-7163.TARG-15-C86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Bates, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breckenridge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D.</span><span> </span><span class="NLM_article-title">The combination of a BET inhibitor (GS-5829) and a BTK Inhibitor (GS-4059) potentiates DLBCL cell line cell death and reduces expression of MYC, IL-10, and IL-6 in vitro</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">5116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1182%2Fblood.V128.22.5116.5116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=5116&author=J.+Batesauthor=S.+Kusamauthor=S.+Tannheimerauthor=J.+Chanauthor=Y.+Liauthor=D.+Breckenridgeauthor=D.+Tumas&title=The+combination+of+a+BET+inhibitor+%28GS-5829%29+and+a+BTK+Inhibitor+%28GS-4059%29+potentiates+DLBCL+cell+line+cell+death+and+reduces+expression+of+MYC%2C+IL-10%2C+and+IL-6+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1182%2Fblood.V128.22.5116.5116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V128.22.5116.5116%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DJ.%26aulast%3DKusam%26aufirst%3DS.%26aulast%3DTannheimer%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBreckenridge%26aufirst%3DD.%26aulast%3DTumas%26aufirst%3DD.%26atitle%3DThe%2520combination%2520of%2520a%2520BET%2520inhibitor%2520%2528GS-5829%2529%2520and%2520a%2520BTK%2520Inhibitor%2520%2528GS-4059%2529%2520potentiates%2520DLBCL%2520cell%2520line%2520cell%2520death%2520and%2520reduces%2520expression%2520of%2520MYC%252C%2520IL-10%252C%2520and%2520IL-6%2520in%2520vitro%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D5116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gjoksi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghayor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenobi-Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, F. E.</span><span> </span><span class="NLM_article-title">The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model</span> <span class="citation_source-journal">Clin. Epigenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="refDoi"> DOI: 10.1186/s13148-016-0209-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1186%2Fs13148-016-0209-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27110299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=42&author=B.+Gjoksiauthor=C.+Ghayorauthor=I.+Bhattacharyaauthor=M.+Zenobi-Wongauthor=F.+E.+Weber&title=The+bromodomain+inhibitor+N-methyl+pyrrolidone+reduced+fat+accumulation+in+an+ovariectomized+rat+model&doi=10.1186%2Fs13148-016-0209-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model</span></div><div class="casAuthors">Gjoksi, Bebeka; Ghayor, Chafik; Bhattacharya, Indranil; Zenobi-Wong, Marcy; Weber, Franz E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42/1-42/10</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Wt. gain is one of the consequences of estrogen deficiency and constitutes a major health problem.  The present study highlights the effects of N-Me pyrrolidone (NMP) on adipogenesis in osteoporosis induced by estrogen deficiency in an ovariectomized rat model.  Results: Ovariectomy resulted in body wt. gain, increased femoral marrow adipocytes, and hypertrophic adipocytes in white adipose tissue, distorted serum leptin, and TNF-α and PPARγ levels.  Treatment with NMP normalized these parameters similar to the control group.  In vitro, NMP inhibited the differentiation of 3T3-L1 pre-adipocytes and hMSCs, indicating its anti-adipogenic effect.  Moreover, PPARγ was significantly reduced with NMP treatment in in vivo and in vitro expts.  NMP inhibited BRD2 and BRD4 binding in an AlphaScreen assay, with an IC50 of 3 and 4 mM, resp.  The effect of NMP was consistent with its role as a bromodomain inhibitor.  Conclusions: Our data indicates that NMP inhibits the adipogenic effect of estrogen deficiency at the level of PPARγ expression by BRD4 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobU9sDz5yB6bVg90H21EOLACvtfcHk0lj7EZjEaJqmnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsrs%253D&md5=021c9e5ec046c8994b1527a873053ef2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1186%2Fs13148-016-0209-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-016-0209-2%26sid%3Dliteratum%253Aachs%26aulast%3DGjoksi%26aufirst%3DB.%26aulast%3DGhayor%26aufirst%3DC.%26aulast%3DBhattacharya%26aufirst%3DI.%26aulast%3DZenobi-Wong%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DF.%2BE.%26atitle%3DThe%2520bromodomain%2520inhibitor%2520N-methyl%2520pyrrolidone%2520reduced%2520fat%2520accumulation%2520in%2520an%2520ovariectomized%2520rat%2520model%26jtitle%3DClin.%2520Epigenet.%26date%3D2016%26volume%3D8%26spage%3D42%26doi%3D10.1186%2Fs13148-016-0209-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Jiang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veschambre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornberg, R. D.</span><span> </span><span class="NLM_article-title">Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">8538</span><span class="NLM_x">–</span> <span class="NLM_lpage">8543</span><span class="refDoi"> DOI: 10.1073/pnas.95.15.8538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.95.15.8538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=9671713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8538-8543&author=Y.+W.+Jiangauthor=P.+Veschambreauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=J.+W.+Conawayauthor=R.+C.+Conawayauthor=R.+D.+Kornberg&title=Mammalian+mediator+of+transcriptional+regulation+and+its+possible+role+as+an+end-point+of+signal+transduction+pathways&doi=10.1073%2Fpnas.95.15.8538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways</span></div><div class="casAuthors">Jiang, Yi Wei; Veschambre, Philippe; Erdjument-Bromage, Hediye; Tempst, Paul; Conaway, Joan W.; Conaway, Ronald C.; Kornberg, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8538-8543</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A multiprotein complex isolated from murine cells is identified as a counterpart of the yeast Mediator of transcriptional regulation on the basis of the following: homologs of two subunits of yeast Mediator, Srb7 and Med7, copurify with the complex; peptide sequencing reveals, in addn., homologs of the yeast Mediator subunits Rgr1 and Med6; as with yeast Mediator, the mouse complex binds to the RNA polymerase II C-terminal domain (CTD) and stimulates phosphorylation of the CTD by TFIIH.  Peptide sequencing also identifies a component of mouse Mediator as a relative of Ring-3 protein, a mitogen-activated nuclear protein kinase, raising the possibility of Mediator as an end point of signal transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMgqVnIZyEDrVg90H21EOLACvtfcHk0lj7EZjEaJqmnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFamu7o%253D&md5=474c58900d675368e6b18c646d2a6cec</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.15.8538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.15.8538%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%2BW.%26aulast%3DVeschambre%26aufirst%3DP.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DKornberg%26aufirst%3DR.%2BD.%26atitle%3DMammalian%2520mediator%2520of%2520transcriptional%2520regulation%2520and%2520its%2520possible%2520role%2520as%2520an%2520end-point%2520of%2520signal%2520transduction%2520pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D8538%26epage%3D8543%26doi%3D10.1073%2Fpnas.95.15.8538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Floyd, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannell, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rameseder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fydrych, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rosario, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, M. B.</span><span> </span><span class="NLM_article-title">The bromodomain protein Brd4 insulates chromatin from DNA damage signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1038/nature12147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature12147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2013&pages=246-250&author=S.+R.+Floydauthor=M.+E.+Pacoldauthor=Q.+Huangauthor=S.+M.+Clarkeauthor=F.+C.+Lamauthor=I.+G.+Cannellauthor=B.+D.+Brysonauthor=J.+Ramesederauthor=M.+J.+Leeauthor=E.+J.+Blakeauthor=A.+Fydrychauthor=R.+Hoauthor=B.+A.+Greenbergerauthor=G.+C.+Chenauthor=A.+Maffaauthor=A.+M.+Del+Rosarioauthor=D.+E.+Rootauthor=A.+E.+Carpenterauthor=W.+C.+Hahnauthor=D.+M.+Sabatiniauthor=C.+C.+Chenauthor=F.+M.+Whiteauthor=J.+E.+Bradnerauthor=M.+B.+Yaffe&title=The+bromodomain+protein+Brd4+insulates+chromatin+from+DNA+damage+signalling&doi=10.1038%2Fnature12147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnature12147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12147%26sid%3Dliteratum%253Aachs%26aulast%3DFloyd%26aufirst%3DS.%2BR.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DClarke%26aufirst%3DS.%2BM.%26aulast%3DLam%26aufirst%3DF.%2BC.%26aulast%3DCannell%26aufirst%3DI.%2BG.%26aulast%3DBryson%26aufirst%3DB.%2BD.%26aulast%3DRameseder%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DBlake%26aufirst%3DE.%2BJ.%26aulast%3DFydrych%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DR.%26aulast%3DGreenberger%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DG.%2BC.%26aulast%3DMaffa%26aufirst%3DA.%26aulast%3DDel%2BRosario%26aufirst%3DA.%2BM.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DCarpenter%26aufirst%3DA.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DWhite%26aufirst%3DF.%2BM.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DYaffe%26aufirst%3DM.%2BB.%26atitle%3DThe%2520bromodomain%2520protein%2520Brd4%2520insulates%2520chromatin%2520from%2520DNA%2520damage%2520signalling%26jtitle%3DNature%26date%3D2013%26volume%3D498%26spage%3D246%26epage%3D250%26doi%3D10.1038%2Fnature12147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. M.</span><span> </span><span class="NLM_article-title">The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">13141</span><span class="NLM_x">–</span> <span class="NLM_lpage">13145</span><span class="refDoi"> DOI: 10.1074/jbc.R700001200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.R700001200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17329240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1Ghtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=13141-13145&author=S.+Y.+Wuauthor=C.+M.+Chiang&title=The+double+bromodomain-containing+chromatin+adaptor+Brd4+and+transcriptional+regulation&doi=10.1074%2Fjbc.R700001200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation</span></div><div class="casAuthors">Wu, Shwu-Yuan; Chiang, Cheng-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">13141-13145</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Brd4 is a double bromodomain-contg. protein that binds preferentially to acetylated chromatin.  It belongs to the BET (bromodomains and extraterminal) family that includes mammalian Brd2, Brd3, Brd4, Brdt, Drosophila Fsh, yeast Bdf1, Bdf2, and corresponding homologues in other species.  Brd4 is essential for cellular growth and has been implicated in cell cycle control, DNA replication, and gene rearrangement found in t(15;19)-assocd. carcinomas.  Recently, Brd4 has been found in several transcription complexes, including the general cofactor Mediator and the P-TEFb elongation factor, and is capable of stimulating HIV-1 transcription in a Tat-independent manner.  In addn., Brd4 is used as a cellular adaptor by some animal and human papillomaviruses (HPV) for anchoring viral genomes to mitotic chromosomes.  This tethering, mediated by Brd4 interaction with virus-encoded E2 protein, facilitates viral genome segregation during mitosis.  Interestingly, Brd4 is also identified in a transcriptional silencing complex assembled by HPV E2 and turns out to be the long sought cellular corepressor that inhibits the expression of HPV-encoded E6 and E7 oncoproteins that antagonize p53 and pRB tumor suppressor activity, resp.  The dual role of Brd4 in gene activation and repression illustrates how a dynamic chromatin-binding adaptor is able to recruit distinct transcriptional regulators to modulate promoter activity through cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohccDdZC9iKLVg90H21EOLACvtfcHk0liZ8juWt7at4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1Ghtbo%253D&md5=b025a5222b510a7009eca4289370b1d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R700001200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R700001200%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DChiang%26aufirst%3DC.%2BM.%26atitle%3DThe%2520double%2520bromodomain-containing%2520chromatin%2520adaptor%2520Brd4%2520and%2520transcriptional%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D13141%26epage%3D13145%26doi%3D10.1074%2Fjbc.R700001200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Histone recognition and large-scale structural analysis of the human bromodomain family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.cell.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22464331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=214-231&author=P.+Filippakopoulosauthor=S.+Picaudauthor=M.+Mangosauthor=T.+Keatesauthor=J.+P.+Lambertauthor=D.+Barsyte-Lovejoyauthor=I.+Felletarauthor=R.+Volkmerauthor=S.+Mullerauthor=T.+Pawsonauthor=A.+C.+Gingrasauthor=C.+H.+Arrowsmithauthor=S.+Knapp&title=Histone+recognition+and+large-scale+structural+analysis+of+the+human+bromodomain+family&doi=10.1016%2Fj.cell.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Muller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-231</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks.  The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity.  Here, we present 29 high-resoln. crystal structures, covering all BRD families.  These proteins are: ASH1L, ATAD2, BAZ2B, BPTF, BRD1, BRD3(1), BRD3(2), BRD4(1), BRD4(2), BRD9, BRDT(1), CECR2, EP300, CREBBP, GCN5L2, KIAA1240, PB1(1), PB1(2), PB1(3), PB1(4), PB1(5), PB1(6), PCAF, PHIP(2), TAF1(2), WDR9(2), BRD4(1).  Comprehensive crossfamily structural anal. identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition.  Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences.  We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-contg. peptides by BRD4.  These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FSIcPoXZLVg90H21EOLACvtfcHk0liZ8juWt7at4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D&md5=05583a01a1cd4c3b59fc59c00e4c4777</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMangos%26aufirst%3DM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DJ.%2BP.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DHistone%2520recognition%2520and%2520large-scale%2520structural%2520analysis%2520of%2520the%2520human%2520bromodomain%2520family%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D214%26epage%3D231%26doi%3D10.1016%2Fj.cell.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. P.</span><span> </span><span class="NLM_article-title">Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.1016/j.ccr.2014.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ccr.2014.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24525235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlCisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=210-225&author=J.+Shiauthor=Y.+Wangauthor=L.+Zengauthor=Y.+Wuauthor=J.+Dengauthor=Q.+Zhangauthor=Y.+Linauthor=J.+Liauthor=T.+Kangauthor=M.+Taoauthor=E.+Rusinovaauthor=G.+Zhangauthor=C.+Wangauthor=H.+Zhuauthor=J.+Yaoauthor=Y.+X.+Zengauthor=B.+M.+Eversauthor=M.+M.+Zhouauthor=B.+P.+Zhou&title=Disrupting+the+interaction+of+BRD4+with+diacetylated+Twist+suppresses+tumorigenesis+in+basal-like+breast+cancer&doi=10.1016%2Fj.ccr.2014.01.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer</span></div><div class="casAuthors">Shi, Jian; Wang, Yifan; Zeng, Lei; Wu, Yadi; Deng, Jiong; Zhang, Qiang; Lin, Yiwei; Li, Junlin; Kang, Tiebang; Tao, Min; Rusinova, Elena; Zhang, Guangtao; Wang, Chi; Zhu, Haining; Yao, Jun; Zeng, Yi-Xin; Evers, B. Mark; Zhou, Ming-Ming; Zhou, Binhua P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-225</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Twist is a key transcription activator of epithelial-mesenchymal transition (EMT).  It remains unclear how Twist induces gene expression.  Here we report a mechanism by which Twist recruits BRD4 to direct WNT5A expression in basal-like breast cancer (BLBC).  Twist contains a "histone H4-mimic" GK-X-GK motif that is diacetylated by Tip60.  The diacetylated Twist binds the second bromodomain of BRD4, whose first bromodomain interacts with acetylated H4, thereby constructing an activated Twist/BRD4/P-TEFb/RNA-Pol II complex at the WNT5A promoter and enhancer.  Pharmacol. inhibition of the Twist-BRD4 assocn. reduced WNT5A expression and suppressed invasion, cancer stem cell (CSC)-like properties, and tumorigenicity of BLBC cells.  Our study indicates that the interaction with BRD4 is crit. for the oncogenic function of Twist in BLBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovIzriI8A6ZrVg90H21EOLACvtfcHk0liZ8juWt7at4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlCisrs%253D&md5=d207cbc1abb187a53d807452b4f10d8f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DT.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DZhou%26aufirst%3DB.%2BP.%26atitle%3DDisrupting%2520the%2520interaction%2520of%2520BRD4%2520with%2520diacetylated%2520Twist%2520suppresses%2520tumorigenesis%2520in%2520basal-like%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D210%26epage%3D225%26doi%3D10.1016%2Fj.ccr.2014.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Vollmuth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenfeldt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M.</span><span> </span><span class="NLM_article-title">Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">36547</span><span class="NLM_x">–</span> <span class="NLM_lpage">36556</span><span class="refDoi"> DOI: 10.1074/jbc.M109.033712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.M109.033712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=36547-36556&author=F.+Vollmuthauthor=W.+Blankenfeldtauthor=M.+Geyer&title=Structures+of+the+dual+bromodomains+of+the+P-TEFb-activating+protein+Brd4+at+atomic+resolution&doi=10.1074%2Fjbc.M109.033712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033712%26sid%3Dliteratum%253Aachs%26aulast%3DVollmuth%26aufirst%3DF.%26aulast%3DBlankenfeldt%26aufirst%3DW.%26aulast%3DGeyer%26aufirst%3DM.%26atitle%3DStructures%2520of%2520the%2520dual%2520bromodomains%2520of%2520the%2520P-TEFb-activating%2520protein%2520Brd4%2520at%2520atomic%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D36547%26epage%3D36556%26doi%3D10.1074%2Fjbc.M109.033712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span><span class="refDoi"> DOI: 10.1021/jm200108t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.+W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.+M.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Clementauthor=A.+B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+characterization+of+small+molecule+inhibitors+of+the+BET+family+bromodomains&doi=10.1021%2Fjm200108t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0liRVlsc2_IyQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520small%2520molecule%2520inhibitors%2520of%2520the%2520BET%2520family%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838%26doi%3D10.1021%2Fjm200108t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Kanno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenardo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">Selective recognition of acetylated histones by bromodomain proteins visualized in living cells</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00482-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS1097-2765%2803%2900482-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=33-43&author=T.+Kannoauthor=Y.+Kannoauthor=R.+M.+Siegelauthor=M.+K.+Jangauthor=M.+J.+Lenardoauthor=K.+Ozato&title=Selective+recognition+of+acetylated+histones+by+bromodomain+proteins+visualized+in+living+cells&doi=10.1016%2FS1097-2765%2803%2900482-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900482-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900482-9%26sid%3Dliteratum%253Aachs%26aulast%3DKanno%26aufirst%3DT.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DSiegel%26aufirst%3DR.%2BM.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DSelective%2520recognition%2520of%2520acetylated%2520histones%2520by%2520bromodomain%2520proteins%2520visualized%2520in%2520living%2520cells%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26spage%3D33%26epage%3D43%26doi%3D10.1016%2FS1097-2765%2803%2900482-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4899</span><span class="NLM_x">–</span> <span class="NLM_lpage">4909</span><span class="refDoi"> DOI: 10.1091/mbc.E09-05-0380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1091%2Fmbc.E09-05-0380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19812244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnslSk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=4899-4909&author=A.+Deyauthor=A.+Nishiyamaauthor=T.+Karpovaauthor=J.+McNallyauthor=K.+Ozato&title=Brd4+marks+select+genes+on+mitotic+chromatin+and+directs+postmitotic+transcription&doi=10.1091%2Fmbc.E09-05-0380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription</span></div><div class="casAuthors">Dey, Anup; Nishiyama, Akira; Karpova, Tatiana; McNally, James; Ozato, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4899-4909</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">On entry into mitosis, many transcription factors dissoc. from chromatin, resulting in global transcriptional shutdown.  During mitosis, some genes are marked to ensure the inheritance of their expression in the next generation of cells.  The nature of mitotic gene marking, however, has been obscure.  Brd4 is a double bromodomain protein that localizes to chromosomes during mitosis and is implicated in holding mitotic memory.  In interphase, Brd4 interacts with P-TEFb and functions as a global transcriptional coactivator.  We found that throughout mitosis, Brd4 remained bound to the transcription start sites of many M/G1 genes that are programmed to be expressed at the end of, or immediately after mitosis.  In contrast, Brd4 did not bind to genes that are expressed at later phases of cell cycle.  Brd4 binding to M/G1 genes increased at telophase, the end phase of mitosis, coinciding with increased acetylation of histone H3 and H4 in these genes.  Increased Brd4 binding was accompanied by the recruitment of P-TEFb and de novo M/G1 gene transcription, the events impaired in Brd4 knockdown cells.  In sum, Brd4 marks M/G1 genes for transcriptional memory during mitosis, and upon exiting mitosis, this mark acts as a signal for initiating their prompt transcription in daughter cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV0990TLKdcrVg90H21EOLACvtfcHk0liRVlsc2_IyQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnslSk&md5=f4225feea3d0ccffeea10159defea447</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E09-05-0380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E09-05-0380%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DA.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DKarpova%26aufirst%3DT.%26aulast%3DMcNally%26aufirst%3DJ.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DBrd4%2520marks%2520select%2520genes%2520on%2520mitotic%2520chromatin%2520and%2520directs%2520postmitotic%2520transcription%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2009%26volume%3D20%26spage%3D4899%26epage%3D4909%26doi%3D10.1091%2Fmbc.E09-05-0380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Dey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellenberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciortino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippincott-Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6537</span><span class="NLM_x">–</span> <span class="NLM_lpage">6549</span><span class="refDoi"> DOI: 10.1128/MCB.20.17.6537-6549.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.20.17.6537-6549.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10938129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFens7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=6537-6549&author=A.+Deyauthor=J.+Ellenbergauthor=A.+Farinaauthor=A.+E.+Colemanauthor=T.+Maruyamaauthor=S.+Sciortinoauthor=J.+Lippincott-Schwartzauthor=K.+Ozato&title=A+bromodomain+protein%2C+MCAP%2C+associates+with+mitotic+chromosomes+and+affects+G%282%29-to-M+transition&doi=10.1128%2FMCB.20.17.6537-6549.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G2-to-M transition</span></div><div class="casAuthors">Dey, Anup; Ellenberg, Jan; Farina, Andrea; Coleman, Allen E.; Maruyama, Tetsuo; Sciortino, Selvaggia; Lippincott-Schwartz, Jennifer; Ozato, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6537-6549</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We describe a novel nuclear factor called mitotic chromosome-assocd. protein (MCAP), which belongs to the poorly understood BET subgroup of the bromodomain superfamily.  Expression of the 200-kDa MCAP was linked to cell division, as it was induced by growth stimulation and repressed by growth inhibition.  The most notable feature of MCAP was its assocn. with chromosomes during mitosis, obsd. at a time when the majority of nuclear regulatory factors were released into the cytoplasm, coinciding with global cessation of transcription.  Indicative of its predominant interaction with euchromatin, MCAP localized on mitotic chromosomes with exquisite specificity: (i) MCAP-chromosome assocn. became evident subsequent to the initiation of histone H3 phosphorylation and early chromosomal condensation; and (ii) MCAP was absent from centromeres, the sites of heterochromatin.  Supporting a role for MCAP in G2/M transition, microinjection of anti-MCAP antibody into HeLa cell nuclei completely inhibited the entry into mitosis, without abrogating the ongoing DNA replication.  These results suggest that MCAP plays a role in a process governing chromosomal dynamics during mitosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAVlo6ULiazrVg90H21EOLACvtfcHk0lhPm5HzlKHdrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFens7s%253D&md5=0a0b95f84770c36457076f04521e116d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.17.6537-6549.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.17.6537-6549.2000%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DA.%26aulast%3DEllenberg%26aufirst%3DJ.%26aulast%3DFarina%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DA.%2BE.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DSciortino%26aufirst%3DS.%26aulast%3DLippincott-Schwartz%26aufirst%3DJ.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DA%2520bromodomain%2520protein%252C%2520MCAP%252C%2520associates%2520with%2520mitotic%2520chromosomes%2520and%2520affects%2520G%25282%2529-to-M%2520transition%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D6537%26epage%3D6549%26doi%3D10.1128%2FMCB.20.17.6537-6549.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">You, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howley, P. M.</span><span> </span><span class="NLM_article-title">Regulation of aurora B expression by the bromodomain protein Brd4</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5094</span><span class="NLM_x">–</span> <span class="NLM_lpage">5103</span><span class="refDoi"> DOI: 10.1128/MCB.00299-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.00299-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19596781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5094-5103&author=J.+Youauthor=Q.+Liauthor=C.+Wuauthor=J.+Kimauthor=M.+Ottingerauthor=P.+M.+Howley&title=Regulation+of+aurora+B+expression+by+the+bromodomain+protein+Brd4&doi=10.1128%2FMCB.00299-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of aurora B expression by the bromodomain protein Brd4</span></div><div class="casAuthors">You, Jianxin; Li, Qing; Wu, Chong; Kim, Jina; Ottinger, Matthias; Howley, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5094-5103</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The bromodomain protein Brd4 plays crit. roles in cellular proliferation and cell cycle progression.  In this study, we investigated the involvement of Brd4 in cell cycle regulation and obsd. aberrant chromosome segregation and failures in cytokinesis in cancer cells as well as in primary keratinocytes in which Brd4 has been knocked down by RNA interference.  Suppression of Brd4 protein levels in proliferating cells decreased Aurora B protein and transcript levels and abolished its chromosomal distribution.  In contrast, exogenous Brd4 expression stimulated Aurora B promoter reporter activity and upregulated endogenous Aurora B expression.  Aurora B kinase is a chromosomal passenger protein that is essential for chromosome segregation and cytokinesis.  Either overexpression of Aurora B or its inactivation can induce defects in centrosome function, spindle assembly, chromosome alignment, and cytokinesis in various cancer cells.  The impaired regulation of Aurora B expression in human cells by Brd4 knockdown or overexpression coincided with mitotic catastrophe and multinucleation that are typically obsd. when Aurora B is inactivated or overexpressed.  Overall, our data suggest that Brd4 is essential for the maintenance of the cell cycle progression mediated at least in part through the control of transcription of the Aurora B kinase cell cycle regulatory gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3p1hw3uxY7rVg90H21EOLACvtfcHk0lhPm5HzlKHdrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjs7rJ&md5=c69f475c1e073d6239c2228b0c3d6704</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FMCB.00299-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00299-09%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOttinger%26aufirst%3DM.%26aulast%3DHowley%26aufirst%3DP.%2BM.%26atitle%3DRegulation%2520of%2520aurora%2520B%2520expression%2520by%2520the%2520bromodomain%2520protein%2520Brd4%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5094%26epage%3D5103%26doi%3D10.1128%2FMCB.00299-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artero, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaiti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alazem, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margulies, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappola, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plutzky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, S. M.</span><span> </span><span class="NLM_article-title">BET bromodomains mediate transcriptional pause release in heart failure</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1016/j.cell.2013.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2013.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23911322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=569-582&author=P.+Anandauthor=J.+D.+Brownauthor=C.+Y.+Linauthor=J.+Qiauthor=R.+Zhangauthor=P.+C.+Arteroauthor=M.+A.+Alaitiauthor=J.+Bullardauthor=K.+Alazemauthor=K.+B.+Marguliesauthor=T.+P.+Cappolaauthor=M.+Lemieuxauthor=J.+Plutzkyauthor=J.+E.+Bradnerauthor=S.+M.+Haldar&title=BET+bromodomains+mediate+transcriptional+pause+release+in+heart+failure&doi=10.1016%2Fj.cell.2013.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure</span></div><div class="casAuthors">Anand, Priti; Brown, Jonathan D.; Lin, Charles Y.; Qi, Jun; Zhang, Rongli; Artero, Pedro Calderon; Alaiti, M. Amer; Bullard, Jace; Alazem, Kareem; Margulies, Kenneth B.; Cappola, Thomas P.; Lemieux, Madeleine; Plutzky, Jorge; Bradner, James E.; Haldar, Saptarsi M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-582</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heart failure (HF) is driven by the interplay between regulatory transcription factors and dynamic alterations in chromatin structure.  Pathol. gene transactivation in HF is assocd. with recruitment of histone acetyl-transferases and local chromatin hyperacetylation.  We therefore assessed the role of acetyl-lysine reader proteins, or bromodomains, in HF.  Using a chem. genetic approach, we establish a central role for BET family bromodomain proteins in gene control during HF pathogenesis.  BET inhibition potently suppresses cardiomyocyte hypertrophy in vitro and pathol. cardiac remodeling in vivo.  Integrative transcriptional and epigenomic analyses reveal that BET proteins function mechanistically as pause-release factors crit. to expression of genes that are central to HF pathogenesis and relevant to the pathobiol. of failing human hearts.  This study implicates epigenetic readers as essential effectors of transcriptional pause release during HF pathogenesis and identifies BET coactivator proteins as therapeutic targets in the heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZbQWpJYqt7bVg90H21EOLACvtfcHk0lhPm5HzlKHdrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WrsbzI&md5=33410607098cb42f1a7a52fa7ec0108b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DArtero%26aufirst%3DP.%2BC.%26aulast%3DAlaiti%26aufirst%3DM.%2BA.%26aulast%3DBullard%26aufirst%3DJ.%26aulast%3DAlazem%26aufirst%3DK.%26aulast%3DMargulies%26aufirst%3DK.%2BB.%26aulast%3DCappola%26aufirst%3DT.%2BP.%26aulast%3DLemieux%26aufirst%3DM.%26aulast%3DPlutzky%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DHaldar%26aufirst%3DS.%2BM.%26atitle%3DBET%2520bromodomains%2520mediate%2520transcriptional%2520pause%2520release%2520in%2520heart%2520failure%26jtitle%3DCell%26date%3D2013%26volume%3D154%26spage%3D569%26epage%3D582%26doi%3D10.1016%2Fj.cell.2013.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Korb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucker-Scharff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span><span class="refDoi"> DOI: 10.1038/nn.4095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnn.4095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26301327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlynsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=1464-1473&author=E.+Korbauthor=M.+Herreauthor=I.+Zucker-Scharffauthor=R.+B.+Darnellauthor=C.+D.+Allis&title=BET+protein+Brd4+activates+transcription+in+neurons+and+BET+inhibitor+Jq1+blocks+memory+in+mice&doi=10.1038%2Fnn.4095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice</span></div><div class="casAuthors">Korb, Erica; Herre, Margo; Zucker-Scharff, Ilana; Darnell, Robert B.; Allis, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1464-1473</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Precise regulation of transcription is crucial for the cellular mechanisms underlying memory formation.  However, the link between neuronal stimulation and the proteins that directly interact with histone modifications to activate transcription in neurons remains unclear.  Brd4 is a member of the bromodomain and extra-terminal domain (BET) protein family, which binds acetylated histones and is a crit. regulator of transcription in many cell types, including transcription in response to external cues.  Small mol. BET inhibitors are in clin. trials, yet almost nothing is known about Brd4 function in the brain.  Here we show that Brd4 mediates the transcriptional regulation underlying learning and memory.  The loss of Brd4 function affects crit. synaptic proteins, which results in memory deficits in mice but also decreases seizure susceptibility.  Thus Brd4 provides a crit. link between neuronal activation and the transcriptional responses that occur during memory formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbuMwCm6NDBLVg90H21EOLACvtfcHk0liTgTudtCHpig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlynsL%252FN&md5=0a09dea39378424cfc003a1e9e40ab9a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnn.4095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4095%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DE.%26aulast%3DHerre%26aufirst%3DM.%26aulast%3DZucker-Scharff%26aufirst%3DI.%26aulast%3DDarnell%26aufirst%3DR.%2BB.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DBET%2520protein%2520Brd4%2520activates%2520transcription%2520in%2520neurons%2520and%2520BET%2520inhibitor%2520Jq1%2520blocks%2520memory%2520in%2520mice%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D1464%26epage%3D1473%26doi%3D10.1038%2Fnn.4095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. H.</span><span> </span><span class="NLM_article-title">Identification of multiple cyclin subunits of human P-TEFb</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span><span class="refDoi"> DOI: 10.1101/gad.12.5.755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1101%2Fgad.12.5.755" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=755-762&author=J.+Pengauthor=Y.+Zhuauthor=J.+T.+Miltonauthor=D.+H.+Price&title=Identification+of+multiple+cyclin+subunits+of+human+P-TEFb&doi=10.1101%2Fgad.12.5.755"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.5.755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.5.755%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DMilton%26aufirst%3DJ.%2BT.%26aulast%3DPrice%26aufirst%3DD.%2BH.%26atitle%3DIdentification%2520of%2520multiple%2520cyclin%2520subunits%2520of%2520human%2520P-TEFb%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D755%26epage%3D762%26doi%3D10.1101%2Fgad.12.5.755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yik, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.06.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.molcel.2005.06.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=16109377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=535-545&author=Z.+Yangauthor=J.+H.+Yikauthor=R.+Chenauthor=N.+Heauthor=M.+K.+Jangauthor=K.+Ozatoauthor=Q.+Zhou&title=Recruitment+of+P-TEFb+for+stimulation+of+transcriptional+elongation+by+the+bromodomain+protein+Brd4&doi=10.1016%2Fj.molcel.2005.06.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4</span></div><div class="casAuthors">Yang, Zhiyuan; Yik, Jasper H. N.; Chen, Ruichuan; He, Nanhai; Jang, Moon Kyoo; Ozato, Keiko; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cyclinT1/Cdk9 heterodimer that constitutes core P-TEFb is generally presumed to be the transcriptionally active form for stimulating RNA polymerase II elongation.  About half of cellular P-TEFb also exists in an inactive complex with the 7SK snRNA and the HEXIM1 protein.  Here, we show that the remaining half assocs. with the bromodomain protein Brd4.  In stress-induced cells, the 7SK/HEXIM1-bound P-TEFb is quant. converted into the Brd4-assocd. form.  The assocn. with Brd4 is necessary to form the transcriptionally active P-TEFb, recruits P-TEFb to a promoter, and enables P-TEFb to contact the Mediator complex, a potential target for the Brd4-mediated recruitment.  Although generally required for transcription, the P-TEFb-recruitment function of Brd4 can be substituted by that of HIV-1 Tat, which recruits P-TEFb directly for activated HIV-1 transcription.  Brd4, HEXIM1, and 7SK are all implicated in regulating cell growth, which may result from their dynamic control of the general transcription factor P-TEFb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFELcZRBnvLVg90H21EOLACvtfcHk0liTgTudtCHpig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur8%253D&md5=50325264e1eb27789eb46999ca3f799d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.06.029%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYik%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DRecruitment%2520of%2520P-TEFb%2520for%2520stimulation%2520of%2520transcriptional%2520elongation%2520by%2520the%2520bromodomain%2520protein%2520Brd4%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D535%26epage%3D545%26doi%3D10.1016%2Fj.molcel.2005.06.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span> </span><span class="NLM_article-title">The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.molcel.2005.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=16109376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=523-534&author=M.+K.+Jangauthor=K.+Mochizukiauthor=M.+Zhouauthor=H.+S.+Jeongauthor=J.+N.+Bradyauthor=K.+Ozato&title=The+bromodomain+protein+Brd4+is+a+positive+regulatory+component+of+P-TEFb+and+stimulates+RNA+polymerase+II-dependent+transcription&doi=10.1016%2Fj.molcel.2005.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription</span></div><div class="casAuthors">Jang, Moon Kyoo; Mochizuki, Kazuki; Zhou, Meisheng; Jeong, Ho-Sang; Brady, John N.; Ozato, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">523-534</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Brd4 is a mammalian bromodomain protein that binds to acetylated chromatin.  Proteomic anal. revealed that Brd4 interacts with cyclinT1 and Cdk9 that constitutes core pos. transcription elongation factor b (P-TEFb).  Brd4 interacted with P-TEFb in the living nucleus through its bromodomain.  About half of P-TEFb was bound to the inhibitory subunit and functionally inactive.  Brd4 interacted with P-TEFb that was free of the inhibitory subunit.  An increase in Brd4 expression led to increased P-TEFb-dependent phosphorylation of RNA polymerase II (RNAPII) CTD and stimulation of transcription from promoters in vivo.  Conversely, a redn. in Brd4 expression by siRNA reduced CTD phosphorylation and transcription, revealing that Brd4 is a pos. regulatory component of P-TEFb.  In chromatin immunopptn. (ChlP) assays, the recruitment of P-TEFb to a promoter was dependent on Brd4 and was enhanced by an increase in chromatin acetylation.  Together, P-TEFb alternately interacts with Brd4 and the inhibitory subunit to maintain functional equil. in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeaKLJgZobzrVg90H21EOLACvtfcHk0liTgTudtCHpig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2lur4%253D&md5=90a7c10d7e7dd0e47d28ac708f9965ae</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DMochizuki%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DJeong%26aufirst%3DH.%2BS.%26aulast%3DBrady%26aufirst%3DJ.%2BN.%26aulast%3DOzato%26aufirst%3DK.%26atitle%3DThe%2520bromodomain%2520protein%2520Brd4%2520is%2520a%2520positive%2520regulatory%2520component%2520of%2520P-TEFb%2520and%2520stimulates%2520RNA%2520polymerase%2520II-dependent%2520transcription%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D523%26epage%3D534%26doi%3D10.1016%2Fj.molcel.2005.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span><span class="refDoi"> DOI: 10.1128/MCB.01020-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.01020-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18039861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=967-976&author=Z.+Yangauthor=N.+Heauthor=Q.+Zhou&title=Brd4+recruits+P-TEFb+to+chromosomes+at+late+mitosis+to+promote+G1+gene+expression+and+cell+cycle+progression&doi=10.1128%2FMCB.01020-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression</span></div><div class="casAuthors">Yang, Zhiyuan; He, Nanhai; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">967-976</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brd4, a bromodomain protein capable of interacting with acetylated histones, is implicated in transmitting epigenetic memory through mitosis.  It also functions as an assocd. factor and pos. regulator of P-TEFb, a Cdk9-cyclin T1 heterodimer that stimulates transcriptional elongation by phosphorylating RNA polymerase II.  In the present study, expts. were performed to det. whether these two functions of Brd4 are interrelated and, if so, how they may impact cell cycle progression.  Our data demonstrate that while the P-TEFb level remains const., the Brd4-P-TEFb interaction increases dramatically in cells progressing from late mitosis to early G1.  Concurrently, P-TEFb is recruited to chromosomes, beginning around mid- to late anaphase and before nuclear envelope/lamina formation and nuclear import of other general transcription factors.  Importantly, the recruitment of P-TEFb depends on Brd4.  Abrogation of this process through Brd4 knockdown reduces the binding of P-TEFb to and expression of key G1 and growth-assocd. genes, leading to G1 cell cycle arrest and apoptosis.  Because P-TEFb is synonymous with productive elongation, its recruitment by Brd4 to chromosomes at late mitosis may indicate those genes whose active transcription status must be preserved across cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_qFlZcTzQiLVg90H21EOLACvtfcHk0ljNmqO9hRR_kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWqur4%253D&md5=99b71de9dec48e64ecbcb59fda3b6d1d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1128%2FMCB.01020-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01020-07%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DBrd4%2520recruits%2520P-TEFb%2520to%2520chromosomes%2520at%2520late%2520mitosis%2520to%2520promote%2520G1%2520gene%2520expression%2520and%2520cell%2520cycle%2520progression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D967%26epage%3D976%26doi%3D10.1128%2FMCB.01020-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubonishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Atayde, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=12543779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Klug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=304-307&author=C.+A.+Frenchauthor=I.+Miyoshiauthor=I.+Kubonishiauthor=H.+E.+Grierauthor=A.+R.+Perez-Ataydeauthor=J.+A.+Fletcher&title=BRD4-NUT+fusion+oncogene%3A+a+novel+mechanism+in+aggressive+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4-NUT Fusion Oncogene: A Novel Mechanism in Aggressive Carcinoma</span></div><div class="casAuthors">French, Christopher A.; Miyoshi, Isao; Kubonishi, Ichiro; Grier, Holcombe E.; Perez-Atayde, Antonio R.; Fletcher, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">304-307</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The poorly differentiated carcinoma with t(15;19)(q13,p13.1) is characterized by its highly aggressive, invariably lethal clin. course.  The chromosome 19 translocation breakpoint targets the BRD4 double bromodomain-contg. gene, which functions in regulation of cell cycle progression.  Herein the authors demonstrate that BRD4 is fused with nearly the entire transcript of the novel 15q13 gene, NUT (nuclear protein in testis), forming a 6.4-kb fusion oncogene, BRD4-NUT.  NUT, like BRD4, is predicted to encode a nuclear protein but, unlike the ubiquitous BRD4 transcript, is expressed only in testis.  These findings establish a model to elucidate the oncogenic consequences of unscheduled NUT expression and altered BRD4 function.  Very few fusion oncogenes have been identified in epithelial tumors, and BRD4-NUT is the first fusion oncogene mechanism identified in a highly lethal form of carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTa0K_kBu2pLVg90H21EOLACvtfcHk0ljNmqO9hRR_kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Klug%253D%253D&md5=e927ea5874b2013c7467f981e10d7efd</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DMiyoshi%26aufirst%3DI.%26aulast%3DKubonishi%26aufirst%3DI.%26aulast%3DGrier%26aufirst%3DH.%2BE.%26aulast%3DPerez-Atayde%26aufirst%3DA.%2BR.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DBRD4-NUT%2520fusion%2520oncogene%253A%2520a%2520novel%2520mechanism%2520in%2520aggressive%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D304%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Delmore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastritis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilpatrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a therapeutic strategy to target c-Myc</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cell.2011.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21889194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=904-917&author=J.+E.+Delmoreauthor=G.+C.+Issaauthor=M.+E.+Lemieuxauthor=P.+B.+Rahlauthor=J.+Shiauthor=H.+M.+Jacobsauthor=E.+Kastritisauthor=T.+Gilpatrickauthor=R.+M.+Paranalauthor=J.+Qiauthor=M.+Chesiauthor=A.+C.+Schinzelauthor=M.+R.+McKeownauthor=T.+P.+Heffernanauthor=C.+R.+Vakocauthor=P.+L.+Bergsagelauthor=I.+M.+Ghobrialauthor=P.+G.+Richardsonauthor=R.+A.+Youngauthor=W.+C.+Hahnauthor=K.+C.+Andersonauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=C.+S.+Mitsiades&title=BET+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-Myc&doi=10.1016%2Fj.cell.2011.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc</span></div><div class="casAuthors">Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E.; Rahl, Peter B.; Shi, Jun-Wei; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Chesi, Marta; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Vakoc, Christopher R.; Bergsagel, P. Leif; Ghobrial, Irene M.; Richardson, Paul G.; Young, Richard A.; Hahn, William C.; Anderson, Kenneth C.; Kung, Andrew L.; Bradner, James E.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904-917</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: MYC contributes to the pathogenesis of a majority of human cancers, yet strategies to modulate the function of the c-Myc oncoprotein do not exist.  Toward this objective, we have targeted MYC transcription by interfering with chromatin-dependent signal transduction to RNA polymerase, specifically by inhibiting the acetyl-lysine recognition domains (bromodomains) of putative coactivator proteins implicated in transcriptional initiation and elongation.  Using a selective small-mol. bromodomain inhibitor, JQ1, we identify BET bromodomain proteins as regulatory factors for c-Myc.  BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes.  In exptl. models of multiple myeloma, a Myc-dependent hematol. malignancy, JQ1 produces a potent antiproliferative effect assocd. with cell-cycle arrest and cellular senescence.  Efficacy of JQ1 in three murine models of multiple myeloma establishes the therapeutic rationale for BET bromodomain inhibition in this disease and other malignancies characterized by pathol. activation of c-Myc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevD1QHKmOhLVg90H21EOLACvtfcHk0ljNmqO9hRR_kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF&md5=013674b8224214a9a1c8f0b75583a5a6</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelmore%26aufirst%3DJ.%2BE.%26aulast%3DIssa%26aufirst%3DG.%2BC.%26aulast%3DLemieux%26aufirst%3DM.%2BE.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DH.%2BM.%26aulast%3DKastritis%26aufirst%3DE.%26aulast%3DGilpatrick%26aufirst%3DT.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520to%2520target%2520c-Myc%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D904%26epage%3D917%26doi%3D10.1016%2Fj.cell.2011.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span> </span><span class="NLM_article-title">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">16669</span><span class="NLM_x">–</span> <span class="NLM_lpage">16674</span><span class="refDoi"> DOI: 10.1073/pnas.1108190108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1108190108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21949397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=16669-16674&author=J.+A.+Mertzauthor=A.+R.+Coneryauthor=B.+M.+Bryantauthor=P.+Sandyauthor=S.+Balasubramanianauthor=D.+A.+Meleauthor=L.+Bergeronauthor=R.+J.+Sims&title=Targeting+MYC+dependence+in+cancer+by+inhibiting+BET+bromodomains&doi=10.1073%2Fpnas.1108190108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span></div><div class="casAuthors">Mertz, Jennifer A.; Conery, Andrew R.; Bryant, Barbara M.; Sandy, Peter; Balasubramanian, Srividya; Mele, Deanna A.; Bergeron, Louise; Sims, Robert J., III</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16669-16674, S16669/1-S16669/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The MYC transcription factor is a master regulator of diverse cellular functions and has been long considered a compelling therapeutic target because of its role in a range of human malignancies.  However, pharmacol. inhibition of MYC function has proven challenging because of both the diverse mechanisms driving its aberrant expression and the challenge of disrupting protein-DNA interactions.  Here, we demonstrate the rapid and potent abrogation of MYC gene transcription by representative small mol. inhibitors of the BET family of chromatin adaptors.  MYC transcriptional suppression was obsd. in the context of the natural, chromosomally translocated, and amplified gene locus.  Inhibition of BET bromodomain-promoter interactions and subsequent redn. of MYC transcript and protein levels resulted in G1 arrest and extensive apoptosis in a variety of leukemia and lymphoma cell lines.  Exogenous expression of MYC from an artificial promoter that is resistant to BET regulation significantly protected cells from cell cycle arrest and growth suppression by BET inhibitors.  MYC suppression was accompanied by deregulation of the MYC transcriptome, including potent reactivation of the p21 tumor suppressor.  Treatment with a BET inhibitor resulted in significant antitumor activity in xenograft models of Burkitt's lymphoma and acute myeloid leukemia.  These findings demonstrate that pharmacol. inhibition of MYC is achievable through targeting BET bromodomains.  Such inhibitors may have clin. utility given the widespread pathogenetic role of MYC in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UHj1YB_ikrVg90H21EOLACvtfcHk0lj5LLLiw732jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL&md5=b1f0fd41fa56bbfcbb1ad6c8d48f7f80</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1108190108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1108190108%26sid%3Dliteratum%253Aachs%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DMele%26aufirst%3DD.%2BA.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520MYC%2520dependence%2520in%2520cancer%2520by%2520inhibiting%2520BET%2520bromodomains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D16669%26epage%3D16674%26doi%3D10.1073%2Fpnas.1108190108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Thangue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Selective inhibition of BET bromodomains</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span><span class="refDoi"> DOI: 10.1038/nature09504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature09504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20871596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1067-1073&author=P.+Filippakopoulosauthor=J.+Qiauthor=S.+Picaudauthor=Y.+Shenauthor=W.+B.+Smithauthor=O.+Fedorovauthor=E.+M.+Morseauthor=T.+Keatesauthor=T.+T.+Hickmanauthor=I.+Felletarauthor=M.+Philpottauthor=S.+Munroauthor=M.+R.+McKeownauthor=Y.+Wangauthor=A.+L.+Christieauthor=N.+Westauthor=M.+J.+Cameronauthor=B.+Schwartzauthor=T.+D.+Heightmanauthor=N.+La+Thangueauthor=C.+A.+Frenchauthor=O.+Wiestauthor=A.+L.+Kungauthor=S.+Knappauthor=J.+E.+Bradner&title=Selective+inhibition+of+BET+bromodomains&doi=10.1038%2Fnature09504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of BET bromodomains</span></div><div class="casAuthors">Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shongah; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic proteins are intently pursued targets in ligand discovery.  So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'.  Potent inhibitors of histone binding modules have not yet been described.  Here the authors report a cell-permeable small mol. (I,JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains.  High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity.  Recurrent translocation of BRD4 is obsd. in a genetically-defined, incurable subtype of human squamous carcinoma.  Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models.  These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chem. scaffold for the development of chem. probes more broadly throughout the bromodomain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ZbtmZM8m_LVg90H21EOLACvtfcHk0lj5LLLiw732jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D&md5=bd9cadac86124d2c6c3cd5b2a92d68c2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnature09504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09504%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMorse%26aufirst%3DE.%2BM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DHickman%26aufirst%3DT.%2BT.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DWest%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DLa%2BThangue%26aufirst%3DN.%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DSelective%2520inhibition%2520of%2520BET%2520bromodomains%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1067%26epage%3D1073%26doi%3D10.1038%2Fnature09504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Asangani, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dommeti, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escara-Wilke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilder-Romans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanireddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1038/nature13229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature13229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24759320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=278-282&author=I.+A.+Asanganiauthor=V.+L.+Dommetiauthor=X.+Wangauthor=R.+Malikauthor=M.+Cieslikauthor=R.+Yangauthor=J.+Escara-Wilkeauthor=K.+Wilder-Romansauthor=S.+Dhanireddyauthor=C.+Engelkeauthor=M.+K.+Iyerauthor=X.+Jingauthor=Y.+M.+Wuauthor=X.+Caoauthor=Z.+S.+Qinauthor=S.+Wangauthor=F.+Y.+Fengauthor=A.+M.+Chinnaiyan&title=Therapeutic+targeting+of+BET+bromodomain+proteins+in+castration-resistant+prostate+cancer&doi=10.1038%2Fnature13229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer</span></div><div class="casAuthors">Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Yang, Rendong; Escara-Wilke, June; Wilder-Romans, Kari; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Qin, Zhaohui S.; Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7504</span>),
    <span class="NLM_cas:pages">278-282</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Men who develop metastatic castration-resistant prostate cancer (CRPC) invariably succumb to the disease.  Progression to CRPC after androgen ablation therapy is predominantly driven by deregulated androgen receptor (AR) signaling.  Despite the success of recently approved therapies targeting AR signaling, such as abiraterone and second-generation anti-androgens including MDV3100 (also known as enzalutamide), durable responses are limited, presumably owing to acquired resistance.  Recently, JQ1 and I-BET762 two selective small-mol. inhibitors that target the N-terminal bromodomains of BRD4, have been shown to exhibit anti-proliferative effects in a range of malignancies.  AR-signaling-competent human CRPC cell lines are preferentially sensitive to bromodomain and extraterminal (BET) inhibition.  BRD4 phys. interacts with the N-terminal domain of AR and can be disrupted by JQ1 (refs 11, 13).  Like the direct AR antagonist MDV3100, JQ1 disrupted AR recruitment to target gene loci.  By contrast with MDV3100, JQ1 functions downstream of AR, and more potently abrogated BRD4 localization to AR target loci and AR-mediated gene transcription, including induction of the TMPRSS2-ERG gene fusion and its oncogenic activity.  In vivo, BET bromodomain inhibition was more efficacious than direct AR antagonism in CRPC xenograft mouse models.  Taken together, these studies provide a novel epigenetic approach for the concerted blockade of oncogenic drivers in advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfXutywHDWrVg90H21EOLACvtfcHk0lj5LLLiw732jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D&md5=bef4b5faf5d23dc7d125ab1941c3ee39</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnature13229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13229%26sid%3Dliteratum%253Aachs%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DDommeti%26aufirst%3DV.%2BL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMalik%26aufirst%3DR.%26aulast%3DCieslik%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DEscara-Wilke%26aufirst%3DJ.%26aulast%3DWilder-Romans%26aufirst%3DK.%26aulast%3DDhanireddy%26aufirst%3DS.%26aulast%3DEngelke%26aufirst%3DC.%26aulast%3DIyer%26aufirst%3DM.%2BK.%26aulast%3DJing%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DZ.%2BS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DTherapeutic%2520targeting%2520of%2520BET%2520bromodomain%2520proteins%2520in%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D278%26epage%3D282%26doi%3D10.1038%2Fnature13229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Segura, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanals-Cirera, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaziel-Sovran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanniford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Gomez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubierre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darvishian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernando, E.</span><span> </span><span class="NLM_article-title">BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6276</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-0122-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F0008-5472.CAN-13-0122-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23950209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ahur7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=6264-6276&author=M.+F.+Seguraauthor=B.+Fontanals-Cireraauthor=A.+Gaziel-Sovranauthor=M.+V.+Guijarroauthor=D.+Hannifordauthor=G.+Zhangauthor=P.+Gonzalez-Gomezauthor=M.+Moranteauthor=L.+Jubierreauthor=W.+Zhangauthor=F.+Darvishianauthor=M.+Ohlmeyerauthor=I.+Osmanauthor=M.+M.+Zhouauthor=E.+Hernando&title=BRD4+sustains+melanoma+proliferation+and+represents+a+new+target+for+epigenetic+therapy&doi=10.1158%2F0008-5472.CAN-13-0122-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy</span></div><div class="casAuthors">Segura, Miguel F.; Fontanals-Cirera, Barbara; Gaziel-Sovran, Avital; Guijarro, Maria V.; Hanniford, Doug; Zhang, Guangtao; Gonzalez-Gomez, Pilar; Morante, Marta; Jubierre, Luz; Zhang, Weijia; Darvishian, Farbod; Ohlmeyer, Michael; Osman, Iman; Zhou, Ming-Ming; Hernando, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6264-6276</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Metastatic melanoma remains a mostly incurable disease.  Although newly approved targeted therapies are efficacious in a subset of patients, resistance and relapse rapidly ensue.  Alternative therapeutic strategies to manipulate epigenetic regulators and disrupt the transcriptional program that maintains tumor cell identity are emerging.  Bromodomain and extraterminal domain (BET) proteins are epigenome readers known to exert key roles at the interface between chromatin remodeling and transcriptional regulation.  Here, we report that BRD4, a BET family member, is significantly upregulated in primary and metastatic melanoma tissues compared with melanocytes and nevi.  Treatment with BET inhibitors impaired melanoma cell proliferation in vitro and tumor growth and metastatic behavior in vivo, effects that were mostly recapitulated by individual silencing of BRD4.  RNA sequencing of BET inhibitor-treated cells followed by Gene Ontol. anal. showed a striking impact on transcriptional programs controlling cell growth, proliferation, cell-cycle regulation, and differentiation.  In particular, we found that, rapidly after BET displacement, key cell-cycle genes (SKP2, ERK1, and c-MYC) were downregulated concomitantly with the accumulation of cyclin-dependent kinase (CDK) inhibitors (p21 and p27), followed by cell-cycle arrest.  Importantly, BET inhibitor efficacy was not influenced by BRAF or NRAS mutational status, opening the possibility of using these small-mol. compds. to treat patients for whom no effective targeted therapy exists.  Collectively, our study reveals a crit. role for BRD4 in melanoma tumor maintenance and renders it a legitimate and novel target for epigenetic therapy directed against the core transcriptional program of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq80TZH2ueQFbVg90H21EOLACvtfcHk0lgANldu0_q9JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ahur7N&md5=a4a77f188de01c4c84f7293a32478fc7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-0122-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-0122-T%26sid%3Dliteratum%253Aachs%26aulast%3DSegura%26aufirst%3DM.%2BF.%26aulast%3DFontanals-Cirera%26aufirst%3DB.%26aulast%3DGaziel-Sovran%26aufirst%3DA.%26aulast%3DGuijarro%26aufirst%3DM.%2BV.%26aulast%3DHanniford%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGonzalez-Gomez%26aufirst%3DP.%26aulast%3DMorante%26aufirst%3DM.%26aulast%3DJubierre%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDarvishian%26aufirst%3DF.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DHernando%26aufirst%3DE.%26atitle%3DBRD4%2520sustains%2520melanoma%2520proliferation%2520and%2520represents%2520a%2520new%2520target%2520for%2520epigenetic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D6264%26epage%3D6276%26doi%3D10.1158%2F0008-5472.CAN-13-0122-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Zuber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sison, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wunderlich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chicas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulloy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span> </span><span class="NLM_article-title">RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1038/nature10334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature10334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21814200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=524-528&author=J.+Zuberauthor=J.+Shiauthor=E.+Wangauthor=A.+R.+Rappaportauthor=H.+Herrmannauthor=E.+A.+Sisonauthor=D.+Magoonauthor=J.+Qiauthor=K.+Blattauthor=M.+Wunderlichauthor=M.+J.+Taylorauthor=C.+Johnsauthor=A.+Chicasauthor=J.+C.+Mulloyauthor=S.+C.+Koganauthor=P.+Brownauthor=P.+Valentauthor=J.+E.+Bradnerauthor=S.+W.+Loweauthor=C.+R.+Vakoc&title=RNAi+screen+identifies+Brd4+as+a+therapeutic+target+in+acute+myeloid+leukaemia&doi=10.1038%2Fnature10334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia</span></div><div class="casAuthors">Zuber, Johannes; Shi, Junwei; Wang, Eric; Rappaport, Amy R.; Herrmann, Harald; Sison, Edward A.; Magoon, Daniel; Qi, Jun; Blatt, Katharina; Wunderlich, Mark; Taylor, Meredith J.; Johns, Christopher; Chicas, Agustin; Mulloy, James C.; Kogan, Scott C.; Brown, Patrick; Valent, Peter; Bradner, James E.; Lowe, Scott W.; Vakoc, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">524-528</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic pathways can regulate gene expression by controlling and interpreting chromatin modifications.  Cancer cells are characterized by altered epigenetic landscapes, and commonly exploit the chromatin regulatory machinery to enforce oncogenic gene expression programs.  Although chromatin alterations are, in principle, reversible and often amenable to drug intervention, the promise of targeting such pathways therapeutically has been limited by an incomplete understanding of cancer-specific dependencies on epigenetic regulators.  Here the authors describe a non-biased approach to probe epigenetic vulnerabilities in acute myeloid leukemia (AML), an aggressive hematopoietic malignancy that is often assocd. with aberrant chromatin states.  By screening a custom library of small hairpin RNAs (shRNAs) targeting known chromatin regulators in a genetically defined AML mouse model, the authors identify the protein bromodomain-contg. 4 (Brd4) as being critically required for disease maintenance.  Suppression of Brd4 using shRNAs or the small-mol. inhibitor JQ1 led to robust antileukemic effects in vitro and in vivo, accompanied by terminal myeloid differentiation and elimination of leukemia stem cells.  Similar sensitivities were obsd. in a variety of human AML cell lines and primary patient samples, revealing that JQ1 has broad activity in diverse AML subtypes.  The effects of Brd4 suppression are, at least in part, due to its role in sustaining Myc expression to promote aberrant self-renewal, which implicates JQ1 as a pharmacol. means to suppress MYC in cancer.  The authors' results establish small-mol. inhibition of Brd4 as a promising therapeutic strategy in AML and, potentially, other cancers, and highlight the utility of RNA interference (RNAi) screening for revealing epigenetic vulnerabilities that can be exploited for direct pharmacol. intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVyWFIqFkUVrVg90H21EOLACvtfcHk0lgANldu0_q9JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers7%252FP&md5=618793a766f037bff5909524743fedb7</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnature10334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10334%26sid%3Dliteratum%253Aachs%26aulast%3DZuber%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DRappaport%26aufirst%3DA.%2BR.%26aulast%3DHerrmann%26aufirst%3DH.%26aulast%3DSison%26aufirst%3DE.%2BA.%26aulast%3DMagoon%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBlatt%26aufirst%3DK.%26aulast%3DWunderlich%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DJohns%26aufirst%3DC.%26aulast%3DChicas%26aufirst%3DA.%26aulast%3DMulloy%26aufirst%3DJ.%2BC.%26aulast%3DKogan%26aufirst%3DS.%2BC.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26atitle%3DRNAi%2520screen%2520identifies%2520Brd4%2520as%2520a%2520therapeutic%2520target%2520in%2520acute%2520myeloid%2520leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D524%26epage%3D528%26doi%3D10.1038%2Fnature10334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Baratta, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhayay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman-Colin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drapkin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span> </span><span class="NLM_article-title">An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1073/pnas.1422165112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1422165112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=232-237&author=M.+G.+Barattaauthor=A.+C.+Schinzelauthor=Y.+Zwangauthor=P.+Bandopadhayayauthor=C.+Bowman-Colinauthor=J.+Kuttauthor=J.+Curtisauthor=H.+Piaoauthor=L.+C.+Wongauthor=A.+L.+Kungauthor=R.+Beroukhimauthor=J.+E.+Bradnerauthor=R.+Drapkinauthor=W.+C.+Hahnauthor=J.+F.+Liuauthor=D.+M.+Livingston&title=An+in-tumor+genetic+screen+reveals+that+the+BET+bromodomain+protein%2C+BRD4%2C+is+a+potential+therapeutic+target+in+ovarian+carcinoma&doi=10.1073%2Fpnas.1422165112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422165112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422165112%26sid%3Dliteratum%253Aachs%26aulast%3DBaratta%26aufirst%3DM.%2BG.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DBandopadhayay%26aufirst%3DP.%26aulast%3DBowman-Colin%26aufirst%3DC.%26aulast%3DKutt%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DJ.%26aulast%3DPiao%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DL.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DDrapkin%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DAn%2520in-tumor%2520genetic%2520screen%2520reveals%2520that%2520the%2520BET%2520bromodomain%2520protein%252C%2520BRD4%252C%2520is%2520a%2520potential%2520therapeutic%2520target%2520in%2520ovarian%2520carcinoma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D232%26epage%3D237%26doi%3D10.1073%2Fpnas.1422165112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Ceribelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews Griner, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staudt, L. M.</span><span> </span><span class="NLM_article-title">Blockade of oncogenic IkappaB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">11365</span><span class="NLM_x">–</span> <span class="NLM_lpage">11370</span><span class="refDoi"> DOI: 10.1073/pnas.1411701111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1411701111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=11365-11370&author=M.+Ceribelliauthor=P.+N.+Kellyauthor=A.+L.+Shafferauthor=G.+W.+Wrightauthor=W.+Xiaoauthor=Y.+Yangauthor=L.+A.+Mathews+Grinerauthor=R.+Guhaauthor=P.+Shinnauthor=J.+M.+Kellerauthor=D.+Liuauthor=P.+R.+Patelauthor=M.+Ferrerauthor=S.+Joshiauthor=S.+Nerleauthor=P.+Sandyauthor=E.+Normantauthor=C.+J.+Thomasauthor=L.+M.+Staudt&title=Blockade+of+oncogenic+IkappaB+kinase+activity+in+diffuse+large+B-cell+lymphoma+by+bromodomain+and+extraterminal+domain+protein+inhibitors&doi=10.1073%2Fpnas.1411701111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1411701111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1411701111%26sid%3Dliteratum%253Aachs%26aulast%3DCeribelli%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DP.%2BN.%26aulast%3DShaffer%26aufirst%3DA.%2BL.%26aulast%3DWright%26aufirst%3DG.%2BW.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMathews%2BGriner%26aufirst%3DL.%2BA.%26aulast%3DGuha%26aufirst%3DR.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DKeller%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DNerle%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DBlockade%2520of%2520oncogenic%2520IkappaB%2520kinase%2520activity%2520in%2520diffuse%2520large%2520B-cell%2520lymphoma%2520by%2520bromodomain%2520and%2520extraterminal%2520domain%2520protein%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D11365%26epage%3D11370%26doi%3D10.1073%2Fpnas.1411701111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Puissant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frumm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassil, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanthery, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nekritz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greninger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmaier, K.</span><span> </span><span class="NLM_article-title">Targeting MYCN in neuroblastoma by BET bromodomain inhibition</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F2159-8290.CD-12-0418" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=308-323&author=A.+Puissantauthor=S.+M.+Frummauthor=G.+Alexeauthor=C.+F.+Bassilauthor=J.+Qiauthor=Y.+H.+Chantheryauthor=E.+A.+Nekritzauthor=R.+Zeidauthor=W.+C.+Gustafsonauthor=P.+Greningerauthor=M.+J.+Garnettauthor=U.+McDermottauthor=C.+H.+Benesauthor=A.+L.+Kungauthor=W.+A.+Weissauthor=J.+E.+Bradnerauthor=K.+Stegmaier&title=Targeting+MYCN+in+neuroblastoma+by+BET+bromodomain+inhibition&doi=10.1158%2F2159-8290.CD-12-0418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0418%26sid%3Dliteratum%253Aachs%26aulast%3DPuissant%26aufirst%3DA.%26aulast%3DFrumm%26aufirst%3DS.%2BM.%26aulast%3DAlexe%26aufirst%3DG.%26aulast%3DBassil%26aufirst%3DC.%2BF.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChanthery%26aufirst%3DY.%2BH.%26aulast%3DNekritz%26aufirst%3DE.%2BA.%26aulast%3DZeid%26aufirst%3DR.%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DU.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DStegmaier%26aufirst%3DK.%26atitle%3DTargeting%2520MYCN%2520in%2520neuroblastoma%2520by%2520BET%2520bromodomain%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D308%26epage%3D323%26doi%3D10.1158%2F2159-8290.CD-12-0418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Lockwood, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H.</span><span> </span><span class="NLM_article-title">Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">19408</span><span class="NLM_x">–</span> <span class="NLM_lpage">19413</span><span class="refDoi"> DOI: 10.1073/pnas.1216363109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1216363109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=19408-19413&author=W.+W.+Lockwoodauthor=K.+Zejnullahuauthor=J.+E.+Bradnerauthor=H.+Varmus&title=Sensitivity+of+human+lung+adenocarcinoma+cell+lines+to+targeted+inhibition+of+BET+epigenetic+signaling+proteins&doi=10.1073%2Fpnas.1216363109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1216363109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1216363109%26sid%3Dliteratum%253Aachs%26aulast%3DLockwood%26aufirst%3DW.%2BW.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DSensitivity%2520of%2520human%2520lung%2520adenocarcinoma%2520cell%2520lines%2520to%2520targeted%2520inhibition%2520of%2520BET%2520epigenetic%2520signaling%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D19408%26epage%3D19413%26doi%3D10.1073%2Fpnas.1216363109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. F.</span><span> </span><span class="NLM_article-title">Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1128/MCB.01365-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FMCB.01365-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19103749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlylsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=1375-1387&author=B.+Huangauthor=X.+D.+Yangauthor=M.+M.+Zhouauthor=K.+Ozatoauthor=L.+F.+Chen&title=Brd4+coactivates+transcriptional+activation+of+NF-kappaB+via+specific+binding+to+acetylated+RelA&doi=10.1128%2FMCB.01365-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Brd4 coactivates transcriptional activation of NF-κB via specific binding to acetylated RelA</span></div><div class="casAuthors">Huang, Bo; Yang, Xiao-Dong; Zhou, Ming-Ming; Ozato, Keiko; Chen, Lin-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1375-1387</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acetylation of the RelA subunit of NF-κB, esp. at lysine-310, is crit. for the transcriptional activation of NF-κB and the expression of inflammatory genes.  In this study, we demonstrate that bromodomains of Brd4 bind to acetylated lysine-310.  Brd4 enhances transcriptional activation of NF-κB and the expression of a subset of NF-κB-responsive inflammatory genes in an acetylated lysine-310-dependent manner.  Bromodomains of Brd4 and acetylated lysine-310 of RelA are both required for the mutual interaction and coactivation function of Brd4.  Finally, we demonstrate that Brd4 further recruits CDK9 to phosphorylate C-terminal domain of RNA polymerase II and facilitate the transcription of NF-κB-dependent inflammatory genes.  Our results identify Brd4 as a novel coactivator of NF-κB through specifically binding to acetylated lysine-310 of RelA.  In addn., these studies reveal a mechanism by which acetylated RelA stimulates the transcriptional activity of NF-κB and the NF-κB-dependent inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBnS4p5wzT2LVg90H21EOLACvtfcHk0liX9q5asnyGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlylsrc%253D&md5=ae4e16c84d17c5e0e268ff80703a4608</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1128%2FMCB.01365-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01365-08%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DX.%2BD.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DL.%2BF.%26atitle%3DBrd4%2520coactivates%2520transcriptional%2520activation%2520of%2520NF-kappaB%2520via%2520specific%2520binding%2520to%2520acetylated%2520RelA%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D1375%26epage%3D1387%26doi%3D10.1128%2FMCB.01365-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Chen, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, W. C.</span><span> </span><span class="NLM_article-title">Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB</span> <span class="citation_source-journal">EMBO. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6539</span><span class="NLM_x">–</span> <span class="NLM_lpage">6548</span><span class="refDoi"> DOI: 10.1093/emboj/cdf660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1093%2Femboj%2Fcdf660" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6539-6548&author=L.+F.+Chenauthor=Y.+Muauthor=W.+C.+Greene&title=Acetylation+of+RelA+at+discrete+sites+regulates+distinct+nuclear+functions+of+NF-kappaB&doi=10.1093%2Femboj%2Fcdf660"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdf660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdf660%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BF.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DGreene%26aufirst%3DW.%2BC.%26atitle%3DAcetylation%2520of%2520RelA%2520at%2520discrete%2520sites%2520regulates%2520distinct%2520nuclear%2520functions%2520of%2520NF-kappaB%26jtitle%3DEMBO.%2520J.%26date%3D2002%26volume%3D21%26spage%3D6539%26epage%3D6548%26doi%3D10.1093%2Femboj%2Fcdf660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Ding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span> </span><span class="NLM_article-title">BRD4 is a novel therapeutic target for liver fibrosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15713</span><span class="NLM_x">–</span> <span class="NLM_lpage">15718</span><span class="refDoi"> DOI: 10.1073/pnas.1522163112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1522163112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15713-15718&author=N.+Dingauthor=N.+Hahauthor=R.+T.+Yuauthor=M.+H.+Shermanauthor=C.+Bennerauthor=M.+Leblancauthor=M.+Heauthor=C.+Liddleauthor=M.+Downesauthor=R.+M.+Evans&title=BRD4+is+a+novel+therapeutic+target+for+liver+fibrosis&doi=10.1073%2Fpnas.1522163112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1522163112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1522163112%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DN.%26aulast%3DHah%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DR.%2BT.%26aulast%3DSherman%26aufirst%3DM.%2BH.%26aulast%3DBenner%26aufirst%3DC.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLiddle%26aufirst%3DC.%26aulast%3DDownes%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DBRD4%2520is%2520a%2520novel%2520therapeutic%2520target%2520for%2520liver%2520fibrosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15713%26epage%3D15718%26doi%3D10.1073%2Fpnas.1522163112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Tian, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasier, A. R.</span><span> </span><span class="NLM_article-title">BRD4 mediates NFkB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">L1183</span><span class="refDoi"> DOI: 10.1152/ajplung.00224.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1152%2Fajplung.00224.2016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=L1183&author=B.+Tianauthor=Y.+Zhaoauthor=H.+Sunauthor=Y.+Zhangauthor=J.+Yangauthor=A.+R.+Brasier&title=BRD4+mediates+NFkB-dependent+epithelial-mesenchymal+transition+and+pulmonary+fibrosis+via+transcriptional+elongation&doi=10.1152%2Fajplung.00224.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00224.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00224.2016%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DBrasier%26aufirst%3DA.%2BR.%26atitle%3DBRD4%2520mediates%2520NFkB-dependent%2520epithelial-mesenchymal%2520transition%2520and%2520pulmonary%2520fibrosis%2520via%2520transcriptional%2520elongation%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2016%26volume%3D311%26spage%3DL1183%26doi%3D10.1152%2Fajplung.00224.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandwani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marazzi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span> </span><span class="NLM_article-title">Suppression of inflammation by a synthetic histone mimic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1038/nature09589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature09589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21068722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1119-1123&author=E.+Nicodemeauthor=K.+L.+Jeffreyauthor=U.+Schaeferauthor=S.+Beinkeauthor=S.+Dewellauthor=C.+W.+Chungauthor=R.+Chandwaniauthor=I.+Marazziauthor=P.+Wilsonauthor=H.+Costeauthor=J.+Whiteauthor=J.+Kirilovskyauthor=C.+M.+Riceauthor=J.+M.+Loraauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=A.+Tarakhovsky&title=Suppression+of+inflammation+by+a+synthetic+histone+mimic&doi=10.1038%2Fnature09589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of inflammation by a synthetic histone mimic</span></div><div class="casAuthors">Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression.  This response, although vital for immune defense, is frequently deleterious to the host due to the exaggerated prodn. of inflammatory proteins.  The scope of inflammatory responses reflects the activation state of signaling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression.  Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a crit. step in the regulation of gene expression.  Here we present a novel pharmacol. approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins.  We describe a synthetic compd. (I-BET) that by mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis.  Our findings suggest that synthetic compds. specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxc3_PNaiuKLVg90H21EOLACvtfcHk0liX9q5asnyGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP&md5=0dfccd9d01b87859512bf591e1c5a93c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnature09589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09589%26sid%3Dliteratum%253Aachs%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DK.%2BL.%26aulast%3DSchaefer%26aufirst%3DU.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DDewell%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChandwani%26aufirst%3DR.%26aulast%3DMarazzi%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520inflammation%2520by%2520a%2520synthetic%2520histone%2520mimic%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1119%26epage%3D1123%26doi%3D10.1038%2Fnature09589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Khan, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Brd4 is essential for IL-1beta-induced inflammation in human airway epithelial cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e95051</span><span class="refDoi"> DOI: 10.1371/journal.pone.0095051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1371%2Fjournal.pone.0095051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e95051&author=Y.+M.+Khanauthor=P.+Kirkhamauthor=P.+J.+Barnesauthor=I.+M.+Adcock&title=Brd4+is+essential+for+IL-1beta-induced+inflammation+in+human+airway+epithelial+cells&doi=10.1371%2Fjournal.pone.0095051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0095051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0095051%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DY.%2BM.%26aulast%3DKirkham%26aufirst%3DP.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DBrd4%2520is%2520essential%2520for%2520IL-1beta-induced%2520inflammation%2520in%2520human%2520airway%2520epithelial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De95051%26doi%3D10.1371%2Fjournal.pone.0095051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguzman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apparsundaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogaboam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span> </span><span class="NLM_article-title">Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2013.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ajpath.2013.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23759512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFynur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2013&pages=470-479&author=X.+Tangauthor=R.+Pengauthor=J.+E.+Phillipsauthor=J.+Deguzmanauthor=Y.+Renauthor=S.+Apparsundaramauthor=Q.+Luoauthor=C.+M.+Bauerauthor=M.+E.+Fuentesauthor=J.+A.+DeMartinoauthor=G.+Tyagiauthor=R.+Garridoauthor=C.+M.+Hogaboamauthor=C.+P.+Dentonauthor=A.+M.+Holmesauthor=C.+Kitsonauthor=C.+S.+Stevensonauthor=D.+C.+Budd&title=Assessment+of+Brd4+inhibition+in+idiopathic+pulmonary+fibrosis+lung+fibroblasts+and+in+vivo+models+of+lung+fibrosis&doi=10.1016%2Fj.ajpath.2013.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of Brd4 Inhibition in Idiopathic Pulmonary Fibrosis Lung Fibroblasts and in Vivo Models of Lung Fibrosis</span></div><div class="casAuthors">Tang, Xiaoyan; Peng, Ruoqi; Phillips, Jonathan E.; Deguzman, Jeremy; Ren, Yonglin; Apparsundaram, Subramanium; Luo, Qi; Bauer, Carla M.; Fuentes, Maria E.; DeMartino, Julie A.; Tyagi, Gaurav; Garrido, Rosario; Hogaboam, Cory M.; Denton, Christopher P.; Holmes, Alan M.; Kitson, Christopher; Stevenson, Christopher S.; Budd, David C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">470-479</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of high unmet medical need.  Although bromodomain (Brd) and extra terminal domain isoforms have recently been implicated in mediating inflammatory and oncol. indications, their roles in lung fibrosis have not been comprehensively assessed.  We investigated the role of Brd on the profibrotic responses of lung fibroblasts (LFs) in patients with rapidly progressing IPF and a mouse bleomycin model of lung fibrosis.  The enhanced migration, proliferation, and IL-6 release obsd. in LFs from patients with rapidly progressing IPF are attenuated by pharmacol. inhibition of Brd4.  These changes are accompanied by enhanced histone H4 lysine5 acetylation and assocn. of Brd4 with genes involved in the profibrotic responses in IPF LFs as demonstrated using chromatin immunopptn. and quant. PCR.  Oral administration of 200 mg/kg per day Brd4 inhibitor JQ1 in a therapeutic dosing regimen substantially attenuated lung fibrosis induced by bleomycin in C57BL/6 mice.  In conclusion, this study shows that the Brd4 inhibitor JQ1, administered in a therapeutic dosage, is capable of inhibiting the profibrotic effects of IPF LFs and attenuates bleomycin-induced lung fibrosis in mice.  These results suggest that Brd4 inhibitors may represent a novel therapy for the treatment of rapidly progressing IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeyA6Tfi6PObVg90H21EOLACvtfcHk0lhljL0neqR6qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFynur7I&md5=8a7b094630ce44df6cd1b2b9de6cc6ec</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2013.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2013.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DPhillips%26aufirst%3DJ.%2BE.%26aulast%3DDeguzman%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DApparsundaram%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DBauer%26aufirst%3DC.%2BM.%26aulast%3DFuentes%26aufirst%3DM.%2BE.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTyagi%26aufirst%3DG.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DHogaboam%26aufirst%3DC.%2BM.%26aulast%3DDenton%26aufirst%3DC.%2BP.%26aulast%3DHolmes%26aufirst%3DA.%2BM.%26aulast%3DKitson%26aufirst%3DC.%26aulast%3DStevenson%26aufirst%3DC.%2BS.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26atitle%3DAssessment%2520of%2520Brd4%2520inhibition%2520in%2520idiopathic%2520pulmonary%2520fibrosis%2520lung%2520fibroblasts%2520and%2520in%2520vivo%2520models%2520of%2520lung%2520fibrosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2013%26volume%3D183%26spage%3D470%26epage%3D479%26doi%3D10.1016%2Fj.ajpath.2013.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apparsundaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguzman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budd, D. C.</span><span> </span><span class="NLM_article-title">BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1124/mol.112.081661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1124%2Fmol.112.081661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23115324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=283-293&author=X.+Tangauthor=R.+Pengauthor=Y.+Renauthor=S.+Apparsundaramauthor=J.+Deguzmanauthor=C.+M.+Bauerauthor=A.+F.+Hoffmanauthor=S.+Hamiltonauthor=Z.+Liangauthor=H.+Zengauthor=M.+E.+Fuentesauthor=J.+A.+Demartinoauthor=C.+Kitsonauthor=C.+S.+Stevensonauthor=D.+C.+Budd&title=BET+bromodomain+proteins+mediate+downstream+signaling+events+following+growth+factor+stimulation+in+human+lung+fibroblasts+and+are+involved+in+bleomycin-induced+pulmonary+fibrosis&doi=10.1124%2Fmol.112.081661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis</span></div><div class="casAuthors">Tang, Xiaoyan; Peng, Ruoqi; Ren, Yonglin; Apparsundaram, Subramanium; Deguzman, Jeremy; Bauer, Carla M.; Hoffman, Ann F.; Hamilton, Shannon; Liang, Zhenmin; Zeng, Hang; Fuentes, Maria E.; DeMartino, Julie A.; Kitson, Christopher; Stevenson, Christopher S.; Budd, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-293</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Epigenetic alterations, such as histone acetylation, regulate the signaling outcomes and phenotypic responses of fibroblasts after growth factor stimulation.  The bromodomain and extra-terminal domain-contg. proteins (Brd) bind to acetylated histone residues, resulting in recruitment of components of the transcriptional machinery and subsequent gene transcription.  Given the central importance of fibroblasts in tissue fibrosis, this study sought to det. the role of Brd proteins in human lung fibroblasts (LFs) after growth factor stimulation and in the murine bleomycin model of lung fibrosis.  Using small interfering RNA against human Brd2 and Brd4 and pharmacol. Brd inhibitors, this study found that Brd2 and Brd4 are essential in mediating the phenotypic responses of LFs downstream of multiple growth factor pathways.  Growth factor stimulation of LFs causes increased histone acetylation, assocn. of Brd4 with growth factor-responsive genes, and enhanced transcription of these genes that could be attenuated with pharmacol. Brd inhibitors.  Of note, lung fibrosis induced after intratracheal bleomycin challenge in mice could be prevented by pretreatment of animals with pharmacol. inhibitors of Brd proteins.  This study is the first demonstration of a role for Brd2 and Brd4 proteins in mediating the responses of LFs after growth factor stimulation and in driving the induction of lung fibrosis in mice in response to bleomycin challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLn5H_z8-iULVg90H21EOLACvtfcHk0lhljL0neqR6qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLc%253D&md5=59f634a394e3a0f09b72e07a1eb0ccda</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.081661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.081661%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DApparsundaram%26aufirst%3DS.%26aulast%3DDeguzman%26aufirst%3DJ.%26aulast%3DBauer%26aufirst%3DC.%2BM.%26aulast%3DHoffman%26aufirst%3DA.%2BF.%26aulast%3DHamilton%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DFuentes%26aufirst%3DM.%2BE.%26aulast%3DDemartino%26aufirst%3DJ.%2BA.%26aulast%3DKitson%26aufirst%3DC.%26aulast%3DStevenson%26aufirst%3DC.%2BS.%26aulast%3DBudd%26aufirst%3DD.%2BC.%26atitle%3DBET%2520bromodomain%2520proteins%2520mediate%2520downstream%2520signaling%2520events%2520following%2520growth%2520factor%2520stimulation%2520in%2520human%2520lung%2520fibroblasts%2520and%2520are%2520involved%2520in%2520bleomycin-induced%2520pulmonary%2520fibrosis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26spage%3D283%26epage%3D293%26doi%3D10.1124%2Fmol.112.081661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafiane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiacchia, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimbou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, J.</span><span> </span><span class="NLM_article-title">RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span><span class="NLM_x">–</span> <span class="NLM_lpage">2589</span><span class="refDoi"> DOI: 10.1016/j.jacc.2010.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.jacc.2010.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20513599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2010&pages=2580-2589&author=D.+Baileyauthor=R.+Jahagirdarauthor=A.+Gordonauthor=A.+Hafianeauthor=S.+Campbellauthor=S.+Chaturauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=F.+S.+Chiacchiaauthor=J.+Johanssonauthor=L.+Krimbouauthor=N.+C.+Wongauthor=J.+Genest&title=RVX-208%3A+a+small+molecule+that+increases+apolipoprotein+A-I+and+high-density+lipoprotein+cholesterol+in+vitro+and+in+vivo&doi=10.1016%2Fj.jacc.2010.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208. A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span></div><div class="casAuthors">Bailey, Dana; Jahagirdar, Ravi; Gordon, Allan; Hafiane, Anouar; Campbell, Steven; Chatur, Safia; Wagner, Gregory S.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; Johansson, Jan; Krimbou, Larbi; Wong, Norman C. W.; Genest, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2580-2589</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to det. whether a novel small mol. RVX-208 affects apolipoprotein (apo)A-I and high-d. lipoprotein cholesterol (HDL-C) levels in vitro and in vivo.  Background: Increased apoA-I and HDL-C levels are potential therapeutic targets for reducing atherosclerotic disease.  Methods: HepG2 cells were treated with 0 to 60 μmol/l RVX-208 followed by assays for apoA-I and HDL-C prodn.  For in vivo studies, African green monkeys (AGMs) received 15 to 60 mg/kg/day RVX-208, and the serum was analyzed for lipoprotein levels, HDL-subparticle distribution, cholesterol efflux, and activity of lipid-modifying enzymes.  A phase I clin. trial was conducted in healthy volunteers (given 1 to 20 mg/kg/day of RVX-208) to assess safety, tolerability, and pharmacokinetics.  Results: The RVX-208 induced apoA-I mRNA and protein synthesis in HepG2 cells, leading to in- creased levels of pre-β-migrating and α-lipoprotein particles contg. apoA-I (LpA-I) in spent media.  Similarly, in AGMs, RVX-208 treatment for 63 days increased serum apoA-I and HDL-C levels (60% and 97%, resp.).  In addn., the levels of pre-β1-LpA-I and α1-LpA-I HDL-subparticles were increased as well as ATP binding cassette AI, ATP binding cassette G1, and scavenger receptor class B type I-dependent cholesterol efflux.  These changes were not mediated by cholesteryl-ester-transfer protein.  Treatment of humans for 1 wk with oral RVX-208 increased apoA-I, pre-β-HDL, and HDL functionality.  Conclusions: RVX-208 increases apoA-I and HDL-C in vitro and in vivo.  In AGMs, RVX-208 raises serum pre-β1-LpA-I and α-LpA-I levels and enhances cholesterol efflux.  Data in humans point to beneficial features of RVX-208 that might be useful for treating atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGExcnx6drLVg90H21EOLACvtfcHk0lj0WA79GXCylA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D&md5=aab9ac26e73704f1cd569e2ff47d0c51</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2010.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2010.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DHafiane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DChatur%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DChiacchia%26aufirst%3DF.%2BS.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DKrimbou%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DGenest%26aufirst%3DJ.%26atitle%3DRVX-208%253A%2520a%2520small%2520molecule%2520that%2520increases%2520apolipoprotein%2520A-I%2520and%2520high-density%2520lipoprotein%2520cholesterol%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2010%26volume%3D55%26spage%3D2580%26epage%3D2589%26doi%3D10.1016%2Fj.jacc.2010.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span> </span><span class="NLM_article-title">A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice</span> <span class="citation_source-journal">Atherosclerosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2014.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.atherosclerosis.2014.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25016363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2014&pages=91-100&author=R.+Jahagirdarauthor=H.+Zhangauthor=S.+Azharauthor=J.+Tobinauthor=S.+Attwellauthor=R.+Yuauthor=J.+Wuauthor=K.+G.+McLureauthor=H.+C.+Hansenauthor=G.+S.+Wagnerauthor=P.+R.+Youngauthor=R.+A.+Srivastavaauthor=N.+C.+Wongauthor=J.+Johansson&title=A+novel+BET+bromodomain+inhibitor%2C+RVX-208%2C+shows+reduction+of+atherosclerosis+in+hyperlipidemic+ApoE+deficient+mice&doi=10.1016%2Fj.atherosclerosis.2014.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice</span></div><div class="casAuthors">Jahagirdar, Ravi; Zhang, Haiyan; Azhar, Salman; Tobin, Jennifer; Attwell, Sarah; Yu, Raymond; Wu, Jin; McLure, Kevin G.; Hansen, Henrik C.; Wagner, Gregory S.; Young, Peter R.; Srivastava, Rai Ajit K.; Wong, Norman C. W.; Johansson, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the benefit of statins in reducing cardiovascular risk, a sizable proportion of patients still remain at risk.  Since HDL reduces CVD risk through a process that involves formation of pre-beta particles that facilitates the removal of cholesterol from the lipid-laden macrophages in the arteries, inducing pre-beta particles, may reduce the risk of CVD.  A novel BET bromodomain antagonist, RVX-208, was reported to raise apoA-I and increase preβ-HDL particles in non-human primates and humans.  In the present study, we investigated the effect of RVX-208 on aortic lesion formation in hyperlipidemic apoE-/- mice.  Oral treatments of apoE-/- mice with 150 mg/kg b.i.d RVX-208 for 12 wk significantly reduced aortic lesion formation, accompanied by 2-fold increases in the levels of circulating HDL-C, and ∼50% decreases in LDL-C, although no significant changes in plasma apoA-I were obsd.  Circulating adhesion mols. as well as cytokines also showed significant redn.  Haptoglobin, a proinflammatory protein, known to bind with HDL/apoA-I, decreased >2.5-fold in the RVX-208 treated group.  With a therapeutic dosing regimen in which mice were fed Western diet for 10 wk to develop lesions followed by switching to a low fat diet and concurrent treatment with RVX-208 for 14 wk, RVX-208 similarly reduced lesion formation by 39% in the whole aorta without significant changes in the plasma lipid parameters.  RVX-208 significantly reduced the proinflammatory cytokines IP-10, MIP1 and MDC.  These results show that the antiatherogenic activity of BET inhibitor, RVX-208, occurs via a combination of lipid changes and anti-inflammatory activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXAgzwwmvsdrVg90H21EOLACvtfcHk0lj0WA79GXCylA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grt77P&md5=135bbfa7ce02b3684be45e9c39f9e092</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2014.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2014.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAzhar%26aufirst%3DS.%26aulast%3DTobin%26aufirst%3DJ.%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DSrivastava%26aufirst%3DR.%2BA.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DJohansson%26aufirst%3DJ.%26atitle%3DA%2520novel%2520BET%2520bromodomain%2520inhibitor%252C%2520RVX-208%252C%2520shows%2520reduction%2520of%2520atherosclerosis%2520in%2520hyperlipidemic%2520ApoE%2520deficient%2520mice%26jtitle%3DAtherosclerosis%26date%3D2014%26volume%3D236%26spage%3D91%26epage%3D100%26doi%3D10.1016%2Fj.atherosclerosis.2014.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Spiltoir, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavasin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demos-Davies, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinsey, T. A.</span><span> </span><span class="NLM_article-title">BET acetyl-lysine binding proteins control pathological cardiac hypertrophy</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2013.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.yjmcc.2013.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23939492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCju7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=175-179&author=J.+I.+Spiltoirauthor=M.+S.+Strattonauthor=M.+A.+Cavasinauthor=K.+Demos-Daviesauthor=B.+G.+Reidauthor=J.+Qiauthor=J.+E.+Bradnerauthor=T.+A.+McKinsey&title=BET+acetyl-lysine+binding+proteins+control+pathological+cardiac+hypertrophy&doi=10.1016%2Fj.yjmcc.2013.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">BET acetyl-lysine binding proteins control pathological cardiac hypertrophy</span></div><div class="casAuthors">Spiltoir, Jessica I.; Stratton, Matthew S.; Cavasin, Maria A.; Demos-Davies, Kim; Reid, Brian G.; Qi, Jun; Bradner, James E.; McKinsey, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175-179</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cardiac hypertrophy is an independent predictor of adverse outcomes in patients with heart failure, and thus represents an attractive target for novel therapeutic intervention.  JQ1, a small mol. inhibitor of bromodomain and extraterminal (BET) acetyl-lysine reader proteins, was identified in a high throughput screen designed to discover novel small mol. regulators of cardiomyocyte hypertrophy.  JQ1 dose-dependently blocked agonist-dependent hypertrophy of cultured neonatal rat ventricular myocytes (NRVMs) and reversed the prototypical gene program assocd. with pathol. cardiac hypertrophy.  JQ1 also blocked left ventricular hypertrophy (LVH) and improved cardiac function in adult mice subjected to transverse aortic constriction (TAC).  The BET family consists of BRD2, BRD3, BRD4 and BRDT.  BRD4 protein expression was increased during cardiac hypertrophy, and hypertrophic stimuli promoted recruitment of BRD4 to the transcriptional start site (TSS) of the gene encoding atrial natriuretic factor (ANF).  Binding of BRD4 to the ANF TSS was assocd. with increased phosphorylation of local RNA polymerase II.  These findings define a novel function for BET proteins as signal-responsive regulators of cardiac hypertrophy, and suggest that small mol. inhibitors of these epigenetic reader proteins have potential as therapeutics for heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDUzCSA2tNtrVg90H21EOLACvtfcHk0lj0WA79GXCylA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCju7%252FF&md5=ffe6d80a94c27e5d89b38baf33af365c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2013.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2013.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DSpiltoir%26aufirst%3DJ.%2BI.%26aulast%3DStratton%26aufirst%3DM.%2BS.%26aulast%3DCavasin%26aufirst%3DM.%2BA.%26aulast%3DDemos-Davies%26aufirst%3DK.%26aulast%3DReid%26aufirst%3DB.%2BG.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMcKinsey%26aufirst%3DT.%2BA.%26atitle%3DBET%2520acetyl-lysine%2520binding%2520proteins%2520control%2520pathological%2520cardiac%2520hypertrophy%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2013%26volume%3D63%26spage%3D175%26epage%3D179%26doi%3D10.1016%2Fj.yjmcc.2013.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Sartor, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brothers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlestedt, C.</span><span> </span><span class="NLM_article-title">Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">15062</span><span class="NLM_x">–</span> <span class="NLM_lpage">15072</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0826-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1523%2FJNEUROSCI.0826-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26558777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1aqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=15062-15072&author=G.+C.+Sartorauthor=S.+K.+Powellauthor=S.+P.+Brothersauthor=C.+Wahlestedt&title=Epigenetic+readers+of+lysine+acetylation+regulate+cocaine-induced+plasticity&doi=10.1523%2FJNEUROSCI.0826-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity</span></div><div class="casAuthors">Sartor, Gregory C.; Powell, Samuel K.; Brothers, Shaun P.; Wahlestedt, Claes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">15062-15072</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Epigenetic processes that regulate histone acetylation play an essential role in behavioral and mol. responses to cocaine.  To date, however, only a small fraction of the mechanisms involved in the addiction-assocd. acetylome have been investigated.  Members of the bromodomain and extraterminal (BET) family of epigenetic "reader" proteins (BRD2, BRD3, BRD4, and BRDT) bind acetylated histones and serve as a scaffold for the recruitment of macromol. complexes to modify chromatin accessibility and transcriptional activity.  The role of BET proteins in cocaine-induced plasticity, however, remains elusive.  Here, we used behavioral, pharmacol., and mol. techniques to examine the involvement of BET bromodomains in cocaine reward.  Of the BET proteins, BRD4, but not BRD2 or BRD3, was significantly elevated in the nucleus accumbens (NAc) of mice and rats following repeated cocaine injections and self-administration.  Systemic and intra-accumbal inhibition of BRD4 with the BET inhibitor, JQ1, attenuated the rewarding effects of cocaine in a conditioned place preference procedure but did not affect conditioned place aversion, nor did JQ1 alone induce conditioned aversion or preference.  Investigating the underlying mechanisms, we found that repeated cocaine injections enhanced the binding of BRD4, but not BRD3, to the promoter region of Bdnf in the NAc, whereas systemic injection of JQ1 attenuated cocaine-induced expression of Bdnf in the NAc.  JQ1 and siRNA-mediated knockdown of BRD4 in vitro also reduced expression of Bdnf.  These findings indicate that disrupting the interaction between BET proteins and their acetylated lysine substrates may provide a new therapeutic avenue for the treatment of drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov84m9moPm7Vg90H21EOLACvtfcHk0limE-isgBkHDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1aqsbs%253D&md5=62570845f668d81a6d90924bc2b7722d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0826-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0826-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DSartor%26aufirst%3DG.%2BC.%26aulast%3DPowell%26aufirst%3DS.%2BK.%26aulast%3DBrothers%26aufirst%3DS.%2BP.%26aulast%3DWahlestedt%26aufirst%3DC.%26atitle%3DEpigenetic%2520readers%2520of%2520lysine%2520acetylation%2520regulate%2520cocaine-induced%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D15062%26epage%3D15072%26doi%3D10.1523%2FJNEUROSCI.0826-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Gacias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerona-Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casaccia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2014.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.chembiol.2014.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24954007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=841-854&author=M.+Gaciasauthor=G.+Gerona-Navarroauthor=A.+N.+Plotnikovauthor=G.+Zhangauthor=L.+Zengauthor=J.+Kaurauthor=G.+Moyauthor=E.+Rusinovaauthor=Y.+Rodriguezauthor=B.+Matikainenauthor=A.+Vincekauthor=J.+Joshuaauthor=P.+Casacciaauthor=M.+M.+Zhou&title=Selective+chemical+modulation+of+gene+transcription+favors+oligodendrocyte+lineage+progression&doi=10.1016%2Fj.chembiol.2014.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression</span></div><div class="casAuthors">Gacias, Mar; Gerona-Navarro, Guillermo; Plotnikov, Alexander N.; Zhang, Guangtao; Zeng, Lei; Kaur, Jasbir; Moy, Gregory; Rusinova, Elena; Rodriguez, Yoel; Matikainen, Bridget; Vincek, Adam; Joshua, Jennifer; Casaccia, Patrizia; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">841-854</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lysine acetylation regulates gene expression through modulating protein-protein interactions in chromatin.  Chem. inhibition of acetyl-lysine binding bromodomains of the major chromatin regulators BET (bromodomain and extraterminal domain) proteins has been shown to effectively block cell proliferation in cancer and inflammation.  However, whether selective inhibition of individual BET bromodomains has distinctive functional consequences remains only partially understood.  In this study, we show that selective chem. inhibition of the first bromodomain of BET proteins using our small-mol. inhibitor, Olinone, accelerated the progression of mouse primary oligodendrocyte progenitors toward differentiation, whereas inhibition of both bromodomains of BET proteins hindered differentiation.  This effect was target specific, as it was not detected in cells treated with inactive analogs and independent of any effect on proliferation.  Therefore, selective chem. modulation of individual bromodomains, rather than use of broad-based inhibitors, may enhance regenerative strategies in disorders characterized by myelin loss such as aging and neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1fCvOR18yE7Vg90H21EOLACvtfcHk0limE-isgBkHDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemtLrK&md5=6b377663a8d0d07441ab4f8a5d8191b3</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DGacias%26aufirst%3DM.%26aulast%3DGerona-Navarro%26aufirst%3DG.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DMoy%26aufirst%3DG.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DRodriguez%26aufirst%3DY.%26aulast%3DMatikainen%26aufirst%3DB.%26aulast%3DVincek%26aufirst%3DA.%26aulast%3DJoshua%26aufirst%3DJ.%26aulast%3DCasaccia%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DSelective%2520chemical%2520modulation%2520of%2520gene%2520transcription%2520favors%2520oligodendrocyte%2520lineage%2520progression%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D841%26epage%3D854%26doi%3D10.1016%2Fj.chembiol.2014.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klase, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashanchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pise-Masison, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J. N.</span><span> </span><span class="NLM_article-title">Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1036</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1128/JVI.01316-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FJVI.01316-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18971272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlCmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=1036-1044&author=M.+Zhouauthor=K.+Huangauthor=K.+J.+Jungauthor=W.+K.+Choauthor=Z.+Klaseauthor=F.+Kashanchiauthor=C.+A.+Pise-Masisonauthor=J.+N.+Brady&title=Bromodomain+protein+Brd4+regulates+human+immunodeficiency+virus+transcription+through+phosphorylation+of+CDK9+at+threonine+29&doi=10.1128%2FJVI.01316-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29</span></div><div class="casAuthors">Zhou, Meisheng; Huang, Keven; Jung, Kyung-Jin; Cho, Won-Kyung; Klase, Zach; Kashanchi, Fatah; Pise-Masison, Cynthia A.; Brady, John N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1036-1044</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pos. transcription elongation factor b (P-TEFb), composed of cyclin-dependent kinase 9 (CDK9) and cyclin T, is a global transcription factor for eukaryotic gene expression, as well as a key factor for human immunodeficiency virus (HIV) transcription elongation.  P-TEFb phosphorylates the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II (RNAP II), facilitating the transition from nonprocessive to processive transcription elongation.  Recently, the bromodomain protein Brd4 has been shown to interact with the low-mol.-wt., active P-TEFb complex and recruit P-TEFb to the HIV type 1 long terminal repeat (LTR) promoter.  However, the subsequent events through which Brd4 regulates CDK9 kinase activity and RNAP II-dependent transcription are not clearly understood.  Here the authors provide evidence that Brd4 regulates P-TEFb kinase activity by inducing a neg. pathway.  Moreover, by analyzing stepwise initiation and elongation complexes, the authors demonstrate that P-TEFb activity is regulated in the transcription complex.  Brd4 induces phosphorylation of CDK9 at threonine 29 (T29) in the HIV transcription initiation complex, inhibiting CDK9 kinase activity.  P-TEFb inhibition is transient, as Brd4 is released from the transcription complex between positions +14 and +36.  Removal of the phosphate group at T29 by an incoming phosphatase released P-TEFb activity, resulting in increased RNAP II CTD phosphorylation and transcription.  Finally, the authors present chromatin immunopptn. studies showing that CDK9 with phosphorylated T29 is assocd. with the HIV promoter region in the integrated and transcriptionally silent HIV genome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjgnBf4fTF37Vg90H21EOLACvtfcHk0limE-isgBkHDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlCmtb4%253D&md5=729579b619a01f2d9b915dfd1b029f4a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1128%2FJVI.01316-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01316-08%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DK.%2BJ.%26aulast%3DCho%26aufirst%3DW.%2BK.%26aulast%3DKlase%26aufirst%3DZ.%26aulast%3DKashanchi%26aufirst%3DF.%26aulast%3DPise-Masison%26aufirst%3DC.%2BA.%26aulast%3DBrady%26aufirst%3DJ.%2BN.%26atitle%3DBromodomain%2520protein%2520Brd4%2520regulates%2520human%2520immunodeficiency%2520virus%2520transcription%2520through%2520phosphorylation%2520of%2520CDK9%2520at%2520threonine%252029%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D1036%26epage%3D1044%26doi%3D10.1128%2FJVI.01316-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frappier, L.</span><span> </span><span class="NLM_article-title">The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">12009</span><span class="NLM_x">–</span> <span class="NLM_lpage">12019</span><span class="refDoi"> DOI: 10.1128/JVI.01680-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FJVI.01680-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=18922874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyms7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=12009-12019&author=A.+Linauthor=S.+Wangauthor=T.+Nguyenauthor=K.+Shireauthor=L.+Frappier&title=The+EBNA1+protein+of+Epstein-Barr+virus+functionally+interacts+with+Brd4&doi=10.1128%2FJVI.01680-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4</span></div><div class="casAuthors">Lin, Ammy; Wang, Shan; Nguyen, Tin; Shire, Kathy; Frappier, Lori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">12009-12019</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The EBNA1 protein of Epstein-Barr virus (EBV) is essential for EBV latent infection in ensuring the replication and stable segregation of the EBV genomes and in activating the transcription of other EBV latency genes.  We have tested the ability of four host proteins (Brd2, Brd4, DEK, and MeCP2) implicated in the segregation of papillomavirus and Kaposi's sarcoma-assocd. herpesvirus to support EBNA1-mediated segregation of EBV-based plasmids in Saccharomyces cerevisiae.  We found that Brd4 enabled EBNA1-mediated segregation while Brd2 and MeCP2 had a general stimulatory effect on plasmid maintenance.  EBNA1 interacted with Brd4 in both yeast and human cells through N-terminal sequences previously shown to mediate transcriptional activation but not segregation.  In keeping with this interaction site, silencing of Brd4 in human cells decreased transcriptional activation by EBNA1 but not the mitotic chromosome attachment of EBNA1 that is required for segregation.  In addn., Brd4 was found to be preferentially localized to the FR enhancer element regulated by EBNA1, over other EBV sequences, in latently EBV-infected cells.  The results indicate that EBNA1 can functionally interact with Brd4 in native and heterologous systems and that this interaction facilitates transcriptional activation by EBNA1 from the FR element.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB-c-UFT5qu7Vg90H21EOLACvtfcHk0ljmsIUJ1--Nbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyms7fP&md5=b56939c63b9ae55c69d5c0b18519ee98</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1128%2FJVI.01680-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01680-08%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DShire%26aufirst%3DK.%26aulast%3DFrappier%26aufirst%3DL.%26atitle%3DThe%2520EBNA1%2520protein%2520of%2520Epstein-Barr%2520virus%2520functionally%2520interacts%2520with%2520Brd4%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26spage%3D12009%26epage%3D12019%26doi%3D10.1128%2FJVI.01680-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Gagnon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senechal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fradet-Turcotte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archambault, J.</span><span> </span><span class="NLM_article-title">Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4127</span><span class="NLM_x">–</span> <span class="NLM_lpage">4139</span><span class="refDoi"> DOI: 10.1128/JVI.02468-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1128%2FJVI.02468-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=19211738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=4127-4139&author=D.+Gagnonauthor=S.+Joubertauthor=H.+Senechalauthor=A.+Fradet-Turcotteauthor=S.+Torreauthor=J.+Archambault&title=Proteasomal+degradation+of+the+papillomavirus+E2+protein+is+inhibited+by+overexpression+of+bromodomain-containing+protein+4&doi=10.1128%2FJVI.02468-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4</span></div><div class="casAuthors">Gagnon, David; Joubert, Simon; Senechal, Helene; Fradet-Turcotte, Amelie; Torre, Sabrina; Archambault, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4127-4139</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The E2 protein of human papillomavirus (HPV) binds to specific sites in the viral genome to regulate its transcription, replication, and maintenance in infected cells.  Like most regulatory proteins, E2 is rapidly turned over.  A high-throughput assay was developed to quantify the expression and stability of E2 in vivo, based on its fusion to Renilla luciferase (RLuc).  The steady-state levels of Rluc-E2 were quantified by measuring the amts. of assocd. luciferase activity, and its degrdn. was measured by monitoring the decrease in enzymic activity occurring after a block of translation with cycloheximide.  Using this assay, the E2 proteins from a low-risk (HPV11) and a high-risk (HPV31) human papillomavirus (HPV) type were found to have short half-lives of 60 min in C33A cervical carcinoma cells and to be ubiquitinated and degraded by the proteasome.  Anal. of mutant proteins showed that the instability of E2 is independent of its DNA-binding and transcriptional activities but is encoded within its transactivation domain, the region that binds to the cellular chromatin factor bromodomain-contg. protein 4 (Brd4) to regulate viral gene transcription.  Overexpression of Brd4, or of its C-terminal E2-interaction domain, was found to increase the steady-state levels and stability of wild-type E2 but not of E2 mutants defective for binding Brd4.  These results indicate that the stability of E2 is increased upon complex formation with Brd4 and highlight the value of the luciferase assay for the study of E2 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZGrEsZsTwYrVg90H21EOLACvtfcHk0ljmsIUJ1--Nbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kqtb4%253D&md5=f3cfe00c7a20c8cb0daf1da94ce9f87c</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1128%2FJVI.02468-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02468-08%26sid%3Dliteratum%253Aachs%26aulast%3DGagnon%26aufirst%3DD.%26aulast%3DJoubert%26aufirst%3DS.%26aulast%3DSenechal%26aufirst%3DH.%26aulast%3DFradet-Turcotte%26aufirst%3DA.%26aulast%3DTorre%26aufirst%3DS.%26aulast%3DArchambault%26aufirst%3DJ.%26atitle%3DProteasomal%2520degradation%2520of%2520the%2520papillomavirus%2520E2%2520protein%2520is%2520inhibited%2520by%2520overexpression%2520of%2520bromodomain-containing%2520protein%25204%26jtitle%3DJ.%2520Virol.%26date%3D2009%26volume%3D83%26spage%3D4127%26epage%3D4139%26doi%3D10.1128%2FJVI.02468-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemper, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. M.</span><span> </span><span class="NLM_article-title">Brd4 links chromatin targeting to HPV transcriptional silencing</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2383</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span><span class="refDoi"> DOI: 10.1101/gad.1448206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1101%2Fgad.1448206" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2383-2396&author=S.+Y.+Wuauthor=A.+Y.+Leeauthor=S.+Y.+Houauthor=J.+K.+Kemperauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=C.+M.+Chiang&title=Brd4+links+chromatin+targeting+to+HPV+transcriptional+silencing&doi=10.1101%2Fgad.1448206"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1101%2Fgad.1448206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1448206%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DA.%2BY.%26aulast%3DHou%26aufirst%3DS.%2BY.%26aulast%3DKemper%26aufirst%3DJ.%2BK.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DChiang%26aufirst%3DC.%2BM.%26atitle%3DBrd4%2520links%2520chromatin%2520targeting%2520to%2520HPV%2520transcriptional%2520silencing%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D2383%26epage%3D2396%26doi%3D10.1101%2Fgad.1448206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">You, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croyle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howley, P. M.</span><span> </span><span class="NLM_article-title">Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/S0092-8674(04)00402-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS0092-8674%2804%2900402-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=349-360&author=J.+Youauthor=J.+L.+Croyleauthor=A.+Nishimuraauthor=K.+Ozatoauthor=P.+M.+Howley&title=Interaction+of+the+bovine+papillomavirus+E2+protein+with+Brd4+tethers+the+viral+DNA+to+host+mitotic+chromosomes&doi=10.1016%2FS0092-8674%2804%2900402-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900402-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900402-7%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DJ.%26aulast%3DCroyle%26aufirst%3DJ.%2BL.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DHowley%26aufirst%3DP.%2BM.%26atitle%3DInteraction%2520of%2520the%2520bovine%2520papillomavirus%2520E2%2520protein%2520with%2520Brd4%2520tethers%2520the%2520viral%2520DNA%2520to%2520host%2520mitotic%2520chromosomes%26jtitle%3DCell%26date%3D2004%26volume%3D117%26spage%3D349%26epage%3D360%26doi%3D10.1016%2FS0092-8674%2804%2900402-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Boehm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span> </span><span class="NLM_article-title">Bromodomain proteins in HIV infection</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span><span class="refDoi"> DOI: 10.3390/v5061571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.3390%2Fv5061571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23793227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKlurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1571-1586&author=D.+Boehmauthor=R.+J.+Conradauthor=M.+Ott&title=Bromodomain+proteins+in+HIV+infection&doi=10.3390%2Fv5061571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomain proteins in HIV infection</span></div><div class="casAuthors">Boehm, Daniela; Conrad, Ryan J.; Ott, Melanie</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1571-1586</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Bromodomains are conserved protein modules of ∼110 amino acids that bind acetylated lysine residues in histone and non-histone proteins.  Bromodomains are present in many chromatin-assocd. transcriptional regulators and have been linked to diverse aspects of the HIV life cycle, including transcription and integration.  Here, we review the role of bromodomain-contg. proteins in HIV infection.  We begin with a focus on acetylated viral factors, followed by a discussion of structural and biol. studies defining the involvement of bromodomain proteins in the HIV life cycle.  We end with an overview of promising new studies of bromodomain inhibitory compds. for the treatment of HIV latency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL1rfpEYvuSbVg90H21EOLACvtfcHk0liMs8ah-xWD6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKlurrE&md5=0bed1b62cf36f41df96918a305658218</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.3390%2Fv5061571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5061571%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DD.%26aulast%3DConrad%26aufirst%3DR.%2BJ.%26aulast%3DOtt%26aufirst%3DM.%26atitle%3DBromodomain%2520proteins%2520in%2520HIV%2520infection%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26spage%3D1571%26epage%3D1586%26doi%3D10.3390%2Fv5061571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Bisgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henklein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">13690</span><span class="NLM_x">–</span> <span class="NLM_lpage">13695</span><span class="refDoi"> DOI: 10.1073/pnas.0705053104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.0705053104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17690245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVOjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=13690-13695&author=D.+A.+Bisgroveauthor=T.+Mahmoudiauthor=P.+Henkleinauthor=E.+Verdin&title=Conserved+P-TEFb-interacting+domain+of+BRD4+inhibits+HIV+transcription&doi=10.1073%2Fpnas.0705053104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription</span></div><div class="casAuthors">Bisgrove, Dwayne A.; Mahmoudi, Tokameh; Henklein, Peter; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">13690-13695</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have identified a conserved region in the C-terminal domain of bromodomain-contg. protein 4 (BRD4) that mediates its specific interaction with pos. transcription elongation factor b (P-TEFb).  This domain is highly conserved in testis-specific bromodomain protein (BRDT) and Drosophila fs(1)h.  Both BRDT and fs(1)h specifically interact with P-TEFb in mammalian cells, and this interaction depends on their C-terminal domains.  Overexpression of the BRD4 P-TEFb-interacting domain disrupts the interaction between the HIV transactivator Tat and P-TEFb and suppresses the ability of Tat to transactivate the HIV promoter.  Incubation of cells with a synthetic peptide contg. the C-terminal domain of BRD4 interferes with transactivation of the HIV promoter by the Tat protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7C_2ZREaOELVg90H21EOLACvtfcHk0liMs8ah-xWD6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVOjsLc%253D&md5=6091d31044bc49d054c0c4b89f690384</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705053104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705053104%26sid%3Dliteratum%253Aachs%26aulast%3DBisgrove%26aufirst%3DD.%2BA.%26aulast%3DMahmoudi%26aufirst%3DT.%26aulast%3DHenklein%26aufirst%3DP.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DConserved%2520P-TEFb-interacting%2520domain%2520of%2520BRD4%2520inhibits%2520HIV%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D13690%26epage%3D13695%26doi%3D10.1073%2Fpnas.0705053104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiha, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, A. L.</span><span> </span><span class="NLM_article-title">Reactivation of latent HIV-1 by inhibition of BRD4</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.celrep.2012.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23041316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCls73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=807-816&author=J.+Zhuauthor=G.+D.+Gaihaauthor=S.+P.+Johnauthor=T.+Pertelauthor=C.+R.+Chinauthor=G.+Gaoauthor=H.+Quauthor=B.+D.+Walkerauthor=S.+J.+Elledgeauthor=A.+L.+Brass&title=Reactivation+of+latent+HIV-1+by+inhibition+of+BRD4&doi=10.1016%2Fj.celrep.2012.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of latent HIV-1 by inhibition of BRD4</span></div><div class="casAuthors">Zhu, Jian; Gaiha, Gaurav D.; John, Sinu P.; Pertel, Thomas; Chin, Christopher R.; Gao, Geng; Qu, Hongjing; Walker, Bruce D.; Elledge, Stephen J.; Brass, Abraham L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-816</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HIV-1 depends on many host factors for propagation.  Other host factors, however, antagonize HIV-1 and may have profound effects on viral activation.  Curing HIV-1 requires the redn. of latent viral reservoirs that remain in the face of antiretroviral therapy.  Using orthologous genetic screens, we identified bromodomain contg. 4 (BRD4) as a neg. regulator of HIV-1 replication.  Antagonism of BRD4, via RNA interference or with a small mol. inhibitor, JQ1, both increased proviral transcriptional elongation and alleviated HIV-1 latency in cell-line models.  In multiple instances, JQ1, when used in combination with the NF-κB activators Prostratin or PHA, enhanced the in vitro reactivation of latent HIV-1 in primary T cells.  These data are consistent with a model wherein BRD4 competes with the virus for HIV-1 dependency factors (HDFs) and suggests that combinatorial therapies that activate HDFs and antagonize HIV-1 competitive factors may be useful for curing HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosSPB0bZraJbVg90H21EOLACvtfcHk0lhNkionOrTriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCls73E&md5=210b459b66ccf10a84c57ef10b03b684</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DGaiha%26aufirst%3DG.%2BD.%26aulast%3DJohn%26aufirst%3DS.%2BP.%26aulast%3DPertel%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DC.%2BR.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DBrass%26aufirst%3DA.%2BL.%26atitle%3DReactivation%2520of%2520latent%2520HIV-1%2520by%2520inhibition%2520of%2520BRD4%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D807%26epage%3D816%26doi%3D10.1016%2Fj.celrep.2012.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">24100</span><span class="refDoi"> DOI: 10.1038/srep24100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fsrep24100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27067814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFalur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=24100&author=P.+Luauthor=X.+Quauthor=Y.+Shenauthor=Z.+Jiangauthor=P.+Wangauthor=H.+Zengauthor=H.+Jiauthor=J.+Dengauthor=X.+Yangauthor=X.+Liauthor=H.+Luauthor=H.+Zhu&title=The+BET+inhibitor+OTX015+reactivates+latent+HIV-1+through+P-TEFb&doi=10.1038%2Fsrep24100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb</span></div><div class="casAuthors">Lu, Panpan; Qu, Xiying; Shen, Yinzhong; Jiang, Zhengtao; Wang, Pengfei; Zeng, Hanxian; Ji, Haiyan; Deng, Junxiao; Yang, Xinyi; Li, Xian; Lu, Hongzhou; Zhu, Huanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24100</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">None of the currently used anti-HIV-1 agents can effectively eliminate latent HIV-1 reservoirs, which is a major hurdle to a complete cure for AIDS.  We report here that a novel oral BET inhibitor OTX015, a thienotriazolodiazepine compd. that has entered phase Ib clin. development for advanced hematol. malignancies, can effectively reactivate HIV-1 in different latency models with an EC50 value 1.95-4.34 times lower than JQ1, a known BET inhibitor that can reactivate HIV-1 latency.  We also found that OTX015 was more potent when used in combination with prostratin.  More importantly, OTX015 treatment induced HIV-1 full-length transcripts and viral outgrowth in resting CD4+ T cells from infected individuals receiving suppressive antiretroviral therapy (ART), while exerting minimal toxicity and effects on T cell activation.  Finally, biochem. anal. showed that OTX015-mediated activation of HIV-1 involved an increase in CDK9 occupancy and RNAP II C-terminal domain (CTD) phosphorylation.  Our results suggest that the BET inhibitor OTX015 may be a candidate for anti-HIV-1-latency therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpous2yyU9wxLVg90H21EOLACvtfcHk0lhNkionOrTriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFalur8%253D&md5=fcd78a52d439c8d151c54a4955a69c52</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fsrep24100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep24100%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DThe%2520BET%2520inhibitor%2520OTX015%2520reactivates%2520latent%2520HIV-1%2520through%2520P-TEFb%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D24100%26doi%3D10.1038%2Fsrep24100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Banerjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaels, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belkina, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastiani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montano, M.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a novel strategy for reactivation of HIV-1</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1189/jlb.0312165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1189%2Fjlb.0312165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22802445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCmu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2012&pages=1147-1154&author=C.+Banerjeeauthor=N.+Archinauthor=D.+Michaelsauthor=A.+C.+Belkinaauthor=G.+V.+Denisauthor=J.+Bradnerauthor=P.+Sebastianiauthor=D.+M.+Margolisauthor=M.+Montano&title=BET+bromodomain+inhibition+as+a+novel+strategy+for+reactivation+of+HIV-1&doi=10.1189%2Fjlb.0312165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibition as a novel strategy for reactivation of HIV-1</span></div><div class="casAuthors">Banerjee, Camellia; Archin, Nancie; Michaels, Daniel; Belkina, Anna C.; Denis, Gerald V.; Bradner, James; Sebastiani, Paola; Margolis, David M.; Montano, Monty</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1147-1154</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">The persistence of latent HIV-1 remains a major challenge in therapeutic efforts to eradicate infection.  We report the capacity for HIV reactivation by a selective small mol. inhibitor of BET family bromodomains, JQ1, a promising therapeutic agent with antioncogenic properties.  JQ1 reactivated HIV transcription in models of latent T cell infection and latent monocyte infection.  We also tested the effect of exposure to JQ1 to allow recovery of replication-competent HIV from pools of resting CD4+ T cells isolated from HIV-infected, ART-treated patients.  In one of three patients, JQ1 allowed recovery of virus at a frequency above unstimulated conditions.  JQ1 potently suppressed T cell proliferation with minimal cytotoxic effect.  Transcriptional profiling of T cells with JQ1 showed potent down-regulation of T cell activation genes, including CD3, CD28, and CXCR4, similar to HDAC inhibitors, but JQ1 also showed potent up-regulation of chromatin modification genes, including SIRT1, HDAC6, and multiple lysine demethylases (KDMs).  Thus, JQ1 reactivates HIV-1 while suppressing T cell activation genes and up-regulating histone modification genes predicted to favor increased Tat activity.  Thus, JQ1 may be useful in studies of potentially novel mechanisms for transcriptional control as well as in translational efforts to identify therapeutic mols. to achieve viral eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Fl0Y8EEG1LVg90H21EOLACvtfcHk0lhNkionOrTriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCmu73P&md5=3de91afdb94e5d65c7fc9089d8e16a47</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1189%2Fjlb.0312165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.0312165%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DC.%26aulast%3DArchin%26aufirst%3DN.%26aulast%3DMichaels%26aufirst%3DD.%26aulast%3DBelkina%26aufirst%3DA.%2BC.%26aulast%3DDenis%26aufirst%3DG.%2BV.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DSebastiani%26aufirst%3DP.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26aulast%3DMontano%26aufirst%3DM.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520novel%2520strategy%2520for%2520reactivation%2520of%2520HIV-1%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2012%26volume%3D92%26spage%3D1147%26epage%3D1154%26doi%3D10.1189%2Fjlb.0312165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Boehm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvanese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planelles, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span> </span><span class="NLM_article-title">BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span><span class="refDoi"> DOI: 10.4161/cc.23309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.4161%2Fcc.23309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=452-462&author=D.+Boehmauthor=V.+Calvaneseauthor=R.+D.+Darauthor=S.+Xingauthor=S.+Schroederauthor=L.+Martinsauthor=K.+Aullauthor=P.+C.+Liauthor=V.+Planellesauthor=J.+E.+Bradnerauthor=M.+M.+Zhouauthor=R.+F.+Silicianoauthor=L.+Weinbergerauthor=E.+Verdinauthor=M.+Ott&title=BET+bromodomain-targeting+compounds+reactivate+HIV+from+latency+via+a+Tat-independent+mechanism&doi=10.4161%2Fcc.23309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.4161%2Fcc.23309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.23309%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DD.%26aulast%3DCalvanese%26aufirst%3DV.%26aulast%3DDar%26aufirst%3DR.%2BD.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DMartins%26aufirst%3DL.%26aulast%3DAull%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DP.%2BC.%26aulast%3DPlanelles%26aufirst%3DV.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26aulast%3DWeinberger%26aufirst%3DL.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DOtt%26aufirst%3DM.%26atitle%3DBET%2520bromodomain-targeting%2520compounds%2520reactivate%2520HIV%2520from%2520latency%2520via%2520a%2520Tat-independent%2520mechanism%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26spage%3D452%26epage%3D462%26doi%3D10.4161%2Fcc.23309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span> </span><span class="NLM_article-title">The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1093/nar/gks976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1093%2Fnar%2Fgks976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=23087374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=277-287&author=Z.+Liauthor=J.+Guoauthor=Y.+Wuauthor=Q.+Zhou&title=The+BET+bromodomain+inhibitor+JQ1+activates+HIV+latency+through+antagonizing+Brd4+inhibition+of+Tat-transactivation&doi=10.1093%2Fnar%2Fgks976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation</span></div><div class="casAuthors">Li, Zichong; Guo, Jia; Wu, Yuntao; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-287</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Latent HIV reservoirs are the primary hurdle to eradication of infection.  Identification of agents, pathways and mol. mechanisms that activate latent provirus may, in the presence of highly active antiretroviral therapy, permit clearance of infected cells by the immune system.  Promoter-proximal pausing of RNA polymerase (Pol) II is a major rate-limiting step in HIV gene expression.  The viral Tat protein recruits human Super Elongation Complex (SEC) to paused Pol II to overcome this limitation.  Here, we identify the bromodomain protein Brd4 and its inhibition of Tat-transactivation as a major impediment to latency reactivation.  Brd4 competitively blocks the Tat-SEC interaction on HIV promoter.  The BET bromodomain inhibitor JQ1 dissocs. Brd4 from the HIV promoter to allow Tat recruitment of SEC to stimulate HIV elongation.  JQ1 synergizes with another latency activator prostratin, which promotes Pol II loading onto the viral promoter.  Because JQ1 activates viral latency without inducing global T cell activation, this and other closely related compds. and their antagonization of Brd4 to promote Tat-SEC interaction merit further investigations as effective agents/strategies for eliminating latent HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod_cOKnnk8oLVg90H21EOLACvtfcHk0lgGzXF1wa2YqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFertQ%253D%253D&md5=87866d81d13af3d5051844ed6c17c98d</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgks976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgks976%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DThe%2520BET%2520bromodomain%2520inhibitor%2520JQ1%2520activates%2520HIV%2520latency%2520through%2520antagonizing%2520Brd4%2520inhibition%2520of%2520Tat-transactivation%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2013%26volume%3D41%26spage%3D277%26epage%3D287%26doi%3D10.1093%2Fnar%2Fgks976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liberty, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashuba, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruc, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strain, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudgens, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1038/nature11286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature11286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22837004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=482-485&author=N.+M.+Archinauthor=A.+L.+Libertyauthor=A.+D.+Kashubaauthor=S.+K.+Choudharyauthor=J.+D.+Kurucauthor=A.+M.+Crooksauthor=D.+C.+Parkerauthor=E.+M.+Andersonauthor=M.+F.+Kearneyauthor=M.+C.+Strainauthor=D.+D.+Richmanauthor=M.+G.+Hudgensauthor=R.+J.+Boschauthor=J.+M.+Coffinauthor=J.+J.+Eronauthor=D.+J.+Hazudaauthor=D.+M.+Margolis&title=Administration+of+vorinostat+disrupts+HIV-1+latency+in+patients+on+antiretroviral+therapy&doi=10.1038%2Fnature11286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span></div><div class="casAuthors">Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7408</span>),
    <span class="NLM_cas:pages">482-485</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection.  Inducing the expression of latent genomes within resting CD4+ T cells is the primary strategy to clear this reservoir.  Although histone deacetylase inhibitors such as suberoylanilide hydroxamic acid (also known as vorinostat, VOR) can disrupt HIV-1 latency in vitro, the utility of this approach has never been directly proven in a translational clin. study of HIV-infected patients.  Here we isolated the circulating resting CD4+ T cells of patients in whom viremia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir.  In each of eight patients, a single dose of VOR increased both biomarkers of cellular acetylation, and simultaneously induced an increase in HIV RNA expression in resting CD4+ cells (mean increase, 4.8-fold).  This demonstrates that a mol. mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK97t6JvwKNrVg90H21EOLACvtfcHk0lgGzXF1wa2YqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP&md5=bfe1b9c441d7eeda40d46897a9801311</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnature11286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11286%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DLiberty%26aufirst%3DA.%2BL.%26aulast%3DKashuba%26aufirst%3DA.%2BD.%26aulast%3DChoudhary%26aufirst%3DS.%2BK.%26aulast%3DKuruc%26aufirst%3DJ.%2BD.%26aulast%3DCrooks%26aufirst%3DA.%2BM.%26aulast%3DParker%26aufirst%3DD.%2BC.%26aulast%3DAnderson%26aufirst%3DE.%2BM.%26aulast%3DKearney%26aufirst%3DM.%2BF.%26aulast%3DStrain%26aufirst%3DM.%2BC.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DHudgens%26aufirst%3DM.%2BG.%26aulast%3DBosch%26aufirst%3DR.%2BJ.%26aulast%3DCoffin%26aufirst%3DJ.%2BM.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DAdministration%2520of%2520vorinostat%2520disrupts%2520HIV-1%2520latency%2520in%2520patients%2520on%2520antiretroviral%2520therapy%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D482%26epage%3D485%26doi%3D10.1038%2Fnature11286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Miyoshi, S.; Ooike, S.; Iwata, K.; Hikawa, H.; Sugahara, K.</span><span> </span><span class="NLM_article-title">Antitumor agents</span>. WO2009084693,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Miyoshi&author=S.+Ooike&author=K.+Iwata&author=H.+Hikawa&author=K.+Sugahara&title=Antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DS.%26atitle%3DAntitumor%2520agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Nasveschuk, C. G.; Audia, J. E.; Leblanc, Y.; Hewitt, M. C.; Côté, A.; Vaswani, R. G.; Albrecht, B. K.; Taylor, A. M.; Harmange, J. C.; Gehling, V. S.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors and uses thereof</span>. US08796261,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+G.+Nasveschuk&author=J.+E.+Audia&author=Y.+Leblanc&author=M.+C.+Hewitt&author=A.+C%C3%B4t%C3%A9&author=R.+G.+Vaswani&author=B.+K.+Albrecht&author=A.+M.+Taylor&author=J.+C.+Harmange&author=V.+S.+Gehling&title=Bromodomain+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26atitle%3DBromodomain%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Jang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, Y. H.</span><span> </span><span class="NLM_article-title">AMPK-ULK1-mediated autophagy confers resistance to BET inhibitor JQ1 in acute myeloid leukemia stem cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1078-0432.CCR-16-1903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1-39&author=J.+E.+Jangauthor=J.+I.+Eomauthor=H.+K.+Jeungauthor=J.+W.+Cheongauthor=J.+Y.+Leeauthor=J.+S.+Kimauthor=Y.+H.+Min&title=AMPK-ULK1-mediated+autophagy+confers+resistance+to+BET+inhibitor+JQ1+in+acute+myeloid+leukemia+stem+cells&doi=10.1158%2F1078-0432.CCR-16-1903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1903%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DJ.%2BE.%26aulast%3DEom%26aufirst%3DJ.%2BI.%26aulast%3DJeung%26aufirst%3DH.%2BK.%26aulast%3DCheong%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DMin%26aufirst%3DY.%2BH.%26atitle%3DAMPK-ULK1-mediated%2520autophagy%2520confers%2520resistance%2520to%2520BET%2520inhibitor%2520JQ1%2520in%2520acute%2520myeloid%2520leukemia%2520stem%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26spage%3D1%26epage%3D39%26doi%3D10.1158%2F1078-0432.CCR-16-1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Yokoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossenkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palozola, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showe, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaret, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speicher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conejo-Garcia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordog, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitler, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span> </span><span class="NLM_article-title">BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">6320</span><span class="NLM_x">–</span> <span class="NLM_lpage">6330</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F0008-5472.CAN-16-0854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=6320-6330&author=Y.+Yokoyamaauthor=H.+Zhuauthor=J.+H.+Leeauthor=A.+V.+Kossenkovauthor=S.+Y.+Wuauthor=J.+M.+Wickramasingheauthor=X.+Yinauthor=K.+C.+Palozolaauthor=A.+Gardiniauthor=L.+C.+Showeauthor=K.+S.+Zaretauthor=Q.+Liuauthor=D.+Speicherauthor=J.+R.+Conejo-Garciaauthor=J.+E.+Bradnerauthor=Z.+Zhangauthor=A.+K.+Soodauthor=T.+Ordogauthor=B.+G.+Bitlerauthor=R.+Zhang&title=BET+inhibitors+suppress+ALDH+activity+by+targeting+ALDH1A1+super-enhancer+in+ovarian+cancer&doi=10.1158%2F0008-5472.CAN-16-0854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0854%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DKossenkov%26aufirst%3DA.%2BV.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DWickramasinghe%26aufirst%3DJ.%2BM.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DPalozola%26aufirst%3DK.%2BC.%26aulast%3DGardini%26aufirst%3DA.%26aulast%3DShowe%26aufirst%3DL.%2BC.%26aulast%3DZaret%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSpeicher%26aufirst%3DD.%26aulast%3DConejo-Garcia%26aufirst%3DJ.%2BR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DOrdog%26aufirst%3DT.%26aulast%3DBitler%26aufirst%3DB.%2BG.%26aulast%3DZhang%26aufirst%3DR.%26atitle%3DBET%2520inhibitors%2520suppress%2520ALDH%2520activity%2520by%2520targeting%2520ALDH1A1%2520super-enhancer%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D6320%26epage%3D6330%26doi%3D10.1158%2F0008-5472.CAN-16-0854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">da Motta, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purshouse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bastiani, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baban, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigfield, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klamt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, A.</span><span> </span><span class="NLM_article-title">The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="refDoi"> DOI: 10.1038/onc.2016.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fonc.2016.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27292261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1ejtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=122&author=L.+L.+da+Mottaauthor=I.+Ledakiauthor=K.+Purshouseauthor=S.+Haiderauthor=M.+A.+De+Bastianiauthor=D.+Babanauthor=M.+Morottiauthor=G.+Steersauthor=S.+Wigfieldauthor=E.+Bridgesauthor=J.+L.+Liauthor=S.+Knappauthor=D.+Ebnerauthor=F.+Klamtauthor=A.+L.+Harrisauthor=A.+McIntyre&title=The+BET+inhibitor+JQ1+selectively+impairs+tumour+response+to+hypoxia+and+downregulates+CA9+and+angiogenesis+in+triple+negative+breast+cancer&doi=10.1038%2Fonc.2016.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer</span></div><div class="casAuthors">da Motta, L. L.; Ledaki, I.; Purshouse, K.; Haider, S.; De Bastiani, M. A.; Baban, D.; Morotti, M.; Steers, G.; Wigfield, S.; Bridges, E.; Li, J.-L.; Knapp, S.; Ebner, D.; Klamt, F.; Harris, A. L.; McIntyre, A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-132</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The availability of bromodomain and extra-terminal inhibitors (BETi) has enabled translational epigenetic studies in cancer.  BET proteins regulate transcription by selectively recognizing acetylated lysine residues on chromatin.  BETi compete with this process leading to both downregulation and upregulation of gene expression.  Hypoxia enables progression of triple neg. breast cancer (TNBC), the most aggressive form of breast cancer, partly by driving metabolic adaptation, angiogenesis and metastasis through upregulation of hypoxia-regulated genes (for example, carbonic anhydrase 9 (CA9) and vascular endothelial growth factor A (VEGF-A).  Responses to hypoxia can be mediated epigenetically, thus we investigated whether BETi JQ1 could impair the TNBC response induced by hypoxia and exert anti-tumor effects.  JQ1 significantly modulated 44% of hypoxia-induced genes, of which two-thirds were downregulated including CA9 and VEGF-A.  JQ1 prevented HIF binding to the hypoxia response element in CA9 promoter, but did not alter HIF expression or activity, suggesting some HIF targets are BET-dependent.  JQ1 reduced TNBC growth in vitro and in vivo and inhibited xenograft vascularization.  These findings identify that BETi dually targets angiogenesis and the hypoxic response, an effective combination at reducing tumor growth in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79-F0o2tp6bVg90H21EOLACvtfcHk0ljA5VAPDjNavw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1ejtr4%253D&md5=9f1592548db8e6306703bdab7e1e1c90</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.184%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BMotta%26aufirst%3DL.%2BL.%26aulast%3DLedaki%26aufirst%3DI.%26aulast%3DPurshouse%26aufirst%3DK.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DDe%2BBastiani%26aufirst%3DM.%2BA.%26aulast%3DBaban%26aufirst%3DD.%26aulast%3DMorotti%26aufirst%3DM.%26aulast%3DSteers%26aufirst%3DG.%26aulast%3DWigfield%26aufirst%3DS.%26aulast%3DBridges%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DJ.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DEbner%26aufirst%3DD.%26aulast%3DKlamt%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DMcIntyre%26aufirst%3DA.%26atitle%3DThe%2520BET%2520inhibitor%2520JQ1%2520selectively%2520impairs%2520tumour%2520response%2520to%2520hypoxia%2520and%2520downregulates%2520CA9%2520and%2520angiogenesis%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D122%26doi%3D10.1038%2Fonc.2016.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Krugmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coadwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguinoa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipp, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manifava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktistakis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Painter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuring, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michell, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grewal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazarian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span> </span><span class="NLM_article-title">Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span><span class="refDoi"> DOI: 10.1016/S1097-2765(02)00434-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS1097-2765%2802%2900434-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=95-108&author=S.+Krugmannauthor=K.+E.+Andersonauthor=S.+H.+Ridleyauthor=N.+Rissoauthor=A.+McGregorauthor=J.+Coadwellauthor=K.+Davidsonauthor=A.+Eguinoaauthor=C.+D.+Ellsonauthor=P.+Lippauthor=M.+Manifavaauthor=N.+Ktistakisauthor=G.+Painterauthor=J.+W.+Thuringauthor=M.+A.+Cooperauthor=Z.+Y.+Limauthor=A.+B.+Holmesauthor=S.+K.+Doveauthor=R.+H.+Michellauthor=A.+Grewalauthor=A.+Nazarianauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=L.+R.+Stephensauthor=P.+T.+Hawkins&title=Identification+of+ARAP3%2C+a+novel+PI3K+effector+regulating+both+Arf+and+Rho+GTPases%2C+by+selective+capture+on+phosphoinositide+affinity+matrices&doi=10.1016%2FS1097-2765%2802%2900434-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2802%2900434-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252802%252900434-3%26sid%3Dliteratum%253Aachs%26aulast%3DKrugmann%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DRidley%26aufirst%3DS.%2BH.%26aulast%3DRisso%26aufirst%3DN.%26aulast%3DMcGregor%26aufirst%3DA.%26aulast%3DCoadwell%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DEguinoa%26aufirst%3DA.%26aulast%3DEllson%26aufirst%3DC.%2BD.%26aulast%3DLipp%26aufirst%3DP.%26aulast%3DManifava%26aufirst%3DM.%26aulast%3DKtistakis%26aufirst%3DN.%26aulast%3DPainter%26aufirst%3DG.%26aulast%3DThuring%26aufirst%3DJ.%2BW.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26aulast%3DLim%26aufirst%3DZ.%2BY.%26aulast%3DHolmes%26aufirst%3DA.%2BB.%26aulast%3DDove%26aufirst%3DS.%2BK.%26aulast%3DMichell%26aufirst%3DR.%2BH.%26aulast%3DGrewal%26aufirst%3DA.%26aulast%3DNazarian%26aufirst%3DA.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DIdentification%2520of%2520ARAP3%252C%2520a%2520novel%2520PI3K%2520effector%2520regulating%2520both%2520Arf%2520and%2520Rho%2520GTPases%252C%2520by%2520selective%2520capture%2520on%2520phosphoinositide%2520affinity%2520matrices%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D9%26spage%3D95%26epage%3D108%26doi%3D10.1016%2FS1097-2765%2802%2900434-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grove, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Painter, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuring, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catimel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ktistakis, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. B.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of phosphatidylinositol phosphate affinity probes</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1039/B913399B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1039%2FB913399B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20024134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFekurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=66-76&author=S.+J.+Conwayauthor=J.+Gardinerauthor=S.+J.+Groveauthor=M.+K.+Johnsauthor=Z.+Y.+Limauthor=G.+F.+Painterauthor=D.+E.+Robinsonauthor=C.+Schieberauthor=J.+W.+Thuringauthor=L.+S.+Wongauthor=M.+X.+Yinauthor=A.+W.+Burgessauthor=B.+Catimelauthor=P.+T.+Hawkinsauthor=N.+T.+Ktistakisauthor=L.+R.+Stephensauthor=A.+B.+Holmes&title=Synthesis+and+biological+evaluation+of+phosphatidylinositol+phosphate+affinity+probes&doi=10.1039%2FB913399B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of phosphatidylinositol phosphate affinity probes</span></div><div class="casAuthors">Conway, Stuart J.; Gardiner, James; Grove, Simon J. A.; Johns, Melloney K.; Lim, Ze-Yi; Painter, Gavin F.; Robinson, Diane E. J. E.; Schieber, Christine; Thuring, Jan W.; Wong, Leon S.-M.; Yin, Meng-Xin; Burgess, Antony W.; Catimel, Bruno; Hawkins, Phillip T.; Ktistakis, Nicholas T.; Stephens, Leonard R.; Holmes, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-76</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of the complete family of phosphatidylinositol phosphate analogs (PIPs) from five key core intermediates is described.  These core compds. were obtained from myo-inositol orthoformate via regioselective DIBAL-H and trimethylaluminium-mediated cleavages and a resoln.-protection process using camphor acetals.  Coupling of cores with phosphoramidites which were derived from the requisite protected lipid side chains afforded the fully-protected PIPs.  Removal of the remaining protecting groups was achieved via hydrogenolysis using palladium black or palladium hydroxide on carbon in the presence of sodium bicarbonate to afford the complete family of dipalmitoyl- and amino-PIP analogs.  Investigations using affinity probes incorporating these compds. have identified novel proteins involved in the PI3K intracellular signaling network and have allowed a comprehensive proteomic anal. of phosphoinositide interacting proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcudQ48YzGrVg90H21EOLACvtfcHk0lik6FNcHmhShw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFekurnI&md5=2a9eed72d2b26e568ed3326744fc3fd0</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2FB913399B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB913399B%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DGardiner%26aufirst%3DJ.%26aulast%3DGrove%26aufirst%3DS.%2BJ.%26aulast%3DJohns%26aufirst%3DM.%2BK.%26aulast%3DLim%26aufirst%3DZ.%2BY.%26aulast%3DPainter%26aufirst%3DG.%2BF.%26aulast%3DRobinson%26aufirst%3DD.%2BE.%26aulast%3DSchieber%26aufirst%3DC.%26aulast%3DThuring%26aufirst%3DJ.%2BW.%26aulast%3DWong%26aufirst%3DL.%2BS.%26aulast%3DYin%26aufirst%3DM.%2BX.%26aulast%3DBurgess%26aufirst%3DA.%2BW.%26aulast%3DCatimel%26aufirst%3DB.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DKtistakis%26aufirst%3DN.%2BT.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHolmes%26aufirst%3DA.%2BB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520phosphatidylinositol%2520phosphate%2520affinity%2520probes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D66%26epage%3D76%26doi%3D10.1039%2FB913399B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">The making of I-BET762, a BET bromodomain inhibitor now in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7498</span><span class="NLM_x">–</span> <span class="NLM_lpage">7500</span><span class="refDoi"> DOI: 10.1021/jm4014407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7498-7500&author=Y.+Zhaoauthor=C.+Y.+Yangauthor=S.+Wang&title=The+making+of+I-BET762%2C+a+BET+bromodomain+inhibitor+now+in+clinical+development&doi=10.1021%2Fjm4014407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The Making of I-BET762, a BET Bromodomain Inhibitor Now in Clinical Development</span></div><div class="casAuthors">Zhao, Yujun; Yang, Chao-Yie; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7498-7500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain and extra-terminal (BET) proteins belong to a class of proteins collectively called epigenetic "readers".  BET bromodomains have emerged as promising drug targets for treatment of cancers, inflammatory diseases, and other medical conditions.  GlaxoSmithKline scientists have successfully optimized a class of benzodiazepines as inhibitors of BET bromodomains, without any prior knowledge of identified mol. targets.  It thus is possible to hit a target without aiming at it.  The optimized lead compd. I-BET762 is currently being evaluated in a phase I clin. trial for treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN-T-2VhynyrVg90H21EOLACvtfcHk0lik6FNcHmhShw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFSmsrbF&md5=61aa569c1b1b129b54229b9f8401f46b</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm4014407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014407%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520making%2520of%2520I-BET762%252C%2520a%2520BET%2520bromodomain%2520inhibitor%2520now%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7498%26epage%3D7500%26doi%3D10.1021%2Fjm4014407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellapantula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bangalore Srinivasamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birudukota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, design, and optimization of isoxazole azepine BET inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1021/ml4001485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4001485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFanu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=835-840&author=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=Y.+Leblancauthor=A.+Coteauthor=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.+C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=R.+Sankaranarayananauthor=S.+Yellapantulaauthor=N.+Bangalore+Srinivasamurthyauthor=S.+Birudukotaauthor=B.+K.+Albrecht&title=Discovery%2C+design%2C+and+optimization+of+isoxazole+azepine+BET+inhibitors&doi=10.1021%2Fml4001485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors</span></div><div class="casAuthors">Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Leblanc, Yves; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaram, Hariharan; Sankaranarayanan, Ravichandran; Yellapantula, Sreegouri; Bangalore Srinivasamurthy, Nandana; Birudukota, Swarnakumari; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">835-840</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of a novel series of small mol. BET inhibitors is described.  Using crystallog. binding modes of an amino-isoxazole fragment and known BET inhibitors, a structure-based drug design effort lead to a novel isoxazole azepine scaffold, e.g. I.  This scaffold showed good potency in biochem. and cellular assays and oral activity in an in vivo model of BET inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCIGHOq7LlgrVg90H21EOLACvtfcHk0liq0QsxIW6XAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFanu7jI&md5=7a3ab8ec50ba88e865c5a6524cf02c48</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fml4001485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001485%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSankaranarayanan%26aufirst%3DR.%26aulast%3DYellapantula%26aufirst%3DS.%26aulast%3DBangalore%2BSrinivasamurthy%26aufirst%3DN.%26aulast%3DBirudukota%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%252C%2520and%2520optimization%2520of%2520isoxazole%2520azepine%2520BET%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D835%26epage%3D840%26doi%3D10.1021%2Fml4001485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Identification of a benzoisoxazoloazepine inhibitor (CPI-0610) of the bromodomain and extra-terminal (BET) Family as a candidate for human clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1330-1339&author=B.+K.+Albrechtauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=A.+Coteauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=S.+Bellonauthor=L.+Bergeronauthor=R.+Campbellauthor=N.+Cantoneauthor=M.+R.+Cooperauthor=R.+T.+Cummingsauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Normantauthor=M.+O%E2%80%99Mearaauthor=E.+Pardoauthor=F.+Poyauthor=P.+Sandyauthor=J.+Supkoauthor=R.+J.+Simsauthor=J.+C.+Harmangeauthor=A.+M.+Taylorauthor=J.+E.+Audia&title=Identification+of+a+benzoisoxazoloazepine+inhibitor+%28CPI-0610%29+of+the+bromodomain+and+extra-terminal+%28BET%29+Family+as+a+candidate+for+human+clinical+trials&doi=10.1021%2Facs.jmedchem.5b01882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span></div><div class="casAuthors">Albrecht, Brian K.; Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Cote, Alexandre; Leblanc, Yves; Nasveschuk, Christopher G.; Bellon, Steve; Bergeron, Louise; Campbell, Robert; Cantone, Nico; Cooper, Michael R.; Cummings, Richard T.; Jayaram, Hariharan; Joshi, Shivangi; Mertz, Jennifer A.; Neiss, Adrianne; Normant, Emmanuel; O'Meara, Michael; Pardo, Eneida; Poy, Florence; Sandy, Peter; Supko, Jeffrey; Sims, Robert J.; Harmange, Jean-Christophe; Taylor, Alexander M.; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1330-1339</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB.  Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clin. trials for hematol. malignancies (CPI-0610).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40qjnYl4EZLVg90H21EOLACvtfcHk0liq0QsxIW6XAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D&md5=5e1c5aab26aa58844a9f6670a7bbd78b</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01882%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520a%2520benzoisoxazoloazepine%2520inhibitor%2520%2528CPI-0610%2529%2520of%2520the%2520bromodomain%2520and%2520extra-terminal%2520%2528BET%2529%2520Family%2520as%2520a%2520candidate%2520for%2520human%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1330%26epage%3D1339%26doi%3D10.1021%2Facs.jmedchem.5b01882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Development of methyl isoxazoleazepines as inhibitors of BET</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2015.03.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25851940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1842-1848&author=M.+C.+Hewittauthor=Y.+Leblancauthor=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=A.+Coteauthor=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.+C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=R.+Cummingsauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Development+of+methyl+isoxazoleazepines+as+inhibitors+of+BET&doi=10.1016%2Fj.bmcl.2015.03.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Development of methyl isoxazoleazepines as inhibitors of BET</span></div><div class="casAuthors">Hewitt, Michael C.; Leblanc, Yves; Gehling, Victor S.; Vaswani, Rishi G.; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Cummings, Rich; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaran, Hariharan; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the Me isoxazoleazepine chemotype) exemplified by carboxamide 23.  The Me isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrdQuVhIoU1rVg90H21EOLACvtfcHk0liq0QsxIW6XAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D&md5=fb9a78528287f82ccf004e751e491ee4</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDevelopment%2520of%2520methyl%2520isoxazoleazepines%2520as%2520inhibitors%2520of%2520BET%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmcl.2015.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery of benzotriazolo[4,3-d][1,4]diazepines as orally active inhibitors of BET bromodomains</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1021/ml500411h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500411h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=145-150&author=A.+M.+Taylorauthor=R.+G.+Vaswaniauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=Y.+Leblancauthor=J.+E.+Audiaauthor=S.+Bellonauthor=R.+T.+Cummingsauthor=A.+Coteauthor=J.+C.+Harmangeauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+M.+Loraauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Pardoauthor=C.+G.+Nasveschukauthor=F.+Poyauthor=P.+Sandyauthor=J.+W.+Setserauthor=R.+J.+Simsauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Discovery+of+benzotriazolo%5B4%2C3-d%5D%5B1%2C4%5Ddiazepines+as+orally+active+inhibitors+of+BET+bromodomains&doi=10.1021%2Fml500411h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains</span></div><div class="casAuthors">Taylor, Alexander M.; Vaswani, Rishi G.; Gehling, Victor S.; Hewitt, Michael C.; Leblanc, Yves; Audia, James E.; Bellon, Steve; Cummings, Richard T.; Cote, Alexandre; Harmange, Jean-Christophe; Jayaram, Hari; Joshi, Shivangi; Lora, Jose M.; Mertz, Jennifer A.; Neiss, Adrianne; Pardo, Eneida; Nasveschuk, Christopher G.; Poy, Florence; Sandy, Peter; Setser, Jeremy W.; Sims, Robert J.; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the bromodomains of the BET family, of which BRD4 is a member, has been shown to decrease myc and interleukin (IL) 6 in vivo, markers that are of therapeutic relevance to cancer and inflammatory disease, resp.  Herein the authors report substituted benzo[b]isoxazolo[4,5-d]azepines and benzotriazolo[4,3-d][1,4]diazepines as fragment-derived novel inhibitors of the bromodomain of BRD4.  Compds. from these series were potent and selective in cells, and subsequent optimization of microsomal stability yielded representatives that demonstrated dose- and time-dependent redn. of plasma IL-6 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDybfuij7kebVg90H21EOLACvtfcHk0liQSLZOk9KT0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D&md5=38759c818814869d6c951a035bad7617</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fml500411h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500411h%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSetser%26aufirst%3DJ.%2BW.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%2520of%2520benzotriazolo%255B4%252C3-d%255D%255B1%252C4%255Ddiazepines%2520as%2520orally%2520active%2520inhibitors%2520of%2520BET%2520bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D145%26epage%3D150%26doi%3D10.1021%2Fml500411h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Landau, S. B.; Kagey, M.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. WO2016069578,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+B.+Landau&author=M.+Kagey&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DS.%2BB.%26atitle%3DBromodomain%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1878</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.10.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmc.2011.10.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22137933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1878-1886&author=P.+Filippakopoulosauthor=S.+Picaudauthor=O.+Fedorovauthor=M.+Kellerauthor=M.+Wrobelauthor=O.+Morgensternauthor=F.+Bracherauthor=S.+Knapp&title=Benzodiazepines+and+benzotriazepines+as+protein+interaction+inhibitors+targeting+bromodomains+of+the+BET+family&doi=10.1016%2Fj.bmc.2011.10.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Fedorov, Oleg; Keller, Marco; Wrobel, Matthias; Morgenstern, Olaf; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1878-1886</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Benzodiazepines are psychoactive drugs with anxiolytic, sedative, skeletal muscle relaxant and amnestic properties.  Recently triazolo-benzodiazepines have been also described as potent and highly selective protein interaction inhibitors of bromodomain and extra-terminal (BET) proteins, a family of transcriptional co-regulators that play a key role in cancer cell survival and proliferation, but the requirements for high affinity interaction of this compd. class with bromodomains has not been described.  Here we provide insight into the structure-activity relationship (SAR) and selectivity of this versatile scaffold.  In addn., using high resoln. crystal structures we compared the binding mode of a series of benzodiazepine (BzD) and related triazolo-benzotriazepines (BzT) derivs. including clin. approved drugs such as alprazolam and midazolam.  Our anal. revealed the importance of the 1-Me triazolo ring system for BET binding and suggests modifications for the development of further high affinity bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9BT8VUvs8_LVg90H21EOLACvtfcHk0liQSLZOk9KT0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOksrw%253D&md5=aed7023bdb44ee0b83af1605f0be0ddd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.10.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.10.080%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DWrobel%26aufirst%3DM.%26aulast%3DMorgenstern%26aufirst%3DO.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DBenzodiazepines%2520and%2520benzotriazepines%2520as%2520protein%2520interaction%2520inhibitors%2520targeting%2520bromodomains%2520of%2520the%2520BET%2520family%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1878%26epage%3D1886%26doi%3D10.1016%2Fj.bmc.2011.10.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Endo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooike, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumichika, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2016.01.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26869194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVahsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1365-1370&author=J.+Endoauthor=H.+Hikawaauthor=M.+Hamadaauthor=S.+Ishibuchiauthor=N.+Fujieauthor=N.+Sugiyamaauthor=M.+Tanakaauthor=H.+Kobayashiauthor=K.+Sugaharaauthor=K.+Oshitaauthor=K.+Iwataauthor=S.+Ooikeauthor=M.+Murataauthor=H.+Sumichikaauthor=K.+Chibaauthor=K.+Adachi&title=A+phenotypic+drug+discovery+study+on+thienodiazepine+derivatives+as+inhibitors+of+T+cell+proliferation+induced+by+CD28+co-stimulation+leads+to+the+discovery+of+a+first+bromodomain+inhibitor&doi=10.1016%2Fj.bmcl.2016.01.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor</span></div><div class="casAuthors">Endo, Junichi; Hikawa, Hidemasa; Hamada, Maiko; Ishibuchi, Seigo; Fujie, Naoto; Sugiyama, Naoki; Tanaka, Minoru; Kobayashi, Haruhito; Sugahara, Kunio; Oshita, Koichi; Iwata, Kazunori; Ooike, Shinsuke; Murata, Meguru; Sumichika, Hiroshi; Chiba, Kenji; Adachi, Kunitomo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1365-1370</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A phenotypic screening of thienodiazepines derived from a hit compd. found through a binding assay targeting co-stimulatory mols. on T cells and antigen presenting cells successfully led to the discovery of a thienotriazolodiazepine compd. (7f) possessing potent immunosuppressive activity.  A chem. biol. approach has succeeded in revealing that 7f is a first inhibitor of epigenetic bromodomain-contg. proteins. 7f is expected to become an anti-cancer agent as well as an immunosuppressive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeajoPFavBUbVg90H21EOLACvtfcHk0lgl_mwh-UFrUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVahsL8%253D&md5=e414d4c7fad718d7b2c5a76a20aed0d7</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.084%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DJ.%26aulast%3DHikawa%26aufirst%3DH.%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DIshibuchi%26aufirst%3DS.%26aulast%3DFujie%26aufirst%3DN.%26aulast%3DSugiyama%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DOshita%26aufirst%3DK.%26aulast%3DIwata%26aufirst%3DK.%26aulast%3DOoike%26aufirst%3DS.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DSumichika%26aufirst%3DH.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DA%2520phenotypic%2520drug%2520discovery%2520study%2520on%2520thienodiazepine%2520derivatives%2520as%2520inhibitors%2520of%2520T%2520cell%2520proliferation%2520induced%2520by%2520CD28%2520co-stimulation%2520leads%2520to%2520the%2520discovery%2520of%2520a%2520first%2520bromodomain%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1365%26epage%3D1370%26doi%3D10.1016%2Fj.bmcl.2016.01.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Schmees, N.; Buchmann, B.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Kruger, M.; Fernandez-Montalvan, A.; Kunzer, H.; Rehwinkel, H.</span><span> </span><span class="NLM_article-title">4-Substituted pyrrolo- and pyrazolo- diazepines</span>. WO2014128111,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=B.+Buchmann&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=M.+Kruger&author=A.+Fernandez-Montalvan&author=H.+Kunzer&author=H.+Rehwinkel&title=4-Substituted+pyrrolo-+and+pyrazolo-+diazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3D4-Substituted%2520pyrrolo-%2520and%2520pyrazolo-%2520diazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Vadivelu, S.; Rajagopal, S.; Chinnapattu, M.; Gondrala, P. K.; Sivanandhan, D.; Mulakala, C.</span><span> </span><span class="NLM_article-title">Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer</span>. WO2016157221,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Vadivelu&author=S.+Rajagopal&author=M.+Chinnapattu&author=P.+K.+Gondrala&author=D.+Sivanandhan&author=C.+Mulakala&title=Tricyclic+fused+derivatives+of+1-%28cyclo%29alkyl+pyridin-2-one+useful+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVadivelu%26aufirst%3DS.%26atitle%3DTricyclic%2520fused%2520derivatives%2520of%25201-%2528cyclo%2529alkyl%2520pyridin-2-one%2520useful%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Liu, D.; Pratt, J.; Wang, L.; Hasvold, L. A.; Bogdan, A.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. US20140256710,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Liu&author=J.+Pratt&author=L.+Wang&author=L.+A.+Hasvold&author=A.+Bogdan&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DBromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, L.</span><span> </span><span class="NLM_article-title">Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ejmech.2016.05.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27266999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSjsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=294-299&author=J.+Liauthor=P.+Wangauthor=B.+Zhouauthor=J.+Shiauthor=J.+Liuauthor=X.+Liauthor=L.+Fanauthor=Y.+Zhengauthor=L.+Ouyang&title=Development+of+4%2C5-dihydro-benzodiazepinone+derivatives+as+a+new+chemical+series+of+BRD4+inhibitors&doi=10.1016%2Fj.ejmech.2016.05.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors</span></div><div class="casAuthors">Li, Jie; Wang, Peiqi; Zhou, Bihui; Shi, Jianyou; Liu, Jie; Li, Xiangrong; Fan, Limei; Zheng, Yaxin; Ouyang, Liang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">294-299</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new chem. scaffold 3,4-dihydroquinoxalin-2(1H)-ones were developed from structural modifications of previously reported BRD4 inhibitors.  A series of compds., e.g., I, were synthesized and the BRD4-inhibitory activity and anti-proliferative effect of these compds. were evaluated.  We found compd., e.g., II, had remarkable anti-proliferative activities toward leukemia cells and could induce apoptosis by mitochondrial pathways.  Notably, the anal. of mol. docking suggested that hydrophobic interaction was essential for compd. II to bind to BD1.  In conclusion, these results demonstrated the potential of compd. II to be utilized as a BRD4 inhibitor with apoptosis inducing effect in future leukemia therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq_MyywxjOrbVg90H21EOLACvtfcHk0lgl_mwh-UFrUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSjsLrL&md5=4fce15e1274d9842310817b17ff3d309</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.057%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DOuyang%26aufirst%3DL.%26atitle%3DDevelopment%2520of%25204%252C5-dihydro-benzodiazepinone%2520derivatives%2520as%2520a%2520new%2520chemical%2520series%2520of%2520BRD4%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D294%26epage%3D299%26doi%3D10.1016%2Fj.ejmech.2016.05.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Siegel, S.; Baurle, S.; Cleve, A.; Haendler, B.; Fernandez-Montalvan, A.; Monning, U.; Krause, S.; Lejeune, P.; Busemann, M.; Kuhnke, J.</span><span> </span><span class="NLM_article-title">Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines</span>. WO2014128067,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Siegel&author=S.+Baurle&author=A.+Cleve&author=B.+Haendler&author=A.+Fernandez-Montalvan&author=U.+Monning&author=S.+Krause&author=P.+Lejeune&author=M.+Busemann&author=J.+Kuhnke&title=Bicyclo+2%2C3-benzodiazepines+and+spirocyclically+substituted+2%2C3-benzodiazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DS.%26atitle%3DBicyclo%25202%252C3-benzodiazepines%2520and%2520spirocyclically%2520substituted%25202%252C3-benzodiazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppusetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6761</span><span class="NLM_x">–</span> <span class="NLM_lpage">6770</span><span class="refDoi"> DOI: 10.1021/jm200640v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200640v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6761-6770&author=D.+S.+Hewingsauthor=M.+Wangauthor=M.+Philpottauthor=O.+Fedorovauthor=S.+Uttarkarauthor=P.+Filippakopoulosauthor=S.+Picaudauthor=C.+Vuppusettyauthor=B.+Marsdenauthor=S.+Knappauthor=S.+J.+Conwayauthor=T.+D.+Heightman&title=3%2C5-dimethylisoxazoles+act+as+acetyl-lysine-mimetic+bromodomain+ligands&doi=10.1021%2Fjm200640v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Wang, Minghua; Philpott, Martin; Fedorov, Oleg; Uttarkar, Sagar; Filippakopoulos, Panagis; Picaud, Sarah; Vuppusetty, Chaitanya; Marsden, Brian; Knapp, Stefan; Conway, Stuart J.; Heightman, Tom D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6761-6770</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone-lysine acetylation is a vital chromatin post-translational modification involved in the epigenetic regulation of gene transcription.  Bromodomains bind acetylated lysines, acting as readers of the histone-acetylation code.  Competitive inhibitors of this interaction have antiproliferative and anti-inflammatory properties.  With 57 distinct bromodomains known, the discovery of subtype-selective inhibitors of the histone-bromodomain interaction is of great importance.  We have identified the 3,5-dimethylisoxazole moiety as a novel acetyl-lysine bioisostere, which displaces acetylated histone-mimicking peptides from bromodomains.  Using X-ray crystallog. anal., we have detd. the interactions responsible for the activity and selectivity of 4-substituted 3,5-dimethylisoxazoles against a selection of phylogenetically diverse bromodomains.  By exploiting these interactions, we have developed compd. 4d, which has IC50 values of <5 μM for the bromodomain-contg. proteins BRD2(1) and BRD4(1).  These compds. are promising leads for the further development of selective probes for the bromodomain and extra C-terminal domain (BET) family and CREBBP bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzK4xMvJhXrVg90H21EOLACvtfcHk0ljv9U8yxtAxkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO&md5=7d6f9eff2735c8a7189dec4fb5c5d13d</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm200640v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200640v%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DUttarkar%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DVuppusetty%26aufirst%3DC.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3D3%252C5-dimethylisoxazoles%2520act%2520as%2520acetyl-lysine-mimetic%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6761%26epage%3D6770%26doi%3D10.1021%2Fjm200640v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3217</span><span class="NLM_x">–</span> <span class="NLM_lpage">3227</span><span class="refDoi"> DOI: 10.1021/jm301588r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301588r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3217-3227&author=D.+S.+Hewingsauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=S.+Picaudauthor=A.+Tumberauthor=C.+Wellsauthor=M.+M.+Olcinaauthor=K.+Freemanauthor=A.+Gillauthor=A.+J.+Ritchieauthor=D.+W.+Sheppardauthor=A.+J.+Russellauthor=E.+M.+Hammondauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=Optimization+of+3%2C5-dimethylisoxazole+derivatives+as+potent+bromodomain+ligands&doi=10.1021%2Fjm301588r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Fedorov, Oleg; Filippakopoulos, Panagis; Martin, Sarah; Picaud, Sarah; Tumber, Anthony; Wells, Christopher; Olcina, Monica M.; Freeman, Katherine; Gill, Andrew; Ritchie, Alison J.; Sheppard, David W.; Russell, Angela J.; Hammond, Ester M.; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3217-3227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Isoxazolylphenyl)arylmethanols such as I (R = H; R1 = HO; R2 = H; R3 = Ph), I (R = HO; R1 = H; R2 = H; R3 = Ph), and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = Ph, 3-FC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4) were prepd. as inhibitors of the bromodomain and extra terminal domain (BET) bromodomain family member BRD4(1) for potential use as antitumor agents.  The structures of I (R = H; R1 = HO; R2 = H; R3 = Ph) and I (R = HO; R1 = H; R2 = H; R3 = Ph) bound to human BRD4(1) were detd. by X-ray crystallog. to det. features useful for selective binding to BRD4(1).  I (R = H, HO; R1 = HO, H; R2 = H, MeCO; R3 = Ph) and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = 3-ClC6H4) inhibited a human acute myeloid leukemia cell line in vitro with 3-4 fold reduced inhibition and reduced toxicity in other human cells compared to a known BRD4(1) inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVEQ5OOJGC8bVg90H21EOLACvtfcHk0ljv9U8yxtAxkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D&md5=bb4890291db8c3e8d404a75dd9dcbb87</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm301588r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301588r%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DFreeman%26aufirst%3DK.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DA.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DOptimization%2520of%25203%252C5-dimethylisoxazole%2520derivatives%2520as%2520potent%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3217%26epage%3D3227%26doi%3D10.1021%2Fjm301588r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodrow, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span><span class="refDoi"> DOI: 10.1021/jm201283q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201283q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=587-596&author=P.+Bamboroughauthor=H.+Dialloauthor=J.+D.+Goodacreauthor=L.+Gordonauthor=A.+Lewisauthor=J.+T.+Sealauthor=D.+M.+Wilsonauthor=M.+D.+Woodrowauthor=C.+W.+Chung&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+2%3A+optimization+of+phenylisoxazole+sulfonamides&doi=10.1021%2Fjm201283q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides</span></div><div class="casAuthors">Bamborough, Paul; Diallo, Hawa; Goodacre, Jonathan D.; Gordon, Laurie; Lewis, Antonia; Seal, Jonathan T.; Wilson, David M.; Woodrow, Michael D.; Chung, Chun-wa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">587-596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are epigenetic reader modules that regulate gene transcription through their recognition of acetyl-lysine modified histone tails.  Inhibitors of this protein-protein interaction have the potential to modulate multiple diseases as demonstrated by the profound anti-inflammatory and antiproliferative effects of a recently disclosed class of BET compds.  While these compds. were discovered using phenotypic assays, here we present a highly efficient alternative approach to find new chem. templates, exploiting the abundant structural knowledge that exists for this target class.  A Ph di-Me isoxazole chemotype resulting from a focused fragment screen has been rapidly optimized through structure-based design, leading to a sulfonamide series showing anti-inflammatory activity in cellular assays.  This proof-of-principle expt. demonstrates the tractability of the BET family and bromodomain target class to fragment-based hit discovery and structure-based lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6lsic9qjJrVg90H21EOLACvtfcHk0ljv9U8yxtAxkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF&md5=e73b16b3fddf88b43b037264b000b276</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm201283q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201283q%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DGoodacre%26aufirst%3DJ.%2BD.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DSeal%26aufirst%3DJ.%2BT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWoodrow%26aufirst%3DM.%2BD.%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520phenylisoxazole%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D587%26epage%3D596%26doi%3D10.1021%2Fjm201283q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marineau, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklow, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Biased multicomponent reactions to develop novel bromodomain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9019</span><span class="NLM_x">–</span> <span class="NLM_lpage">9027</span><span class="refDoi"> DOI: 10.1021/jm501120z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501120z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9019-9027&author=M.+R.+McKeownauthor=D.+L.+Shawauthor=H.+Fuauthor=S.+Liuauthor=X.+Xuauthor=J.+J.+Marineauauthor=Y.+Huangauthor=X.+Zhangauthor=D.+L.+Buckleyauthor=A.+Kadamauthor=Z.+Zhangauthor=S.+C.+Blacklowauthor=J.+Qiauthor=W.+Zhangauthor=J.+E.+Bradner&title=Biased+multicomponent+reactions+to+develop+novel+bromodomain+inhibitors&doi=10.1021%2Fjm501120z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors</span></div><div class="casAuthors">McKeown, Michael R.; Shaw, Daniel L.; Fu, Harry; Liu, Shuai; Xu, Xiang; Marineau, Jason J.; Huang, Yibo; Zhang, Xiaofeng; Buckley, Dennis L.; Kadam, Asha; Zhang, Zijuan; Blacklow, Stephen C.; Qi, Jun; Zhang, Wei; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9019-9027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer.  Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands as probes of bromodomain function.  Using fluorous-tagged multicomponent reactions, we developed a focused chem. library of bromodomain inhibitors around a 3,5-dimethylisoxazole biasing element with micromolar biochem. IC50.  Iterative synthesis and biochem. assessment allowed optimization of novel BET bromodomain inhibitors based on an imidazo[1,2-a]pyrazine scaffold.  Lead compd. I (UMB-32) binds BRD4 with a Kd of 550 nM and 724 nM cellular potency in BRD4-dependent lines.  Addnl., compd. I shows potency against TAF1, a bromodomain-contg. transcription factor previously unapproached by discovery chem.  Compd. I was cocrystd. with BRD4, yielding a 1.56 Å resoln. crystal structure.  This research showcases new applications of fluorous and multicomponent chem. synthesis for the development of novel epigenetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocWEf4LoDJTrVg90H21EOLACvtfcHk0lj-9qKCWi-xcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN&md5=a4e20101f5a0b547451814af73c0418f</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm501120z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501120z%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DShaw%26aufirst%3DD.%2BL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DMarineau%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DKadam%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DBiased%2520multicomponent%2520reactions%2520to%2520develop%2520novel%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9019%26epage%3D9027%26doi%3D10.1021%2Fjm501120z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delannee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudit, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2963</span><span class="NLM_x">–</span> <span class="NLM_lpage">2967</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2012.01.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22386529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2963-2967&author=O.+Mirguetauthor=Y.+Lamotteauthor=F.+Doncheauthor=J.+Toumauthor=F.+Gellibertauthor=A.+Bouillotauthor=R.+Gosminiauthor=V.+L.+Nguyenauthor=D.+Delanneeauthor=J.+Sealauthor=F.+Blandelauthor=A.+B.+Boullayauthor=E.+Boursierauthor=S.+Martinauthor=J.+M.+Brusqauthor=G.+Krysaauthor=A.+Riouauthor=R.+Tellierauthor=A.+Costazauthor=P.+Huetauthor=Y.+Duditauthor=L.+Trottetauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=From+ApoA1+upregulation+to+BET+family+bromodomain+inhibition%3A+discovery+of+I-BET151&doi=10.1016%2Fj.bmcl.2012.01.125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151</span></div><div class="casAuthors">Mirguet, Olivier; Lamotte, Yann; Donche, Frederic; Toum, Jerome; Gellibert, Francoise; Bouillot, Anne; Gosmini, Romain; Nguyen, Van-Loc; Delannee, Delphine; Seal, Jonathan; Blandel, Florence; Boullay, Anne-Benedicte; Boursier, Eric; Martin, Sandrine; Brusq, Jean-Marie; Krysa, Gael; Riou, Alizon; Tellier, Remi; Costaz, Agnes; Huet, Pascal; Dudit, Yann; Trottet, Lionel; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2963-2967</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery, synthesis, and biol. evaluation of a novel series of 7-isoxazoloquinolines is described.  Several analogs are shown to increase ApoA1 expression within the nanomolar range in the human hepatic cell line HepG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIu6f80tbgE7Vg90H21EOLACvtfcHk0lj-9qKCWi-xcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D&md5=48c9a8dc4b70bea4a86807f7a1cec5f1</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.125%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DDelannee%26aufirst%3DD.%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DBlandel%26aufirst%3DF.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DRiou%26aufirst%3DA.%26aulast%3DTellier%26aufirst%3DR.%26aulast%3DCostaz%26aufirst%3DA.%26aulast%3DHuet%26aufirst%3DP.%26aulast%3DDudit%26aufirst%3DY.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DFrom%2520ApoA1%2520upregulation%2520to%2520BET%2520family%2520bromodomain%2520inhibition%253A%2520discovery%2520of%2520I-BET151%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2963%26epage%3D2967%26doi%3D10.1016%2Fj.bmcl.2012.01.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioja, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span> </span><span class="NLM_article-title">Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2968</span><span class="NLM_x">–</span> <span class="NLM_lpage">2972</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2012.02.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22437115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2968-2972&author=J.+Sealauthor=Y.+Lamotteauthor=F.+Doncheauthor=A.+Bouillotauthor=O.+Mirguetauthor=F.+Gellibertauthor=E.+Nicodemeauthor=G.+Krysaauthor=J.+Kirilovskyauthor=S.+Beinkeauthor=S.+McClearyauthor=I.+Riojaauthor=P.+Bamboroughauthor=C.+W.+Chungauthor=L.+Gordonauthor=T.+Lewisauthor=A.+L.+Walkerauthor=L.+Cutlerauthor=D.+Lugoauthor=D.+M.+Wilsonauthor=J.+Witheringtonauthor=K.+Leeauthor=R.+K.+Prinjha&title=Identification+of+a+novel+series+of+BET+family+bromodomain+inhibitors%3A+binding+mode+and+profile+of+I-BET151+%28GSK1210151A%29&doi=10.1016%2Fj.bmcl.2012.02.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)</span></div><div class="casAuthors">Seal, Jonathan; Lamotte, Yann; Donche, Frederic; Bouillot, Anne; Mirguet, Olivier; Gellibert, Francoise; Nicodeme, Edwige; Krysa, Gael; Kirilovsky, Jorge; Beinke, Soren; McCleary, Scott; Rioja, Inma; Bamborough, Paul; Chung, Chun-Wa; Gordon, Laurie; Lewis, Toni; Walker, Ann L.; Cutler, Leanne; Lugo, David; Wilson, David M.; Witherington, Jason; Lee, Kevin; Prinjha, Rab K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2968-2972</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of quinoline isoxazole BET family bromodomain inhibitors are discussed.  Crystallog. is used to illustrate binding modes and rationalize their SAR.  One member, I-BET151 (GSK1210151A), shows good oral bioavailability in both the rat and minipig as well as demonstrating efficient suppression of bacterial induced inflammation and sepsis in a murine in vivo endotoxemia model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJKtxBCr-pRbVg90H21EOLACvtfcHk0liJSivkLyacAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D&md5=a8037c89bcb93948d663208bd1ebfd55</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.041%26sid%3Dliteratum%253Aachs%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DRioja%26aufirst%3DI.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520BET%2520family%2520bromodomain%2520inhibitors%253A%2520binding%2520mode%2520and%2520profile%2520of%2520I-BET151%2520%2528GSK1210151A%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2968%26epage%3D2972%26doi%3D10.1016%2Fj.bmcl.2012.02.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudgin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.1038/nature10509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature10509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=21964340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=529-533&author=M.+A.+Dawsonauthor=R.+K.+Prinjhaauthor=A.+Dittmannauthor=G.+Giotopoulosauthor=M.+Bantscheffauthor=W.+I.+Chanauthor=S.+C.+Robsonauthor=C.+W.+Chungauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=C.+Huthmacherauthor=E.+Gudginauthor=D.+Lugoauthor=S.+Beinkeauthor=T.+D.+Chapmanauthor=E.+J.+Robertsauthor=P.+E.+Sodenauthor=K.+R.+Augerauthor=O.+Mirguetauthor=K.+Doehnerauthor=R.+Delwelauthor=A.+K.+Burnettauthor=P.+Jeffreyauthor=G.+Drewesauthor=K.+Leeauthor=B.+J.+Huntlyauthor=T.+Kouzarides&title=Inhibition+of+BET+recruitment+to+chromatin+as+an+effective+treatment+for+MLL-fusion+leukaemia&doi=10.1038%2Fnature10509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span></div><div class="casAuthors">Dawson, Mark A.; Prinjha, Rab K.; Dittman, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">529-533</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent chromosomal translocations involving the mixed lineage leukemia (MLL) gene initiate aggressive forms of leukemia, which are often refractory to conventional therapies.  Many MLL-fusion partners are members of the super elongation complex (SEC), a crit. regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukemia induction.  Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-assocd. factor complex (PAFc), are assocd. with the BET family of acetyl-lysine recognizing, chromatin adaptor' proteins.  These data provided the basis for therapeutic intervention in MLL-fusion leukemia, via the displacement of the BET family of proteins from chromatin.  We show that a novel small mol. inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukemic cell lines, through the induction of early cell cycle arrest and apoptosis.  I-BET151 treatment in two human leukemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes.  The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin.  In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukemia.  Finally, the efficacy of I-BET151 against human leukemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential.  These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4FbgJpjftv7Vg90H21EOLACvtfcHk0liJSivkLyacAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO&md5=dffb4b81da4ca8291c27139d0df86324</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fnature10509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10509%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.%2BI.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DGudgin%26aufirst%3DE.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%2BD.%26aulast%3DRoberts%26aufirst%3DE.%2BJ.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DDoehner%26aufirst%3DK.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520BET%2520recruitment%2520to%2520chromatin%2520as%2520an%2520effective%2520treatment%2520for%2520MLL-fusion%2520leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D529%26epage%3D533%26doi%3D10.1038%2Fnature10509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Ran, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaswamy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of gamma-carboline analogues as potent and specific BET bromodomain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4927-4939&author=X.+Ranauthor=Y.+Zhaoauthor=L.+Liuauthor=L.+Baiauthor=C.+Y.+Yangauthor=B.+Zhouauthor=J.+L.+Meagherauthor=K.+Chinnaswamyauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Structure-based+design+of+gamma-carboline+analogues+as+potent+and+specific+BET+bromodomain+inhibitors&doi=10.1021%2Facs.jmedchem.5b00613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors</span></div><div class="casAuthors">Ran, Xu; Zhao, Yujun; Liu, Liu; Bai, Longchuan; Yang, Chao-Yie; Zhou, Bing; Meagher, Jennifer L.; Chinnaswamy, Krishnapriya; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4927-4939</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of bromodomain and extra terminal proteins (BET), including BRD2, BRD3, and BRD4 proteins have therapeutic potential for the treatment of human cancers and other diseases and conditions.  In this paper, the authors report the design, synthesis, and evaluation of γ-carboline-contg. compds. as a new class of small-mol. BET inhibitors.  The most potent inhibitor I (RX-37) obtained from this study binds to BET bromodomain proteins (BRD2, BRD3, and BRD4) with Ki values of 3.2-24.7 nM and demonstrates high selectivity over other non-BET bromodomain-contg. proteins.  Compd. I potently and selectively inhibits cell growth in human acute leukemia cell lines harboring the rearranged mixed lineage leukemia 1 gene.  The authors have detd. a cocrystal structure of I in complex with BRD4 BD2 at 1.4 Å resoln., which provides a solid structural basis for the compd.'s high binding affinity and for its further structure-based optimization.  Compd. I represents a promising lead compd. for the development of a new class of therapeutics for the treatment of human cancer and other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-VCfWLBWYLVg90H21EOLACvtfcHk0lidnrAOY-1kmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM&md5=e6e150169812e439c1d7d91416eb3ee9</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00613%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520gamma-carboline%2520analogues%2520as%2520potent%2520and%2520specific%2520BET%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4927%26epage%3D4939%26doi%3D10.1021%2Facs.jmedchem.5b00613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Slassi, A.; Dove, P.</span><span> </span><span class="NLM_article-title">Fluorinated imidazo[4,5-<i>c</i>]quinoline derivatives as inhibitors of bromodomain containing proteins</span>. WO2016123709,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Slassi&author=P.+Dove&title=Fluorinated+imidazo%5B4%2C5-c%5Dquinoline+derivatives+as+inhibitors+of+bromodomain+containing+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSlassi%26aufirst%3DA.%26atitle%3DFluorinated%2520imidazo%255B4%252C5-c%255Dquinoline%2520derivatives%2520as%2520inhibitors%2520of%2520bromodomain%2520containing%2520proteins%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Norris, D. J.; Dellucca, G. V.; Gavai, A. V.; Quesnelle, C. A.; Gill, P.; O’malley, D.; Vaccaro, W.; lEE, F. Y.; Debenedetto, M. V.; Degnan, A. P.; Fang, H.; Hill, M. D.; Huang, H.; Schmitz, W. D.; Starrett, J. E.; Han, W.; Tokarski, J. S.; Mandal, S. K.</span><span> </span><span class="NLM_article-title">Tricyclic compounds as anticancer agents</span>. WO2015100282,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+J.+Norris&author=G.+V.+Dellucca&author=A.+V.+Gavai&author=C.+A.+Quesnelle&author=P.+Gill&author=D.+O%E2%80%99malley&author=W.+Vaccaro&author=F.+Y.+lEE&author=M.+V.+Debenedetto&author=A.+P.+Degnan&author=H.+Fang&author=M.+D.+Hill&author=H.+Huang&author=W.+D.+Schmitz&author=J.+E.+Starrett&author=W.+Han&author=J.+S.+Tokarski&author=S.+K.+Mandal&title=Tricyclic+compounds+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNorris%26aufirst%3DD.%2BJ.%26atitle%3DTricyclic%2520compounds%2520as%2520anticancer%2520agents%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Foster, A. B.</span><span> </span><span class="NLM_article-title">Deuterium isotope effects in studies of drug metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1016/0165-6147(84)90534-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2F0165-6147%2884%2990534-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADyaL2MXovFCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1984&pages=524-527&author=A.+B.+Foster&title=Deuterium+isotope+effects+in+studies+of+drug+metabolism&doi=10.1016%2F0165-6147%2884%2990534-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterium isotope effects in studies of drug metabolism</span></div><div class="casAuthors">Foster, Allan B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">524-7</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 16 refs.  Substitution of one or more C-bonded H atoms in a drug mol. with deuterium imposes negligible steric effects and influences phys.-chem. properties minimally.  Yet the resultant increased bond stability may cause dramatic changes in biol. properties, particularly by retarding certain pathways of its metab.  The potential of deuteration in modifying drug action is described.  A specific biol. action of a drug may be enhanced, reduced or prolonged; its metab. may be diverted along a pathway which promotes formation of highly active metabolites, or avoids the formation of toxic metabolites.  Cost of toxicol. testing and clin. trials may underline the pharmaceutical industry's reluctance to synthesize deuterated analogs.  Nonetheless, deuteration remains a promising possibility for future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAE7REz_uf8LVg90H21EOLACvtfcHk0lidnrAOY-1kmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXovFCktQ%253D%253D&md5=0084c0f831cd80b8ae6b51f557c9bd78</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2884%2990534-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252884%252990534-0%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BB.%26atitle%3DDeuterium%2520isotope%2520effects%2520in%2520studies%2520of%2520drug%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1984%26volume%3D5%26spage%3D524%26epage%3D527%26doi%3D10.1016%2F0165-6147%2884%2990534-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Timmins, G. S.</span><span> </span><span class="NLM_article-title">Deuterated drugs: where are we now?</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1075</span><span class="refDoi"> DOI: 10.1517/13543776.2014.943184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1517%2F13543776.2014.943184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25069517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1067-1075&author=G.+S.+Timmins&title=Deuterated+drugs%3A+where+are+we+now%3F&doi=10.1517%2F13543776.2014.943184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Deuterated drugs: where are we now?</span></div><div class="casAuthors">Timmins, Graham S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1067-1075</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Deuterated versions of existing drugs can exhibit improved pharmacokinetic or toxicol. properties due the stronger deuterium- carbon bond modifying their metab.  There is great interest in the current state of development of this approach.  Areas covered: This review covers recent US patent applications and prosecutions in this area that are based on beneficial modifications in metab. of deuterated versions of existing drugs.  The current state of 35 U.S.C. 103 'obviousness' rejections are emphasized, as is the development of strategies to overcome such rejections.  Current trials and market considerations are also discussed.  Expert opinion: Deuterated drugs collectively are worth at least US$1 billion.  It would seem that the likelihood of obviousness rejections is increasing in this area.  However, careful elucidation of metabolic outcomes from deuteration that would not be anticipated from the prior art, and are instead unexpected and unobvious, has enabled allowance.  Showing that drug deuteration alters pharmacokinetics by mechanisms not currently part of the prior art surrounding deuterated drugs has also been successful.  Development of these and other strategies, combined with developing the extensive base of issued patents will enable the field to remain com. attractive for some time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0xlLKQqhufrVg90H21EOLACvtfcHk0lidnrAOY-1kmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGhsbfE&md5=c697e60a642f7ea3d8ad9f4588bc3ade</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.943184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.943184%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26atitle%3DDeuterated%2520drugs%253A%2520where%2520are%2520we%2520now%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1067%26epage%3D1075%26doi%3D10.1517%2F13543776.2014.943184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Hay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1039/C2MD20189E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1039%2FC2MD20189E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=140-144&author=D.+Hayauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=M.+Philpottauthor=S.+Picaudauthor=D.+S.+Hewingsauthor=S.+Uttakarauthor=T.+D.+Heightmanauthor=S.+J.+Conwayauthor=S.+Knappauthor=P.+E.+Brennan&title=The+design+and+synthesis+of+5-+and+6-isoxazolylbenzimidazoles+as+selective+inhibitors+of+the+BET+bromodomains&doi=10.1039%2FC2MD20189E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1039%2FC2MD20189E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20189E%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DUttakar%26aufirst%3DS.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%25205-%2520and%25206-isoxazolylbenzimidazoles%2520as%2520selective%2520inhibitors%2520of%2520the%2520BET%2520bromodomains%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D140%26epage%3D144%26doi%3D10.1039%2FC2MD20189E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Ren, B.; Zhou, C.; Wang, H.</span><span> </span><span class="NLM_article-title">Substituted 5-(3,5-dimethylisoxazole-4-yl)indoline-2-ones</span>. WO2014173241,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Ren&author=C.+Zhou&author=H.+Wang&title=Substituted+5-%283%2C5-dimethylisoxazole-4-yl%29indoline-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DB.%26atitle%3DSubstituted%25205-%25283%252C5-dimethylisoxazole-4-yl%2529indoline-2-ones%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Aktoudianakis, E.; Chin, G.; Corkey, B. K.; Elbel, J. D.; Jiang, K.; Kobayashi, R.; Martinez, T.; Metobo, T. R.; Mish, S. E.; Shevick, M.; Sperandio, S.; Yang, D.; Zablocki, H.</span><span> </span><span class="NLM_article-title">J. Benzimidazolone derivatives as bromodomain inhibitors</span>. WO2014160873,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=E.+Aktoudianakis&author=G.+Chin&author=B.+K.+Corkey&author=J.+D.+Elbel&author=K.+Jiang&author=R.+Kobayashi&author=T.+Martinez&author=T.+R.+Metobo&author=S.+E.+Mish&author=M.+Shevick&author=S.+Sperandio&author=D.+Yang&author=H.+Zablocki&title=J.+Benzimidazolone+derivatives+as+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAktoudianakis%26aufirst%3DE.%26atitle%3DJ.%2520Benzimidazolone%2520derivatives%2520as%2520bromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Mantoulidis, A.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Indolinone analogues as BRD4 inhibitors</span>. WO2014154760,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+Engelhardt&author=D.+Gianni&author=A.+Mantoulidis&author=C.+Smethurst&title=Indolinone+analogues+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DIndolinone%2520analogues%2520as%2520BRD4%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Smethurst, C.; Engelhardt, H.; Gianni, D.; Reiser, U.</span><span> </span><span class="NLM_article-title">Dihydroquinazolinone analogues as BRD4 inhibitors</span>. WO2014154762,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Smethurst&author=H.+Engelhardt&author=D.+Gianni&author=U.+Reiser&title=Dihydroquinazolinone+analogues+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmethurst%26aufirst%3DC.%26atitle%3DDihydroquinazolinone%2520analogues%2520as%2520BRD4%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Bogdan, A.; Kati, W. M.; Mcdaniel, K. F.; Park, C. H.; Sheppard, G. S.; Wang, L.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. US20150158873,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Bogdan&author=W.+M.+Kati&author=K.+F.+Mcdaniel&author=C.+H.+Park&author=G.+S.+Sheppard&author=L.+Wang&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBogdan%26aufirst%3DA.%26atitle%3DBromodomain%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Wang, L.; Frey, R. R.; Hansen, T. M.; Liu, D.; Mcclellan, W. J.; Mcdaniel, K. F.; Pratt, J. K.; Wada, C. K.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. WO2015085925,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Wang&author=R.+R.+Frey&author=T.+M.+Hansen&author=D.+Liu&author=W.+J.+Mcclellan&author=K.+F.+Mcdaniel&author=J.+K.+Pratt&author=C.+K.+Wada&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Engelhardt, H.</span><span> </span><span class="NLM_article-title">Benzimidazole derivatives</span>. WO2015169962,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&title=Benzimidazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DBenzimidazole%2520derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Engelhardt, H.; Martin, L.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Pyridinones</span>. WO2015022332,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&author=L.+Martin&author=C.+Smethurst&title=Pyridinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DPyridinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Wang, L.; Dai, Y.; Holms, J.; Liu, D.; Mcclellan, W.; Mcdaniel, K.; Hasvold, L.; Fidanze, S. D.; Sheppard, G.; Marjanovic, J.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitors</span>. WO2014206150,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Wang&author=Y.+Dai&author=J.+Holms&author=D.+Liu&author=W.+Mcclellan&author=K.+Mcdaniel&author=L.+Hasvold&author=S.+D.+Fidanze&author=G.+Sheppard&author=J.+Marjanovic&title=Bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span> </span><span class="NLM_article-title">Inhibitors of BRD4 as potential cancer therapy</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00259</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00259" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=728-729&author=A.+F.+Abdel-Magid&title=Inhibitors+of+BRD4+as+potential+cancer+therapy&doi=10.1021%2Facsmedchemlett.6b00259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00259%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26atitle%3DInhibitors%2520of%2520BRD4%2520as%2520potential%2520cancer%2520therapy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D728%26epage%3D729%26doi%3D10.1021%2Facsmedchemlett.6b00259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Substituted [1,2,4]triazolo[4,3-<i>a</i>]pyrazines as BRD4 inhibitors</span>. US20160129001,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Engelhardt&author=D.+Gianni&author=C.+Smethurst&title=Substituted+%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazines+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DSubstituted%2520%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazines%2520as%2520BRD4%2520inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Engelhardt, H.</span><span> </span><span class="NLM_article-title">Triazolopyrazine derivatives as BRD4 inhibitors</span>. WO2015067770,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&title=Triazolopyrazine+derivatives+as+BRD4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DTriazolopyrazine%2520derivatives%2520as%2520BRD4%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Bordas, V.; Cotesta, S.; Guagnano, V.; Rueeger, H.; Vaupel, A.</span><span> </span><span class="NLM_article-title">Pyrazolopyrrolidine derivatives and their use in the treatment of disease</span>. US20140349990,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=V.+Bordas&author=S.+Cotesta&author=V.+Guagnano&author=H.+Rueeger&author=A.+Vaupel&title=Pyrazolopyrrolidine+derivatives+and+their+use+in+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBordas%26aufirst%3DV.%26atitle%3DPyrazolopyrrolidine%2520derivatives%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520disease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Blank, J.; Bold, G.; Bordas, V.; Cotesta, S.; Guagnano, V.; Rueger, H.; Vaupel, A.</span><span> </span><span class="NLM_article-title">Pyrrolopyrrolone derivatives and their use as BET inhibitors</span>. WO2015075665,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Blank&author=G.+Bold&author=V.+Bordas&author=S.+Cotesta&author=V.+Guagnano&author=H.+Rueger&author=A.+Vaupel&title=Pyrrolopyrrolone+derivatives+and+their+use+as+BET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlank%26aufirst%3DJ.%26atitle%3DPyrrolopyrrolone%2520derivatives%2520and%2520their%2520use%2520as%2520BET%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou-Eymard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8111</span><span class="NLM_x">–</span> <span class="NLM_lpage">8131</span><span class="refDoi"> DOI: 10.1021/jm5010539</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010539" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8111-8131&author=R.+Gosminiauthor=V.+L.+Nguyenauthor=J.+Toumauthor=C.+Simonauthor=J.+M.+Brusqauthor=G.+Krysaauthor=O.+Mirguetauthor=A.+M.+Riou-Eymardauthor=E.+V.+Boursierauthor=L.+Trottetauthor=P.+Bamboroughauthor=H.+Clarkauthor=C.+W.+Chungauthor=L.+Cutlerauthor=E.+H.+Demontauthor=R.+Kaurauthor=A.+J.+Lewisauthor=M.+B.+Schillingauthor=P.+E.+Sodenauthor=S.+Taylorauthor=A.+L.+Walkerauthor=M.+D.+Walkerauthor=R.+K.+Prinjhaauthor=E.+Nicodeme&title=The+discovery+of+I-BET726+%28GSK1324726A%29%2C+a+potent+tetrahydroquinoline+ApoA1+up-regulator+and+selective+BET+bromodomain+inhibitor&doi=10.1021%2Fjm5010539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor</span></div><div class="casAuthors">Gosmini, Romain; Nguyen, Van Loc; Toum, Jerome; Simon, Christophe; Brusq, Jean-Marie G.; Krysa, Gael; Mirguet, Olivier; Riou-Eymard, Alizon M.; Boursier, Eric V.; Trottet, Lionel; Bamborough, Paul; Clark, Hugh; Chung, Chun-wa; Cutler, Leanne; Demont, Emmanuel H.; Kaur, Rejbinder; Lewis, Antonia J.; Schilling, Mark B.; Soden, Peter E.; Taylor, Simon; Walker, Ann L.; Walker, Matthew D.; Prinjha, Rab K.; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8111-8131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through their function as epigenetic readers of the histone code, the BET family of bromodomain-contg. proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation.  BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncol. and inflammation models, and the first compds. have now progressed into clin. trials.  The exciting biol. of the BETs has led to great interest in the discovery of novel inhibitor classes.  Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compds. active in murine models of septic shock and neuroblastoma.  At the mol. level, these effects are produced by inhibition of BET bromodomains.  X-ray crystallog. reveals the interactions explaining the structure-activity relationships of binding.  The resulting lead mol., I-BET726, represents a new, potent, and selective class of tetrahydroquinoline-based BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5OdMn_TjoFLVg90H21EOLACvtfcHk0li_LQS0WZK_VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J&md5=b1c9c9cae73c41252cf73908d561bd9b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm5010539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010539%26sid%3Dliteratum%253Aachs%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DC.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DRiou-Eymard%26aufirst%3DA.%2BM.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DClark%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DA.%2BJ.%26aulast%3DSchilling%26aufirst%3DM.%2BB.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DThe%2520discovery%2520of%2520I-BET726%2520%2528GSK1324726A%2529%252C%2520a%2520potent%2520tetrahydroquinoline%2520ApoA1%2520up-regulator%2520and%2520selective%2520BET%2520bromodomain%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8111%26epage%3D8131%26doi%3D10.1021%2Fjm5010539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolven, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span><span class="refDoi"> DOI: 10.1021/jm201320w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201320w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=576-586&author=C.+W.+Chungauthor=A.+W.+Deanauthor=J.+M.+Woolvenauthor=P.+Bamborough&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+1%3A+inhibitor+binding+modes+and+implications+for+lead+discovery&doi=10.1021%2Fjm201320w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery</span></div><div class="casAuthors">Chung, Chun-wa; Dean, Anthony W.; Woolven, James M.; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">576-586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. proteins are key epigenetic regulators of gene transcription and readers of the histone code.  However, the therapeutic benefits of modulating this target class are largely unexplored due to the lack of suitable chem. probes.  This article describes the generation of lead mols. for the BET bromodomains through screening a fragment set chosen using structural insights and computational approaches.  Anal. of 40 BRD2/fragment x-ray complexes highlights both shared and disparate interaction features that may be exploited for affinity and selectivity.  Six representative crystal structures are then exemplified in detail.  Two of the fragments are completely new bromodomain chemotypes, and three have never before been crystd. in a bromodomain, so our results significantly extend the limited public knowledge-base of crystallog. small mol./bromodomain interactions.  Certain fragments (including paracetamol) bind in a consistent mode to different bromodomains such as CREBBP, suggesting their potential to act as generic bromodomain templates.  An important implication is that the bromodomains are not only a phylogenetic family but also a system in which chem. and structural knowledge of one bromodomain gives insights transferable to others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonNb7GnZnS_rVg90H21EOLACvtfcHk0lj8neYMO7KZMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN&md5=5b7d7239d0de57266d94beef1ea080ae</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm201320w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201320w%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDean%26aufirst%3DA.%2BW.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25201%253A%2520inhibitor%2520binding%2520modes%2520and%2520implications%2520for%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D576%26epage%3D586%26doi%3D10.1021%2Fjm201320w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Wyce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbash, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy-Wilson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span> </span><span class="NLM_article-title">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e72967</span><span class="refDoi"> DOI: 10.1371/journal.pone.0072967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1371%2Fjournal.pone.0072967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24009722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72967&author=A.+Wyceauthor=G.+Ganjiauthor=K.+N.+Smithemanauthor=C.+W.+Chungauthor=S.+Korenchukauthor=Y.+Baiauthor=O.+Barbashauthor=B.+Leauthor=P.+D.+Craggsauthor=M.+T.+McCabeauthor=K.+M.+Kennedy-Wilsonauthor=L.+V.+Sanchezauthor=R.+L.+Gosminiauthor=N.+Parrauthor=C.+F.+McHughauthor=D.+Dhanakauthor=R.+K.+Prinjhaauthor=K.+R.+Augerauthor=P.+J.+Tummino&title=BET+inhibition+silences+expression+of+MYCN+and+BCL2+and+induces+cytotoxicity+in+neuroblastoma+tumor+models&doi=10.1371%2Fjournal.pone.0072967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span></div><div class="casAuthors">Wyce, Anastasia; Ganji, Gopinath; Smitheman, Kimberly N.; Chung, Chun-Wa; Korenchuk, Susan; Bai, Yuchen; Barbash, Olena; Le, Bao Chau; Craggs, Peter D.; McCabe, Michael T.; Kennedy-Wilson, Karen M.; Sanchez, Lydia V.; Gosmini, Romain L.; Parr, Nigel; McHugh, Charles F.; Dhanak, Dashyant; Prinjha, Rab K.; Auger, Kurt R.; Tummino, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e72967</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">BET family proteins are epigenetic regulators known to control expression of genes involved in cell growth and oncogenesis.  Selective inhibitors of BET proteins exhibit potent anti-proliferative activity in a no. of hematol. cancer models, in part through suppression of the MYC oncogene and downstream Myc-driven pathways.  However, little is currently known about the activity of BET inhibitors in solid tumor models, and whether down-regulation of MYC family genes contributes to sensitivity.  Here we provide evidence for potent BET inhibitor activity in neuroblastoma, a pediatric solid tumor assocd. with a high frequency of MYCN amplifications.  We treated a panel of neuroblastoma cell lines with a novel small mol. inhibitor of BET proteins, GSK1324726A (I-BET726), and obsd. potent growth inhibition and cytotoxicity in most cell lines irresp. of MYCN copy no. or expression level.  Gene expression analyses in neuroblastoma cell lines suggest a role of BET inhibition in apoptosis, signaling, and N-Myc-driven pathways, including the direct suppression of BCL2 and MYCN.  Reversal of MYCN or BCL2 suppression reduces the potency of I-BET726-induced cytotoxicity in a cell line-specific manner; however, neither factor fully accounts for I-BET726 sensitivity.  Oral administration of I-BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down-regulation MYCN and BCL2 expression, suggesting a potential role for these genes in tumor growth.  Taken together, our data highlight the potential of BET inhibitors as novel therapeutics for neuroblastoma, and suggest that sensitivity is driven by pleiotropic effects on cell growth and apoptotic pathways in a context-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecB0_0elFVbVg90H21EOLACvtfcHk0lj8neYMO7KZMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI&md5=d39ce25a50de58f18a278a9f67935bbc</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072967%26sid%3Dliteratum%253Aachs%26aulast%3DWyce%26aufirst%3DA.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DBarbash%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DB.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DKennedy-Wilson%26aufirst%3DK.%2BM.%26aulast%3DSanchez%26aufirst%3DL.%2BV.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26atitle%3DBET%2520inhibition%2520silences%2520expression%2520of%2520MYCN%2520and%2520BCL2%2520and%2520induces%2520cytotoxicity%2520in%2520neuroblastoma%2520tumor%2520models%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De72967%26doi%3D10.1371%2Fjournal.pone.0072967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Amans, D.; Atkinson, S. J.; Harrison, D. J.; Hirst, D. J.; Law, R. P.; Lindon, M.; Preston, A.; Seal, J. T.; Wellaway, C. R.</span><span> </span><span class="NLM_article-title">2,3-Disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors</span>. WO2014140076,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Amans&author=S.+J.+Atkinson&author=D.+J.+Harrison&author=D.+J.+Hirst&author=R.+P.+Law&author=M.+Lindon&author=A.+Preston&author=J.+T.+Seal&author=C.+R.+Wellaway&title=2%2C3-Disubstituted+1-acyl-4-amino-1%2C2%2C3%2C4-tetrahydroquinoline+derivatives+and+their+use+as+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmans%26aufirst%3DD.%26atitle%3D2%252C3-Disubstituted%25201-acyl-4-amino-1%252C2%252C3%252C4-tetrahydroquinoline%2520derivatives%2520and%2520their%2520use%2520as%2520bromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Bair, K. W.; Herbertz, T.; Kauffman, G. S.; Kayser-Bricker, K. J.; Luke, G. P.; Martin, M. W.; Millan, D. S.; Schiller, S. R.; Talbot, A. C.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline composition as BET bromodomain inhibitors</span>. WO2015074064,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+W.+Bair&author=T.+Herbertz&author=G.+S.+Kauffman&author=K.+J.+Kayser-Bricker&author=G.+P.+Luke&author=M.+W.+Martin&author=D.+S.+Millan&author=S.+R.+Schiller&author=A.+C.+Talbot&title=Tetrahydroquinoline+composition+as+BET+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DTetrahydroquinoline%2520composition%2520as%2520BET%2520bromodomain%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Schmees, N.; Haendler, B.; Stockigt, D.; Gallenkamp, D.; Bissell, R. A.; Bouglas, R. A.</span><span> </span><span class="NLM_article-title">Modified BET-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones</span>. WO2015004075,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Schmees&author=B.+Haendler&author=D.+Stockigt&author=D.+Gallenkamp&author=R.+A.+Bissell&author=R.+A.+Bouglas&title=Modified+BET-protein-inhibiting+dihydroquinoxalinones+and+dihydropyridopyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DModified%2520BET-protein-inhibiting%2520dihydroquinoxalinones%2520and%2520dihydropyridopyrazinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primiano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciammetta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span> </span><span class="NLM_article-title">Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9831</span><span class="NLM_x">–</span> <span class="NLM_lpage">9837</span><span class="refDoi"> DOI: 10.1021/jm3010515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9831-9837&author=P.+V.+Fishauthor=P.+Filippakopoulosauthor=G.+Bishauthor=P.+E.+Brennanauthor=M.+E.+Bunnageauthor=A.+S.+Cookauthor=O.+Federovauthor=B.+S.+Gerstenbergerauthor=H.+Jonesauthor=S.+Knappauthor=B.+Marsdenauthor=K.+Nockaauthor=D.+R.+Owenauthor=M.+Philpottauthor=S.+Picaudauthor=M.+J.+Primianoauthor=M.+J.+Ralphauthor=N.+Sciammettaauthor=J.+D.+Trzupek&title=Identification+of+a+chemical+probe+for+bromo+and+extra+C-terminal+bromodomain+inhibition+through+optimization+of+a+fragment-derived+hit&doi=10.1021%2Fjm3010515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit</span></div><div class="casAuthors">Fish, Paul V.; Filippakopoulos, Panagis; Bish, Gerwyn; Brennan, Paul E.; Bunnage, Mark E.; Cook, Andrew S.; Federov, Oleg; Gerstenberger, Brian S.; Jones, Hannah; Knapp, Stefan; Marsden, Brian; Nocka, Karl; Owen, Dafydd R.; Philpott, Martin; Picaud, Sarah; Primiano, Michael J.; Ralph, Michael J.; Sciammetta, Nunzio; Trzupek, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9831-9837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The posttranslational modification of chromatin through acetylation at selected histone lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (HDACs).  The significance of this subset of the epigenetic code is interrogated and interpreted by an acetyllysine-specific protein-protein interaction with bromodomain reader modules.  Selective inhibition of the bromo and extra C-terminal domain (BET) family of bromodomains with a small mol. is feasible, and this may represent an opportunity for disease intervention through the recently disclosed antiproliferative and anti-inflammatory properties of such inhibitors.  Herein, we describe the discovery and structure-activity relationship (SAR) of a novel, small-mol. chem. probe for BET family inhibition that was identified through the application of structure-based fragment assessment and optimization techniques.  This has yielded a potent, selective compd. with cell-based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzpWnuXoLdrVg90H21EOLACvtfcHk0liaDODAv5b3mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE&md5=ba864f3916bea5f793dd0b26732784f0</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm3010515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010515%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DFederov%26aufirst%3DO.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPrimiano%26aufirst%3DM.%2BJ.%26aulast%3DRalph%26aufirst%3DM.%2BJ.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520chemical%2520probe%2520for%2520bromo%2520and%2520extra%2520C-terminal%2520bromodomain%2520inhibition%2520through%2520optimization%2520of%2520a%2520fragment-derived%2520hit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9831%26epage%3D9837%26doi%3D10.1021%2Fjm3010515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Xue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Discovery of benzo[cd]indol-2(1H)-ones as potent and specific BET bromodomain inhibitors: Structure-based virtual screening, optimization, and biological evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1579</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01511</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01511" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1565-1579&author=X.+Xueauthor=Y.+Zhangauthor=Z.+Liuauthor=M.+Songauthor=Y.+Xingauthor=Q.+Xiangauthor=Z.+Wangauthor=Z.+Tuauthor=Y.+Zhouauthor=K.+Dingauthor=Y.+Xu&title=Discovery+of+benzo%5Bcd%5Dindol-2%281H%29-ones+as+potent+and+specific+BET+bromodomain+inhibitors%3A+Structure-based+virtual+screening%2C+optimization%2C+and+biological+evaluation&doi=10.1021%2Facs.jmedchem.5b01511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation</span></div><div class="casAuthors">Xue, Xiaoqian; Zhang, Yan; Liu, Zhaoxuan; Song, Ming; Xing, Yanli; Xiang, Qiuping; Wang, Zhen; Tu, Zhengchao; Zhou, Yulai; Ding, Ke; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1565-1579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of inhibitors of bromodomain and extra terminal domain (BET) has achieved great progress, and at least seven inhibitors have progressed into clin. trials for the treatment of cancer or inflammatory diseases.  Here, the authors describe the identification, optimization, and evaluation of benzo[cd]indol-2(1H)-one contg. compds. as a new class of BET bromodomain inhibitors, starting from structure-based virtual screening (SBVS).  Through structure-based optimization, potent compds. were obtained with significantly improved activity.  The two most potent compds. bind to the BRD4 bromodomain, with Kd values of 124 and 137 nM.  Selected compds. exhibited high selectivity over other non-BET subfamily members.  Notably, compd. I demonstrated a reasonable antiproliferation effect on MV4;11 leukemia cells and exhibited a good pharmacokinetic profile with high oral bioavailability (75.8%) and moderate half-life (T1/2 = 3.95 h).  The resulting lead mol. I represents a new, potent, and selective class of BET bromodomain inhibitors for the development of therapeutics to treat cancer and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl7CO2ESpHObVg90H21EOLACvtfcHk0liaDODAv5b3mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqsA%253D%253D&md5=d1cd7b961fd4c417c886a1c2274cdacb</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01511%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520benzo%255Bcd%255Dindol-2%25281H%2529-ones%2520as%2520potent%2520and%2520specific%2520BET%2520bromodomain%2520inhibitors%253A%2520Structure-based%2520virtual%2520screening%252C%2520optimization%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1565%26epage%3D1579%26doi%3D10.1021%2Facs.jmedchem.5b01511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Hasvold, L. A.; Pratt, J. K.; Mcdaniel, K. F.; Sheppard, G. S.; Liu, D.; Elmore, S. W.; Hubbard, R. D.</span><span> </span><span class="NLM_article-title">Pyrrole-3-carboxamide bromodomain inhibitors</span>. US20140275079,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+A.+Hasvold&author=J.+K.+Pratt&author=K.+F.+Mcdaniel&author=G.+S.+Sheppard&author=D.+Liu&author=S.+W.+Elmore&author=R.+D.+Hubbard&title=Pyrrole-3-carboxamide+bromodomain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DPyrrole-3-carboxamide%2520bromodomain%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Hasvold, L. A.; Liu, D.; Park, C. H.; Pratt, J. K.; Sheppard, G. S.; Wang, L.</span><span> </span><span class="NLM_article-title">Isoindolone derivatives</span>. WO2013158952,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+A.+Hasvold&author=D.+Liu&author=C.+H.+Park&author=J.+K.+Pratt&author=G.+S.+Sheppard&author=L.+Wang&title=Isoindolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DIsoindolone%2520derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Lucas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlwend, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schule, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, S.</span><span> </span><span class="NLM_article-title">4-Acyl pyrroles: mimicking acetylated lysines in histone code reading</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">14055</span><span class="NLM_x">–</span> <span class="NLM_lpage">14059</span><span class="refDoi"> DOI: 10.1002/anie.201307652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1002%2Fanie.201307652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVaksrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=14055-14059&author=X.+Lucasauthor=D.+Wohlwendauthor=M.+Hugleauthor=K.+Schmidtkunzauthor=S.+Gerhardtauthor=R.+Schuleauthor=M.+Jungauthor=O.+Einsleauthor=S.+Gunther&title=4-Acyl+pyrroles%3A+mimicking+acetylated+lysines+in+histone+code+reading&doi=10.1002%2Fanie.201307652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">4-Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading</span></div><div class="casAuthors">Lucas, Xavier; Wohlwend, Daniel; Huegle, Martin; Schmidtkunz, Karin; Gerhardt, Stefan; Schuele, Roland; Jung, Manfred; Einsle, Oliver; Guenther, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">14055-14059</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors performed a high throughput virtual screening expt. using a library contg. more than 7 million small mol. compds., aiming at the identification of novel inhibitors of the first bromodomain of BRD4.  The authors selected 22 candidate compds. for further exptl. validation by ITC measurements, eventually leading to the discovery of 7 compds. (XD1, XD14, XD15, XD16, XD19, XD22 and XD24) with significant binding affinity towards BRD4.  The validated hits comprise 6 different previously unknown scaffolds that are potent binders of BRD4.  Notably, the 4-acyl pyrrole XD14 showed a 700-fold increase in binding affinity as compared to the structurally closely related 5-isoxazole XD15 (KD = 0.2 μM and 168 μM, resp.), rendering XD14 the most potent binder of the entire screening.  Furthermore, the authors also found that poisonous alkaloid colchiceine (XD1) and its methoxylated analog colchicine (XD25) have affinity for the protein (KD-46 μM and 20 μM, resp.).  For co-crystn. and X-ray structure anal. we chose the most promising candidates XD14, XD1 and XD25.  The authors further assessed the antiproliferative potential of XD14 by the NCI60 human tumor cell line anticancer drug screen.  The results reported herein stress the validity of high-throughput virtual screening in the identification of novel active mols. in the epigenetics field, and indicate that the newly discovered XD14 is a representative of a new class of BET bromodomain inhibitors featuring a 4-acyl pyrrole moiety.  Future studies will be directed at assessing the therapeutic potential of XD14, and performing a knowledge-driven lead optimization of the identified hits.  The core compd. XD46 will be subjected to fragment-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl3sU9EWWqorVg90H21EOLACvtfcHk0li8fBtEPn9sjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVaksrzP&md5=cd905bc3c772a8b2e74779b65182dbbb</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307652%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DWohlwend%26aufirst%3DD.%26aulast%3DHugle%26aufirst%3DM.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DSchule%26aufirst%3DR.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DGunther%26aufirst%3DS.%26atitle%3D4-Acyl%2520pyrroles%253A%2520mimicking%2520acetylated%2520lysines%2520in%2520histone%2520code%2520reading%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D14055%26epage%3D14059%26doi%3D10.1002%2Fanie.201307652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Hugle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovskyi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlwend, D.</span><span> </span><span class="NLM_article-title">4-Acyl pyrrole derivatives yield novel vectors for designing inhibitors of the acetyl-lysine recognition site of BRD4(1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">–</span> <span class="NLM_lpage">1530</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1518-1530&author=M.+Hugleauthor=X.+Lucasauthor=G.+Weitzelauthor=D.+Ostrovskyiauthor=B.+Breitauthor=S.+Gerhardtauthor=O.+Einsleauthor=S.+Guntherauthor=D.+Wohlwend&title=4-Acyl+pyrrole+derivatives+yield+novel+vectors+for+designing+inhibitors+of+the+acetyl-lysine+recognition+site+of+BRD4%281%29&doi=10.1021%2Facs.jmedchem.5b01267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01267%26sid%3Dliteratum%253Aachs%26aulast%3DHugle%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DWeitzel%26aufirst%3DG.%26aulast%3DOstrovskyi%26aufirst%3DD.%26aulast%3DBreit%26aufirst%3DB.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DWohlwend%26aufirst%3DD.%26atitle%3D4-Acyl%2520pyrrole%2520derivatives%2520yield%2520novel%2520vectors%2520for%2520designing%2520inhibitors%2520of%2520the%2520acetyl-lysine%2520recognition%2520site%2520of%2520BRD4%25281%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1518%26epage%3D1530%26doi%3D10.1021%2Facs.jmedchem.5b01267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3833</span><span class="NLM_x">–</span> <span class="NLM_lpage">3851</span><span class="refDoi"> DOI: 10.1021/jm301793a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301793a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3833-3851&author=L.+Zhaoauthor=D.+Caoauthor=T.+Chenauthor=Y.+Wangauthor=Z.+Miaoauthor=Y.+Xuauthor=W.+Chenauthor=X.+Wangauthor=Y.+Liauthor=Z.+Duauthor=B.+Xiongauthor=J.+Liauthor=C.+Xuauthor=N.+Zhangauthor=J.+Heauthor=J.+Shen&title=Fragment-based+drug+discovery+of+2-thiazolidinones+as+inhibitors+of+the+histone+reader+BRD4+bromodomain&doi=10.1021%2Fjm301793a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain</span></div><div class="casAuthors">Zhao, Lele; Cao, Danyan; Chen, Tiantian; Wang, Yingqing; Miao, Zehong; Xu, Yechun; Chen, Wuyan; Wang, Xin; Li, Yanlian; Du, Zhiyan; Xiong, Bing; Li, Jian; Xu, Chunyan; Zhang, Naixia; He, Jianhua; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3833-3851</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recognizing acetyllysine of histone is a vital process of epigenetic regulation that is mediated by a protein module called bromodomain.  To contribute novel scaffolds for developing into bromodomain inhibitors, the authors utilize a fragment-based drug discovery approach.  By successively applying docking and x-ray crystallog., they were able to identify 9 fragment hits from diffracting more than 60 crystals.  In the present work, they described four of them and carried out the integrated lead optimization for fragment I, which bears a 2-thiazolidinone core.  After several rounds of structure guided modifications, they assessed the druggability of 2-thiazolidinone by modulating in vitro pharmacokinetic studies and cellular activity assay.  The results showed that two potent of 2-thiazolidinone compds. II and III have good metabolic stability.  Also, the cellular assay confirmed the activities of 2-thiazolidinones.  Together, they hope the identified 2-thiazolidinone chemotype and other fragment hits described herein can stimulate researchers to develop more diversified bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfi2pyYq6c4LVg90H21EOLACvtfcHk0li8fBtEPn9sjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D&md5=8308db5d83cb72b29f261cc134514ece</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fjm301793a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301793a%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520of%25202-thiazolidinones%2520as%2520inhibitors%2520of%2520the%2520histone%2520reader%2520BRD4%2520bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3833%26epage%3D3851%26doi%3D10.1021%2Fjm301793a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1021/jm501504k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501504k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1281-1297&author=L.+Zhaoauthor=Y.+Wangauthor=D.+Caoauthor=T.+Chenauthor=Q.+Wangauthor=Y.+Liauthor=Y.+Xuauthor=N.+Zhangauthor=X.+Wangauthor=D.+Chenauthor=L.+Chenauthor=Y.+L.+Chenauthor=G.+Xiaauthor=Z.+Shiauthor=Y.+C.+Liuauthor=Y.+Linauthor=Z.+Miaoauthor=J.+Shenauthor=B.+Xiong&title=Fragment-based+drug+discovery+of+2-thiazolidinones+as+BRD4+inhibitors%3A+2.+Structure-based+optimization&doi=10.1021%2Fjm501504k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: Structure-Based Optimization</span></div><div class="casAuthors">Zhao, Lele; Wang, Yingqing; Cao, Danyan; Chen, Tiantian; Wang, Qi; Li, Yanlian; Xu, Yechun; Zhang, Naixia; Wang, Xin; Chen, Danqi; Chen, Lin; Chen, Yue-Lei; Xia, Guangxin; Shi, Zhe; Liu, Yu-Chih; Lin, Yijyun; Miao, Zehong; Shen, Jingkang; Xiong, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1281-1297</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The signal transduction of acetylated histone can be processed through a recognition module, bromodomain.  Several inhibitors targeting BRD4, one of the bromodomain members, are in clin. trials as anticancer drugs.  Hereby, the authors report the efforts on discovery and optimization of a new series of 2-thiazolidinones as BRD4 inhibitors along the previous study.  In this work, guided by crystal structure anal., the authors reversed the sulfonamide group and identified a new binding mode.  A structure-activity relationship study on this new series led to several potent BRD4 inhibitors with IC50 of about 0.05-0.1 μM in FP binding assay and GI50 of 0.1-0.3 μM in cell based assays.  To complete the lead-like assessment of this series, the authors further checked its effects on BRD4 downstream protein c-Myc, investigated its selectivity among five different bromodomain proteins, as well as the metabolic stability test, and reinforced the utility of 2-thiazolidinone scaffold as BET bromodomain inhibitors in novel anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4x-5lE2iPzbVg90H21EOLACvtfcHk0lhUmKvnNzO1ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D&md5=4056ac1a6d6598dc61be7cc7ef82a3da</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm501504k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501504k%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%2BC.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DFragment-based%2520drug%2520discovery%2520of%25202-thiazolidinones%2520as%2520BRD4%2520inhibitors%253A%25202.%2520Structure-based%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1281%26epage%3D1297%26doi%3D10.1021%2Fjm501504k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Toure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-molecule PROTACS: new approaches to protein degradation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span><span class="refDoi"> DOI: 10.1002/anie.201507978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1002%2Fanie.201507978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1966-1973&author=M.+Toureauthor=C.+M.+Crews&title=Small-molecule+PROTACS%3A+new+approaches+to+protein+degradation&doi=10.1002%2Fanie.201507978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule PROTACS: New Approaches to Protein Degradation</span></div><div class="casAuthors">Toure, Momar; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1966-1973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The current inhibitor-based approach to therapeutics has inherent limitations owing to its occupancy-based model: there is a need to maintain high systemic exposure to ensure sufficient in vivo inhibition, high in vivo concns. bring potential for off-target side effects, and there is a need to bind to an active site, thus limiting the drug target space.  As an alternative, induced protein degrdn. lacks these limitations.  Based on an event-driven model, this approach offers a novel catalytic mechanism to irreversibly inhibit protein function by targeting protein destruction through recruitment to the cellular quality control machinery.  Prior protein degrading strategies have lacked therapeutic potential.  However, recent reports of small-mol.-based proteolysis-targeting chimeras (PROTACs) have demonstrated that this technol. can effectively decrease the cellular levels of several protein classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdaqlIjCSsgrVg90H21EOLACvtfcHk0lg_54Q3eXHeDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D&md5=47838cd15719757317cb8282c26cc59e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507978%26sid%3Dliteratum%253Aachs%26aulast%3DToure%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520PROTACS%253A%2520new%2520approaches%2520to%2520protein%2520degradation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D1966%26epage%3D1973%26doi%3D10.1002%2Fanie.201507978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span><span class="refDoi"> DOI: 10.1002/anie.201307761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1002%2Fanie.201307761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=2312-2330&author=D.+L.+Buckleyauthor=C.+M.+Crews&title=Small-molecule+control+of+intracellular+protein+levels+through+modulation+of+the+ubiquitin+proteasome+system&doi=10.1002%2Fanie.201307761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Control of Intracellular Protein Levels through Modulation of the Ubiquitin Proteasome System</span></div><div class="casAuthors">Buckley, Dennis L.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2312-2330</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Traditionally, biol. probes and drugs have targeted the activities of proteins (such as enzymes and receptors) that can be readily controlled by small mols.  The remaining majority of the proteome has been deemed "undruggable".  By using small-mol. modulators of the ubiquitin proteasome, protein levels, rather than protein activity, can be targeted instead, thus increasing the no. of druggable targets.  Whereas targeting of the proteasome itself can lead to a global increase in protein levels, the targeting of other components of the UPS (e.g., the E3 ubiquitin ligases) can lead to an increase in protein levels in a more targeted fashion.  Alternatively, multiple strategies for inducing protein degrdn. with small-mol. probes are emerging.  With the ability to induce and inhibit the degrdn. of targeted proteins, small-mol. modulators of the UPS have the potential to significantly expand the druggable portion of the proteome beyond traditional targets, such as enzymes and receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUSadJB1NNJ7Vg90H21EOLACvtfcHk0lg_54Q3eXHeDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlegsLo%253D&md5=4d88e9c3f2dbf92c9db4aa81bd8cdac1</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307761%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520control%2520of%2520intracellular%2520protein%2520levels%2520through%2520modulation%2520of%2520the%2520ubiquitin%2520proteasome%2520system%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D2312%26epage%3D2330%26doi%3D10.1002%2Fanie.201307761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Chemical inducers of targeted protein degradation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">11057</span><span class="NLM_x">–</span> <span class="NLM_lpage">11060</span><span class="refDoi"> DOI: 10.1074/jbc.R109.078105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.R109.078105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=20147751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFGlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=11057-11060&author=K.+Rainaauthor=C.+M.+Crews&title=Chemical+inducers+of+targeted+protein+degradation&doi=10.1074%2Fjbc.R109.078105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Inducers of Targeted Protein Degradation</span></div><div class="casAuthors">Raina, Kanak; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">11057-11060</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  The functions of many cellular proteins have been elucidated by selective gene inactivation and subsequent phenotypic anal.  For example, genetic mutations, gene knock-out generation, and the use of RNA interference to target mRNA for degrdn. can all result in decreased prodn. of a specific protein, yielding informative cellular phenotypes.  However, these techniques each have certain inherent limitations.  This minireview focuses on the recent development of new approaches to study protein function at the post-translational level, namely chem. induction of targeted protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAHr6BsXliLVg90H21EOLACvtfcHk0lj_WSQEmF0U_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFGlsrs%253D&md5=f5142a890c2e1c859d58ddb25c077052</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R109.078105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R109.078105%26sid%3Dliteratum%253Aachs%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DChemical%2520inducers%2520of%2520targeted%2520protein%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D11057%26epage%3D11060%26doi%3D10.1074%2Fjbc.R109.078105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Bulatov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.1042/BJ20141450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1042%2FBJ20141450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2015&pages=365-386&author=E.+Bulatovauthor=A.+Ciulli&title=Targeting+Cullin%E2%80%93RING+E3+ubiquitin+ligases+for+drug+discovery%3A+structure%2C+assembly+and+small-molecule+modulation&doi=10.1042%2FBJ20141450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1042%2FBJ20141450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20141450%26sid%3Dliteratum%253Aachs%26aulast%3DBulatov%26aufirst%3DE.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DTargeting%2520Cullin%25E2%2580%2593RING%2520E3%2520ubiquitin%2520ligases%2520for%2520drug%2520discovery%253A%2520structure%252C%2520assembly%2520and%2520small-molecule%2520modulation%26jtitle%3DBiochem.%2520J.%26date%3D2015%26volume%3D467%26spage%3D365%26epage%3D386%26doi%3D10.1042%2FBJ20141450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Winter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span><span class="refDoi"> DOI: 10.1126/science.aab1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1126%2Fscience.aab1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25999370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1376-1381&author=G.+E.+Winterauthor=D.+L.+Buckleyauthor=J.+Paulkauthor=J.+M.+Robertsauthor=A.+Souzaauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=DRUG+DEVELOPMENT.+Phthalimide+conjugation+as+a+strategy+for+in+vivo+target+protein+degradation&doi=10.1126%2Fscience.aab1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalimide conjugation as a strategy for in vivo target protein degradation</span></div><div class="casAuthors">Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6241</span>),
    <span class="NLM_cas:pages">1376-1381</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The development of effective pharmacol. inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem.  In part, this is because many small-mol. antagonists disrupt the activity of only one domain in the target protein.  The authors devised a chem. strategy that promotes ligand-dependent target protein degrdn. using as an example the transcriptional coactivator BRD4, a protein crit. for cancer cell growth and survival.  The authors appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex.  The resultant compd., dBET1, induced highly selective cereblon-dependent BET protein degrdn. in vitro and in vivo and delayed leukemia progression in mice.  A second series of probes resulted in selective degrdn. of the cytosolic protein FKBP12.  This chem. strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ZW4zjRjXi7Vg90H21EOLACvtfcHk0lj_WSQEmF0U_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D&md5=b0277cc95d318d926b96e7a119066e3b</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1126%2Fscience.aab1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aab1433%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%2BE.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DDRUG%2520DEVELOPMENT.%2520Phthalimide%2520conjugation%2520as%2520a%2520strategy%2520for%2520in%2520vivo%2520target%2520protein%2520degradation%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D1376%26epage%3D1381%26doi%3D10.1126%2Fscience.aab1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+E3+ubiquitin+ligase+cereblon+to+efficiently+target+BRD4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0lj_WSQEmF0U_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520E3%2520ubiquitin%2520ligase%2520cereblon%2520to%2520efficiently%2520target%2520BRD4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selective small molecule induced degradation of the BET bromodomain protein BRD4</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1777</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1770-1777&author=M.+Zengerleauthor=K.+H.+Chanauthor=A.+Ciulli&title=Selective+small+molecule+induced+degradation+of+the+BET+bromodomain+protein+BRD4&doi=10.1021%2Facschembio.5b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span></div><div class="casAuthors">Zengerle, Michael; Chan, Kwok-Ho; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1770-1777</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bromo- and Extra-Terminal (BET) proteins BRD2, BRD3, and BRD4 play important roles in transcriptional regulation, epigenetics, and cancer and are the targets of pan-BET selective bromodomain inhibitor JQ1.  However, the lack of intra-BET selectivity limits the scope of current inhibitors as probes for target validation and could lead to unwanted side effects or toxicity in a therapeutic setting.  We designed Proteolysis Targeted Chimeras (PROTACs) that tether JQ1 to a ligand for the E3 ubiquitin ligase VHL, aimed at triggering the intracellular destruction of BET proteins.  Compd. MZ1 potently and rapidly induces reversible, long-lasting, and unexpectedly selective removal of BRD4 over BRD2 and BRD3.  The activity of MZ1 is dependent on binding to VHL but is achieved at a sufficiently low concn. not to induce stabilization of HIF-1α.  Gene expression profiles of selected cancer-related genes responsive to JQ1 reveal distinct and more limited transcriptional responses induced by MZ1, consistent with selective suppression of BRD4.  Our discovery opens up new opportunities to elucidate the cellular phenotypes and therapeutic implications assocd. with selective targeting of BRD4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmSv7p9MZOrVg90H21EOLACvtfcHk0ljkXOa0_R8Uog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D&md5=b7514fd274eff8e4bb6a771f5aaf9ab5</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00216%26sid%3Dliteratum%253Aachs%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelective%2520small%2520molecule%2520induced%2520degradation%2520of%2520the%2520BET%2520bromodomain%2520protein%2520BRD4%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1770%26epage%3D1777%26doi%3D10.1021%2Facschembio.5b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Design and characterization of bivalent BET inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1038/nchembio.2209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnchembio.2209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27775715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslehurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1089-1096&author=M.+Tanakaauthor=J.+M.+Robertsauthor=H.+S.+Seoauthor=A.+Souzaauthor=J.+Paulkauthor=T.+G.+Scottauthor=S.+L.+DeAngeloauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=Design+and+characterization+of+bivalent+BET+inhibitors&doi=10.1038%2Fnchembio.2209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Design and characterization of bivalent BET inhibitors</span></div><div class="casAuthors">Tanaka, Minoru; Roberts, Justin M.; Seo, Hyuk-Soo; Souza, Amanda; Paulk, Joshiawa; Scott, Thomas G.; DeAngelo, Stephen L.; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1089-1096</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cellular signaling is often propagated by multivalent interactions.  Multivalency creates avidity, allowing stable biophys. recognition.  Multivalency is an attractive strategy for achieving potent binding to protein targets, as the affinity of bivalent ligands is often greater than the sum of monovalent affinities.  The bromodomain and extraterminal domain (BET) family of transcriptional coactivators features tandem bromodomains through which BET proteins bind acetylated histones and transcription factors.  All reported antagonists of the BET protein BRD4 bind in a monovalent fashion.  Here the authors describe, to the knowledge for the first time, a bivalent BET bromodomain inhibitor-MT1-which has unprecedented potency.  Biophys. and biochem. studies suggest MT1 is an intramol. bivalent BRD4 binder that is more than 100-fold more potent, in cellular assays, than the corresponding monovalent antagonist, JQ1.  MT1 significantly (P < 0.05) delayed leukemia progression in mice, as compared to JQ1.  These data qualify a powerful chem. probe for BET bromodomains and a rationale for further development of multidomain inhibitors of epigenetic reader proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQwc6X0VYYbVg90H21EOLACvtfcHk0ljkXOa0_R8Uog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslehurrM&md5=7319203dac409d5dee3c580b49fcf185</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2209%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSeo%26aufirst%3DH.%2BS.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DT.%2BG.%26aulast%3DDeAngelo%26aufirst%3DS.%2BL.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DDesign%2520and%2520characterization%2520of%2520bivalent%2520BET%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D1089%26epage%3D1096%26doi%3D10.1038%2Fnchembio.2209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Rhyasen, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattersley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petteruti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriotta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahdesmaki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabow, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">AZD5153: A novel bivalent BET bromodomain inhibitor highly active against hematologic malignancies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2563</span><span class="NLM_x">–</span> <span class="NLM_lpage">2574</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1535-7163.MCT-16-0141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27573426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=2563-2574&author=G.+W.+Rhyasenauthor=M.+M.+Hattersleyauthor=Y.+Yaoauthor=A.+Dulakauthor=W.+Wangauthor=P.+Petterutiauthor=I.+L.+Daleauthor=S.+Boikoauthor=T.+Cheungauthor=J.+Zhangauthor=S.+Wenauthor=L.+Castriottaauthor=D.+Lawsonauthor=M.+Collinsauthor=L.+Baoauthor=M.+J.+Ahdesmakiauthor=G.+Walkerauthor=G.+O%E2%80%99Connorauthor=T.+C.+Yehauthor=A.+A.+Rabowauthor=J.+R.+Dryauthor=C.+Reimerauthor=P.+Lyneauthor=G.+B.+Millsauthor=S.+E.+Fawellauthor=M.+J.+Waringauthor=M.+Zindaauthor=E.+Clarkauthor=H.+Chen&title=AZD5153%3A+A+novel+bivalent+BET+bromodomain+inhibitor+highly+active+against+hematologic+malignancies&doi=10.1158%2F1535-7163.MCT-16-0141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">AZD5153: a novel bivalent BET bromodomain inhibitor highly active against hematologic malignancies</span></div><div class="casAuthors">Rhyasen, Garrett W.; Hattersley, Maureen M.; Yao, Yi; Dulak, Austin; Wang, Wenxian; Petteruti, Philip; Dale, Ian L.; Boiko, Scott; Cheung, Tony; Zhang, Jingwen; Wen, Shenghua; Castriotta, Lillian; Lawson, Deborah; Collins, Michael; Bao, Larry; Ahdesmaki, Miika J.; Walker, Graeme; O'Connor, Greg; Yeh, Tammie C.; Rabow, Alfred A.; Dry, Jonathan R.; Reimer, Corinne; Lyne, Paul; Mills, Gordon B.; Fawell, Stephen E.; Waring, Michael J.; Zinda, Michael; Clark, Edwin; Chen, Huawei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2563-2574</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The bromodomain and extraterminal (BET) protein BRD4 regulates gene expression via recruitment of transcriptional regulatory complexes to acetylated chromatin.  Pharmacol. targeting of BRD4 bromodomains by small mol. inhibitors has proven to be an effective means to disrupt aberrant transcriptional programs crit. for tumor growth and/or survival.  Herein, we report AZD5153, a potent, selective, and orally available BET/BRD4 bromodomain inhibitor possessing a bivalent binding mode.  Unlike previously described monovalent inhibitors, AZD5153 ligates two bromodomains in BRD4 simultaneously.  The enhanced avidity afforded through bivalent binding translates into increased cellular and antitumor activity in preclin. hematol. tumor models.  In vivo administration of AZD5153 led to tumor stasis or regression in multiple xenograft models of acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma.  The relationship between AZD5153 exposure and efficacy suggests that prolonged BRD4 target coverage is a primary efficacy driver.  AZD5153 treatment markedly affects transcriptional programs of MYC, E2F, and mTOR.  Of note, mTOR pathway modulation is assocd. with cell line sensitivity to AZD5153.  Transcriptional modulation of MYC and HEXIM1 was confirmed in AZD5153-treated human whole blood, thus supporting their use as clin. pharmacodynamic biomarkers.  This study establishes AZD5153 as a highly potent, orally available BET/BRD4 inhibitor and provides a rationale for clin. development in hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAiKYOFhro1bVg90H21EOLACvtfcHk0ljkXOa0_R8Uog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVOqsrk%253D&md5=8d0ac899d081705aaa12d49fd90165a3</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0141%26sid%3Dliteratum%253Aachs%26aulast%3DRhyasen%26aufirst%3DG.%2BW.%26aulast%3DHattersley%26aufirst%3DM.%2BM.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDulak%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DPetteruti%26aufirst%3DP.%26aulast%3DDale%26aufirst%3DI.%2BL.%26aulast%3DBoiko%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DCastriotta%26aufirst%3DL.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DAhdesmaki%26aufirst%3DM.%2BJ.%26aulast%3DWalker%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DG.%26aulast%3DYeh%26aufirst%3DT.%2BC.%26aulast%3DRabow%26aufirst%3DA.%2BA.%26aulast%3DDry%26aufirst%3DJ.%2BR.%26aulast%3DReimer%26aufirst%3DC.%26aulast%3DLyne%26aufirst%3DP.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DFawell%26aufirst%3DS.%2BE.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DZinda%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DAZD5153%253A%2520A%2520novel%2520bivalent%2520BET%2520bromodomain%2520inhibitor%2520highly%2520active%2520against%2520hematologic%2520malignancies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D2563%26epage%3D2574%26doi%3D10.1158%2F1535-7163.MCT-16-0141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2360</span><span class="NLM_x">–</span> <span class="NLM_lpage">2365</span><span class="refDoi"> DOI: 10.1021/cb4003283</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4003283" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2360-2365&author=M.+P.+Martinauthor=S.+H.+Olesenauthor=G.+I.+Georgauthor=E.+Schonbrunn&title=Cyclin-dependent+kinase+inhibitor+dinaciclib+interacts+with+the+acetyl-lysine+recognition+site+of+bromodomains&doi=10.1021%2Fcb4003283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains</span></div><div class="casAuthors">Martin, Mathew P.; Olesen, Sanne H.; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2360-2365</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. proteins are considered atypical kinases, but their potential to interact with kinase inhibitors is unknown.  Dinaciclib is a potent inhibitor of cyclin-dependent kinases (CDKs), which recently advanced to Phase III clin. trials for the treatment of leukemia.  The authors detd. the crystal structure of dinaciclib in complex with CDK2 at 1.7 Å resoln., revealing an elaborate network of binding interactions in the ATP site, which explains the extraordinary potency and selectivity of this inhibitor.  Remarkably, dinaciclib also interacted with the acetyl-lysine recognition site of the bromodomain testis-specific protein BRDT, a member of the BET family of bromodomains.  The binding mode of dinaciclib to BRDT at 2.0 Å resoln. suggests that general kinase inhibitors (hinge binders) possess a previously unrecognized potential to act as protein-protein inhibitors of bromodomains.  The findings may provide a new structural framework for the design of next-generation bromodomain inhibitors using the vast chem. space of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonrxl9QUxkE7Vg90H21EOLACvtfcHk0linTY8uJHVGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtbvN&md5=1ae089e8e571ad11aadcdc4a1a5769b5</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fcb4003283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4003283%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DOlesen%26aufirst%3DS.%2BH.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DCyclin-dependent%2520kinase%2520inhibitor%2520dinaciclib%2520interacts%2520with%2520the%2520acetyl-lysine%2520recognition%2520site%2520of%2520bromodomains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2360%26epage%3D2365%26doi%3D10.1021%2Fcb4003283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Ember, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span><span class="refDoi"> DOI: 10.1021/cb500072z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500072z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1160-1171&author=S.+W.+Emberauthor=J.+Y.+Zhuauthor=S.+H.+Olesenauthor=M.+P.+Martinauthor=A.+Beckerauthor=N.+Berndtauthor=G.+I.+Georgauthor=E.+Schonbrunn&title=Acetyl-lysine+binding+site+of+bromodomain-containing+protein+4+%28BRD4%29+interacts+with+diverse+kinase+inhibitors&doi=10.1021%2Fcb500072z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors</span></div><div class="casAuthors">Ember, Stuart W. J.; Zhu, Jin-Yi; Olesen, Sanne H.; Martin, Mathew P.; Becker, Andreas; Berndt, Norbert; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1160-1171</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the bromodomain and extra terminal (BET) family of proteins are essential for the recognition of acetylated lysine (KAc) residues in histones and have emerged as promising drug targets in cancer, inflammation, and contraception research.  In co-crystn. screening campaigns using the first bromodomain of BRD4 (BRD4-1) against kinase inhibitor libraries, we identified and characterized 14 kinase inhibitors (10 distinct chem. scaffolds) as ligands of the KAc binding site.  Among these, the PLK1 inhibitor BI2536 and the JAK2 inhibitor TG101209 displayed strongest inhibitory potential against BRD4 (IC50 = 25 nM and 130 nM, resp.) and high selectivity for BET bromodomains.  Comparative structural anal. revealed markedly different binding modes of kinase hinge-binding scaffolds in the KAc binding site, suggesting that BET proteins are potential off-targets of diverse kinase inhibitors.  Combined, these findings provide a new structural framework for the rational design of next-generation BET-selective and dual-activity BET-kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0X1hjt7cBbVg90H21EOLACvtfcHk0linTY8uJHVGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D&md5=5ca37df00cdaa0ba81c0cb4a0f70ba5d</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fcb500072z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500072z%26sid%3Dliteratum%253Aachs%26aulast%3DEmber%26aufirst%3DS.%2BW.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DOlesen%26aufirst%3DS.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DAcetyl-lysine%2520binding%2520site%2520of%2520bromodomain-containing%2520protein%25204%2520%2528BRD4%2529%2520interacts%2520with%2520diverse%2520kinase%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1160%26epage%3D1171%26doi%3D10.1021%2Fcb500072z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Steegmaier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petronczki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krssak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurtler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolf, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1016/j.cub.2006.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.cub.2006.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=17291758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=316-322&author=M.+Steegmaierauthor=M.+Hoffmannauthor=A.+Baumauthor=P.+Lenartauthor=M.+Petronczkiauthor=M.+Krssakauthor=U.+Gurtlerauthor=P.+Garin-Chesaauthor=S.+Liebauthor=J.+Quantauthor=M.+Grauertauthor=G.+R.+Adolfauthor=N.+Krautauthor=J.+M.+Petersauthor=W.+J.+Rettig&title=BI+2536%2C+a+potent+and+selective+inhibitor+of+polo-like+kinase+1%2C+inhibits+tumor+growth+in+vivo&doi=10.1016%2Fj.cub.2006.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo</span></div><div class="casAuthors">Steegmaier, Martin; Hoffmann, Matthias; Baum, Anke; Lenart, Peter; Petronczki, Mark; Krssak, Martin; Guertler, Ulrich; Garin-Chesa, Pilar; Lieb, Simone; Quant, Jens; Grauert, Matthias; Adolf, Guenther R.; Kraut, Norbert; Peters, Jan-Michael; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">316-322</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fine-mapping of the cell-division cycle, notably the identification of mitotic kinase signaling pathways, provides novel opportunities for cancer-drug discovery.  As a key regulator of multiple steps during mitotic progression across eukaryotic species, the serine/threonine-specific Polo-like kinase 1 (Plk1) is highly expressed in malignant cells and serves as a neg. prognostic marker in specific human cancer types .  Here, we report the discovery of a potent small-mol. inhibitor of mammalian Plk1, BI 2536, which inhibits Plk1 enzyme activity at low nanomolar concns.  The compd. potently causes a mitotic arrest and induces apoptosis in human cancer cell lines of diverse tissue origin and oncogenome signature.  BI 2536 inhibits growth of human tumor xenografts in nude mice and induces regression of large tumors with well-tolerated i.v. dose regimens.  In treated tumors, cells arrest in prometaphase, accumulate phosphohistone H3, and contain aberrant mitotic spindles.  This mitotic arrest is followed by a surge in apoptosis, detectable by immunohistochem. and noninvasive optical and magnetic resonance imaging.  For addressing the therapeutic potential of Plk1 inhibition, BI 2536 has progressed into clin. studies in patients with locally advanced or metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eEWnSYWORbVg90H21EOLACvtfcHk0linTY8uJHVGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D&md5=49807e335b4ab8cf8209b55597fc7b4e</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2006.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2006.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DSteegmaier%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DLenart%26aufirst%3DP.%26aulast%3DPetronczki%26aufirst%3DM.%26aulast%3DKrssak%26aufirst%3DM.%26aulast%3DGurtler%26aufirst%3DU.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DLieb%26aufirst%3DS.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DGrauert%26aufirst%3DM.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DBI%25202536%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520polo-like%2520kinase%25201%252C%2520inhibits%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DCurr.%2520Biol.%26date%3D2007%26volume%3D17%26spage%3D316%26epage%3D322%26doi%3D10.1016%2Fj.cub.2006.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasater, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/nchembio.1471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnchembio.1471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24584101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=305-312&author=P.+Ciceriauthor=S.+Mullerauthor=A.+O%E2%80%99Mahonyauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=J.+P.+Huntauthor=E.+A.+Lasaterauthor=G.+Pallaresauthor=S.+Picaudauthor=C.+Wellsauthor=S.+Martinauthor=L.+M.+Wodickaauthor=N.+P.+Shahauthor=D.+K.+Treiberauthor=S.+Knapp&title=Dual+kinase-bromodomain+inhibitors+for+rationally+designed+polypharmacology&doi=10.1038%2Fnchembio.1471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</span></div><div class="casAuthors">Ciceri, Pietro; Mueller, Susanne; O'Mahony, Alison; Fedorov, Oleg; Filippakopoulos, Panagis; Hunt, Jeremy P.; Lasater, Elisabeth A.; Pallares, Gabriel; Picaud, Sarah; Wells, Christopher; Martin, Sarah; Wodicka, Lisa M.; Shah, Neil P.; Treiber, Daniel K.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clin. responses to targeted therapies.  The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clin. development challenges.  Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy.  Here the authors report that several clin. kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors.  Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clin. PLK1 and JAK2-FLT3 kinase inhibitors, resp., is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacol. targeting.  Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotPedDED4FJLVg90H21EOLACvtfcHk0liyxXatzoSk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D&md5=a00117db2648ea38dd03750faf3b3cb9</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1471%26sid%3Dliteratum%253Aachs%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLasater%26aufirst%3DE.%2BA.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DDual%2520kinase-bromodomain%2520inhibitors%2520for%2520rationally%2520designed%2520polypharmacology%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D305%26epage%3D312%26doi%3D10.1038%2Fnchembio.1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanning, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fountain, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheenstra, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strovel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span> </span><span class="NLM_article-title">BRD4 structure-activity relationships of dual PLK1 kinase/BRD4 bromodomain inhibitor BI-2536</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=764-769&author=L.+Chenauthor=J.+L.+Yapauthor=M.+Yoshiokaauthor=M.+E.+Lanningauthor=R.+N.+Fountainauthor=M.+Rajeauthor=J.+A.+Scheenstraauthor=J.+W.+Strovelauthor=S.+Fletcher&title=BRD4+structure-activity+relationships+of+dual+PLK1+kinase%2FBRD4+bromodomain+inhibitor+BI-2536&doi=10.1021%2Facsmedchemlett.5b00084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536</span></div><div class="casAuthors">Chen, Lijia; Yap, Jeremy L.; Yoshioka, Makoto; Lanning, Maryanna E.; Fountain, Rachel N.; Raje, Mithun; Scheenstra, Jacob A.; Strovel, Jeffrey W.; Fletcher, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A focused library of analogs of the dual PLK1 kinase/BRD4 bromodomain inhibitor BI-2536 was prepd. and then analyzed for BRD4 and PLK1 inhibitory activities.  Particularly, replacement of the cyclopentyl group with a 3-bromobenzyl moiety afforded the most potent BRD4 inhibitor of the series (39j) with a Ki = 8.7 nM, which was equipotent against PLK1.  The superior affinity of 39j over the parental compd. to BRD4 possibly derives from improved interactions with the WPF shelf.  Meanwhile, substitution of the pyrimidine NH with an oxygen atom reversed the PLK1/BRD4 selectivity to convert BI-2536 into a BRD4-selective inhibitor, likely owing to the loss of a crit. hydrogen bond in PLK1.  We believe further fine-tuning will furnish a BRD4 "magic bullet" or an even more potent PLK1/BRD4 dual inhibitor toward the expansion and improved efficacy of the chemotherapy arsenal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UnNSmf1L17Vg90H21EOLACvtfcHk0liyxXatzoSk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D&md5=f39070e652bca20c03a3bc5fe070a7fc</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00084%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYap%26aufirst%3DJ.%2BL.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DLanning%26aufirst%3DM.%2BE.%26aulast%3DFountain%26aufirst%3DR.%2BN.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DScheenstra%26aufirst%3DJ.%2BA.%26aulast%3DStrovel%26aufirst%3DJ.%2BW.%26aulast%3DFletcher%26aufirst%3DS.%26atitle%3DBRD4%2520structure-activity%2520relationships%2520of%2520dual%2520PLK1%2520kinase%252FBRD4%2520bromodomain%2520inhibitor%2520BI-2536%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D764%26epage%3D769%26doi%3D10.1021%2Facsmedchemlett.5b00084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falth Savitski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/cb400789e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400789e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=495-502&author=A.+Dittmannauthor=T.+Wernerauthor=C.+W.+Chungauthor=M.+M.+Savitskiauthor=M.+Falth+Savitskiauthor=P.+Grandiauthor=C.+Hopfauthor=M.+Lindonauthor=G.+Neubauerauthor=R.+K.+Prinjhaauthor=M.+Bantscheffauthor=G.+Drewes&title=The+commonly+used+PI3-kinase+probe+LY294002+is+an+inhibitor+of+BET+bromodomains&doi=10.1021%2Fcb400789e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains</span></div><div class="casAuthors">Dittmann, Antje; Werner, Thilo; Chung, Chun-Wa; Savitski, Mikhail M.; Faelth Savitski, Maria; Grandi, Paola; Hopf, Carsten; Lindon, Matthew; Neubauer, Gitte; Prinjha, Rabinder K.; Bantscheff, Marcus; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A commonly used small-mol. probe in cell-signaling research is the phosphoinositide 3-kinase inhibitor LY294002.  Quant. chemoproteomic profiling shows that LY294002 and LY303511, a close analog devoid of PI3K activity, inhibit the BET bromodomain proteins BRD2, BRD3, and BRD4 that comprise a family of targets structurally unrelated to PI3K.  Both compds. competitively inhibit acetyl-lysine binding of the first but not the second bromodomain of BET proteins in cell exts.  X-ray crystallog. shows that the chromen-4-one scaffold represents a new bromodomain pharmacophore and establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, whereas LY303511 exhibits anti-inflammatory and antiproliferative effects similar to the recently discovered BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbIVXFQARTKLVg90H21EOLACvtfcHk0liyxXatzoSk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO&md5=13435c7d6a6747dc5699e3c3865c8243</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1021%2Fcb400789e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400789e%26sid%3Dliteratum%253Aachs%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DFalth%2BSavitski%26aufirst%3DM.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DLindon%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DThe%2520commonly%2520used%2520PI3-kinase%2520probe%2520LY294002%2520is%2520an%2520inhibitor%2520of%2520BET%2520bromodomains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D495%26epage%3D502%26doi%3D10.1021%2Fcb400789e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Allen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ember, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurer, S. C.</span><span> </span><span class="NLM_article-title">Large-scale computational screening identifies first in class multitarget inhibitor of EGFR kinase and BRD4</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">16924</span><span class="refDoi"> DOI: 10.1038/srep16924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fsrep16924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26596901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFentrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=16924&author=B.+K.+Allenauthor=S.+Mehtaauthor=S.+W.+Emberauthor=E.+Schonbrunnauthor=N.+Ayadauthor=S.+C.+Schurer&title=Large-scale+computational+screening+identifies+first+in+class+multitarget+inhibitor+of+EGFR+kinase+and+BRD4&doi=10.1038%2Fsrep16924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4</span></div><div class="casAuthors">Allen, Bryce K.; Mehta, Saurabh; Ember, Stewart W. J.; Schonbrunn, Ernst; Ayad, Nagi; Schurer, Stephan C.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16924</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of cancer-promoting kinases is an established therapeutic strategy for the treatment of many cancers, although resistance to kinase inhibitors is common.  One way to overcome resistance is to target orthogonal cancer-promoting pathways.  Bromo and Extra-Terminal (BET) domain proteins, which belong to the family of epigenetic readers, have recently emerged as promising therapeutic targets in multiple cancers.  The development of multitarget drugs that inhibit kinase and BET proteins therefore may be a promising strategy to overcome tumor resistance and prolong therapeutic efficacy in the clinic.  We developed a general computational screening approach to identify novel dual kinase/bromodomain inhibitors from millions of com. available small mols.  Our method integrated machine learning using big datasets of kinase inhibitors and structure-based drug design.  Here we describe the computational methodol., including validation and characterization of our models and their application and integration into a scalable virtual screening pipeline.  We screened over 6 million com. available compds. and selected 24 for testing in BRD4 and EGFR biochem. assays.  We identified several novel BRD4 inhibitors, among them a first in class dual EGFR-BRD4 inhibitor.  Our studies suggest that this computational screening approach may be broadly applicable for identifying dual kinase/BET inhibitors with potential for treating various cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2LBJWDL9se7Vg90H21EOLACvtfcHk0lj7ya_0EwJ9Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFentrrI&md5=341f9fedbdfd9e66829e5c43d602d510</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1038%2Fsrep16924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep16924%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DB.%2BK.%26aulast%3DMehta%26aufirst%3DS.%26aulast%3DEmber%26aufirst%3DS.%2BW.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DAyad%26aufirst%3DN.%26aulast%3DSchurer%26aufirst%3DS.%2BC.%26atitle%3DLarge-scale%2520computational%2520screening%2520identifies%2520first%2520in%2520class%2520multitarget%2520inhibitor%2520of%2520EGFR%2520kinase%2520and%2520BRD4%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D16924%26doi%3D10.1038%2Fsrep16924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2931</span><span class="NLM_x">–</span> <span class="NLM_lpage">2935</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2016.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27142751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XntFCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2931-2935&author=Z.+Zhangauthor=S.+Houauthor=H.+Chenauthor=T.+Ranauthor=F.+Jiangauthor=Y.+Bianauthor=D.+Zhangauthor=Y.+Zhiauthor=L.+Wangauthor=L.+Zhangauthor=H.+Liauthor=Y.+Zhangauthor=W.+Tangauthor=T.+Luauthor=Y.+Chen&title=Targeting+epigenetic+reader+and+eraser%3A+Rational+design%2C+synthesis+and+in+vitro+evaluation+of+dimethylisoxazoles+derivatives+as+BRD4%2FHDAC+dual+inhibitors&doi=10.1016%2Fj.bmcl.2016.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors</span></div><div class="casAuthors">Zhang, Zhimin; Hou, Shaohua; Chen, Hongli; Ran, Ting; Jiang, Fei; Bian, Yuanyuan; Zhang, Dewei; Zhi, Yanle; Wang, Lu; Zhang, Li; Li, Hongmei; Zhang, Yanmin; Tang, Weifang; Lu, Tao; Chen, Yadong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2931-2935</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bromodomain protein module and histone deacetylase (HDAC), which recognize and remove acetylated lysine, resp., have emerged as important epigenetic therapeutic targets in cancer treatments.  Herein the authors presented a novel design approach for cancer drug development by combination of bromodomain and HDAC inhibitory activity in one mol.  The designed compds. were synthesized which showed inhibitory activity against bromodomain 4 and HDAC1.  The representative dual bromodomain/HDAC inhibitors, compds. N1-(3-benzoyl-5-(3,5-dimethylisoxazol-4-yl)phenyl)-N7-hydroxyheptanediamide and N1-(3-benzoyl-5-(3,5-dimethylisoxazol-4-yl)phenyl)-N8-hydroxyoctanediamide showed potent antiproliferative activities against human leukemia cell line K562 and MV4-11 in cellular assays.  This work may lay the foundation for developing dual bromodomain/HDAC inhibitors as potential anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriS0VB1G-QoLVg90H21EOLACvtfcHk0lj7ya_0EwJ9Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntFCmt7o%253D&md5=a6ebdbd6402e3117a2f9d96ed071790c</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRan%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DTargeting%2520epigenetic%2520reader%2520and%2520eraser%253A%2520Rational%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520dimethylisoxazoles%2520derivatives%2520as%2520BRD4%252FHDAC%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2931%26epage%3D2935%26doi%3D10.1016%2Fj.bmcl.2016.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9251</span><span class="NLM_x">–</span> <span class="NLM_lpage">9264</span><span class="refDoi"> DOI: 10.1021/jm401334s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401334s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9251-9264&author=G.+Zhangauthor=A.+N.+Plotnikovauthor=E.+Rusinovaauthor=T.+Shenauthor=K.+Morohashiauthor=J.+Joshuaauthor=L.+Zengauthor=S.+Mujtabaauthor=M.+Ohlmeyerauthor=M.+M.+Zhou&title=Structure-guided+design+of+potent+diazobenzene+inhibitors+for+the+BET+bromodomains&doi=10.1021%2Fjm401334s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains</span></div><div class="casAuthors">Zhang, Guangtao; Plotnikov, Alexander N.; Rusinova, Elena; Shen, Tong; Morohashi, Keita; Joshua, Jennifer; Zeng, Lei; Mujtaba, Shiraz; Ohlmeyer, Michael; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9251-9264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BRD4, characterized by two acetyl-lysine binding bromodomains and an extra-terminal (ET) domain, is a key chromatin organizer that directs gene activation in chromatin through transcription factor recruitment, enhancer assembly, and pause release of the RNA polymerase II complex for transcription elongation.  BRD4 has been recently validated as a new epigenetic drug target for cancer and inflammation.  Our current knowledge of the functional differences of the two bromodomains of BRD4, however, is limited and is hindered by the lack of selective inhibitors.  Here, we report our structure-guided development of diazobenzene-based small-mol. inhibitors for the BRD4 bromodomains that have over 90% sequence identity at the acetyl-lysine binding site.  Our lead compd., MS436, through a set of water-mediated interactions, exhibits low nanomolar affinity (estd. Ki of 30-50 nM), with preference for the first bromodomain over the second.  We demonstrated that MS436 effectively inhibits BRD4 activity in NF-κB-directed prodn. of nitric oxide and proinflammatory cytokine interleukin-6 in murine macrophages.  MS436 represents a new class of bromodomain inhibitors and will facilitate further investigation of the biol. functions of the two bromodomains of BRD4 in gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlT4IPx_3s7rVg90H21EOLACvtfcHk0lj7ya_0EwJ9Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO&md5=24c7b50636fc4e0bbbfb80446e4dd23c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fjm401334s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401334s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DMorohashi%26aufirst%3DK.%26aulast%3DJoshua%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DStructure-guided%2520design%2520of%2520potent%2520diazobenzene%2520inhibitors%2520for%2520the%2520BET%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9251%26epage%3D9264%26doi%3D10.1021%2Fjm401334s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.4155%2Ffmc-2016-0059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27193077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1655-1680&author=C.+Galdeanoauthor=A.+Ciulli&title=Selectivity+on-target+of+bromodomain+chemical+probes+by+structure-guided+medicinal+chemistry+and+chemical+biology&doi=10.4155%2Ffmc-2016-0059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology</span></div><div class="casAuthors">Galdeano, Carles; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1655-1680</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Targeting epigenetic proteins is a rapidly growing area for medicinal chem. and drug discovery.  Recent years have seen an explosion of interest in developing small mols. binding to bromodomains, the readers of acetyl-lysine modifications.  A plethora of co-crystal structures has motivated focused fragment-based design and optimization programs within both industry and academia.  These efforts have yielded several compds. entering the clinic, and many more are increasingly being used as chem. probes to interrogate bromodomain biol.  High selectivity of chem. probes is necessary to ensure biol. activity is due to an on-target effect.  Here, we review the state-of-the-art of bromodomain-targeting compds., focusing on the structural basis for their on-target selectivity or lack thereof.  We also highlight chem. biol. approaches to enhance on-target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1bg8K3kh-RLVg90H21EOLACvtfcHk0lioqYVNBjmeqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKhsr3K&md5=a4c02dd517e8582755a918eabd7bfeea</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0059%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelectivity%2520on-target%2520of%2520bromodomain%2520chemical%2520probes%2520by%2520structure-guided%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1655%26epage%3D1680%26doi%3D10.4155%2Ffmc-2016-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Raux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voitovich, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derviaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebuffet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinquet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collette, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, X.</span><span> </span><span class="NLM_article-title">Exploring selective inhibition of the first bromodomain of the human bromodomain and extra-terminal domain (BET) proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1634-1641&author=B.+Rauxauthor=Y.+Voitovichauthor=C.+Derviauxauthor=A.+Lugariauthor=E.+Rebuffetauthor=S.+Milhasauthor=S.+Prietauthor=T.+Rouxauthor=E.+Trinquetauthor=J.+C.+Guillemotauthor=S.+Knappauthor=J.+M.+Brunelauthor=A.+Y.+Fedorovauthor=Y.+Colletteauthor=P.+Rocheauthor=S.+Betziauthor=S.+Combesauthor=X.+Morelli&title=Exploring+selective+inhibition+of+the+first+bromodomain+of+the+human+bromodomain+and+extra-terminal+domain+%28BET%29+proteins&doi=10.1021%2Facs.jmedchem.5b01708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins</span></div><div class="casAuthors">Raux, Brigitt; Voitovich, Yuliia; Derviaux, Carine; Lugari, Adrien; Rebuffet, Etienne; Milhas, Sabine; Priet, Stephane; Roux, Thomas; Trinquet, Eric; Guillemot, Jean-Claude; Knapp, Stefan; Brunel, Jean-Michel; Fedorov, Alexey Yu.; Collette, Yves; Roche, Philippe; Betzi, Stephane; Combes, Sebastien; Morelli, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1634-1641</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A midthroughput screening follow-up program targeting the first bromodomain of the human BRD4 protein, BRD4(BD1), identified an acetylated-mimic xanthine deriv. inhibitor.  This compd. binds with an affinity in the low micromolar range yet exerts suitable unexpected selectivity in vitro against the other members of the bromodomain and extra-terminal domain (BET) family.  A structure-based program pinpointed a role of the ZA loop, paving the way for the development of potent and selective BET-BRDi probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQdXvF3r4zLVg90H21EOLACvtfcHk0lioqYVNBjmeqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKhsr0%253D&md5=fb9cfc20c76f65fcf409370b60aecc0a</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01708%26sid%3Dliteratum%253Aachs%26aulast%3DRaux%26aufirst%3DB.%26aulast%3DVoitovich%26aufirst%3DY.%26aulast%3DDerviaux%26aufirst%3DC.%26aulast%3DLugari%26aufirst%3DA.%26aulast%3DRebuffet%26aufirst%3DE.%26aulast%3DMilhas%26aufirst%3DS.%26aulast%3DPriet%26aufirst%3DS.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DGuillemot%26aufirst%3DJ.%2BC.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrunel%26aufirst%3DJ.%2BM.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26aulast%3DCollette%26aufirst%3DY.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DMorelli%26aufirst%3DX.%26atitle%3DExploring%2520selective%2520inhibition%2520of%2520the%2520first%2520bromodomain%2520of%2520the%2520human%2520bromodomain%2520and%2520extra-terminal%2520domain%2520%2528BET%2529%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1634%26epage%3D1641%26doi%3D10.1021%2Facs.jmedchem.5b01708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Devaiah, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, D. S.</span><span> </span><span class="NLM_article-title">BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">6927</span><span class="NLM_x">–</span> <span class="NLM_lpage">6932</span><span class="refDoi"> DOI: 10.1073/pnas.1120422109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1073%2Fpnas.1120422109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=22509028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVWksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=6927-6932&author=B.+N.+Devaiahauthor=B.+A.+Lewisauthor=N.+Chermanauthor=M.+C.+Hewittauthor=B.+K.+Albrechtauthor=P.+G.+Robeyauthor=K.+Ozatoauthor=R.+J.+Simsauthor=D.+S.+Singer&title=BRD4+is+an+atypical+kinase+that+phosphorylates+serine2+of+the+RNA+polymerase+II+carboxy-terminal+domain&doi=10.1073%2Fpnas.1120422109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA polymerase II carboxy-terminal domain</span></div><div class="casAuthors">Devaiah, Ballachanda N.; Lewis, Brian A.; Cherman, Natasha; Hewitt, Michael C.; Albrecht, Brian K.; Robey, Pamela G.; Ozato, Keiko; Sims, Robert J., III; Singer, Dinah S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6927-6932, S6927/1-S6927/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bromodomain protein BRD4 has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt's lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer.  BRD4 also contributes to regulation of both cell cycle and transcription of oncogenes, HIV, and human papilloma virus (HPV).  Despite its role in a broad range of biol. processes, the precise mol. mechanism of BRD4 function remains unknown.  Here, the authors report that BRD4 is an atypical kinase that binds to the C-terminal domain (CTD) of RNA polymerase II and directly phosphorylates its Ser-2 sites both in vitro and in vivo under conditions where other CTD kinases are inactive.  Phosphorylation of the CTD Ser-2 residue was inhibited in vivo by a BRD4 inhibitor that blocked its binding to chromatin.  This finding that BRD4 is an RNA polymerase II CTD Ser-2 kinase implicates it as a regulator of eukaryotic transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_kIxSaI3kbVg90H21EOLACvtfcHk0lioqYVNBjmeqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVWksL4%253D&md5=0c682d9f376133840a874cc8854352d8</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1120422109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1120422109%26sid%3Dliteratum%253Aachs%26aulast%3DDevaiah%26aufirst%3DB.%2BN.%26aulast%3DLewis%26aufirst%3DB.%2BA.%26aulast%3DCherman%26aufirst%3DN.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DRobey%26aufirst%3DP.%2BG.%26aulast%3DOzato%26aufirst%3DK.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DSinger%26aufirst%3DD.%2BS.%26atitle%3DBRD4%2520is%2520an%2520atypical%2520kinase%2520that%2520phosphorylates%2520serine2%2520of%2520the%2520RNA%2520polymerase%2520II%2520carboxy-terminal%2520domain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D6927%26epage%3D6932%26doi%3D10.1073%2Fpnas.1120422109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Baud, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin-Shiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardote, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pschibul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1126/science.1249830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1126%2Fscience.1249830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25323695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2014&pages=638-641&author=M.+G.+Baudauthor=E.+Lin-Shiaoauthor=T.+Cardoteauthor=C.+Tallantauthor=A.+Pschibulauthor=K.+H.+Chanauthor=M.+Zengerleauthor=J.+R.+Garciaauthor=T.+T.+Kwanauthor=F.+M.+Fergusonauthor=A.+Ciulli&title=Chemical+biology.+A+bump-and-hole+approach+to+engineer+controlled+selectivity+of+BET+bromodomain+chemical+probes&doi=10.1126%2Fscience.1249830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes</span></div><div class="casAuthors">Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Tallant, Cynthia; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Kwan, Terence T.-L.; Ferguson, Fleur M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6209</span>),
    <span class="NLM_cas:pages">638-641</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. are useful tools for probing the biol. function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins.  The bromodomain and extra-terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer.  The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-mol. inhibitors, but these inhibitors lack selectivity for individual family members.  We developed an Et deriv. of an existing small-mol. inhibitor, I-BET/JQ1, and showed that it binds leucine/alanine mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains.  Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin.  Expansion of this approach could help identify the individual roles of single BET proteins in human physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9EnzLtvUKwbVg90H21EOLACvtfcHk0lgPPTPM9FExnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL&md5=04fe967e4681fb4b2b3168f4d5f8ff81</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249830%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%26aulast%3DLin-Shiao%26aufirst%3DE.%26aulast%3DCardote%26aufirst%3DT.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DPschibul%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DJ.%2BR.%26aulast%3DKwan%26aufirst%3DT.%2BT.%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DChemical%2520biology.%2520A%2520bump-and-hole%2520approach%2520to%2520engineer%2520controlled%2520selectivity%2520of%2520BET%2520bromodomain%2520chemical%2520probes%26jtitle%3DScience%26date%3D2014%26volume%3D346%26spage%3D638%26epage%3D641%26doi%3D10.1126%2Fscience.1249830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Garnier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1517/13543776.2014.859244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1517%2F13543776.2014.859244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24261714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=185-199&author=J.+M.+Garnierauthor=P.+P.+Sharpauthor=C.+J.+Burns&title=BET+bromodomain+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2014.859244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibitors: a patent review</span></div><div class="casAuthors">Garnier, Jean-Marc; Sharp, Phillip P.; Burns, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The bromodomain (BRD) and extra-C terminal domain (BET) protein family consists of four members (BRD2, BRD3, BRD4 and BRDT).  These "epigenetic readers" bind to acetyllysine (KAc) residues on the tails of histones H3 and H4, and regulate chromatin structure and gene expression.  There is increasing evidence of their role in human disease, and recently a no. of small-mol. inhibitors have been reported.  There is increasing interest in the inhibition of BET proteins for a variety of therapeutic applications that have resulted in considerable patent activity from academia and biotechnol. and pharmaceutical companies.  Areas covered: Data supporting the use of BET inhibitors in treating disease are outlined, and the current patent literature is discussed.  The survey is focused on patents claiming compds. as BET inhibitors and addnl. patents covering compds. now reported as BET inhibitors have been included.  Expert opinion: There is now compelling preclin. data demonstrating BET inhibition as a strategy to target processes known to be involved in disease development and progression with clin. trials of two bona fide BET inhibitors now underway.  Patent activity in this area is increasing with initial activity focused on variations to reported BET inhibitors and more recent patents disclosing novel chemotypes as BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6PVpCrReabVg90H21EOLACvtfcHk0lgPPTPM9FExnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlWgtg%253D%253D&md5=bb33008eefa34f3689e0ee4a49a2539e</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.859244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.859244%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier%26aufirst%3DJ.%2BM.%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBET%2520bromodomain%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D185%26epage%3D199%26doi%3D10.1517%2F13543776.2014.859244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badock, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberspacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosmayer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmees, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Montalvan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haendler, B.</span><span> </span><span class="NLM_article-title">Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">9304</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span><span class="refDoi"> DOI: 10.1074/jbc.M113.523019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1074%2Fjbc.M113.523019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=24497639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVWjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=9304-9319&author=M.+Jungauthor=M.+Philpottauthor=S.+Mullerauthor=J.+Schulzeauthor=V.+Badockauthor=U.+Eberspacherauthor=D.+Moosmayerauthor=B.+Baderauthor=N.+Schmeesauthor=A.+Fernandez-Montalvanauthor=B.+Haendler&title=Affinity+map+of+bromodomain+protein+4+%28BRD4%29+interactions+with+the+histone+H4+tail+and+the+small+molecule+inhibitor+JQ1&doi=10.1074%2Fjbc.M113.523019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity Map of Bromodomain Protein 4 (BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1</span></div><div class="casAuthors">Jung, Marie; Philpott, Martin; Mueller, Susanne; Schulze, Jessica; Badock, Volker; Eberspaecher, Uwe; Moosmayer, Dieter; Bader, Benjamin; Schmees, Norbert; Fernandez-Montalvan, Amaury; Haendler, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">9304-9319</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain (BET) protein family.  It binds to acetylated histone tails via its tandem bromodomains BD1 and BD2 and forms a complex with the pos. transcription elongation factor b, which controls phosphorylation of RNA polymerase II, ultimately leading to stimulation of transcription elongation.  An essential role of BRD4 in cell proliferation and cancer growth has been reported in several recent studies.  We analyzed the binding of BRD4 BD1 and BD2 to different partners and showed that the strongest interactions took place with di- and tetra-acetylated peptides derived from the histone 4 N-terminal tail.  We also found that several histone 4 residues neighboring the acetylated lysines significantly influenced binding.  We generated 10 different BRD4 BD1 mutants and analyzed their affinities to acetylated histone tails and to the BET inhibitor JQ1 using several complementary biochem. and biophys. methods.  The impact of these mutations was confirmed in a cellular environment.  Altogether, the results show that Trp-81, Tyr-97, Asn-140, and Met-149 play similarly important roles in the recognition of acetylated histones and JQ1.  Pro-82, Leu-94, Asp-145, and Ile-146 have a more differentiated role, suggesting that different kinds of interactions take place and that resistance mutations compatible with BRD4 function are possible.  Our study extends the knowledge on the contribution of individual BRD4 amino acids to histone and JQ1 binding and may help in the design of new BET antagonists with improved pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8wAGYLccT1bVg90H21EOLACvtfcHk0lgPPTPM9FExnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVWjs70%253D&md5=bf1d882e680e82660065b3e7b0a0f0f9</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.523019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.523019%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DEberspacher%26aufirst%3DU.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DSchmees%26aufirst%3DN.%26aulast%3DFernandez-Montalvan%26aufirst%3DA.%26aulast%3DHaendler%26aufirst%3DB.%26atitle%3DAffinity%2520map%2520of%2520bromodomain%2520protein%25204%2520%2528BRD4%2529%2520interactions%2520with%2520the%2520histone%2520H4%2520tail%2520and%2520the%2520small%2520molecule%2520inhibitor%2520JQ1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D9304%26epage%3D9319%26doi%3D10.1074%2Fjbc.M113.523019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Sharp, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span> </span><span class="NLM_article-title">Evaluation of functional groups as acetyl-lysine mimetics for BET bromodomain inhibition</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1834</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span><span class="refDoi"> DOI: 10.1039/C4MD00182F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1039%2FC4MD00182F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1834-1842&author=P.+P.+Sharpauthor=J.-M.+Garnierauthor=D.+C.+S.+Huangauthor=C.+J.+Burns&title=Evaluation+of+functional+groups+as+acetyl-lysine+mimetics+for+BET+bromodomain+inhibition&doi=10.1039%2FC4MD00182F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1039%2FC4MD00182F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00182F%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DGarnier%26aufirst%3DJ.-M.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520functional%2520groups%2520as%2520acetyl-lysine%2520mimetics%2520for%2520BET%2520bromodomain%2520inhibition%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D1834%26epage%3D1842%26doi%3D10.1039%2FC4MD00182F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Duffy, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarasimhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitchen, D. B.</span><span> </span><span class="NLM_article-title">Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2818</span><span class="NLM_x">–</span> <span class="NLM_lpage">2823</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2015.04.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2818-2823&author=B.+C.+Duffyauthor=S.+Liuauthor=G.+S.+Martinauthor=R.+Wangauthor=M.+M.+Hsiaauthor=H.+Zhaoauthor=C.+Guoauthor=M.+Ellisauthor=J.+F.+Quinnauthor=O.+A.+Kharenkoauthor=K.+Norekauthor=E.+M.+Gesnerauthor=P.+R.+Youngauthor=K.+G.+McLureauthor=G.+S.+Wagnerauthor=D.+Lakshminarasimhanauthor=A.+Whiteauthor=R.+K.+Sutoauthor=H.+C.+Hansenauthor=D.+B.+Kitchen&title=Discovery+of+a+new+chemical+series+of+BRD4%281%29+inhibitors+using+protein-ligand+docking+and+structure-guided+design&doi=10.1016%2Fj.bmcl.2015.04.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.107%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DB.%2BC.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DHsia%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DEllis%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DNorek%26aufirst%3DK.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DLakshminarasimhan%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DKitchen%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520new%2520chemical%2520series%2520of%2520BRD4%25281%2529%2520inhibitors%2520using%2520protein-ligand%2520docking%2520and%2520structure-guided%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2818%26epage%3D2823%26doi%3D10.1016%2Fj.bmcl.2015.04.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartenmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliotopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2496</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmcl.2014.04.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2493-2496&author=H.+Zhaoauthor=L.+Gartenmannauthor=J.+Dongauthor=D.+Spiliotopoulosauthor=A.+Caflisch&title=Discovery+of+BRD4+bromodomain+inhibitors+by+fragment-based+high-throughput+docking&doi=10.1016%2Fj.bmcl.2014.04.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGartenmann%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520BRD4%2520bromodomain%2520inhibitors%2520by%2520fragment-based%2520high-throughput%2520docking%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2493%26epage%3D2496%26doi%3D10.1016%2Fj.bmcl.2014.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Noguchi-Yachide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span> </span><span class="NLM_article-title">Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.bmc.2015.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25678016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=953-959&author=T.+Noguchi-Yachideauthor=T.+Sakaiauthor=Y.+Hashimotoauthor=T.+Yamaguchi&title=Discovery+and+structure-activity+relationship+studies+of+N6-benzoyladenine+derivatives+as+novel+BRD4+inhibitors&doi=10.1016%2Fj.bmc.2015.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors</span></div><div class="casAuthors">Noguchi-Yachide, Tomomi; Sakai, Taki; Hashimoto, Yuichi; Yamaguchi, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">953-959</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that bind to acetylated lysines in histones.  Among them, BRD4 is a candidate target mol. of therapeutic agents for diverse diseases, including cancer and inflammatory disease.  As a part of the continuing structural development studies of thalidomide to obtain a broad spectrum of biol. modifiers based on the 'multitemplate' approach, in this work the authors focused on BRD4-inhibitory activity, and discovered that N6-benzoyladenine derivs. exhibit this activity.  Structure-activity relationship studies led to N6-(2,4,5-trimethoxybenzoyl)adenine I, which exhibits potent BRD4 bromodomain1 inhibitory activity with an IC50 value of 0.427 μM.  N6-Benzoyladenine appears to be a new chem. scaffold for development of BRD4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwaLfpkAET7Vg90H21EOLACvtfcHk0lghY7tlSbtysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D&md5=889cf81c25fd1e62def22cb2f32dc06e</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi-Yachide%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520N6-benzoyladenine%2520derivatives%2520as%2520novel%2520BRD4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D953%26epage%3D959%26doi%3D10.1016%2Fj.bmc.2015.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8073</span><span class="NLM_x">–</span> <span class="NLM_lpage">8088</span><span class="refDoi"> DOI: 10.1021/jm4011302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8073-8088&author=L.+R.+Vidlerauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=S.+Martinauthor=M.+Tomsettauthor=H.+Woodwardauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Discovery+of+novel+small-molecule+inhibitors+of+BRD4+using+structure-based+virtual+screening&doi=10.1021%2Fjm4011302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening</span></div><div class="casAuthors">Vidler, Lewis R.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Martin, Sarah; Tomsett, Michael; Woodward, Hannah; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8073-8088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are epigenetic readers that recognize acetylated-lysine (KAc) on proteins and are implicated in a no. of diseases.  We describe a virtual screening approach to identify BRD inhibitors.  Key elements of this approach are the extensive design and use of substructure queries to compile a set of com. available compds. featuring novel putative KAc mimetics and docking this set for final compd. selection.  We describe the validation of this approach by applying it to the first BRD of BRD4.  The selection and testing of 143 compds. lead to the discovery of six novel hits, including four unprecedented KAc mimetics.  We solved the crystal structure of four hits, detd. their binding mode, and improved their potency through synthesis and the purchase of derivs.  This work provides a validated virtual screening approach that is applicable to other BRDs and describes novel KAc mimetics that can be further explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow5yj8bnohUbVg90H21EOLACvtfcHk0lghY7tlSbtysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI&md5=c1f76e4838713335be7a93ebe4c68701</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Fjm4011302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011302%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTomsett%26aufirst%3DM.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520BRD4%2520using%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8073%26epage%3D8088%26doi%3D10.1021%2Fjm4011302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.drudis.2014.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=25263697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=105-113&author=H.+Chenauthor=X.+Zhouauthor=A.+Wangauthor=Y.+Zhengauthor=Y.+Gaoauthor=J.+Zhou&title=Evolutions+in+fragment-based+drug+design%3A+the+deconstruction-reconstruction+approach&doi=10.1016%2Fj.drudis.2014.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span></div><div class="casAuthors">Chen, Haijun; Zhou, Xiaobin; Wang, Ailan; Zheng, Yunquan; Gao, Yu; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of mol. recognition and protein-ligand interactions have facilitated rapid development of potent and selective ligands for therapeutically relevant targets.  Over the past two decades, a variety of useful approaches and emerging techniques have been developed to promote the identification and optimization of leads that have high potential for generating new therapeutic agents.  Intriguingly, the innovation of a fragment-based drug design (FBDD) approach has enabled rapid and efficient progress in drug discovery.  In this crit. review, we focus on the construction of fragment libraries and the advantages and disadvantages of various fragment-based screening (FBS) for constructing such libraries.  We also highlight the deconstruction-reconstruction strategy by utilizing privileged fragments of reported ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWzbA5c5707Vg90H21EOLACvtfcHk0lg7_YZkkJYgDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO&md5=13ce52517b336a860136ac3eb4151b16</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEvolutions%2520in%2520fragment-based%2520drug%2520design%253A%2520the%2520deconstruction-reconstruction%2520approach%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D105%26epage%3D113%26doi%3D10.1016%2Fj.drudis.2014.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Herait, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieblemont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffoux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magarotto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leleu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Roca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odore, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesnel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucca, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michallet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvitkovic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preudhomme, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span> </span><span class="NLM_article-title">Abstract CT231: BET-bromodomain inhibitor OTX015 shows clinically meaningful activity at nontoxic doses: interim results of an ongoing phase I trial in hematologic malignancies</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">CT231</span><span class="NLM_x">–</span> <span class="NLM_lpage">CT231</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-CT231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1158%2F1538-7445.AM2014-CT231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=CT231-CT231&author=P.+E.+Heraitauthor=C.+Berthonauthor=C.+Thieblemontauthor=E.+Raffouxauthor=V.+Magarottoauthor=A.+Stathisauthor=X.+Thomasauthor=X.+Leleuauthor=C.+Gomez-Rocaauthor=E.+Odoreauthor=C.+Roumierauthor=F.+Bourdelauthor=B.+Quesnelauthor=E.+Zuccaauthor=M.+Michalletauthor=C.+Recherauthor=E.+Cvitkovicauthor=K.+Rezaiauthor=C.+Preudhommeauthor=T.+Faconauthor=A.+Palumboauthor=H.+Dombret&title=Abstract+CT231%3A+BET-bromodomain+inhibitor+OTX015+shows+clinically+meaningful+activity+at+nontoxic+doses%3A+interim+results+of+an+ongoing+phase+I+trial+in+hematologic+malignancies&doi=10.1158%2F1538-7445.AM2014-CT231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-CT231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-CT231%26sid%3Dliteratum%253Aachs%26aulast%3DHerait%26aufirst%3DP.%2BE.%26aulast%3DBerthon%26aufirst%3DC.%26aulast%3DThieblemont%26aufirst%3DC.%26aulast%3DRaffoux%26aufirst%3DE.%26aulast%3DMagarotto%26aufirst%3DV.%26aulast%3DStathis%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DX.%26aulast%3DLeleu%26aufirst%3DX.%26aulast%3DGomez-Roca%26aufirst%3DC.%26aulast%3DOdore%26aufirst%3DE.%26aulast%3DRoumier%26aufirst%3DC.%26aulast%3DBourdel%26aufirst%3DF.%26aulast%3DQuesnel%26aufirst%3DB.%26aulast%3DZucca%26aufirst%3DE.%26aulast%3DMichallet%26aufirst%3DM.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DCvitkovic%26aufirst%3DE.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DPreudhomme%26aufirst%3DC.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DDombret%26aufirst%3DH.%26atitle%3DAbstract%2520CT231%253A%2520BET-bromodomain%2520inhibitor%2520OTX015%2520shows%2520clinically%2520meaningful%2520activity%2520at%2520nontoxic%2520doses%253A%2520interim%2520results%2520of%2520an%2520ongoing%2520phase%2520I%2520trial%2520in%2520hematologic%2520malignancies%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3DCT231%26epage%3DCT231%26doi%3D10.1158%2F1538-7445.AM2014-CT231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Fong, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ftouni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papenfuss, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M. A.</span><span> </span><span class="NLM_article-title">BET inhibitor resistance emerges from leukaemia stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1038/nature14888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature14888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26367796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=538-542&author=C.+Y.+Fongauthor=O.+Gilanauthor=E.+Y.+Lamauthor=A.+F.+Rubinauthor=S.+Ftouniauthor=D.+Tylerauthor=K.+Stanleyauthor=D.+Sinhaauthor=P.+Yehauthor=J.+Morisonauthor=G.+Giotopoulosauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+C.+Leeauthor=C.+Carpenterauthor=R.+Gregoryauthor=R.+G.+Ramsayauthor=S.+W.+Laneauthor=O.+Abdel-Wahabauthor=T.+Kouzaridesauthor=R.+W.+Johnstoneauthor=S.+J.+Dawsonauthor=B.+J.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+T.+Papenfussauthor=M.+A.+Dawson&title=BET+inhibitor+resistance+emerges+from+leukaemia+stem+cells&doi=10.1038%2Fnature14888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor resistance emerges from leukaemia stem cells</span></div><div class="casAuthors">Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Rubin, Alan F.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Morison, Jessica; Giotopoulos, George; Lugo, Dave; Jeffrey, Philip; Lee, Stanley Chun-Wei; Carpenter, Christopher; Gregory, Richard; Ramsay, Robert G.; Lane, Steven W.; Abdel-Wahab, Omar; Kouzarides, Tony; Johnstone, Ricky W.; Dawson, Sarah-Jane; Huntly, Brian J. P.; Prinjha, Rab K.; Papenfuss, Anthony T.; Dawson, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">538-542</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks.  Early clin. trials have shown promise, esp. in acute myeloid leukemia, and therefore the evaluation of resistance mechanisms is crucial to optimize the clin. efficacy of these drugs.  Here we use primary mouse hematopoietic stem and progenitor cells immortalized with the fusion protein MLL-AF9 to generate several single-cell clones that demonstrate resistance, in vitro and in vivo, to the prototypical BET inhibitor, I-BET.  Resistance to I-BET confers cross-resistance to chem. distinct BET inhibitors such as JQ1, as well as resistance to genetic knockdown of BET proteins.  Resistance is not mediated through increased drug efflux or metab., but is shown to emerge from leukemia stem cells both ex vivo and in vivo.  Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate transcription.  We demonstrate that resistance to BET inhibitors, in human and mouse leukemia cells, is in part a consequence of increased Wnt/β-catenin signaling, and neg. regulation of this pathway results in restoration of sensitivity to I-BET in vitro and in vivo.  Together, these findings provide new insights into the biol. of acute myeloid leukemia, highlight potential therapeutic limitations of BET inhibitors, and identify strategies that may enhance the clin. utility of these unique targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Lg1n64SCWrVg90H21EOLACvtfcHk0lg7_YZkkJYgDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL&md5=47d1769e077b1c6c92ff52a051368404</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fnature14888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14888%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DC.%2BY.%26aulast%3DGilan%26aufirst%3DO.%26aulast%3DLam%26aufirst%3DE.%2BY.%26aulast%3DRubin%26aufirst%3DA.%2BF.%26aulast%3DFtouni%26aufirst%3DS.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DStanley%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMorison%26aufirst%3DJ.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DCarpenter%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DR.%26aulast%3DRamsay%26aufirst%3DR.%2BG.%26aulast%3DLane%26aufirst%3DS.%2BW.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DDawson%26aufirst%3DS.%2BJ.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DPapenfuss%26aufirst%3DA.%2BT.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26atitle%3DBET%2520inhibitor%2520resistance%2520emerges%2520from%2520leukaemia%2520stem%2520cells%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D538%26epage%3D542%26doi%3D10.1038%2Fnature14888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Rathert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muerdter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deswal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny-Reiterer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jude, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boryn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweifer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuber, J.</span><span> </span><span class="NLM_article-title">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">525</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1038/nature14898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature14898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26367798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=543-547&author=P.+Rathertauthor=M.+Rothauthor=T.+Neumannauthor=F.+Muerdterauthor=J.+S.+Roeauthor=M.+Muharauthor=S.+Deswalauthor=S.+Cerny-Reitererauthor=B.+Peterauthor=J.+Judeauthor=T.+Hoffmannauthor=L.+M.+Borynauthor=E.+Axelssonauthor=N.+Schweiferauthor=U.+Tontsch-Gruntauthor=L.+E.+Dowauthor=D.+Gianniauthor=M.+Pearsonauthor=P.+Valentauthor=A.+Starkauthor=N.+Krautauthor=C.+R.+Vakocauthor=J.+Zuber&title=Transcriptional+plasticity+promotes+primary+and+acquired+resistance+to+BET+inhibition&doi=10.1038%2Fnature14898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span></div><div class="casAuthors">Rathert, Philipp; Roth, Mareike; Neumann, Tobias; Muerdter, Felix; Roe, Jae-Seok; Muhar, Matthias; Deswal, Sumit; Cerny-Reiterer, Sabine; Peter, Barbara; Jude, Julian; Hoffmann, Thomas; Boryn, Lukasz M.; Axelsson, Elin; Schweifer, Norbert; Tontsch-Grunt, Ulrike; Dow, Lukas E.; Gianni, Davide; Pearson, Mark; Valent, Peter; Stark, Alexander; Kraut, Norbert; Vakoc, Christopher R.; Zuber, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">543-547</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Following the discovery of BRD4 as a non-oncogene addiction target in acute myeloid leukemia (AML), bromodomain and extra terminal protein (BET) inhibitors are being explored as a promising therapeutic avenue in numerous cancers.  While clin. trials have reported single-agent activity in advanced hematol. malignancies, mechanisms detg. the response to BET inhibition remain poorly understood.  To identify factors involved in primary and acquired BET resistance in leukemia, here we perform a chromatin-focused RNAi screen in a sensitive MLL-AF9;NrasG12D-driven AML mouse model, and investigate dynamic transcriptional profiles in sensitive and resistant mouse and human leukemias.  Our screen shows that suppression of the PRC2 complex, contrary to effects in other contexts, promotes BET inhibitor resistance in AML.  PRC2 suppression does not directly affect the regulation of Brd4-dependent transcripts, but facilitates the remodelling of regulatory pathways that restore the transcription of key targets such as Myc.  Similarly, while BET inhibition triggers acute MYC repression in human leukemias regardless of their sensitivity, resistant leukemias are uniformly characterized by their ability to rapidly restore MYC transcription.  This process involves the activation and recruitment of WNT signaling components, which compensate for the loss of BRD4 and drive resistance in various cancer models.  Dynamic chromatin immunopptn. sequencing and self-transcribing active regulatory region sequencing of enhancer profiles reveal that BET-resistant states are characterized by remodelled regulatory landscapes, involving the activation of a focal MYC enhancer that recruits WNT machinery in response to BET inhibition.  Together, our results identify and validate WNT signaling as a driver and candidate biomarker of primary and acquired BET resistance in leukemia, and implicate the rewiring of transcriptional programs as an important mechanism promoting resistance to BET inhibitors and, potentially, other chromatin-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDgeY3nFr4GrVg90H21EOLACvtfcHk0liDWgLoYBbAUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO&md5=6d6cf4c4123ad6a698b88f02f95a2ebe</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1038%2Fnature14898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14898%26sid%3Dliteratum%253Aachs%26aulast%3DRathert%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DT.%26aulast%3DMuerdter%26aufirst%3DF.%26aulast%3DRoe%26aufirst%3DJ.%2BS.%26aulast%3DMuhar%26aufirst%3DM.%26aulast%3DDeswal%26aufirst%3DS.%26aulast%3DCerny-Reiterer%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DB.%26aulast%3DJude%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DBoryn%26aufirst%3DL.%2BM.%26aulast%3DAxelsson%26aufirst%3DE.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DGianni%26aufirst%3DD.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DA.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DZuber%26aufirst%3DJ.%26atitle%3DTranscriptional%2520plasticity%2520promotes%2520primary%2520and%2520acquired%2520resistance%2520to%2520BET%2520inhibition%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D543%26epage%3D547%26doi%3D10.1038%2Fnature14898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Shu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witwicki, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabassum, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammed, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekram, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peluffo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Santos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krop, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span> </span><span class="NLM_article-title">Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">529</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1038/nature16508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fnature16508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=26735014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1Gmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=529&publication_year=2016&pages=413-417&author=S.+Shuauthor=C.+Y.+Linauthor=H.+H.+Heauthor=R.+M.+Witwickiauthor=D.+P.+Tabassumauthor=J.+M.+Robertsauthor=M.+Janiszewskaauthor=S.+J.+Huhauthor=Y.+Liangauthor=J.+Ryanauthor=E.+Dohertyauthor=H.+Mohammedauthor=H.+Guoauthor=D.+G.+Stoverauthor=M.+B.+Ekramauthor=G.+Peluffoauthor=J.+Brownauthor=C.+D%E2%80%99Santosauthor=I.+E.+Kropauthor=D.+Dillonauthor=M.+McKeownauthor=C.+Ottauthor=J.+Qiauthor=M.+Niauthor=P.+K.+Raoauthor=M.+Duarteauthor=S.+Y.+Wuauthor=C.+M.+Chiangauthor=L.+Andersauthor=R.+A.+Youngauthor=E.+P.+Winerauthor=A.+Letaiauthor=W.+T.+Barryauthor=J.+S.+Carrollauthor=H.+W.+Longauthor=M.+Brownauthor=X.+S.+Liuauthor=C.+A.+Meyerauthor=J.+E.+Bradnerauthor=K.+Polyak&title=Response+and+resistance+to+BET+bromodomain+inhibitors+in+triple-negative+breast+cancer&doi=10.1038%2Fnature16508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer</span></div><div class="casAuthors">Shu, Shaokun; Lin, Charles Y.; He, Housheng Hansen; Witwicki, Robert M.; Tabassum, Doris P.; Roberts, Justin M.; Janiszewska, Michalina; Huh, Sung Jin; Liang, Yi; Ryan, Jeremy; Doherty, Ernest; Mohammed, Hisham; Guo, Hao; Stover, Daniel G.; Ekram, Muhammad B.; Peluffo, Guillermo; Brown, Jonathan; D'Santos, Clive; Krop, Ian E.; Dillon, Deborah; McKeown, Michael; Ott, Christopher; Qi, Jun; Ni, Min; Rao, Prakash K.; Duarte, Melissa; Wu, Shwu-Yuan; Chiang, Cheng-Ming; Anders, Lars; Young, Richard A.; Winer, Eric P.; Letai, Antony; Barry, William T.; Carroll, Jason S.; Long, Henry W.; Brown, Myles; Shirley Liu, X.; Meyer, Clifford A.; Bradner, James E.; Polyak, Kornelia</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">529</span>
        (<span class="NLM_cas:issue">7586</span>),
    <span class="NLM_cas:pages">413-417</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a heterogeneous and clin. aggressive disease for which there is no targeted therapy.  BET bromodomain inhibitors, which have shown efficacy in several models of cancer, have not been evaluated in TNBC.  These inhibitors displace BET bromodomain proteins such as BRD4 from chromatin by competing with their acetyl-lysine recognition modules, leading to inhibition of oncogenic transcriptional programs.  Here we report the preferential sensitivity of TNBCs to BET bromodomain inhibition in vitro and in vivo, establishing a rationale for clin. investigation and further motivation to understand mechanisms of resistance.  In paired cell lines selected for acquired resistance to BET inhibition from previously sensitive TNBCs, we failed to identify gatekeeper mutations, new driver events or drug pump activation.  BET-resistant TNBC cells remain dependent on wild-type BRD4, which supports transcription and cell proliferation in a bromodomain-independent manner.  Proteomic studies of resistant TNBC identify strong assocn. with MED1 and hyper-phosphorylation of BRD4 attributable to decreased activity of PP2A, identified here as a principal BRD4 serine phosphatase.  Together, these studies provide a rationale for BET inhibition in TNBC and present mechanism-based combination strategies to anticipate clin. drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZu5A85pdQDbVg90H21EOLACvtfcHk0liDWgLoYBbAUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1Gmtw%253D%253D&md5=50a03861d9156ee6e344e95c5f5361b9</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fnature16508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16508%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DHe%26aufirst%3DH.%2BH.%26aulast%3DWitwicki%26aufirst%3DR.%2BM.%26aulast%3DTabassum%26aufirst%3DD.%2BP.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DJaniszewska%26aufirst%3DM.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DMohammed%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DStover%26aufirst%3DD.%2BG.%26aulast%3DEkram%26aufirst%3DM.%2BB.%26aulast%3DPeluffo%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Santos%26aufirst%3DC.%26aulast%3DKrop%26aufirst%3DI.%2BE.%26aulast%3DDillon%26aufirst%3DD.%26aulast%3DMcKeown%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DNi%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DP.%2BK.%26aulast%3DDuarte%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DChiang%26aufirst%3DC.%2BM.%26aulast%3DAnders%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DW.%2BT.%26aulast%3DCarroll%26aufirst%3DJ.%2BS.%26aulast%3DLong%26aufirst%3DH.%2BW.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BS.%26aulast%3DMeyer%26aufirst%3DC.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DResponse%2520and%2520resistance%2520to%2520BET%2520bromodomain%2520inhibitors%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DNature%26date%3D2016%26volume%3D529%26spage%3D413%26epage%3D417%26doi%3D10.1038%2Fnature16508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Kurimchak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbasov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounsbury, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chernoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, J. S.</span><span> </span><span class="NLM_article-title">Resistance to BET bromodomain inhibitors is mediated by kinome reprogramming in ovarian cancer</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span><span class="refDoi"> DOI: 10.1016/j.celrep.2016.06.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.celrep.2016.06.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27452461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1CksrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1273-1286&author=A.+M.+Kurimchakauthor=C.+Sheltonauthor=K.+E.+Duncanauthor=K.+J.+Johnsonauthor=J.+Brownauthor=S.+O%E2%80%99Brienauthor=R.+Gabbasovauthor=L.+S.+Finkauthor=Y.+Liauthor=N.+Lounsburyauthor=M.+Abou-Gharbiaauthor=W.+E.+Childersauthor=D.+C.+Connollyauthor=J.+Chernoffauthor=J.+R.+Petersonauthor=J.+S.+Duncan&title=Resistance+to+BET+bromodomain+inhibitors+is+mediated+by+kinome+reprogramming+in+ovarian+cancer&doi=10.1016%2Fj.celrep.2016.06.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer</span></div><div class="casAuthors">Kurimchak, Alison M.; Shelton, Claude; Duncan, Kelly E.; Johnson, Katherine J.; Brown, Jennifer; O'Brien, Shane; Gabbasov, Rashid; Fink, Lauren S.; Li, Yuesheng; Lounsbury, Nicole; Abou-Gharbia, Magid; Childers, Wayne E.; Connolly, Denise C.; Chernoff, Jonathan; Peterson, Jeffrey R.; Duncan, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1273-1286</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Small-mol. BET bromodomain inhibitors (BETis) are actively being pursued in clin. trials for the treatment of a variety of cancers, but the mechanisms of resistance to BETis remain poorly understood.  Using a mass spectrometry approach that globally measures kinase signaling at the proteomic level, we evaluated the response of the kinome to targeted BETi treatment in a panel of BRD4-dependent ovarian carcinoma (OC) cell lines.  Despite initial inhibitory effects of BETi, OC cells acquired resistance following sustained treatment with the BETi JQ1.  Through application of multiplexed inhibitor beads (MIBs) and mass spectrometry, we demonstrate that BETi resistance is mediated by adaptive kinome reprogramming, where activation of compensatory pro-survival kinase networks overcomes BET protein inhibition.  Furthermore, drug combinations blocking these kinases may prevent or delay the development of drug resistance and enhance the efficacy of BETi therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPzs6AVtF-WbVg90H21EOLACvtfcHk0li236oZ2cnV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1CksrzP&md5=a6634682be95335e2616c94d123b1265</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.06.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.06.091%26sid%3Dliteratum%253Aachs%26aulast%3DKurimchak%26aufirst%3DA.%2BM.%26aulast%3DShelton%26aufirst%3DC.%26aulast%3DDuncan%26aufirst%3DK.%2BE.%26aulast%3DJohnson%26aufirst%3DK.%2BJ.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DGabbasov%26aufirst%3DR.%26aulast%3DFink%26aufirst%3DL.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLounsbury%26aufirst%3DN.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DConnolly%26aufirst%3DD.%2BC.%26aulast%3DChernoff%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26aulast%3DDuncan%26aufirst%3DJ.%2BS.%26atitle%3DResistance%2520to%2520BET%2520bromodomain%2520inhibitors%2520is%2520mediated%2520by%2520kinome%2520reprogramming%2520in%2520ovarian%2520cancer%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D16%26spage%3D1273%26epage%3D1286%26doi%3D10.1016%2Fj.celrep.2016.06.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Muralidharan, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhadury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. A.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4689</span><span class="NLM_x">–</span> <span class="NLM_lpage">4697</span><span class="refDoi"> DOI: 10.1038/onc.2015.521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1038%2Fonc.2015.521" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=4689-4697&author=S.+V.+Muralidharanauthor=J.+Bhaduryauthor=L.+M.+Nilssonauthor=L.+C.+Greenauthor=K.+G.+McLureauthor=J.+A.+Nilsson&title=BET+bromodomain+inhibitors+synergize+with+ATR+inhibitors+to+induce+DNA+damage%2C+apoptosis%2C+senescence-associated+secretory+pathway+and+ER+stress+in+Myc-induced+lymphoma+cells&doi=10.1038%2Fonc.2015.521"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.521%26sid%3Dliteratum%253Aachs%26aulast%3DMuralidharan%26aufirst%3DS.%2BV.%26aulast%3DBhadury%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DL.%2BM.%26aulast%3DGreen%26aufirst%3DL.%2BC.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DNilsson%26aufirst%3DJ.%2BA.%26atitle%3DBET%2520bromodomain%2520inhibitors%2520synergize%2520with%2520ATR%2520inhibitors%2520to%2520induce%2520DNA%2520damage%252C%2520apoptosis%252C%2520senescence-associated%2520secretory%2520pathway%2520and%2520ER%2520stress%2520in%2520Myc-induced%2520lymphoma%2520cells%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D4689%26epage%3D4697%26doi%3D10.1038%2Fonc.2015.521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Amorim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magarotto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leleu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morschhauser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broussais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herait, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahatt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokiec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucca, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieblemont, C.</span><span> </span><span class="NLM_article-title">Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study</span> <span class="citation_source-journal">Lancet Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e196</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1016/S2352-3026(16)00021-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2FS2352-3026%2816%2900021-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27063978" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=e196-204&author=S.+Amorimauthor=A.+Stathisauthor=M.+Gleesonauthor=S.+Iyengarauthor=V.+Magarottoauthor=X.+Leleuauthor=F.+Morschhauserauthor=L.+Karlinauthor=F.+Broussaisauthor=K.+Rezaiauthor=P.+Heraitauthor=C.+Kahattauthor=F.+Lokiecauthor=G.+Sallesauthor=T.+Faconauthor=A.+Palumboauthor=D.+Cunninghamauthor=E.+Zuccaauthor=C.+Thieblemont&title=Bromodomain+inhibitor+OTX015+in+patients+with+lymphoma+or+multiple+myeloma%3A+a+dose-escalation%2C+open-label%2C+pharmacokinetic%2C+phase+1+study&doi=10.1016%2FS2352-3026%2816%2900021-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2FS2352-3026%2816%2900021-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2352-3026%252816%252900021-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmorim%26aufirst%3DS.%26aulast%3DStathis%26aufirst%3DA.%26aulast%3DGleeson%26aufirst%3DM.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DMagarotto%26aufirst%3DV.%26aulast%3DLeleu%26aufirst%3DX.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DKarlin%26aufirst%3DL.%26aulast%3DBroussais%26aufirst%3DF.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DHerait%26aufirst%3DP.%26aulast%3DKahatt%26aufirst%3DC.%26aulast%3DLokiec%26aufirst%3DF.%26aulast%3DSalles%26aufirst%3DG.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DZucca%26aufirst%3DE.%26aulast%3DThieblemont%26aufirst%3DC.%26atitle%3DBromodomain%2520inhibitor%2520OTX015%2520in%2520patients%2520with%2520lymphoma%2520or%2520multiple%2520myeloma%253A%2520a%2520dose-escalation%252C%2520open-label%252C%2520pharmacokinetic%252C%2520phase%25201%2520study%26jtitle%3DLancet%2520Haematol.%26date%3D2016%26volume%3D3%26spage%3De196%26epage%3D204%26doi%3D10.1016%2FS2352-3026%2816%2900021-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Amarnath Praphakar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munusamy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadasivuni, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajan, M.</span><span> </span><span class="NLM_article-title">Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x">, </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2016.09.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=10.1016%2Fj.ijpharm.2016.09.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=27693734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Sjs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2016&pages=628-635&author=R.+Amarnath+Praphakarauthor=M.+A.+Munusamyauthor=K.+K.+Sadasivuniauthor=M.+Rajan&title=Targeted+delivery+of+rifampicin+to+tuberculosis-infected+macrophages%3A+design%2C+in-vitro%2C+and+in-vivo+performance+of+rifampicin-loaded+poly%28ester+amide%29s+nanocarriers&doi=10.1016%2Fj.ijpharm.2016.09.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers</span></div><div class="casAuthors">Amarnath Praphakar, Rajendran; Munusamy, Murugan A.; Sadasivuni, Kishor Kumar; Rajan, Mariappan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">628-635</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have developed a nano drug delivery system for the treatment of tuberculosis (TB) using rifampicin (RF) encapsulated in poly(ester amide)s nanoparticles (PEA-RF-NPs), which are biocompatible polymers.  In this study, biodegradable amino acid based poly(ester amide)s (PEAs) were synthesized by the poly condensation reaction and RF-loaded NPs were fabricated by the dialysis method.  The surface morphol. and in-vitro drug release efficiency were examd.  The effect of time and temp. on the cellular uptake of PEA-RF-NPs in NR8383 cells was evaluated.  Fluorescence microscopic results of PEA-RF-NPs from NR8383 cell lines suggest its potential application in treating TB.  The antibacterial activity of RF against Mycobacterium smegmatis was also evaluated.  Based on these results, this approach provides a new means for controlled and efficient release of RF using the PEA-NPs delivery system and is promising for the treatment of TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnJhfkg3lyULVg90H21EOLACvtfcHk0li236oZ2cnV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Sjs77L&md5=cb499632c63621bf06a4ba47aefb9a45</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2016.09.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2016.09.080%26sid%3Dliteratum%253Aachs%26aulast%3DAmarnath%2BPraphakar%26aufirst%3DR.%26aulast%3DMunusamy%26aufirst%3DM.%2BA.%26aulast%3DSadasivuni%26aufirst%3DK.%2BK.%26aulast%3DRajan%26aufirst%3DM.%26atitle%3DTargeted%2520delivery%2520of%2520rifampicin%2520to%2520tuberculosis-infected%2520macrophages%253A%2520design%252C%2520in-vitro%252C%2520and%2520in-vivo%2520performance%2520of%2520rifampicin-loaded%2520poly%2528ester%2520amide%2529s%2520nanocarriers%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2016%26volume%3D513%26spage%3D628%26epage%3D635%26doi%3D10.1016%2Fj.ijpharm.2016.09.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UW9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UW9','PDB','3UW9'); return false;">PDB: 3UW9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF','PDB','3MXF'); return false;">PDB: 3MXF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q','PDB','4Z1Q'); return false;">PDB: 4Z1Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BJX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BJX','PDB','4BJX'); return false;">PDB: 4BJX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGI','PDB','4OGI'); return false;">PDB: 4OGI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RKU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RKU','PDB','2RKU'); return false;">PDB: 2RKU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O76" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O76','PDB','4O76'); return false;">PDB: 4O76</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JI9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JI9','PDB','4JI9'); return false;">PDB: 4JI9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O77" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O77','PDB','4O77'); return false;">PDB: 4O77</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZS5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZS5','PDB','3ZS5'); return false;">PDB: 3ZS5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR4','PDB','4MR4'); return false;">PDB: 4MR4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MR6','PDB','4MR6'); return false;">PDB: 4MR6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4QB3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4QB3','PDB','4QB3'); return false;">PDB: 4QB3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OSS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OSS','PDB','2OSS'); return false;">PDB: 2OSS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EGU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EGU','PDB','5EGU'); return false;">PDB: 5EGU</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01761&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-11%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01761%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01761" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b41f88b0e32cd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
